sampleID	CDE_ID_3226963	_EVENT	_INTEGRATION	_OS	_OS_IND	_PANCAN_CNA_PANCAN_K8	_PANCAN_Cluster_Cluster_PANCAN	_PANCAN_DNAMethyl_PANCAN	_PANCAN_DNAMethyl_UCEC	_PANCAN_RPPA_PANCAN_K8	_PANCAN_UNC_RNAseq_PANCAN_K16	_PANCAN_miRNA_PANCAN	_PANCAN_mirna_UCEC	_PANCAN_mutation_PANCAN	_PATIENT	_RFS	_RFS_IND	_TIME_TO_EVENT	_anatomical_origin	_cohort	_primary_disease	additional_pharmaceutical_therapy	additional_radiation_therapy	additional_surgery_locoregional_procedure	additional_treatment_completion_success_outcome	age_at_initial_pathologic_diagnosis	aln_pos_ihc	aln_pos_light_micro	bcr_followup_barcode	birth_control_pill_history_usage_category	clinical_stage	colorectal_cancer	days_to_additional_surgery_metastatic_procedure	days_to_birth	days_to_collection	days_to_death	days_to_initial_pathologic_diagnosis	days_to_last_followup	days_to_last_known_alive	days_to_new_tumor_event_additional_surgery_procedure	days_to_new_tumor_event_after_initial_treatment	diabetes	disease_code	followup_case_report_form_submission_reason	form_completion_date	gender	height	histological_type	history_of_neoadjuvant_treatment	horm_ther	hypertension	icd_10	icd_o_3_histology	icd_o_3_site	informed_consent_verified	init_pathology_dx_method_other	initial_pathologic_diagnosis_method	initial_weight	is_ffpe	lost_follow_up	menopause_status	neoplasm_histologic_grade	new_neoplasm_event_occurrence_anatomic_site	new_neoplasm_event_type	new_neoplasm_occurrence_anatomic_site_text	new_tumor_event_additional_surgery_procedure	new_tumor_event_after_initial_treatment	oct_embedded	pathology_report_file_name	pct_tumor_invasion	percent_lymphocyte_infiltration_BOTTOM	percent_lymphocyte_infiltration_TOP	percent_monocyte_infiltration_BOTTOM	percent_monocyte_infiltration_TOP	percent_necrosis_BOTTOM	percent_necrosis_TOP	percent_neutrophil_infiltration_BOTTOM	percent_neutrophil_infiltration_TOP	percent_normal_cells_BOTTOM	percent_normal_cells_TOP	percent_stromal_cells_BOTTOM	percent_stromal_cells_TOP	percent_tumor_cells_BOTTOM	percent_tumor_cells_TOP	percent_tumor_nuclei_BOTTOM	percent_tumor_nuclei_TOP	peritoneal_wash	person_neoplasm_cancer_status	pln_pos_ihc	pln_pos_light_micro	postoperative_rx_tx	pregnancies	primary_therapy_outcome_success	prior_dx	prior_tamoxifen_administered_usage_category	project_code	radiation_therapy	recurrence_second_surgery_neoplasm_surgical_procedure_name	recurrence_second_surgery_neoplasm_surgical_procedure_name_other	residual_disease_post_new_tumor_event_margin_status	residual_tumor	sample_type	sample_type_id	surgical_approach	system_version	targeted_molecular_therapy	tissue_prospective_collection_indicator	tissue_retrospective_collection_indicator	tissue_source_site	total_aor_lnp	total_aor_lnr	total_pelv_lnp	total_pelv_lnr	tumor_tissue_site	vial_number	vital_status	weight	year_of_initial_pathologic_diagnosis	_GENOMIC_ID_TCGA_UCEC_exp_GAV2_exon	_GENOMIC_ID_TCGA_UCEC_PDMarrayCNV	_GENOMIC_ID_TCGA_UCEC_PDMRNAseqCNV	_GENOMIC_ID_TCGA_UCEC_exp_HiSeqV2	_GENOMIC_ID_TCGA_UCEC_miRNA_HiSeq	_GENOMIC_ID_TCGA_UCEC_gistic2	_GENOMIC_ID_TCGA_UCEC_PDMarray	_GENOMIC_ID_TCGA_UCEC_hMethyl27	_GENOMIC_ID_TCGA_UCEC_exp_GAV2	_GENOMIC_ID_TCGA_UCEC_hMethyl450	_GENOMIC_ID_TCGA_UCEC_RPPA	_GENOMIC_ID_TCGA_UCEC_miRNA_GA	_GENOMIC_ID_TCGA_UCEC_mutation_wustl_gene	_GENOMIC_ID_TCGA_UCEC_RPPA_RBN	_GENOMIC_ID_TCGA_UCEC_GSNP6raw	_GENOMIC_ID_TCGA_UCEC_PDMRNAseq	_GENOMIC_ID_TCGA_UCEC_exp_HiSeqV2_percentile	_GENOMIC_ID_TCGA_UCEC_mutation_broad_gene	_GENOMIC_ID_TCGA_UCEC_G4502A_07_3	_GENOMIC_ID_TCGA_UCEC_mutation	_GENOMIC_ID_TCGA_UCEC_GSNP6noCNV	_GENOMIC_ID_TCGA_UCEC_gistic2thd	_GENOMIC_ID_TCGA_UCEC_exp_HiSeqV2_PANCAN	_GENOMIC_ID_TCGA_UCEC_miRNA	_GENOMIC_ID_TCGA_UCEC_exp_HiSeqV2_exon
TCGA-2E-A9G8-01	Indeterminate	0	TCGA-2E-A9G8-01	1249	0										TCGA-2E-A9G8	396	1	1249	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	YES		Partial Response	59	0	0	TCGA-2E-A9G8-F66642	Never Used	Stage III	NO			957		0	1249			396	NO			2014-10-21	FEMALE	157	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.3	8380/3	C54.1	YES		Office Endometrial Biopsy	90	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2	Other, specify	Locoregional Recurrence	port site		YES	false	TCGA-2E-A9G8.921E6140-A03E-4FBD-9FB8-554AE96FD16C.pdf	280		10		0		5		0		0		15		80		80		TUMOR FREE	0	0	YES	2	Progressive Disease	Yes	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009		NO	YES	2E	0	9	0	19	Endometrial	A	LIVING	71	2011				8e9f2a41-dddc-4761-8883-ca58f5934d5f	TCGA-2E-A9G8-01A-11R-A404-13	TCGA-2E-A9G8-01A-11D-A402-01				TCGA-2E-A9G8-01A-11D-A409-05					18f505a8-5a1e-4325-a244-b3b5e372b5c0		8e9f2a41-dddc-4761-8883-ca58f5934d5f				18f505a8-5a1e-4325-a244-b3b5e372b5c0	TCGA-2E-A9G8-01A-11D-A402-01	8e9f2a41-dddc-4761-8883-ca58f5934d5f	TCGA-2E-A9G8-01A-11R-A404-13	8e9f2a41-dddc-4761-8883-ca58f5934d5f
TCGA-4E-A92E-01	MSS		TCGA-4E-A92E-01												TCGA-4E-A92E				Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma														90																							140	NO									false	TCGA-4E-A92E.BC43D6CA-235C-4217-BF72-F33B089C532B.pdf			40		20		5		20		0		15		80		80																Primary Tumor	01												A						TCGA-4E-A92E-01	87087b2e-a589-4a75-a005-2c61cb44b414	TCGA-4E-A92E-01A-11R-A37P-13	TCGA-4E-A92E-01A-11D-A37M-01				TCGA-4E-A92E-01A-11D-A37Q-05					790a9852-a659-4698-a203-265464faea21	TCGA-4E-A92E-01	87087b2e-a589-4a75-a005-2c61cb44b414				790a9852-a659-4698-a203-265464faea21	TCGA-4E-A92E-01A-11D-A37M-01	87087b2e-a589-4a75-a005-2c61cb44b414	TCGA-4E-A92E-01A-11R-A37P-13	87087b2e-a589-4a75-a005-2c61cb44b414
TCGA-5B-A90C-01	MSS	0	TCGA-5B-A90C-01	1116	0										TCGA-5B-A90C	517	1	1116	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	NO		Complete Response	69			TCGA-5B-A90C-F66754		Stage IA	NO		-25518	811		0	1116		517	517	NO			2014-10-23	FEMALE	158	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	50	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2	Other, specify	Locoregional Recurrence	right pelvic mass	YES	YES	false	TCGA-5B-A90C.608E2698-6A3A-4673-89D2-3BE98A74EBE5.pdf			60		20		10		20		0		10		80		80		TUMOR FREE		0	NO	2		No			YES	Excisional Biopsy				Primary Tumor	01	Minimally Invasive	2009		NO	YES	5B			0	42	Endometrial	A	LIVING	98	2011			TCGA-5B-A90C-01	4a299385-e7a5-4a82-940b-ff6e36c596c2	TCGA-5B-A90C-01A-11R-A37P-13	TCGA-5B-A90C-01A-11D-A37M-01				TCGA-5B-A90C-01A-11D-A37Q-05					c6b007c6-f193-4f00-9792-c7968bcc261e	TCGA-5B-A90C-01	4a299385-e7a5-4a82-940b-ff6e36c596c2				c6b007c6-f193-4f00-9792-c7968bcc261e	TCGA-5B-A90C-01A-11D-A37M-01	4a299385-e7a5-4a82-940b-ff6e36c596c2	TCGA-5B-A90C-01A-11R-A37P-13	4a299385-e7a5-4a82-940b-ff6e36c596c2
TCGA-5S-A9Q8-01	MSS	0	TCGA-5S-A9Q8-01	313	0										TCGA-5S-A9Q8	313	0	313	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					51			TCGA-5S-A9Q8-F64486		Stage IIIA	NO		-18785	103		0	313				YES			2014-9-4	FEMALE	162	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Excisional Biopsy	690	NO	NO		G2					NO	true	TCGA-5S-A9Q8.3F89A501-BE16-4E08-9846-41B4BBDDFCF9.pdf	50		2		0		3		0		2		5		90		90			0	0	YES	0	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	2009		YES	NO	5S		0	0	5	Endometrial	A	LIVING	86	2013				5eb217b7-bf79-475d-8476-a66670ad9ed2	TCGA-5S-A9Q8-01A-11R-A404-13	TCGA-5S-A9Q8-01A-11D-A402-01				TCGA-5S-A9Q8-01A-11D-A409-05					053be5c7-f81f-4c2f-9190-58db6f65b09e		5eb217b7-bf79-475d-8476-a66670ad9ed2				053be5c7-f81f-4c2f-9190-58db6f65b09e	TCGA-5S-A9Q8-01A-11D-A402-01	5eb217b7-bf79-475d-8476-a66670ad9ed2	TCGA-5S-A9Q8-01A-11R-A404-13	5eb217b7-bf79-475d-8476-a66670ad9ed2
TCGA-A5-A0G1-01	MSI-H	1	TCGA-A5-A0G1-01	3251	1	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 14	cluster 2		TCGA-A5-A0G1			3251	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					67	0	0	TCGA-A5-A0G1-F5839	Former User	Stage IA	NO		-24477	5015	3251	0					NO			2011-1-7	FEMALE	168	Serous endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	190	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	TCGA-A5-A0G1.A2EB7E85-E836-462E-ABBA-65D5110CEB1C.pdf	10	90	90	0	0	5	5	0	0	10	10	25	25	60	60	60	60		TUMOR FREE	0	0		3	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open		NO	NO	YES	A5	0	4	0	10	Endometrial	A	DECEASED	59	1996	c4bc1759-7de2-427c-a936-431f343ea929		TCGA-A5-A0G1-01		TCGA-A5-A0G1-01A-11R-A119-13	TCGA-A5-A0G1-01A-11D-A120-01			c4bc1759-7de2-427c-a936-431f343ea929	TCGA-A5-A0G1-01A-11D-A123-05	cd92c224-42a7-4cc0-bbef-fe688be73f3e			TCGA-A5-A0G1-01A-21-A162-20	2bf8abaf-8c88-4905-bbd6-9a16e80b2c18	TCGA-A5-A0G1-01					2bf8abaf-8c88-4905-bbd6-9a16e80b2c18	TCGA-A5-A0G1-01A-11D-A120-01		TCGA-A5-A0G1-01A-11R-A119-13	
TCGA-A5-A0G2-01	MSI-L	0	TCGA-A5-A0G2-01	4549	0	GBM	C6-UCEC	BRCA CIMP c7	cluster 1	BRCA basal-like c6	UCEC-like c11	miRNA cluster 13	cluster 2		TCGA-A5-A0G2	4549	0	4549	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	57	0	0	TCGA-A5-A0G2-F17136	Never Used	Stage IIIB	NO		-20953	4825		0	4549	4144			NO		Scheduled Follow-up Submission	2011-11-3	FEMALE	152	Serous endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	200	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-A5-A0G2.A3CD42AF-D356-415B-958D-D14D7AC52693.pdf		20	20	0	0	10	5	10	5	5	10	0	0	85	85	90	90		WITH TUMOR	0	0		4+	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open		NO	NO	YES	A5	0	0	0	0	Endometrial	A	LIVING	60	1997	4b998fee-a0c6-4039-824f-e5f43d5a3dbc	TCGA-A5-A0G2-01	TCGA-A5-A0G2-01			TCGA-A5-A0G2-01A-11D-A042-01	TCGA-A5-A0G2-01	TCGA-A5-A0G2-01A-11D-A039-05	4b998fee-a0c6-4039-824f-e5f43d5a3dbc		f1e8aa4e-0f31-4476-8be4-4284b284cc3a	TCGA-A5-A0G2-01A-11R-A041-13		TCGA-A5-A0G2-01A-21-A162-20	dec5f42a-e6ac-4af4-85b7-9e111eb33ad9	TCGA-A5-A0G2-01			TCGA-A5-A0G2-01A-11R-A040-07		dec5f42a-e6ac-4af4-85b7-9e111eb33ad9	TCGA-A5-A0G2-01A-11D-A042-01		TCGA-A5-A0G2-01A-11R-A041-13	
TCGA-A5-A0G3-01	MSS	0	TCGA-A5-A0G3-01	1428	0		C6-UCEC	UCEC Serous c4	cluster 3	KIRC-like c1	UCEC-like c11	miRNA cluster 15	cluster 2	mutation cluster 5	TCGA-A5-A0G3	1428	0	1428	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma		YES	NO	Progressive Disease	61	2	0	TCGA-A5-A0G3-F16785	Former User	Stage IIIC2	NO		-22421	987		0	1428			795	NO		Additional New Tumor Event	2011-10-3	FEMALE	165	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	230	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-A5-A0G3.66DEDB33-CA2C-4967-8074-1EFC1FC3CF29.pdf	50	0	0	0	0	5	20	0	0	0	0	0	0	95	80	90	90		WITH TUMOR	2	0		2	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open		YES	NO	YES	A5	2	2	2	3	Endometrial	A	LIVING	64	2007	cf384574-5895-4708-b29c-6906de020406						TCGA-A5-A0G3-01	TCGA-A5-A0G3-01A-11D-A039-05	cf384574-5895-4708-b29c-6906de020406		86cc5ef9-0d7d-4187-8002-cc774c70eeb1	TCGA-A5-A0G3-01A-11R-A041-13	TCGA-A5-A0G3-01A-11W-A062-09	TCGA-A5-A0G3-01A-21-A162-20	9a5539d4-bd00-4a7f-9fa1-b17adf7d20a2	TCGA-A5-A0G3-01		TCGA-A5-A0G3-01A-11W-A062-09	TCGA-A5-A0G3-01A-11R-A040-07	TCGA-A5-A0G3-01A-11W-A062-09	9a5539d4-bd00-4a7f-9fa1-b17adf7d20a2			TCGA-A5-A0G3-01A-11R-A041-13	
TCGA-A5-A0G5-01	MSI-L	0	TCGA-A5-A0G5-01	1126	0	High	C6-UCEC	UCEC non-CIMP c3	cluster 2	BRCA basal-like c6	UCEC-like c11	miRNA cluster 14	cluster 2	mutation cluster 5	TCGA-A5-A0G5	1126	0	1126	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	73	0	0	TCGA-A5-A0G5-F17153	Never Used	Stage IB	NO		-26827	856		0	1126				NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	160	Serous endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8310/3	C54.1	YES		Office Endometrial Biopsy	240	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-A5-A0G5.C7C6ABB1-32EE-4D2B-898A-91A1F596EC53.pdf		20	15	3	3	0	5	0	0	0	0	0	0	100	95	75	80	negative	TUMOR FREE	0	0		4+	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open		NO	NO	YES	A5	0	9	0	21	Endometrial	A	LIVING	48	2008	a7ed680c-2af2-47a1-846a-2169f7dd0971	TCGA-A5-A0G5-01	TCGA-A5-A0G5-01			TCGA-A5-A0G5-01A-11D-A042-01	TCGA-A5-A0G5-01	TCGA-A5-A0G5-01A-11D-A039-05	a7ed680c-2af2-47a1-846a-2169f7dd0971		105c061d-b8cc-4224-ba49-bbb94112091e	TCGA-A5-A0G5-01A-11R-A041-13	TCGA-A5-A0G5-01A-11W-A062-09	TCGA-A5-A0G5-01A-21-A162-20	83db59b6-adb3-4c1b-b11e-7717a0a23515	TCGA-A5-A0G5-01		TCGA-A5-A0G5-01A-11W-A062-09	TCGA-A5-A0G5-01A-11R-A040-07	TCGA-A5-A0G5-01A-11W-A062-09	83db59b6-adb3-4c1b-b11e-7717a0a23515	TCGA-A5-A0G5-01A-11D-A042-01		TCGA-A5-A0G5-01A-11R-A041-13	
TCGA-A5-A0G9-01	MSI-H	0	TCGA-A5-A0G9-01	2540	0	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 4	TCGA-A5-A0G9	2540	0	2540	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	79	0	0	TCGA-A5-A0G9-F17142	Never Used	Stage IB	NO		-29122	2095		0	2540				NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	172	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	210	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-A5-A0G9.32FB682E-B73F-4525-A845-7F240F9F40CE.pdf	70	0	0	0	0	0	0	0	0	0	0	0	0	100	100	85	85	negative	TUMOR FREE	0	0		0	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	A5	0	5	0	7	Endometrial	A	LIVING	82	2004	4575ca5e-968c-419d-9707-4e99d55dddb7		TCGA-A5-A0G9-01			TCGA-A5-A0G9-01A-11D-A042-01		TCGA-A5-A0G9-01A-11D-A039-05	4575ca5e-968c-419d-9707-4e99d55dddb7		807ac87f-d82c-4f87-8014-4414e40d4a0b	TCGA-A5-A0G9-01A-11R-A041-13	TCGA-A5-A0G9-01A-11W-A062-09	TCGA-A5-A0G9-01A-21-A162-20	f366864d-3985-4bff-9b68-c9e842f800cf	TCGA-A5-A0G9-01		TCGA-A5-A0G9-01A-11W-A062-09		TCGA-A5-A0G9-01A-11W-A062-09	f366864d-3985-4bff-9b68-c9e842f800cf	TCGA-A5-A0G9-01A-11D-A042-01		TCGA-A5-A0G9-01A-11R-A041-13	
TCGA-A5-A0GA-01	MSI-H	1	TCGA-A5-A0GA-01	543	1	Iq	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 4	cluster 2	mutation cluster 1	TCGA-A5-A0GA			543	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					67	0	3	TCGA-A5-A0GA-F3146	Former User	Stage IIIC2	NO		-24659	1312	543	0					NO			2010-9-13	FEMALE	170	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	320	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	TCGA-A5-A0GA.36A4F391-2F46-4896-8E53-223202E42A38.pdf	46	0	0	0	0	0	0	0	0	0	0	10	20	90	80	85	75		WITH TUMOR	0	3		1	Partial Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open		YES	NO	YES	A5	3	3	3	3	Endometrial	A	DECEASED	90	2006	e2aee7fd-1c60-471a-931d-878805f4a443	TCGA-A5-A0GA-01	TCGA-A5-A0GA-01			TCGA-A5-A0GA-01A-11D-A042-01	TCGA-A5-A0GA-01	TCGA-A5-A0GA-01A-11D-A039-05	e2aee7fd-1c60-471a-931d-878805f4a443		4fcec56d-45ce-420a-868b-3726f1cc9347	TCGA-A5-A0GA-01A-11R-A041-13	TCGA-A5-A0GA-01A-11W-A062-09	TCGA-A5-A0GA-01A-21-A162-20	a3c7e2b8-d140-4f6e-b338-46b893d020cc	TCGA-A5-A0GA-01		TCGA-A5-A0GA-01A-11W-A062-09	TCGA-A5-A0GA-01A-11R-A040-07	TCGA-A5-A0GA-01A-11W-A062-09	a3c7e2b8-d140-4f6e-b338-46b893d020cc	TCGA-A5-A0GA-01A-11D-A042-01		TCGA-A5-A0GA-01A-11R-A041-13	
TCGA-A5-A0GB-01	MSI-H	0	TCGA-A5-A0GB-01	997	0	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11			mutation cluster 11	TCGA-A5-A0GB	997	0	997	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	65	0	0	TCGA-A5-A0GB-F17157	Never Used	Stage IB	NO		-23883	583		0	997				NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	190	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-A5-A0GB.8AC80DBE-46DE-46D5-B900-C807CBE941A6.pdf		0	0	0	0	0	0	0	0	0	0	0	0	100	100	90	90		TUMOR FREE	0	0		4+	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	1995	NO	NO	YES	A5	0	10	0	5	Endometrial	A	LIVING	122	2008	12960b87-9d83-41e5-8980-a1ebe955fd73	TCGA-A5-A0GB-01	TCGA-A5-A0GB-01		TCGA-A5-A0GB-01A-11R-A041-13	TCGA-A5-A0GB-01A-11D-A042-01	TCGA-A5-A0GB-01	TCGA-A5-A0GB-01A-11D-A039-05	12960b87-9d83-41e5-8980-a1ebe955fd73		3e2e3076-d429-48e0-8eb2-4021717bedb3		TCGA-A5-A0GB-01A-11W-A062-09	TCGA-A5-A0GB-01A-21-A162-20	3d7029a2-c02b-4420-a8fa-fa31db8e879e	TCGA-A5-A0GB-01		TCGA-A5-A0GB-01A-11W-A062-09	TCGA-A5-A0GB-01A-11R-A040-07	TCGA-A5-A0GB-01A-11W-A062-09	3d7029a2-c02b-4420-a8fa-fa31db8e879e	TCGA-A5-A0GB-01A-11D-A042-01		TCGA-A5-A0GB-01A-11R-A041-13	
TCGA-A5-A0GD-01	MSI-H	1	TCGA-A5-A0GD-01	3423	1	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-A5-A0GD	3423	0	3423	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	75	0	0	TCGA-A5-A0GD-F17139	Never Used	Stage IA	NO		-27399	4119	3423	0	98				NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	170	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	TCGA-A5-A0GD.44561792-F2F8-42F7-B697-5D7752F8430E.pdf		0	0	0	0	0	0	0	0	0	0	0	0	100	100	85	80	negative	TUMOR FREE	0	0		4+	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	A5	0	3	0	9	Endometrial	A	DECEASED	74	1999	7e36dab1-7cb0-42df-acfc-615f7c0bba2c		TCGA-A5-A0GD-01			TCGA-A5-A0GD-01A-11D-A042-01		TCGA-A5-A0GD-01A-11D-A039-05	7e36dab1-7cb0-42df-acfc-615f7c0bba2c		f1a29822-a75f-46f5-acad-6a8c99d7b543	TCGA-A5-A0GD-01A-11R-A041-13	TCGA-A5-A0GD-01A-11W-A062-09	TCGA-A5-A0GD-01A-21-A162-20	bf292c6a-f8a6-4ace-9bd0-af6e73b12423	TCGA-A5-A0GD-01		TCGA-A5-A0GD-01A-11W-A062-09		TCGA-A5-A0GD-01A-11W-A062-09	bf292c6a-f8a6-4ace-9bd0-af6e73b12423	TCGA-A5-A0GD-01A-11D-A042-01		TCGA-A5-A0GD-01A-11R-A041-13	
TCGA-A5-A0GE-01	MSS	0	TCGA-A5-A0GE-01	3205	0	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 2	mutation cluster 14	TCGA-A5-A0GE	3205	0	3205	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	38	0	0	TCGA-A5-A0GE-F17140	Never Used	Stage IA	NO		-14170	2941		0	3205				NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	155	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	200	NO		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2					NO	true	TCGA-A5-A0GE.7686A445-554F-43EF-BE79-6EA5E5C4DB21.pdf		60	60	0	0	10	5	30	30	10	10	5	5	75	80	85	85		TUMOR FREE	0	0		1	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open		NO	NO	YES	A5	0	5	0	3	Endometrial	A	LIVING	57	2002	34294f7a-7f80-443c-854e-5fe22b4391e0	TCGA-A5-A0GE-01	TCGA-A5-A0GE-01			TCGA-A5-A0GE-01A-11D-A042-01	TCGA-A5-A0GE-01	TCGA-A5-A0GE-01A-11D-A039-05	34294f7a-7f80-443c-854e-5fe22b4391e0		cffa7bd4-5310-4035-8ada-943d90fc2344	TCGA-A5-A0GE-01A-11R-A041-13	TCGA-A5-A0GE-01A-11W-A062-09	TCGA-A5-A0GE-01A-21-A162-20	eb4758c7-e66f-423e-9942-d5161fb48256	TCGA-A5-A0GE-01		TCGA-A5-A0GE-01A-11W-A062-09	TCGA-A5-A0GE-01A-11R-A040-07	TCGA-A5-A0GE-01A-11W-A062-09	eb4758c7-e66f-423e-9942-d5161fb48256	TCGA-A5-A0GE-01A-11D-A042-01		TCGA-A5-A0GE-01A-11R-A041-13	
TCGA-A5-A0GG-01	MSI-H	0	TCGA-A5-A0GG-01	2656	0	BRCA-LUAD+	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 4		TCGA-A5-A0GG	2656	0	2656	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	76	0	0	TCGA-A5-A0GG-F17141	Never Used	Stage IA	NO		-27809	2369		0	2656				NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	220	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	TCGA-A5-A0GG.6867E576-1020-41D7-BC18-25160FE17F81.pdf	10	0	0	0	0	0	0	0	0	30	20	10	0	60	80	50	70		TUMOR FREE	0	0		4+	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open		NO	NO	YES	A5	0	2	0	13	Endometrial	A	LIVING	64	2003	88e9cdc4-bcf1-49e9-8965-7dc6b3688585		TCGA-A5-A0GG-01		TCGA-A5-A0GG-01A-11R-A119-13	TCGA-A5-A0GG-01A-11D-A120-01			88e9cdc4-bcf1-49e9-8965-7dc6b3688585	TCGA-A5-A0GG-01A-11D-A123-05	b9da4be2-52b2-4824-a299-8e0d9b3e91e4			TCGA-A5-A0GG-01A-21-A163-20	3b04b800-b5e0-4864-93e2-e27957b8f119	TCGA-A5-A0GG-01					3b04b800-b5e0-4864-93e2-e27957b8f119	TCGA-A5-A0GG-01A-11D-A120-01		TCGA-A5-A0GG-01A-11R-A119-13	
TCGA-A5-A0GH-01	MSI-H	0	TCGA-A5-A0GH-01	2254	0	Quiet	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	COADREAD-like c15	miRNA cluster 13	cluster 2	mutation c1uster 10	TCGA-A5-A0GH	2254	0	2254	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	57	0	0	TCGA-A5-A0GH-F17143	Former User	Stage IA	NO		-21090	2256		0	2254				NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	230	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-A5-A0GH.8E29A939-5581-4176-B19E-14076F17726B.pdf	33	20	20	0	0	20	10	10	10	5	10	0	0	75	80	95	90		TUMOR FREE	0	0		0	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	A5	0		0		Endometrial	A	LIVING	55	2004	ec3e03af-251e-497f-8cb4-b05816df2e12	TCGA-A5-A0GH-01	TCGA-A5-A0GH-01			TCGA-A5-A0GH-01A-21D-A042-01	TCGA-A5-A0GH-01	TCGA-A5-A0GH-01A-21D-A039-05	ec3e03af-251e-497f-8cb4-b05816df2e12		0893b82f-1b83-470d-b60f-6200e66e10f7	TCGA-A5-A0GH-01A-21R-A041-13	TCGA-A5-A0GH-01A-21W-A062-09	TCGA-A5-A0GH-01A-11-A162-20	3f8f1c66-bd17-4350-ac20-8533d090efab	TCGA-A5-A0GH-01		TCGA-A5-A0GH-01A-21W-A062-09	TCGA-A5-A0GH-01A-21R-A040-07	TCGA-A5-A0GH-01A-21W-A062-09	3f8f1c66-bd17-4350-ac20-8533d090efab	TCGA-A5-A0GH-01A-21D-A042-01		TCGA-A5-A0GH-01A-21R-A041-13	
TCGA-A5-A0GI-01	MSI-H	0	TCGA-A5-A0GI-01	1750	0	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 4	TCGA-A5-A0GI			1750	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					63	0	0	TCGA-A5-A0GI-F4922	Never Used	Stage IA	NO		-23195	1779		0	1750				NO			2010-12-15	FEMALE	168	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	130	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2						true	TCGA-A5-A0GI.F1D23669-8247-4727-8D38-BD444C16FAAE.pdf	19	1	1	0	0	0	0	0	0	0	0	0	0	100	100	90	90		TUMOR FREE	0	0		2	Complete Remission/Response	Yes	Never Used		YES				R0	Primary Tumor	01	open		NO	NO	YES	A5	0	1	0	6	Endometrial	A	LIVING	66	2005	ccf469e7-f403-4661-b5c4-e3ea020901b5		TCGA-A5-A0GI-01			TCGA-A5-A0GI-01A-11D-A042-01		TCGA-A5-A0GI-01A-11D-A039-05	ccf469e7-f403-4661-b5c4-e3ea020901b5		604b177e-903c-4cc5-ae62-6e473ff21eaf	TCGA-A5-A0GI-01A-11R-A041-13	TCGA-A5-A0GI-01A-11W-A062-09	TCGA-A5-A0GI-01A-21-A162-20	a891df8a-bfe4-4327-8472-be99146e8934	TCGA-A5-A0GI-01				TCGA-A5-A0GI-01A-11W-A062-09	a891df8a-bfe4-4327-8472-be99146e8934	TCGA-A5-A0GI-01A-11D-A042-01		TCGA-A5-A0GI-01A-11R-A041-13	
TCGA-A5-A0GJ-01	MSS	0	TCGA-A5-A0GJ-01	2000	0	High	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-A5-A0GJ	2000	0	2000	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	NO	YES	Complete Response	44	0	0	TCGA-A5-A0GJ-F17144	Former User	Stage IA	NO	12	-16421	1708		0	2000			12	NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	220	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	TCGA-A5-A0GJ.83743C19-A9FF-42F0-947E-5697709151C5.pdf	0	10	10	0	0	30	10	15	5	0	30	0	0	70	60	100	70		TUMOR FREE	0	0		1	Complete Remission/Response	No	Never Used		NO	Surgical Resection		R0	R0	Primary Tumor	01	open		YES	NO	YES	A5	0	3	0	4	Endometrial	A	LIVING	115	2005	2b483617-1fc6-4809-b15c-d48d687ca3b8		TCGA-A5-A0GJ-01			TCGA-A5-A0GJ-01A-11D-A042-01		TCGA-A5-A0GJ-01A-11D-A039-05	2b483617-1fc6-4809-b15c-d48d687ca3b8		ae211cf8-6f17-463c-9f5f-dc177fa3c373	TCGA-A5-A0GJ-01A-11R-A041-13	TCGA-A5-A0GJ-01A-11W-A062-09	TCGA-A5-A0GJ-01A-21-A162-20	2e874eaf-a718-4948-a70d-cc9361c253a5	TCGA-A5-A0GJ-01		TCGA-A5-A0GJ-01A-11W-A062-09		TCGA-A5-A0GJ-01A-11W-A062-09	2e874eaf-a718-4948-a70d-cc9361c253a5	TCGA-A5-A0GJ-01A-11D-A042-01		TCGA-A5-A0GJ-01A-11R-A041-13	
TCGA-A5-A0GM-01	MSS	0	TCGA-A5-A0GM-01	1841	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 4	TCGA-A5-A0GM	1841	0	1841	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	53	0	0	TCGA-A5-A0GM-F17150	Former User	Stage IA	NO		-19452	1518		0	1841				NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	360	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	TCGA-A5-A0GM.4AAFF034-45D3-4F4F-A283-262BA641D03A.pdf	49	1	1	0	0	0	0	0	0	5	10	0	0	95	90	90	85		TUMOR FREE	0	0		2	Complete Remission/Response	Yes	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	A5	0	0	0	5	Endometrial	A	LIVING	97	2006	75da1901-49d7-4a96-b195-6e38625898e5	TCGA-A5-A0GM-01	TCGA-A5-A0GM-01			TCGA-A5-A0GM-01A-11D-A042-01	TCGA-A5-A0GM-01	TCGA-A5-A0GM-01A-11D-A039-05	75da1901-49d7-4a96-b195-6e38625898e5		2245e2d9-a240-4577-a231-7034d705cf82	TCGA-A5-A0GM-01A-11R-A041-13	TCGA-A5-A0GM-01A-11W-A062-09	TCGA-A5-A0GM-01A-21-A162-20	10fcfb6e-7b2f-4b17-b9aa-d505dd948180	TCGA-A5-A0GM-01		TCGA-A5-A0GM-01A-11W-A062-09	TCGA-A5-A0GM-01A-11R-A040-07	TCGA-A5-A0GM-01A-11W-A062-09	10fcfb6e-7b2f-4b17-b9aa-d505dd948180	TCGA-A5-A0GM-01A-11D-A042-01		TCGA-A5-A0GM-01A-11R-A041-13	
TCGA-A5-A0GN-01	MSS	0	TCGA-A5-A0GN-01	1841	0	BRCA-LUAD+	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11			mutation cluster 4	TCGA-A5-A0GN	1841	0	1841	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	65	0	0	TCGA-A5-A0GN-F17151	Never Used	Stage IB	NO		-24020	1354		0	1841				NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	164	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	340	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	TCGA-A5-A0GN.7A76BDC7-62D9-4A8D-AAEF-CECF9F819D58.pdf	56	1	1	0	0	0	0	0	0	0	0	0	0	100	100	80	80		TUMOR FREE	0	0		2	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open		NO	NO	YES	A5	0	0	0	5	Endometrial	A	LIVING	68	2006	53a3dd36-866d-4c44-9b79-b9f9564996b3		TCGA-A5-A0GN-01		TCGA-A5-A0GN-01A-11R-A041-13	TCGA-A5-A0GN-01A-11D-A042-01		TCGA-A5-A0GN-01A-11D-A039-05	53a3dd36-866d-4c44-9b79-b9f9564996b3		5622d6d1-dc8d-41ec-9088-6ada060749c4		TCGA-A5-A0GN-01A-11W-A062-09	TCGA-A5-A0GN-01A-21-A162-20	dad78f03-11e7-4f04-acc4-915cbd9e9822	TCGA-A5-A0GN-01		TCGA-A5-A0GN-01A-11W-A062-09		TCGA-A5-A0GN-01A-11W-A062-09	dad78f03-11e7-4f04-acc4-915cbd9e9822	TCGA-A5-A0GN-01A-11D-A042-01		TCGA-A5-A0GN-01A-11R-A041-13	
TCGA-A5-A0GP-01	MSS	0	TCGA-A5-A0GP-01	1416	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 2		UCEC-like c11	miRNA cluster 13	cluster 3	mutation cluster 11	TCGA-A5-A0GP	1416	0	1416	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	58	0	0	TCGA-A5-A0GP-F17152	Never Used	Stage IA	NO		-21365	1030		0	1416				NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	160	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	TCGA-A5-A0GP.A730192C-227E-4A86-96B9-8670D3F5EF59.pdf		1	1	0	0	0	0	0	0	0	0	0	0	100	100	90	90		TUMOR FREE	0	0		2	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	A5	0	1	0	1	Endometrial	A	LIVING	60	2007	0ac50ce8-8c72-4b83-98c3-6efdb138d7a1	TCGA-A5-A0GP-01	TCGA-A5-A0GP-01			TCGA-A5-A0GP-01A-11D-A042-01	TCGA-A5-A0GP-01	TCGA-A5-A0GP-01A-11D-A039-05	0ac50ce8-8c72-4b83-98c3-6efdb138d7a1			TCGA-A5-A0GP-01A-11R-A041-13	TCGA-A5-A0GP-01A-11W-A062-09		6966dd35-3294-4db0-a3ca-4c7c60d8fa9c	TCGA-A5-A0GP-01			TCGA-A5-A0GP-01A-11R-A040-07	TCGA-A5-A0GP-01A-11W-A062-09	6966dd35-3294-4db0-a3ca-4c7c60d8fa9c	TCGA-A5-A0GP-01A-11D-A042-01		TCGA-A5-A0GP-01A-11R-A041-13	
TCGA-A5-A0GQ-01	MSS	0	TCGA-A5-A0GQ-01	1167	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 12	TCGA-A5-A0GQ			1167	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					76	0	0	TCGA-A5-A0GQ-F5826	Never Used	Stage IB	NO		-28078	1022		0	1167				NO			2011-1-7	FEMALE	150	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	140	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1						true	TCGA-A5-A0GQ.7B57FD81-AA42-4C76-BF65-0BA2B3451065.pdf	50	20	35	5	20	3	5	30	25	0	0	92	25	5	70	2	70		TUMOR FREE	0	0		2		No	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	A5	0	0	0	2	Endometrial	A	LIVING	57	2007	2386cca4-1d9d-490e-b188-c0e266952a5f		TCGA-A5-A0GQ-01		TCGA-A5-A0GQ-01A-11R-A119-13	TCGA-A5-A0GQ-01A-11D-A120-01			2386cca4-1d9d-490e-b188-c0e266952a5f	TCGA-A5-A0GQ-01A-11D-A123-05	35256b27-92b1-4905-9571-7269212e85a6		TCGA-A5-A0GQ-01A-11D-A122-09	TCGA-A5-A0GQ-01A-21-A162-20	e21627e9-b15c-4dee-8f8c-64bdb820291b	TCGA-A5-A0GQ-01		TCGA-A5-A0GQ-01A-11D-A122-09		TCGA-A5-A0GQ-01A-11D-A122-09	e21627e9-b15c-4dee-8f8c-64bdb820291b	TCGA-A5-A0GQ-01A-11D-A120-01		TCGA-A5-A0GQ-01A-11R-A119-13	
TCGA-A5-A0GR-01	MSS	0	TCGA-A5-A0GR-01	1120	0	Squamous	C6-UCEC	Cluster 5	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 6		TCGA-A5-A0GR	1120	0	1120	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	69	0	0	TCGA-A5-A0GR-F17155	Never Used	Stage IA	NO		-25353	632		0	1120				YES		Scheduled Follow-up Submission	2011-10-3	FEMALE	177	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	160	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	TCGA-A5-A0GR.009B5049-74B7-49B8-8B64-28184A3ACA2B.pdf	10	40	35	2	20	10	10	2	25	0	0	75	30	15	60	8	70		TUMOR FREE	0	0		1	Complete Remission/Response	No	Former User		NO				R0	Primary Tumor	01	open		NO	NO	YES	A5	0	3	0	0	Endometrial	A	LIVING	88	2008	10b2b797-1ddd-4ef8-b0e7-38f96fb06f57		TCGA-A5-A0GR-01		TCGA-A5-A0GR-01A-11R-A119-13	TCGA-A5-A0GR-01A-11D-A120-01			10b2b797-1ddd-4ef8-b0e7-38f96fb06f57	TCGA-A5-A0GR-01A-11D-A123-05	2f6c92af-8f69-4f30-b8dd-d752a11df831			TCGA-A5-A0GR-01A-21-A162-20	7b0a6186-9413-4936-8256-34c49be49893	TCGA-A5-A0GR-01					7b0a6186-9413-4936-8256-34c49be49893	TCGA-A5-A0GR-01A-11D-A120-01		TCGA-A5-A0GR-01A-11R-A119-13	
TCGA-A5-A0GU-01	MSS	0	TCGA-A5-A0GU-01	860	0	Iq	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 14	TCGA-A5-A0GU	860	0	860	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	58	0	0	TCGA-A5-A0GU-F17158	Never Used	Stage IA	NO		-21192	471		0	860				NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	190	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	TCGA-A5-A0GU.B284E409-4AC1-45E5-9133-39659987D7F9.pdf	18	4	25	3	20	10	10	1	20	0	0	8	30	82	60	90	70		TUMOR FREE	0	0		2	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	A5	0	0	0	10	Endometrial	A	LIVING	95	2009	95ea81fa-025d-4338-94db-ec7024562d8f	TCGA-A5-A0GU-01	TCGA-A5-A0GU-01			TCGA-A5-A0GU-01A-11D-A042-01	TCGA-A5-A0GU-01	TCGA-A5-A0GU-01A-11D-A039-05	95ea81fa-025d-4338-94db-ec7024562d8f		5bd1cbd7-ef39-4774-8a6a-3badd82989f0	TCGA-A5-A0GU-01A-11R-A041-13	TCGA-A5-A0GU-01A-11W-A062-09	TCGA-A5-A0GU-01A-21-A162-20	a6390e2c-1c1d-426b-8b31-e1f9275ec35b	TCGA-A5-A0GU-01		TCGA-A5-A0GU-01A-11W-A062-09	TCGA-A5-A0GU-01A-11R-A040-07	TCGA-A5-A0GU-01A-11W-A062-09	a6390e2c-1c1d-426b-8b31-e1f9275ec35b	TCGA-A5-A0GU-01A-11D-A042-01		TCGA-A5-A0GU-01A-11R-A041-13	
TCGA-A5-A0GV-01	MSS	0	TCGA-A5-A0GV-01	633	0	BRCA-LUAD+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 4	TCGA-A5-A0GV	633	0	633	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	NO	YES	NO	Complete Response	67	0	0	TCGA-A5-A0GV-F17159	Former User	Stage IA	NO		-24540			0	633			304	NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	158	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO																				negative	TUMOR FREE	0	0		4+	Complete Remission/Response	No	Never Used		NO	Other Method, Specify Below	Locoregional		R0	Primary Tumor	01	open		NO	NO	YES	A5	0	0	0	21	Endometrial		LIVING	63	2009	e1c80dfd-3db5-4005-9bb5-245124d4dc0f		TCGA-A5-A0GV-01			TCGA-A5-A0GV-01A-31D-A042-01		TCGA-A5-A0GV-01A-31D-A039-05	e1c80dfd-3db5-4005-9bb5-245124d4dc0f		c86e0866-3f2c-4364-91f3-ba8602f13866	TCGA-A5-A0GV-01A-31R-A041-13	TCGA-A5-A0GV-01A-31W-A062-09	TCGA-A5-A0GV-01A-21-A162-20	d2a7f16e-74cf-4587-bf74-48460c10c88a	TCGA-A5-A0GV-01		TCGA-A5-A0GV-01A-31W-A062-09		TCGA-A5-A0GV-01A-31W-A062-09	d2a7f16e-74cf-4587-bf74-48460c10c88a	TCGA-A5-A0GV-01A-31D-A042-01		TCGA-A5-A0GV-01A-31R-A041-13	
TCGA-A5-A0GW-01	MSI-H	0	TCGA-A5-A0GW-01	706	0	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 4	mutation cluster 2	TCGA-A5-A0GW	706	0	706	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	46	0	0	TCGA-A5-A0GW-F17162	Never Used	Stage IA	NO		-17092	302		0	706				YES		Scheduled Follow-up Submission	2011-10-3	FEMALE	142	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	160	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-A5-A0GW.0EE4FD56-D0BA-43E8-A434-CD86B21F21BF.pdf	7	0	0	0	0	0	0	0	0	0	0	0	0	100	100	90	90		TUMOR FREE	0	0		0	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open		NO	NO	YES	A5	0	5	0	4	Endometrial	A	LIVING	49	2009	1e4969e5-6bf8-4b8d-970e-96f4424356a8		TCGA-A5-A0GW-01			TCGA-A5-A0GW-01A-11D-A042-01		TCGA-A5-A0GW-01A-11D-A039-05	1e4969e5-6bf8-4b8d-970e-96f4424356a8		f6bce3d4-f521-491c-ae2e-978bd90b9cad	TCGA-A5-A0GW-01A-11R-A041-13	TCGA-A5-A0GW-01A-11W-A062-09	TCGA-A5-A0GW-01A-21-A162-20	38217ac9-e4ca-4bd7-be8a-09288c9871ef	TCGA-A5-A0GW-01		TCGA-A5-A0GW-01A-11W-A062-09		TCGA-A5-A0GW-01A-11W-A062-09	38217ac9-e4ca-4bd7-be8a-09288c9871ef	TCGA-A5-A0GW-01A-11D-A042-01		TCGA-A5-A0GW-01A-11R-A041-13	
TCGA-A5-A0GX-01	MSS	0	TCGA-A5-A0GX-01	2088	0	Iq	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 4	mutation cluster 4	TCGA-A5-A0GX	2088	0	2088	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	53	0	0	TCGA-A5-A0GX-F17145	Never Used	Stage IA	NO		-19625	1654		0	2088				NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	164	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	250	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	TCGA-A5-A0GX.AE5229ED-8906-4D55-9B11-4E8E214D6446.pdf	10	0	0	0	0	0	0	0	0	10	10	0	0	90	90	85	85		TUMOR FREE	0	0		1	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open		NO	NO	YES	A5	0	0	0	0	Endometrial	A	LIVING	108	2005	d98e99e1-ee3e-4427-90ec-24e624aa1b46		TCGA-A5-A0GX-01			TCGA-A5-A0GX-01A-11D-A042-01		TCGA-A5-A0GX-01A-11D-A039-05	d98e99e1-ee3e-4427-90ec-24e624aa1b46		8abb876d-f6cd-4120-9949-8aa46323b51b	TCGA-A5-A0GX-01A-11R-A041-13	TCGA-A5-A0GX-01A-11W-A062-09	TCGA-A5-A0GX-01A-21-A162-20	b9d16a4a-0d31-4763-9eb4-a8405c1a3f3d	TCGA-A5-A0GX-01		TCGA-A5-A0GX-01A-11W-A062-09		TCGA-A5-A0GX-01A-11W-A062-09	b9d16a4a-0d31-4763-9eb4-a8405c1a3f3d	TCGA-A5-A0GX-01A-11D-A042-01		TCGA-A5-A0GX-01A-11R-A041-13	
TCGA-A5-A0R6-01	MSS	0	TCGA-A5-A0R6-01	607	0	Squamous	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 2	mutation cluster 3	TCGA-A5-A0R6	607	0	607	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	64	0	0	TCGA-A5-A0R6-F17163	Never Used	Stage IIIC1	NO		-23449	259		0	607				NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	157	Serous endometrial adenocarcinoma	No		NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	200	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-A5-A0R6.2F8BAD18-8A37-4F1A-A1BA-31494035E05F.pdf	82	30	30	15	15	10	10	25	35	10	0	5	20	75	70	75	70		TUMOR FREE	0	1		2	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open		YES	NO	YES	A5	0	3	1	17	Endometrial	A	LIVING	68	2009	20977188-9019-4672-a435-760abd19ee5b		TCGA-A5-A0R6-01			TCGA-A5-A0R6-01A-11D-A102-01		TCGA-A5-A0R6-01A-11D-A10Q-05	20977188-9019-4672-a435-760abd19ee5b		353d2d07-37fd-40ec-9d30-d608ab218149	TCGA-A5-A0R6-01A-11R-A103-13	TCGA-A5-A0R6-01A-11D-A10B-09	TCGA-A5-A0R6-01A-21-A163-20	9c208bbc-f4a6-45ac-90ee-643b6e091488	TCGA-A5-A0R6-01		TCGA-A5-A0R6-01A-11D-A10B-09		TCGA-A5-A0R6-01A-11D-A10B-09	9c208bbc-f4a6-45ac-90ee-643b6e091488	TCGA-A5-A0R6-01A-11D-A102-01		TCGA-A5-A0R6-01A-11R-A103-13	
TCGA-A5-A0R7-01	MSS	0	TCGA-A5-A0R7-01	535	0	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 2	mutation cluster 3	TCGA-A5-A0R7	535	0	535	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	55	0	0	TCGA-A5-A0R7-F17164		Stage IA	NO		-20250	173		0	535				NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	290	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	TCGA-A5-A0R7.3BBA7591-082A-44CE-829F-23D16A91772D.pdf	40	40	40	10	30	0	5	20	30	0	0	30	25	70	70	70	70		TUMOR FREE	0	0		0	Complete Remission/Response	No			NO				R0	Primary Tumor	01	open		NO	NO	YES	A5	0	8	0	8	Endometrial	A	LIVING	136	2010	0824e6ac-f3f0-4b71-81a3-7ee671a256eb		TCGA-A5-A0R7-01			TCGA-A5-A0R7-01A-31D-A102-01		TCGA-A5-A0R7-01A-31D-A10Q-05	0824e6ac-f3f0-4b71-81a3-7ee671a256eb		819982ff-44f4-47ca-8897-9718955eca98	TCGA-A5-A0R7-01A-31R-A103-13	TCGA-A5-A0R7-01A-31D-A10B-09	TCGA-A5-A0R7-01A-21-A162-20	73e10359-86a1-467f-8881-3d524c47690b	TCGA-A5-A0R7-01		TCGA-A5-A0R7-01A-31D-A10B-09		TCGA-A5-A0R7-01A-31D-A10B-09	73e10359-86a1-467f-8881-3d524c47690b	TCGA-A5-A0R7-01A-31D-A102-01		TCGA-A5-A0R7-01A-31R-A103-13	
TCGA-A5-A0R8-01	MSS	0	TCGA-A5-A0R8-01	596	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-A5-A0R8	596	0	596	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	NO	YES	YES	Complete Response	81	0	0	TCGA-A5-A0R8-F17165	Never Used	Stage IB	NO	66	-29777	155		0	596			42	NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	180	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	TCGA-A5-A0R8.CA537524-B83F-4AC5-B721-38570E5B21BB.pdf	57	30	30	30	20	10	5	30	30	0	0	20	20	70	75	70	75		TUMOR FREE	0	0		0	Complete Remission/Response	No	Never Used		YES	Surgical Resection		R0	R0	Primary Tumor	01	open		NO	NO	YES	A5	0	0	0	7	Endometrial	A	LIVING	62	2010	414c904a-29d0-44d0-bceb-ce7d024f1a58		TCGA-A5-A0R8-01			TCGA-A5-A0R8-01A-11D-A102-01		TCGA-A5-A0R8-01A-11D-A10Q-05	414c904a-29d0-44d0-bceb-ce7d024f1a58		9c6ec7cc-4e83-4de9-b194-f83829765c1d	TCGA-A5-A0R8-01A-11R-A103-13	TCGA-A5-A0R8-01A-11D-A10B-09	TCGA-A5-A0R8-01A-21-A163-20	1b77b17c-0182-46c2-a820-d909a8f00144	TCGA-A5-A0R8-01		TCGA-A5-A0R8-01A-11D-A10B-09		TCGA-A5-A0R8-01A-11D-A10B-09	1b77b17c-0182-46c2-a820-d909a8f00144	TCGA-A5-A0R8-01A-11D-A102-01		TCGA-A5-A0R8-01A-11R-A103-13	
TCGA-A5-A0R9-01	MSS	0	TCGA-A5-A0R9-01	749	0	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 4	TCGA-A5-A0R9	749	0	749	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	51	0	0	TCGA-A5-A0R9-F17161	Never Used	Stage IA	NO		-18982	471		0	749				NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	270	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	TCGA-A5-A0R9.0AAD58D4-7865-4235-AE18-8685DC5F4FE1.pdf	49	0	0	0	0	0	0	0	0	0	0	5	0	95	100	95	98		TUMOR FREE	0	0		1	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	1995	NO	NO	YES	A5	0	0	0	4	Endometrial	A	LIVING	145	2009	d4ab800e-e0c4-40ae-8256-7271d22d1470		TCGA-A5-A0R9-01			TCGA-A5-A0R9-01A-11D-A102-01		TCGA-A5-A0R9-01A-11D-A10Q-05	d4ab800e-e0c4-40ae-8256-7271d22d1470		3b00efd8-7548-464c-879b-67da5d69f15c	TCGA-A5-A0R9-01A-11R-A103-13	TCGA-A5-A0R9-01A-11D-A10B-09	TCGA-A5-A0R9-01A-21-A163-20	2a41f58a-9c92-4fb0-9bea-a9ed3432b3d2	TCGA-A5-A0R9-01		TCGA-A5-A0R9-01A-11D-A10B-09		TCGA-A5-A0R9-01A-11D-A10B-09	2a41f58a-9c92-4fb0-9bea-a9ed3432b3d2	TCGA-A5-A0R9-01A-11D-A102-01		TCGA-A5-A0R9-01A-11R-A103-13	
TCGA-A5-A0RA-01	MSS	0	TCGA-A5-A0RA-01	884	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 2	mutation cluster 4	TCGA-A5-A0RA	884	0	884	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	68	0	0	TCGA-A5-A0RA-F17160	Never Used	Stage IB	NO		-25060	492		0	884				NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	155	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	270	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	TCGA-A5-A0RA.EB6E4309-9CE1-468A-A94B-907874BDE9DE.pdf	75	20	30	20	20	10	5	40	30	0	5	5	20	85	70	80	70		TUMOR FREE	0	0		1	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open		NO	NO	YES	A5	0	0	0	6	Endometrial	A	LIVING	113	2009	7a051ecb-ad2d-4c98-8b91-96b66110a46e		TCGA-A5-A0RA-01			TCGA-A5-A0RA-01A-21D-A102-01		TCGA-A5-A0RA-01A-21D-A10Q-05	7a051ecb-ad2d-4c98-8b91-96b66110a46e		83a77885-4d57-487b-ae02-bb38572e0e44	TCGA-A5-A0RA-01A-21R-A103-13	TCGA-A5-A0RA-01A-21D-A10B-09	TCGA-A5-A0RA-01A-11-A163-20	669db125-d541-470b-8d42-7bf84a85a0e5	TCGA-A5-A0RA-01		TCGA-A5-A0RA-01A-21D-A10B-09		TCGA-A5-A0RA-01A-21D-A10B-09	669db125-d541-470b-8d42-7bf84a85a0e5	TCGA-A5-A0RA-01A-21D-A102-01		TCGA-A5-A0RA-01A-21R-A103-13	
TCGA-A5-A0VO-01	MSS	0	TCGA-A5-A0VO-01	364	0		C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 2	mutation cluster 1	TCGA-A5-A0VO	364	0	364	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	64	0	0	TCGA-A5-A0VO-F17168	Former User	Stage IB	NO		-23547	133		0	364				NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	320	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	TCGA-A5-A0VO.6ABBA2C9-8920-4785-BFAB-40E560D2DBE6.pdf	64	20	0	0	0	10	0	20	0	20	0	0	10	70	90	70	70		TUMOR FREE	0	0		2	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open		NO	NO	YES	A5	0	4	0	5	Endometrial	A	LIVING	86	2010	b07b341a-32ba-4863-b202-6fae769d1dd2								b07b341a-32ba-4863-b202-6fae769d1dd2	TCGA-A5-A0VO-01A-21D-A10A-05	5d42c10d-e328-4165-961d-cf8eee9efbe1	TCGA-A5-A0VO-01A-21R-A108-13	TCGA-A5-A0VO-01A-21D-A10G-09	TCGA-A5-A0VO-01A-11-A163-20		TCGA-A5-A0VO-01		TCGA-A5-A0VO-01A-21D-A10G-09		TCGA-A5-A0VO-01A-21D-A10G-09				TCGA-A5-A0VO-01A-21R-A108-13	
TCGA-A5-A0VP-01	MSI-H	0	TCGA-A5-A0VP-01	1288	0	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 6	mutation cluster 11	TCGA-A5-A0VP	1288	0	1288	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	74	0	0	TCGA-A5-A0VP-F17166	Never Used	Stage IA	NO		-27335	930		0	1288				NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	210	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-A5-A0VP.960B26D6-F9BA-4099-B6F4-6D1DEA6C0F0F.pdf		10	20	0	0	10	20	10	20	0	0	0	0	90	80	100	100		TUMOR FREE	0	0		0	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open		NO	NO	YES	A5	0	0	0	14	Endometrial	A	LIVING	58	2008	65e557db-24de-47df-827c-d8336cb099eb		TCGA-A5-A0VP-01			TCGA-A5-A0VP-01A-21D-A102-01		TCGA-A5-A0VP-01A-21D-A10Q-05	65e557db-24de-47df-827c-d8336cb099eb		82add7f4-facd-40df-a2f0-fac4dcfeb876	TCGA-A5-A0VP-01A-21R-A103-13	TCGA-A5-A0VP-01A-21D-A10B-09	TCGA-A5-A0VP-01A-11-A163-20	ac7c90ef-ead8-4540-becb-4fcbd0143542	TCGA-A5-A0VP-01				TCGA-A5-A0VP-01A-21D-A10B-09	ac7c90ef-ead8-4540-becb-4fcbd0143542	TCGA-A5-A0VP-01A-21D-A102-01		TCGA-A5-A0VP-01A-21R-A103-13	
TCGA-A5-A0VQ-01	MSI-H	0	TCGA-A5-A0VQ-01	485	0	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 4	TCGA-A5-A0VQ	485	0	485	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	62	0	0	TCGA-A5-A0VQ-F17167		Stage IA	NO		-22995	133		0	485				NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	158	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	320	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-A5-A0VQ.6FE81DF0-D9DF-420F-8A91-40421175A12F.pdf	36	20	10	0	0	10	10	10	10	20	0	10	10	60	80	70	90		TUMOR FREE	0	0		4+	Complete Remission/Response	No			YES				R0	Primary Tumor	01	open		YES	NO	YES	A5	0	12	0	12	Endometrial	A	LIVING	89	2010	e8b8fe3e-29ff-4f1a-af7a-d12b8cd5560d		TCGA-A5-A0VQ-01			TCGA-A5-A0VQ-01A-11D-A102-01		TCGA-A5-A0VQ-01A-11D-A10Q-05	e8b8fe3e-29ff-4f1a-af7a-d12b8cd5560d		9e0707c4-cbb5-4afd-8528-fb9f95ec5a91	TCGA-A5-A0VQ-01A-11R-A103-13	TCGA-A5-A0VQ-01A-11D-A10B-09	TCGA-A5-A0VQ-01A-21-A163-20	0f426ffa-23af-4c80-b580-6c00e76badc9	TCGA-A5-A0VQ-01		TCGA-A5-A0VQ-01A-11D-A10B-09		TCGA-A5-A0VQ-01A-11D-A10B-09	0f426ffa-23af-4c80-b580-6c00e76badc9	TCGA-A5-A0VQ-01A-11D-A102-01		TCGA-A5-A0VQ-01A-11R-A103-13	
TCGA-A5-A1OF-01	MSI-H	0	TCGA-A5-A1OF-01	241	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 2		TCGA-A5-A1OF	241	0	241	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	47	0	0	TCGA-A5-A1OF-F14493	Never Used	Stage IA	NO		-17308	128		0	241				NO		Scheduled Follow-up Submission	2011-8-1	FEMALE	155	Mixed serous and endometrioid	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	210	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	High Grade					NO	true	TCGA-A5-A1OF.C0A753A3-5202-4DD2-948E-2921AFBCB3BC.pdf	13		30		0		20		10		0		10		70		90		TUMOR FREE	0	0		4+	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	2009	NO	YES	NO	A5	0	3	0	4	Endometrial	A	LIVING	70	2010	56fa9065-a4cd-435b-941b-d4507aef815b		TCGA-A5-A1OF-01		TCGA-A5-A1OF-01A-11R-A14C-13	TCGA-A5-A1OF-01A-11D-A14F-01			56fa9065-a4cd-435b-941b-d4507aef815b	TCGA-A5-A1OF-01A-11D-A14H-05				TCGA-A5-A1OF-01A-21-A18Q-20	8309f142-36d4-42d8-998b-e4ef3cf0a3f6	TCGA-A5-A1OF-01					8309f142-36d4-42d8-998b-e4ef3cf0a3f6	TCGA-A5-A1OF-01A-11D-A14F-01		TCGA-A5-A1OF-01A-11R-A14C-13	
TCGA-A5-A1OG-01	MSS	0	TCGA-A5-A1OG-01	348	0	High	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 2	cluster 2		TCGA-A5-A1OG	337	1	348	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	NO	NO	Progressive Disease	65	0	4	TCGA-A5-A1OG-F14462	Never Used	Stage IIIC2	NO		-23956	223		0	348			337	YES		Scheduled Follow-up Submission	2011-8-1	FEMALE	158	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	190	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Lung	Metastatic			YES	true	TCGA-A5-A1OG.7BE01FDF-C4CF-471E-B395-8D7C4531CD6F.pdf	70		10		0		20		10		0		30		50		70		WITH TUMOR	0	3		2	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	2009	YES	YES	NO	A5	4	4	3	3	Endometrial	A	LIVING	64	2010	f501c084-03d5-48ad-b365-085773a7bd2d		TCGA-A5-A1OG-01		TCGA-A5-A1OG-01A-11R-A14C-13	TCGA-A5-A1OG-01A-11D-A14F-01			f501c084-03d5-48ad-b365-085773a7bd2d	TCGA-A5-A1OG-01A-11D-A14H-05				TCGA-A5-A1OG-01A-21-A18Q-20	3e66c95e-de64-48ca-9e71-a619e7312102	TCGA-A5-A1OG-01					3e66c95e-de64-48ca-9e71-a619e7312102	TCGA-A5-A1OG-01A-11D-A14F-01		TCGA-A5-A1OG-01A-11R-A14C-13	
TCGA-A5-A1OH-01	MSS	0	TCGA-A5-A1OH-01	539	0	High		UCEC Serous c4		KIRC-like c1		miRNA c1uster 9			TCGA-A5-A1OH	539	0	539	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	86	0	0	TCGA-A5-A1OH-F33809	Former User	Stage IIIA	NO		-31451	358		0	539				NO			2012-8-3	FEMALE	155	Serous endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	200	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-A5-A1OH.AAF1B591-1A0D-48D2-BF59-95B0D605950A.pdf	100		1		1		10		0		0		0		90		95	positive	TUMOR FREE	0	0	YES	4+	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	2009		NO	YES	A5	0	0	0	0	Endometrial	A	LIVING	59	2010			TCGA-A5-A1OH-01	303036f4-8c7a-484d-8458-8db4803ad6b5	TCGA-A5-A1OH-01A-21R-A22I-13	TCGA-A5-A1OH-01A-21D-A227-01				TCGA-A5-A1OH-01A-21D-A22B-05				TCGA-A5-A1OH-01A-32-A23Z-20	9a7e9567-dd88-43e4-a3d9-fd73a59c75ab	TCGA-A5-A1OH-01	303036f4-8c7a-484d-8458-8db4803ad6b5				9a7e9567-dd88-43e4-a3d9-fd73a59c75ab	TCGA-A5-A1OH-01A-21D-A227-01	303036f4-8c7a-484d-8458-8db4803ad6b5	TCGA-A5-A1OH-01A-21R-A22I-13	303036f4-8c7a-484d-8458-8db4803ad6b5
TCGA-A5-A1OJ-01	MSS	0	TCGA-A5-A1OJ-01	292	0	Iq	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1		TCGA-A5-A1OJ	292	0	292	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	31	0	0	TCGA-A5-A1OJ-F14491	Former User	Stage IA	NO		-11635			0	292				NO		Scheduled Follow-up Submission	2011-8-1	FEMALE	155	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure				Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2					NO			10																		TUMOR FREE	0	0		0	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	YES	NO	A5	0	0	0	17	Endometrial		LIVING	94	2010	adddccb0-d276-4450-a8cf-aef663a6f45c		TCGA-A5-A1OJ-01		TCGA-A5-A1OJ-01A-11R-A14C-13	TCGA-A5-A1OJ-01A-11D-A14F-01			adddccb0-d276-4450-a8cf-aef663a6f45c	TCGA-A5-A1OJ-01A-11D-A14H-05				TCGA-A5-A1OJ-01A-21-A18Q-20	da574f39-0486-4c3b-9a4c-48b8ccae9c70	TCGA-A5-A1OJ-01					da574f39-0486-4c3b-9a4c-48b8ccae9c70	TCGA-A5-A1OJ-01A-11D-A14F-01		TCGA-A5-A1OJ-01A-11R-A14C-13	
TCGA-A5-A1OK-01	MSS	0	TCGA-A5-A1OK-01	244	0	Iq	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 5	cluster 4		TCGA-A5-A1OK	244	0	244	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	63	0	0	TCGA-A5-A1OK-F14471	Former User	Stage IIIA	NO		-23179	113		0	244				YES		Scheduled Follow-up Submission	2011-8-1	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	250	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-A5-A1OK.1B0C95FC-7AA7-4F82-807D-85C579B6BF74.pdf	100		40		20		5		20		0		15		80		80		TUMOR FREE	0	0		0	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	2009	YES	YES	NO	A5	0	3	0	13	Endometrial	A	LIVING	87	2010	f26a449d-f3c6-4968-a2f7-4708a5686707		TCGA-A5-A1OK-01		TCGA-A5-A1OK-01A-11R-A14L-13	TCGA-A5-A1OK-01A-11D-A14J-01			f26a449d-f3c6-4968-a2f7-4708a5686707	TCGA-A5-A1OK-01A-11D-A14N-05				TCGA-A5-A1OK-01A-21-A18Q-20	73e3aa3b-86cd-43af-9dab-4a71e4164d25	TCGA-A5-A1OK-01					73e3aa3b-86cd-43af-9dab-4a71e4164d25	TCGA-A5-A1OK-01A-11D-A14J-01		TCGA-A5-A1OK-01A-11R-A14L-13	
TCGA-A5-A2K2-01	MSS	0	TCGA-A5-A2K2-01	2769	0	Squamous		UCEC non-CIMP c3				miRNA cluster 14			TCGA-A5-A2K2	2769	0	2769	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	77	0	0	TCGA-A5-A2K2-F17191	Former User	Stage IA	NO		-28456	2812		0	2769				NO		Scheduled Follow-up Submission	2011-10-4	FEMALE	155	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	70	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-A5-A2K2.D8065FA8-DC0E-4F1C-8FA4-5D8A567AC24C.pdf	49		1		1		5		3		0		15		80		80		TUMOR FREE	0	0		0	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	2009	YES	NO	YES	A5	0	0	0	6	Endometrial	A	LIVING	50	2003			TCGA-A5-A2K2-01	4341d180-bcb4-47e5-83b4-df5ecc4f7eec	TCGA-A5-A2K2-01A-11R-A18L-13	TCGA-A5-A2K2-01A-11D-A18N-01				TCGA-A5-A2K2-01A-11D-A18O-05					6b1acda5-81bd-4e5f-afc6-0be0707cf8d1	TCGA-A5-A2K2-01	4341d180-bcb4-47e5-83b4-df5ecc4f7eec				6b1acda5-81bd-4e5f-afc6-0be0707cf8d1	TCGA-A5-A2K2-01A-11D-A18N-01	4341d180-bcb4-47e5-83b4-df5ecc4f7eec	TCGA-A5-A2K2-01A-11R-A18L-13	4341d180-bcb4-47e5-83b4-df5ecc4f7eec
TCGA-A5-A2K3-01	MSI-H	0	TCGA-A5-A2K3-01	1409	0	High		BRCA CIMP c7		BRCA basal-like c6		miRNA cluster 5			TCGA-A5-A2K3	1409	0	1409	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	68	0	0	TCGA-A5-A2K3-F17199	Never Used	Stage IA	NO		-24907	1431		0	1409				NO		Scheduled Follow-up Submission	2011-10-4	FEMALE	160	Serous endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	120	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-A5-A2K3.D38D2FD4-78EF-4F49-976E-529055A6D9A9.pdf	0		3		1		5		0		0		5		90		85		TUMOR FREE	0	0		4+	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	2009	YES	NO	YES	A5	0	0	0	9	Endometrial	A	LIVING	80	2007			TCGA-A5-A2K3-01	ef76bd16-f313-4d92-8040-44e7068958a7	TCGA-A5-A2K3-01A-11R-A17X-13	TCGA-A5-A2K3-01A-11D-A17U-01				TCGA-A5-A2K3-01A-11D-A17Z-05				TCGA-A5-A2K3-01A-21-A18Q-20	9c4e6cb0-0b50-42fb-b5c4-0763c1938bf5	TCGA-A5-A2K3-01	ef76bd16-f313-4d92-8040-44e7068958a7				9c4e6cb0-0b50-42fb-b5c4-0763c1938bf5	TCGA-A5-A2K3-01A-11D-A17U-01	ef76bd16-f313-4d92-8040-44e7068958a7	TCGA-A5-A2K3-01A-11R-A17X-13	ef76bd16-f313-4d92-8040-44e7068958a7
TCGA-A5-A2K4-01	MSI-L	1	TCGA-A5-A2K4-01	871	1	Squamous		UCEC Serous c4		UCEC-like c5		miRNA cluster 14			TCGA-A5-A2K4	528	1	871	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	NO	NO	Complete Response	69	0	0	TCGA-A5-A2K4-F17269	Former User	Stage IIIA	NO		-25270	849	871	0				528	NO		Scheduled Follow-up Submission	2011-10-6	FEMALE	168	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Tumor resection	140	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Metastatic	Bowel		YES	true	TCGA-A5-A2K4.CB29CD1C-584B-42EA-BF1D-11B6DF8EA756.pdf	53		10		4		5		1		0		10		85		75		WITH TUMOR	0	0		3	Complete Remission/Response	No	Never Used		NO				R1	Primary Tumor	01	open	2009	YES	NO	YES	A5	0	0	0	0	Endometrial	A	DECEASED	51	2009			TCGA-A5-A2K4-01	586c18a6-7278-4200-9d64-20b2c7ccbc60	TCGA-A5-A2K4-01A-11R-A18L-13	TCGA-A5-A2K4-01A-11D-A18N-01				TCGA-A5-A2K4-01A-11D-A18O-05				TCGA-A5-A2K4-01A-21-A23Z-20	04d6b736-2227-427f-aa84-0121aedeac9d	TCGA-A5-A2K4-01	586c18a6-7278-4200-9d64-20b2c7ccbc60				04d6b736-2227-427f-aa84-0121aedeac9d	TCGA-A5-A2K4-01A-11D-A18N-01	586c18a6-7278-4200-9d64-20b2c7ccbc60	TCGA-A5-A2K4-01A-11R-A18L-13	586c18a6-7278-4200-9d64-20b2c7ccbc60
TCGA-A5-A2K5-01	MSS	0	TCGA-A5-A2K5-01	162	0	Quiet		UCEC CIMP c18		UCEC-like c5		miRNA c1uster 10			TCGA-A5-A2K5	162	0	162	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					76	0	0	TCGA-A5-A2K5-F17196	Never Used	Stage IA	NO		-28057	171		0	162				YES		Scheduled Follow-up Submission	2011-10-4	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	290	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-A5-A2K5.FF305857-5814-4815-90D3-B54BAA0DACB4.pdf	49		5		3		5		0		0		20		75		90			0	0		1		No	Never Used		YES				R0	Primary Tumor	01	open	2009	NO	YES	NO	A5	0	0	0	4	Endometrial	A	LIVING	127	2011			TCGA-A5-A2K5-01	98327e51-9e30-4d72-a4b1-19b62b4d3cd2	TCGA-A5-A2K5-01A-11R-A17X-13	TCGA-A5-A2K5-01A-11D-A17U-01				TCGA-A5-A2K5-01A-11D-A17Z-05				TCGA-A5-A2K5-01A-21-A18R-20	9f5d4a76-d517-48c9-9ce1-f26895c147af	TCGA-A5-A2K5-01	98327e51-9e30-4d72-a4b1-19b62b4d3cd2				9f5d4a76-d517-48c9-9ce1-f26895c147af	TCGA-A5-A2K5-01A-11D-A17U-01	98327e51-9e30-4d72-a4b1-19b62b4d3cd2	TCGA-A5-A2K5-01A-11R-A17X-13	98327e51-9e30-4d72-a4b1-19b62b4d3cd2
TCGA-A5-A2K7-01	MSI-H	0	TCGA-A5-A2K7-01	157	0	Quiet		UCEC CIMP c18		UCEC-like c5		miRNA cluster 5			TCGA-A5-A2K7	157	0	157	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	41	0	0	TCGA-A5-A2K7-F19645		Stage II	NO		-14980	195		0	157				YES		Scheduled Follow-up Submission	2011-12-19	FEMALE	157	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	170	NO		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3					NO	true	TCGA-A5-A2K7.1880F604-34C9-4B58-92DC-D67C7E656E3B.pdf	50		1		0		0		0		0		25		75		85		TUMOR FREE	0	0		3	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	2009	YES	YES	NO	A5	0	7	0	11	Endometrial	A	LIVING	72	2011			TCGA-A5-A2K7-01	7f9fd176-6826-4472-bf00-89632783b629	TCGA-A5-A2K7-01A-11R-A17X-13	TCGA-A5-A2K7-01A-11D-A17U-01				TCGA-A5-A2K7-01A-11D-A17Z-05				TCGA-A5-A2K7-01A-21-A18R-20	125e0e90-0e11-4c0a-af73-3d74a89b02cd	TCGA-A5-A2K7-01	7f9fd176-6826-4472-bf00-89632783b629				125e0e90-0e11-4c0a-af73-3d74a89b02cd	TCGA-A5-A2K7-01A-11D-A17U-01	7f9fd176-6826-4472-bf00-89632783b629	TCGA-A5-A2K7-01A-11R-A17X-13	7f9fd176-6826-4472-bf00-89632783b629
TCGA-A5-A3LO-01	MSS	0	TCGA-A5-A3LO-01	223	0	Squamous		UCEC non-CIMP c3		squamous c3		miRNA cluster 5			TCGA-A5-A3LO	223	0	223	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	64	0	0	TCGA-A5-A3LO-F29474		Stage IB	NO		-23401	182		0	223				NO		Scheduled Follow-up Submission	2012-3-19	FEMALE	168	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	160	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-A5-A3LO.2AB1F28D-151D-4AFE-807A-9F98B48C51CE.pdf	65		0		0		0		0		0		15		85		75	negative	TUMOR FREE	0	0		2	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	2009	YES	YES	NO	A5	0	6	0	7	Endometrial	A	LIVING	103	2011			TCGA-A5-A3LO-01	70a9e739-6f24-44b7-97cc-7197097a4f83	TCGA-A5-A3LO-01A-11R-A22I-13	TCGA-A5-A3LO-01A-11D-A227-01				TCGA-A5-A3LO-01A-11D-A22B-05				TCGA-A5-A3LO-01A-21-A23Z-20	03e5e936-8b9e-42c0-9eab-e8d598e64513	TCGA-A5-A3LO-01	70a9e739-6f24-44b7-97cc-7197097a4f83				03e5e936-8b9e-42c0-9eab-e8d598e64513	TCGA-A5-A3LO-01A-11D-A227-01	70a9e739-6f24-44b7-97cc-7197097a4f83	TCGA-A5-A3LO-01A-11R-A22I-13	70a9e739-6f24-44b7-97cc-7197097a4f83
TCGA-A5-A3LP-01	MSS	0	TCGA-A5-A3LP-01	455	0	High		UCEC Serous c4		BRCA basal-like c6		miRNA cluster 4			TCGA-A5-A3LP	455	0	455	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	74	0	0	TCGA-A5-A3LP-F43459	Former User	Stage IB	NO		-27131	111		0	455				NO		Scheduled Follow-up Submission	2013-5-22	FEMALE	159	Serous endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	150	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-A5-A3LP.A20CDB07-D90C-42B7-AE0A-254E27C6153B.pdf	90		0		0		0		0		0		0		100		75	negative	TUMOR FREE	0	0	YES	2	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	YES	YES	NO	A5	0	0	0	6	Endometrial	A	LIVING	46	2011			TCGA-A5-A3LP-01	5359ca45-0d86-43b9-b318-adbee53c7381	TCGA-A5-A3LP-01A-11R-A22I-13	TCGA-A5-A3LP-01A-11D-A227-01				TCGA-A5-A3LP-01A-11D-A22B-05				TCGA-A5-A3LP-01A-21-A23Z-20	42bb894c-2eb0-44ff-9cce-e9733fc7a6ca	TCGA-A5-A3LP-01	5359ca45-0d86-43b9-b318-adbee53c7381				42bb894c-2eb0-44ff-9cce-e9733fc7a6ca	TCGA-A5-A3LP-01A-11D-A227-01	5359ca45-0d86-43b9-b318-adbee53c7381	TCGA-A5-A3LP-01A-11R-A22I-13	5359ca45-0d86-43b9-b318-adbee53c7381
TCGA-A5-A7WJ-01	MSI-H		TCGA-A5-A7WJ-01												TCGA-A5-A7WJ				Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma														439																							140	NO									true	TCGA-A5-A7WJ.402A6ED4-B9EC-43A0-B47C-A0B95282678D.pdf			40		20		10		20		0		20		70		70																Primary Tumor	01												A						TCGA-A5-A7WJ-01	382f8e3e-6414-4bfd-81de-fa4260be7ede	TCGA-A5-A7WJ-01A-12R-A34O-13	TCGA-A5-A7WJ-01A-12D-A34P-01				TCGA-A5-A7WJ-01A-12D-A34S-05					57d44505-85c9-4d30-b750-4209cb109550	TCGA-A5-A7WJ-01	382f8e3e-6414-4bfd-81de-fa4260be7ede				57d44505-85c9-4d30-b750-4209cb109550	TCGA-A5-A7WJ-01A-12D-A34P-01	382f8e3e-6414-4bfd-81de-fa4260be7ede	TCGA-A5-A7WJ-01A-12R-A34O-13	382f8e3e-6414-4bfd-81de-fa4260be7ede
TCGA-A5-A7WK-01	MSS		TCGA-A5-A7WK-01												TCGA-A5-A7WK				Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma														253																							160	NO									true	TCGA-A5-A7WK.9101DD17-9216-4526-9A87-8C4E94B1F435.pdf			40		20		10		20		0		10		80		80																Primary Tumor	01												A						TCGA-A5-A7WK-01	e2c72ce3-f010-4f7f-832b-6277b8409f87	TCGA-A5-A7WK-01A-11R-A34O-13	TCGA-A5-A7WK-01A-11D-A34P-01				TCGA-A5-A7WK-01A-11D-A34S-05					989d3607-7b92-4edc-ae0e-946161bae5ac	TCGA-A5-A7WK-01	e2c72ce3-f010-4f7f-832b-6277b8409f87				989d3607-7b92-4edc-ae0e-946161bae5ac	TCGA-A5-A7WK-01A-11D-A34P-01	e2c72ce3-f010-4f7f-832b-6277b8409f87	TCGA-A5-A7WK-01A-11R-A34O-13	e2c72ce3-f010-4f7f-832b-6277b8409f87
TCGA-A5-AB3J-01	MSS		TCGA-A5-AB3J-01												TCGA-A5-AB3J				Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma														126																							210	NO									true	TCGA-A5-AB3J.41CDFB48-33A6-4FCD-97CA-30C73A9E6FED.pdf			5		0		0		0		30		10		60		60																Primary Tumor	01												A							8cda2390-3a6c-422e-b827-5c62c015f020	TCGA-A5-AB3J-01A-11R-A404-13	TCGA-A5-AB3J-01A-11D-A402-01				TCGA-A5-AB3J-01A-11D-A409-05					2c1a247e-d950-4ff5-8906-3c29541d9fcf		8cda2390-3a6c-422e-b827-5c62c015f020				2c1a247e-d950-4ff5-8906-3c29541d9fcf	TCGA-A5-AB3J-01A-11D-A402-01	8cda2390-3a6c-422e-b827-5c62c015f020	TCGA-A5-AB3J-01A-11R-A404-13	8cda2390-3a6c-422e-b827-5c62c015f020
TCGA-AJ-A23M-01	MSS	0	TCGA-AJ-A23M-01	36	0	High	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 5	mutation cluster 3	TCGA-AJ-A23M			36	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					61					Stage II			-22430	274		0	36							2011-7-14	FEMALE	152	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES			90	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	TCGA-AJ-A23M.B9651546-290B-405B-8275-24C8A53A10A3.pdf			60		10		10		20		0		30		60		60	positive			0				No								Primary Tumor	01	open	2009		NO	YES	AJ		0		4	Endometrial	A	LIVING	141	2010	9cde3009-e59c-4a08-bd85-e3f5ab521d41		TCGA-AJ-A23M-01		TCGA-AJ-A23M-01A-11R-A156-13	TCGA-AJ-A23M-01A-11D-A160-01			9cde3009-e59c-4a08-bd85-e3f5ab521d41	TCGA-AJ-A23M-01A-11D-A161-05			TCGA-AJ-A23M-01A-11D-A159-09	TCGA-AJ-A23M-01A-21-A18R-20	b614c02d-24ad-40c8-b5dd-19ba38d31c46	TCGA-AJ-A23M-01				TCGA-AJ-A23M-01A-11D-A159-09	b614c02d-24ad-40c8-b5dd-19ba38d31c46	TCGA-AJ-A23M-01A-11D-A160-01		TCGA-AJ-A23M-01A-11R-A156-13	
TCGA-AJ-A23N-01	MSS	1	TCGA-AJ-A23N-01	439	1	High		UCEC Serous c4		OV-like c4		miRNA cluster 14			TCGA-AJ-A23N	439	0	439	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Progressive Disease	70			TCGA-AJ-A23N-F47000	Former User	Stage IIIA	NO		-25772		439	0	33				NO			2013-8-21	FEMALE		Serous endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	YES	C54.1	8441/3	C54.1	YES		Cytology (e.g. Peritoneal or pleural fluid)			NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO			27																	negative	WITH TUMOR			YES	2	Progressive Disease	No	Never Used		YES				R2	Primary Tumor	01		2009		YES	NO	AJ		0		0	Endometrial		DECEASED		2011			TCGA-AJ-A23N-01	fefa50dc-29a7-4c27-a735-ab6eb500a5d5	TCGA-AJ-A23N-01A-11R-A22I-13	TCGA-AJ-A23N-01A-11D-A227-01				TCGA-AJ-A23N-01A-11D-A22B-05				TCGA-AJ-A23N-01A-21-A23Z-20	f488f0b0-ec7e-4899-a771-86c0f98c79c6	TCGA-AJ-A23N-01	fefa50dc-29a7-4c27-a735-ab6eb500a5d5				f488f0b0-ec7e-4899-a771-86c0f98c79c6	TCGA-AJ-A23N-01A-11D-A227-01	fefa50dc-29a7-4c27-a735-ab6eb500a5d5	TCGA-AJ-A23N-01A-11R-A22I-13	fefa50dc-29a7-4c27-a735-ab6eb500a5d5
TCGA-AJ-A23O-01	MSI-H	1	TCGA-AJ-A23O-01	312	1	Iq	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 4		TCGA-AJ-A23O	312	0	312	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					69		0	TCGA-AJ-A23O-F22151		Stage IB	NO		-25433		312	0	60				NO		Scheduled Follow-up Submission	2012-2-24	FEMALE	157	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.		C54.1	8380/3	C54.1	YES		Dilation and curettage procedure				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO			81																	negative	TUMOR FREE		0				No	Never Used		NO				R0	Primary Tumor	01		2009	NO	NO	YES	AJ		4		15	Endometrial		DECEASED	60	2010	aaece63d-8d6f-4048-81e3-d4e7e3706948		TCGA-AJ-A23O-01		TCGA-AJ-A23O-01A-11R-A156-13	TCGA-AJ-A23O-01A-11D-A160-01			aaece63d-8d6f-4048-81e3-d4e7e3706948	TCGA-AJ-A23O-01A-11D-A161-05				TCGA-AJ-A23O-01A-21-A18R-20	abd583d0-822c-4a08-9f2a-89c9226ad1df	TCGA-AJ-A23O-01					abd583d0-822c-4a08-9f2a-89c9226ad1df	TCGA-AJ-A23O-01A-11D-A160-01		TCGA-AJ-A23O-01A-11R-A156-13	
TCGA-AJ-A2QK-01	MSS	0	TCGA-AJ-A2QK-01	12	0	Squamous	C6-UCEC	UCEC non-CIMP c3		UCEC-like c5	UCEC-like c11	miRNA c1uster 10			TCGA-AJ-A2QK			12	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					65		0			Stage IA			-23945	146		0	12							2011-10-18	FEMALE	155	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	170	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	TCGA-AJ-A2QK.01A114A2-098F-4AAD-9010-54910FB89B4A.pdf	25		40		20		10		20		0		30		60		60		TUMOR FREE		0				No							R0	Primary Tumor	01		2009		YES	NO	AJ	0	6	0	18	Endometrial	A	LIVING	119	2011	3ec89fd3-b1fe-495c-99ef-122ab708e633		TCGA-AJ-A2QK-01		TCGA-AJ-A2QK-01A-11R-A18L-13	TCGA-AJ-A2QK-01A-11D-A18N-01			3ec89fd3-b1fe-495c-99ef-122ab708e633	TCGA-AJ-A2QK-01A-11D-A18O-05				TCGA-AJ-A2QK-01A-21-A23Z-20	bb422231-40cd-47b8-95e4-2e4da788bf83	TCGA-AJ-A2QK-01					bb422231-40cd-47b8-95e4-2e4da788bf83	TCGA-AJ-A2QK-01A-11D-A18N-01		TCGA-AJ-A2QK-01A-11R-A18L-13	
TCGA-AJ-A2QL-01	MSS	0	TCGA-AJ-A2QL-01	602	0	Kirc+	C6-UCEC	UCEC CIMP c18		UCEC-like c5	UCEC-like c11	miRNA cluster 12			TCGA-AJ-A2QL	602	0	602	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	60	0	0	TCGA-AJ-A2QL-F43202		Stage IIIC1	NO		-22057	138		0	602				YES			2013-5-15	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	170	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-AJ-A2QL.4AD4E8D1-5DA7-4134-A0C0-0AF1C3A8BCD4.pdf			8		5		0		3		0		20		80		80	negative	TUMOR FREE	1	0	YES		Complete Remission/Response	No	Never Used		NO					Primary Tumor	01	Minimally Invasive	2009		YES	NO	AJ	0	7	1	18	Endometrial	A	LIVING	112	2011	575c927a-b846-4ef3-9644-7879d522a2cb		TCGA-AJ-A2QL-01		TCGA-AJ-A2QL-01A-11R-A18L-13	TCGA-AJ-A2QL-01A-11D-A18N-01			575c927a-b846-4ef3-9644-7879d522a2cb	TCGA-AJ-A2QL-01A-11D-A18O-05				TCGA-AJ-A2QL-01A-21-A23Z-20	95a1b5fa-2402-4337-bff1-77c683e9946e	TCGA-AJ-A2QL-01					95a1b5fa-2402-4337-bff1-77c683e9946e	TCGA-AJ-A2QL-01A-11D-A18N-01		TCGA-AJ-A2QL-01A-11R-A18L-13	
TCGA-AJ-A2QL-11	MSS	0	TCGA-AJ-A2QL-11	602	0		C6-UCEC								TCGA-AJ-A2QL	602	0	602	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	60	0	0	TCGA-AJ-A2QL-F43202		Stage IIIC1	NO		-22057	138		0	602				YES			2013-5-15	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	100	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false				8		0		0		0		5		95		0		0	negative	TUMOR FREE	1	0	YES		Complete Remission/Response	No	Never Used		NO					Solid Tissue Normal	11	Minimally Invasive	2009		YES	NO	AJ	0	7	1	18	Endometrial	A	LIVING	112	2011	59022898-5d0a-4109-90fa-9f8ad89b9758				TCGA-AJ-A2QL-11A-11R-A18L-13				59022898-5d0a-4109-90fa-9f8ad89b9758	TCGA-AJ-A2QL-11A-11D-A18O-05														TCGA-AJ-A2QL-11A-11R-A18L-13	
TCGA-AJ-A2QM-01	MSS	0	TCGA-AJ-A2QM-01	894	0	High		UCEC non-CIMP c3		UCEC-like c5		miRNA c1uster 10			TCGA-AJ-A2QM	894	0	894	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	67	0	0	TCGA-AJ-A2QM-F60105		Stage II	NO		-24776	108		0	894				NO			2014-5-29	FEMALE	170	Serous endometrial adenocarcinoma	No		YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	210	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-AJ-A2QM.282D10FF-370D-4252-B1CB-3410A43C8F82.pdf			3		8		4		5		0		10		86		90	negative	TUMOR FREE	0	0	YES		Complete Remission/Response	Yes	Never Used		YES					Primary Tumor	01	open	2009		YES	NO	AJ	0	13	0	20	Endometrial	A	LIVING	74	2011			TCGA-AJ-A2QM-01	2bd4aa66-5a09-4bac-bfd0-fc3519d398a1	TCGA-AJ-A2QM-01A-11R-A18L-13	TCGA-AJ-A2QM-01A-11D-A18N-01				TCGA-AJ-A2QM-01A-11D-A18O-05				TCGA-AJ-A2QM-01A-21-A23Z-20	094331c4-7236-4918-ba8e-6227aeea2926	TCGA-AJ-A2QM-01	2bd4aa66-5a09-4bac-bfd0-fc3519d398a1				094331c4-7236-4918-ba8e-6227aeea2926	TCGA-AJ-A2QM-01A-11D-A18N-01	2bd4aa66-5a09-4bac-bfd0-fc3519d398a1	TCGA-AJ-A2QM-01A-11R-A18L-13	2bd4aa66-5a09-4bac-bfd0-fc3519d398a1
TCGA-AJ-A2QN-01	MSS	0	TCGA-AJ-A2QN-01	73	0	Kirc+		UCEC non-CIMP c3			UCEC-like c11	miRNA cluster 5			TCGA-AJ-A2QN			73	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					60		0			Stage II			-21915	289		0	73							2011-10-18	FEMALE	170	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	25	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	TCGA-AJ-A2QN.F92EF591-695A-4E48-9ACF-67497880AC20.pdf			0		0		10		0		0		15		75		75	negative			0				No							R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	AJ	0	8	0	4	Endometrial	A	LIVING	132	2010	13a499dd-2bb6-4750-b24a-1c76993f5b97		TCGA-AJ-A2QN-01		TCGA-AJ-A2QN-01A-11R-A18L-13	TCGA-AJ-A2QN-01A-11D-A18N-01			13a499dd-2bb6-4750-b24a-1c76993f5b97	TCGA-AJ-A2QN-01A-11D-A18O-05					f6f393ae-8733-4d73-8436-a18918c69ac6	TCGA-AJ-A2QN-01					f6f393ae-8733-4d73-8436-a18918c69ac6	TCGA-AJ-A2QN-01A-11D-A18N-01		TCGA-AJ-A2QN-01A-11R-A18L-13	
TCGA-AJ-A2QO-01	MSI-H	1	TCGA-AJ-A2QO-01	1045	1	Quiet		UCEC CIMP c18				miRNA cluster 12			TCGA-AJ-A2QO	1045	0	1045	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	85		0	TCGA-AJ-A2QO-F58978		Stage IB	NO		-31222	174	1045	0	92				NO			2014-4-29	FEMALE	165	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	16	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-AJ-A2QO.5351BF98-9E1D-4F4D-A3EE-26A83B867D58.pdf	84		0		0		15		0		0		30		55		65	negative	TUMOR FREE		0	NO	2	Complete Remission/Response	No	Never Used		NO					Primary Tumor	01	Minimally Invasive	2009		YES	NO	AJ	0	5	0	11	Endometrial	A	DECEASED	67	2011			TCGA-AJ-A2QO-01	0ebc7d28-128d-4842-9e10-28abb1953b72	TCGA-AJ-A2QO-01A-11R-A18L-13	TCGA-AJ-A2QO-01A-11D-A18N-01				TCGA-AJ-A2QO-01A-11D-A18O-05					7a272f6f-49f6-42e9-9277-f677471defe1	TCGA-AJ-A2QO-01	0ebc7d28-128d-4842-9e10-28abb1953b72				7a272f6f-49f6-42e9-9277-f677471defe1	TCGA-AJ-A2QO-01A-11D-A18N-01	0ebc7d28-128d-4842-9e10-28abb1953b72	TCGA-AJ-A2QO-01A-11R-A18L-13	0ebc7d28-128d-4842-9e10-28abb1953b72
TCGA-AJ-A3BD-01	MSS	0	TCGA-AJ-A3BD-01	1039	0	Squamous		UCEC Serous c4		UCEC-like c5		miRNA c1uster 10			TCGA-AJ-A3BD	1039	0	1039	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	57	0	2	TCGA-AJ-A3BD-F58983		Stage IIIC2	NO		-20998	170		0	1039				NO			2014-4-29	FEMALE	152	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8460/3	C54.1	YES		Office Endometrial Biopsy	200	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-AJ-A3BD.8B7CB7C6-86B5-41EA-A6CB-FC496C311888.pdf			2		0		3		0		5		2		90		95	negative	TUMOR FREE	0	3	YES	2	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	2009		YES	NO	AJ	2	9	3	17	Endometrial	A	LIVING	85	2011			TCGA-AJ-A3BD-01	b38f9ed4-266f-4b44-b42f-48396fb0be68	TCGA-AJ-A3BD-01A-11R-A19V-13	TCGA-AJ-A3BD-01A-11D-A19X-01				TCGA-AJ-A3BD-01A-11D-A19Z-05				TCGA-AJ-A3BD-01A-21-A23Z-20	8120414f-c0a8-4687-8a9f-29531b17c6a7	TCGA-AJ-A3BD-01	b38f9ed4-266f-4b44-b42f-48396fb0be68				8120414f-c0a8-4687-8a9f-29531b17c6a7	TCGA-AJ-A3BD-01A-11D-A19X-01	b38f9ed4-266f-4b44-b42f-48396fb0be68	TCGA-AJ-A3BD-01A-11R-A19V-13	b38f9ed4-266f-4b44-b42f-48396fb0be68
TCGA-AJ-A3BF-01	MSS	0	TCGA-AJ-A3BF-01	34	0	Squamous		UCEC Serous c4		UCEC-like c5		miRNA cluster 2			TCGA-AJ-A3BF			34	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					65	0	6			Stage IIIC2			-23906	92		0	34							2012-2-3	FEMALE	170	Serous endometrial adenocarcinoma	No			C54.1	8460/3	C54.1	YES		Dilation and curettage procedure	150	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	TCGA-AJ-A3BF.3673A111-6F2E-4374-A0E7-BA436D644F0D.pdf			2		1		2		0		5		3		90		90	negative	TUMOR FREE	0	2				No							R0	Primary Tumor	01	open	2009		YES	NO	AJ	6	14	2	43	Endometrial	A	LIVING	113	2011			TCGA-AJ-A3BF-01	f282d6e9-6a6a-4515-8efd-d5fff0367ee8	TCGA-AJ-A3BF-01A-11R-A214-13	TCGA-AJ-A3BF-01A-11D-A20R-01				TCGA-AJ-A3BF-01A-11D-A212-05				TCGA-AJ-A3BF-01A-21-A23Z-20	2372ec32-42d1-471b-8598-46b6ea83402e	TCGA-AJ-A3BF-01	f282d6e9-6a6a-4515-8efd-d5fff0367ee8				2372ec32-42d1-471b-8598-46b6ea83402e	TCGA-AJ-A3BF-01A-11D-A20R-01	f282d6e9-6a6a-4515-8efd-d5fff0367ee8	TCGA-AJ-A3BF-01A-11R-A214-13	f282d6e9-6a6a-4515-8efd-d5fff0367ee8
TCGA-AJ-A3BG-01	MSI-H	0	TCGA-AJ-A3BG-01	23	0	Kirc+		BRCA CIMP c7				miRNA c1uster 10			TCGA-AJ-A3BG			23	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					65	0	0			Stage IA			-23861			0	23							2012-2-3	FEMALE	163	Mixed serous and endometrioid	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3								33																	negative	TUMOR FREE	0	0				Yes							R0	Primary Tumor	01	open	2009		YES	NO	AJ	0	4	0	13	Endometrial		LIVING	66	2011			TCGA-AJ-A3BG-01	f3004f55-be95-4c2c-92f8-9ec3e96701cd	TCGA-AJ-A3BG-01A-11R-A19V-13	TCGA-AJ-A3BG-01A-11D-A19X-01				TCGA-AJ-A3BG-01A-11D-A19Z-05					e78a4de6-b939-4ce8-9528-cc9c106fe05a	TCGA-AJ-A3BG-01	f3004f55-be95-4c2c-92f8-9ec3e96701cd				e78a4de6-b939-4ce8-9528-cc9c106fe05a	TCGA-AJ-A3BG-01A-11D-A19X-01	f3004f55-be95-4c2c-92f8-9ec3e96701cd	TCGA-AJ-A3BG-01A-11R-A19V-13	f3004f55-be95-4c2c-92f8-9ec3e96701cd
TCGA-AJ-A3BH-01	MSI-H		TCGA-AJ-A3BH-01			Kirc+		UCEC non-CIMP c3		UCEC-like c5		miRNA cluster 4			TCGA-AJ-A3BH				Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					81					Stage IB														2012-2-3	FEMALE	157	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES			100	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	TCGA-AJ-A3BH.469A2D52-09E6-4B67-B8D0-D6292AC22285.pdf	69		2		1		2		0		6		2		90		90		TUMOR FREE		0				No							R0	Primary Tumor	01	open	2009		YES	NO	AJ				1	Endometrial	A	LIVING	71	2011			TCGA-AJ-A3BH-01	9f7b98f9-86c1-4c0c-8727-b8ecfb7b5e4e	TCGA-AJ-A3BH-01A-11R-A19V-13	TCGA-AJ-A3BH-01A-11D-A19X-01				TCGA-AJ-A3BH-01A-11D-A19Z-05				TCGA-AJ-A3BH-01A-21-A23Z-20	dd34d753-2345-4db8-af4f-657e9bc605f5	TCGA-AJ-A3BH-01	9f7b98f9-86c1-4c0c-8727-b8ecfb7b5e4e				dd34d753-2345-4db8-af4f-657e9bc605f5	TCGA-AJ-A3BH-01A-11D-A19X-01	9f7b98f9-86c1-4c0c-8727-b8ecfb7b5e4e	TCGA-AJ-A3BH-01A-11R-A19V-13	9f7b98f9-86c1-4c0c-8727-b8ecfb7b5e4e
TCGA-AJ-A3BI-01	MSS	0	TCGA-AJ-A3BI-01	575	0	High		UCEC non-CIMP c3				miRNA c1uster 10			TCGA-AJ-A3BI	373	1	575	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	NO		Complete Response	67		0	TCGA-AJ-A3BI-F43699		Stage IA	NO		-24623	137		0	575			373	YES			2013-5-31	FEMALE	157	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	19	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Locoregional Recurrence	Anterior Abd. Mass	NO	YES	false	TCGA-AJ-A3BI.19B5518D-075F-40BE-A104-75C925F133A4.pdf	15		0		0		20		0		0		0		80		85	negative	TUMOR FREE		0	NO			No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	AJ	0	6	0	10	Endometrial	A	LIVING	100	2011			TCGA-AJ-A3BI-01	5dc20b99-8440-4d30-a803-1e10cdb29dbe	TCGA-AJ-A3BI-01A-11R-A214-13	TCGA-AJ-A3BI-01A-11D-A20R-01				TCGA-AJ-A3BI-01A-11D-A212-05					17f78fb2-cc13-4e78-aac9-9de54a32f201	TCGA-AJ-A3BI-01	5dc20b99-8440-4d30-a803-1e10cdb29dbe				17f78fb2-cc13-4e78-aac9-9de54a32f201	TCGA-AJ-A3BI-01A-11D-A20R-01	5dc20b99-8440-4d30-a803-1e10cdb29dbe	TCGA-AJ-A3BI-01A-11R-A214-13	5dc20b99-8440-4d30-a803-1e10cdb29dbe
TCGA-AJ-A3BK-01	MSI-L	0	TCGA-AJ-A3BK-01	51	0	Kirc+		UCEC CIMP c18		UCEC-like c5		miRNA c1uster 10			TCGA-AJ-A3BK			51	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					68					Stage IC			-24943	547		0	51							2012-2-3	FEMALE	163	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	170	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	TCGA-AJ-A3BK.026350F0-3203-49E5-8CCC-9DE88B2C8625.pdf	66		2		1		5		0		10		0		85		90	negative			0				No							R0	Primary Tumor	01	Minimally Invasive	2009		NO	YES	AJ		0	0	22	Endometrial	A	LIVING	92	2010			TCGA-AJ-A3BK-01	18b41a91-88d1-4938-a57f-0464fc7422bc	TCGA-AJ-A3BK-01A-11R-A19V-13	TCGA-AJ-A3BK-01A-11D-A19X-01				TCGA-AJ-A3BK-01A-11D-A19Z-05				TCGA-AJ-A3BK-01A-21-A23Z-20	5bcbff7f-3076-4dc0-9a84-074efd2bb6cd	TCGA-AJ-A3BK-01	18b41a91-88d1-4938-a57f-0464fc7422bc				5bcbff7f-3076-4dc0-9a84-074efd2bb6cd	TCGA-AJ-A3BK-01A-11D-A19X-01	18b41a91-88d1-4938-a57f-0464fc7422bc	TCGA-AJ-A3BK-01A-11R-A19V-13	18b41a91-88d1-4938-a57f-0464fc7422bc
TCGA-AJ-A3EJ-01	MSS	1	TCGA-AJ-A3EJ-01	50	1	High		UCEC Serous c4				miRNA cluster 13			TCGA-AJ-A3EJ	50	0	50	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					74		2	TCGA-AJ-A3EJ-F43201		Stage IIIC2	NO		-27317	332	50	0					NO			2013-5-15	FEMALE	168	Mixed serous and endometrioid	No	Yes, I am currently taking menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	20	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-AJ-A3EJ.FB99D237-4583-4298-844F-43B2F99F83E3.pdf	85		0		0		10		0		0		15		75		70	negative	WITH TUMOR		9	NO	4+		No	Never Used		NO				R0	Primary Tumor	01		2009		YES	NO	AJ	2	11	9	26	Endometrial	A	DECEASED	73	2010			TCGA-AJ-A3EJ-01	6c10f0d4-fd7e-459e-af27-8cde9dc42860	TCGA-AJ-A3EJ-01A-11R-A19V-13	TCGA-AJ-A3EJ-01A-11D-A19X-01				TCGA-AJ-A3EJ-01A-11D-A19Z-05					ee8de32e-390b-4068-bbbc-e3d2a11f3c48	TCGA-AJ-A3EJ-01	6c10f0d4-fd7e-459e-af27-8cde9dc42860				ee8de32e-390b-4068-bbbc-e3d2a11f3c48	TCGA-AJ-A3EJ-01A-11D-A19X-01	6c10f0d4-fd7e-459e-af27-8cde9dc42860	TCGA-AJ-A3EJ-01A-11R-A19V-13	6c10f0d4-fd7e-459e-af27-8cde9dc42860
TCGA-AJ-A3EK-01	MSI-H	0	TCGA-AJ-A3EK-01	446	0	Quiet		UCEC CIMP c18		UCEC-like c5		miRNA cluster 4			TCGA-AJ-A3EK	446	0	446	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	53		0	TCGA-AJ-A3EK-F45626		Stage IA	NO		-19609	127		0	446				NO			2013-7-17	FEMALE	157	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	220	NO	NO	Peri (6-12 months since last menstrual period)	G3					NO	false	TCGA-AJ-A3EK.F153EAC2-7347-4CEF-916A-995C7BB8B0F1.pdf	5		4		0		5		0		5		0		90		85	negative	TUMOR FREE		0	YES	3	Complete Remission/Response	No	Never Used		YES					Primary Tumor	01	Minimally Invasive	2009		YES	NO	AJ	0	9	0	10	Endometrial	A	LIVING	60	2011			TCGA-AJ-A3EK-01	1ff9e0b8-b682-4da8-86f3-c510b7e6e1f4	TCGA-AJ-A3EK-01A-11R-A19V-13	TCGA-AJ-A3EK-01A-11D-A19X-01				TCGA-AJ-A3EK-01A-11D-A19Z-05				TCGA-AJ-A3EK-01A-21-A23Z-20	ce277277-39b4-4e3a-bcc5-e4b3e85c6dab	TCGA-AJ-A3EK-01	1ff9e0b8-b682-4da8-86f3-c510b7e6e1f4				ce277277-39b4-4e3a-bcc5-e4b3e85c6dab	TCGA-AJ-A3EK-01A-11D-A19X-01	1ff9e0b8-b682-4da8-86f3-c510b7e6e1f4	TCGA-AJ-A3EK-01A-11R-A19V-13	1ff9e0b8-b682-4da8-86f3-c510b7e6e1f4
TCGA-AJ-A3EL-01	MSI-L	0	TCGA-AJ-A3EL-01	684	0	Quiet		UCEC non-CIMP c3				miRNA c1uster 10			TCGA-AJ-A3EL	684	0	684	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	47		0	TCGA-AJ-A3EL-F46677		Stage IA	NO		-17442	317		0	684							2013-8-13	FEMALE	155	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	20	NO	NO	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3					NO	false	TCGA-AJ-A3EL.CB5EF343-EDD4-46B1-82DD-48C49FF7E778.pdf	6		0		0		0		0		0		10		90		85	negative	TUMOR FREE		0	NO	0	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	AJ	0	13	0	15	Endometrial	A	LIVING	57	2010			TCGA-AJ-A3EL-01	a7a5bc3b-d82d-447d-8679-47b48612834a	TCGA-AJ-A3EL-01A-11R-A214-13	TCGA-AJ-A3EL-01A-11D-A20R-01				TCGA-AJ-A3EL-01A-11D-A212-05					15405b1c-66d8-4c26-a050-cdde51b29a00	TCGA-AJ-A3EL-01	a7a5bc3b-d82d-447d-8679-47b48612834a				15405b1c-66d8-4c26-a050-cdde51b29a00	TCGA-AJ-A3EL-01A-11D-A20R-01	a7a5bc3b-d82d-447d-8679-47b48612834a	TCGA-AJ-A3EL-01A-11R-A214-13	a7a5bc3b-d82d-447d-8679-47b48612834a
TCGA-AJ-A3EM-01	MSS	0	TCGA-AJ-A3EM-01	677	0	High		UCEC non-CIMP c3				miRNA cluster 5			TCGA-AJ-A3EM	677	0	677	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	69		0	TCGA-AJ-A3EM-F46680		Stage IB	NO		-25557	296		0	677				NO			2013-8-13	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	9	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-AJ-A3EM.E5CE38FD-DB53-49D9-92B3-BA075BDDC5CF.pdf	3.6		0		0		20		0		0		5		75		80	negative	TUMOR FREE		0	NO	4+	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	AJ	0	8	0	6	Endometrial	A	LIVING	82	2011			TCGA-AJ-A3EM-01	4835dbe5-983f-458a-91d2-8e1d754259c3	TCGA-AJ-A3EM-01A-11R-A214-13	TCGA-AJ-A3EM-01A-11D-A20R-01				TCGA-AJ-A3EM-01A-11D-A212-05					2b4f880f-6103-49a7-8c22-9fc3832c5241	TCGA-AJ-A3EM-01	4835dbe5-983f-458a-91d2-8e1d754259c3				2b4f880f-6103-49a7-8c22-9fc3832c5241	TCGA-AJ-A3EM-01A-11D-A20R-01	4835dbe5-983f-458a-91d2-8e1d754259c3	TCGA-AJ-A3EM-01A-11R-A214-13	4835dbe5-983f-458a-91d2-8e1d754259c3
TCGA-AJ-A3I9-01	MSS	1	TCGA-AJ-A3I9-01	519	1	Squamous		UCEC non-CIMP c3				miRNA cluster 12			TCGA-AJ-A3I9	370	1	519	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	NO		Progressive Disease	52	0	0	TCGA-AJ-A3I9-F66208	Former User	Stage II	NO		-19139	84	519	0	39			370	NO			2014-10-3	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	27	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Bone	Distant Metastasis		NO	YES	false	TCGA-AJ-A3I9.095789FC-7C20-4A6A-A6F0-13315481EBD0.pdf			0		0		0		0		0		0		100		80		WITH TUMOR	0	0	NO	0	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	AJ	0	7	0	11	Endometrial	A	DECEASED	72	2011			TCGA-AJ-A3I9-01	e7517bb2-68d3-49c5-b298-4203845ae7db	TCGA-AJ-A3I9-01A-11R-A22I-13	TCGA-AJ-A3I9-01A-11D-A227-01				TCGA-AJ-A3I9-01A-11D-A22B-05					6dfbe539-ee68-49dd-a0df-6c74cecdda29	TCGA-AJ-A3I9-01	e7517bb2-68d3-49c5-b298-4203845ae7db				6dfbe539-ee68-49dd-a0df-6c74cecdda29	TCGA-AJ-A3I9-01A-11D-A227-01	e7517bb2-68d3-49c5-b298-4203845ae7db	TCGA-AJ-A3I9-01A-11R-A22I-13	e7517bb2-68d3-49c5-b298-4203845ae7db
TCGA-AJ-A3IA-01	MSS	0	TCGA-AJ-A3IA-01	633	0	High		OV-like c1				miRNA cluster 5			TCGA-AJ-A3IA	633	0	633	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	77	0	0	TCGA-AJ-A3IA-F48781		Stage IB	NO		-28470	66		0	633				NO			2013-9-20	FEMALE	157	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	35	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-AJ-A3IA.883486F6-0EDF-4BBC-8412-67F31351427B.pdf	88		0		0		0		0		0		10		90		75	negative	TUMOR FREE	0	0	NO	2	Complete Remission/Response	Yes	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	AJ	0	9	0	17	Endometrial	A	LIVING	58	2011			TCGA-AJ-A3IA-01	c32dabac-90ce-4b8c-b08c-85a1a2fe8ccf	TCGA-AJ-A3IA-01A-11R-A214-13	TCGA-AJ-A3IA-01A-11D-A20R-01				TCGA-AJ-A3IA-01A-11D-A212-05					38b2804b-97da-4b71-8b16-6342a40f97b0	TCGA-AJ-A3IA-01	c32dabac-90ce-4b8c-b08c-85a1a2fe8ccf				38b2804b-97da-4b71-8b16-6342a40f97b0	TCGA-AJ-A3IA-01A-11D-A20R-01	c32dabac-90ce-4b8c-b08c-85a1a2fe8ccf	TCGA-AJ-A3IA-01A-11R-A214-13	c32dabac-90ce-4b8c-b08c-85a1a2fe8ccf
TCGA-AJ-A3NC-01	MSS	0	TCGA-AJ-A3NC-01	616	0	Iq		UCEC CIMP c18		squamous c3		miRNA c1uster 10			TCGA-AJ-A3NC	616	0	616	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	63			TCGA-AJ-A3NC-F46679		Stage IA	NO		-23353			0	616				YES			2013-8-13	FEMALE	168	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy			NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO			21																	negative	TUMOR FREE	0	0	NO		Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	AJ		0	0	13	Endometrial		LIVING	110	2011			TCGA-AJ-A3NC-01	e6dbc0a5-b610-406a-9c7a-43eb8b6b6b53	TCGA-AJ-A3NC-01A-11R-A22I-13	TCGA-AJ-A3NC-01A-11D-A227-01				TCGA-AJ-A3NC-01A-11D-A22B-05				TCGA-AJ-A3NC-01A-21-A23Z-20	be116fad-037d-4ed3-818f-d82715e27bcf	TCGA-AJ-A3NC-01	e6dbc0a5-b610-406a-9c7a-43eb8b6b6b53				be116fad-037d-4ed3-818f-d82715e27bcf	TCGA-AJ-A3NC-01A-11D-A227-01	e6dbc0a5-b610-406a-9c7a-43eb8b6b6b53	TCGA-AJ-A3NC-01A-11R-A22I-13	e6dbc0a5-b610-406a-9c7a-43eb8b6b6b53
TCGA-AJ-A3NC-11	MSS	0	TCGA-AJ-A3NC-11	616	0										TCGA-AJ-A3NC	616	0	616	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	63			TCGA-AJ-A3NC-F46679		Stage IA	NO		-23353	282		0	616				YES			2013-8-13	FEMALE	168	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	70	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false		21		1		0		0		0		100		0		0		0	negative	TUMOR FREE	0	0	NO		Complete Remission/Response	No	Never Used		NO				R0	Solid Tissue Normal	11	Minimally Invasive	2009		YES	NO	AJ		0	0	13	Endometrial	A	LIVING	110	2011				cd0ccc13-2ce8-408e-aceb-1b363e98584f	TCGA-AJ-A3NC-11A-11R-A22I-13					TCGA-AJ-A3NC-11A-11D-A22B-05							cd0ccc13-2ce8-408e-aceb-1b363e98584f						cd0ccc13-2ce8-408e-aceb-1b363e98584f	TCGA-AJ-A3NC-11A-11R-A22I-13	cd0ccc13-2ce8-408e-aceb-1b363e98584f
TCGA-AJ-A3NE-01	MSI-H	0	TCGA-AJ-A3NE-01	628	0	Kirc+		UCEC non-CIMP c3				miRNA cluster 11			TCGA-AJ-A3NE	628	0	628	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	46		0	TCGA-AJ-A3NE-F47713		Stage IA	NO		-16957	134		0	628							2013-8-28	FEMALE	160	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	23	NO	NO	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3					NO	false	TCGA-AJ-A3NE.4618A1F6-B969-4746-8190-7D856A21C25F.pdf	4	0	0	0	0	5	5	0	0	0	0	15	15	80	80	65	60	negative	TUMOR FREE		0	NO	3	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	AJ	0	12	0	24	Endometrial	A	LIVING	80	2011			TCGA-AJ-A3NE-01	a133035a-7076-4fe7-b260-f866b409aba4	TCGA-AJ-A3NE-01A-11R-A22I-13	TCGA-AJ-A3NE-01A-11D-A227-01				TCGA-AJ-A3NE-01A-11D-A22B-05					6a1b0a97-0db1-4bac-90bf-8a7a84d51964	TCGA-AJ-A3NE-01	a133035a-7076-4fe7-b260-f866b409aba4				6a1b0a97-0db1-4bac-90bf-8a7a84d51964	TCGA-AJ-A3NE-01A-11D-A227-01	a133035a-7076-4fe7-b260-f866b409aba4	TCGA-AJ-A3NE-01A-11R-A22I-13	a133035a-7076-4fe7-b260-f866b409aba4
TCGA-AJ-A3NE-11	MSI-H	0	TCGA-AJ-A3NE-11	628	0										TCGA-AJ-A3NE	628	0	628	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	46		0	TCGA-AJ-A3NE-F47713		Stage IA	NO		-16957	134		0	628							2013-8-28	FEMALE	160	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	80	NO	NO	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3					NO	false		4		1		0		0		0		100		0		0		0	negative	TUMOR FREE		0	NO	3	Complete Remission/Response	No	Never Used		NO				R0	Solid Tissue Normal	11	Minimally Invasive	2009		YES	NO	AJ	0	12	0	24	Endometrial	A	LIVING	80	2011				b4a85000-c0fd-4287-83f2-fc0757fe4a60	TCGA-AJ-A3NE-11A-11R-A22I-13					TCGA-AJ-A3NE-11A-11D-A22B-05							b4a85000-c0fd-4287-83f2-fc0757fe4a60						b4a85000-c0fd-4287-83f2-fc0757fe4a60	TCGA-AJ-A3NE-11A-11R-A22I-13	b4a85000-c0fd-4287-83f2-fc0757fe4a60
TCGA-AJ-A3NF-01	MSS	0	TCGA-AJ-A3NF-01	645	0	Squamous		UCEC Serous c4				miRNA cluster 5			TCGA-AJ-A3NF	645	0	645	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	60	0	0	TCGA-AJ-A3NF-F58988		Stage IIIC	NO		-22210	85		0	645				NO			2014-4-29	FEMALE	160	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	22	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-AJ-A3NF.7003815D-F09A-46A0-8A8E-E0685A765788.pdf	54		0		0		0		0		0		20		80		60	negative	TUMOR FREE	0	1	YES	3	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	AJ	0	9	1	23	Endometrial	A	LIVING	117	2011			TCGA-AJ-A3NF-01	5ab8bc7b-9e70-426f-8f84-d8c691440e98	TCGA-AJ-A3NF-01A-11R-A22I-13	TCGA-AJ-A3NF-01A-11D-A227-01				TCGA-AJ-A3NF-01A-11D-A22B-05					60a0ae98-b745-414c-bae2-61d187479e19	TCGA-AJ-A3NF-01	5ab8bc7b-9e70-426f-8f84-d8c691440e98				60a0ae98-b745-414c-bae2-61d187479e19	TCGA-AJ-A3NF-01A-11D-A227-01	5ab8bc7b-9e70-426f-8f84-d8c691440e98	TCGA-AJ-A3NF-01A-11R-A22I-13	5ab8bc7b-9e70-426f-8f84-d8c691440e98
TCGA-AJ-A3NG-01	MSS	0	TCGA-AJ-A3NG-01	475	0	Kirc+		Cluster 5		squamous c3		miRNA cluster 5			TCGA-AJ-A3NG	475	0	475	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	83		0	TCGA-AJ-A3NG-F47019		Stage II	NO		-30351	101		0	475				NO			2013-8-21	FEMALE	155	Mixed serous and endometrioid	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	150	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-AJ-A3NG.32C3C850-5F65-424E-894C-75B4725BBD09.pdf	60		2		0		2		1		13		0		85		90	negative	TUMOR FREE		0	NO	3	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	AJ	0	7	0	10	Endometrial	A	LIVING	93	2011			TCGA-AJ-A3NG-01	3bf26a40-da0a-4b9f-9c8d-ef307c8f239b	TCGA-AJ-A3NG-01A-11R-A22I-13	TCGA-AJ-A3NG-01A-11D-A227-01				TCGA-AJ-A3NG-01A-11D-A22B-05				TCGA-AJ-A3NG-01A-21-A23Z-20	78deaeaf-a6c0-4220-869e-e0d592e9b816	TCGA-AJ-A3NG-01	3bf26a40-da0a-4b9f-9c8d-ef307c8f239b				78deaeaf-a6c0-4220-869e-e0d592e9b816	TCGA-AJ-A3NG-01A-11D-A227-01	3bf26a40-da0a-4b9f-9c8d-ef307c8f239b	TCGA-AJ-A3NG-01A-11R-A22I-13	3bf26a40-da0a-4b9f-9c8d-ef307c8f239b
TCGA-AJ-A3NH-01	MSS	1	TCGA-AJ-A3NH-01	310	1	High		UCEC non-CIMP c3		UCEC-like c5		miRNA c1uster 10			TCGA-AJ-A3NH	310	0	310	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	90			TCGA-AJ-A3NH-F46995	Never Used	Stage IB	NO		-32871	67	310	0	23				NO			2013-8-21	FEMALE	162	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	130	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-AJ-A3NH.8FC0BB09-C917-4552-96A4-B4868FD33D27.pdf			2		0		0		0		10		0		90		90	positive	TUMOR FREE			YES	3	Complete Remission/Response	Yes	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	AJ		0		0	Endometrial	A	DECEASED	65	2011			TCGA-AJ-A3NH-01	1b48e1cd-3c89-4508-9326-7fdd69841776	TCGA-AJ-A3NH-01A-11R-A22I-13	TCGA-AJ-A3NH-01A-11D-A227-01				TCGA-AJ-A3NH-01A-11D-A22B-05				TCGA-AJ-A3NH-01A-21-A23Z-20	03f43069-e75e-4f18-ae60-1796fccdefb0	TCGA-AJ-A3NH-01	1b48e1cd-3c89-4508-9326-7fdd69841776				03f43069-e75e-4f18-ae60-1796fccdefb0	TCGA-AJ-A3NH-01A-11D-A227-01	1b48e1cd-3c89-4508-9326-7fdd69841776	TCGA-AJ-A3NH-01A-11R-A22I-13	1b48e1cd-3c89-4508-9326-7fdd69841776
TCGA-AJ-A3NH-11	MSS	1	TCGA-AJ-A3NH-11	310	1										TCGA-AJ-A3NH	310	0	310	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	90			TCGA-AJ-A3NH-F46995	Never Used	Stage IB	NO		-32871	67	310	0	23				NO			2013-8-21	FEMALE	162	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	70	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false				0		0		0		0		100		0		0		0	positive	TUMOR FREE			YES	3	Complete Remission/Response	Yes	Never Used		NO				R0	Solid Tissue Normal	11	Minimally Invasive	2009		YES	NO	AJ		0		0	Endometrial	A	DECEASED	65	2011				1b2609b8-8c1f-4407-aba5-e47f9e83ebb1	TCGA-AJ-A3NH-11A-11R-A22I-13					TCGA-AJ-A3NH-11A-11D-A22B-05							1b2609b8-8c1f-4407-aba5-e47f9e83ebb1						1b2609b8-8c1f-4407-aba5-e47f9e83ebb1	TCGA-AJ-A3NH-11A-11R-A22I-13	1b2609b8-8c1f-4407-aba5-e47f9e83ebb1
TCGA-AJ-A3OJ-01	MSI-H	0	TCGA-AJ-A3OJ-01	467	0	Quiet		BRCA CIMP c7		UCEC-like c5		miRNA cluster 4			TCGA-AJ-A3OJ	467	0	467	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	54		0	TCGA-AJ-A3OJ-F47049		Stage II	NO		-19826	97		0	467				NO			2013-8-21	FEMALE	157	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	260	NO	NO	Indeterminate (neither Pre or Postmenopausal)	G3					NO	false	TCGA-AJ-A3OJ.89CAF35B-187A-499C-9E01-3992A0DEBCFD.pdf	95		5		1		5		2		5		0		90		80	negative	TUMOR FREE		0	YES	2	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	AJ	0	11	0	14	Endometrial	A	LIVING	104	2011			TCGA-AJ-A3OJ-01	f141342e-fbed-4ccf-8e4a-7299397e6e77	TCGA-AJ-A3OJ-01A-11R-A22I-13	TCGA-AJ-A3OJ-01A-11D-A227-01				TCGA-AJ-A3OJ-01A-11D-A22B-05				TCGA-AJ-A3OJ-01A-21-A23Z-20	3c9a8971-74c9-4b73-b049-8abc36425ebc	TCGA-AJ-A3OJ-01	f141342e-fbed-4ccf-8e4a-7299397e6e77				3c9a8971-74c9-4b73-b049-8abc36425ebc	TCGA-AJ-A3OJ-01A-11D-A227-01	f141342e-fbed-4ccf-8e4a-7299397e6e77	TCGA-AJ-A3OJ-01A-11R-A22I-13	f141342e-fbed-4ccf-8e4a-7299397e6e77
TCGA-AJ-A3OK-01	MSI-L	0	TCGA-AJ-A3OK-01	485	0	Quiet		UCEC non-CIMP c3		UCEC-like c5		miRNA c1uster 10			TCGA-AJ-A3OK	485	0	485	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	73		0	TCGA-AJ-A3OK-F45615		Stage IA	NO		-26851	162		0	485							2013-7-17	FEMALE	160	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	80	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-AJ-A3OK.54D4BBBE-D458-44B2-8F7C-0185DD16D961.pdf	20		3		0		3		1		5		0		92		85	negative	TUMOR FREE		0	YES	2	Complete Remission/Response	No			YES				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	AJ	0	3	0	21	Endometrial	A	LIVING	75	2011			TCGA-AJ-A3OK-01	33dc8709-5c3e-4944-8e41-2bc36b26fced	TCGA-AJ-A3OK-01A-12R-A22I-13	TCGA-AJ-A3OK-01A-12D-A227-01				TCGA-AJ-A3OK-01A-12D-A22B-05				TCGA-AJ-A3OK-01A-21-A23Z-20	f4a0d9ad-6bfd-4263-86ea-3b2ba940f71c	TCGA-AJ-A3OK-01	33dc8709-5c3e-4944-8e41-2bc36b26fced				f4a0d9ad-6bfd-4263-86ea-3b2ba940f71c	TCGA-AJ-A3OK-01A-12D-A227-01	33dc8709-5c3e-4944-8e41-2bc36b26fced	TCGA-AJ-A3OK-01A-12R-A22I-13	33dc8709-5c3e-4944-8e41-2bc36b26fced
TCGA-AJ-A3OL-01	MSI-H	1	TCGA-AJ-A3OL-01	449	1	BRCA-LUAD+		UCEC CIMP c18		UCEC-like c5		miRNA cluster 12			TCGA-AJ-A3OL	424	1	449	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	NO	NO		Progressive Disease	55		0	TCGA-AJ-A3OL-F47006		Stage IIIA	NO		-20115	81	449	0	57			424	NO			2013-8-21	FEMALE	160	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	190	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Distant Metastasis	Lung, Liver, and Brain	NO	YES	false	TCGA-AJ-A3OL.B42FF342-34F0-4611-A275-B979D7658510.pdf	80		3		0		3		0		0		0		97		90	negative	WITH TUMOR		0	YES	2	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01		2009		YES	NO	AJ	0	6	0	9	Endometrial	A	DECEASED	64	2011			TCGA-AJ-A3OL-01	69fbadaa-5a9f-4fc6-b676-e938179ee830	TCGA-AJ-A3OL-01A-11R-A22I-13	TCGA-AJ-A3OL-01A-11D-A227-01				TCGA-AJ-A3OL-01A-11D-A22B-05				TCGA-AJ-A3OL-01A-21-A23Z-20	e5432fd5-8679-4e4a-9bdc-4107fa52a156	TCGA-AJ-A3OL-01	69fbadaa-5a9f-4fc6-b676-e938179ee830				e5432fd5-8679-4e4a-9bdc-4107fa52a156	TCGA-AJ-A3OL-01A-11D-A227-01	69fbadaa-5a9f-4fc6-b676-e938179ee830	TCGA-AJ-A3OL-01A-11R-A22I-13	69fbadaa-5a9f-4fc6-b676-e938179ee830
TCGA-AJ-A3QS-01	Indeterminate	0	TCGA-AJ-A3QS-01	513	0	High		UCEC Serous c4				miRNA cluster 5			TCGA-AJ-A3QS	513	0	513	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	57		0	TCGA-AJ-A3QS-F47011		Stage IIIA	NO		-21162	129		0	513				YES			2013-8-21	FEMALE	165	Serous endometrial adenocarcinoma	No		YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	34	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-AJ-A3QS.73D1F890-5799-4166-9F9A-F9852979FD29.pdf	0	0	0	0	0	0	0	0	0	0	0	60	5	40	95	40	60	negative	TUMOR FREE		1	YES	3	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01		2009		YES	NO	AJ	0	6	1	1	Endometrial	A	LIVING	71	2011			TCGA-AJ-A3QS-01	6f0ffee6-d69f-459e-b401-f7dbcb17cb13	TCGA-AJ-A3QS-01A-11R-A22I-13	TCGA-AJ-A3QS-01A-11D-A227-01				TCGA-AJ-A3QS-01A-11D-A22B-05					49f6700a-5b48-47f7-939b-002c1862212c	TCGA-AJ-A3QS-01	6f0ffee6-d69f-459e-b401-f7dbcb17cb13				49f6700a-5b48-47f7-939b-002c1862212c	TCGA-AJ-A3QS-01A-11D-A227-01	6f0ffee6-d69f-459e-b401-f7dbcb17cb13	TCGA-AJ-A3QS-01A-11R-A22I-13	6f0ffee6-d69f-459e-b401-f7dbcb17cb13
TCGA-AJ-A3TW-01	MSS	0	TCGA-AJ-A3TW-01	513	0	High		UCEC Serous c4		BRCA basal-like c6		miRNA cluster 4			TCGA-AJ-A3TW	513	0	513	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	78		0	TCGA-AJ-A3TW-F48779		Stage IB	NO		-28559			0	513				NO			2013-9-20	FEMALE	160	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy			NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO																				negative	TUMOR FREE		0	NO	3	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01		2009		YES	NO	AJ	0	1	0	18	Endometrial		LIVING	55	2012			TCGA-AJ-A3TW-01	a1ba7666-0fb4-4fa6-8530-242d32ca3708	TCGA-AJ-A3TW-01A-11R-A22I-13	TCGA-AJ-A3TW-01A-11D-A227-01				TCGA-AJ-A3TW-01A-11D-A22B-05				TCGA-AJ-A3TW-01A-21-A23Z-20	cc378541-b512-464b-adaf-484d457b1339	TCGA-AJ-A3TW-01	a1ba7666-0fb4-4fa6-8530-242d32ca3708				cc378541-b512-464b-adaf-484d457b1339	TCGA-AJ-A3TW-01A-11D-A227-01	a1ba7666-0fb4-4fa6-8530-242d32ca3708	TCGA-AJ-A3TW-01A-11R-A22I-13	a1ba7666-0fb4-4fa6-8530-242d32ca3708
TCGA-AJ-A5DV-01	MSS	0	TCGA-AJ-A5DV-01	679	0										TCGA-AJ-A5DV	679	0	679	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	65			TCGA-AJ-A5DV-F64110	Never Used	Stage IA	NO		-23892	220		0	679				YES			2014-8-26	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES	Biopsy, NOS	Other method, specify:	70	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-AJ-A5DV.049C45D6-6FC6-42EE-BD51-AC344D1E3CD9.pdf	3		5		0		10		0		0		0		90		75	negative	TUMOR FREE		0	NO	4+	Complete Remission/Response	No	Never Used		NO				RX	Primary Tumor	01		2009		YES	NO	AJ		0	0	5	Endometrial	A	LIVING	147	2012			TCGA-AJ-A5DV-01	f9cc97ae-9b1a-46fa-ab38-c46bccf84380	TCGA-AJ-A5DV-01A-11R-A27R-13	TCGA-AJ-A5DV-01A-11D-A27O-01				TCGA-AJ-A5DV-01A-11D-A27Y-05					205acd0c-5e1a-4865-b197-b061e13ded32	TCGA-AJ-A5DV-01	f9cc97ae-9b1a-46fa-ab38-c46bccf84380				205acd0c-5e1a-4865-b197-b061e13ded32	TCGA-AJ-A5DV-01A-11D-A27O-01	f9cc97ae-9b1a-46fa-ab38-c46bccf84380	TCGA-AJ-A5DV-01A-11R-A27R-13	f9cc97ae-9b1a-46fa-ab38-c46bccf84380
TCGA-AJ-A5DW-01	MSS	0	TCGA-AJ-A5DW-01	390	0										TCGA-AJ-A5DW	390	0	390	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	56		0	TCGA-AJ-A5DW-F66007	Never Used	Stage IA	NO		-20711	133		0	390				NO			2014-10-1	FEMALE	167	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES	Biopsy, NOS	Other method, specify:	80	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	TCGA-AJ-A5DW.8B641F9B-ACF5-448B-9AC3-8C8E6B1F0724.pdf			2		0		0		0		0		0		100		80		TUMOR FREE	0	0	NO	3	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01		2009		YES	NO	AJ	0	13	0	12	Endometrial	A	LIVING	109	2012			TCGA-AJ-A5DW-01	25b2c2d1-38b6-4fa7-ab1c-c2de3b6fb2fd	TCGA-AJ-A5DW-01A-11R-A27R-13	TCGA-AJ-A5DW-01A-11D-A27O-01				TCGA-AJ-A5DW-01A-11D-A27Y-05					37d2114a-41f6-46b1-9284-526a5a0e3dd7	TCGA-AJ-A5DW-01	25b2c2d1-38b6-4fa7-ab1c-c2de3b6fb2fd				37d2114a-41f6-46b1-9284-526a5a0e3dd7	TCGA-AJ-A5DW-01A-11D-A27O-01	25b2c2d1-38b6-4fa7-ab1c-c2de3b6fb2fd	TCGA-AJ-A5DW-01A-11R-A27R-13	25b2c2d1-38b6-4fa7-ab1c-c2de3b6fb2fd
TCGA-AJ-A6NU-01	MSS	0	TCGA-AJ-A6NU-01	632	0										TCGA-AJ-A6NU	632	0	632	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	64		0	TCGA-AJ-A6NU-F66207	Former User	Stage II	NO		-23498	439		0	632				NO			2014-10-3	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	50	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	TCGA-AJ-A6NU.43BA8AFC-DE95-4260-88BF-EB184430B5A4.pdf	0		5		0		0		5		10		10		80		80	negative	TUMOR FREE		0	NO	2	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	AJ	0	0	0	10	Endometrial	A	LIVING	167	2012			TCGA-AJ-A6NU-01	31594ace-9586-4e98-ab81-1dfe4fb9d20e	TCGA-AJ-A6NU-01A-11R-A34O-13	TCGA-AJ-A6NU-01A-11D-A34P-01				TCGA-AJ-A6NU-01A-11D-A34S-05					5f3a5f82-4af3-443e-92a4-63812471c90e	TCGA-AJ-A6NU-01	31594ace-9586-4e98-ab81-1dfe4fb9d20e				5f3a5f82-4af3-443e-92a4-63812471c90e	TCGA-AJ-A6NU-01A-11D-A34P-01	31594ace-9586-4e98-ab81-1dfe4fb9d20e	TCGA-AJ-A6NU-01A-11R-A34O-13	31594ace-9586-4e98-ab81-1dfe4fb9d20e
TCGA-AJ-A8CT-01	MSI-H	0	TCGA-AJ-A8CT-01	82	0										TCGA-AJ-A8CT	82	0	82	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	58			TCGA-AJ-A8CT-F61504		Stage IA	NO		-21515	587		0	82							2014-6-30	FEMALE	165	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	60	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	TCGA-AJ-A8CT.67EF8128-8F99-4B19-9B64-9C5E5BD0786F.pdf	17		5		5		0		0		20		20		60		60	negative	TUMOR FREE		0			Complete Remission/Response	No	Never Used						R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	AJ		0	0	18	Endometrial	A	LIVING	115	2012			TCGA-AJ-A8CT-01	4c56a6cc-f912-4b2f-b301-d6a64f211d31	TCGA-AJ-A8CT-01A-11R-A37P-13	TCGA-AJ-A8CT-01A-11D-A37M-01				TCGA-AJ-A8CT-01A-11D-A37Q-05					e47848c3-b3b5-4a4f-9504-2bf4e181037b	TCGA-AJ-A8CT-01	4c56a6cc-f912-4b2f-b301-d6a64f211d31				e47848c3-b3b5-4a4f-9504-2bf4e181037b	TCGA-AJ-A8CT-01A-11D-A37M-01	4c56a6cc-f912-4b2f-b301-d6a64f211d31	TCGA-AJ-A8CT-01A-11R-A37P-13	4c56a6cc-f912-4b2f-b301-d6a64f211d31
TCGA-AJ-A8CV-01	MSI-H		TCGA-AJ-A8CV-01												TCGA-AJ-A8CV				Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma														966																							30	NO									false	TCGA-AJ-A8CV.9A08EA28-EF0B-40CE-B2B4-0A0B0EE1EDA7.pdf			5		5		0		0		10		30		60		60																Primary Tumor	01												A						TCGA-AJ-A8CV-01	ff8eb6f4-876e-4b08-8ed7-8c7930765bee	TCGA-AJ-A8CV-01A-11R-A37P-13	TCGA-AJ-A8CV-01A-11D-A37M-01				TCGA-AJ-A8CV-01A-11D-A37Q-05					6c843af0-3723-47fc-a1b8-ae33df7a9d0b	TCGA-AJ-A8CV-01	ff8eb6f4-876e-4b08-8ed7-8c7930765bee				6c843af0-3723-47fc-a1b8-ae33df7a9d0b	TCGA-AJ-A8CV-01A-11D-A37M-01	ff8eb6f4-876e-4b08-8ed7-8c7930765bee	TCGA-AJ-A8CV-01A-11R-A37P-13	ff8eb6f4-876e-4b08-8ed7-8c7930765bee
TCGA-AJ-A8CW-01	MSI-H	0	TCGA-AJ-A8CW-01	4	0										TCGA-AJ-A8CW	4	0	4	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					64					Stage IA	NO		-23554	840		0	4							2014-2-27	FEMALE	168	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Tumor resection	90	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	TCGA-AJ-A8CW.146E0540-B6F0-495F-ADD5-90F7564C14CA.pdf	6		3		0		2		0		5		8		85		85	negative	TUMOR FREE		0				No	Never Used						R0	Primary Tumor	01	open	2009		YES	NO	AJ		0	0	28	Endometrial	A	LIVING	134	2011			TCGA-AJ-A8CW-01	409104d7-db15-448e-96c6-e50fb7e5d67b	TCGA-AJ-A8CW-01A-11R-A37P-13	TCGA-AJ-A8CW-01A-11D-A37M-01				TCGA-AJ-A8CW-01A-11D-A37Q-05					efd4202b-614a-4d80-954f-960d3a83afd9	TCGA-AJ-A8CW-01	409104d7-db15-448e-96c6-e50fb7e5d67b				efd4202b-614a-4d80-954f-960d3a83afd9	TCGA-AJ-A8CW-01A-11D-A37M-01	409104d7-db15-448e-96c6-e50fb7e5d67b	TCGA-AJ-A8CW-01A-11R-A37P-13	409104d7-db15-448e-96c6-e50fb7e5d67b
TCGA-AP-A051-01	MSI-H	0	TCGA-AP-A051-01	2545	0	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 11	TCGA-AP-A051			2545	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					69	0	0	TCGA-AP-A051-F3385	Never Used	Stage IA	NO		-25269	2475		0	2545				NO			2010-9-23	FEMALE	159	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	430	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	TCGA-AP-A051.2146A2FC-99EE-4939-AD9F-086BB77D2B21.pdf	37	0	0	0	0	4	4	0	0	0	0	6	4	90	92	98	98	negative	TUMOR FREE	0	0		3	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open		NO	NO	YES	AP	0	0	0	0	Endometrial	A	LIVING	97	2003	520ac0a0-a49f-4990-8a49-dfe312361e30	TCGA-AP-A051-01	TCGA-AP-A051-01			TCGA-AP-A051-01A-21D-A00X-01	TCGA-AP-A051-01	TCGA-AP-A051-01A-21D-A00U-05	520ac0a0-a49f-4990-8a49-dfe312361e30		e1f9f4c1-cbb9-49fb-bbac-e1ca174f5fcb	TCGA-AP-A051-01A-21R-A00W-13	TCGA-AP-A051-01A-21W-A027-09	TCGA-AP-A051-01A-11-A162-20	392e8082-fda9-4664-a3d5-6abd799143ba	TCGA-AP-A051-01			TCGA-AP-A051-01A-21R-A00V-07	TCGA-AP-A051-01A-21W-A027-09	392e8082-fda9-4664-a3d5-6abd799143ba	TCGA-AP-A051-01A-21D-A00X-01		TCGA-AP-A051-01A-21R-A00W-13	
TCGA-AP-A052-01	MSS	1	TCGA-AP-A052-01	669	1	Squamous	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11			mutation cluster 3	TCGA-AP-A052			669	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	NO	NO	Progressive Disease	59	0	0	TCGA-AP-A052-F3393	Former User	Stage IVB	NO		-21721	2211	669	0				394	NO			2010-9-23	FEMALE	165	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	500	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	TCGA-AP-A052.830EF496-4672-4E9A-B662-DCB4678E99B0.pdf	0	1	3	1	1	5	2	0	0	0	0	20	15	75	83	90	85	negative	WITH TUMOR	0	0		1	Complete Remission/Response	No	Never Used		NO				R2	Primary Tumor	01	open		YES	NO	YES	AP	0	0	0	0	Endometrial	A	DECEASED	126	2004	2b64fee1-6e95-417d-b9b7-25bad9db4dc3	TCGA-AP-A052-01	TCGA-AP-A052-01			TCGA-AP-A052-01A-11D-A00X-01	TCGA-AP-A052-01	TCGA-AP-A052-01A-11D-A00U-05	2b64fee1-6e95-417d-b9b7-25bad9db4dc3		48950750-af24-4930-a739-4d029a0d5b2d		TCGA-AP-A052-01A-11W-A027-09	TCGA-AP-A052-01A-21-A162-20	52e7aae5-51fd-441c-a0d4-edea3cc46ec2	TCGA-AP-A052-01		TCGA-AP-A052-01A-11W-A027-09	TCGA-AP-A052-01A-11R-A00V-07	TCGA-AP-A052-01A-11W-A027-09	52e7aae5-51fd-441c-a0d4-edea3cc46ec2	TCGA-AP-A052-01A-11D-A00X-01			
TCGA-AP-A053-01	MSS	0	TCGA-AP-A053-01	2209	0	High	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 2	mutation cluster 3	TCGA-AP-A053			2209	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					90	0	0	TCGA-AP-A053-F6983	Never Used	Stage IA	NO		-32872	2163		0	181	2209			YES			2011-2-1	FEMALE	156	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	220	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	TCGA-AP-A053.6179478F-93BE-4C03-9F65-D74E66AFE449.pdf	25	0	0	0	0	15	8	0	0	0	30	2	2	83	60	98	70	negative	TUMOR FREE	0	0		2	Complete Remission/Response	Yes	Former User		YES				R0	Primary Tumor	01	open		NO	NO	YES	AP	0	3	0	12	Endometrial	A	LIVING	48	2004	bd558781-2e3b-4fb0-aeb8-a8cefbf3272d	TCGA-AP-A053-01	TCGA-AP-A053-01			TCGA-AP-A053-01A-21D-A00X-01	TCGA-AP-A053-01	TCGA-AP-A053-01A-21D-A00U-05	bd558781-2e3b-4fb0-aeb8-a8cefbf3272d		c6d00b82-9791-4c99-ac08-263a2bc2e33e	TCGA-AP-A053-01A-21R-A00W-13	TCGA-AP-A053-01A-21W-A027-09	TCGA-AP-A053-01A-11-A162-20	65e9e7d4-38f5-4690-835d-298b81b5971d	TCGA-AP-A053-01		TCGA-AP-A053-01A-21W-A027-09	TCGA-AP-A053-01A-21R-A00V-07	TCGA-AP-A053-01A-21W-A027-09	65e9e7d4-38f5-4690-835d-298b81b5971d	TCGA-AP-A053-01A-21D-A00X-01		TCGA-AP-A053-01A-21R-A00W-13	
TCGA-AP-A054-01	MSI-H	1	TCGA-AP-A054-01	709	1	Iq	C11-small-various	UCEC CIMP c18	cluster 1	OV-like c4	GBM-like c6	miRNA cluster 12	cluster 5	mutation cluster 8	TCGA-AP-A054			709	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	NO	NO	YES	Progressive Disease	64	0	0	TCGA-AP-A054-F3409	Never Used	Stage IIIC1	NO	604	-23404	2086	709	0				566	NO			2010-9-23	FEMALE	167	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	410	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	TCGA-AP-A054.72028DF7-DAD0-487E-914B-C3AA69A1E6C4.pdf	100	0	0	0	0	20	8	0	0	8	23	2	2	70	67	94	88	positive	WITH TUMOR	0	1		2	Complete Remission/Response	No	Never Used		NO	Other Method, Specify Below	Metastatic	R0	R1	Primary Tumor	01	open		YES	NO	YES	AP	0	4	1	22	Endometrial	A	DECEASED	75	2004	2fc92e79-f56f-46b9-b378-a242dd7642d6	TCGA-AP-A054-01	TCGA-AP-A054-01			TCGA-AP-A054-01A-11D-A042-01	TCGA-AP-A054-01	TCGA-AP-A054-01A-11D-A039-05	2fc92e79-f56f-46b9-b378-a242dd7642d6		566c65b2-4775-4ac8-b63d-21ed246b0523	TCGA-AP-A054-01A-11R-A041-13	TCGA-AP-A054-01A-11W-A062-09	TCGA-AP-A054-01A-21-A162-20	4a7f9325-d026-467b-8ab1-c69ab26f927d	TCGA-AP-A054-01			TCGA-AP-A054-01A-11R-A040-07	TCGA-AP-A054-01A-11W-A062-09	4a7f9325-d026-467b-8ab1-c69ab26f927d	TCGA-AP-A054-01A-11D-A042-01		TCGA-AP-A054-01A-11R-A041-13	
TCGA-AP-A056-01	MSI-L	0	TCGA-AP-A056-01	2618	0	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11			mutation cluster 11	TCGA-AP-A056	2618	0	2618	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	64	0	0	TCGA-AP-A056-F29046		Stage II	NO		-23707	2017		0	2618	2096			NO			2012-3-6	FEMALE	151	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES	Pap Smear	Other method, specify:	400	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-AP-A056.008786AD-6CA8-488D-A5AC-BA558985E765.pdf	96	14	1	0	0	6	3	0	0	0	0	40	25	54	72	60	88	negative	TUMOR FREE	0	0		2	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	AP	0	18	0	20	Endometrial	A	LIVING	56	2004	833990d5-5a6c-4d68-b15b-f2cc2309c611	TCGA-AP-A056-01	TCGA-AP-A056-01			TCGA-AP-A056-01A-11D-A00X-01	TCGA-AP-A056-01	TCGA-AP-A056-01A-11D-A00U-05	833990d5-5a6c-4d68-b15b-f2cc2309c611		7940cc0d-31a6-4780-9516-a7ddf53eebbf		TCGA-AP-A056-01A-11W-A027-09	TCGA-AP-A056-01A-21-A162-20	74c69c29-5fb9-4b23-afc5-a8f81db27163	TCGA-AP-A056-01			TCGA-AP-A056-01A-11R-A00V-07	TCGA-AP-A056-01A-11W-A027-09	74c69c29-5fb9-4b23-afc5-a8f81db27163	TCGA-AP-A056-01A-11D-A00X-01			
TCGA-AP-A059-01	MSI-H	0	TCGA-AP-A059-01	1461	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 5	cluster 4	mutation cluster 11	TCGA-AP-A059			1461	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					69	0	0	TCGA-AP-A059-F6985	Never Used	Stage IA	NO		-25311	1476		0	250	1461			NO			2011-2-1	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	230	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	TCGA-AP-A059.29A150D3-D5F0-4222-B082-6ABE35A2BB46.pdf	12	40	25	0	0	1	1	0	2	0	0	1	1	98	98	50	60	negative	TUMOR FREE	0	0		4+	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open		NO	NO	YES	AP	0	6	0	13	Endometrial	A	LIVING	99	2006	1d8b3e3b-590d-4087-9506-d6b0b2bab9a9		TCGA-AP-A059-01		TCGA-AP-A059-01A-21R-A119-13	TCGA-AP-A059-01A-21D-A120-01			1d8b3e3b-590d-4087-9506-d6b0b2bab9a9	TCGA-AP-A059-01A-21D-A123-05	f2b96570-cb63-4102-95c8-a42a6f59f620		TCGA-AP-A059-01A-21D-A122-09	TCGA-AP-A059-01A-11-A162-20	8bde26b5-b725-4632-b01b-34b3a46f53dc	TCGA-AP-A059-01				TCGA-AP-A059-01A-21D-A122-09	8bde26b5-b725-4632-b01b-34b3a46f53dc	TCGA-AP-A059-01A-21D-A120-01		TCGA-AP-A059-01A-21R-A119-13	
TCGA-AP-A05A-01	MSS	1	TCGA-AP-A05A-01	1944	1	High	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11			mutation cluster 5	TCGA-AP-A05A	1944	0	1944	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	81	0	0	TCGA-AP-A05A-F29051		Stage II	NO		-29914	1479	1944	0	1199	1634			YES			2012-3-6	FEMALE		Serous endometrial adenocarcinoma	No		NO	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	260	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-AP-A05A.1DAE9968-7D20-45A9-B2BC-5F32F6EC7A08.pdf	91	2	0	0	0	3	2	0	0	10	0	5	5	82	93	90	96	negative	TUMOR FREE	0	0		4+	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	AP	0	0	0	6	Endometrial	A	DECEASED		2006	02528092-3a7a-4ddf-8801-e47a48fdeafe	TCGA-AP-A05A-01	TCGA-AP-A05A-01			TCGA-AP-A05A-01A-11D-A00X-01	TCGA-AP-A05A-01	TCGA-AP-A05A-01A-11D-A00U-05	02528092-3a7a-4ddf-8801-e47a48fdeafe		4db12d27-16c1-4be7-b060-977f3f5caa30		TCGA-AP-A05A-01A-11W-A027-09	TCGA-AP-A05A-01A-21-A162-20	23a28001-6e8e-4895-9a47-6aa88288a422	TCGA-AP-A05A-01		TCGA-AP-A05A-01A-11W-A027-09	TCGA-AP-A05A-01A-11R-A00V-07	TCGA-AP-A05A-01A-11W-A027-09	23a28001-6e8e-4895-9a47-6aa88288a422	TCGA-AP-A05A-01A-11D-A00X-01			
TCGA-AP-A05D-01	MSS	0	TCGA-AP-A05D-01	1758	0	COAD-READ	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11			mutation cluster 3	TCGA-AP-A05D	1758	0	1758	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	67	0	1	TCGA-AP-A05D-F29055	Never Used	Stage IIIC2	YES		-24597	1063		0	1758				NO			2012-3-6	FEMALE	161	Serous endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	190	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-AP-A05D.3312F531-00A3-4104-8C9C-8734C32C89C0.pdf	73	8	10	0	0	1	1	0	0	0	0	15	20	84	79	80	70	negative	TUMOR FREE	0	1		2	Complete Remission/Response	Yes	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	AP	1	8	1	29	Endometrial	A	LIVING	98	2007	c60df680-5bd6-48cc-a112-985f73d9092c	TCGA-AP-A05D-01	TCGA-AP-A05D-01			TCGA-AP-A05D-01A-11D-A00X-01	TCGA-AP-A05D-01	TCGA-AP-A05D-01A-11D-A00U-05	c60df680-5bd6-48cc-a112-985f73d9092c		8949703e-7677-4a5f-9de7-19c9edbcf894		TCGA-AP-A05D-01A-11W-A027-09	TCGA-AP-A05D-01A-21-A162-20	a8954f27-46a7-4523-9ad5-c5b5bb0f4c3e	TCGA-AP-A05D-01		TCGA-AP-A05D-01A-11W-A027-09	TCGA-AP-A05D-01A-11R-A00V-07	TCGA-AP-A05D-01A-11W-A027-09	a8954f27-46a7-4523-9ad5-c5b5bb0f4c3e	TCGA-AP-A05D-01A-11D-A00X-01			
TCGA-AP-A05H-01	MSS	0	TCGA-AP-A05H-01	1385	0	High	C6-UCEC	OV-like c1	cluster 3	UCEC-like c5	UCEC-like c11			mutation cluster 13	TCGA-AP-A05H	1385	0	1385	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	75	0	0	TCGA-AP-A05H-F29059		Stage IB	NO		-27744	706		0	1385	863			NO			2012-3-6	FEMALE	153	Serous endometrial adenocarcinoma	No		YES	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	210	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-AP-A05H.805B997D-9755-4AC1-8695-294806148F25.pdf	61	1	3	0	0	5	10	0	0	10	15	5	10	80	65	90	75	negative	TUMOR FREE	0	0		3	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive		NO	NO	YES	AP	0	7	0	24	Endometrial	A	LIVING	89	2008	b3516570-4a66-418f-87e1-32829d67ec1c	TCGA-AP-A05H-01	TCGA-AP-A05H-01			TCGA-AP-A05H-01A-11D-A00X-01	TCGA-AP-A05H-01	TCGA-AP-A05H-01A-11D-A00U-05	b3516570-4a66-418f-87e1-32829d67ec1c		9e9c27a1-ebef-41dc-891a-7256f805297f		TCGA-AP-A05H-01A-11W-A027-09	TCGA-AP-A05H-01A-21-A162-20	66e3afd8-4b5c-41a2-a714-5b10444aaae7	TCGA-AP-A05H-01		TCGA-AP-A05H-01A-11W-A027-09	TCGA-AP-A05H-01A-11R-A00V-07	TCGA-AP-A05H-01A-11W-A027-09	66e3afd8-4b5c-41a2-a714-5b10444aaae7	TCGA-AP-A05H-01A-11D-A00X-01			
TCGA-AP-A05J-01	MSS	0	TCGA-AP-A05J-01	1122	0	COAD-READ	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11			mutation cluster 5	TCGA-AP-A05J	1122	0	1122	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	66	0	0	TCGA-AP-A05J-F29060		Stage II	NO		-24119	566		0	1122	729			NO			2012-3-6	FEMALE	168	Serous endometrial adenocarcinoma	No		NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	170	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-AP-A05J.C6426DA0-86C5-49CC-9983-A0002DA0D4F2.pdf	0	0	0	0	1	10	5	0	0	0	0	5	5	85	90	95	95	negative	TUMOR FREE	0	0		4+	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	AP	0	1	0	14	Endometrial	A	LIVING	79	2008	dbe07c69-fd67-4dcd-b69d-6bdc4a85110c	TCGA-AP-A05J-01	TCGA-AP-A05J-01			TCGA-AP-A05J-01A-11D-A00X-01	TCGA-AP-A05J-01	TCGA-AP-A05J-01A-11D-A00U-05	dbe07c69-fd67-4dcd-b69d-6bdc4a85110c		7b9d2566-40dc-4a4f-a4be-a5cd1e56bfa2		TCGA-AP-A05J-01A-11W-A027-09	TCGA-AP-A05J-01A-21-A162-20	60dab789-34da-4607-8a20-467b8adc2f7f	TCGA-AP-A05J-01		TCGA-AP-A05J-01A-11W-A027-09	TCGA-AP-A05J-01A-11R-A00V-07	TCGA-AP-A05J-01A-11W-A027-09	60dab789-34da-4607-8a20-467b8adc2f7f	TCGA-AP-A05J-01A-11D-A00X-01			
TCGA-AP-A05N-01	MSI-H	1	TCGA-AP-A05N-01	726	1	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11			mutation cluster 14	TCGA-AP-A05N	726	0	726	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	58	0	0	TCGA-AP-A05N-F16693	Former User	Stage IA	NO		-21254	232	726	0	239	394			NO		Scheduled Follow-up Submission	2011-9-23	FEMALE	162	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	350	NO		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1					NO	true	TCGA-AP-A05N.E4FF43F2-5CBD-4B68-9CD5-BE4E84AD67D5.pdf	23	20	15	5	10	5	5	10	20	0	0	20	30	75	65	75	65	negative	TUMOR FREE	0	0		3	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive		NO	NO	YES	AP	0	0	0	2	Endometrial	A	DECEASED	123	2009	63ba785b-9345-4cc3-b0af-a1a1d45b59b3	TCGA-AP-A05N-01	TCGA-AP-A05N-01			TCGA-AP-A05N-01A-11D-A00X-01	TCGA-AP-A05N-01	TCGA-AP-A05N-01A-11D-A00U-05	63ba785b-9345-4cc3-b0af-a1a1d45b59b3		e5eb1353-69a4-4a11-bb90-b4c98225b1da		TCGA-AP-A05N-01A-11W-A027-09	TCGA-AP-A05N-01A-21-A162-20	07e8b0ac-d1e2-4305-a0b7-67c214602f38	TCGA-AP-A05N-01		TCGA-AP-A05N-01A-11W-A027-09	TCGA-AP-A05N-01A-11R-A00V-07	TCGA-AP-A05N-01A-11W-A027-09	07e8b0ac-d1e2-4305-a0b7-67c214602f38	TCGA-AP-A05N-01A-11D-A00X-01			
TCGA-AP-A05O-01	MSI-H	0	TCGA-AP-A05O-01	384	0	Iq	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 5	cluster 4		TCGA-AP-A05O			384	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma			YES		68	0	0	TCGA-AP-A05O-F6987	Never Used	Stage IB	NO	344	-24978	209		0	371	384		340	YES			2011-2-1	FEMALE	158	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	270	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	TCGA-AP-A05O.9C8BD34A-DC49-4547-850A-80DCD2D073F8.pdf	80	10	20	20	20	10	5	20	20	0	0	50	35	40	60	45	60	negative	TUMOR FREE	0	0		3	Complete Remission/Response	No	Never Used		YES	Surgical Resection		RX	R0	Primary Tumor	01	Minimally Invasive		YES	NO	YES	AP	0	0	0	23	Endometrial	A	LIVING	103	2009	00186124-cecf-4580-9dca-cef7c09f741c		TCGA-AP-A05O-01		TCGA-AP-A05O-01A-12R-A119-13	TCGA-AP-A05O-01A-12D-A120-01			00186124-cecf-4580-9dca-cef7c09f741c	TCGA-AP-A05O-01A-12D-A123-05	fa95d970-8b04-40e4-b2df-1a2e9e2910e7			TCGA-AP-A05O-01A-21-A162-20	1a6daa42-b8de-48bb-a3a2-f3d686f39204	TCGA-AP-A05O-01					1a6daa42-b8de-48bb-a3a2-f3d686f39204	TCGA-AP-A05O-01A-12D-A120-01		TCGA-AP-A05O-01A-12R-A119-13	
TCGA-AP-A05P-01	MSS	0	TCGA-AP-A05P-01	636	0	Iq	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 6	mutation cluster 7	TCGA-AP-A05P	636	0	636	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	54	0	0	TCGA-AP-A05P-F16694	Never Used	Stage IA	NO		-20017	203		0	636				NO		Scheduled Follow-up Submission	2011-9-23	FEMALE	161	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	170	NO		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1					NO	true	TCGA-AP-A05P.5BA23C70-805A-4356-B739-AFBAFD29D7FC.pdf	0	10	5	5	5	0	5	10	10	0	0	10	10	90	85	90	85	negative	TUMOR FREE	0	0		1	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive		NO	NO	YES	AP	0	0	0	4	Endometrial	A	LIVING	74	2009	167b2ac1-034d-4eac-982e-b96f65bedfb2	TCGA-AP-A05P-01	TCGA-AP-A05P-01			TCGA-AP-A05P-01A-11D-A042-01	TCGA-AP-A05P-01	TCGA-AP-A05P-01A-11D-A039-05	167b2ac1-034d-4eac-982e-b96f65bedfb2		7e58efef-758a-4b54-a989-7e76ad97d014	TCGA-AP-A05P-01A-11R-A041-13	TCGA-AP-A05P-01A-11W-A062-09	TCGA-AP-A05P-01A-21-A162-20	22c16b8d-3df5-43fa-9730-5e68fe5cf67c	TCGA-AP-A05P-01		TCGA-AP-A05P-01A-11W-A062-09	TCGA-AP-A05P-01A-11R-A040-07	TCGA-AP-A05P-01A-11W-A062-09	22c16b8d-3df5-43fa-9730-5e68fe5cf67c	TCGA-AP-A05P-01A-11D-A042-01		TCGA-AP-A05P-01A-11R-A041-13	
TCGA-AP-A0L8-01	MSS	1	TCGA-AP-A0L8-01	1484	1	High	C6-UCEC	UCEC Serous c4	cluster 4		UCEC-like c11	miRNA cluster 13	cluster 6	mutation cluster 5	TCGA-AP-A0L8			1484	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	NO	YES	NO	Progressive Disease	70	0	1	TCGA-AP-A0L8-F3824	Never Used	Stage IIIC2	NO		-25733	3510	1484	0				1453	NO			2010-9-23	FEMALE		Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	110	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	TCGA-AP-A0L8.A708C154-A635-4423-A1A0-BB1FC23D3613.pdf	87	10	10	0	0	10	10	10	10	30	30	0	0	60	60	70	70	negative	WITH TUMOR	0	0		4+	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open		NO	NO	YES	AP	1	6	0	6	Endometrial	A	DECEASED	61	2000	ca1e32b0-7daf-403e-a3b2-7cfd3948cedf	TCGA-AP-A0L8-01	TCGA-AP-A0L8-01			TCGA-AP-A0L8-01A-11D-A042-01	TCGA-AP-A0L8-01	TCGA-AP-A0L8-01A-11D-A039-05	ca1e32b0-7daf-403e-a3b2-7cfd3948cedf			TCGA-AP-A0L8-01A-11R-A041-13	TCGA-AP-A0L8-01A-11W-A062-09		2638b4bd-34f9-4d01-8866-0efb68891e37	TCGA-AP-A0L8-01		TCGA-AP-A0L8-01A-11W-A062-09	TCGA-AP-A0L8-01A-11R-A040-07	TCGA-AP-A0L8-01A-11W-A062-09	2638b4bd-34f9-4d01-8866-0efb68891e37	TCGA-AP-A0L8-01A-11D-A042-01		TCGA-AP-A0L8-01A-11R-A041-13	
TCGA-AP-A0L9-01	MSS	0	TCGA-AP-A0L9-01	3815	0	High	C6-UCEC	UCEC Serous c4	cluster 3		UCEC-like c11	miRNA cluster 12	cluster 5	mutation cluster 3	TCGA-AP-A0L9	3815	0	3815	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	71	0	0	TCGA-AP-A0L9-F29042		Stage IA	NO		-26185	3402		0	3815	3456			NO			2012-3-6	FEMALE	152	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	140	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-AP-A0L9.62E44C56-838D-4318-B8F7-80476A148C03.pdf	0	20	20	0	0	20	20	20	20	0	0	0	0	80	80	100	100	negative	TUMOR FREE	0	0		3	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	AP	0	2	0	12	Endometrial	A	LIVING	60	2001	43abe272-41cb-4b54-b6f6-50a27c670e46	TCGA-AP-A0L9-01	TCGA-AP-A0L9-01			TCGA-AP-A0L9-01A-11D-A042-01	TCGA-AP-A0L9-01	TCGA-AP-A0L9-01A-11D-A039-05	43abe272-41cb-4b54-b6f6-50a27c670e46			TCGA-AP-A0L9-01A-11R-A041-13	TCGA-AP-A0L9-01A-11W-A062-09		cd42ea40-356d-4b7a-a89b-36527c038425	TCGA-AP-A0L9-01		TCGA-AP-A0L9-01A-11W-A062-09	TCGA-AP-A0L9-01A-11R-A040-07	TCGA-AP-A0L9-01A-11W-A062-09	cd42ea40-356d-4b7a-a89b-36527c038425	TCGA-AP-A0L9-01A-11D-A042-01		TCGA-AP-A0L9-01A-11R-A041-13	
TCGA-AP-A0LD-01	MSI-H	0	TCGA-AP-A0LD-01	3589	0	BRCA-LUAD+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 4	mutation cluster 1	TCGA-AP-A0LD	3589	0	3589	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	63	0	0	TCGA-AP-A0LD-F29043	Never Used	Stage IB	NO		-23216	2993		0	3589	3083			YES			2012-3-6	FEMALE	158	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	230	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-AP-A0LD.10B9E917-C1FB-480D-9DB2-8E93FA446ADC.pdf	87	10	10	0	0	10	10	10	10	10	10	0	0	80	80	90	90	negative	TUMOR FREE	0	0		1	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	AP	0	12	0	20	Endometrial	A	LIVING	68	2002	c094698b-0de5-4f14-9b3e-7f2deedde428	TCGA-AP-A0LD-01	TCGA-AP-A0LD-01			TCGA-AP-A0LD-01A-11D-A042-01	TCGA-AP-A0LD-01	TCGA-AP-A0LD-01A-11D-A039-05	c094698b-0de5-4f14-9b3e-7f2deedde428		833628b6-91ca-4896-9796-6d9f0f57dcf1	TCGA-AP-A0LD-01A-11R-A041-13	TCGA-AP-A0LD-01A-11W-A062-09	TCGA-AP-A0LD-01A-21-A162-20	dc745cc9-9d29-4776-bd4c-6d3cba65b367	TCGA-AP-A0LD-01		TCGA-AP-A0LD-01A-11W-A062-09	TCGA-AP-A0LD-01A-11R-A040-07	TCGA-AP-A0LD-01A-11W-A062-09	dc745cc9-9d29-4776-bd4c-6d3cba65b367	TCGA-AP-A0LD-01A-11D-A042-01		TCGA-AP-A0LD-01A-11R-A041-13	
TCGA-AP-A0LE-01	MSI-H	0	TCGA-AP-A0LE-01	3357	0	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 1	TCGA-AP-A0LE	3357	0	3357	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	57	0	0	TCGA-AP-A0LE-F29044	Former User	Stage IA	NO		-20967	2988		0	3357				YES			2012-3-6	FEMALE	160	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	170	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-AP-A0LE.3EA84930-6B34-43B8-A5A8-3D2B3754155F.pdf	5	1	5	0	1	1	1	0	0	0	0	5	20	94	79	95	85	negative	TUMOR FREE	0	0		3	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	AP	0	5	0	19	Endometrial	A	LIVING	75	2002	3701ff8a-afd6-4a3d-aae4-735325390d1f		TCGA-AP-A0LE-01			TCGA-AP-A0LE-01A-11D-A102-01		TCGA-AP-A0LE-01A-11D-A10Q-05	3701ff8a-afd6-4a3d-aae4-735325390d1f		164f62ff-a3be-465d-b511-eba500c9e7fa	TCGA-AP-A0LE-01A-11R-A103-13	TCGA-AP-A0LE-01A-11D-A127-09	TCGA-AP-A0LE-01A-21-A162-20	b5bb60b2-4d37-4925-9246-8fba432ab6a0	TCGA-AP-A0LE-01		TCGA-AP-A0LE-01A-11D-A127-09		TCGA-AP-A0LE-01A-11D-A127-09	b5bb60b2-4d37-4925-9246-8fba432ab6a0	TCGA-AP-A0LE-01A-11D-A102-01		TCGA-AP-A0LE-01A-11R-A103-13	
TCGA-AP-A0LF-01	MSS	0	TCGA-AP-A0LF-01	2859	0	High	C6-UCEC	UCEC Serous c4	cluster 4	BRCA basal-like c6	UCEC-like c11	miRNA cluster 13	cluster 2	mutation cluster 13	TCGA-AP-A0LF			2859	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					82	0	0	TCGA-AP-A0LF-F6989	Never Used	Stage IVB	NO		-30027	2891		0	103	2859			NO			2011-2-1	FEMALE	161	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	240	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	TCGA-AP-A0LF.7112CE75-9EFD-4989-9F2A-4D0F517B8EDE.pdf	17	0	0	0	0	0	0	0	0	0	0	0	0	100	100	60	60		WITH TUMOR	0	14		2		Yes	Never Used		NO				R2	Primary Tumor	01	open		NO	NO	YES	AP	0	10	14	32	Endometrial	A	LIVING	72	2002	2c5d86e0-2e3d-4259-97e9-023df54c8c56		TCGA-AP-A0LF-01		TCGA-AP-A0LF-01A-11R-A119-13	TCGA-AP-A0LF-01A-11D-A120-01			2c5d86e0-2e3d-4259-97e9-023df54c8c56	TCGA-AP-A0LF-01A-11D-A123-05	4f747b8b-48bd-4672-ad42-b142645b56f5		TCGA-AP-A0LF-01A-11D-A122-09	TCGA-AP-A0LF-01A-21-A162-20	d022d05c-c054-496c-a0c8-b80d9116b38c	TCGA-AP-A0LF-01		TCGA-AP-A0LF-01A-11D-A122-09		TCGA-AP-A0LF-01A-11D-A122-09	d022d05c-c054-496c-a0c8-b80d9116b38c	TCGA-AP-A0LF-01A-11D-A120-01		TCGA-AP-A0LF-01A-11R-A119-13	
TCGA-AP-A0LG-01	MSI-H	0	TCGA-AP-A0LG-01	2015	0	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 1	TCGA-AP-A0LG			2015	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					54	0	0	TCGA-AP-A0LG-F3848	Never Used	Stage IA	NO		-20047	2833		0	1921	2015			NO			2010-9-23	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	360	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	TCGA-AP-A0LG.7343A9B5-276E-4EE1-AC06-27835D63B0E2.pdf	18	0	0	0	0	20	0	0	0	0	0	0	0	80	100	90	90	negative	TUMOR FREE	0	0		3	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive		NO	NO	YES	AP	0	2	0	3	Endometrial	A	LIVING	76	2002	e4db21b5-9a76-47c1-b838-10f49d2696d0	TCGA-AP-A0LG-01	TCGA-AP-A0LG-01			TCGA-AP-A0LG-01A-11D-A042-01	TCGA-AP-A0LG-01	TCGA-AP-A0LG-01A-11D-A039-05	e4db21b5-9a76-47c1-b838-10f49d2696d0		7058b69a-0f87-471d-a36d-e355bc950f3e	TCGA-AP-A0LG-01A-11R-A041-13	TCGA-AP-A0LG-01A-11W-A062-09	TCGA-AP-A0LG-01A-21-A162-20	f861a0e5-c07e-4a23-b666-05f0ee71c4e8	TCGA-AP-A0LG-01		TCGA-AP-A0LG-01A-11W-A062-09	TCGA-AP-A0LG-01A-11R-A040-07	TCGA-AP-A0LG-01A-11W-A062-09	f861a0e5-c07e-4a23-b666-05f0ee71c4e8	TCGA-AP-A0LG-01A-11D-A042-01		TCGA-AP-A0LG-01A-11R-A041-13	
TCGA-AP-A0LH-01	MSS	1	TCGA-AP-A0LH-01	1106	1	High	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	COADREAD-like c15	miRNA c1uster 10	cluster 2	mutation cluster 3	TCGA-AP-A0LH			1106	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	NO	NO	Progressive Disease	60	0	0	TCGA-AP-A0LH-F3950	Never Used	Stage IA	NO		-22169	2772	1106	0				302	NO			2010-9-23	FEMALE	164	Mixed serous and endometrioid	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	210	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	TCGA-AP-A0LH.78E73020-1173-45DA-BDBA-DFB1CF7BCB41.pdf	0	0	0	0	0	0	0	0	0	30	5	0	0	70	95	60	90	positive	WITH TUMOR	0	0		2	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open		YES	NO	YES	AP	0	14	0	17	Endometrial	A	DECEASED	83	2002	39dbc57b-dd7d-4ebe-a905-47b500adef88	TCGA-AP-A0LH-01	TCGA-AP-A0LH-01			TCGA-AP-A0LH-01A-11D-A042-01	TCGA-AP-A0LH-01	TCGA-AP-A0LH-01A-11D-A039-05	39dbc57b-dd7d-4ebe-a905-47b500adef88		186cd641-e906-4f42-b3ce-8cf9b361ae3a	TCGA-AP-A0LH-01A-11R-A041-13	TCGA-AP-A0LH-01A-11W-A062-09	TCGA-AP-A0LH-01A-21-A162-20	8ca813fc-8942-458b-a9ab-544acbe0d06c	TCGA-AP-A0LH-01		TCGA-AP-A0LH-01A-11W-A062-09	TCGA-AP-A0LH-01A-11R-A040-07	TCGA-AP-A0LH-01A-11W-A062-09	8ca813fc-8942-458b-a9ab-544acbe0d06c	TCGA-AP-A0LH-01A-11D-A042-01		TCGA-AP-A0LH-01A-11R-A041-13	
TCGA-AP-A0LI-01	MSS	0	TCGA-AP-A0LI-01	2972	0	High	C6-UCEC	UCEC non-CIMP c3	cluster 4	BRCA basal-like c6	UCEC-like c11	miRNA cluster 14	cluster 2	mutation cluster 13	TCGA-AP-A0LI	2972	0	2972	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	67	0	2	TCGA-AP-A0LI-F29045	Never Used	Stage IIIC2	NO		-24573	2567		0	2972				NO			2012-3-6	FEMALE	161	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES	Cervical biopsy	Other method, specify:	180	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-AP-A0LI.EFEA05D7-E720-4FE4-977C-6A6369B1BA2E.pdf	83	0	0	0	0	0	0	0	0	0	0	0	0	100	100	90	85	negative	TUMOR FREE	0			4+	Complete Remission/Response	No	Never Used		NO				R2	Primary Tumor	01	open		NO	NO	YES	AP	2	3		26	Endometrial	A	LIVING	86	2003	0fd52e18-275a-4c3d-8c8d-9e27859a5482		TCGA-AP-A0LI-01			TCGA-AP-A0LI-01A-11D-A042-01		TCGA-AP-A0LI-01A-11D-A039-05	0fd52e18-275a-4c3d-8c8d-9e27859a5482		7625df56-46c8-401f-9fe3-d95d692bc04a	TCGA-AP-A0LI-01A-11R-A041-13	TCGA-AP-A0LI-01A-11W-A062-09	TCGA-AP-A0LI-01A-21-A162-20	930a8541-cf1b-4845-b336-1c6f93e320e2	TCGA-AP-A0LI-01		TCGA-AP-A0LI-01A-11W-A062-09		TCGA-AP-A0LI-01A-11W-A062-09	930a8541-cf1b-4845-b336-1c6f93e320e2	TCGA-AP-A0LI-01A-11D-A042-01		TCGA-AP-A0LI-01A-11R-A041-13	
TCGA-AP-A0LJ-01	MSS	0	TCGA-AP-A0LJ-01	1421	0	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 2	mutation cluster 4	TCGA-AP-A0LJ			1421	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					42	0	0	TCGA-AP-A0LJ-F3979	Never Used	Stage IA	NO		-15577	2290		0	965	1421			NO			2010-9-23	FEMALE	152	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	680	NO		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1						true	TCGA-AP-A0LJ.859CBF70-D72E-4843-B3AA-6226B707AA2B.pdf	0	0	0	0	0	0	0	0	0	0	0	0	0	100	100	75	75	negative	TUMOR FREE	0	0		2	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	AP	0	6	0	14	Endometrial	A	LIVING	80	2004	db3d4b8a-6ef3-4bb9-acca-2cbc4cf5f8c6	TCGA-AP-A0LJ-01	TCGA-AP-A0LJ-01			TCGA-AP-A0LJ-01A-11D-A042-01	TCGA-AP-A0LJ-01	TCGA-AP-A0LJ-01A-11D-A039-05	db3d4b8a-6ef3-4bb9-acca-2cbc4cf5f8c6		fe469d1c-3900-4649-a36e-562f8047f8e0	TCGA-AP-A0LJ-01A-11R-A041-13	TCGA-AP-A0LJ-01A-11W-A062-09	TCGA-AP-A0LJ-01A-21-A162-20	9bcbac18-118f-43d8-b9f9-191406f39b19	TCGA-AP-A0LJ-01		TCGA-AP-A0LJ-01A-11W-A062-09	TCGA-AP-A0LJ-01A-11R-A040-07	TCGA-AP-A0LJ-01A-11W-A062-09	9bcbac18-118f-43d8-b9f9-191406f39b19	TCGA-AP-A0LJ-01A-11D-A042-01		TCGA-AP-A0LJ-01A-11R-A041-13	
TCGA-AP-A0LL-01	MSS	0	TCGA-AP-A0LL-01	2554	0	Iq	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation c1uster 9	TCGA-AP-A0LL	2554	0	2554	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	NO	YES	Complete Response	56	0	0	TCGA-AP-A0LL-F29047		Stage IA	NO	792	-20700	2066		0	2554			790	NO			2012-3-6	FEMALE	161	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	160	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	TCGA-AP-A0LL.B4A6F5DE-E477-48FD-ADA1-EAE436FBC576.pdf	8	0	0	0	0	0	0	0	0	0	0	0	0	100	100	90	95	negative	TUMOR FREE	0	0		3	Complete Remission/Response	No	Never Used		NO	Other Method, Specify Below	LOCOREGIOL	R0	R0	Primary Tumor	01	open		NO	NO	YES	AP	0	8	0	29	Endometrial	A	LIVING	72	2004	96756b4d-0e43-404d-a819-dc6da126eef8		TCGA-AP-A0LL-01			TCGA-AP-A0LL-01A-12D-A102-01		TCGA-AP-A0LL-01A-12D-A10Q-05	96756b4d-0e43-404d-a819-dc6da126eef8		5b026f34-12b6-4dcc-838a-e65120aed9c7	TCGA-AP-A0LL-01A-12R-A103-13	TCGA-AP-A0LL-01A-12D-A127-09	TCGA-AP-A0LL-01A-21-A162-20	e1b809e3-d0ee-4d7e-8c8c-7c53b9cd67ac	TCGA-AP-A0LL-01		TCGA-AP-A0LL-01A-12D-A127-09		TCGA-AP-A0LL-01A-12D-A127-09	e1b809e3-d0ee-4d7e-8c8c-7c53b9cd67ac	TCGA-AP-A0LL-01A-12D-A102-01		TCGA-AP-A0LL-01A-12R-A103-13	
TCGA-AP-A0LM-01	MSS	0	TCGA-AP-A0LM-01	825	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 5	cluster 4	mutation cluster 11	TCGA-AP-A0LM			825	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					33	0	1	TCGA-AP-A0LM-F6990		Stage IIIC2	NO		-12309	2019		0	825				NO			2011-2-1	FEMALE	166	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	200	NO		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3						true	TCGA-AP-A0LM.BF380986-0279-41FC-AAE8-BA9772456CE6.pdf	71	0	0	0	0	0	0	0	0	60	15	0	0	40	85	30	65	negative	TUMOR FREE	0	0		1	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open		YES	NO	YES	AP	1	13	0	40	Endometrial	A	LIVING	100	2004	db91880d-1e53-4852-8a94-dd40e2b9aa6c		TCGA-AP-A0LM-01		TCGA-AP-A0LM-01A-11R-A119-13	TCGA-AP-A0LM-01A-11D-A120-01			db91880d-1e53-4852-8a94-dd40e2b9aa6c	TCGA-AP-A0LM-01A-11D-A123-05	11fa828b-c9e3-4bd4-b7c6-35f19ebeaa9a		TCGA-AP-A0LM-01A-11D-A122-09	TCGA-AP-A0LM-01A-21-A162-20	e0005839-1a18-491f-b31c-af4524f9e345	TCGA-AP-A0LM-01				TCGA-AP-A0LM-01A-11D-A122-09	e0005839-1a18-491f-b31c-af4524f9e345	TCGA-AP-A0LM-01A-11D-A120-01		TCGA-AP-A0LM-01A-11R-A119-13	
TCGA-AP-A0LN-01	MSS	0	TCGA-AP-A0LN-01	2510	0	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 4	TCGA-AP-A0LN	2510	0	2510	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	56			TCGA-AP-A0LN-F29048		Stage IA	NO		-20704	1907		0	2510				NO		Scheduled Follow-up Submission	2012-3-6	FEMALE	166	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	250	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	TCGA-AP-A0LN.D50C7207-D840-48A2-8D73-E1C71FFA73E1.pdf	0	0	0	0	0	0	0	0	0	0	0	0	0	100	100	80	85	negative	TUMOR FREE	0	0		0	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	AP		0	0	36	Endometrial	A	LIVING	119	2005	cc57fe2e-2370-4697-828f-eee51aacbe0b	TCGA-AP-A0LN-01	TCGA-AP-A0LN-01			TCGA-AP-A0LN-01A-11D-A042-01	TCGA-AP-A0LN-01	TCGA-AP-A0LN-01A-11D-A039-05	cc57fe2e-2370-4697-828f-eee51aacbe0b		dc2d620e-e811-473a-8780-61287fc2f992	TCGA-AP-A0LN-01A-11R-A041-13	TCGA-AP-A0LN-01A-11W-A062-09	TCGA-AP-A0LN-01A-21-A162-20	1c5e1b40-9050-4d80-b7a6-401b28b73fb5	TCGA-AP-A0LN-01		TCGA-AP-A0LN-01A-11W-A062-09	TCGA-AP-A0LN-01A-11R-A040-07	TCGA-AP-A0LN-01A-11W-A062-09	1c5e1b40-9050-4d80-b7a6-401b28b73fb5	TCGA-AP-A0LN-01A-11D-A042-01		TCGA-AP-A0LN-01A-11R-A041-13	
TCGA-AP-A0LO-01	MSS	1	TCGA-AP-A0LO-01	1016	1	BRCA-LUAD+	C6-UCEC	UCEC CIMP c18	cluster 2		UCEC-like c11			mutation cluster 4	TCGA-AP-A0LO			1016	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	NO	YES	YES	Complete Response	45	0	0	TCGA-AP-A0LO-F4021	Former User	Stage IA	NO	585	-16493	1894	1016	0				516	YES			2010-9-23	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	140	NO		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2						true	TCGA-AP-A0LO.DC0116C2-788E-46F5-A4AC-115D857C1F85.pdf	0	0	0	0	0	0	0	0	0	0	0	0	0	100	100	80	90	negative	WITH TUMOR	0	0		3	Complete Remission/Response	No	Never Used		NO	Other Method, Specify Below	LOCOREGIOL	R2	R0	Primary Tumor	01	Minimally Invasive		NO	NO	YES	AP	0	6	0	15	Endometrial	A	DECEASED	67	2005	e563cfb5-6904-45c6-acbb-ac96bfb9770b		TCGA-AP-A0LO-01		TCGA-AP-A0LO-01A-11R-A041-13	TCGA-AP-A0LO-01A-11D-A042-01		TCGA-AP-A0LO-01A-11D-A039-05	e563cfb5-6904-45c6-acbb-ac96bfb9770b				TCGA-AP-A0LO-01A-11W-A062-09		89b820f4-d8f2-490c-a3b5-8bc8ade34ce6	TCGA-AP-A0LO-01		TCGA-AP-A0LO-01A-11W-A062-09		TCGA-AP-A0LO-01A-11W-A062-09	89b820f4-d8f2-490c-a3b5-8bc8ade34ce6	TCGA-AP-A0LO-01A-11D-A042-01		TCGA-AP-A0LO-01A-11R-A041-13	
TCGA-AP-A0LP-01	MSI-H	0	TCGA-AP-A0LP-01	1875	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 14	TCGA-AP-A0LP			1875	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					76	0	0	TCGA-AP-A0LP-F4030	Never Used	Stage IA	NO		-27898	1884		0	1875				NO			2010-9-23	FEMALE	167	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	150	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1						true	TCGA-AP-A0LP.ECA6E3D1-141B-4DB1-90B6-FE6A2E355AD3.pdf	12	0	0	0	0	0	0	0	0	0	5	0	0	100	95	80	85	positive	TUMOR FREE	0	0		3	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open		YES	NO	YES	AP	0	10	0	17	Endometrial	A	LIVING	60	2005	1fea8c9c-7f1f-40d9-944a-f542b91c16b5		TCGA-AP-A0LP-01			TCGA-AP-A0LP-01A-12D-A102-01		TCGA-AP-A0LP-01A-12D-A10Q-05	1fea8c9c-7f1f-40d9-944a-f542b91c16b5		1a47b25b-e5b8-4d98-900b-f0d2d0abb3a8	TCGA-AP-A0LP-01A-12R-A103-13	TCGA-AP-A0LP-01A-12D-A10B-09	TCGA-AP-A0LP-01A-21-A162-20	cdcefa69-c1e3-49a6-bbf2-c2c7f1479324	TCGA-AP-A0LP-01		TCGA-AP-A0LP-01A-12D-A10B-09		TCGA-AP-A0LP-01A-12D-A10B-09	cdcefa69-c1e3-49a6-bbf2-c2c7f1479324	TCGA-AP-A0LP-01A-12D-A102-01		TCGA-AP-A0LP-01A-12R-A103-13	
TCGA-AP-A0LQ-01	MSS	0	TCGA-AP-A0LQ-01	2457	0	Kirc+		UCEC non-CIMP c3	cluster 4			miRNA cluster 11	cluster 2	mutation cluster 4	TCGA-AP-A0LQ	2457	0	2457	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	59	0	0	TCGA-AP-A0LQ-F29049		Stage IA	NO		-21629	1848		0	2457				NO			2012-3-6	FEMALE	163	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	170	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	TCGA-AP-A0LQ.D37DBE11-B7EA-4356-901C-35AF3A7FCC89.pdf	5	0	0	0	0	0	0	0	0	0	0	0	0	100	100	85	90	negative	TUMOR FREE	0	0		3	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	AP	0	6	0	33	Endometrial	A	LIVING	95	2005						TCGA-AP-A0LQ-01A-12D-A102-01		TCGA-AP-A0LQ-01A-12D-A10Q-05				TCGA-AP-A0LQ-01A-12R-A103-13	TCGA-AP-A0LQ-01A-12D-A10B-09		77b81c4a-4463-4611-a301-6f4398751fa1			TCGA-AP-A0LQ-01A-12D-A10B-09		TCGA-AP-A0LQ-01A-12D-A10B-09	77b81c4a-4463-4611-a301-6f4398751fa1	TCGA-AP-A0LQ-01A-12D-A102-01		TCGA-AP-A0LQ-01A-12R-A103-13	
TCGA-AP-A0LS-01	MSI-H	0	TCGA-AP-A0LS-01	1668	0	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-AP-A0LS	1668	0	1668	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	63	0	0	TCGA-AP-A0LS-F14429	Never Used	Stage IA	NO		-23126	1421		0	1668				YES		Scheduled Follow-up Submission	2011-9-23	FEMALE	169	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	200	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	TCGA-AP-A0LS.E802CEF6-BC3F-4C35-85E8-2B37531571CD.pdf	21	0	0	0	0	0	0	0	0	0	0	0	20	100	80	80	65		TUMOR FREE	0	0		2	Complete Remission/Response	Yes	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	AP	0	0	0	14	Endometrial	A	LIVING	81	2006	929006f8-5f5c-4215-80a9-0ff6a91ef1d6		TCGA-AP-A0LS-01		TCGA-AP-A0LS-01A-11R-A14C-13	TCGA-AP-A0LS-01A-11D-A14F-01			929006f8-5f5c-4215-80a9-0ff6a91ef1d6	TCGA-AP-A0LS-01A-11D-A14H-05				TCGA-AP-A0LS-01A-21-A18Q-20	df16dc83-a826-4d7c-a8ac-0da972e50ce9	TCGA-AP-A0LS-01					df16dc83-a826-4d7c-a8ac-0da972e50ce9	TCGA-AP-A0LS-01A-11D-A14F-01		TCGA-AP-A0LS-01A-11R-A14C-13	
TCGA-AP-A0LT-01	MSI-H	0	TCGA-AP-A0LT-01	1497	0	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 11	TCGA-AP-A0LT	1497	0	1497	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	57	0	0	TCGA-AP-A0LT-F29053	Former User	Stage II	NO		-21107			0	1497				NO			2012-3-6	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO			38																	negative	TUMOR FREE	0	0		1	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive		NO	NO	YES	AP	0	0	0	16	Endometrial		LIVING	91	2006	cda60e53-f917-454b-b1f5-d1f0f8b8f130	TCGA-AP-A0LT-01	TCGA-AP-A0LT-01			TCGA-AP-A0LT-01A-11D-A042-01	TCGA-AP-A0LT-01	TCGA-AP-A0LT-01A-11D-A039-05	cda60e53-f917-454b-b1f5-d1f0f8b8f130		d535b5d0-490a-41ce-8fbf-9d6b01dd164a	TCGA-AP-A0LT-01A-11R-A041-13	TCGA-AP-A0LT-01A-11W-A062-09	TCGA-AP-A0LT-01A-21-A162-20	d79b4dc6-d61d-4ca8-9654-429f0db7779c	TCGA-AP-A0LT-01		TCGA-AP-A0LT-01A-11W-A062-09	TCGA-AP-A0LT-01A-11R-A040-07	TCGA-AP-A0LT-01A-11W-A062-09	d79b4dc6-d61d-4ca8-9654-429f0db7779c	TCGA-AP-A0LT-01A-11D-A042-01		TCGA-AP-A0LT-01A-11R-A041-13	
TCGA-AP-A0LV-01	MSS	0	TCGA-AP-A0LV-01	763	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 2	mutation cluster 4	TCGA-AP-A0LV	763	0	763	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	39	0	0	TCGA-AP-A0LV-F29062	Former User	Stage IA	NO		-14556	341		0	763				NO			2012-3-6	FEMALE	152	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	280	NO		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1					NO	true	TCGA-AP-A0LV.75767B04-9FDF-4EE9-8DFF-350B60AF281C.pdf	36	0	0	0	0	0	0	0	0	0	0	0	0	100	100	90	85	negative	TUMOR FREE	0	0		0	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	AP	0	0	0	16	Endometrial	A	LIVING	76	2009	0d04e718-95ff-4eb9-b56f-99c0ee5970d2	TCGA-AP-A0LV-01	TCGA-AP-A0LV-01			TCGA-AP-A0LV-01A-11D-A042-01	TCGA-AP-A0LV-01	TCGA-AP-A0LV-01A-11D-A039-05	0d04e718-95ff-4eb9-b56f-99c0ee5970d2		f9285ff1-70d2-4e1c-b8ee-9ccde52d9d46	TCGA-AP-A0LV-01A-11R-A041-13	TCGA-AP-A0LV-01A-11W-A062-09	TCGA-AP-A0LV-01A-21-A162-20	c99e981c-8819-4376-b88a-08abbd6dd8c7	TCGA-AP-A0LV-01		TCGA-AP-A0LV-01A-11W-A062-09	TCGA-AP-A0LV-01A-11R-A040-07	TCGA-AP-A0LV-01A-11W-A062-09	c99e981c-8819-4376-b88a-08abbd6dd8c7	TCGA-AP-A0LV-01A-11D-A042-01		TCGA-AP-A0LV-01A-11R-A041-13	
TCGA-AP-A1DH-01		0	TCGA-AP-A1DH-01	1816	0	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5		TCGA-AP-A1DH	1816	0	1816	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	62	0	0	TCGA-AP-A1DH-F13621		Stage IA	NO		-22652	1843		0	1816				NO		Scheduled Follow-up Submission	2011-9-23	FEMALE	168	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	150	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-AP-A1DH.B77EE1CD-716C-4441-B4A9-CCCC37BD1379.pdf	41		0		0		15		0		0		0		85		80	negative	TUMOR FREE	0	0		3	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	2009	NO	NO	YES	AP	0	0	0	25	Endometrial	A	LIVING	127	2005	c5d7f9d3-70d3-469d-8588-5a125a24efa3		TCGA-AP-A1DH-01		TCGA-AP-A1DH-01A-31R-A136-13	TCGA-AP-A1DH-01A-31D-A134-01			c5d7f9d3-70d3-469d-8588-5a125a24efa3	TCGA-AP-A1DH-01A-31D-A138-05				TCGA-AP-A1DH-01A-21-A18Q-20	9231e670-3bd3-4a59-9768-0f0fc6856ed7	TCGA-AP-A1DH-01					9231e670-3bd3-4a59-9768-0f0fc6856ed7	TCGA-AP-A1DH-01A-31D-A134-01		TCGA-AP-A1DH-01A-31R-A136-13	
TCGA-AP-A1DK-01	MSI-H	0	TCGA-AP-A1DK-01	1650	0	Quiet		UCEC Serous c4	cluster 3		UCEC-like c11	miRNA cluster 13	cluster 4		TCGA-AP-A1DK	1650	0	1650	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	53	0	0	TCGA-AP-A1DK-F13645		Stage IA	NO		-19509	1541		0	1650				NO		Scheduled Follow-up Submission	2011-9-23	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	70	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-AP-A1DK.9A3BB88B-F16F-4773-8912-CF519B847354.pdf	36		20		0		20		20		0		20		60		80	negative	TUMOR FREE	0	0		4+	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	AP	0	7	0	20	Endometrial	A	LIVING	56	2006	13096ff9-ae2d-4ccb-8127-8e4238cef4d3		TCGA-AP-A1DK-01		TCGA-AP-A1DK-01A-11R-A136-13	TCGA-AP-A1DK-01A-11D-A134-01			13096ff9-ae2d-4ccb-8127-8e4238cef4d3	TCGA-AP-A1DK-01A-11D-A138-05					0b6883cd-f377-4ed8-b0e1-4bb1638998a0	TCGA-AP-A1DK-01					0b6883cd-f377-4ed8-b0e1-4bb1638998a0	TCGA-AP-A1DK-01A-11D-A134-01		TCGA-AP-A1DK-01A-11R-A136-13	
TCGA-AP-A1DM-01	MSI-H	0	TCGA-AP-A1DM-01	1457	0	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1		TCGA-AP-A1DM	1457	0	1457	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	60	0	0	TCGA-AP-A1DM-F13618	Former User	Stage IA	NO		-22239	1309		0	1457				NO		Scheduled Follow-up Submission	2011-9-23	FEMALE	159	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	110	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	TCGA-AP-A1DM.E25BA7AD-5C24-4953-B9C3-7509AE6E9F4C.pdf	23		20		20		20		20		20		20		40		60	negative	TUMOR FREE	0	0		0	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	AP	0	4	0	22	Endometrial	A	LIVING	92	2007	631c96e1-7e11-4c0f-a6ea-49cd942f4390		TCGA-AP-A1DM-01		TCGA-AP-A1DM-01A-21R-A136-13	TCGA-AP-A1DM-01A-21D-A134-01			631c96e1-7e11-4c0f-a6ea-49cd942f4390	TCGA-AP-A1DM-01A-21D-A138-05				TCGA-AP-A1DM-01A-11-A18Q-20	66f81eef-3a0d-407a-9826-8fd4c998bd61	TCGA-AP-A1DM-01					66f81eef-3a0d-407a-9826-8fd4c998bd61	TCGA-AP-A1DM-01A-21D-A134-01		TCGA-AP-A1DM-01A-21R-A136-13	
TCGA-AP-A1DO-01	MSI-H	0	TCGA-AP-A1DO-01	952	0	Iq	C6-UCEC	BRCA CIMP c7	cluster 1	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 1		TCGA-AP-A1DO	952	0	952	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	62	0	0	TCGA-AP-A1DO-F13624	Never Used	Stage IA	NO		-22787	1210		0	952				NO		Scheduled Follow-up Submission	2011-9-23	FEMALE	156	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	220	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	TCGA-AP-A1DO.EAC1A113-68BB-4D45-AB57-E59E392029BC.pdf	24		2		1		20		2		0		2		78		98	negative	TUMOR FREE	0	0		0	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	AP	0	9	0	17	Endometrial	A	LIVING	80	2007	6ff22866-1896-4200-bef2-f05724bf15a3		TCGA-AP-A1DO-01		TCGA-AP-A1DO-01A-11R-A136-13	TCGA-AP-A1DO-01A-11D-A134-01			6ff22866-1896-4200-bef2-f05724bf15a3	TCGA-AP-A1DO-01A-11D-A138-05				TCGA-AP-A1DO-01A-21-A18Q-20	e4000848-7248-4fa9-9420-9209c041b6ff	TCGA-AP-A1DO-01					e4000848-7248-4fa9-9420-9209c041b6ff	TCGA-AP-A1DO-01A-11D-A134-01		TCGA-AP-A1DO-01A-11R-A136-13	
TCGA-AP-A1DP-01	MSI-H	1	TCGA-AP-A1DP-01	1081	1	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 1		TCGA-AP-A1DP	831	1	1081	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	NO	NO	Progressive Disease	70	0	0	TCGA-AP-A1DP-F13648	Never Used	Stage IA	NO		-25601	1105	1081	0				831	YES		Scheduled Follow-up Submission	2011-9-23	FEMALE	158	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	YES	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	230	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2	Other, specify	Metastatic	Lung, liver, lymph nodes		YES	true	TCGA-AP-A1DP.20EEB047-0185-4B65-9A6A-43D6C97307C8.pdf	46		5		0		0		2		0		10		90		90	negative	WITH TUMOR	0	0		3	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	2009	NO	NO	YES	AP	0	7	0	17	Endometrial	A	DECEASED	83	2008	97b9cac2-2c23-4759-b558-24f7b90fe787		TCGA-AP-A1DP-01		TCGA-AP-A1DP-01A-11R-A136-13	TCGA-AP-A1DP-01A-11D-A134-01			97b9cac2-2c23-4759-b558-24f7b90fe787	TCGA-AP-A1DP-01A-11D-A138-05				TCGA-AP-A1DP-01A-21-A18Q-20	c5238ac3-dee7-46a4-adc3-8bc6ca4310b4	TCGA-AP-A1DP-01					c5238ac3-dee7-46a4-adc3-8bc6ca4310b4	TCGA-AP-A1DP-01A-11D-A134-01		TCGA-AP-A1DP-01A-11R-A136-13	
TCGA-AP-A1DQ-01	MSS	0	TCGA-AP-A1DQ-01	1276	0	Squamous	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 2	mutation cluster 3	TCGA-AP-A1DQ	905	1	1276	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	YES	NO	Progressive Disease	76	0	0	TCGA-AP-A1DQ-F13651	Former User	Stage IIIC1	NO		-27815	1074		0	1276			905	NO		Scheduled Follow-up Submission	2011-9-23	FEMALE	163	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	100	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	High Grade	Other, specify	Metastatic	Lymph nodes, lung, bone		YES	true	TCGA-AP-A1DQ.F5983E58-F466-42CF-8905-B942D2BDF702.pdf	82		3		4		0		3		0		30		70		70	negative	WITH TUMOR	0	6		0	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	2009	YES	NO	YES	AP	0	1	6	20	Endometrial	A	LIVING	60	2008	19d3602e-79e6-467f-b49d-c2fa216418ed		TCGA-AP-A1DQ-01		TCGA-AP-A1DQ-01A-11R-A136-13	TCGA-AP-A1DQ-01A-11D-A134-01			19d3602e-79e6-467f-b49d-c2fa216418ed	TCGA-AP-A1DQ-01A-11D-A138-05			TCGA-AP-A1DQ-01A-11D-A135-09	TCGA-AP-A1DQ-01A-21-A18Q-20	7810f823-458a-45e4-909a-e87c29f96449	TCGA-AP-A1DQ-01				TCGA-AP-A1DQ-01A-11D-A135-09	7810f823-458a-45e4-909a-e87c29f96449	TCGA-AP-A1DQ-01A-11D-A134-01		TCGA-AP-A1DQ-01A-11R-A136-13	
TCGA-AP-A1DR-01	MSI-H	0	TCGA-AP-A1DR-01	1332	0	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 1		TCGA-AP-A1DR	1332	0	1332	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	59	0	0	TCGA-AP-A1DR-F13626	Never Used	Stage IIIC1	NO		-21904	1095		0	1332				YES		Scheduled Follow-up Submission	2011-9-23	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	270	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	TCGA-AP-A1DR.75A10A08-04CB-49C2-8086-5F7B1D57524E.pdf	27		4		6		2		2		0		10		88		90	negative	TUMOR FREE	2	0		2	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009	YES	NO	YES	AP	0	0	2	18	Endometrial	A	LIVING	109	2008	2aacc974-7ee5-4be2-b511-1543745df0bf		TCGA-AP-A1DR-01		TCGA-AP-A1DR-01A-11R-A136-13	TCGA-AP-A1DR-01A-11D-A134-01			2aacc974-7ee5-4be2-b511-1543745df0bf	TCGA-AP-A1DR-01A-11D-A138-05				TCGA-AP-A1DR-01A-21-A18Q-20	5150ed45-bff8-4bad-81e4-0e987a9a9c4f	TCGA-AP-A1DR-01					5150ed45-bff8-4bad-81e4-0e987a9a9c4f	TCGA-AP-A1DR-01A-11D-A134-01		TCGA-AP-A1DR-01A-11R-A136-13	
TCGA-AP-A1DV-01	MSI-L	0	TCGA-AP-A1DV-01	204	0	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-AP-A1DV	204	0	204	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	59	0	0	TCGA-AP-A1DV-F13635	Former User	Stage II	NO		-21901	876		0	204				NO		Scheduled Follow-up Submission	2011-9-23	FEMALE	147	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	170	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-AP-A1DV.F3163501-DD37-4C13-A921-3C2A74928BA7.pdf	94		2		4		5		2		0		10		85		90	negative	TUMOR FREE	0	0		0	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	2009	NO	NO	YES	AP	0	5	0	21	Endometrial	A	LIVING	46	2008	ca0261c0-0935-450b-9e9c-db02f92ecb0e		TCGA-AP-A1DV-01		TCGA-AP-A1DV-01A-21R-A136-13	TCGA-AP-A1DV-01A-21D-A134-01			ca0261c0-0935-450b-9e9c-db02f92ecb0e	TCGA-AP-A1DV-01A-21D-A138-05				TCGA-AP-A1DV-01A-11-A18Q-20	28c530f1-d81c-4a5a-b1fe-88ba61a92d2e	TCGA-AP-A1DV-01					28c530f1-d81c-4a5a-b1fe-88ba61a92d2e	TCGA-AP-A1DV-01A-21D-A134-01		TCGA-AP-A1DV-01A-21R-A136-13	
TCGA-AP-A1E0-01	MSI-L	0	TCGA-AP-A1E0-01	814	0	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 6		TCGA-AP-A1E0	814	0	814	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	40	0	1	TCGA-AP-A1E0-F13637	Former User	Stage IIIC2	NO		-14653	582		0	814				NO		Scheduled Follow-up Submission	2011-9-23	FEMALE	158	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	110	NO		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2					NO	true	TCGA-AP-A1E0.700FD29A-69DC-4B34-B841-FFFA7E76A5AF.pdf	35		0		0		0		0		0		0		100		85	positive	TUMOR FREE	0	0		0	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	YES	NO	YES	AP	0	9	0	3	Endometrial	A	LIVING	59	2009	d2b4e23b-6cfa-4831-b0ea-8d15f2a55e61		TCGA-AP-A1E0-01		TCGA-AP-A1E0-01A-11R-A136-13	TCGA-AP-A1E0-01A-11D-A134-01			d2b4e23b-6cfa-4831-b0ea-8d15f2a55e61	TCGA-AP-A1E0-01A-11D-A138-05				TCGA-AP-A1E0-01A-21-A18Q-20	361afe43-3800-41c5-b113-6590d0012c37	TCGA-AP-A1E0-01					361afe43-3800-41c5-b113-6590d0012c37	TCGA-AP-A1E0-01A-11D-A134-01		TCGA-AP-A1E0-01A-11R-A136-13	
TCGA-AP-A1E1-01	MSI-H	0	TCGA-AP-A1E1-01	317	0	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1		TCGA-AP-A1E1	317	0	317	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	74	0	0	TCGA-AP-A1E1-F13647		Stage IA	NO		-27072	470		0	317				NO		Scheduled Follow-up Submission	2011-9-23	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	Yes, I am currently taking menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	260	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	TCGA-AP-A1E1.E8873536-294D-4E41-9165-EE403A11B439.pdf	10		0		0		0		0		0		0		100		70	negative	TUMOR FREE	0	0		2	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	AP	0	0	0	2	Endometrial	A	LIVING	73	2009	2e11f69d-8c0d-484e-8f22-1ad97f26c78d		TCGA-AP-A1E1-01		TCGA-AP-A1E1-01A-11R-A136-13	TCGA-AP-A1E1-01A-11D-A134-01			2e11f69d-8c0d-484e-8f22-1ad97f26c78d	TCGA-AP-A1E1-01A-11D-A138-05				TCGA-AP-A1E1-01A-21-A18Q-20	8b05dfaa-157b-46d4-9ea1-dd4f39eb0ca0	TCGA-AP-A1E1-01					8b05dfaa-157b-46d4-9ea1-dd4f39eb0ca0	TCGA-AP-A1E1-01A-11D-A134-01		TCGA-AP-A1E1-01A-11R-A136-13	
TCGA-AP-A1E3-01	MSS	0	TCGA-AP-A1E3-01	679	0	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 5	cluster 4		TCGA-AP-A1E3	679	0	679	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Partial Response	45	0	0	TCGA-AP-A1E3-F13655	Never Used	Stage IIIC1	NO		-16544	440		0	679				NO		Scheduled Follow-up Submission	2011-9-23	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	350	NO		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3					NO	true	TCGA-AP-A1E3.FDA2C217-5267-41CC-AC07-CBACFF8E7B8D.pdf	77		0		0		5		0		0		30		65		60	negative	WITH TUMOR	0	1		0	Partial Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	2009	YES	NO	YES	AP	0	0	1	1	Endometrial	A	LIVING	130	2009	0aa199cd-4fa0-4773-9659-1a246e42ad88		TCGA-AP-A1E3-01		TCGA-AP-A1E3-01A-11R-A136-13	TCGA-AP-A1E3-01A-11D-A134-01			0aa199cd-4fa0-4773-9659-1a246e42ad88	TCGA-AP-A1E3-01A-11D-A138-05				TCGA-AP-A1E3-01A-21-A18Q-20	f524c423-2abd-49e9-ab79-3d52f3cc1a35	TCGA-AP-A1E3-01					f524c423-2abd-49e9-ab79-3d52f3cc1a35	TCGA-AP-A1E3-01A-11D-A134-01		TCGA-AP-A1E3-01A-11R-A136-13	
TCGA-AP-A1E4-01	MSS	0	TCGA-AP-A1E4-01	407	0	Iq	C6-UCEC	OV-like c1	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 6		TCGA-AP-A1E4	158	1	407	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	NO	NO	Complete Response	54	0	0	TCGA-AP-A1E4-F13641	Former User	Stage IB	NO		-19814	154		0	407			158	NO		Scheduled Follow-up Submission	2011-9-23	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	90	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2	Other, specify	Metastatic	Bone, lymph nodes		YES	true	TCGA-AP-A1E4.1E33ABA3-0B55-4021-A370-DB8E2CA4C022.pdf	58		0		0		0		0		0		20		80		75	negative	TUMOR FREE	0	0		2	Progressive Disease	No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	AP	0	0	0	3	Endometrial	A	LIVING	54	2010	2a549626-7bc3-4ba9-9822-35af631afd0c		TCGA-AP-A1E4-01		TCGA-AP-A1E4-01A-12R-A136-13	TCGA-AP-A1E4-01A-12D-A134-01			2a549626-7bc3-4ba9-9822-35af631afd0c	TCGA-AP-A1E4-01A-12D-A138-05				TCGA-AP-A1E4-01A-21-A18Q-20	65bbac25-550d-4063-8d92-dd51f2829b29	TCGA-AP-A1E4-01					65bbac25-550d-4063-8d92-dd51f2829b29	TCGA-AP-A1E4-01A-12D-A134-01		TCGA-AP-A1E4-01A-12R-A136-13	
TCGA-AP-A3K1-01	MSI-L	1	TCGA-AP-A3K1-01	666	1	High		UCEC Serous c4		UCEC-like c5		miRNA cluster 13			TCGA-AP-A3K1	198	1	666	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	NO		Progressive Disease	56	0	12	TCGA-AP-A3K1-F38425	Never Used	Stage IVB	NO		-20594		666	0	555			198	NO			2012-12-14	FEMALE	157	Serous endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8441/3	C54.1	YES		Cytology (e.g. Peritoneal or pleural fluid)			NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	High Grade	Other, specify	Locoregional Recurrence	Paracolic gutter	NO	YES			58.8																	positive	WITH TUMOR	0	3	YES	0	Progressive Disease	No	Never Used		NO				RX	Primary Tumor	01	open	2009		NO	YES	AP	12	29	3	34	Endometrial		DECEASED	60	2010			TCGA-AP-A3K1-01	c6b592eb-d131-4344-9135-7d9964143c28	TCGA-AP-A3K1-01A-11R-A214-13	TCGA-AP-A3K1-01A-11D-A20R-01				TCGA-AP-A3K1-01A-11D-A212-05				TCGA-AP-A3K1-01A-21-A23Z-20	b572cdd5-ce2e-44f6-91e0-9cfaf1587476	TCGA-AP-A3K1-01	c6b592eb-d131-4344-9135-7d9964143c28				b572cdd5-ce2e-44f6-91e0-9cfaf1587476	TCGA-AP-A3K1-01A-11D-A20R-01	c6b592eb-d131-4344-9135-7d9964143c28	TCGA-AP-A3K1-01A-11R-A214-13	c6b592eb-d131-4344-9135-7d9964143c28
TCGA-AP-A5FX-01	MSS	1	TCGA-AP-A5FX-01	1099	1										TCGA-AP-A5FX	1099	0	1099	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Progressive Disease	68	0	0	TCGA-AP-A5FX-F58067	Never Used	Stage IIIC1	NO		-25063		1099	0	1026				YES			2014-3-31	FEMALE	168	Mixed serous and endometrioid	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8255/3	C54.1	YES		Dilation and curettage procedure			NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO			96																	positive	WITH TUMOR	0	4	YES	4+	Complete Remission/Response	No	Never Used		YES				RX	Primary Tumor	01	open	2009		NO	YES	AP	0	0	4	4	Endometrial		DECEASED	80	2010			TCGA-AP-A5FX-01	e55857c5-0581-471c-ba7a-cd9b83afbc14	TCGA-AP-A5FX-01A-11R-A27R-13	TCGA-AP-A5FX-01A-11D-A27O-01				TCGA-AP-A5FX-01A-11D-A27Y-05					a81f2e88-d57f-4368-8f65-9e1738d8da39	TCGA-AP-A5FX-01	e55857c5-0581-471c-ba7a-cd9b83afbc14				a81f2e88-d57f-4368-8f65-9e1738d8da39	TCGA-AP-A5FX-01A-11D-A27O-01	e55857c5-0581-471c-ba7a-cd9b83afbc14	TCGA-AP-A5FX-01A-11R-A27R-13	e55857c5-0581-471c-ba7a-cd9b83afbc14
TCGA-AW-A1PO-01	MSS	0	TCGA-AW-A1PO-01	17	0	High	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5		TCGA-AW-A1PO			17	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					66	0	0	TCGA-AW-A1PO-F68990		Stage IIIA			-24225	331		0	17							2014-12-24	FEMALE	162	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Tumor resection	190	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	TCGA-AW-A1PO.B5351001-32B2-4BA9-998D-F6631F6BE705.pdf	70		40		20		20		30		0		10		70		70		TUMOR FREE	0	0	NO			No			NO				R0	Primary Tumor	01	open	2009		NO	YES	AW	0	0	0	7	Endometrial	A	LIVING	58	2010	c9bdd9d8-f0f6-4abb-aca8-11d274f90995		TCGA-AW-A1PO-01		TCGA-AW-A1PO-01A-12R-A156-13	TCGA-AW-A1PO-01A-12D-A160-01			c9bdd9d8-f0f6-4abb-aca8-11d274f90995	TCGA-AW-A1PO-01A-12D-A161-05				TCGA-AW-A1PO-01A-21-A18Q-20	6e1efa7d-86cc-406a-a604-a399e2a115b4	TCGA-AW-A1PO-01					6e1efa7d-86cc-406a-a604-a399e2a115b4	TCGA-AW-A1PO-01A-12D-A160-01		TCGA-AW-A1PO-01A-12R-A156-13	
TCGA-AX-A05S-01	MSI-H	1	TCGA-AX-A05S-01	413	1	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 2	mutation cluster 4	TCGA-AX-A05S			413	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma			NO		81		0	TCGA-AX-A05S-F5583		Stage IIIC	NO		-29928	507	413	0				338	NO			2011-5-23	FEMALE	152	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	230	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	TCGA-AX-A05S.571B1EC2-3698-4FF2-89DD-7C5A8A048660.pdf	50	1	14	0	0	10	1	1	0	25	14	0	0	65	85	70	80	negative	WITH TUMOR		5		3	Progressive Disease	No			YES				R2	Primary Tumor	01	open	1988	YES	NO	YES	AX	0	4	5	18	Endometrial	A	DECEASED	48	2008	f9533750-9b2f-44a2-8b4e-941fe0c53acb	TCGA-AX-A05S-01	TCGA-AX-A05S-01			TCGA-AX-A05S-01A-11D-A00X-01	TCGA-AX-A05S-01	TCGA-AX-A05S-01A-11D-A00U-05	f9533750-9b2f-44a2-8b4e-941fe0c53acb		51e13f14-0aa7-4df2-a28c-9b20734eec2e	TCGA-AX-A05S-01A-11R-A00W-13	TCGA-AX-A05S-01A-11W-A027-09	TCGA-AX-A05S-01A-21-A162-20	9efd702f-cac2-44f9-9e05-1106b263a657	TCGA-AX-A05S-01		TCGA-AX-A05S-01A-11W-A027-09	TCGA-AX-A05S-01A-11R-A00V-07	TCGA-AX-A05S-01A-11W-A027-09	9efd702f-cac2-44f9-9e05-1106b263a657	TCGA-AX-A05S-01A-11D-A00X-01		TCGA-AX-A05S-01A-11R-A00W-13	
TCGA-AX-A05T-01	MSS	0	TCGA-AX-A05T-01	603	0	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 4	TCGA-AX-A05T			603	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					82		0	TCGA-AX-A05T-F5581		Stage IB	NO		-30137	310		0	603							2011-5-23	FEMALE	161	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	160	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1						false	TCGA-AX-A05T.85F75553-6E10-4AF5-9BDF-DAB52D00615B.pdf	50	1	1	3	1	10	10	1	1	2	2	5	5	83	83	85	85	negative	TUMOR FREE		0		4+	Complete Remission/Response	No			NO				R1	Primary Tumor	01	Minimally Invasive	1988	NO	NO	YES	AX	0	7	0	14	Endometrial	A	LIVING	61	2009	8cfdaa7a-34fe-4b0f-9916-60e7158c893e	TCGA-AX-A05T-01	TCGA-AX-A05T-01			TCGA-AX-A05T-01A-11D-A00X-01	TCGA-AX-A05T-01	TCGA-AX-A05T-01A-11D-A00U-05	8cfdaa7a-34fe-4b0f-9916-60e7158c893e		92b1baec-3052-4773-ab10-466cfb9cce84	TCGA-AX-A05T-01A-11R-A00W-13	TCGA-AX-A05T-01A-11W-A027-09	TCGA-AX-A05T-01A-21-A162-20	988118b4-bf87-4358-aa57-103ed67f68ad	TCGA-AX-A05T-01		TCGA-AX-A05T-01A-11W-A027-09	TCGA-AX-A05T-01A-11R-A00V-07	TCGA-AX-A05T-01A-11W-A027-09	988118b4-bf87-4358-aa57-103ed67f68ad	TCGA-AX-A05T-01A-11D-A00X-01		TCGA-AX-A05T-01A-11R-A00W-13	
TCGA-AX-A05U-01	MSS	0	TCGA-AX-A05U-01	903	0	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 4	TCGA-AX-A05U			903	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					56		0	TCGA-AX-A05U-F5579		Stage IB	NO		-20533	500		0	903				YES			2011-5-23	FEMALE	155	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	180	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1						false	TCGA-AX-A05U.1F51E982-37A1-40C6-BFAC-782B93D9967F.pdf	50	0	0	0	0	5	5	0	0	2	12	3	3	90	80	90	85	negative	TUMOR FREE		0		4+	Complete Remission/Response	No			NO				R0	Primary Tumor	01	Minimally Invasive	1988	NO	NO	YES	AX	0	11	0	12	Endometrial	A	LIVING	62	2008	cadb8d53-b172-421d-ac3e-1583f5e55049	TCGA-AX-A05U-01	TCGA-AX-A05U-01			TCGA-AX-A05U-01A-11D-A00X-01	TCGA-AX-A05U-01	TCGA-AX-A05U-01A-11D-A00U-05	cadb8d53-b172-421d-ac3e-1583f5e55049		83bdfcc6-9e1f-4683-ad35-d6978da1a959	TCGA-AX-A05U-01A-11R-A00W-13	TCGA-AX-A05U-01A-11W-A027-09	TCGA-AX-A05U-01A-21-A162-20	296801a3-cb05-4b70-8686-50210308a4c8	TCGA-AX-A05U-01		TCGA-AX-A05U-01A-11W-A027-09	TCGA-AX-A05U-01A-11R-A00V-07	TCGA-AX-A05U-01A-11W-A027-09	296801a3-cb05-4b70-8686-50210308a4c8	TCGA-AX-A05U-01A-11D-A00X-01		TCGA-AX-A05U-01A-11R-A00W-13	
TCGA-AX-A05W-01	MSS	0	TCGA-AX-A05W-01	2079	0	BRCA-LUAD+	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5		miRNA cluster 4	cluster 2	mutation cluster 1	TCGA-AX-A05W			2079	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					60		0	TCGA-AX-A05W-F5572		Stage IIB	NO		-22200	1935		0	2079							2011-5-23	FEMALE	161	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	210	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1						false	TCGA-AX-A05W.4C960E79-D109-4C4C-B99F-F73D4DD73B40.pdf	50	3	3	0	0	5	10	2	0	6	3	4	2	85	85	90	95	negative	TUMOR FREE		0		2	Complete Remission/Response	No			NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	6	0	15	Endometrial	A	LIVING	74	2004		TCGA-AX-A05W-01				TCGA-AX-A05W-01A-21D-A00X-01	TCGA-AX-A05W-01	TCGA-AX-A05W-01A-21D-A00U-05			2ddfa76d-9935-4b66-bac4-051e44960a93	TCGA-AX-A05W-01A-21R-A00W-13	TCGA-AX-A05W-01A-21W-A027-09	TCGA-AX-A05W-01A-11-A162-20	e99f4134-39c5-45ed-b010-d5fd1bb588bd			TCGA-AX-A05W-01A-21W-A027-09	TCGA-AX-A05W-01A-21R-A00V-07	TCGA-AX-A05W-01A-21W-A027-09	e99f4134-39c5-45ed-b010-d5fd1bb588bd	TCGA-AX-A05W-01A-21D-A00X-01		TCGA-AX-A05W-01A-21R-A00W-13	
TCGA-AX-A05Y-01	MSI-H	0	TCGA-AX-A05Y-01	2191	0	Iq	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 4	TCGA-AX-A05Y			2191	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	NO	NO	YES		57		0	TCGA-AX-A05Y-F5568		Stage IB	NO		-20904	1967		0	2191			194	YES			2011-5-23	FEMALE	166	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	230	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1						false	TCGA-AX-A05Y.7E7D9403-AA77-4F14-9017-3B69F66D8EBC.pdf	50	0	0	0	0	2	3	2	5	0	0	2	5	96	92	96	92	negative	TUMOR FREE		0		4+	Complete Remission/Response	No			NO	Other Method, Specify Below	Whipple Procedure		R0	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	6	0	24	Endometrial	A	LIVING	92	2004	153cecfe-8963-4b96-8cc3-d2870ce8e584	TCGA-AX-A05Y-01	TCGA-AX-A05Y-01			TCGA-AX-A05Y-01A-11D-A00X-01	TCGA-AX-A05Y-01	TCGA-AX-A05Y-01A-11D-A00U-05	153cecfe-8963-4b96-8cc3-d2870ce8e584		52ef3e35-2a73-4880-91be-e768e8dd7d08	TCGA-AX-A05Y-01A-11R-A00W-13	TCGA-AX-A05Y-01A-11W-A027-09	TCGA-AX-A05Y-01A-21-A162-20	19a46451-57c1-4d2c-8154-50a110ce28eb	TCGA-AX-A05Y-01		TCGA-AX-A05Y-01A-11W-A027-09	TCGA-AX-A05Y-01A-11R-A00V-07	TCGA-AX-A05Y-01A-11W-A027-09	19a46451-57c1-4d2c-8154-50a110ce28eb	TCGA-AX-A05Y-01A-11D-A00X-01		TCGA-AX-A05Y-01A-11R-A00W-13	
TCGA-AX-A05Y-11	MSI-H	0	TCGA-AX-A05Y-11	2191	0		C6-UCEC							mutation cluster 4	TCGA-AX-A05Y			2191	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	NO	NO	YES		57		0	TCGA-AX-A05Y-F5568		Stage IB	NO		-20904	2391		0	2191			194	YES			2011-5-23	FEMALE	166	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	140	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1						false		50		0		0		0		0		100		0		0		0	negative	TUMOR FREE		0		4+	Complete Remission/Response	No			NO	Other Method, Specify Below	Whipple Procedure		R0	Solid Tissue Normal	11	open	1988	NO	NO	YES	AX	0	6	0	24	Endometrial	A	LIVING	92	2004				1011cb92-17a6-48b0-95ab-da22acddfb5a	TCGA-AX-A05Y-11A-11R-A27R-13					TCGA-AX-A05Y-11A-11D-A27Y-05							1011cb92-17a6-48b0-95ab-da22acddfb5a						1011cb92-17a6-48b0-95ab-da22acddfb5a	TCGA-AX-A05Y-11A-11R-A27R-13	1011cb92-17a6-48b0-95ab-da22acddfb5a
TCGA-AX-A05Z-01	MSS	0	TCGA-AX-A05Z-01	1413	0	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 2	mutation cluster 11	TCGA-AX-A05Z			1413	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					37		0	TCGA-AX-A05Z-F5560		Stage IIIA	NO		-13529	1416		0	1413							2011-5-24	FEMALE	150	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	180	NO		Indeterminate (neither Pre or Postmenopausal)	G2						false	TCGA-AX-A05Z.5938A010-17E7-41FB-9F4D-8B4F1A3C0F2F.pdf	50	5	10	0	0	10	10	0	0	0	0	10	10	80	80	80	80	negative	TUMOR FREE		0			Complete Remission/Response	No			NO				R1	Primary Tumor	01	Minimally Invasive	1988	YES	NO	YES	AX	0	7	0	13	Endometrial	A	LIVING	66	2006	5e6246e7-35a3-4ce5-b234-b4dec034a6a8	TCGA-AX-A05Z-01	TCGA-AX-A05Z-01			TCGA-AX-A05Z-01A-11D-A00X-01	TCGA-AX-A05Z-01	TCGA-AX-A05Z-01A-11D-A00U-05	5e6246e7-35a3-4ce5-b234-b4dec034a6a8		5adb0efc-74e1-4c20-8516-88d70cb851a0	TCGA-AX-A05Z-01A-11R-A00W-13	TCGA-AX-A05Z-01A-11W-A027-09	TCGA-AX-A05Z-01A-21-A162-20	d7e27177-1f90-40af-882d-07164914eb94	TCGA-AX-A05Z-01			TCGA-AX-A05Z-01A-11R-A00V-07	TCGA-AX-A05Z-01A-11W-A027-09	d7e27177-1f90-40af-882d-07164914eb94	TCGA-AX-A05Z-01A-11D-A00X-01		TCGA-AX-A05Z-01A-11R-A00W-13	
TCGA-AX-A060-01	MSI-H	0	TCGA-AX-A060-01	1075	0	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 2	TCGA-AX-A060			1075	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					77		0	TCGA-AX-A060-F5558		Stage IC	NO		-28472	1033		0	1075							2011-5-24	FEMALE	163	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	170	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	TCGA-AX-A060.9086A79B-F764-42D4-BD9A-4C4F9F65C92B.pdf	50	0	1	0	0	11	15	2	0	4	3	4	2	81	80	96	95	negative	TUMOR FREE		0		4+	Complete Remission/Response	No			YES				R1	Primary Tumor	01	open	1988	YES	NO	YES	AX	0	6	0	17	Endometrial	A	LIVING	87	2007	3289fb8a-7268-4669-8d0c-471fc24a8607	TCGA-AX-A060-01	TCGA-AX-A060-01			TCGA-AX-A060-01A-11D-A00X-01	TCGA-AX-A060-01	TCGA-AX-A060-01A-11D-A00U-05	3289fb8a-7268-4669-8d0c-471fc24a8607		97d25271-925a-4d51-95d3-ae0c5b584bb3	TCGA-AX-A060-01A-11R-A00W-13	TCGA-AX-A060-01A-11W-A027-09	TCGA-AX-A060-01A-21-A162-20	2e3df463-b6a3-4767-aeda-fe59cdb64196	TCGA-AX-A060-01		TCGA-AX-A060-01A-11W-A027-09	TCGA-AX-A060-01A-11R-A00V-07	TCGA-AX-A060-01A-11W-A027-09	2e3df463-b6a3-4767-aeda-fe59cdb64196	TCGA-AX-A060-01A-11D-A00X-01		TCGA-AX-A060-01A-11R-A00W-13	
TCGA-AX-A062-01	MSS	0	TCGA-AX-A062-01	1399	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 2	mutation cluster 4	TCGA-AX-A062			1399	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					53		0	TCGA-AX-A062-F5504		Stage IB	NO		-19643	1610		0	1399							2011-5-24	FEMALE	173	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	200	NO		Indeterminate (neither Pre or Postmenopausal)	G1						false	TCGA-AX-A062.FAAFB078-A6DF-4E1B-BD5F-A3B30E45BE1E.pdf	50	1	1	0	0	7	5	1	0	11	14	2	1	80	80	85	85	negative	TUMOR FREE		0		1	Complete Remission/Response	No			NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	8	0	25	Endometrial	A	LIVING	122	2005	cfa7827b-f6bb-4714-ba9f-17e4adfdf3a9	TCGA-AX-A062-01	TCGA-AX-A062-01			TCGA-AX-A062-01A-11D-A00X-01	TCGA-AX-A062-01	TCGA-AX-A062-01A-11D-A00U-05	cfa7827b-f6bb-4714-ba9f-17e4adfdf3a9		dec72adb-614c-4e2a-a8dc-db9fdaba89a6	TCGA-AX-A062-01A-11R-A00W-13	TCGA-AX-A062-01A-11W-A027-09	TCGA-AX-A062-01A-21-A162-20	2e763c4b-bded-45a1-8a79-c49f9f81a69b	TCGA-AX-A062-01		TCGA-AX-A062-01A-11W-A027-09	TCGA-AX-A062-01A-11R-A00V-07	TCGA-AX-A062-01A-11W-A027-09	2e763c4b-bded-45a1-8a79-c49f9f81a69b	TCGA-AX-A062-01A-11D-A00X-01		TCGA-AX-A062-01A-11R-A00W-13	
TCGA-AX-A063-01	MSI-H	0	TCGA-AX-A063-01	2025	0	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 3	TCGA-AX-A063			2025	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					63		0	TCGA-AX-A063-F5501		Stage IB	NO		-23045	1950		0	2025							2011-5-24	FEMALE	160	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	190	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2						false	TCGA-AX-A063.E911408A-8447-4CB8-8A3F-B2C24875ACF0.pdf	50	1	4	0	0	4	1	0	0	6	8	2	6	88	85	92	92	negative	TUMOR FREE		0		4+	Complete Remission/Response	No			NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	3	0	19	Endometrial	A	LIVING	88	2004	4c101954-7344-4cf7-a1bd-4cfcf472e05d	TCGA-AX-A063-01	TCGA-AX-A063-01			TCGA-AX-A063-01A-11D-A00X-01	TCGA-AX-A063-01	TCGA-AX-A063-01A-11D-A00U-05	4c101954-7344-4cf7-a1bd-4cfcf472e05d		c40db171-2b0b-48bd-aa20-c787378d57d3	TCGA-AX-A063-01A-11R-A00W-13	TCGA-AX-A063-01A-11W-A027-09	TCGA-AX-A063-01A-21-A162-20	6ca2cd74-8091-466a-8ba4-af8890e267e6	TCGA-AX-A063-01			TCGA-AX-A063-01A-11R-A00V-07	TCGA-AX-A063-01A-11W-A027-09	6ca2cd74-8091-466a-8ba4-af8890e267e6	TCGA-AX-A063-01A-11D-A00X-01		TCGA-AX-A063-01A-11R-A00W-13	
TCGA-AX-A064-01	MSI-H	0	TCGA-AX-A064-01	1064	0	Iq	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11			mutation cluster 4	TCGA-AX-A064			1064	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					81		0	TCGA-AX-A064-F5498		Stage IIA	NO		-29625	1024		0	1064							2010-9-29	FEMALE	154	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	180	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2						false	TCGA-AX-A064.F760DFF2-7A11-4465-8581-397ABAA76BE4.pdf	50	0	0	0	0	15	15	4	4	2	0	3	2	80	83	90	92	negative	TUMOR FREE		0			Complete Remission/Response	No			NO					Primary Tumor	01	open	1988	NO	NO	YES	AX	0	5	0	29	Endometrial	A	LIVING	48	2007	91340f00-f5e1-496d-b7d5-08c2ccf57292	TCGA-AX-A064-01	TCGA-AX-A064-01		TCGA-AX-A064-01A-11R-A00W-13	TCGA-AX-A064-01A-11D-A00X-01	TCGA-AX-A064-01	TCGA-AX-A064-01A-11D-A00U-05	91340f00-f5e1-496d-b7d5-08c2ccf57292		146a3777-8123-40f5-91e7-117dd9ce360b		TCGA-AX-A064-01A-11W-A027-09	TCGA-AX-A064-01A-21-A162-20	71b8091a-1875-4783-8e28-63916ffeea77	TCGA-AX-A064-01		TCGA-AX-A064-01A-11W-A027-09	TCGA-AX-A064-01A-11R-A00V-07	TCGA-AX-A064-01A-11W-A027-09	71b8091a-1875-4783-8e28-63916ffeea77	TCGA-AX-A064-01A-11D-A00X-01		TCGA-AX-A064-01A-11R-A00W-13	
TCGA-AX-A06B-01	MSS	0	TCGA-AX-A06B-01	1640	0	High	C6-UCEC	UCEC Serous c4	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 5	cluster 4	mutation cluster 3	TCGA-AX-A06B			1640	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					72			TCGA-AX-A06B-F5473		Stage IIA	NO		-26348	1563		0	1640							2011-5-25	FEMALE	151	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	210	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	TCGA-AX-A06B.394E8BCD-1BE6-44C4-BDAC-D251A6C08E2B.pdf	50	5	7	0	0	2	2	0	0	36	18	2	2	60	78	72	85	negative	TUMOR FREE		0		3	Complete Remission/Response	Yes			YES				R0	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	8	0	13	Endometrial	A	LIVING	93	2005	e62793b0-8fb2-4c91-9f64-c0eae21571a7	TCGA-AX-A06B-01	TCGA-AX-A06B-01			TCGA-AX-A06B-01A-11D-A00X-01	TCGA-AX-A06B-01	TCGA-AX-A06B-01A-11D-A00U-05	e62793b0-8fb2-4c91-9f64-c0eae21571a7		3a631688-46e7-40e7-baba-daa439da508d	TCGA-AX-A06B-01A-11R-A00W-13	TCGA-AX-A06B-01A-11W-A027-09	TCGA-AX-A06B-01A-21-A162-20	eeed3e03-dc6e-4038-8a86-f17e42271798	TCGA-AX-A06B-01		TCGA-AX-A06B-01A-11W-A027-09	TCGA-AX-A06B-01A-11R-A00V-07	TCGA-AX-A06B-01A-11W-A027-09	eeed3e03-dc6e-4038-8a86-f17e42271798	TCGA-AX-A06B-01A-11D-A00X-01		TCGA-AX-A06B-01A-11R-A00W-13	
TCGA-AX-A06D-01	MSS	1	TCGA-AX-A06D-01	373	1	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 6		TCGA-AX-A06D			373	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	NO	NO		82		0	TCGA-AX-A06D-F9718		Stage IIIA	NO		-30024	1066	373	0				253	YES			2011-5-13	FEMALE	160	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	190	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2						false	TCGA-AX-A06D.B523C3E8-6FE7-4D6A-B6CE-7DEA1C32D33F.pdf	50	1	3	0	0	10	25	0	0	30	15	10	5	50	55	60	60	positive	WITH TUMOR		0			Progressive Disease	Yes	Former User		NO				R1	Primary Tumor	01	Minimally Invasive	1988	YES	NO	YES	AX	0	3	0	7	Endometrial	A	DECEASED	91	2007	f29cd33b-c1eb-4c17-b2b0-5cf553beb2a9		TCGA-AX-A06D-01		TCGA-AX-A06D-01A-11R-A119-13	TCGA-AX-A06D-01A-11D-A120-01			f29cd33b-c1eb-4c17-b2b0-5cf553beb2a9	TCGA-AX-A06D-01A-11D-A123-05	5269e40a-c8f6-4f21-baef-cd506b1d8493			TCGA-AX-A06D-01A-21-A162-20	2bc89d79-7ea9-47df-b5b9-799c42ac9b36	TCGA-AX-A06D-01					2bc89d79-7ea9-47df-b5b9-799c42ac9b36	TCGA-AX-A06D-01A-11D-A120-01		TCGA-AX-A06D-01A-11R-A119-13	
TCGA-AX-A06F-01	MSI-L	0	TCGA-AX-A06F-01	1554	0	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 2		TCGA-AX-A06F			1554	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					59		0	TCGA-AX-A06F-F5555		Stage IVA	YES		-21624	1267		0	1554							2011-5-25	FEMALE	165	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	210	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	TCGA-AX-A06F.4904C404-B17E-4471-AA2F-6DC705E4FBF2.pdf	50	0	0	1	0	5	8	0	0	9	10	1	2	85	80	90	90		TUMOR FREE		2		2	Complete Remission/Response	No			NO				R0	Primary Tumor	01	open	1988	YES	NO	YES	AX	0	1	2	16	Endometrial	A	LIVING	84	2006	6eb1ae77-4d92-4823-ad9e-2a15cae95db2	TCGA-AX-A06F-01	TCGA-AX-A06F-01			TCGA-AX-A06F-01A-11D-A00X-01	TCGA-AX-A06F-01	TCGA-AX-A06F-01A-11D-A00U-05	6eb1ae77-4d92-4823-ad9e-2a15cae95db2		7c89db66-fe87-47ca-b4cf-7a851f36f37f	TCGA-AX-A06F-01A-11R-A00W-13		TCGA-AX-A06F-01A-21-A162-20	a4fd183a-a484-4a8a-a53a-1dd1e14561fa	TCGA-AX-A06F-01			TCGA-AX-A06F-01A-11R-A00V-07		a4fd183a-a484-4a8a-a53a-1dd1e14561fa	TCGA-AX-A06F-01A-11D-A00X-01		TCGA-AX-A06F-01A-11R-A00W-13	
TCGA-AX-A06H-01	MSI-H	0	TCGA-AX-A06H-01	833	0	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1		UCEC-like c11	miRNA cluster 13	cluster 4	mutation cluster 6	TCGA-AX-A06H	833	0	833	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					60		0	TCGA-AX-A06H-F29312		Stage IIIA	NO		-22270			0	833						Scheduled Follow-up Submission	2011-5-17	FEMALE	160	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Dilation and curettage procedure				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO			50																	negative	WITH TUMOR		0		1	Complete Remission/Response	No			NO				R1	Primary Tumor	01	Minimally Invasive	1988	YES	NO	YES	AX	0	4	0	20	Endometrial		LIVING	98	2008	fb8cfa19-3dfb-4ad5-a64e-7f51837e56cf		TCGA-AX-A06H-01		TCGA-AX-A06H-01A-11R-A119-13	TCGA-AX-A06H-01A-11D-A120-01			fb8cfa19-3dfb-4ad5-a64e-7f51837e56cf	TCGA-AX-A06H-01A-11D-A123-05			TCGA-AX-A06H-01A-11D-A122-09		e6f16197-fce0-410d-94b3-bb6b912270ab	TCGA-AX-A06H-01		TCGA-AX-A06H-01A-11D-A122-09		TCGA-AX-A06H-01A-11D-A122-09	e6f16197-fce0-410d-94b3-bb6b912270ab	TCGA-AX-A06H-01A-11D-A120-01		TCGA-AX-A06H-01A-11R-A119-13	
TCGA-AX-A06J-01	MSS	0	TCGA-AX-A06J-01	913	0	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 2		TCGA-AX-A06J			913	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					71		0	TCGA-AX-A06J-F5542		Stage IB	NO		-26000	662		0	913							2011-5-26	FEMALE	161	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	200	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	TCGA-AX-A06J.553324CE-44B8-416F-B965-074CE5FF9834.pdf	50	0	0	4	1	20	1	0	1	3	3	2	8	75	88	95	95	negative	TUMOR FREE		0		3	Complete Remission/Response	No			YES				R0	Primary Tumor	01	Minimally Invasive	1988	YES	NO	YES	AX	0	10	0	15	Endometrial	A	LIVING	119	2008	3d4e6413-b717-45c2-8531-118ed3a593a0	TCGA-AX-A06J-01	TCGA-AX-A06J-01			TCGA-AX-A06J-01A-11D-A00X-01	TCGA-AX-A06J-01	TCGA-AX-A06J-01A-11D-A00U-05	3d4e6413-b717-45c2-8531-118ed3a593a0		06500a95-b79c-47b8-8777-34e5db32ab3c	TCGA-AX-A06J-01A-11R-A00W-13		TCGA-AX-A06J-01A-21-A162-20	78e13958-f27b-4005-a829-1921b419bcc2	TCGA-AX-A06J-01			TCGA-AX-A06J-01A-11R-A00V-07		78e13958-f27b-4005-a829-1921b419bcc2	TCGA-AX-A06J-01A-11D-A00X-01		TCGA-AX-A06J-01A-11R-A00W-13	
TCGA-AX-A06L-01	MSS	0	TCGA-AX-A06L-01	1845	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 3	mutation cluster 4	TCGA-AX-A06L			1845	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					63		0	TCGA-AX-A06L-F9726		Stage IB	NO		-23294	1499		0	1845							2011-5-17	FEMALE	161	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	250	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1						false	TCGA-AX-A06L.926937F8-6057-4D39-BB3B-0115B0ACFE1A.pdf	50	2	12	0	0	10	8	0	1	30	25	0	2	60	65	60	60	negative	TUMOR FREE		0			Complete Remission/Response	No			NO				R1	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	4	0	21	Endometrial	A	LIVING	112	2006	06ee29fc-036c-4c36-b62b-f304c6ccad50		TCGA-AX-A06L-01		TCGA-AX-A06L-01A-11R-A119-13	TCGA-AX-A06L-01A-11D-A120-01			06ee29fc-036c-4c36-b62b-f304c6ccad50	TCGA-AX-A06L-01A-11D-A123-05	bf44a950-e005-4031-8f27-52901f8e5963		TCGA-AX-A06L-01A-11D-A122-09	TCGA-AX-A06L-01A-21-A162-20	851a31fa-6941-4c36-8409-88716578ab78	TCGA-AX-A06L-01				TCGA-AX-A06L-01A-11D-A122-09	851a31fa-6941-4c36-8409-88716578ab78	TCGA-AX-A06L-01A-11D-A120-01		TCGA-AX-A06L-01A-11R-A119-13	
TCGA-AX-A0IS-01	MSS	0	TCGA-AX-A0IS-01	1065	0	Iq	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 1	mutation cluster 4	TCGA-AX-A0IS			1065	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma			NO		52		0	TCGA-AX-A0IS-F9731		Stage IC	NO		-19173	805		0	1065			448	YES			2011-5-17	FEMALE	168	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES	Endocervical Biopsy	Other method, specify:	90	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2						false	TCGA-AX-A0IS.35606B48-9820-4F59-8090-1F8D448DB9FB.pdf	50	4	8	0	0	2	3	0	1	0	10	15	10	83	77	90	80	negative	WITH TUMOR		0			Complete Remission/Response	No			YES				R1	Primary Tumor	01	Minimally Invasive	1988	YES	NO	YES	AX	0	4	0	10	Endometrial	A	LIVING	132	2008	0cbb432d-fbb9-4c0e-b126-3bb862ab8602		TCGA-AX-A0IS-01			TCGA-AX-A0IS-01A-12D-A10L-01			0cbb432d-fbb9-4c0e-b126-3bb862ab8602	TCGA-AX-A0IS-01A-12D-A10N-05	bd9fe914-a8a6-4f03-9c96-557466d03cac	TCGA-AX-A0IS-01A-12R-A10I-13	TCGA-AX-A0IS-01A-12D-A10M-09	TCGA-AX-A0IS-01A-21-A162-20	60ce7d4a-a298-44e1-9df8-56957c309077	TCGA-AX-A0IS-01		TCGA-AX-A0IS-01A-12D-A10M-09		TCGA-AX-A0IS-01A-12D-A10M-09	60ce7d4a-a298-44e1-9df8-56957c309077	TCGA-AX-A0IS-01A-12D-A10L-01		TCGA-AX-A0IS-01A-12R-A10I-13	
TCGA-AX-A0IU-01	MSS	0	TCGA-AX-A0IU-01	868	0	High	C6-UCEC	UCEC Serous c4	cluster 3		UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 5	TCGA-AX-A0IU			868	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					79		1	TCGA-AX-A0IU-F5533		Stage IIIC	NO		-29063	636		0	868				YES			2011-5-23	FEMALE	158	Serous endometrial adenocarcinoma	No		YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	240	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	TCGA-AX-A0IU.454539FB-7B1B-43DF-87D1-E7E47C1776E7.pdf	50	7	10	0	4	30	10	1	2	0	0	15	45	55	45	85	60	negative	TUMOR FREE		1			Complete Remission/Response	No			NO				R0	Primary Tumor	01	open	1988	YES	NO	YES	AX	1	6	1	7	Endometrial	A	LIVING	76	2008	fb355c45-282b-4eff-8d06-074d9acf1ea5		TCGA-AX-A0IU-01			TCGA-AX-A0IU-01A-11D-A102-01		TCGA-AX-A0IU-01A-11D-A10Q-05	fb355c45-282b-4eff-8d06-074d9acf1ea5			TCGA-AX-A0IU-01A-11R-A103-13	TCGA-AX-A0IU-01A-11D-A10B-09		6100b977-5a8a-40d4-b5d4-829f2bac027a	TCGA-AX-A0IU-01		TCGA-AX-A0IU-01A-11D-A10B-09		TCGA-AX-A0IU-01A-11D-A10B-09	6100b977-5a8a-40d4-b5d4-829f2bac027a	TCGA-AX-A0IU-01A-11D-A102-01		TCGA-AX-A0IU-01A-11R-A103-13	
TCGA-AX-A0IW-01	MSI-L	0	TCGA-AX-A0IW-01	1149	0	High	C6-UCEC	OV-like c1	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 2	mutation cluster 5	TCGA-AX-A0IW			1149	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					67		0	TCGA-AX-A0IW-F5518		Stage IIIA	NO		-24488	854		0	1149							2011-5-23	FEMALE	163	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	190	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	TCGA-AX-A0IW.DE971C2D-31E8-42AC-A943-29E76FCD8F68.pdf	50	0	15	0	0	5	5	0	0	0	0	5	25	90	70	95	75	negative	TUMOR FREE		0		3	Complete Remission/Response	No			NO				R0	Primary Tumor	01	open	1988	YES	NO	YES	AX	0	9	0	24	Endometrial	A	LIVING	61	2008	60bb00e3-9ac9-4c61-bb38-b85b27bff865	TCGA-AX-A0IW-01	TCGA-AX-A0IW-01			TCGA-AX-A0IW-01A-11D-A042-01	TCGA-AX-A0IW-01	TCGA-AX-A0IW-01A-11D-A039-05	60bb00e3-9ac9-4c61-bb38-b85b27bff865		1619e238-c173-4981-a0bd-8f7138f26fdd	TCGA-AX-A0IW-01A-11R-A041-13	TCGA-AX-A0IW-01A-11W-A062-09	TCGA-AX-A0IW-01A-21-A162-20	8c9988b4-30fc-47fc-a0c7-248271506e11	TCGA-AX-A0IW-01		TCGA-AX-A0IW-01A-11W-A062-09	TCGA-AX-A0IW-01A-11R-A040-07	TCGA-AX-A0IW-01A-11W-A062-09	8c9988b4-30fc-47fc-a0c7-248271506e11	TCGA-AX-A0IW-01A-11D-A042-01		TCGA-AX-A0IW-01A-11R-A041-13	
TCGA-AX-A0IZ-01	MSI-H	0	TCGA-AX-A0IZ-01	1333	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 5	cluster 4		TCGA-AX-A0IZ			1333	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					53		0	TCGA-AX-A0IZ-F10299		Stage IB	NO		-19364	1114		0	1333							2011-5-18	FEMALE	160	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	200	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	TCGA-AX-A0IZ.1DEA7C0C-3280-4E11-B0A4-13562DDF307B.pdf	50	4	4	0	0	3	3	0	0	0	0	40	40	57	57	55	60	negative	TUMOR FREE		0		2	Complete Remission/Response	No			NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	3	0	21	Endometrial	A	LIVING	60	2007	e76c4434-3eaf-4ab2-a994-6c27237d344d		TCGA-AX-A0IZ-01		TCGA-AX-A0IZ-01A-11R-A119-13	TCGA-AX-A0IZ-01A-11D-A120-01			e76c4434-3eaf-4ab2-a994-6c27237d344d	TCGA-AX-A0IZ-01A-11D-A123-05	9aadb315-ed0b-44ab-9391-6e3e04b0b4fa			TCGA-AX-A0IZ-01A-21-A162-20	0813f965-9829-458c-a571-66e2ce0372f8	TCGA-AX-A0IZ-01					0813f965-9829-458c-a571-66e2ce0372f8	TCGA-AX-A0IZ-01A-11D-A120-01		TCGA-AX-A0IZ-01A-11R-A119-13	
TCGA-AX-A0IZ-11	MSI-H	0	TCGA-AX-A0IZ-11	1333	0		C6-UCEC								TCGA-AX-A0IZ			1333	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					53		0	TCGA-AX-A0IZ-F10299		Stage IB	NO		-19364	1485		0	1333							2011-5-18	FEMALE	160	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	160	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false		50		0		0		0		0		100		0		0		0	negative	TUMOR FREE		0		2	Complete Remission/Response	No			NO				R0	Solid Tissue Normal	11	open	1988	NO	NO	YES	AX	0	3	0	21	Endometrial	A	LIVING	60	2007				9d6c70ea-ec88-4b78-a495-cd31cc048ece	TCGA-AX-A0IZ-11A-11R-A27R-13					TCGA-AX-A0IZ-11A-11D-A27Y-05							9d6c70ea-ec88-4b78-a495-cd31cc048ece						9d6c70ea-ec88-4b78-a495-cd31cc048ece	TCGA-AX-A0IZ-11A-11R-A27R-13	9d6c70ea-ec88-4b78-a495-cd31cc048ece
TCGA-AX-A0J0-01	MSI-L	0	TCGA-AX-A0J0-01	1220	0	Quiet	C6-UCEC	UCEC Serous c4	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 2	mutation cluster 11	TCGA-AX-A0J0			1220	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					47		0	TCGA-AX-A0J0-F5464		Stage IB	NO		-17466	1581		0	1220							2011-5-23	FEMALE	163	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	180	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2						false	TCGA-AX-A0J0.EC377A34-B219-4A4F-95DB-DF6E0050A63A.pdf	50	1	0	0	0	20	10	0	0	0	0	5	5	75	85	90	90	negative	TUMOR FREE		0		2	Complete Remission/Response	No			NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	3	0	26	Endometrial	A	LIVING	53	2006	cb236783-68e6-4522-8618-ea19fd0b8ab5		TCGA-AX-A0J0-01			TCGA-AX-A0J0-01A-11D-A107-01			cb236783-68e6-4522-8618-ea19fd0b8ab5	TCGA-AX-A0J0-01A-11D-A10A-05	2b44d365-a7f6-4a4e-99c5-019a2bdc6384	TCGA-AX-A0J0-01A-11R-A108-13	TCGA-AX-A0J0-01A-11D-A117-09	TCGA-AX-A0J0-01A-21-A162-20	49a7c2cd-6b47-4e52-9720-9cbe482c619f	TCGA-AX-A0J0-01				TCGA-AX-A0J0-01A-11D-A117-09	49a7c2cd-6b47-4e52-9720-9cbe482c619f	TCGA-AX-A0J0-01A-11D-A107-01		TCGA-AX-A0J0-01A-11R-A108-13	
TCGA-AX-A0J0-11	MSI-L	0	TCGA-AX-A0J0-11	1220	0		C6-UCEC							mutation cluster 11	TCGA-AX-A0J0			1220	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					47		0	TCGA-AX-A0J0-F5464		Stage IB	NO		-17466	1952		0	1220							2011-5-23	FEMALE	163	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	110	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2						false		50		0		0		0		0		100		0		0		0	negative	TUMOR FREE		0		2	Complete Remission/Response	No			NO				R0	Solid Tissue Normal	11	open	1988	NO	NO	YES	AX	0	3	0	26	Endometrial	A	LIVING	53	2006				bdb31196-8bc4-4c2a-bbcf-641e1916733f	TCGA-AX-A0J0-11A-11R-A27R-13					TCGA-AX-A0J0-11A-11D-A27Y-05							bdb31196-8bc4-4c2a-bbcf-641e1916733f						bdb31196-8bc4-4c2a-bbcf-641e1916733f	TCGA-AX-A0J0-11A-11R-A27R-13	bdb31196-8bc4-4c2a-bbcf-641e1916733f
TCGA-AX-A0J1-01	MSI-H	0	TCGA-AX-A0J1-01	2004	0	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 2	mutation cluster 11	TCGA-AX-A0J1			2004	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					80		0	TCGA-AX-A0J1-F5458		Stage IB	NO		-29501	1721		0	2004							2011-5-23	FEMALE	160	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	220	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2						false	TCGA-AX-A0J1.38FCBC4A-2CAB-46EF-805D-121BEF85912E.pdf	50	0	0	0	0	10	1	1	0	13	30	2	5	75	64	80	70	negative	TUMOR FREE		0			Complete Remission/Response	No			NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	7	0	15	Endometrial	A	LIVING	57	2005	20b8dd9b-c6b1-4a16-aeeb-e5aa49e62247	TCGA-AX-A0J1-01	TCGA-AX-A0J1-01			TCGA-AX-A0J1-01A-11D-A042-01	TCGA-AX-A0J1-01	TCGA-AX-A0J1-01A-11D-A039-05	20b8dd9b-c6b1-4a16-aeeb-e5aa49e62247		2ee962c0-8925-47c7-8aea-9ae3b1375a6b	TCGA-AX-A0J1-01A-11R-A041-13	TCGA-AX-A0J1-01A-11W-A062-09	TCGA-AX-A0J1-01A-21-A162-20	12cf013a-dbf0-4e9c-94ec-020b8bc12283	TCGA-AX-A0J1-01			TCGA-AX-A0J1-01A-11R-A040-07	TCGA-AX-A0J1-01A-11W-A062-09	12cf013a-dbf0-4e9c-94ec-020b8bc12283	TCGA-AX-A0J1-01A-11D-A042-01		TCGA-AX-A0J1-01A-11R-A041-13	
TCGA-AX-A1C4-01	MSI-H	0	TCGA-AX-A1C4-01	404	0	Kirc+		UCEC CIMP c18	cluster 1		UCEC-like c11	miRNA cluster 7	cluster 1		TCGA-AX-A1C4			404	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					52		0	TCGA-AX-A1C4-F10395		Stage IB	NO		-19209	575		0	404				YES			2011-5-12	FEMALE	178	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	120	NO		Indeterminate (neither Pre or Postmenopausal)	G2						false	TCGA-AX-A1C4.81C6DDE6-ACC3-4659-91EC-D986671B592A.pdf	50		1		0		1		0		6		2		91		95	negative	TUMOR FREE		0		0		No			YES				R1	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	8	0	13	Endometrial	A	LIVING	115	2009	58623d8a-f51b-470a-bde3-f31e91f9bd80		TCGA-AX-A1C4-01		TCGA-AX-A1C4-01A-11R-A136-13	TCGA-AX-A1C4-01A-11D-A134-01			58623d8a-f51b-470a-bde3-f31e91f9bd80	TCGA-AX-A1C4-01A-11D-A138-05					0b238799-9dc6-4032-8954-b8db42337101	TCGA-AX-A1C4-01					0b238799-9dc6-4032-8954-b8db42337101	TCGA-AX-A1C4-01A-11D-A134-01		TCGA-AX-A1C4-01A-11R-A136-13	
TCGA-AX-A1C5-01	MSI-H	0	TCGA-AX-A1C5-01	584	0	Kirc+		UCEC non-CIMP c3	cluster 2		UCEC-like c11	miRNA cluster 12	cluster 5		TCGA-AX-A1C5			584	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					47		1	TCGA-AX-A1C5-F10397		Stage IIIC	NO		-17383	517		0	584	404			YES			2011-5-12	FEMALE	160	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	130	NO		Indeterminate (neither Pre or Postmenopausal)	G3						false	TCGA-AX-A1C5.6F79B83A-90B4-45DF-8542-A6BC2F93470D.pdf	50		5		1		1		1		5		34		60		70	negative			1				No			YES				R2	Primary Tumor	01	open	1988	YES	NO	YES	AX	1	1	1	2	Endometrial	A	LIVING	107	2009	1bce2d6c-cbe9-4191-b23c-a3bb815ec5e1		TCGA-AX-A1C5-01		TCGA-AX-A1C5-01A-11R-A136-13	TCGA-AX-A1C5-01A-11D-A134-01			1bce2d6c-cbe9-4191-b23c-a3bb815ec5e1	TCGA-AX-A1C5-01A-11D-A138-05					38171ced-1527-4ec2-81b7-3cd6e5167053	TCGA-AX-A1C5-01					38171ced-1527-4ec2-81b7-3cd6e5167053	TCGA-AX-A1C5-01A-11D-A134-01		TCGA-AX-A1C5-01A-11R-A136-13	
TCGA-AX-A1C7-01	MSS	0	TCGA-AX-A1C7-01	516	0	COAD-READ	C6-UCEC	UCEC Serous c4	cluster 3		UCEC-like c11	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-AX-A1C7			516	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	NO	NO		77		0	TCGA-AX-A1C7-F10354		Stage IB			-28198	423		0	516			390				2011-5-11	FEMALE	152	Serous endometrial adenocarcinoma	No		YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	90	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	TCGA-AX-A1C7.10458026-49D7-40EC-BC7B-0D6A381FB025.pdf	50		1		1		2		1		0		5		93		94	negative			0				No			NO				R0	Primary Tumor	01	open	1988	YES	NO	YES	AX	0	9	0	24	Endometrial	A	LIVING	60	2009	284f6163-92f2-4e21-8649-45dcfce6634f		TCGA-AX-A1C7-01	284f6163-92f2-4e21-8649-45dcfce6634f	TCGA-AX-A1C7-01A-11R-A136-13	TCGA-AX-A1C7-01A-11D-A134-01			284f6163-92f2-4e21-8649-45dcfce6634f	TCGA-AX-A1C7-01A-11D-A138-05			TCGA-AX-A1C7-01A-11D-A135-09		ef55b016-694d-4388-b285-9e531cc23915	TCGA-AX-A1C7-01	284f6163-92f2-4e21-8649-45dcfce6634f			TCGA-AX-A1C7-01A-11D-A135-09	ef55b016-694d-4388-b285-9e531cc23915	TCGA-AX-A1C7-01A-11D-A134-01	284f6163-92f2-4e21-8649-45dcfce6634f	TCGA-AX-A1C7-01A-11R-A136-13	284f6163-92f2-4e21-8649-45dcfce6634f
TCGA-AX-A1C8-01	MSS	0	TCGA-AX-A1C8-01	412	0	Squamous	C6-UCEC	UCEC Serous c4	cluster 3		UCEC-like c11	miRNA cluster 13	cluster 2	mutation cluster 13	TCGA-AX-A1C8			412	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					77		0	TCGA-AX-A1C8-F10361		Stage IIIC	NO		-28452	475		0	412							2011-5-11	FEMALE	156	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	100	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	TCGA-AX-A1C8.5F0E78BA-B827-4DB6-99EB-5FA3D3598793.pdf	50		1		1		5		0		0		20		75		80	negative			1		4+		No			NO				R1	Primary Tumor	01	Minimally Invasive	1988	YES	NO	YES	AX	0	3	1	12	Endometrial	A	LIVING	66	2009	34149234-2d6a-46ac-b7e0-52787cf2c49a		TCGA-AX-A1C8-01		TCGA-AX-A1C8-01A-11R-A136-13	TCGA-AX-A1C8-01A-11D-A134-01			34149234-2d6a-46ac-b7e0-52787cf2c49a	TCGA-AX-A1C8-01A-11D-A138-05			TCGA-AX-A1C8-01A-11D-A135-09		b19b999a-5d30-4fc8-a522-1c19c433caf6	TCGA-AX-A1C8-01		TCGA-AX-A1C8-01A-11D-A135-09		TCGA-AX-A1C8-01A-11D-A135-09	b19b999a-5d30-4fc8-a522-1c19c433caf6	TCGA-AX-A1C8-01A-11D-A134-01		TCGA-AX-A1C8-01A-11R-A136-13	
TCGA-AX-A1C9-01	MSI-H	0	TCGA-AX-A1C9-01	464	0	Kirc+		UCEC non-CIMP c3	cluster 2		UCEC-like c11	miRNA cluster 13	cluster 6		TCGA-AX-A1C9			464	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					73		0	TCGA-AX-A1C9-F10350		Stage IB	NO		-26903	521		0	464				YES			2011-5-10	FEMALE	152	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	110	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2						false	TCGA-AX-A1C9.54E63A5C-C0E4-408B-9911-CE822CECD362.pdf	50		8		0		1		6		0		10		89		80	negative	TUMOR FREE		0				No			NO				R2	Primary Tumor	01	Minimally Invasive	1988	NO	NO	YES	AX	0	3	0	17	Endometrial	A	LIVING	73	2009	a5a45936-135b-499e-a0bb-7c2d992ef962		TCGA-AX-A1C9-01		TCGA-AX-A1C9-01A-11R-A136-13	TCGA-AX-A1C9-01A-11D-A134-01			a5a45936-135b-499e-a0bb-7c2d992ef962	TCGA-AX-A1C9-01A-11D-A138-05					9a75d900-b250-46d8-bda8-dacb7b509105	TCGA-AX-A1C9-01					9a75d900-b250-46d8-bda8-dacb7b509105	TCGA-AX-A1C9-01A-11D-A134-01		TCGA-AX-A1C9-01A-11R-A136-13	
TCGA-AX-A1CA-01	Indeterminate	0	TCGA-AX-A1CA-01	617	0	High		UCEC Serous c4	cluster 3		UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-AX-A1CA			617	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					70		0	TCGA-AX-A1CA-F10391		Stage IB	NO		-25817	591		0	617							2011-5-12	FEMALE	157	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	110	NO			G3						false	TCGA-AX-A1CA.5906346F-CB34-421F-BBC3-3B6D2239AA7F.pdf	50		1		0		1		0		30		10		59		60	negative	TUMOR FREE		0				No							R1	Primary Tumor	01	open	1988	YES	NO	YES	AX	0	4	0	10	Endometrial	A	LIVING	77	2009	cadf8449-cd8e-4581-ad35-37a0aa2f7a9b		TCGA-AX-A1CA-01		TCGA-AX-A1CA-01A-12R-A136-13	TCGA-AX-A1CA-01A-12D-A134-01			cadf8449-cd8e-4581-ad35-37a0aa2f7a9b	TCGA-AX-A1CA-01A-12D-A138-05					8551f90d-9c76-444d-8275-77fb7a24fd31	TCGA-AX-A1CA-01					8551f90d-9c76-444d-8275-77fb7a24fd31	TCGA-AX-A1CA-01A-12D-A134-01		TCGA-AX-A1CA-01A-12R-A136-13	
TCGA-AX-A1CC-01	MSI-L	0	TCGA-AX-A1CC-01	378	0	COAD-READ		Low purity c2	cluster 3		UCEC-like c11	miRNA cluster 13	cluster 6		TCGA-AX-A1CC			378	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					65		0	TCGA-AX-A1CC-F10388		Stage IC	NO		-23795	356		0	378				NO			2011-5-11	FEMALE	156	Serous endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	90	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	TCGA-AX-A1CC.C621C7A6-FF3F-453E-94A2-9789F66750E3.pdf	50		20		1		2		1		10		20		68		65	negative	TUMOR FREE		0		2		No			YES				R0	Primary Tumor	01	open	1988	YES	NO	YES	AX	0	9	0	11	Endometrial	A	LIVING	99	2010	ac3b86dc-2dd8-41e8-832a-5625f5cd5a27		TCGA-AX-A1CC-01		TCGA-AX-A1CC-01A-11R-A136-13	TCGA-AX-A1CC-01A-11D-A134-01			ac3b86dc-2dd8-41e8-832a-5625f5cd5a27	TCGA-AX-A1CC-01A-11D-A138-05					5c2f730a-57de-492a-b2bd-3fafa2d68bf2	TCGA-AX-A1CC-01					5c2f730a-57de-492a-b2bd-3fafa2d68bf2	TCGA-AX-A1CC-01A-11D-A134-01		TCGA-AX-A1CC-01A-11R-A136-13	
TCGA-AX-A1CE-01	MSI-H	0	TCGA-AX-A1CE-01	610	0	Quiet		UCEC CIMP c18	cluster 1		UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-AX-A1CE			610	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					60		0	TCGA-AX-A1CE-F10383		Stage IB	NO		-21969	504		0	610	386						2011-5-11	FEMALE	160	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES	Total hysterectomy, bilateral salpingo-oophorectomy with pelvic and para-aortic lymph node dissection	Other method, specify:	130	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	TCGA-AX-A1CE.79482353-F9A0-4A36-97B3-F270241B2B50.pdf	50		10		0		8		0		8		2		82		80	negative			0		3		No			YES				R0	Primary Tumor	01	Minimally Invasive	1988	YES	NO	YES	AX	0	5	0	12	Endometrial	A	LIVING	58	2009	2a9c8cdb-71bc-480d-b9d5-c6b8c0198daf		TCGA-AX-A1CE-01		TCGA-AX-A1CE-01A-11R-A136-13	TCGA-AX-A1CE-01A-11D-A134-01			2a9c8cdb-71bc-480d-b9d5-c6b8c0198daf	TCGA-AX-A1CE-01A-11D-A138-05					10f6da3e-f444-4214-b4af-ddea563a95f1	TCGA-AX-A1CE-01					10f6da3e-f444-4214-b4af-ddea563a95f1	TCGA-AX-A1CE-01A-11D-A134-01		TCGA-AX-A1CE-01A-11R-A136-13	
TCGA-AX-A1CF-01	MSS	0	TCGA-AX-A1CF-01	2337	0	Squamous		OV-like c1	cluster 3		UCEC-like c11	miRNA c1uster 10	cluster 2		TCGA-AX-A1CF			2337	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	YES	NO		69		0	TCGA-AX-A1CF-F10338		Stage IVB	NO		-25300	2284		0	2337			875				2011-5-10	FEMALE	150	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	130	NO			G3						false	TCGA-AX-A1CF.CB16E769-AFE1-4555-A65D-691266C4898E.pdf	50		1		0		2		0		20		5		73		75	positive	WITH TUMOR					Progressive Disease	No	Former User		YES				R2	Primary Tumor	01	open	1988	YES	NO	YES	AX	0	7	0	0	Endometrial	A	LIVING	79	2004	ee60f261-392f-4583-8ddb-b29f07f20e6e		TCGA-AX-A1CF-01		TCGA-AX-A1CF-01A-11R-A136-13	TCGA-AX-A1CF-01A-11D-A134-01			ee60f261-392f-4583-8ddb-b29f07f20e6e	TCGA-AX-A1CF-01A-11D-A138-05					3b55db21-08fe-4fcc-a260-261396556323	TCGA-AX-A1CF-01					3b55db21-08fe-4fcc-a260-261396556323	TCGA-AX-A1CF-01A-11D-A134-01		TCGA-AX-A1CF-01A-11R-A136-13	
TCGA-AX-A1CF-11	MSS	0	TCGA-AX-A1CF-11	2337	0										TCGA-AX-A1CF			2337	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	YES	NO		69		0	TCGA-AX-A1CF-F10338		Stage IVB	NO		-25300	2284		0	2337			875				2011-5-10	FEMALE	150	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	50	NO			G3						false		50										100				0			positive	WITH TUMOR					Progressive Disease	No	Former User		YES				R2	Solid Tissue Normal	11	open	1988	YES	NO	YES	AX	0	7	0	0	Endometrial	A	LIVING	79	2004	c588b29f-0abf-47c6-bff2-d0589ea506ee				TCGA-AX-A1CF-11A-11R-A136-13				c588b29f-0abf-47c6-bff2-d0589ea506ee	TCGA-AX-A1CF-11A-11D-A138-05														TCGA-AX-A1CF-11A-11R-A136-13	
TCGA-AX-A1CI-01	MSS	0	TCGA-AX-A1CI-01	2207	0	Iq		UCEC CIMP c18	cluster 2		UCEC-like c11	miRNA cluster 13	cluster 6		TCGA-AX-A1CI			2207	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					61		0	TCGA-AX-A1CI-F10561		Stage IB	NO		-22582	2222		0	2207							2011-5-10	FEMALE	164	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	120	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1						false	TCGA-AX-A1CI.7F264403-0A76-4FAD-9A57-7C555F69375C.pdf	50		2		0		1		0		3		3		93		95	negative	TUMOR FREE		0				No			NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	3	0	13	Endometrial	A	LIVING	74	2004	e54b7e44-82a3-4016-bc32-129799097b4c		TCGA-AX-A1CI-01		TCGA-AX-A1CI-01A-11R-A136-13	TCGA-AX-A1CI-01A-11D-A134-01			e54b7e44-82a3-4016-bc32-129799097b4c	TCGA-AX-A1CI-01A-11D-A138-05					03a549d6-026f-4ffe-9deb-b5d5641a874c	TCGA-AX-A1CI-01					03a549d6-026f-4ffe-9deb-b5d5641a874c	TCGA-AX-A1CI-01A-11D-A134-01		TCGA-AX-A1CI-01A-11R-A136-13	
TCGA-AX-A1CI-11	MSS	0	TCGA-AX-A1CI-11	2207	0										TCGA-AX-A1CI			2207	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					61		0	TCGA-AX-A1CI-F10561		Stage IB	NO		-22582	2222		0	2207							2011-5-10	FEMALE	164	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	100	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1						false		50										100				0			negative	TUMOR FREE		0				No			NO				R0	Solid Tissue Normal	11	open	1988	NO	NO	YES	AX	0	3	0	13	Endometrial	A	LIVING	74	2004	ce5b0ba0-2777-4c92-ac50-483174cc5dca				TCGA-AX-A1CI-11A-11R-A136-13				ce5b0ba0-2777-4c92-ac50-483174cc5dca	TCGA-AX-A1CI-11A-11D-A138-05														TCGA-AX-A1CI-11A-11R-A136-13	
TCGA-AX-A1CJ-01	Indeterminate	0	TCGA-AX-A1CJ-01	1646	0	Iq		UCEC non-CIMP c3	cluster 4		UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-AX-A1CJ			1646	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					59			TCGA-AX-A1CJ-F10309		Stage IC	NO		-21655	1758		0	1646							2011-5-10	FEMALE	163	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	90	NO		Indeterminate (neither Pre or Postmenopausal)	G2						false	TCGA-AX-A1CJ.AC9C3BB1-9B41-4B1F-BCEA-F6A0C68921B3.pdf	50		8		2		2		2		0		7		91		90	negative	TUMOR FREE						No			YES				R0	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	0	0	0	Endometrial	A	LIVING	115	2006	87d95a5d-174b-4f13-a00f-85a28bfd1fb7		TCGA-AX-A1CJ-01		TCGA-AX-A1CJ-01A-11R-A136-13	TCGA-AX-A1CJ-01A-11D-A134-01			87d95a5d-174b-4f13-a00f-85a28bfd1fb7	TCGA-AX-A1CJ-01A-11D-A138-05					48392610-7a3d-48e8-89fd-0cde8a7f0743	TCGA-AX-A1CJ-01					48392610-7a3d-48e8-89fd-0cde8a7f0743	TCGA-AX-A1CJ-01A-11D-A134-01		TCGA-AX-A1CJ-01A-11R-A136-13	
TCGA-AX-A1CJ-11	Indeterminate	0	TCGA-AX-A1CJ-11	1646	0										TCGA-AX-A1CJ			1646	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					59			TCGA-AX-A1CJ-F10309		Stage IC	NO		-21655	1758		0	1646							2011-5-10	FEMALE	163	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	120	NO		Indeterminate (neither Pre or Postmenopausal)	G2						false		50										100				0			negative	TUMOR FREE						No			YES				R0	Solid Tissue Normal	11	open	1988	NO	NO	YES	AX	0	0	0	0	Endometrial	A	LIVING	115	2006										TCGA-AX-A1CJ-11A-11D-A138-05															
TCGA-AX-A1CK-01	MSS	0	TCGA-AX-A1CK-01	2053	0	BRCA-LUAD+		UCEC CIMP c18	cluster 1		UCEC-like c11	miRNA cluster 12	cluster 5		TCGA-AX-A1CK			2053	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	NO	YES		58		0	TCGA-AX-A1CK-F10304		Stage IB	NO	1027	-21200	2115		0	2053				NO			2011-5-10	FEMALE	163	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	100	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2						false	TCGA-AX-A1CK.5810919B-7778-4566-A024-2D70BDE9A4F5.pdf	50		8		1		2		1		1		8		89		85	negative	WITH TUMOR		0				No			NO	Surgical Resection			R0	Primary Tumor	01	open	1988	YES	NO	YES	AX	0	3	0	14	Endometrial	A	LIVING	72	2005	5755caa5-b187-498f-a7a9-22e8ddcd2830		TCGA-AX-A1CK-01		TCGA-AX-A1CK-01A-11R-A136-13	TCGA-AX-A1CK-01A-11D-A134-01			5755caa5-b187-498f-a7a9-22e8ddcd2830	TCGA-AX-A1CK-01A-11D-A138-05					e28c5efc-4b70-4ab8-9243-5846e16978c9	TCGA-AX-A1CK-01					e28c5efc-4b70-4ab8-9243-5846e16978c9	TCGA-AX-A1CK-01A-11D-A134-01		TCGA-AX-A1CK-01A-11R-A136-13	
TCGA-AX-A1CK-11	MSS	0	TCGA-AX-A1CK-11	2053	0										TCGA-AX-A1CK			2053	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	NO	YES		58		0	TCGA-AX-A1CK-F10304		Stage IB	NO	1027	-21200	2115		0	2053				NO			2011-5-10	FEMALE	163	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	100	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2						false		50										100				0			negative	WITH TUMOR		0				No			NO	Surgical Resection			R0	Solid Tissue Normal	11	open	1988	YES	NO	YES	AX	0	3	0	14	Endometrial	A	LIVING	72	2005	3aba63fa-86d2-4ca9-b064-fe782a749161				TCGA-AX-A1CK-11A-11R-A136-13				3aba63fa-86d2-4ca9-b064-fe782a749161	TCGA-AX-A1CK-11A-11D-A138-05														TCGA-AX-A1CK-11A-11R-A136-13	
TCGA-AX-A1CN-01	MSI-L	0	TCGA-AX-A1CN-01	764	0	Kirc+		OV-like c1	cluster 3		RNA cluster 3	miRNA cluster 12	cluster 5		TCGA-AX-A1CN			764	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					54		0	TCGA-AX-A1CN-F10301		Stage IIB	NO		-19860	701		0	764							2011-5-10	FEMALE	175	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	110	NO		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3						false	TCGA-AX-A1CN.D0FB2179-60D4-4B3C-9D88-B07D802F772E.pdf	50		1		0		10		1		13		2		75		90	negative	TUMOR FREE		0		1		No			YES				R0	Primary Tumor	01	open	1988	YES	NO	YES	AX	0	5	0	13	Endometrial	A	LIVING	146	2009	222512dc-7088-4c86-a82c-99c2e4cd427c		TCGA-AX-A1CN-01		TCGA-AX-A1CN-01A-11R-A136-13	TCGA-AX-A1CN-01A-11D-A134-01			222512dc-7088-4c86-a82c-99c2e4cd427c	TCGA-AX-A1CN-01A-11D-A138-05					23929fac-163f-40be-b7f5-38b4e09f8e49	TCGA-AX-A1CN-01					23929fac-163f-40be-b7f5-38b4e09f8e49	TCGA-AX-A1CN-01A-11D-A134-01		TCGA-AX-A1CN-01A-11R-A136-13	
TCGA-AX-A1CP-01	MSS	0	TCGA-AX-A1CP-01	1107	0	Squamous	C6-UCEC	OV-like c1	cluster 3		UCEC-like c11	miRNA cluster 13	cluster 6	mutation cluster 3	TCGA-AX-A1CP			1107	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma			NO		84		0	TCGA-AX-A1CP-F9828		Stage IA	NO		-30737	1080		0	1107			722	YES			2011-5-12	FEMALE	156	Serous endometrial adenocarcinoma	No		YES	C54.1	8441/3	C54.1	YES			110	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	TCGA-AX-A1CP.E2F94D2B-C53B-4112-AFBB-06A6751CAE4B.pdf	0		5		0		1		0		35		4		60		70	negative			0				Yes			NO				R1	Primary Tumor	01	Minimally Invasive	1988	YES	NO	YES	AX	0	5	0	11	Endometrial	A	LIVING	55	2008	da204d4a-922e-4501-9db6-8034ae6b8177		TCGA-AX-A1CP-01		TCGA-AX-A1CP-01A-11R-A136-13	TCGA-AX-A1CP-01A-11D-A134-01			da204d4a-922e-4501-9db6-8034ae6b8177	TCGA-AX-A1CP-01A-11D-A138-05			TCGA-AX-A1CP-01A-11D-A135-09		65ba21c9-2627-4bcb-b4c0-9d39ce80462f	TCGA-AX-A1CP-01		TCGA-AX-A1CP-01A-11D-A135-09		TCGA-AX-A1CP-01A-11D-A135-09	65ba21c9-2627-4bcb-b4c0-9d39ce80462f	TCGA-AX-A1CP-01A-11D-A134-01		TCGA-AX-A1CP-01A-11R-A136-13	
TCGA-AX-A1CR-01	MSS	0	TCGA-AX-A1CR-01	337	0	High		UCEC Serous c4	cluster 3		UCEC-like c11	miRNA cluster 4	cluster 2		TCGA-AX-A1CR	337	0	337	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					70			TCGA-AX-A1CR-F12541		Stage IIB	NO		-25812	274		0	337							2011-5-12	FEMALE	165	Mixed serous and endometrioid	No		YES	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	110	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-AX-A1CR.7623CA86-87C5-43E8-A0A7-25BD9526D1AA.pdf	50		4		0		1		1		10		9		80		88	negative	TUMOR FREE				0		Yes			NO				R1	Primary Tumor	01	open	1988	YES	NO	YES	AX	0	12	0	17	Endometrial	A	LIVING	97	2010	d979abda-1498-41e5-848c-8dc20d6c7eee		TCGA-AX-A1CR-01		TCGA-AX-A1CR-01A-12R-A136-13	TCGA-AX-A1CR-01A-12D-A134-01			d979abda-1498-41e5-848c-8dc20d6c7eee	TCGA-AX-A1CR-01A-12D-A138-05					2c852ae6-d223-4737-a41d-c5794f9af73e	TCGA-AX-A1CR-01					2c852ae6-d223-4737-a41d-c5794f9af73e	TCGA-AX-A1CR-01A-12D-A134-01		TCGA-AX-A1CR-01A-12R-A136-13	
TCGA-AX-A2H2-01	MSS	1	TCGA-AX-A2H2-01	145	1	High	C6-UCEC	UCEC Serous c4		UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 2		TCGA-AX-A2H2	145	0	145	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	86			TCGA-AX-A2H2-F31588		Stage IIA	NO		-31524	1079	145	0					YES		Scheduled Follow-up Submission	2012-5-7	FEMALE	162	Serous endometrial adenocarcinoma	No		YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	160	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-AX-A2H2.1BDF6880-A5E1-4DD8-A7E5-1E91BBCF8F60.pdf			1		0		2		0		0		1		97		96	negative	TUMOR FREE				4+	Complete Remission/Response	No			NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	0	0	5	Endometrial	A	DECEASED	65	2008	245e65eb-ec7a-4a85-a524-194afbdf67ef		TCGA-AX-A2H2-01		TCGA-AX-A2H2-01A-11R-A17X-13	TCGA-AX-A2H2-01A-11D-A17U-01			245e65eb-ec7a-4a85-a524-194afbdf67ef	TCGA-AX-A2H2-01A-11D-A17Z-05				TCGA-AX-A2H2-01A-21-A18R-20	9a6c0f2b-6ca5-44a6-a001-e8885156ef94	TCGA-AX-A2H2-01					9a6c0f2b-6ca5-44a6-a001-e8885156ef94	TCGA-AX-A2H2-01A-11D-A17U-01		TCGA-AX-A2H2-01A-11R-A17X-13	
TCGA-AX-A2H4-01	MSS	1	TCGA-AX-A2H4-01	916	1	Squamous		UCEC non-CIMP c3				miRNA cluster 14			TCGA-AX-A2H4	520	1	916	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	NO	NO		Progressive Disease	66			TCGA-AX-A2H4-F31597		Stage IIIA	NO		-24234	1981	916	0				520	YES		Scheduled Follow-up Submission	2012-5-7	FEMALE	157	Serous endometrial adenocarcinoma	No		YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	120	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Locoregional Disease	Vaginal cuff, iliac		YES	false	TCGA-AX-A2H4.5230A27B-4AA6-4ED9-90BB-98C6671E0B2E.pdf			10		1		5		2		0		35		60		80	negative	WITH TUMOR					Complete Remission/Response	No			NO				R2	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	0	0	0	Endometrial	A	DECEASED	84	2006			TCGA-AX-A2H4-01	46eaeac0-bacb-4c76-b86d-5bd912229f69	TCGA-AX-A2H4-01A-21R-A18L-13	TCGA-AX-A2H4-01A-21D-A18N-01				TCGA-AX-A2H4-01A-21D-A18O-05					26eef856-9692-4618-8000-9f5877fe457a	TCGA-AX-A2H4-01	46eaeac0-bacb-4c76-b86d-5bd912229f69				26eef856-9692-4618-8000-9f5877fe457a	TCGA-AX-A2H4-01A-21D-A18N-01	46eaeac0-bacb-4c76-b86d-5bd912229f69	TCGA-AX-A2H4-01A-21R-A18L-13	46eaeac0-bacb-4c76-b86d-5bd912229f69
TCGA-AX-A2H4-11	MSS	1	TCGA-AX-A2H4-11	916	1										TCGA-AX-A2H4	520	1	916	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	NO	NO		Progressive Disease	66			TCGA-AX-A2H4-F31597		Stage IIIA	NO		-24234	1981	916	0				520	YES		Scheduled Follow-up Submission	2012-5-7	FEMALE	157	Serous endometrial adenocarcinoma	No		YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	180	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Locoregional Disease	Vaginal cuff, iliac		YES	false				0		0		0		0		100		0		0		0	negative	WITH TUMOR					Complete Remission/Response	No			NO				R2	Solid Tissue Normal	11	open	1988	NO	NO	YES	AX	0	0	0	0	Endometrial	A	DECEASED	84	2006										TCGA-AX-A2H4-11A-11D-A18O-05															
TCGA-AX-A2H5-01	MSS	0	TCGA-AX-A2H5-01	2167	0	High	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 2	mutation cluster 2	TCGA-AX-A2H5			2167	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					67					Stage IIIC			-24757	2206		0	2167							2011-10-28	FEMALE	161	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	100	NO			G3						false	TCGA-AX-A2H5.BF4BE7F8-7D37-4CB2-B340-FAE14155F257.pdf			1		1		2		0		0		4		94		97	negative							No							R1	Primary Tumor	01	open	1988		NO	YES	AX	3	5	9	13	Endometrial	A	LIVING	87	2005	2f712e62-f400-4922-bdc5-d5d06276101d		TCGA-AX-A2H5-01		TCGA-AX-A2H5-01A-11R-A17A-13	TCGA-AX-A2H5-01A-11D-A17C-01			2f712e62-f400-4922-bdc5-d5d06276101d	TCGA-AX-A2H5-01A-11D-A17F-05			TCGA-AX-A2H5-01A-11D-A17D-09	TCGA-AX-A2H5-01A-21-A18R-20	265e67a7-bb8c-45d3-ab08-d3d4cae68468	TCGA-AX-A2H5-01		TCGA-AX-A2H5-01A-11D-A17D-09		TCGA-AX-A2H5-01A-11D-A17D-09	265e67a7-bb8c-45d3-ab08-d3d4cae68468	TCGA-AX-A2H5-01A-11D-A17C-01		TCGA-AX-A2H5-01A-11R-A17A-13	
TCGA-AX-A2H5-11	MSS	0	TCGA-AX-A2H5-11	2167	0		C6-UCEC							mutation cluster 2	TCGA-AX-A2H5			2167	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					67					Stage IIIC			-24757	2206		0	2167							2011-10-28	FEMALE	161	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	130	NO			G3						false				0		0		0		0		100		0		0		0	negative							No							R1	Solid Tissue Normal	11	open	1988		NO	YES	AX	3	5	9	13	Endometrial	A	LIVING	87	2005										TCGA-AX-A2H5-11A-11D-A17F-05															
TCGA-AX-A2H7-01	MSS	1	TCGA-AX-A2H7-01	1241	1	BRCA-LUAD+	C6-UCEC	UCEC non-CIMP c3		UCEC-like c5	UCEC-like c11	miRNA cluster 12			TCGA-AX-A2H7	684	1	1241	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	NO	NO	NO	Progressive Disease	87			TCGA-AX-A2H7-F31704		Stage IC	NO		-32100	951	1241	0	1020			684	YES		Scheduled Follow-up Submission	2012-5-8	FEMALE	151	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	160	NO			G3	Lung	Metastatic			YES	false	TCGA-AX-A2H7.76630DF8-2D08-4CF8-8B07-ACCE872B3ED1.pdf			0		1		2		0		0		5		93		97	negative	WITH TUMOR				4+	Complete Remission/Response	No			YES				R0	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	3	0	12	Endometrial	A	DECEASED	60	2008	25dd0765-735c-4146-9551-cdfdd9213593		TCGA-AX-A2H7-01		TCGA-AX-A2H7-01A-12R-A18L-13	TCGA-AX-A2H7-01A-12D-A18N-01			25dd0765-735c-4146-9551-cdfdd9213593	TCGA-AX-A2H7-01A-12D-A18O-05				TCGA-AX-A2H7-01A-21-A23Z-20	5f5965f9-bb43-42a4-ad05-74f8780b697a	TCGA-AX-A2H7-01					5f5965f9-bb43-42a4-ad05-74f8780b697a	TCGA-AX-A2H7-01A-12D-A18N-01		TCGA-AX-A2H7-01A-12R-A18L-13	
TCGA-AX-A2H7-11	MSS	1	TCGA-AX-A2H7-11	1241	1		C6-UCEC								TCGA-AX-A2H7	684	1	1241	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	NO	NO	NO	Progressive Disease	87			TCGA-AX-A2H7-F31704		Stage IC	NO		-32100	951	1241	0	1020			684	YES		Scheduled Follow-up Submission	2012-5-8	FEMALE	151	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	140	NO			G3	Lung	Metastatic			YES	false				0		0		0		0		100		0		0		0	negative	WITH TUMOR				4+	Complete Remission/Response	No			YES				R0	Solid Tissue Normal	11	open	1988	NO	NO	YES	AX	0	3	0	12	Endometrial	A	DECEASED	60	2008										TCGA-AX-A2H7-11A-11D-A18O-05															
TCGA-AX-A2H8-01	MSI-L	0	TCGA-AX-A2H8-01	1861	0	High	C6-UCEC	UCEC non-CIMP c3	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 2		TCGA-AX-A2H8			1861	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					64					Stage IB			-23448	1974		0	1861							2011-10-31	FEMALE	160	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	150	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	TCGA-AX-A2H8.1D1AF737-8A5A-4274-B9AD-2F4BA3127DDD.pdf			1		0		1		0		0		5		94		96	negative	TUMOR FREE						Yes							R0	Primary Tumor	01	open	1988		NO	YES	AX	0	17	0	22	Endometrial	A	LIVING	113	2006	99d5ea34-d803-41f1-a7bc-3d9e0fb3dbda		TCGA-AX-A2H8-01		TCGA-AX-A2H8-01A-11R-A17A-13	TCGA-AX-A2H8-01A-11D-A17C-01			99d5ea34-d803-41f1-a7bc-3d9e0fb3dbda	TCGA-AX-A2H8-01A-11D-A17F-05				TCGA-AX-A2H8-01A-21-A18R-20	ae782754-e5b2-4d0b-8ee4-46641e6b3a43	TCGA-AX-A2H8-01					ae782754-e5b2-4d0b-8ee4-46641e6b3a43	TCGA-AX-A2H8-01A-11D-A17C-01		TCGA-AX-A2H8-01A-11R-A17A-13	
TCGA-AX-A2H8-11	MSI-L	0	TCGA-AX-A2H8-11	1861	0		C6-UCEC								TCGA-AX-A2H8			1861	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					64					Stage IB			-23448	1974		0	1861							2011-10-31	FEMALE	160	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	140	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false				0		0		0		0		100		0		0		0	negative	TUMOR FREE						Yes							R0	Solid Tissue Normal	11	open	1988		NO	YES	AX	0	17	0	22	Endometrial	A	LIVING	113	2006	8e59d005-8361-457f-9316-04c989d0b74f				TCGA-AX-A2H8-11A-11R-A17A-13				8e59d005-8361-457f-9316-04c989d0b74f	TCGA-AX-A2H8-11A-11D-A17F-05														TCGA-AX-A2H8-11A-11R-A17A-13	
TCGA-AX-A2HA-01	MSI-H	0	TCGA-AX-A2HA-01	2475	0	Iq	C6-UCEC	UCEC CIMP c18		UCEC-like c5	UCEC-like c11	miRNA cluster 12			TCGA-AX-A2HA	2475	0	2475	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	35			TCGA-AX-A2HA-F31721	Former User	Stage IB	NO		-13142	2188		0	2475				NO		Scheduled Follow-up Submission	2012-5-8	FEMALE	167	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	100	NO			G3					NO	false	TCGA-AX-A2HA.E44408C9-53DE-4FF7-8D8E-6BFAB24302C3.pdf			6		0		3		0		10		7		80		85	negative	TUMOR FREE					Complete Remission/Response	No			NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	3	0	24	Endometrial	A	LIVING	60	2005	3df718d2-9089-4055-8190-adc218fd3216		TCGA-AX-A2HA-01		TCGA-AX-A2HA-01A-12R-A18L-13	TCGA-AX-A2HA-01A-12D-A18N-01			3df718d2-9089-4055-8190-adc218fd3216	TCGA-AX-A2HA-01A-12D-A18O-05				TCGA-AX-A2HA-01A-21-A23Z-20	500582f4-bc1c-4cdf-bdce-479abc908b6d	TCGA-AX-A2HA-01					500582f4-bc1c-4cdf-bdce-479abc908b6d	TCGA-AX-A2HA-01A-12D-A18N-01		TCGA-AX-A2HA-01A-12R-A18L-13	
TCGA-AX-A2HA-11	MSI-H	0	TCGA-AX-A2HA-11	2475	0		C6-UCEC								TCGA-AX-A2HA	2475	0	2475	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	35			TCGA-AX-A2HA-F31721	Former User	Stage IB	NO		-13142	2188		0	2475				NO		Scheduled Follow-up Submission	2012-5-8	FEMALE	167	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	100	NO			G3					NO	false				1		0		1		0		99		0		0		0	negative	TUMOR FREE					Complete Remission/Response	No			NO				R0	Solid Tissue Normal	11	open	1988	NO	NO	YES	AX	0	3	0	24	Endometrial	A	LIVING	60	2005	0f659732-62d9-4b13-b4c4-cd6b231bdedb				TCGA-AX-A2HA-11A-11R-A18L-13				0f659732-62d9-4b13-b4c4-cd6b231bdedb	TCGA-AX-A2HA-11A-11D-A18O-05														TCGA-AX-A2HA-11A-11R-A18L-13	
TCGA-AX-A2HC-01	MSI-H	0	TCGA-AX-A2HC-01	1044	0	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	GBM-like c6	miRNA cluster 12	cluster 5		TCGA-AX-A2HC	756	1	1044	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	YES	NO	Progressive Disease	53			TCGA-AX-A2HC-F31735		Stage IIIC	NO		-19485	1786		0	1044			756			Scheduled Follow-up Submission	2012-5-8	FEMALE	158	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	120	NO			G3	Other, specify	Metastatic	Abdomen		YES	false	TCGA-AX-A2HC.90DC9BBA-4666-4702-8BA1-F57253E43CDD.pdf			0		0		3		0		0		3		94		98	negative	WITH TUMOR				2	Complete Remission/Response	No			NO				R0	Primary Tumor	01	open	1988	YES	NO	YES	AX	1	1	3	20	Endometrial	A	LIVING	118	2006	3e40a983-aba5-4454-88df-a271c296ada6		TCGA-AX-A2HC-01		TCGA-AX-A2HC-01A-11R-A17A-13	TCGA-AX-A2HC-01A-11D-A17C-01			3e40a983-aba5-4454-88df-a271c296ada6	TCGA-AX-A2HC-01A-11D-A17F-05				TCGA-AX-A2HC-01A-21-A18R-20	07f7c5a2-1da8-4f7c-b6ec-f2d24ad91a36	TCGA-AX-A2HC-01					07f7c5a2-1da8-4f7c-b6ec-f2d24ad91a36	TCGA-AX-A2HC-01A-11D-A17C-01		TCGA-AX-A2HC-01A-11R-A17A-13	
TCGA-AX-A2HC-11	MSI-H	0	TCGA-AX-A2HC-11	1044	0		C6-UCEC								TCGA-AX-A2HC	756	1	1044	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	YES	NO	Progressive Disease	53			TCGA-AX-A2HC-F31735		Stage IIIC	NO		-19485	1786		0	1044			756			Scheduled Follow-up Submission	2012-5-8	FEMALE	158	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	120	NO			G3	Other, specify	Metastatic	Abdomen		YES	false				5		0		0		0		100		0		0		0	negative	WITH TUMOR				2	Complete Remission/Response	No			NO				R0	Solid Tissue Normal	11	open	1988	YES	NO	YES	AX	1	1	3	20	Endometrial	A	LIVING	118	2006				0959be20-00aa-4736-9cf1-41b3c1d5c5b4	TCGA-AX-A2HC-11A-11R-A17A-13					TCGA-AX-A2HC-11A-11D-A17F-05							0959be20-00aa-4736-9cf1-41b3c1d5c5b4						0959be20-00aa-4736-9cf1-41b3c1d5c5b4	TCGA-AX-A2HC-11A-11R-A17A-13	0959be20-00aa-4736-9cf1-41b3c1d5c5b4
TCGA-AX-A2HD-01	MSI-H	0	TCGA-AX-A2HD-01	1414	0	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1		TCGA-AX-A2HD	1414	0	1414	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Partial Response	69			TCGA-AX-A2HD-F31844		Stage IIIA	NO		-25499	1175		0	1414						Scheduled Follow-up Submission	2012-5-9	FEMALE	149	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	100	NO			G3					NO	false	TCGA-AX-A2HD.83BDA3FE-254F-4F99-B41E-FC1F8C128906.pdf			1		0		2		0		0		2		96		96	positive	WITH TUMOR				4+	Partial Remission/Response	No			NO				R1	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	5	0	21	Endometrial	A	LIVING	51	2008	03141105-bc66-4e89-ad97-c54fcf189468		TCGA-AX-A2HD-01		TCGA-AX-A2HD-01A-21R-A17A-13	TCGA-AX-A2HD-01A-21D-A17C-01			03141105-bc66-4e89-ad97-c54fcf189468	TCGA-AX-A2HD-01A-21D-A17F-05				TCGA-AX-A2HD-01A-11-A18R-20	15aef3e6-6b4e-48ff-b719-5819b7a7bcf9	TCGA-AX-A2HD-01					15aef3e6-6b4e-48ff-b719-5819b7a7bcf9	TCGA-AX-A2HD-01A-21D-A17C-01		TCGA-AX-A2HD-01A-21R-A17A-13	
TCGA-AX-A2HD-11	MSI-H	0	TCGA-AX-A2HD-11	1414	0		C6-UCEC								TCGA-AX-A2HD	1414	0	1414	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Partial Response	69			TCGA-AX-A2HD-F31844		Stage IIIA	NO		-25499	1175		0	1414						Scheduled Follow-up Submission	2012-5-9	FEMALE	149	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	110	NO			G3					NO	false				0		0		3		0		97		0		0		0	positive	WITH TUMOR				4+	Partial Remission/Response	No			NO				R1	Solid Tissue Normal	11	open	1988	NO	NO	YES	AX	0	5	0	21	Endometrial	A	LIVING	51	2008				773d237c-995c-4e0b-aaf1-3b78763ae704	TCGA-AX-A2HD-11A-11R-A17A-13					TCGA-AX-A2HD-11A-11D-A17F-05							773d237c-995c-4e0b-aaf1-3b78763ae704						773d237c-995c-4e0b-aaf1-3b78763ae704	TCGA-AX-A2HD-11A-11R-A17A-13	773d237c-995c-4e0b-aaf1-3b78763ae704
TCGA-AX-A2HF-01	MSS	0	TCGA-AX-A2HF-01	589	0	High	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5	mutation cluster 3	TCGA-AX-A2HF	589	0	589	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	67			TCGA-AX-A2HF-F31656		Stage IB			-24689	440		0	589				YES		Scheduled Follow-up Submission	2012-5-8	FEMALE	157	Serous endometrial adenocarcinoma	No		YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	140	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-AX-A2HF.5454BF58-3D26-4D61-B0A8-30A06ECD0E60.pdf			0		0		2		0		0		2		96		98	negative	TUMOR FREE					Complete Remission/Response	Yes			YES				R0	Primary Tumor	01	open	1988	YES	NO	YES	AX	0	9	0	27	Endometrial	A	LIVING	70	2010	2ffda10e-5941-4c80-9291-a5ebbe0d5a2a		TCGA-AX-A2HF-01		TCGA-AX-A2HF-01A-11R-A17A-13	TCGA-AX-A2HF-01A-11D-A17C-01			2ffda10e-5941-4c80-9291-a5ebbe0d5a2a	TCGA-AX-A2HF-01A-11D-A17F-05			TCGA-AX-A2HF-01A-11D-A17D-09	TCGA-AX-A2HF-01A-21-A18R-20	5f386226-6ff9-4832-ac15-0d62ec806ef7	TCGA-AX-A2HF-01		TCGA-AX-A2HF-01A-11D-A17D-09		TCGA-AX-A2HF-01A-11D-A17D-09	5f386226-6ff9-4832-ac15-0d62ec806ef7	TCGA-AX-A2HF-01A-11D-A17C-01		TCGA-AX-A2HF-01A-11R-A17A-13	
TCGA-AX-A2HG-01	MSI-H	0	TCGA-AX-A2HG-01	801	0	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 6		TCGA-AX-A2HG	801	0	801	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	56			TCGA-AX-A2HG-F31657		Stage IC	NO		-20771	582		0	801				NO		Scheduled Follow-up Submission	2012-5-8	FEMALE	157	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	150	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-AX-A2HG.EF863B73-4C80-42E6-8AAF-2EF72559212A.pdf	67		20		0		1		0		20		9		70		70		TUMOR FREE					Complete Remission/Response	No			YES				R1	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	2	0	27	Endometrial	A	LIVING	115	2009	8d2b2907-863e-4db9-8d4b-ce877e562531		TCGA-AX-A2HG-01		TCGA-AX-A2HG-01A-11R-A17A-13	TCGA-AX-A2HG-01A-11D-A17C-01			8d2b2907-863e-4db9-8d4b-ce877e562531	TCGA-AX-A2HG-01A-11D-A17F-05				TCGA-AX-A2HG-01A-21-A18R-20	a8d038ce-6cf0-44b3-ac18-b31e4d44ea57	TCGA-AX-A2HG-01					a8d038ce-6cf0-44b3-ac18-b31e4d44ea57	TCGA-AX-A2HG-01A-11D-A17C-01		TCGA-AX-A2HG-01A-11R-A17A-13	
TCGA-AX-A2HH-01	MSS	0	TCGA-AX-A2HH-01	540	0	Kirc+		UCEC CIMP c18	cluster 2	UCEC-like c5		miRNA cluster 13	cluster 6		TCGA-AX-A2HH	540	0	540	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Partial Response	60			TCGA-AX-A2HH-F31851		Stage IA	NO		-21924	462		0	540						Scheduled Follow-up Submission	2012-5-9	FEMALE	155	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	150	NO			G3					NO	false	TCGA-AX-A2HH.2EE7245F-7069-456A-A215-41E59D9FE606.pdf			1		0		18		0		0		2		80		96	negative	WITH TUMOR					Partial Remission/Response	No			NO				R1	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	4	0	18	Endometrial	A	LIVING	65	2010			TCGA-AX-A2HH-01	9cfe7287-c1aa-4fc0-8d4f-dc72655b2810	TCGA-AX-A2HH-01A-11R-A17A-13	TCGA-AX-A2HH-01A-11D-A17C-01				TCGA-AX-A2HH-01A-11D-A17F-05				TCGA-AX-A2HH-01A-21-A18R-20	a3d37c72-cf27-4bc1-9782-9a3e6b278e1e	TCGA-AX-A2HH-01	9cfe7287-c1aa-4fc0-8d4f-dc72655b2810				a3d37c72-cf27-4bc1-9782-9a3e6b278e1e	TCGA-AX-A2HH-01A-11D-A17C-01	9cfe7287-c1aa-4fc0-8d4f-dc72655b2810	TCGA-AX-A2HH-01A-11R-A17A-13	9cfe7287-c1aa-4fc0-8d4f-dc72655b2810
TCGA-AX-A2HJ-01	MSI-H	0	TCGA-AX-A2HJ-01	935	0	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5		TCGA-AX-A2HJ	935	0	935	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	35			TCGA-AX-A2HJ-F31575		Stage IC	NO		-13112	779		0	935						Scheduled Follow-up Submission	2012-5-7	FEMALE	152	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	140	NO			G3					NO	false	TCGA-AX-A2HJ.84FF1AB9-47F4-4884-9345-43878BDEF379.pdf	80		1		0		5		0		0		25		70		90	negative	TUMOR FREE				0	Complete Remission/Response	No			YES				R0	Primary Tumor	01	open	1988	YES	NO	YES	AX	0	11	0	7	Endometrial	A	LIVING	56	2009	b3b47f11-3e7c-475e-8f39-cefb8db8fa35		TCGA-AX-A2HJ-01		TCGA-AX-A2HJ-01A-11R-A17A-13	TCGA-AX-A2HJ-01A-11D-A17C-01			b3b47f11-3e7c-475e-8f39-cefb8db8fa35	TCGA-AX-A2HJ-01A-11D-A17F-05				TCGA-AX-A2HJ-01A-21-A18R-20	3af89ae5-4918-4a28-9dcb-4ae81264c5de	TCGA-AX-A2HJ-01					3af89ae5-4918-4a28-9dcb-4ae81264c5de	TCGA-AX-A2HJ-01A-11D-A17C-01		TCGA-AX-A2HJ-01A-11R-A17A-13	
TCGA-AX-A2HK-01	MSS	1	TCGA-AX-A2HK-01	90	1	High	C6-UCEC	UCEC Serous c4	cluster 3	KIRC-like c1	UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-AX-A2HK	90	0	90	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	77			TCGA-AX-A2HK-F31847		Stage IIIC	NO		-28316	2045	90	0							Scheduled Follow-up Submission	2012-5-9	FEMALE	154	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	240	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-AX-A2HK.DBC5CE66-3BC0-4A86-A53C-06DEF90A752B.pdf	84		0		0		18		0		0		2		88		96	negative	WITH TUMOR				4+	Complete Remission/Response	No			NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	AX	2	6	3	25	Endometrial	A	DECEASED	73	2005	28e3b0f0-29e2-4726-8e28-c6f5a2275fff		TCGA-AX-A2HK-01		TCGA-AX-A2HK-01A-11R-A17A-13	TCGA-AX-A2HK-01A-11D-A17C-01			28e3b0f0-29e2-4726-8e28-c6f5a2275fff	TCGA-AX-A2HK-01A-11D-A17F-05				TCGA-AX-A2HK-01A-21-A18R-20	f7491453-cb3e-4cfc-9636-20b5dd36d1a0	TCGA-AX-A2HK-01					f7491453-cb3e-4cfc-9636-20b5dd36d1a0	TCGA-AX-A2HK-01A-11D-A17C-01		TCGA-AX-A2HK-01A-11R-A17A-13	
TCGA-AX-A2IN-01	MSI-H	1	TCGA-AX-A2IN-01	947	1	Iq		UCEC CIMP c18				miRNA cluster 6	cluster 1		TCGA-AX-A2IN	358	1	947	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Progressive Disease	63			TCGA-AX-A2IN-F58273		Stage IC			-23275	1321	947	0				358				2014-4-3	FEMALE	157	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	60	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Brain	Distant Metastasis			YES	false	TCGA-AX-A2IN.3C67A037-8A4C-4345-B842-43F1F0A6A53E.pdf	85		6		0		10		0		20		20		60		80	negative	WITH TUMOR			NO			No			YES				R0	Primary Tumor	01	open	1988		NO	YES	AX	0	4	0	21	Endometrial	A	DECEASED	100	2007			TCGA-AX-A2IN-01	af153b10-b6c0-4345-b242-9ad4c676e6c4	TCGA-AX-A2IN-01A-12R-A17X-13	TCGA-AX-A2IN-01A-12D-A17U-01				TCGA-AX-A2IN-01A-12D-A17Z-05					424c49bd-5178-4f9f-ac74-144644d95368	TCGA-AX-A2IN-01	af153b10-b6c0-4345-b242-9ad4c676e6c4				424c49bd-5178-4f9f-ac74-144644d95368	TCGA-AX-A2IN-01A-12D-A17U-01	af153b10-b6c0-4345-b242-9ad4c676e6c4	TCGA-AX-A2IN-01A-12R-A17X-13	af153b10-b6c0-4345-b242-9ad4c676e6c4
TCGA-AX-A2IO-01	MSS	0	TCGA-AX-A2IO-01	1975	0	High		UCEC Serous c4			UCEC-like c11	miRNA cluster 5	cluster 4		TCGA-AX-A2IO	1975	0	1975	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Stable Disease	83			TCGA-AX-A2IO-F58276		Stage IIA			-30539	1262		0	1975							2014-4-3	FEMALE	162	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	40	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-AX-A2IO.5482CC06-7854-459E-8A23-81ABC45DD076.pdf			10		0		2		0		38		10		50		60	negative	TUMOR FREE			YES			No			YES				R1	Primary Tumor	01	open	1988		NO	YES	AX	0	3	0	7	Endometrial	A	LIVING	64	2008	e216a53d-5300-45af-985d-9d397e990acf		TCGA-AX-A2IO-01		TCGA-AX-A2IO-01A-11R-A17X-13	TCGA-AX-A2IO-01A-11D-A17U-01			e216a53d-5300-45af-985d-9d397e990acf	TCGA-AX-A2IO-01A-11D-A17Z-05					3f74a42d-1ae0-4e1c-bd2f-eecfd8b18d50	TCGA-AX-A2IO-01					3f74a42d-1ae0-4e1c-bd2f-eecfd8b18d50	TCGA-AX-A2IO-01A-11D-A17U-01		TCGA-AX-A2IO-01A-11R-A17X-13	
TCGA-AX-A3FS-01	MSI-H	0	TCGA-AX-A3FS-01	1	0	Kirc+		UCEC CIMP c18		BRCA basal-like c6		miRNA cluster 5			TCGA-AX-A3FS			1	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					82			TCGA-AX-A3FS-F58279		Stage IA			-30102	609		0	1							2014-4-3	FEMALE	139	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES	Laparoscopy, robotic-assisted lysis of adhesions, robotic-assisted lysis total hysterectomy, bso, bilateral pelvic lymphadenectomy and cystoscopy	Other method, specify:	80	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	TCGA-AX-A3FS.1AEA9AC0-3B22-4819-9542-1F6A6AD474BC.pdf			1		0		10		0		10		5		75		95	negative							No								Primary Tumor	01	open	1988		NO	YES	AX		0	0	16	Endometrial	A	LIVING	98	2010			TCGA-AX-A3FS-01	2db9f19e-4614-44f9-a9f5-7541d6a20369	TCGA-AX-A3FS-01A-11R-A22I-13	TCGA-AX-A3FS-01A-11D-A227-01				TCGA-AX-A3FS-01A-11D-A22B-05				TCGA-AX-A3FS-01A-21-A23Z-20	703b9152-50c3-458a-943d-02192ab0152e	TCGA-AX-A3FS-01	2db9f19e-4614-44f9-a9f5-7541d6a20369				703b9152-50c3-458a-943d-02192ab0152e	TCGA-AX-A3FS-01A-11D-A227-01	2db9f19e-4614-44f9-a9f5-7541d6a20369	TCGA-AX-A3FS-01A-11R-A22I-13	2db9f19e-4614-44f9-a9f5-7541d6a20369
TCGA-AX-A3FT-01	MSI-H	0	TCGA-AX-A3FT-01	6	0	Kirc+		BRCA CIMP c7		UCEC-like c5		miRNA cluster 13			TCGA-AX-A3FT			6	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					64			TCGA-AX-A3FT-F58280		Stage IB			-23543	524		0	6							2014-4-3	FEMALE	161	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES	Exploratory Laparotomy, TAH, BSO, Pelvic and pariaortic LND.	Other method, specify:	110	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	TCGA-AX-A3FT.EF16D53F-14A2-4127-B5F7-F318EC60C5C0.pdf			10		0		2		0		8		20		70		80								No								Primary Tumor	01	open	1988		NO	YES	AX	0	4	0	21	Endometrial	A	LIVING	82	2010			TCGA-AX-A3FT-01	9c9dcb46-e9c5-4a85-9bf5-00d7cd9e871b	TCGA-AX-A3FT-01A-11R-A22I-13	TCGA-AX-A3FT-01A-11D-A227-01				TCGA-AX-A3FT-01A-11D-A22B-05				TCGA-AX-A3FT-01A-21-A23Z-20	cff946db-7df6-4a64-89a0-d25950130d5d	TCGA-AX-A3FT-01	9c9dcb46-e9c5-4a85-9bf5-00d7cd9e871b				cff946db-7df6-4a64-89a0-d25950130d5d	TCGA-AX-A3FT-01A-11D-A227-01	9c9dcb46-e9c5-4a85-9bf5-00d7cd9e871b	TCGA-AX-A3FT-01A-11R-A22I-13	9c9dcb46-e9c5-4a85-9bf5-00d7cd9e871b
TCGA-AX-A3FV-01	MSS		TCGA-AX-A3FV-01			High		Cluster 13 (HNSC-LUSC)		BRCA basal-like c6		miRNA cluster 12			TCGA-AX-A3FV				Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					62			TCGA-AX-A3FV-F58281		Stage IIIA			-22752	799		0	-6							2014-4-3	FEMALE	152	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	100	NO	YES		G3						false	TCGA-AX-A3FV.0D1601D0-E0F4-4DBA-91EA-62092FE8621F.pdf			0		0		5		0		0		5		90		97								No								Primary Tumor	01	open	1988		NO	YES	AX		0		0	Endometrial	A	LIVING	113	2009			TCGA-AX-A3FV-01	3f24dcf1-9ec6-4ec4-9379-f9051151c639	TCGA-AX-A3FV-01A-11R-A22I-13	TCGA-AX-A3FV-01A-11D-A227-01				TCGA-AX-A3FV-01A-11D-A22B-05				TCGA-AX-A3FV-01A-21-A23Z-20	a41d3c1d-d709-45fb-999f-f98c2b8ff793	TCGA-AX-A3FV-01	3f24dcf1-9ec6-4ec4-9379-f9051151c639				a41d3c1d-d709-45fb-999f-f98c2b8ff793	TCGA-AX-A3FV-01A-11D-A227-01	3f24dcf1-9ec6-4ec4-9379-f9051151c639	TCGA-AX-A3FV-01A-11R-A22I-13	3f24dcf1-9ec6-4ec4-9379-f9051151c639
TCGA-AX-A3FW-01	MSS	0	TCGA-AX-A3FW-01	17	0	Squamous		UCEC non-CIMP c3		UCEC-like c5		miRNA c1uster 10			TCGA-AX-A3FW			17	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					66			TCGA-AX-A3FW-F58282		Stage IB			-24419	723		0	17							2014-4-3	FEMALE	167	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES	Robotic hysterectomy with Lymph Node Dissection	Other method, specify:	90	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	TCGA-AX-A3FW.AAB4F0FC-D6D5-4D5F-B36C-E4D4869E1A15.pdf	27		2		1		2		0		0		2		96		95								No								Primary Tumor	01	open	1988		NO	YES	AX		0	0	12	Endometrial	A	LIVING	84	2009			TCGA-AX-A3FW-01	bbf7786d-0996-47fc-8af9-482d2087ccb1	TCGA-AX-A3FW-01A-11R-A22I-13	TCGA-AX-A3FW-01A-11D-A227-01				TCGA-AX-A3FW-01A-11D-A22B-05				TCGA-AX-A3FW-01A-21-A23Z-20	78af4999-6a03-4ac1-8130-0116eb32b5f3	TCGA-AX-A3FW-01	bbf7786d-0996-47fc-8af9-482d2087ccb1				78af4999-6a03-4ac1-8130-0116eb32b5f3	TCGA-AX-A3FW-01A-11D-A227-01	bbf7786d-0996-47fc-8af9-482d2087ccb1	TCGA-AX-A3FW-01A-11R-A22I-13	bbf7786d-0996-47fc-8af9-482d2087ccb1
TCGA-AX-A3FX-01	MSS	1	TCGA-AX-A3FX-01	1333	1	Squamous		UCEC non-CIMP c3		UCEC-like c5		miRNA cluster 12			TCGA-AX-A3FX	938	1	1333	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES			Progressive Disease	69			TCGA-AX-A3FX-F58283		Stage IIB			-25260	736	1333	0	4			938				2014-4-3	FEMALE	149	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES	TAH/BSO/LND/Panniculectomy	Other method, specify:	100	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Locoregional Recurrence	Chest		YES	false	TCGA-AX-A3FX.B3326BA1-71E3-4207-9727-B157A3E195E7.pdf			1		1		2		0		5		1		92		96					YES			No			NO					Primary Tumor	01	open	1988		NO	YES	AX	0	2	0	24	Endometrial	A	DECEASED	85	2009			TCGA-AX-A3FX-01	73d3142f-9060-488c-9108-3b1abd12f323	TCGA-AX-A3FX-01A-11R-A22I-13	TCGA-AX-A3FX-01A-11D-A227-01				TCGA-AX-A3FX-01A-11D-A22B-05				TCGA-AX-A3FX-01A-21-A23Z-20	48c9e2b3-6091-4eff-b7cd-4d6abc9492df	TCGA-AX-A3FX-01	73d3142f-9060-488c-9108-3b1abd12f323				48c9e2b3-6091-4eff-b7cd-4d6abc9492df	TCGA-AX-A3FX-01A-11D-A227-01	73d3142f-9060-488c-9108-3b1abd12f323	TCGA-AX-A3FX-01A-11R-A22I-13	73d3142f-9060-488c-9108-3b1abd12f323
TCGA-AX-A3FZ-01	MSS	0	TCGA-AX-A3FZ-01	2	0	High		UCEC non-CIMP c3		KIRC-like c1		miRNA cluster 15			TCGA-AX-A3FZ			2	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					33			TCGA-AX-A3FZ-F58286		Stage IIIB			-12331	658		0	2							2014-4-3	FEMALE	152	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES	Exploratory laparotomy, total abdominal hysterectomy, bso, major debulking, omentectomy, appendectomy, bilateral pelvic lymphadenectomy, segmental small bowel resection, cystoscopy	Other method, specify:	100	NO	YES		G3						false	TCGA-AX-A3FZ.4989F66F-57F8-4B1C-97DD-69F3036EB0BA.pdf			1		0		3		0		0		3		94		96	positive							No								Primary Tumor	01	open	1988		NO	YES	AX		0	0	9	Endometrial	A	LIVING	113	2010			TCGA-AX-A3FZ-01	da84a25d-fd15-40ff-80c1-e3f2d2b2b301	TCGA-AX-A3FZ-01A-11R-A22I-13	TCGA-AX-A3FZ-01A-11D-A227-01				TCGA-AX-A3FZ-01A-11D-A22B-05				TCGA-AX-A3FZ-01A-21-A23Z-20	73fdd267-cb26-472d-894c-e517aebbefff	TCGA-AX-A3FZ-01	da84a25d-fd15-40ff-80c1-e3f2d2b2b301				73fdd267-cb26-472d-894c-e517aebbefff	TCGA-AX-A3FZ-01A-11D-A227-01	da84a25d-fd15-40ff-80c1-e3f2d2b2b301	TCGA-AX-A3FZ-01A-11R-A22I-13	da84a25d-fd15-40ff-80c1-e3f2d2b2b301
TCGA-AX-A3G1-01	MSS	1	TCGA-AX-A3G1-01	624	1	Squamous		UCEC non-CIMP c3				miRNA cluster 12			TCGA-AX-A3G1	624	0	624	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					84			TCGA-AX-A3G1-F21258		Stage IC	NO		-31037	765	624	0							Scheduled Follow-up Submission	2012-2-7	FEMALE	160	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES	Total abdominal hysterectomy with bso	Other method, specify:	40	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-AX-A3G1.AEAB9EBE-7BDA-45E4-B2D8-82680BE9B4D4.pdf			3		1		2		0		0		5		93		92						4+		No			NO					Primary Tumor	01	open	1988	NO	NO	YES	AX	0	6	0	21	Endometrial	A	DECEASED	61	2009			TCGA-AX-A3G1-01	b774f929-57f2-4f5a-9080-82b390a7a7f9	TCGA-AX-A3G1-01A-11R-A22I-13	TCGA-AX-A3G1-01A-11D-A227-01				TCGA-AX-A3G1-01A-11D-A22B-05					3c676f76-70f3-4036-87ba-06a4467e951f	TCGA-AX-A3G1-01	b774f929-57f2-4f5a-9080-82b390a7a7f9				3c676f76-70f3-4036-87ba-06a4467e951f	TCGA-AX-A3G1-01A-11D-A227-01	b774f929-57f2-4f5a-9080-82b390a7a7f9	TCGA-AX-A3G1-01A-11R-A22I-13	b774f929-57f2-4f5a-9080-82b390a7a7f9
TCGA-AX-A3G3-01	MSS	0	TCGA-AX-A3G3-01	42	0	High		OV-like c1		UCEC-like c5		miRNA cluster 4			TCGA-AX-A3G3			42	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					58			TCGA-AX-A3G3-F58287		Stage IIIA			-21308	713		0	42							2014-4-3	FEMALE	167	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES	total laparascopic hysterectomy, bso, bilateral pelvic and obturator lymphadenectomy, omentectomy and staging biopsies	Other method, specify:	140	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	TCGA-AX-A3G3.3D86258F-2C9B-4DF2-86C5-E12B3FCB480D.pdf			0		0		15		0		0		3		82		97								Yes								Primary Tumor	01	open	1988		NO	YES	AX	0	3	0	14	Endometrial	A	LIVING	55	2009			TCGA-AX-A3G3-01	11e82091-a9fb-4b7b-b0a2-7908e50e2c60	TCGA-AX-A3G3-01A-11R-A214-13	TCGA-AX-A3G3-01A-11D-A20R-01				TCGA-AX-A3G3-01A-11D-A212-05				TCGA-AX-A3G3-01A-21-A23Z-20	61f0069a-e832-442a-aa11-0e06d7474da8	TCGA-AX-A3G3-01	11e82091-a9fb-4b7b-b0a2-7908e50e2c60				61f0069a-e832-442a-aa11-0e06d7474da8	TCGA-AX-A3G3-01A-11D-A20R-01	11e82091-a9fb-4b7b-b0a2-7908e50e2c60	TCGA-AX-A3G3-01A-11R-A214-13	11e82091-a9fb-4b7b-b0a2-7908e50e2c60
TCGA-AX-A3G4-01	MSS	0	TCGA-AX-A3G4-01	9	0	BRCA-LUAD+		UCEC Serous c4		UCEC-like c5		miRNA cluster 5			TCGA-AX-A3G4			9	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					60			TCGA-AX-A3G4-F58288		Stage IIIC			-22099	463		0	9							2014-4-3	FEMALE	167	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES	TAH, BSO, bilateral pelvic and periaortic lymphadenectomy and omentecomy.	Other method, specify:	130	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	TCGA-AX-A3G4.7E8857D6-4347-4BC5-8655-40AAD7197789.pdf			1		0		4		1		3		3		90		94								No								Primary Tumor	01	open	1988		NO	YES	AX	2	4		2	Endometrial	A	LIVING	107	2010			TCGA-AX-A3G4-01	a598aef0-10a2-41bb-b755-4b2788b32e10	TCGA-AX-A3G4-01A-11R-A214-13	TCGA-AX-A3G4-01A-11D-A20R-01				TCGA-AX-A3G4-01A-11D-A212-05				TCGA-AX-A3G4-01A-21-A23Z-20	597029d3-33a7-4131-ab5a-3b25cf3c1e62	TCGA-AX-A3G4-01	a598aef0-10a2-41bb-b755-4b2788b32e10				597029d3-33a7-4131-ab5a-3b25cf3c1e62	TCGA-AX-A3G4-01A-11D-A20R-01	a598aef0-10a2-41bb-b755-4b2788b32e10	TCGA-AX-A3G4-01A-11R-A214-13	a598aef0-10a2-41bb-b755-4b2788b32e10
TCGA-AX-A3G6-01	MSS	0	TCGA-AX-A3G6-01	8	0	Squamous		UCEC non-CIMP c3				miRNA cluster 12			TCGA-AX-A3G6			8	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					67			TCGA-AX-A3G6-F58289		Stage IA			-24681	456		0	8							2014-4-3	FEMALE	167	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES	TAH, BSO, bilateral pelvic lymphadenectomy, periaortic node dissection	Other method, specify:	50	NO	YES		G2						false	TCGA-AX-A3G6.53586ED5-5C68-4517-8543-7508AF37F68C.pdf			1		0		8		1		0		2		90		94								No								Primary Tumor	01	open	1988		NO	YES	AX	0	5	0	11	Endometrial	A	LIVING	60	2010			TCGA-AX-A3G6-01	99e76a2e-9162-4345-9155-cc7267c0325b	TCGA-AX-A3G6-01A-11R-A214-13	TCGA-AX-A3G6-01A-11D-A20R-01				TCGA-AX-A3G6-01A-11D-A212-05					b2475697-6b9a-419b-af79-e785b8197ac4	TCGA-AX-A3G6-01	99e76a2e-9162-4345-9155-cc7267c0325b				b2475697-6b9a-419b-af79-e785b8197ac4	TCGA-AX-A3G6-01A-11D-A20R-01	99e76a2e-9162-4345-9155-cc7267c0325b	TCGA-AX-A3G6-01A-11R-A214-13	99e76a2e-9162-4345-9155-cc7267c0325b
TCGA-AX-A3G7-01	MSS	0	TCGA-AX-A3G7-01	9	0	Squamous		UCEC Serous c4							TCGA-AX-A3G7			9	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					71			TCGA-AX-A3G7-F58290		Stage IVB			-26187	520		0	9							2014-4-3	FEMALE	154	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES	Exploratory laparotomy, TAH, BSO, radical optimal tumor debulking with gastrocolic omentectomy	Other method, specify:	50	NO	YES		G3						false	TCGA-AX-A3G7.81608C78-6495-4FC7-9210-1132E9335D01.pdf			6		0		5		0		0		6		89		90								No								Primary Tumor	01	open	1988		NO	YES	AX		0		0	Endometrial	A	LIVING	74	2010			TCGA-AX-A3G7-01	8d020165-5475-4257-87c3-c98fc2d201d2	TCGA-AX-A3G7-01A-12R-A214-13	TCGA-AX-A3G7-01A-12D-A20R-01				TCGA-AX-A3G7-01A-12D-A212-05					46c06b3c-05fe-43a3-b367-260f425d485e	TCGA-AX-A3G7-01	8d020165-5475-4257-87c3-c98fc2d201d2				46c06b3c-05fe-43a3-b367-260f425d485e	TCGA-AX-A3G7-01A-12D-A20R-01	8d020165-5475-4257-87c3-c98fc2d201d2	TCGA-AX-A3G7-01A-12R-A214-13	8d020165-5475-4257-87c3-c98fc2d201d2
TCGA-AX-A3G8-01	MSI-H	0	TCGA-AX-A3G8-01	30	0	Iq		UCEC CIMP c18		UCEC-like c5		miRNA cluster 13			TCGA-AX-A3G8			30	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					76			TCGA-AX-A3G8-F58291		Stage IA			-27899	350		0	30							2014-4-3	FEMALE	157	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	110	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	TCGA-AX-A3G8.FD22A233-9333-4DA2-A913-4DBA90600247.pdf			1		0		2		0		0		2		96		97	negative							No								Primary Tumor	01	open	1988		NO	YES	AX	0	2	0	30	Endometrial	A	LIVING	62	2010			TCGA-AX-A3G8-01	9c949f30-455e-48a6-ae31-73f26c609ffd	TCGA-AX-A3G8-01A-11R-A22I-13	TCGA-AX-A3G8-01A-11D-A227-01				TCGA-AX-A3G8-01A-11D-A22B-05				TCGA-AX-A3G8-01A-21-A23Z-20	7f8b07bc-976e-4eef-8ef3-fbb0b3bf7717	TCGA-AX-A3G8-01	9c949f30-455e-48a6-ae31-73f26c609ffd				7f8b07bc-976e-4eef-8ef3-fbb0b3bf7717	TCGA-AX-A3G8-01A-11D-A227-01	9c949f30-455e-48a6-ae31-73f26c609ffd	TCGA-AX-A3G8-01A-11R-A22I-13	9c949f30-455e-48a6-ae31-73f26c609ffd
TCGA-AX-A3G9-01	MSI-H	0	TCGA-AX-A3G9-01	558	0	Quiet		UCEC CIMP c18		UCEC-like c5		miRNA cluster 4			TCGA-AX-A3G9	558	0	558	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					63			TCGA-AX-A3G9-F21262		Stage IIIC			-23361			0	558						Scheduled Follow-up Submission	2012-2-7	FEMALE	154	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES	Robotic laparoscopic hysterectomy, BSO, pelvic and periaortic LND	Other method, specify:					G3					NO																				negative					2		No			YES				R1	Primary Tumor	01	open	1988	YES	NO	YES	AX	0	1	1	4	Endometrial		LIVING	60	2010			TCGA-AX-A3G9-01	f31b5e70-af25-4f1a-b7e3-13f17998e7e2	TCGA-AX-A3G9-01A-11R-A22I-13	TCGA-AX-A3G9-01A-11D-A227-01				TCGA-AX-A3G9-01A-11D-A22B-05				TCGA-AX-A3G9-01A-21-A23Z-20	c29bf4dd-47e2-488b-96bc-90070ea48802	TCGA-AX-A3G9-01	f31b5e70-af25-4f1a-b7e3-13f17998e7e2				c29bf4dd-47e2-488b-96bc-90070ea48802	TCGA-AX-A3G9-01A-11D-A227-01	f31b5e70-af25-4f1a-b7e3-13f17998e7e2	TCGA-AX-A3G9-01A-11R-A22I-13	f31b5e70-af25-4f1a-b7e3-13f17998e7e2
TCGA-AX-A3GB-01	MSS	0	TCGA-AX-A3GB-01	440	0	Iq		UCEC CIMP c18				miRNA c1uster 9			TCGA-AX-A3GB	440	0	440	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					73			TCGA-AX-A3GB-F21266		Stage IB	NO		-26724	469		0	440						Scheduled Follow-up Submission	2012-2-7	FEMALE	158	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES	TAH, BSO, pelvic and paraaortic LND, intracolic omentectomy	Other method, specify:	80	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-AX-A3GB.50C8217A-6834-46E9-9727-5B6B3D37347D.pdf			2		1		2		0		0		20		78		90	negative							No			NO				R0	Primary Tumor	01	open	1988	YES	NO	YES	AX	0	6	0	19	Endometrial	A	LIVING	87	2010			TCGA-AX-A3GB-01	ba01a4cb-d7cd-4a9a-ae28-978262154683	TCGA-AX-A3GB-01A-11R-A22I-13	TCGA-AX-A3GB-01A-11D-A227-01				TCGA-AX-A3GB-01A-11D-A22B-05					78ea41b9-d537-46ae-bb86-da7be0b3f686	TCGA-AX-A3GB-01	ba01a4cb-d7cd-4a9a-ae28-978262154683				78ea41b9-d537-46ae-bb86-da7be0b3f686	TCGA-AX-A3GB-01A-11D-A227-01	ba01a4cb-d7cd-4a9a-ae28-978262154683	TCGA-AX-A3GB-01A-11R-A22I-13	ba01a4cb-d7cd-4a9a-ae28-978262154683
TCGA-AX-A3GI-01	Indeterminate	0	TCGA-AX-A3GI-01	12	0	Squamous		UCEC Serous c4		UCEC-like c5		miRNA c1uster 10			TCGA-AX-A3GI			12	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					66			TCGA-AX-A3GI-F58292		Stage IIIC			-24388	300		0	12							2014-4-3	FEMALE	167	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES	Exploratory Laparotomy, TAH, BSO, bilateral pelvic and periaortic LND.	Other method, specify:	110	NO	YES		G3						false	TCGA-AX-A3GI.A803E376-399C-4841-A6AE-E82B99CD57B7.pdf			0		0		4		0		0		2		94		98								No								Primary Tumor	01	open	1988		NO	YES	AX	3	4	4	4	Endometrial	A	LIVING	87	2011			TCGA-AX-A3GI-01	9d42a9c4-305b-4e25-a260-82805d6b059a	TCGA-AX-A3GI-01A-11R-A214-13	TCGA-AX-A3GI-01A-11D-A20R-01				TCGA-AX-A3GI-01A-11D-A212-05				TCGA-AX-A3GI-01A-21-A23Z-20	14b9dc67-a85e-4867-87a7-b0f153816e50	TCGA-AX-A3GI-01	9d42a9c4-305b-4e25-a260-82805d6b059a				14b9dc67-a85e-4867-87a7-b0f153816e50	TCGA-AX-A3GI-01A-11D-A20R-01	9d42a9c4-305b-4e25-a260-82805d6b059a	TCGA-AX-A3GI-01A-11R-A214-13	9d42a9c4-305b-4e25-a260-82805d6b059a
TCGA-B5-A0JN-01	MSI-L	0	TCGA-B5-A0JN-01	2445	0	High	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5		miRNA c1uster 10	cluster 2	mutation cluster 3	TCGA-B5-A0JN			2445	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					84	0	0	TCGA-B5-A0JN-F11873		Stage IVB	NO		-30933	2164		0	2445				NO			2011-5-18	FEMALE	154	Serous endometrial adenocarcinoma	Yes	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Tumor resection	440	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	TCGA-B5-A0JN.A22F4C33-7630-4595-8415-24C87949B211.pdf	0	0	0	0	0	0	0	0	0	0	0	0	0	100	100	90	90	positive	TUMOR FREE	0	0		0	Complete Remission/Response	Yes	Former User		NO					Primary Tumor	01	open	1988	YES	NO	YES	B5	0	0	0	0	Endometrial	A	LIVING	58	2004			TCGA-B5-A0JN-01	cbd18c2a-4544-4a90-904e-533c3f776f32		TCGA-B5-A0JN-01A-11D-A102-01		TCGA-B5-A0JN-01A-11D-A10Q-05			90ffcffb-c276-438c-ad00-0da5caba8596	TCGA-B5-A0JN-01A-11R-A103-13	TCGA-B5-A0JN-01A-11D-A10B-09	TCGA-B5-A0JN-01A-21-A163-20	40e8e0af-0ac6-4b5a-8db8-e33d4d17430d	TCGA-B5-A0JN-01	cbd18c2a-4544-4a90-904e-533c3f776f32	TCGA-B5-A0JN-01A-11D-A10B-09		TCGA-B5-A0JN-01A-11D-A10B-09	40e8e0af-0ac6-4b5a-8db8-e33d4d17430d	TCGA-B5-A0JN-01A-11D-A102-01	cbd18c2a-4544-4a90-904e-533c3f776f32	TCGA-B5-A0JN-01A-11R-A103-13	cbd18c2a-4544-4a90-904e-533c3f776f32
TCGA-B5-A0JR-01	MSI-H	0	TCGA-B5-A0JR-01	1731	0	BRCA-LUAD+		UCEC CIMP c18	cluster 1					mutation cluster 7	TCGA-B5-A0JR	1731	0	1731	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	73	0	0	TCGA-B5-A0JR-F12807		Stage IB	NO		-26814			0	1731				NO		Scheduled Follow-up Submission	2011-6-8	FEMALE	161	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO			71																	negative	TUMOR FREE	0	0		2	Complete Remission/Response	No	Never Used		NO					Primary Tumor	01	Minimally Invasive	1988	NO	NO	YES	B5	0	6	0	32	Endometrial		LIVING	105	2006		TCGA-B5-A0JR-01			TCGA-B5-A0JR-01A-13R-A041-13	TCGA-B5-A0JR-01A-13D-A042-01	TCGA-B5-A0JR-01	TCGA-B5-A0JR-01A-13D-A039-05					TCGA-B5-A0JR-01A-13W-A062-09		bedc8364-4d3e-448d-b2b5-472e1d90036b			TCGA-B5-A0JR-01A-13W-A062-09	TCGA-B5-A0JR-01A-13R-A040-07	TCGA-B5-A0JR-01A-13W-A062-09	bedc8364-4d3e-448d-b2b5-472e1d90036b	TCGA-B5-A0JR-01A-13D-A042-01		TCGA-B5-A0JR-01A-13R-A041-13	
TCGA-B5-A0JS-01	MSS	0	TCGA-B5-A0JS-01	1422	0	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4		UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 1	TCGA-B5-A0JS	1422	0	1422	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	54	0	0	TCGA-B5-A0JS-F12982		Stage IA	NO		-19995			0	1422				NO		Scheduled Follow-up Submission	2011-6-15	FEMALE	170	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO			11																	negative	TUMOR FREE	0	0		2	Complete Remission/Response	No	Never Used		NO					Primary Tumor	01	Minimally Invasive	1988	NO	NO	YES	B5	0	0	0	28	Endometrial		LIVING	110	2007	a18fa5ae-5c28-426a-a7ae-d0c0b223991f		TCGA-B5-A0JS-01			TCGA-B5-A0JS-01A-11D-A102-01		TCGA-B5-A0JS-01A-11D-A10Q-05	a18fa5ae-5c28-426a-a7ae-d0c0b223991f			TCGA-B5-A0JS-01A-11R-A103-13	TCGA-B5-A0JS-01A-11D-A10B-09		df520b51-d6d1-408d-80c1-fa979a37427f	TCGA-B5-A0JS-01		TCGA-B5-A0JS-01A-11D-A10B-09		TCGA-B5-A0JS-01A-11D-A10B-09	df520b51-d6d1-408d-80c1-fa979a37427f	TCGA-B5-A0JS-01A-11D-A102-01		TCGA-B5-A0JS-01A-11R-A103-13	
TCGA-B5-A0JT-01	MSS	0	TCGA-B5-A0JT-01	1312	0	BRCA-LUAD+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 4	mutation cluster 4	TCGA-B5-A0JT	1312	0	1312	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	63			TCGA-B5-A0JT-F13514	Former User	Stage IIIA	NO		-23041	1128		0	1312				YES		Scheduled Follow-up Submission	2011-6-29	FEMALE	168	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	750	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	TCGA-B5-A0JT.CC6EE5B1-5548-4DE7-873F-332DBF81710F.pdf	12	0	0	0	0	0	0	0	0	20	50	0	0	80	50	65	40	positive	TUMOR FREE				0	Complete Remission/Response	No			NO					Primary Tumor	01	Minimally Invasive	1988	YES	NO	YES	B5	0	0	0	14	Endometrial	A	LIVING	119	2007	b3e039bf-945c-4974-a4ec-8e3b177aef8d		TCGA-B5-A0JT-01		TCGA-B5-A0JT-01A-21R-A119-13	TCGA-B5-A0JT-01A-21D-A120-01			b3e039bf-945c-4974-a4ec-8e3b177aef8d	TCGA-B5-A0JT-01A-21D-A123-05	4e93b9df-d389-4edb-b2d5-cfd48cebb426		TCGA-B5-A0JT-01A-21D-A122-09	TCGA-B5-A0JT-01A-11-A162-20	5d4f3e1d-4869-4d80-9460-15d3f2a6d686	TCGA-B5-A0JT-01				TCGA-B5-A0JT-01A-21D-A122-09	5d4f3e1d-4869-4d80-9460-15d3f2a6d686	TCGA-B5-A0JT-01A-21D-A120-01		TCGA-B5-A0JT-01A-21R-A119-13	
TCGA-B5-A0JU-01	MSI-H	0	TCGA-B5-A0JU-01	1483	0	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 1		TCGA-B5-A0JU			1483	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					57					Stage IB			-21159	1345		0	1483							2011-8-5	FEMALE	158	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	300	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2						true		19		3		0		0		0		0		10		90		90	negative	TUMOR FREE						No								Primary Tumor	01	Minimally Invasive	1988		NO	YES	B5	0	0	0	17	Endometrial	B	LIVING	137	2007	26ef4a16-ddf1-4585-949b-14057cc8a5bf		TCGA-B5-A0JU-01		TCGA-B5-A0JU-01B-11R-A14C-13	TCGA-B5-A0JU-01B-11D-A14F-01			26ef4a16-ddf1-4585-949b-14057cc8a5bf	TCGA-B5-A0JU-01B-11D-A14H-05				TCGA-B5-A0JU-01B-21-A18Q-20	613f98cb-ddae-4b25-9814-c1de684433ea	TCGA-B5-A0JU-01					613f98cb-ddae-4b25-9814-c1de684433ea	TCGA-B5-A0JU-01B-11D-A14F-01		TCGA-B5-A0JU-01B-11R-A14C-13	
TCGA-B5-A0JV-01	MSI-H	0	TCGA-B5-A0JV-01	1237	0	Iq	C6-UCEC	UCEC CIMP c18	cluster 1		UCEC-like c11	miRNA cluster 13	cluster 6	mutation cluster 1	TCGA-B5-A0JV	698	1	1237	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	NO	NO	YES	Complete Response	63	0	0	TCGA-B5-A0JV-F12985		Stage IA	NO	728	-23295	1001		0	1237			698			Scheduled Follow-up Submission	2011-6-15	FEMALE	166	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	40	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2	Other, specify	Locoregional Disease	vaginal wall		YES	true	TCGA-B5-A0JV.71A1DE5B-7CE5-4884-A91E-3BE753036E4F.pdf	26	10	30	0	0	20	20	10	10	10	5	5	25	65	50	85	70	negative	TUMOR FREE	0	0		2	Complete Remission/Response	No			YES	Surgical Resection		R0		Primary Tumor	01	Minimally Invasive	1988	NO	NO	YES	B5	0	2	0	16	Endometrial	A	LIVING	94	2007	39b1ee4d-b57a-44d5-8b14-20b02f878123		TCGA-B5-A0JV-01			TCGA-B5-A0JV-01A-11D-A102-01		TCGA-B5-A0JV-01A-11D-A10Q-05	39b1ee4d-b57a-44d5-8b14-20b02f878123			TCGA-B5-A0JV-01A-11R-A103-13	TCGA-B5-A0JV-01A-11D-A10B-09		836973fa-2c55-4ec7-9422-01bacbee3a47	TCGA-B5-A0JV-01		TCGA-B5-A0JV-01A-11D-A10B-09		TCGA-B5-A0JV-01A-11D-A10B-09	836973fa-2c55-4ec7-9422-01bacbee3a47	TCGA-B5-A0JV-01A-11D-A102-01		TCGA-B5-A0JV-01A-11R-A103-13	
TCGA-B5-A0JX-01	MSS	0	TCGA-B5-A0JX-01	1360	0	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 4		TCGA-B5-A0JX			1360	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					62					Stage IB			-22834	952		0	1360							2011-8-5	FEMALE	168	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	170	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	TCGA-B5-A0JX.E511CFF9-9687-4134-B85D-37C037B71643.pdf	23	20	20	0	0	20	10	10	10	30	10	0	0	50	90	70	90	negative	TUMOR FREE						No								Primary Tumor	01	Minimally Invasive	1988		NO	YES	B5	0	2	0	40	Endometrial	A	LIVING	113	2007	093be209-e5ac-4129-83b2-5f79f6a5c15f		TCGA-B5-A0JX-01		TCGA-B5-A0JX-01A-21R-A14L-13	TCGA-B5-A0JX-01A-21D-A14J-01			093be209-e5ac-4129-83b2-5f79f6a5c15f	TCGA-B5-A0JX-01A-21D-A14N-05				TCGA-B5-A0JX-01A-11-A18Q-20	f67d8675-b970-4ab0-be88-1996c00b038d	TCGA-B5-A0JX-01					f67d8675-b970-4ab0-be88-1996c00b038d	TCGA-B5-A0JX-01A-21D-A14J-01		TCGA-B5-A0JX-01A-21R-A14L-13	
TCGA-B5-A0JY-01	MSS	0	TCGA-B5-A0JY-01	990	0	Quiet	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 2	mutation cluster 11	TCGA-B5-A0JY	990	0	990	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	50			TCGA-B5-A0JY-F12990		Stage IIIC1	NO		-18475	632		0	990				NO		Scheduled Follow-up Submission	2011-6-15	FEMALE	168	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8020/3	C54.1	YES		Dilation and curettage procedure	1170	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-B5-A0JY.9708BE95-175D-458B-8BA1-02D9C488225D.pdf	100	20	20	0	0	10	30	10	10	20	30	0	0	70	40	80	70	negative	TUMOR FREE				2	Complete Remission/Response	No			NO					Primary Tumor	01	open	1988	YES	NO	YES	B5		0	2	17	Endometrial	A	LIVING	67	2008	bbc76639-b9f4-4e9f-afa2-e319eee91b48		TCGA-B5-A0JY-01			TCGA-B5-A0JY-01A-11D-A102-01		TCGA-B5-A0JY-01A-11D-A10Q-05	bbc76639-b9f4-4e9f-afa2-e319eee91b48		67f7ace8-bfc1-4162-b334-d70adf7a75ef	TCGA-B5-A0JY-01A-11R-A103-13	TCGA-B5-A0JY-01A-11D-A10B-09	TCGA-B5-A0JY-01A-21-A162-20	d7c8557f-681c-4387-b053-5b011e6f52b4	TCGA-B5-A0JY-01				TCGA-B5-A0JY-01A-11D-A10B-09	d7c8557f-681c-4387-b053-5b011e6f52b4	TCGA-B5-A0JY-01A-11D-A102-01		TCGA-B5-A0JY-01A-11R-A103-13	
TCGA-B5-A0JZ-01	MSI-H	0	TCGA-B5-A0JZ-01	871	0	Quiet	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 6	cluster 1	mutation cluster 6	TCGA-B5-A0JZ	356	1	871	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	NO	YES	YES	Complete Response	60			TCGA-B5-A0JZ-F12994	Never Used	Stage IIIC1	NO	356	-22106	642		0	871			356			Scheduled Follow-up Submission	2011-6-15	FEMALE	162	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	400	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Metastatic	inguinal lymph node		YES	true	TCGA-B5-A0JZ.B275A085-067D-42ED-8E41-8461D5183A6E.pdf	61	20	20	0	0	10	10	10	10	0	0	30	30	60	60	70	70	negative	TUMOR FREE				0	Progressive Disease	No			YES	Other Method, Specify Below	lymph node dissection			Primary Tumor	01	open	1988	YES	NO	YES	B5	0	8	1	19	Endometrial	A	LIVING	87	2008	3bc43656-d16a-4ec6-9fde-aab0446c6e50	TCGA-B5-A0JZ-01	TCGA-B5-A0JZ-01			TCGA-B5-A0JZ-01A-11D-A042-01	TCGA-B5-A0JZ-01	TCGA-B5-A0JZ-01A-11D-A039-05	3bc43656-d16a-4ec6-9fde-aab0446c6e50		d30ac09f-6cfc-4660-a8bf-6c5538c8456d	TCGA-B5-A0JZ-01A-11R-A041-13	TCGA-B5-A0JZ-01A-11W-A062-09	TCGA-B5-A0JZ-01A-21-A162-20	88459d76-a7a2-476f-aa91-a527b3a04da4	TCGA-B5-A0JZ-01		TCGA-B5-A0JZ-01A-11W-A062-09	TCGA-B5-A0JZ-01A-11R-A040-07	TCGA-B5-A0JZ-01A-11W-A062-09	88459d76-a7a2-476f-aa91-a527b3a04da4	TCGA-B5-A0JZ-01A-11D-A042-01		TCGA-B5-A0JZ-01A-11R-A041-13	
TCGA-B5-A0K0-01	MSS	0	TCGA-B5-A0K0-01	862	0	BRCA-LUAD+	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 4	TCGA-B5-A0K0	862	0	862	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	48			TCGA-B5-A0K0-F12995	Former User	Stage IA	NO		-17810	615		0	862				YES		Scheduled Follow-up Submission	2011-6-15	FEMALE	168	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	440	NO		Indeterminate (neither Pre or Postmenopausal)	G1					NO	true	TCGA-B5-A0K0.6284E0A9-FACB-4297-ABC6-308715ABAFCD.pdf	0	30		0		10		10		10		10		70		80		negative	TUMOR FREE				3	Complete Remission/Response	No			NO					Primary Tumor	01	Minimally Invasive	1988	NO	NO	YES	B5	0	0	0	15	Endometrial	A	LIVING	140	2008	2df1abb0-b25b-4486-a5ed-728964eb0a1b	TCGA-B5-A0K0-01	TCGA-B5-A0K0-01			TCGA-B5-A0K0-01A-11D-A042-01	TCGA-B5-A0K0-01	TCGA-B5-A0K0-01A-11D-A039-05	2df1abb0-b25b-4486-a5ed-728964eb0a1b		712b8668-113a-4ae1-92c6-8d3104282749	TCGA-B5-A0K0-01A-11R-A041-13	TCGA-B5-A0K0-01A-11W-A062-09	TCGA-B5-A0K0-01A-21-A162-20	52b5007f-627c-4315-b98b-47cd04b9dc23	TCGA-B5-A0K0-01		TCGA-B5-A0K0-01A-11W-A062-09	TCGA-B5-A0K0-01A-11R-A040-07	TCGA-B5-A0K0-01A-11W-A062-09	52b5007f-627c-4315-b98b-47cd04b9dc23	TCGA-B5-A0K0-01A-11D-A042-01		TCGA-B5-A0K0-01A-11R-A041-13	
TCGA-B5-A0K1-01	MSS	0	TCGA-B5-A0K1-01	928	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 4	TCGA-B5-A0K1	928	0	928	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	69			TCGA-B5-A0K1-F12996		Stage IA	NO		-25291	636		0	928				YES		Scheduled Follow-up Submission	2011-6-15	FEMALE	174	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	180	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	TCGA-B5-A0K1.826BF8E6-F928-4962-9322-78FA74F9FB0E.pdf	45	0	0	0	0	0	0	0	0	0	0	0	0	100	100	85	85	negative	TUMOR FREE				4+		No			NO					Primary Tumor	01	open	1988	NO	NO	YES	B5	0	0	0	22	Endometrial	A	LIVING	117	2008	bacdb0de-d29b-4ac1-a163-35376a7b2b9b	TCGA-B5-A0K1-01	TCGA-B5-A0K1-01			TCGA-B5-A0K1-01A-11D-A042-01	TCGA-B5-A0K1-01	TCGA-B5-A0K1-01A-11D-A039-05	bacdb0de-d29b-4ac1-a163-35376a7b2b9b		6e5666f2-50be-4591-878c-723948cdf9c8	TCGA-B5-A0K1-01A-11R-A041-13	TCGA-B5-A0K1-01A-11W-A062-09	TCGA-B5-A0K1-01A-21-A162-20	75dcdde5-3390-4b81-b583-af844be12d28	TCGA-B5-A0K1-01		TCGA-B5-A0K1-01A-11W-A062-09	TCGA-B5-A0K1-01A-11R-A040-07	TCGA-B5-A0K1-01A-11W-A062-09	75dcdde5-3390-4b81-b583-af844be12d28	TCGA-B5-A0K1-01A-11D-A042-01		TCGA-B5-A0K1-01A-11R-A041-13	
TCGA-B5-A0K2-01	MSI-H	0	TCGA-B5-A0K2-01	788	0	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 2	mutation cluster 1	TCGA-B5-A0K2	788	0	788	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	54			TCGA-B5-A0K2-F13261	Never Used	Stage IIIA	NO		-20080	534		0	788				NO		Scheduled Follow-up Submission	2011-6-22	FEMALE	159	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	270	NO		Indeterminate (neither Pre or Postmenopausal)	G1					NO	true	TCGA-B5-A0K2.5D780459-F4E6-4BB8-939D-5FDFD9BF7073.pdf	0	0	0	0	0	0	0	0	0	0	0	0	0	100	100	75	90	positive	TUMOR FREE				2	Complete Remission/Response	No			NO					Primary Tumor	01	Minimally Invasive	1988	YES	NO	YES	B5	0	0	0	25	Endometrial	A	LIVING	84	2008	c30924bd-cb0b-43ee-832e-1b470ec39d21		TCGA-B5-A0K2-01			TCGA-B5-A0K2-01A-12D-A102-01		TCGA-B5-A0K2-01A-12D-A10Q-05	c30924bd-cb0b-43ee-832e-1b470ec39d21		a0da1e80-290c-4af2-ae26-9492b418c580	TCGA-B5-A0K2-01A-12R-A103-13	TCGA-B5-A0K2-01A-12W-A10C-09	TCGA-B5-A0K2-01A-21-A162-20	04dc2e3c-0fcb-4742-a91a-1d3be7a355d3	TCGA-B5-A0K2-01		TCGA-B5-A0K2-01A-12W-A10C-09		TCGA-B5-A0K2-01A-12W-A10C-09	04dc2e3c-0fcb-4742-a91a-1d3be7a355d3	TCGA-B5-A0K2-01A-12D-A102-01		TCGA-B5-A0K2-01A-12R-A103-13	
TCGA-B5-A0K3-01	MSS	1	TCGA-B5-A0K3-01	830	1	High	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 2	mutation cluster 2	TCGA-B5-A0K3	256	1	830	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	NO	NO	Progressive Disease	62			TCGA-B5-A0K3-F13266	Never Used	Stage IA	NO		-22664	523	830	0	700			256	YES		Scheduled Follow-up Submission	2011-6-22	FEMALE	164	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	390	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Locoregional Disease	vaginal cuff		YES	true	TCGA-B5-A0K3.2D78431C-7385-4BD3-B597-85E613D89BF6.pdf	10	0	0	0	0	5	5	0	0	0	0	10	0	85	95	85	90	negative	WITH TUMOR				4+		No			NO					Primary Tumor	01	Minimally Invasive	2009	YES	NO	YES	B5	0	11	0	27	Endometrial	A	DECEASED	88	2009	a2d46b53-d9bd-4c19-9a0a-fecb48d3c06a		TCGA-B5-A0K3-01			TCGA-B5-A0K3-01A-11D-A042-01		TCGA-B5-A0K3-01A-11D-A039-05	a2d46b53-d9bd-4c19-9a0a-fecb48d3c06a		7854e580-34cd-4714-a5ff-58219fdc22be	TCGA-B5-A0K3-01A-11R-A041-13	TCGA-B5-A0K3-01A-11W-A062-09	TCGA-B5-A0K3-01A-21-A162-20	5dcc7526-fd50-480d-b9ed-0a4bb2323d6a	TCGA-B5-A0K3-01		TCGA-B5-A0K3-01A-11W-A062-09		TCGA-B5-A0K3-01A-11W-A062-09	5dcc7526-fd50-480d-b9ed-0a4bb2323d6a	TCGA-B5-A0K3-01A-11D-A042-01		TCGA-B5-A0K3-01A-11R-A041-13	
TCGA-B5-A0K4-01	MSS	0	TCGA-B5-A0K4-01	544	0	BRCA-LUAD+	C6-UCEC	UCEC non-CIMP c3	cluster 4	squamous c3	UCEC-like c11	miRNA cluster 12	cluster 3	mutation c1uster 10	TCGA-B5-A0K4	544	0	544	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	51			TCGA-B5-A0K4-F13279	Never Used	Stage IB	NO		-18631	264		0	544						Scheduled Follow-up Submission	2011-6-22	FEMALE	162	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	280	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	TCGA-B5-A0K4.80DE2981-089A-47A2-B221-F7C28ECAF3F2.pdf	87	0	0	0	0	15	20	0	0	0	0	15	20	70	60	80	70	negative	TUMOR FREE				0	Complete Remission/Response	No			YES					Primary Tumor	01	Minimally Invasive	2009	YES	NO	YES	B5	0	3	0	23	Endometrial	A	LIVING	75	2009	73e01a38-164c-44ce-ab36-ed429af8af44	TCGA-B5-A0K4-01	TCGA-B5-A0K4-01			TCGA-B5-A0K4-01A-11D-A042-01	TCGA-B5-A0K4-01	TCGA-B5-A0K4-01A-11D-A039-05	73e01a38-164c-44ce-ab36-ed429af8af44		ab1e33d6-97e4-43ca-bac8-612e767be9ef	TCGA-B5-A0K4-01A-11R-A041-13	TCGA-B5-A0K4-01A-11W-A062-09	TCGA-B5-A0K4-01A-21-A162-20	ae58a3df-1c3e-4b55-a2f7-d0ef5a25570f	TCGA-B5-A0K4-01		TCGA-B5-A0K4-01A-11W-A062-09	TCGA-B5-A0K4-01A-11R-A040-07	TCGA-B5-A0K4-01A-11W-A062-09	ae58a3df-1c3e-4b55-a2f7-d0ef5a25570f	TCGA-B5-A0K4-01A-11D-A042-01		TCGA-B5-A0K4-01A-11R-A041-13	
TCGA-B5-A0K6-01	MSI-H	0	TCGA-B5-A0K6-01	418	0	Iq	C6-UCEC	UCEC CIMP c18	cluster 1		UCEC-like c11	miRNA cluster 13	cluster 1	mutation cluster 1	TCGA-B5-A0K6	418	0	418	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	58			TCGA-B5-A0K6-F13281		Stage IA	NO		-21515	206		0	418				YES		Scheduled Follow-up Submission	2011-2-22	FEMALE	167	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	110	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	TCGA-B5-A0K6.B7F34F79-DB7F-4C98-B1B3-80C3187AE91C.pdf	7	0	0	0	0	0	0	0	0	0	0	20	0	80	100	60	90	negative	TUMOR FREE				0		No			NO					Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	B5		0		0	Endometrial	A	LIVING	132	2009	4534628b-5eb9-4123-b56b-b00447ee730b		TCGA-B5-A0K6-01			TCGA-B5-A0K6-01A-11D-A042-01		TCGA-B5-A0K6-01A-11D-A039-05	4534628b-5eb9-4123-b56b-b00447ee730b			TCGA-B5-A0K6-01A-11R-A041-13	TCGA-B5-A0K6-01A-11W-A062-09		dc5e5aff-8c3c-405a-874a-c9a48dcaf003	TCGA-B5-A0K6-01		TCGA-B5-A0K6-01A-11W-A062-09		TCGA-B5-A0K6-01A-11W-A062-09	dc5e5aff-8c3c-405a-874a-c9a48dcaf003	TCGA-B5-A0K6-01A-11D-A042-01		TCGA-B5-A0K6-01A-11R-A041-13	
TCGA-B5-A0K7-01	MSS	0	TCGA-B5-A0K7-01	520	0	Iq	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 1	mutation cluster 4	TCGA-B5-A0K7	322	1	520	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	NO	YES	NO	Complete Response	64			TCGA-B5-A0K7-F13511		Stage IA	NO		-23429	184		0	520			322			Scheduled Follow-up Submission	2011-6-29	FEMALE	168	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.		C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	1160	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1	Other, specify	Metastatic	vagina		YES	true	TCGA-B5-A0K7.5C3818CE-5DA9-403E-B895-61DEA4BBFA57.pdf	0	0	0	0	0	0	0	0	0	0	0	0	0	100	100	85	85	negative	TUMOR FREE				2	Complete Remission/Response	No			NO					Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	B5		0	0	6	Endometrial	A	LIVING	61	2009	444a9114-2e40-4e7c-979a-624bc95d4c47		TCGA-B5-A0K7-01			TCGA-B5-A0K7-01A-11D-A102-01		TCGA-B5-A0K7-01A-11D-A10Q-05	444a9114-2e40-4e7c-979a-624bc95d4c47		4cc6cb63-cd6a-4683-b5c9-4c9f9fbf09c8	TCGA-B5-A0K7-01A-11R-A103-13	TCGA-B5-A0K7-01A-11W-A10C-09	TCGA-B5-A0K7-01A-21-A162-20	ca9ab018-3b10-4904-ad09-69d9d617007f	TCGA-B5-A0K7-01		TCGA-B5-A0K7-01A-11W-A10C-09		TCGA-B5-A0K7-01A-11W-A10C-09	ca9ab018-3b10-4904-ad09-69d9d617007f	TCGA-B5-A0K7-01A-11D-A102-01		TCGA-B5-A0K7-01A-11R-A103-13	
TCGA-B5-A0K8-01	MSS	0	TCGA-B5-A0K8-01	543	0	Squamous	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation c1uster 9	TCGA-B5-A0K8			543	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					71					Stage IB			-25992	191		0	543							2011-8-5	FEMALE	160	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	260	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	TCGA-B5-A0K8.1E7C9CA2-73AA-4443-A125-D5588F93BEF9.pdf	5	10	10	0	0	10	10	0	0	0	0	10	30	80	60	90	70	negative	TUMOR FREE						No								Primary Tumor	01	Minimally Invasive	2009		NO	YES	B5	0	0	0	12	Endometrial	A	LIVING	61	2009	71cdc7a1-4bbb-461c-ab98-34cad8c3a767		TCGA-B5-A0K8-01		TCGA-B5-A0K8-01A-11R-A14L-13	TCGA-B5-A0K8-01A-11D-A14J-01			71cdc7a1-4bbb-461c-ab98-34cad8c3a767	TCGA-B5-A0K8-01A-11D-A14N-05			TCGA-B5-A0K8-01A-11D-A14K-09	TCGA-B5-A0K8-01A-21-A18Q-20	d45d8bee-8432-4d58-ba54-5604e0316921	TCGA-B5-A0K8-01		TCGA-B5-A0K8-01A-11D-A14K-09		TCGA-B5-A0K8-01A-11D-A14K-09	d45d8bee-8432-4d58-ba54-5604e0316921	TCGA-B5-A0K8-01A-11D-A14J-01		TCGA-B5-A0K8-01A-11R-A14L-13	
TCGA-B5-A0K9-01	MSI-H	0	TCGA-B5-A0K9-01	335	0	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5		miRNA cluster 13	cluster 6	mutation cluster 6	TCGA-B5-A0K9	335	0	335	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	88			TCGA-B5-A0K9-F13512	Never Used	Stage II	NO		-32289	182		0	335				YES		Scheduled Follow-up Submission	2011-6-29	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	600	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	TCGA-B5-A0K9.8278F457-C0A5-4441-9105-3FC015E3F0EF.pdf	87	20	20	0	0	10	10	20	10	20	20	0	0	70	70	80	80	negative	TUMOR FREE				3	Complete Remission/Response	No			YES					Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	B5		0		0	Endometrial	A	LIVING	65	2009			TCGA-B5-A0K9-01	ac3970c9-575a-4d72-a2b3-45f1ab671bbb		TCGA-B5-A0K9-01A-21D-A102-01		TCGA-B5-A0K9-01A-21D-A10Q-05			bfe971a5-cadc-45ee-8ce3-991809a3479e	TCGA-B5-A0K9-01A-21R-A103-13	TCGA-B5-A0K9-01A-21D-A10O-09	TCGA-B5-A0K9-01A-11-A162-20	425eb6d1-b163-4dd1-be36-dedd49d77c83	TCGA-B5-A0K9-01	ac3970c9-575a-4d72-a2b3-45f1ab671bbb	TCGA-B5-A0K9-01A-21D-A10O-09		TCGA-B5-A0K9-01A-21D-A10O-09	425eb6d1-b163-4dd1-be36-dedd49d77c83	TCGA-B5-A0K9-01A-21D-A102-01	ac3970c9-575a-4d72-a2b3-45f1ab671bbb	TCGA-B5-A0K9-01A-21R-A103-13	ac3970c9-575a-4d72-a2b3-45f1ab671bbb
TCGA-B5-A0KB-01	MSS	0	TCGA-B5-A0KB-01	125	0	Squamous	C6-UCEC	UCEC Serous c4	cluster 4	squamous c3	UCEC-like c11	miRNA c1uster 10	cluster 2		TCGA-B5-A0KB			125	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					62					Stage IB			-22669	368		0	125							2011-8-5	FEMALE	161	Endometrioid endometrial adenocarcinoma	Yes			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	430	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true		72		40		10		10		20		0		30		60		70	negative	TUMOR FREE						Yes								Primary Tumor	01	Minimally Invasive	2009		NO	YES	B5	0	0	0	0	Endometrial	B	LIVING	76	2010	b5ee1a9b-caca-4abf-9317-d6bf673b8e65		TCGA-B5-A0KB-01		TCGA-B5-A0KB-01B-11R-A14C-13	TCGA-B5-A0KB-01B-11D-A14F-01			b5ee1a9b-caca-4abf-9317-d6bf673b8e65	TCGA-B5-A0KB-01B-11D-A14H-05				TCGA-B5-A0KB-01B-21-A18Q-20	2b83f094-c657-4d73-8310-41650f69b0b6	TCGA-B5-A0KB-01					2b83f094-c657-4d73-8310-41650f69b0b6	TCGA-B5-A0KB-01B-11D-A14F-01		TCGA-B5-A0KB-01B-11R-A14C-13	
TCGA-B5-A11E-01	MSI-L	0	TCGA-B5-A11E-01	265	0	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5	mutation cluster 11	TCGA-B5-A11E	265	0	265	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	53			TCGA-B5-A11E-F17835		Stage IB	NO		-19458	198		0	265						Scheduled Follow-up Submission	2011-10-26	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	890	NO		Peri (6-12 months since last menstrual period)	G3					NO	true	TCGA-B5-A11E.2058131C-09EA-4DC7-A84A-EB055A68F1B6.pdf	69	4	4	0	0	3	2	1	1	0	0	1	3	96	95	96	95	negative	TUMOR FREE				2	Complete Remission/Response	No			NO					Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	B5	0	4	0	20	Endometrial	A	LIVING	52	2010	7e923dc8-9920-4f06-a98b-085a5935b29c		TCGA-B5-A11E-01			TCGA-B5-A11E-01A-11D-A10L-01			7e923dc8-9920-4f06-a98b-085a5935b29c	TCGA-B5-A11E-01A-11D-A10N-05	e4f73cb4-df3f-467f-be19-6037f9871cce	TCGA-B5-A11E-01A-11R-A10I-13	TCGA-B5-A11E-01A-11D-A10M-09	TCGA-B5-A11E-01A-21-A163-20	621f67e0-e8a5-4f5b-af08-8abeb5f95d28	TCGA-B5-A11E-01				TCGA-B5-A11E-01A-11D-A10M-09	621f67e0-e8a5-4f5b-af08-8abeb5f95d28	TCGA-B5-A11E-01A-11D-A10L-01		TCGA-B5-A11E-01A-11R-A10I-13	
TCGA-B5-A11F-01	MSS	0	TCGA-B5-A11F-01	5651	0	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 3	mutation cluster 4	TCGA-B5-A11F	1610	1	5651	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	YES	NO	Complete Response	55			TCGA-B5-A11F-F17642		Stage IA	NO		-20171	5482		0	5651			1610	NO		Scheduled Follow-up Submission	2011-10-20	FEMALE		Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	380	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2	Bone	Metastatic			YES	true	TCGA-B5-A11F.228E437D-FB45-452B-A5A0-299C125F4CC4.pdf	7	3	2	6	6	5	1	1	1	0	0	5	0	90	99	90	99	negative	TUMOR FREE					Complete Remission/Response	No			YES	Other Method, Specify Below	CT guided thin needle aspirate			Primary Tumor	01	Minimally Invasive	1988	YES	NO	YES	B5	0	0	0	13	Endometrial	A	LIVING		1995	fb1c341a-34f7-482c-a954-de07652990b1		TCGA-B5-A11F-01			TCGA-B5-A11F-01A-11D-A10L-01			fb1c341a-34f7-482c-a954-de07652990b1	TCGA-B5-A11F-01A-11D-A10N-05	8c6d529c-dad0-4264-a2fd-d7250a73c825	TCGA-B5-A11F-01A-11R-A10I-13	TCGA-B5-A11F-01A-11D-A10M-09	TCGA-B5-A11F-01A-21-A163-20	09e6ef2e-e5cf-40a1-8ccf-d2ea8e655354	TCGA-B5-A11F-01		TCGA-B5-A11F-01A-11D-A10M-09		TCGA-B5-A11F-01A-11D-A10M-09	09e6ef2e-e5cf-40a1-8ccf-d2ea8e655354	TCGA-B5-A11F-01A-11D-A10L-01		TCGA-B5-A11F-01A-11R-A10I-13	
TCGA-B5-A11G-01	MSI-H	0	TCGA-B5-A11G-01	3448	0	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 6	cluster 1	mutation cluster 11	TCGA-B5-A11G	3448	0	3448	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	71			TCGA-B5-A11G-F17657		Stage IA	NO		-25995			0	3448				NO		Scheduled Follow-up Submission	2011-5-23	FEMALE	160	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO			0																	negative	TUMOR FREE				2	Complete Remission/Response	No			NO					Primary Tumor	01	open	1988	NO	NO	YES	B5	0	0	0	10	Endometrial		LIVING	77	2001	b213f9e2-4253-41db-9a05-e91791f4ec7e		TCGA-B5-A11G-01		TCGA-B5-A11G-01A-13R-A119-13	TCGA-B5-A11G-01A-13D-A120-01			b213f9e2-4253-41db-9a05-e91791f4ec7e	TCGA-B5-A11G-01A-13D-A123-05	a166ddc1-c6d9-4125-81ae-7ca62778d347		TCGA-B5-A11G-01A-13D-A122-09	TCGA-B5-A11G-01A-21-A163-20	f2786439-cb59-43cf-8e81-3b7af9b60585	TCGA-B5-A11G-01				TCGA-B5-A11G-01A-13D-A122-09	f2786439-cb59-43cf-8e81-3b7af9b60585	TCGA-B5-A11G-01A-13D-A120-01		TCGA-B5-A11G-01A-13R-A119-13	
TCGA-B5-A11H-01	MSI-H	0	TCGA-B5-A11H-01	2687	0	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 1	TCGA-B5-A11H	2687	0	2687	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	67			TCGA-B5-A11H-F17659		Stage IIIA	NO		-24556	2324		0	2687				YES		Scheduled Follow-up Submission	2011-10-20	FEMALE		Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	620	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	TCGA-B5-A11H.40813C61-4B78-4677-89A4-4B9488613F57.pdf	0	5	5	10	10	10	10	5	2	0	0	5	5	85	85	85	85	positive	TUMOR FREE					Complete Remission/Response	No			NO					Primary Tumor	01	open	1988	YES	NO	YES	B5	0	0	0	15	Endometrial	A	LIVING	101	2004	c0294497-87d4-481f-864a-e4fa9baab8c5		TCGA-B5-A11H-01		TCGA-B5-A11H-01A-11R-A119-13	TCGA-B5-A11H-01A-11D-A120-01			c0294497-87d4-481f-864a-e4fa9baab8c5	TCGA-B5-A11H-01A-11D-A123-05	84a856df-6e1c-48d8-af42-3430608432f1		TCGA-B5-A11H-01A-11D-A122-09	TCGA-B5-A11H-01A-21-A163-20	92463749-a605-444d-815a-3b7dcdca0058	TCGA-B5-A11H-01				TCGA-B5-A11H-01A-11D-A122-09	92463749-a605-444d-815a-3b7dcdca0058	TCGA-B5-A11H-01A-11D-A120-01		TCGA-B5-A11H-01A-11R-A119-13	
TCGA-B5-A11I-01	MSS	0	TCGA-B5-A11I-01	2303	0	High	C6-UCEC	UCEC Serous c4	cluster 3	squamous c3	UCEC-like c11	miRNA cluster 4	cluster 2	mutation cluster 3	TCGA-B5-A11I	705	1	2303	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	NO	YES	Stable Disease	65			TCGA-B5-A11I-F17674		Stage IVB	NO	704	-23857	1974		0	2303			705	YES		Scheduled Follow-up Submission	2011-10-21	FEMALE	159	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8140/3	C54.1	YES		Office Endometrial Biopsy	970	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Lung	Metastatic			YES	true	TCGA-B5-A11I.850EFCC5-484B-4E09-801A-2FAFB4CFD72B.pdf	8	30	30	30	25	5	7	3	2	0	0	3	3	92	90	92	90	negative	TUMOR FREE				0	Complete Remission/Response	No	Current User		YES	Surgical Resection				Primary Tumor	01	open	1988	YES	NO	YES	B5	0	7	0	6	Endometrial	A	LIVING	124	2005	5706f1b9-2c2c-4906-a9fb-64ba5a57d47e		TCGA-B5-A11I-01			TCGA-B5-A11I-01A-11D-A10L-01			5706f1b9-2c2c-4906-a9fb-64ba5a57d47e	TCGA-B5-A11I-01A-11D-A10N-05	354106a1-ba91-416a-b95c-05acae0ec86b	TCGA-B5-A11I-01A-11R-A10I-13	TCGA-B5-A11I-01A-11D-A10M-09	TCGA-B5-A11I-01A-21-A163-20	b23a0b07-9239-4207-9c01-2250c5b412dd	TCGA-B5-A11I-01		TCGA-B5-A11I-01A-11D-A10M-09		TCGA-B5-A11I-01A-11D-A10M-09	b23a0b07-9239-4207-9c01-2250c5b412dd	TCGA-B5-A11I-01A-11D-A10L-01		TCGA-B5-A11I-01A-11R-A10I-13	
TCGA-B5-A11J-01	MSI-H	0	TCGA-B5-A11J-01	1656	0	Quiet	C6-UCEC	UCEC CIMP c18	cluster 2		UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 2	TCGA-B5-A11J	1656	0	1656	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	64			TCGA-B5-A11J-F17687		Stage IA	NO		-23485	1536		0	1656				YES		Scheduled Follow-up Submission	2011-10-21	FEMALE		Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	90	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	TCGA-B5-A11J.1F9E7FAB-ADA0-4EFF-8A86-F5344357ADED.pdf	9	8	5	10	8	1	1	1	1	0	0	7	4	92	95	92	95	negative	TUMOR FREE				1	Complete Remission/Response	No			NO					Primary Tumor	01	open	1988	NO	NO	YES	B5	0	0	0	17	Endometrial	A	LIVING	134	2006	4f3e68ae-cf3c-491d-a3ed-0fc30261ead3		TCGA-B5-A11J-01		TCGA-B5-A11J-01A-11R-A119-13	TCGA-B5-A11J-01A-11D-A120-01			4f3e68ae-cf3c-491d-a3ed-0fc30261ead3	TCGA-B5-A11J-01A-11D-A123-05			TCGA-B5-A11J-01A-11D-A122-09		9475b2ac-aa56-419f-a2c1-2528c4e82f38	TCGA-B5-A11J-01				TCGA-B5-A11J-01A-11D-A122-09	9475b2ac-aa56-419f-a2c1-2528c4e82f38	TCGA-B5-A11J-01A-11D-A120-01		TCGA-B5-A11J-01A-11R-A119-13	
TCGA-B5-A11L-01	MSS	0	TCGA-B5-A11L-01	1396	0	COAD-READ	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 5	cluster 4		TCGA-B5-A11L			1396	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					71	0				Stage IC			-26120			0	1396							2011-8-9	FEMALE	163	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Dilation and curettage procedure				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2								85																	negative	TUMOR FREE						No								Primary Tumor	01	Minimally Invasive	1988		NO	YES	B5		0	0	9	Endometrial		LIVING	92	2007	d262b256-5452-4df1-9526-9a1b11da775f		TCGA-B5-A11L-01		TCGA-B5-A11L-01B-21R-A13R-13	TCGA-B5-A11L-01B-21D-A13J-01			d262b256-5452-4df1-9526-9a1b11da775f	TCGA-B5-A11L-01B-21D-A13K-05				TCGA-B5-A11L-01B-11-A18Q-20	f41f2ccb-2a60-42f3-ab5b-fa141de0f60c	TCGA-B5-A11L-01					f41f2ccb-2a60-42f3-ab5b-fa141de0f60c	TCGA-B5-A11L-01B-21D-A13J-01		TCGA-B5-A11L-01B-21R-A13R-13	
TCGA-B5-A11M-01	MSS	0	TCGA-B5-A11M-01	1362	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 3		UCEC-like c11	miRNA cluster 13	cluster 6	mutation cluster 1	TCGA-B5-A11M	1362	0	1362	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	43			TCGA-B5-A11M-F17720	Former User	Stage IA	NO		-16063			0	1362				YES		Scheduled Follow-up Submission	2011-10-24	FEMALE	153	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure				Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1					NO			4																	negative	TUMOR FREE				0	Complete Remission/Response	No			NO					Primary Tumor	01	open	1988	NO	NO	YES	B5	0	0	0	0	Endometrial		LIVING	139	2007	aefe6191-1196-4614-b319-4ce263d3cc90				TCGA-B5-A11M-01A-11R-A119-13				aefe6191-1196-4614-b319-4ce263d3cc90	TCGA-B5-A11M-01A-11D-A123-05			TCGA-B5-A11M-01A-11D-A122-09			TCGA-B5-A11M-01		TCGA-B5-A11M-01A-11D-A122-09		TCGA-B5-A11M-01A-11D-A122-09				TCGA-B5-A11M-01A-11R-A119-13	
TCGA-B5-A11N-01	MSI-L	0	TCGA-B5-A11N-01	1337	0	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 11	TCGA-B5-A11N	1337	0	1337	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	69			TCGA-B5-A11N-F17759		Stage IA	NO		-25442	1140		0	1337						Scheduled Follow-up Submission	2011-10-25	FEMALE	174	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	370	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	TCGA-B5-A11N.A4C1DE15-A45A-4D31-B363-C6652370C09C.pdf	5	30	35	2	0	5	5	0	0	0	0	25	30	70	65	75	70	negative	TUMOR FREE				3	Complete Remission/Response	No			NO					Primary Tumor	01	Minimally Invasive	1988	NO	NO	YES	B5	0	0	0	46	Endometrial	A	LIVING	90	2007	823aed7c-3bf3-4ace-b17d-dc4f8a4e0e2f		TCGA-B5-A11N-01		TCGA-B5-A11N-01A-11R-A119-13	TCGA-B5-A11N-01A-11D-A120-01			823aed7c-3bf3-4ace-b17d-dc4f8a4e0e2f	TCGA-B5-A11N-01A-11D-A123-05	0da12aa8-1686-4705-90cd-b50db7f41c24		TCGA-B5-A11N-01A-11D-A122-09	TCGA-B5-A11N-01A-21-A163-20	87054c4d-1381-4b90-9a28-9cf613d3e45f	TCGA-B5-A11N-01				TCGA-B5-A11N-01A-11D-A122-09	87054c4d-1381-4b90-9a28-9cf613d3e45f	TCGA-B5-A11N-01A-11D-A120-01		TCGA-B5-A11N-01A-11R-A119-13	
TCGA-B5-A11O-01	MSI-L	0	TCGA-B5-A11O-01	1232	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4		UCEC-like c11	miRNA cluster 13	cluster 2	mutation cluster 1	TCGA-B5-A11O	1232	0	1232	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	62			TCGA-B5-A11O-F17769		Stage IA	NO		-22720	993		0	1232				YES		Scheduled Follow-up Submission	2011-10-25	FEMALE	177	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	130	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	TCGA-B5-A11O.078AA8A2-E812-4603-9084-8414937B88E1.pdf	13	20	20	8	8	10	8	8	5	0	0	5	10	85	82	95	90	negative	TUMOR FREE				2	Complete Remission/Response	No			NO					Primary Tumor	01	Minimally Invasive	1988	NO	NO	YES	B5	0	0	0	18	Endometrial	A	LIVING	114	2008	7e3666db-df81-4413-b742-c475e786772e		TCGA-B5-A11O-01		TCGA-B5-A11O-01A-11R-A119-13	TCGA-B5-A11O-01A-11D-A120-01			7e3666db-df81-4413-b742-c475e786772e	TCGA-B5-A11O-01A-11D-A123-05			TCGA-B5-A11O-01A-11D-A122-09		6bb48112-222b-4739-bddc-05d7e0755caa	TCGA-B5-A11O-01		TCGA-B5-A11O-01A-11D-A122-09		TCGA-B5-A11O-01A-11D-A122-09	6bb48112-222b-4739-bddc-05d7e0755caa	TCGA-B5-A11O-01A-11D-A120-01		TCGA-B5-A11O-01A-11R-A119-13	
TCGA-B5-A11P-01	MSI-L	0	TCGA-B5-A11P-01	1120	0	Squamous	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-B5-A11P			1120	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					87					Stage IB			-32047	979		0	1120							2011-8-9	FEMALE		Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	120	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true		20		8		2		5		4		0		5		90		95		TUMOR FREE						No								Primary Tumor	01	Minimally Invasive	1988		NO	YES	B5					Endometrial	B	LIVING	74	2008	2d49f9b3-88bc-4e99-a2ea-ba900713563d		TCGA-B5-A11P-01		TCGA-B5-A11P-01B-11R-A14C-13	TCGA-B5-A11P-01B-11D-A14F-01			2d49f9b3-88bc-4e99-a2ea-ba900713563d	TCGA-B5-A11P-01B-11D-A14H-05				TCGA-B5-A11P-01B-21-A18Q-20	818dded1-4fa2-4783-8842-698fcefb8a5a	TCGA-B5-A11P-01					818dded1-4fa2-4783-8842-698fcefb8a5a	TCGA-B5-A11P-01B-11D-A14F-01		TCGA-B5-A11P-01B-11R-A14C-13	
TCGA-B5-A11Q-01	MSS	0	TCGA-B5-A11Q-01	976	0	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation c1uster 9	TCGA-B5-A11Q	976	0	976	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	64			TCGA-B5-A11Q-F17770	Former User	Stage IIIA	NO		-23538	702		0	976						Scheduled Follow-up Submission	2011-10-25	FEMALE	161	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	120	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	TCGA-B5-A11Q.5117F490-9CE1-465F-BDF7-7B545B314703.pdf	34	8	1	5	1	15	2	6	0	0	0	25	30	60	68	75	70	negative	TUMOR FREE				0	Complete Remission/Response	No			YES					Primary Tumor	01	Minimally Invasive	1988	YES	NO	YES	B5	0	0	0	8	Endometrial	A	LIVING	88	2008	3b8301c9-646f-43e7-9b8c-7690294d0356		TCGA-B5-A11Q-01		TCGA-B5-A11Q-01A-11R-A119-13	TCGA-B5-A11Q-01A-11D-A120-01			3b8301c9-646f-43e7-9b8c-7690294d0356	TCGA-B5-A11Q-01A-11D-A123-05	418eaa98-126b-4b44-b332-944d38386927		TCGA-B5-A11Q-01A-11D-A122-09	TCGA-B5-A11Q-01A-21-A163-20	efaf5eb4-5b23-4511-92fe-23236c236809	TCGA-B5-A11Q-01				TCGA-B5-A11Q-01A-11D-A122-09	efaf5eb4-5b23-4511-92fe-23236c236809	TCGA-B5-A11Q-01A-11D-A120-01		TCGA-B5-A11Q-01A-11R-A119-13	
TCGA-B5-A11R-01	MSS	0	TCGA-B5-A11R-01	1019	0	Iq		UCEC CIMP c18	cluster 2			miRNA cluster 12	cluster 5	mutation cluster 1	TCGA-B5-A11R	1019	0	1019	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	51			TCGA-B5-A11R-F17771		Stage II	NO		-18878	734		0	1019						Scheduled Follow-up Submission	2011-10-25	FEMALE	168	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	100	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-B5-A11R.0AC5670B-7EA6-438C-9326-843BB7A6A81C.pdf	60	5	8	3	3	2	4	0	0	0	0	5	30	93	66	95	70	negative	TUMOR FREE				2	Complete Remission/Response	No			YES					Primary Tumor	01	Minimally Invasive	1988	YES	NO	YES	B5	0	12	0	6	Endometrial	A	LIVING	89	2008			TCGA-B5-A11R-01	6152d141-ed7d-4c03-9af9-4647dc455c4f	TCGA-B5-A11R-01A-11R-A119-13	TCGA-B5-A11R-01A-11D-A120-01				TCGA-B5-A11R-01A-11D-A123-05			TCGA-B5-A11R-01A-11D-A122-09		8839f1c4-e541-4022-b494-dd2e8bf4aa33	TCGA-B5-A11R-01	6152d141-ed7d-4c03-9af9-4647dc455c4f			TCGA-B5-A11R-01A-11D-A122-09	8839f1c4-e541-4022-b494-dd2e8bf4aa33	TCGA-B5-A11R-01A-11D-A120-01	6152d141-ed7d-4c03-9af9-4647dc455c4f	TCGA-B5-A11R-01A-11R-A119-13	6152d141-ed7d-4c03-9af9-4647dc455c4f
TCGA-B5-A11S-01	MSS	0	TCGA-B5-A11S-01	832	0	BRCA-LUAD+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 4	TCGA-B5-A11S	41	1	832	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma			YES	Complete Response	63			TCGA-B5-A11S-F17772	Never Used	Stage IA	NO	68	-23085	615		0	832			41			Scheduled Follow-up Submission	2011-10-25	FEMALE	157	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.		C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	200	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2	Other, specify	New Primary Tumor	Breast		YES	true	TCGA-B5-A11S.A1E96BA3-7DFB-4E3C-A6CF-B0B99D4C44FA.pdf	17	30	35	6	6	0	0	10	3	10	5	40	5	50	90	60	95	negative	TUMOR FREE				2	Complete Remission/Response	Yes			NO	Surgical Resection				Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	B5	0	2	0	28	Endometrial	A	LIVING	118	2009	eb6cac23-997e-4d0b-82cf-f74fd5fb57d2		TCGA-B5-A11S-01		TCGA-B5-A11S-01A-11R-A119-13	TCGA-B5-A11S-01A-11D-A120-01			eb6cac23-997e-4d0b-82cf-f74fd5fb57d2	TCGA-B5-A11S-01A-11D-A123-05	69621795-517f-4376-81bc-4450be17f9ef		TCGA-B5-A11S-01A-11D-A122-09	TCGA-B5-A11S-01A-21-A163-20	b9e18080-e533-4d75-826c-17fee5d5bcfd	TCGA-B5-A11S-01		TCGA-B5-A11S-01A-11D-A122-09		TCGA-B5-A11S-01A-11D-A122-09	b9e18080-e533-4d75-826c-17fee5d5bcfd	TCGA-B5-A11S-01A-11D-A120-01		TCGA-B5-A11S-01A-11R-A119-13	
TCGA-B5-A11U-01	MSI-H	0	TCGA-B5-A11U-01	509	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 5	cluster 4	mutation cluster 13	TCGA-B5-A11U	509	0	509	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	74			TCGA-B5-A11U-F17774		Stage IVB	NO		-27160	371		0	509				YES		Scheduled Follow-up Submission	2011-10-25	FEMALE	152	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	220	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-B5-A11U.1EF2CB28-A515-4E9D-9148-CC1A2DF77F60.pdf	23	35	10	4	0	4	20	3	10	0	0	60	30	36	50	40	70		TUMOR FREE				2	Complete Remission/Response	No			YES					Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	B5	0	0	0	0	Endometrial	A	LIVING	61	2009	714254dd-834a-4b70-8f88-c48bc7b4fdb8		TCGA-B5-A11U-01		TCGA-B5-A11U-01A-11R-A119-13	TCGA-B5-A11U-01A-11D-A120-01			714254dd-834a-4b70-8f88-c48bc7b4fdb8	TCGA-B5-A11U-01A-11D-A123-05	73ae6942-57b1-4104-8d42-3d5ba79480b2		TCGA-B5-A11U-01A-11D-A122-09	TCGA-B5-A11U-01A-21-A163-20	91d41a03-5058-4754-9079-434d8493ddfe	TCGA-B5-A11U-01				TCGA-B5-A11U-01A-11D-A122-09	91d41a03-5058-4754-9079-434d8493ddfe	TCGA-B5-A11U-01A-11D-A120-01		TCGA-B5-A11U-01A-11R-A119-13	
TCGA-B5-A11V-01	MSS	0	TCGA-B5-A11V-01	595	0	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 1	mutation cluster 4	TCGA-B5-A11V	595	0	595	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	64			TCGA-B5-A11V-F17776		Stage IA	NO		-23630	294		0	595				YES		Scheduled Follow-up Submission	2011-10-25	FEMALE	157	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	760	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	TCGA-B5-A11V.E1B5A941-5EEB-4207-84DC-F3BF22D5FC29.pdf	29	10	10	0	0	10	10	0	0	0	10	30	10	60	70	70	80	positive	TUMOR FREE				0		No			NO					Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	B5	0	0	0	3	Endometrial	A	LIVING	71	2010	986bddf6-4dde-4bfb-94c3-123674a4ca45		TCGA-B5-A11V-01			TCGA-B5-A11V-01A-11D-A10L-01			986bddf6-4dde-4bfb-94c3-123674a4ca45	TCGA-B5-A11V-01A-11D-A10N-05	597aafa9-8552-4364-abb2-2b013c305a8b	TCGA-B5-A11V-01A-11R-A10I-13	TCGA-B5-A11V-01A-11D-A10M-09	TCGA-B5-A11V-01A-21-A163-20	55100492-d06b-45c0-a100-715581e39d79	TCGA-B5-A11V-01		TCGA-B5-A11V-01A-11D-A10M-09		TCGA-B5-A11V-01A-11D-A10M-09	55100492-d06b-45c0-a100-715581e39d79	TCGA-B5-A11V-01A-11D-A10L-01		TCGA-B5-A11V-01A-11R-A10I-13	
TCGA-B5-A11W-01	MSS	0	TCGA-B5-A11W-01	593	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 7	TCGA-B5-A11W	593	0	593	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	61			TCGA-B5-A11W-F17779	Never Used	Stage IB			-22365	258		0	593				YES		Scheduled Follow-up Submission	2011-10-25	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	310	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	TCGA-B5-A11W.C5762F7C-AB69-40D0-A9D0-71A6281F30AF.pdf	52	10	10	0	0	10	30	0	20	10	0	0	10	80	60	90	90	positive	TUMOR FREE				1		No			YES					Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	B5	0	0	0	17	Endometrial	A	LIVING	102	2010	168116db-99c5-4d7a-9e9f-3858e1824298		TCGA-B5-A11W-01		TCGA-B5-A11W-01A-12R-A119-13	TCGA-B5-A11W-01A-12D-A120-01			168116db-99c5-4d7a-9e9f-3858e1824298	TCGA-B5-A11W-01A-12D-A123-05	2868a3e3-9d6e-4f91-8e5d-ebdf6893272d		TCGA-B5-A11W-01A-12D-A122-09	TCGA-B5-A11W-01A-21-A163-20	30c3f9f1-fd13-4b4d-9241-0424c2b91204	TCGA-B5-A11W-01				TCGA-B5-A11W-01A-12D-A122-09	30c3f9f1-fd13-4b4d-9241-0424c2b91204	TCGA-B5-A11W-01A-12D-A120-01		TCGA-B5-A11W-01A-12R-A119-13	
TCGA-B5-A11X-01	MSI-L	0	TCGA-B5-A11X-01	596	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	BRCA basal-like c6	RNA cluster 3	miRNA cluster 12	cluster 5	mutation cluster 4	TCGA-B5-A11X	397	1	596	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES		NO	Complete Response	66			TCGA-B5-A11X-F17790		Stage IIIC2	NO		-24217			0	596			397			Scheduled Follow-up Submission	2011-10-25	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	YES	C54.1	8020/3	C54.1	YES		Dilation and curettage procedure				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Metastatic	lymph nodes		YES			100																	negative	TUMOR FREE				2		No			NO					Primary Tumor	01	open	2009	YES	NO	YES	B5	5	5	1	5	Endometrial		LIVING	71	2010	bca7a3e6-57e9-44e6-b33f-a5e62011884d								bca7a3e6-57e9-44e6-b33f-a5e62011884d	TCGA-B5-A11X-01A-11D-A10N-05	c94e9ffc-592e-41b8-9552-bac7ae2f7404	TCGA-B5-A11X-01A-11R-A10I-13	TCGA-B5-A11X-01A-11D-A10M-09	TCGA-B5-A11X-01A-21-A163-20		TCGA-B5-A11X-01		TCGA-B5-A11X-01A-11D-A10M-09		TCGA-B5-A11X-01A-11D-A10M-09				TCGA-B5-A11X-01A-11R-A10I-13	
TCGA-B5-A11Y-01	MSI-L	0	TCGA-B5-A11Y-01	560	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 2	mutation cluster 6	TCGA-B5-A11Y	560	0	560	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	59			TCGA-B5-A11Y-F17795	Former User	Stage IB	NO		-21860	244		0	560						Scheduled Follow-up Submission	2011-10-25	FEMALE	162	Endometrioid endometrial adenocarcinoma	No			C54.1	8382/3	C54.1	YES		Office Endometrial Biopsy	580	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	TCGA-B5-A11Y.4FA7876E-EF1B-4EBA-99F9-1D26099B2CA1.pdf	54	0	0	0	0	0	0	0	0	0	0	0	0	100	100	70	75	negative	TUMOR FREE				1	Complete Remission/Response	No			NO					Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	B5	0	0	0	8	Endometrial	A	LIVING	63	2010	f192adcd-d613-400e-9737-725083638ee4		TCGA-B5-A11Y-01			TCGA-B5-A11Y-01A-21D-A10L-01			f192adcd-d613-400e-9737-725083638ee4	TCGA-B5-A11Y-01A-21D-A10N-05	016db1f0-de63-48f1-9c2a-1c77e23306ed	TCGA-B5-A11Y-01A-21R-A10I-13	TCGA-B5-A11Y-01A-21D-A10M-09	TCGA-B5-A11Y-01A-31-A163-20	c1babd9f-daa7-48b4-9be2-110c48a2a729	TCGA-B5-A11Y-01				TCGA-B5-A11Y-01A-21D-A10M-09	c1babd9f-daa7-48b4-9be2-110c48a2a729	TCGA-B5-A11Y-01A-21D-A10L-01		TCGA-B5-A11Y-01A-21R-A10I-13	
TCGA-B5-A11Z-01	MSS	0	TCGA-B5-A11Z-01	528	0	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 4	TCGA-B5-A11Z	528	0	528	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	61			TCGA-B5-A11Z-F17833		Stage IA	NO		-22505	213		0	528				NO		Scheduled Follow-up Submission	2011-10-26	FEMALE	172	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	340	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	TCGA-B5-A11Z.62C170A9-710F-45C0-B6BB-3F491A86A7E4.pdf	0	0	0	0	0	0	0	0	0	0	0	0	0	100	100	85	90	negative	TUMOR FREE				3	Complete Remission/Response	No			NO					Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	B5		0		0	Endometrial	A	LIVING	84	2010	640190cd-cd16-4a1a-8e63-9e41db6c3f89		TCGA-B5-A11Z-01		TCGA-B5-A11Z-01A-11R-A10I-13	TCGA-B5-A11Z-01A-11D-A10L-01			640190cd-cd16-4a1a-8e63-9e41db6c3f89	TCGA-B5-A11Z-01A-11D-A10N-05	6cee54d4-5fa9-4d01-82bf-c5b6a6341ab3		TCGA-B5-A11Z-01A-11D-A10M-09	TCGA-B5-A11Z-01A-21-A163-20	09d39c88-deaa-47af-baca-c4e21dfad647	TCGA-B5-A11Z-01		TCGA-B5-A11Z-01A-11D-A10M-09		TCGA-B5-A11Z-01A-11D-A10M-09	09d39c88-deaa-47af-baca-c4e21dfad647	TCGA-B5-A11Z-01A-11D-A10L-01		TCGA-B5-A11Z-01A-11R-A10I-13	
TCGA-B5-A121-01	MSS	0	TCGA-B5-A121-01	504	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 4	mutation c1uster 9	TCGA-B5-A121	504	0	504	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	57			TCGA-B5-A121-F17838		Stage IIIA	NO		-21018	188		0	504						Scheduled Follow-up Submission	2011-10-26	FEMALE	165	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	280	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	TCGA-B5-A121.82B20A1F-99AC-4CC8-BAF2-B7132809D4F2.pdf	48		25		3		0		0		0		15		85		85	negative	TUMOR FREE				2	Complete Remission/Response	No			YES					Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	B5	0	0	0	0	Endometrial	A	LIVING	80	2010	3e0f0d9d-31cc-4e48-b4ca-d53deec9b7d3		TCGA-B5-A121-01		TCGA-B5-A121-01A-31R-A119-13	TCGA-B5-A121-01A-31D-A120-01			3e0f0d9d-31cc-4e48-b4ca-d53deec9b7d3	TCGA-B5-A121-01A-31D-A123-05	a4da0446-b32e-4a47-8d1d-f4934d134f1d		TCGA-B5-A121-01A-31D-A122-09	TCGA-B5-A121-01A-21-A163-20	030bcf0f-2c81-4a0c-bc13-f54678b3b4ad	TCGA-B5-A121-01				TCGA-B5-A121-01A-31D-A122-09	030bcf0f-2c81-4a0c-bc13-f54678b3b4ad	TCGA-B5-A121-01A-31D-A120-01		TCGA-B5-A121-01A-31R-A119-13	
TCGA-B5-A1MR-01	MSS	0	TCGA-B5-A1MR-01	5835	0	Kirc+		UCEC non-CIMP c3	cluster 2		LAML-like c13	miRNA cluster 4	cluster 2		TCGA-B5-A1MR	5835	0	5835	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	65			TCGA-B5-A1MR-F19108		Stage IIIA	NO		-24017			0	5835				NO		Scheduled Follow-up Submission	2011-12-2	FEMALE		Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO			4																	negative	TUMOR FREE				3	Complete Remission/Response	No	Never Used		YES					Primary Tumor	01	open	1988	NO	NO	YES	B5	0	7	0	15	Endometrial		LIVING	58	1995	a644742b-ae08-41e3-810e-800bf0eef8fe		TCGA-B5-A1MR-01		TCGA-B5-A1MR-01A-31R-A14C-13	TCGA-B5-A1MR-01A-31D-A14F-01			a644742b-ae08-41e3-810e-800bf0eef8fe	TCGA-B5-A1MR-01A-31D-A14H-05					c4056dca-dbb4-48de-9abf-515e4d1b6fb1	TCGA-B5-A1MR-01					c4056dca-dbb4-48de-9abf-515e4d1b6fb1	TCGA-B5-A1MR-01A-31D-A14F-01		TCGA-B5-A1MR-01A-31R-A14C-13	
TCGA-B5-A1MS-01	MSS	1	TCGA-B5-A1MS-01	3112	1	BRCA-LUAD+		UCEC Serous c4		UCEC-like c5		miRNA cluster 14			TCGA-B5-A1MS	2706	1	3112	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	NO	YES		Progressive Disease	60			TCGA-B5-A1MS-F44649		Stage IC	NO		-22068	3117	3112	0				2706	NO			2013-8-20	FEMALE	166	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	440	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Locoregional Recurrence	Supraclavicular Fossa	NO	YES	true		55		1		2		5		0		0		0		95		90	negative	WITH TUMOR			NO	4+	Partial Remission/Response	No	Never Used		NO				RX	Primary Tumor	01	Minimally Invasive	1988		NO	YES	B5	0	4	0	25	Endometrial	B	DECEASED	74	2003			TCGA-B5-A1MS-01	6acf7672-ec9d-4765-85db-43c311d5f124	TCGA-B5-A1MS-01B-11R-A22I-13	TCGA-B5-A1MS-01B-11D-A227-01				TCGA-B5-A1MS-01B-11D-A22B-05				TCGA-B5-A1MS-01B-21-A23Z-20	8a201fc0-66d6-4cbc-a095-2de9f97653e3	TCGA-B5-A1MS-01	6acf7672-ec9d-4765-85db-43c311d5f124				8a201fc0-66d6-4cbc-a095-2de9f97653e3	TCGA-B5-A1MS-01B-11D-A227-01	6acf7672-ec9d-4765-85db-43c311d5f124	TCGA-B5-A1MS-01B-11R-A22I-13	6acf7672-ec9d-4765-85db-43c311d5f124
TCGA-B5-A1MU-01	MSS	1	TCGA-B5-A1MU-01	1548	1	BRCA-LUAD+	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 5	cluster 4	mutation cluster 3	TCGA-B5-A1MU	1365	1	1548	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	NO	YES	Progressive Disease	79			TCGA-B5-A1MU-F19109		Stage IVB	NO	1374	-29027	1834	1548	0				1365	NO		Scheduled Follow-up Submission	2011-12-2	FEMALE	147	Serous endometrial adenocarcinoma	No		NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	260	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	New Primary Tumor	Breast		YES	true	TCGA-B5-A1MU.FC3D9B79-4CAD-4F62-892C-C830B24E50DD.pdf	100		8		3		0		3		0		15		85		85	positive	TUMOR FREE				3		No	Former User		NO	Surgical Resection				Primary Tumor	01	open	1988	NO	NO	YES	B5		0		0	Endometrial	A	DECEASED	44	2006	5afaa343-65f0-4499-a44d-c3c87106443a		TCGA-B5-A1MU-01		TCGA-B5-A1MU-01A-11R-A13R-13	TCGA-B5-A1MU-01A-11D-A13J-01			5afaa343-65f0-4499-a44d-c3c87106443a	TCGA-B5-A1MU-01A-11D-A13K-05			TCGA-B5-A1MU-01A-11D-A13L-09	TCGA-B5-A1MU-01A-21-A18Q-20	a1e05ea6-801a-442d-b6a1-98f2d55198a3	TCGA-B5-A1MU-01		TCGA-B5-A1MU-01A-11D-A13L-09		TCGA-B5-A1MU-01A-11D-A13L-09	a1e05ea6-801a-442d-b6a1-98f2d55198a3	TCGA-B5-A1MU-01A-11D-A13J-01		TCGA-B5-A1MU-01A-11R-A13R-13	
TCGA-B5-A1MV-01	MSI-L	0	TCGA-B5-A1MV-01	438	0	BRCA-LUAD+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 4		TCGA-B5-A1MV	438	0	438	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	84			TCGA-B5-A1MV-F21608	Former User	Stage IA	NO		-30926	226		0	438						Scheduled Follow-up Submission	2012-2-16	FEMALE	151	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	470	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	TCGA-B5-A1MV.E536759E-F47A-4EE9-B855-AFEC6BCF5EE0.pdf	47		40		20		10		20		0		20		70		70	negative	TUMOR FREE				2	Complete Remission/Response	No			NO					Primary Tumor	01	open	2009	NO	NO	YES	B5	0	7	0	19	Endometrial	A	LIVING	72	2010	ef62242e-872b-4bd3-ac3d-a6645f771020		TCGA-B5-A1MV-01		TCGA-B5-A1MV-01A-31R-A14C-13	TCGA-B5-A1MV-01A-31D-A14F-01			ef62242e-872b-4bd3-ac3d-a6645f771020	TCGA-B5-A1MV-01A-31D-A14H-05				TCGA-B5-A1MV-01A-41-A18Q-20	53352422-396a-4df1-aa26-bb4d59737617	TCGA-B5-A1MV-01					53352422-396a-4df1-aa26-bb4d59737617	TCGA-B5-A1MV-01A-31D-A14F-01		TCGA-B5-A1MV-01A-31R-A14C-13	
TCGA-B5-A1MW-01	MSI-H	0	TCGA-B5-A1MW-01	447	0	Kirc+		UCEC non-CIMP c3	cluster 2	UCEC-like c5		miRNA cluster 7	cluster 1		TCGA-B5-A1MW	311	1	447	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	NO	YES		Complete Response	55			TCGA-B5-A1MW-F21619	Former User	Stage IA	NO		-20183	148		0	447			311			Scheduled Follow-up Submission	2012-2-16	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	340	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Locoregional Disease	vaginal cuff		YES	true	TCGA-B5-A1MW.870882D8-D89A-4A89-B516-DADAB95BE285.pdf	31		10		0		3		5		0		10		87		90	negative	TUMOR FREE				1	Complete Remission/Response	No			YES					Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	B5	0	8	0	31	Endometrial	A	LIVING	62	2010			TCGA-B5-A1MW-01	7ad9720d-18e2-472f-a267-525f191a23ca	TCGA-B5-A1MW-01A-11R-A17A-13	TCGA-B5-A1MW-01A-11D-A17C-01				TCGA-B5-A1MW-01A-11D-A17F-05				TCGA-B5-A1MW-01A-21-A18Q-20	184c041c-30aa-468f-8fc9-1eec1ebf6a8d	TCGA-B5-A1MW-01	7ad9720d-18e2-472f-a267-525f191a23ca				184c041c-30aa-468f-8fc9-1eec1ebf6a8d	TCGA-B5-A1MW-01A-11D-A17C-01	7ad9720d-18e2-472f-a267-525f191a23ca	TCGA-B5-A1MW-01A-11R-A17A-13	7ad9720d-18e2-472f-a267-525f191a23ca
TCGA-B5-A1MX-01	MSI-H	0	TCGA-B5-A1MX-01	356	0	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5		TCGA-B5-A1MX	356	0	356	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	47			TCGA-B5-A1MX-F21625	Never Used	Stage IB	NO		-17320	103		0	356						Scheduled Follow-up Submission	2012-2-16	FEMALE	152	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Tumor resection	560	NO		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3					NO	true	TCGA-B5-A1MX.C8962646-1A09-4EAA-8864-2539A0CCEC4C.pdf	100		5		2		2		2		0		3		95		97		TUMOR FREE				4+	Complete Remission/Response	No			YES					Primary Tumor	01	Minimally Invasive	2009	YES	NO	YES	B5	0	2	0	14	Endometrial	A	LIVING	58	2010	1cb61aae-c6d4-4afc-889e-4060d109c83e		TCGA-B5-A1MX-01		TCGA-B5-A1MX-01A-11R-A143-13	TCGA-B5-A1MX-01A-11D-A141-01			1cb61aae-c6d4-4afc-889e-4060d109c83e	TCGA-B5-A1MX-01A-11D-A145-05				TCGA-B5-A1MX-01A-21-A18Q-20	925106e1-6ee1-4a16-82d7-1c8d94024d10	TCGA-B5-A1MX-01					925106e1-6ee1-4a16-82d7-1c8d94024d10	TCGA-B5-A1MX-01A-11D-A141-01		TCGA-B5-A1MX-01A-11R-A143-13	
TCGA-B5-A1MY-01	MSS	1	TCGA-B5-A1MY-01	361	1	High	C6-UCEC	UCEC Serous c4	cluster 3	BRCA basal-like c6	UCEC-like c11	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-B5-A1MY	333	1	361	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	NO	NO	NO	Progressive Disease	62			TCGA-B5-A1MY-F22095		Stage IIIC2	NO		-22805	128	361	0				333			Scheduled Follow-up Submission	2012-2-23	FEMALE	146	Serous endometrial adenocarcinoma	No		YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	360	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Locoregional Disease	peritoneum		YES	true	TCGA-B5-A1MY.A5328E25-1433-4331-83B8-148780F6A6DA.pdf	100		3		3		5		0		0		20		75		80	negative	WITH TUMOR				4+		No			YES					Primary Tumor	01	Minimally Invasive	2009	YES	NO	YES	B5	2	5		0	Endometrial	A	DECEASED	67	2010	fcb43e1a-3b34-4ff1-8d3e-849fbf901877		TCGA-B5-A1MY-01		TCGA-B5-A1MY-01A-11R-A143-13	TCGA-B5-A1MY-01A-11D-A141-01			fcb43e1a-3b34-4ff1-8d3e-849fbf901877	TCGA-B5-A1MY-01A-11D-A145-05			TCGA-B5-A1MY-01A-11D-A142-09	TCGA-B5-A1MY-01A-21-A18Q-20	2ea42ae0-4d58-4dfc-bf31-b78c3f40e92e	TCGA-B5-A1MY-01		TCGA-B5-A1MY-01A-11D-A142-09		TCGA-B5-A1MY-01A-11D-A142-09	2ea42ae0-4d58-4dfc-bf31-b78c3f40e92e	TCGA-B5-A1MY-01A-11D-A141-01		TCGA-B5-A1MY-01A-11R-A143-13	
TCGA-B5-A1MZ-01	MSI-L	0	TCGA-B5-A1MZ-01	465	0	Iq	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 1		TCGA-B5-A1MZ	465	0	465	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	54			TCGA-B5-A1MZ-F22099		Stage IA	NO		-19955	114		0	465						Scheduled Follow-up Submission	2012-2-23	FEMALE	166	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	130	NO		Indeterminate (neither Pre or Postmenopausal)	G1					NO	true	TCGA-B5-A1MZ.071A53F9-6E40-4402-8353-BB963AFE5C33.pdf	31		20		3		0		5		0		15		85		85	negative	TUMOR FREE				1	Complete Remission/Response	No			NO					Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	B5	0	0	0	32	Endometrial	A	LIVING	114	2010	770fd2b7-24cf-432b-829d-39364a11277d		TCGA-B5-A1MZ-01		TCGA-B5-A1MZ-01A-11R-A143-13	TCGA-B5-A1MZ-01A-11D-A141-01			770fd2b7-24cf-432b-829d-39364a11277d	TCGA-B5-A1MZ-01A-11D-A145-05				TCGA-B5-A1MZ-01A-21-A18Q-20	ece3002c-e2c1-4332-b0e4-106ff6c70a46	TCGA-B5-A1MZ-01					ece3002c-e2c1-4332-b0e4-106ff6c70a46	TCGA-B5-A1MZ-01A-11D-A141-01		TCGA-B5-A1MZ-01A-11R-A143-13	
TCGA-B5-A1N2-01	MSS	0	TCGA-B5-A1N2-01	389	0	Squamous	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 5	cluster 4		TCGA-B5-A1N2	389	0	389	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	70			TCGA-B5-A1N2-F22136	Former User	Stage IIIC1	NO		-25612			0	389				YES		Scheduled Follow-up Submission	2012-2-24	FEMALE	168	Serous endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO			12.5																	positive	TUMOR FREE				4+	Complete Remission/Response	No			YES					Primary Tumor	01	Minimally Invasive	2009	YES	NO	YES	B5	0	0	1	1	Endometrial		LIVING	114	2010	c45110ae-6ba6-44d7-8bff-5fa16c45d962		TCGA-B5-A1N2-01		TCGA-B5-A1N2-01A-21R-A143-13	TCGA-B5-A1N2-01A-21D-A141-01			c45110ae-6ba6-44d7-8bff-5fa16c45d962	TCGA-B5-A1N2-01A-21D-A145-05				TCGA-B5-A1N2-01A-11-A18Q-20	e5bdf2b3-a30c-4c47-876b-36547838410f	TCGA-B5-A1N2-01					e5bdf2b3-a30c-4c47-876b-36547838410f	TCGA-B5-A1N2-01A-21D-A141-01		TCGA-B5-A1N2-01A-21R-A143-13	
TCGA-B5-A3F9-01	MSS	0	TCGA-B5-A3F9-01	3536	0	Squamous		UCEC non-CIMP c3				miRNA c1uster 10			TCGA-B5-A3F9	3536	0	3536	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	56			TCGA-B5-A3F9-F37012		Stage IB			-20523	3159		0	3536				YES			2012-11-21	FEMALE	166	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	110	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-B5-A3F9.E4AD1574-653C-444D-BB43-B4DE701B109F.pdf	6		1		2		3		0		0		0		97		95		TUMOR FREE			NO			No			NO					Primary Tumor	01	Minimally Invasive	1988		NO	YES	B5		0		0	Endometrial	A	LIVING	155	2003			TCGA-B5-A3F9-01	654f3c17-dc98-4e53-8ff8-b1f92d6bd8bd	TCGA-B5-A3F9-01A-21R-A22I-13	TCGA-B5-A3F9-01A-21D-A227-01				TCGA-B5-A3F9-01A-21D-A22B-05					14c9b521-9094-41a4-ae59-dae7effd5f4b	TCGA-B5-A3F9-01	654f3c17-dc98-4e53-8ff8-b1f92d6bd8bd				14c9b521-9094-41a4-ae59-dae7effd5f4b	TCGA-B5-A3F9-01A-21D-A227-01	654f3c17-dc98-4e53-8ff8-b1f92d6bd8bd	TCGA-B5-A3F9-01A-21R-A22I-13	654f3c17-dc98-4e53-8ff8-b1f92d6bd8bd
TCGA-B5-A3FA-01	MSI-L	0	TCGA-B5-A3FA-01	2929	0	Quiet		UCEC Serous c4		UCEC-like c5		miRNA cluster 13			TCGA-B5-A3FA	2929	0	2929	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	73			TCGA-B5-A3FA-F37049		Stage IC			-26850			0	2929							2012-11-21	FEMALE	158	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy			NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO			52																	negative	TUMOR FREE			NO	4+		No			NO					Primary Tumor	01	Minimally Invasive	1988		NO	YES	B5	0	2	0	11	Endometrial		LIVING	74	2004			TCGA-B5-A3FA-01	ae424bbe-6970-4afc-aa3b-7ae842f9a9d9	TCGA-B5-A3FA-01A-11R-A19V-13	TCGA-B5-A3FA-01A-11D-A19X-01				TCGA-B5-A3FA-01A-11D-A19Z-05				TCGA-B5-A3FA-01A-21-A23Z-20	f590f9c1-53b3-458e-b14e-5728c2da2364	TCGA-B5-A3FA-01	ae424bbe-6970-4afc-aa3b-7ae842f9a9d9				f590f9c1-53b3-458e-b14e-5728c2da2364	TCGA-B5-A3FA-01A-11D-A19X-01	ae424bbe-6970-4afc-aa3b-7ae842f9a9d9	TCGA-B5-A3FA-01A-11R-A19V-13	ae424bbe-6970-4afc-aa3b-7ae842f9a9d9
TCGA-B5-A3FB-01	MSS	0	TCGA-B5-A3FB-01	2397	0	Kirc+		UCEC Serous c4		squamous c3		miRNA cluster 12			TCGA-B5-A3FB	2397	0	2397	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	73			TCGA-B5-A3FB-F37050		Stage IB			-26779	2066		0	2397				YES			2012-11-21	FEMALE	170	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	350	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-B5-A3FB.FA278AFC-C294-48A5-BE7B-B26F4AE3FC5B.pdf	4		1		5		15		5		0		0		85		80	negative	TUMOR FREE			NO			No			NO					Primary Tumor	01	Minimally Invasive	1988		NO	YES	B5		0	0	33	Endometrial	A	LIVING	115	2006			TCGA-B5-A3FB-01	0421d738-8236-46c5-8b98-6b261defb294	TCGA-B5-A3FB-01A-11R-A19V-13	TCGA-B5-A3FB-01A-11D-A19X-01				TCGA-B5-A3FB-01A-11D-A19Z-05				TCGA-B5-A3FB-01A-21-A23Z-20	1792a6e8-61c3-4b06-8897-8d363b7bf2c8	TCGA-B5-A3FB-01	0421d738-8236-46c5-8b98-6b261defb294				1792a6e8-61c3-4b06-8897-8d363b7bf2c8	TCGA-B5-A3FB-01A-11D-A19X-01	0421d738-8236-46c5-8b98-6b261defb294	TCGA-B5-A3FB-01A-11R-A19V-13	0421d738-8236-46c5-8b98-6b261defb294
TCGA-B5-A3FC-01	MSI-H	0	TCGA-B5-A3FC-01	1890	0	Quiet		UCEC CIMP c18		UCEC-like c5		miRNA c1uster 10			TCGA-B5-A3FC			1890	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					53					Stage II			-19422			0	1890							2012-3-23	FEMALE	169	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3								0																	negative	TUMOR FREE						No								Primary Tumor	01	open	1988		NO	YES	B5		0		0	Endometrial		LIVING	76	2006			TCGA-B5-A3FC-01	cfc3065f-652c-458b-926f-24092edb803f	TCGA-B5-A3FC-01A-11R-A22I-13	TCGA-B5-A3FC-01A-11D-A227-01				TCGA-B5-A3FC-01A-11D-A22B-05				TCGA-B5-A3FC-01A-21-A23Z-20	bedd6123-cfaa-49e3-a339-5ee320725046	TCGA-B5-A3FC-01	cfc3065f-652c-458b-926f-24092edb803f				bedd6123-cfaa-49e3-a339-5ee320725046	TCGA-B5-A3FC-01A-11D-A227-01	cfc3065f-652c-458b-926f-24092edb803f	TCGA-B5-A3FC-01A-11R-A22I-13	cfc3065f-652c-458b-926f-24092edb803f
TCGA-B5-A3FD-01	Indeterminate	0	TCGA-B5-A3FD-01	1007	0	Kirc+		UCEC Serous c4		UCEC-like c5		miRNA c1uster 10			TCGA-B5-A3FD	562	1	1007	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES			Progressive Disease	70			TCGA-B5-A3FD-F37052		Stage IA			-25813	679		0	1007			562				2012-11-21	FEMALE	174	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	370	NO	NO	Indeterminate (neither Pre or Postmenopausal)	G3	Other, specify	Locoregional Recurrence	endometrium		YES	true	TCGA-B5-A3FD.7AC30D60-097A-4FED-A928-7A4BCAFB6C8D.pdf	30		2		2		5		1		0		5		90		90	negative	TUMOR FREE			NO			No			NO	Other Method, Specify Below	6 cycles chemotherapy			Primary Tumor	01	Minimally Invasive	2009		NO	YES	B5	0	7	0	34	Endometrial	A	LIVING	115	2009			TCGA-B5-A3FD-01	6fbe6214-bdfd-4688-bae3-d12a931f9989	TCGA-B5-A3FD-01A-11R-A19V-13	TCGA-B5-A3FD-01A-11D-A19X-01				TCGA-B5-A3FD-01A-11D-A19Z-05				TCGA-B5-A3FD-01A-21-A23Z-20	6a2be731-b8a6-4125-a579-de50759169a0	TCGA-B5-A3FD-01	6fbe6214-bdfd-4688-bae3-d12a931f9989				6a2be731-b8a6-4125-a579-de50759169a0	TCGA-B5-A3FD-01A-11D-A19X-01	6fbe6214-bdfd-4688-bae3-d12a931f9989	TCGA-B5-A3FD-01A-11R-A19V-13	6fbe6214-bdfd-4688-bae3-d12a931f9989
TCGA-B5-A3FH-01	MSI-L	0	TCGA-B5-A3FH-01	434	0	Iq		UCEC non-CIMP c3		UCEC-like c5		miRNA c1uster 10			TCGA-B5-A3FH	434	0	434	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	74			TCGA-B5-A3FH-F37053		Stage IA			-27221	97		0	434							2012-11-21	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	480	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-B5-A3FH.05AD8EE1-E2F8-42F7-8E6A-380A8EE4770E.pdf	6		1		5		15		2		0		0		85		80	negative	TUMOR FREE			NO	3		No			NO					Primary Tumor	01	Minimally Invasive	2009		NO	YES	B5	0	9	0	17	Endometrial	A	LIVING	85	2011			TCGA-B5-A3FH-01	2bb3a670-627e-4aa7-8dfc-88f6cc06d1a7	TCGA-B5-A3FH-01A-11R-A19V-13	TCGA-B5-A3FH-01A-11D-A19X-01				TCGA-B5-A3FH-01A-11D-A19Z-05				TCGA-B5-A3FH-01A-21-A23Z-20	be9b30f4-15df-426e-bf5f-10ced3cf8fb0	TCGA-B5-A3FH-01	2bb3a670-627e-4aa7-8dfc-88f6cc06d1a7				be9b30f4-15df-426e-bf5f-10ced3cf8fb0	TCGA-B5-A3FH-01A-11D-A19X-01	2bb3a670-627e-4aa7-8dfc-88f6cc06d1a7	TCGA-B5-A3FH-01A-11R-A19V-13	2bb3a670-627e-4aa7-8dfc-88f6cc06d1a7
TCGA-B5-A3S1-01	MSS	0	TCGA-B5-A3S1-01	902	0	High		UCEC non-CIMP c3		UCEC-like c5		miRNA cluster 4			TCGA-B5-A3S1	902	0	902	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	71			TCGA-B5-A3S1-F59469	Former User	Stage IIIC1	NO		-26031	127		0	902				NO			2014-5-13	FEMALE	155	Serous endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	140	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-B5-A3S1.72F97A0D-1245-4C80-B2D2-B7B217BEC06B.pdf	87.6		1		1		5		0		0		0		95		90	negative	WITH TUMOR			YES	1	Complete Remission/Response	No	Never Used		YES					Primary Tumor	01	Minimally Invasive	2009		NO	YES	B5	0	7	3	24	Endometrial	A	LIVING	68	2011			TCGA-B5-A3S1-01	77db73b5-24ef-47a3-b54b-4457ae62d562	TCGA-B5-A3S1-01A-11R-A22I-13	TCGA-B5-A3S1-01A-11D-A227-01				TCGA-B5-A3S1-01A-11D-A22B-05				TCGA-B5-A3S1-01A-21-A23Z-20	04445d7b-bc5a-45a2-b5b5-9a534848e9a7	TCGA-B5-A3S1-01	77db73b5-24ef-47a3-b54b-4457ae62d562				04445d7b-bc5a-45a2-b5b5-9a534848e9a7	TCGA-B5-A3S1-01A-11D-A227-01	77db73b5-24ef-47a3-b54b-4457ae62d562	TCGA-B5-A3S1-01A-11R-A22I-13	77db73b5-24ef-47a3-b54b-4457ae62d562
TCGA-B5-A5OC-01	MSI-H	0	TCGA-B5-A5OC-01	1249	0										TCGA-B5-A5OC	1249	0	1249	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	71			TCGA-B5-A5OC-F59471	Never Used	Stage IIIB	NO		-26109	732		0	1249				YES			2014-5-13	FEMALE		Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES			750	NO	NO		G3					NO	true	TCGA-B5-A5OC.2B1515A6-001A-46AF-952C-D393944DE57F.pdf			20		40		0		20		0		40		60		60		TUMOR FREE			YES	3		No	Never Used		YES				R2	Primary Tumor	01		2009		YES	NO	B5					Endometrial	A	LIVING		2011			TCGA-B5-A5OC-01	12be39a5-bbae-439a-84a9-28b790e89aa9	TCGA-B5-A5OC-01A-21R-A27R-13	TCGA-B5-A5OC-01A-21D-A27O-01				TCGA-B5-A5OC-01A-21D-A27Y-05					22249761-29c5-4139-b7fc-5885ccae52f5	TCGA-B5-A5OC-01	12be39a5-bbae-439a-84a9-28b790e89aa9				22249761-29c5-4139-b7fc-5885ccae52f5	TCGA-B5-A5OC-01A-21D-A27O-01	12be39a5-bbae-439a-84a9-28b790e89aa9	TCGA-B5-A5OC-01A-21R-A27R-13	12be39a5-bbae-439a-84a9-28b790e89aa9
TCGA-B5-A5OD-01	MSS	0	TCGA-B5-A5OD-01	1038	0										TCGA-B5-A5OD	1038	0	1038	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	67			TCGA-B5-A5OD-F59472		Stage IIIC	NO		-24775	662		0	1038				NO			2014-5-13	FEMALE		Serous endometrial adenocarcinoma	No		NO	C54.1	8441/3	C54.1	YES			370	NO	NO		G3					NO	true	TCGA-B5-A5OD.8A0B9737-98D2-4A61-95FF-18842056A6DE.pdf			2		2		5		2		0		15		80		85		TUMOR FREE			YES	0		No	Never Used		YES					Primary Tumor	01		2009		YES	NO	B5					Endometrial	A	LIVING		2011			TCGA-B5-A5OD-01	0dfc3298-73ab-4c7b-b4f5-1314a5713c92	TCGA-B5-A5OD-01A-11R-A31S-13	TCGA-B5-A5OD-01A-11D-A31T-01				TCGA-B5-A5OD-01A-11D-A31V-05					044c938b-35f5-48eb-8edc-345608583259	TCGA-B5-A5OD-01	0dfc3298-73ab-4c7b-b4f5-1314a5713c92				044c938b-35f5-48eb-8edc-345608583259	TCGA-B5-A5OD-01A-11D-A31T-01	0dfc3298-73ab-4c7b-b4f5-1314a5713c92	TCGA-B5-A5OD-01A-11R-A31S-13	0dfc3298-73ab-4c7b-b4f5-1314a5713c92
TCGA-B5-A5OE-01	MSS	0	TCGA-B5-A5OE-01	1063	0										TCGA-B5-A5OE	1063	0	1063	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	68			TCGA-B5-A5OE-F59473		Stage IIIC2	NO		-24905	609		0	1063				NO			2014-5-14	FEMALE		Serous endometrial adenocarcinoma	No		YES	C54.1	8441/3	C54.1	YES			1540	NO	NO		G3					NO	true	TCGA-B5-A5OE.82A668E5-6B89-4C94-BEED-F4FF227BD0B1.pdf			2		2		10		2		0		10		80		80		TUMOR FREE			YES	4+		No			NO					Primary Tumor	01		2009		YES	NO	B5					Endometrial	A	LIVING		2011			TCGA-B5-A5OE-01	0595a9e2-f382-4f97-8d0e-69af86b9fb78	TCGA-B5-A5OE-01A-11R-A31S-13	TCGA-B5-A5OE-01A-11D-A31T-01				TCGA-B5-A5OE-01A-11D-A31V-05					bbb222f7-89c1-4753-8121-1e34b10ed0db	TCGA-B5-A5OE-01	0595a9e2-f382-4f97-8d0e-69af86b9fb78				bbb222f7-89c1-4753-8121-1e34b10ed0db	TCGA-B5-A5OE-01A-11D-A31T-01	0595a9e2-f382-4f97-8d0e-69af86b9fb78	TCGA-B5-A5OE-01A-11R-A31S-13	0595a9e2-f382-4f97-8d0e-69af86b9fb78
TCGA-BG-A0LW-01	MSS	0	TCGA-BG-A0LW-01	566	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation c1uster 9	TCGA-BG-A0LW	566	0	566	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	47			TCGA-BG-A0LW-F19329	Never Used	Stage IA			-17369	107		0	566						Scheduled Follow-up Submission	2011-12-8	FEMALE	157	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.		C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	190	NO		Indeterminate (neither Pre or Postmenopausal)	G2					NO	true	TCGA-BG-A0LW.75A97BED-AB64-46CC-AE6B-59860673D53E.pdf	5	0	0	0	0	0	0	0	0	0	0	0	0	100	100	90	90	negative	TUMOR FREE	0	0		0	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	BG		0	0	6	Endometrial	A	LIVING	141	2010	e91d204d-8790-4438-add0-52f520fa532b	TCGA-BG-A0LW-01	TCGA-BG-A0LW-01			TCGA-BG-A0LW-01A-11D-A042-01	TCGA-BG-A0LW-01	TCGA-BG-A0LW-01A-11D-A039-05	e91d204d-8790-4438-add0-52f520fa532b		1af915c6-7503-4190-9013-ea95d556d6d2	TCGA-BG-A0LW-01A-11R-A041-13	TCGA-BG-A0LW-01A-11W-A062-09	TCGA-BG-A0LW-01A-21-A163-20	c0dbcb79-4bb2-4dc1-9c09-450c892c936b	TCGA-BG-A0LW-01		TCGA-BG-A0LW-01A-11W-A062-09	TCGA-BG-A0LW-01A-11R-A040-07	TCGA-BG-A0LW-01A-11W-A062-09	c0dbcb79-4bb2-4dc1-9c09-450c892c936b	TCGA-BG-A0LW-01A-11D-A042-01		TCGA-BG-A0LW-01A-11R-A041-13	
TCGA-BG-A0LX-01	MSI-H	0	TCGA-BG-A0LX-01	614	0	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5	mutation cluster 6	TCGA-BG-A0LX	614	0	614	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	57	0	0	TCGA-BG-A0LX-F19323	Never Used	Stage IB			-20928	120		0	614				NO		Scheduled Follow-up Submission	2011-12-8	FEMALE	170	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	250	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	TCGA-BG-A0LX.4306E592-FA36-4AB9-BF84-7232CC599A64.pdf	90	0	0	0	0	30	10	0	0	0	0	0	0	70	90	90	85		TUMOR FREE	0	0		0	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	2009	NO	NO	YES	BG	0	7	0	15	Endometrial	A	LIVING	96	2010	7961370a-641d-4dc9-a530-99789e7d0036		TCGA-BG-A0LX-01			TCGA-BG-A0LX-01A-11D-A042-01		TCGA-BG-A0LX-01A-11D-A039-05	7961370a-641d-4dc9-a530-99789e7d0036		5f4e9178-6219-44bf-a4a2-d02f0ab33ad8	TCGA-BG-A0LX-01A-11R-A041-13	TCGA-BG-A0LX-01A-11W-A062-09	TCGA-BG-A0LX-01A-21-A163-20	1d2ce36b-88be-4251-b679-922bc3601376	TCGA-BG-A0LX-01		TCGA-BG-A0LX-01A-11W-A062-09		TCGA-BG-A0LX-01A-11W-A062-09	1d2ce36b-88be-4251-b679-922bc3601376	TCGA-BG-A0LX-01A-11D-A042-01		TCGA-BG-A0LX-01A-11R-A041-13	
TCGA-BG-A0M0-01	MSI-H	0	TCGA-BG-A0M0-01	588	0	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 4	TCGA-BG-A0M0	588	0	588	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	66			TCGA-BG-A0M0-F19320	Never Used	Stage IA			-24427	147		0	588				NO		Scheduled Follow-up Submission	2011-12-8	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	800	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	TCGA-BG-A0M0.BDDACDFC-E3D4-4EA7-9591-DB6371713E8E.pdf	6	0	0	2	2	0	0	2	2	0	0	0	0	100	100	95	95	negative	TUMOR FREE	0	0			Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	BG		0	0	1	Endometrial	A	LIVING	117	2010	5343a292-c0ee-4764-8051-ee24716cf79d		TCGA-BG-A0M0-01			TCGA-BG-A0M0-01A-11D-A102-01		TCGA-BG-A0M0-01A-11D-A10Q-05	5343a292-c0ee-4764-8051-ee24716cf79d		5007b1ab-8651-4b64-8777-885393a6a284	TCGA-BG-A0M0-01A-11R-A103-13	TCGA-BG-A0M0-01A-11W-A10C-09	TCGA-BG-A0M0-01A-21-A163-20	96a7c56b-59e5-4244-ac35-0d67a270dcde	TCGA-BG-A0M0-01		TCGA-BG-A0M0-01A-11W-A10C-09		TCGA-BG-A0M0-01A-11W-A10C-09	96a7c56b-59e5-4244-ac35-0d67a270dcde	TCGA-BG-A0M0-01A-11D-A102-01		TCGA-BG-A0M0-01A-11R-A103-13	
TCGA-BG-A0M2-01	MSS	0	TCGA-BG-A0M2-01	637	0	BRCA-LUAD+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation c1uster 9	TCGA-BG-A0M2	637	0	637	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	62	0	0	TCGA-BG-A0M2-F19319	Never Used	Stage IB			-22822	185		0	637				NO		Scheduled Follow-up Submission	2011-12-8	FEMALE	168	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	510	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	TCGA-BG-A0M2.A0087300-81E9-4733-8497-95E0F95575B4.pdf	59	0	0	0	0	0	1	0	0	0	0	0	2	100	97	90	90	negative	TUMOR FREE	0	0			Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	BG	0	1	0	8	Endometrial	A	LIVING	76	2009	4487eb24-a67d-4406-9a1f-b2c2fde39787		TCGA-BG-A0M2-01			TCGA-BG-A0M2-01A-11D-A102-01		TCGA-BG-A0M2-01A-11D-A10Q-05	4487eb24-a67d-4406-9a1f-b2c2fde39787		dd52c56d-2806-4f0f-906c-7518b5cc058f	TCGA-BG-A0M2-01A-11R-A103-13	TCGA-BG-A0M2-01A-11D-A10O-09	TCGA-BG-A0M2-01A-21-A163-20	490c2a69-5dfa-4bf4-8c84-3a1e81fbfcde	TCGA-BG-A0M2-01		TCGA-BG-A0M2-01A-11D-A10O-09		TCGA-BG-A0M2-01A-11D-A10O-09	490c2a69-5dfa-4bf4-8c84-3a1e81fbfcde	TCGA-BG-A0M2-01A-11D-A102-01		TCGA-BG-A0M2-01A-11R-A103-13	
TCGA-BG-A0M3-01	MSS	0	TCGA-BG-A0M3-01	1071	0	BRCA-LUAD+	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 1	mutation cluster 4	TCGA-BG-A0M3	1071	0	1071	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	74	0	0	TCGA-BG-A0M3-F19332	Never Used	Stage IB			-27183	597		0	1071				NO		Scheduled Follow-up Submission	2011-12-8	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	100	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	TCGA-BG-A0M3.19AABBD8-3DC5-418E-9B62-37CF7500F174.pdf	53	0	0	0	0	0	5	0	0	0	0	0	0	100	95	90	90	positive	TUMOR FREE	0	0			Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	1988	NO	NO	YES	BG	0	5	0	12	Endometrial	A	LIVING	75	2008	e5b97796-bf64-458e-8ed8-246c2b303ce7		TCGA-BG-A0M3-01			TCGA-BG-A0M3-01A-11D-A102-01		TCGA-BG-A0M3-01A-11D-A10Q-05	e5b97796-bf64-458e-8ed8-246c2b303ce7		00f34c1b-8b1b-47d2-9d64-12591734faa1	TCGA-BG-A0M3-01A-11R-A103-13	TCGA-BG-A0M3-01A-11W-A10C-09	TCGA-BG-A0M3-01A-21-A163-20	adaaac92-a501-49fc-80a0-9e78a2be8cc4	TCGA-BG-A0M3-01		TCGA-BG-A0M3-01A-11W-A10C-09		TCGA-BG-A0M3-01A-11W-A10C-09	adaaac92-a501-49fc-80a0-9e78a2be8cc4	TCGA-BG-A0M3-01A-11D-A102-01		TCGA-BG-A0M3-01A-11R-A103-13	
TCGA-BG-A0M4-01	MSI-H	0	TCGA-BG-A0M4-01	1064	0	BRCA-LUAD+	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 4	cluster 2	mutation cluster 6	TCGA-BG-A0M4	1064	0	1064	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	60	0	0	TCGA-BG-A0M4-F19294	Never Used	Stage IA			-22090	643		0	1064						Scheduled Follow-up Submission	2011-12-7	FEMALE	178	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.		C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	240	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-BG-A0M4.95002D96-C9D8-43BE-ADD1-072E93994194.pdf	5	0	0	0	0	0	0	0	0	0	0	0	0	100	100	90	75	negative	TUMOR FREE	0	0			Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	1988	YES	YES	NO	BG	0	3	0	14	Endometrial	A	LIVING	97	2008	174acfe1-d3ab-4912-9d05-7aa598ae1add		TCGA-BG-A0M4-01			TCGA-BG-A0M4-01A-11D-A102-01		TCGA-BG-A0M4-01A-11D-A10Q-05	174acfe1-d3ab-4912-9d05-7aa598ae1add		57311fa8-c83f-4b62-8310-be9a12e10b2e	TCGA-BG-A0M4-01A-11R-A103-13	TCGA-BG-A0M4-01A-11W-A10C-09	TCGA-BG-A0M4-01A-21-A163-20	b561d132-b380-4dbd-8f48-48eeb2e15006	TCGA-BG-A0M4-01		TCGA-BG-A0M4-01A-11W-A10C-09		TCGA-BG-A0M4-01A-11W-A10C-09	b561d132-b380-4dbd-8f48-48eeb2e15006	TCGA-BG-A0M4-01A-11D-A102-01		TCGA-BG-A0M4-01A-11R-A103-13	
TCGA-BG-A0M6-01	MSS	1	TCGA-BG-A0M6-01	671	1	High	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 2	mutation cluster 3	TCGA-BG-A0M6	671	0	671	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Partial Response	73	0	3	TCGA-BG-A0M6-F19331	Never Used	Stage IIIC2			-26666	618	671	0	241				NO		Scheduled Follow-up Submission	2011-12-8	FEMALE	152	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Tumor resection	320	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-BG-A0M6.39EC3673-5B31-403B-8328-9DEA5FF7CD1A.pdf	100	10	10	0	0	10	10	0	0	40	20	0	0	50	70	60	80	positive	TUMOR FREE	0	5			Partial Remission/Response	Yes	Never Used		YES				R0	Primary Tumor	01	open	1988	YES	NO	YES	BG	3	5	5	16	Endometrial	A	DECEASED	55	2008	989bcd83-f8c2-4027-a10c-19ce3b67e348		TCGA-BG-A0M6-01			TCGA-BG-A0M6-01A-31D-A102-01		TCGA-BG-A0M6-01A-31D-A10Q-05	989bcd83-f8c2-4027-a10c-19ce3b67e348		61ae62d3-8662-47bb-b2a1-fe0a5d787e24	TCGA-BG-A0M6-01A-31R-A103-13	TCGA-BG-A0M6-01A-31D-A10B-09	TCGA-BG-A0M6-01A-21-A163-20	c2f2f785-e2d3-484d-a2ae-f70446ff12bd	TCGA-BG-A0M6-01		TCGA-BG-A0M6-01A-31D-A10B-09		TCGA-BG-A0M6-01A-31D-A10B-09	c2f2f785-e2d3-484d-a2ae-f70446ff12bd	TCGA-BG-A0M6-01A-31D-A102-01		TCGA-BG-A0M6-01A-31R-A103-13	
TCGA-BG-A0M7-01	MSS	0	TCGA-BG-A0M7-01	1167	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 2	mutation cluster 2	TCGA-BG-A0M7	1167	0	1167	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	60			TCGA-BG-A0M7-F19292		Stage IIIC1			-22096	659		0	1167						Scheduled Follow-up Submission	2011-12-7	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.		C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	260	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	TCGA-BG-A0M7.F9128DAE-F3D0-4738-AC20-E665F22DDC63.pdf	75	0	0	0	0	0	0	0	0	0	0	0	0	100	100	75	80	negative	TUMOR FREE					Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	1988	YES	NO	YES	BG					Endometrial	A	LIVING	102	2008	a832a6a6-1998-41c2-9dab-87076a1f11cf		TCGA-BG-A0M7-01			TCGA-BG-A0M7-01A-11D-A042-01		TCGA-BG-A0M7-01A-11D-A039-05	a832a6a6-1998-41c2-9dab-87076a1f11cf		7ceaf55f-fb25-46a2-b3b8-24ca17f2477d	TCGA-BG-A0M7-01A-11R-A041-13	TCGA-BG-A0M7-01A-11W-A062-09	TCGA-BG-A0M7-01A-21-A163-20	a74850d0-251e-4874-b436-62dda3a2f378	TCGA-BG-A0M7-01		TCGA-BG-A0M7-01A-11W-A062-09		TCGA-BG-A0M7-01A-11W-A062-09	a74850d0-251e-4874-b436-62dda3a2f378	TCGA-BG-A0M7-01A-11D-A042-01		TCGA-BG-A0M7-01A-11R-A041-13	
TCGA-BG-A0M8-01	MSS	0	TCGA-BG-A0M8-01	1110	0	High	C6-UCEC	OV-like c1	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 2	TCGA-BG-A0M8	1110	0	1110	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	50	0	0	TCGA-BG-A0M8-F19289	Never Used	Stage IA			-18308	734		0	1110				NO		Scheduled Follow-up Submission	2011-12-7	FEMALE	160	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	630	NO		Indeterminate (neither Pre or Postmenopausal)	G3					NO	true	TCGA-BG-A0M8.42DBC6F7-E413-41A6-994E-1391099818A0.pdf	50	0	0	0	0	0	0	0	0	0	0	0	0	100	100	85	90	negative	TUMOR FREE	0	0			Complete Remission/Response	Yes	Never Used		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	BG	0	0	0	0	Endometrial	A	LIVING	209	2008	90962783-12b4-434d-9b27-6c6f8f3b8d10		TCGA-BG-A0M8-01			TCGA-BG-A0M8-01A-12D-A102-01		TCGA-BG-A0M8-01A-12D-A10Q-05	90962783-12b4-434d-9b27-6c6f8f3b8d10		e01a90ac-a64f-4ad2-8c5b-374d2f9fbf75	TCGA-BG-A0M8-01A-12R-A103-13	TCGA-BG-A0M8-01A-12D-A10B-09	TCGA-BG-A0M8-01A-21-A163-20	cb3358a0-f0e9-424c-94eb-1b267aa8d27a	TCGA-BG-A0M8-01		TCGA-BG-A0M8-01A-12D-A10B-09		TCGA-BG-A0M8-01A-12D-A10B-09	cb3358a0-f0e9-424c-94eb-1b267aa8d27a	TCGA-BG-A0M8-01A-12D-A102-01		TCGA-BG-A0M8-01A-12R-A103-13	
TCGA-BG-A0M9-01	MSS	0	TCGA-BG-A0M9-01	860	0	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 3	mutation cluster 1	TCGA-BG-A0M9	860	0	860	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	73	0	0	TCGA-BG-A0M9-F19282	Never Used	Stage IB			-26708	772		0	860				NO		Scheduled Follow-up Submission	2011-12-7	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	220	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	TCGA-BG-A0M9.08D832C7-9B5F-4B6E-9C3E-2F3E58305016.pdf	75	0	0	0	0	0	0	0	0	0	0	0	0	100	100	90	80	negative	TUMOR FREE	0	0			Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	BG	0	4	0	5	Endometrial	A	LIVING	93	2008	55874b54-441d-4a28-b2a7-a90e96774ff9		TCGA-BG-A0M9-01			TCGA-BG-A0M9-01A-21D-A102-01		TCGA-BG-A0M9-01A-21D-A10Q-05	55874b54-441d-4a28-b2a7-a90e96774ff9		6af1c2fb-89e2-4fcc-9774-858ed6cac492	TCGA-BG-A0M9-01A-21R-A103-13	TCGA-BG-A0M9-01A-21W-A10C-09	TCGA-BG-A0M9-01A-11-A163-20	a31e7ac0-df73-41d7-8bdd-14e98749db42	TCGA-BG-A0M9-01		TCGA-BG-A0M9-01A-21W-A10C-09		TCGA-BG-A0M9-01A-21W-A10C-09	a31e7ac0-df73-41d7-8bdd-14e98749db42	TCGA-BG-A0M9-01A-21D-A102-01		TCGA-BG-A0M9-01A-21R-A103-13	
TCGA-BG-A0MA-01	MSS	1	TCGA-BG-A0MA-01	326	1	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-BG-A0MA	85	1	326	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma			NO	Progressive Disease	60	0	0	TCGA-BG-A0MA-F19281		Stage IB			-22036	805	326	0				85			Scheduled Follow-up Submission	2011-12-7	FEMALE	170	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	130	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Bone	Metastatic			YES	true	TCGA-BG-A0MA.E5908692-5B04-407B-818A-D202756DD880.pdf	78	20	0	0	0	20	0	20	0	20	0	0	0	60	100	80	85	negative	WITH TUMOR	0	0		0	Progressive Disease	No			NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	BG	0	6	0	10	Endometrial	A	DECEASED	111	2008	e93ac169-2fab-4312-9239-a9141d347763		TCGA-BG-A0MA-01		TCGA-BG-A0MA-01A-11R-A17A-13	TCGA-BG-A0MA-01A-11D-A17C-01			e93ac169-2fab-4312-9239-a9141d347763	TCGA-BG-A0MA-01A-11D-A17F-05				TCGA-BG-A0MA-01A-21-A18Q-20	3a1f58ed-7be8-4532-9d74-ffa813ee9f79	TCGA-BG-A0MA-01					3a1f58ed-7be8-4532-9d74-ffa813ee9f79	TCGA-BG-A0MA-01A-11D-A17C-01		TCGA-BG-A0MA-01A-11R-A17A-13	
TCGA-BG-A0MA-11	MSS	1	TCGA-BG-A0MA-11	326	1		C6-UCEC								TCGA-BG-A0MA	85	1	326	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma			NO	Progressive Disease	60	0	0	TCGA-BG-A0MA-F19281		Stage IB			-22036	1134	326	0				85			Scheduled Follow-up Submission	2011-12-7	FEMALE	170	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	120	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Bone	Metastatic			YES	true		78		30		20		0		30		100		0		0		0	negative	WITH TUMOR	0	0		0	Progressive Disease	No			NO				R0	Solid Tissue Normal	11	open	1988	NO	NO	YES	BG	0	6	0	10	Endometrial	A	DECEASED	111	2008										TCGA-BG-A0MA-11A-11D-A17F-05															
TCGA-BG-A0MC-01	MSS	0	TCGA-BG-A0MC-01	1263	0	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 2	mutation cluster 1	TCGA-BG-A0MC	1263	0	1263	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	74			TCGA-BG-A0MC-F19280	Never Used	Stage IA			-27136	779		0	1263				YES		Scheduled Follow-up Submission	2011-12-7	FEMALE	155	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Tumor resection	630	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	TCGA-BG-A0MC.100F4900-491A-438B-9704-51D4E016B325.pdf	0	0	0	0	0	0	0	0	0	0	0	0	0	100	100	80	75	negative	TUMOR FREE					Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	1988	NO	NO	YES	BG		0		0	Endometrial	A	LIVING	135	2008	1ad1a4dc-b34a-4f34-990b-05c2c14fb4c9		TCGA-BG-A0MC-01			TCGA-BG-A0MC-01A-21D-A042-01		TCGA-BG-A0MC-01A-21D-A039-05	1ad1a4dc-b34a-4f34-990b-05c2c14fb4c9		27ebfa46-c09d-471b-a9d5-b3ba90ee832e	TCGA-BG-A0MC-01A-21R-A041-13	TCGA-BG-A0MC-01A-21W-A062-09	TCGA-BG-A0MC-01A-11-A163-20	4616a1d7-ca85-43d4-8e06-57238b83a32c	TCGA-BG-A0MC-01		TCGA-BG-A0MC-01A-21W-A062-09		TCGA-BG-A0MC-01A-21W-A062-09	4616a1d7-ca85-43d4-8e06-57238b83a32c	TCGA-BG-A0MC-01A-21D-A042-01		TCGA-BG-A0MC-01A-21R-A041-13	
TCGA-BG-A0MG-01	MSS	0	TCGA-BG-A0MG-01	1477	0	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 2	mutation cluster 4	TCGA-BG-A0MG	1477	0	1477	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	73	0	0	TCGA-BG-A0MG-F19272	Never Used	Stage IA	NO		-26957	980		0	1477				NO		Scheduled Follow-up Submission	2011-12-6	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	240	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	TCGA-BG-A0MG.65A0B84A-72AD-42E2-B0DB-DA8D2BD54E9B.pdf	36	1	2	1	1	3	10	20	7	10	0	10	5	77	85	65	85	negative	TUMOR FREE	0	0		4+	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	BG	0	2	0	5	Endometrial	A	LIVING	61	2007	a21894d9-a459-4dbd-b9de-6c39f6fc61c2		TCGA-BG-A0MG-01			TCGA-BG-A0MG-01A-21D-A102-01		TCGA-BG-A0MG-01A-21D-A10Q-05	a21894d9-a459-4dbd-b9de-6c39f6fc61c2		107d6429-ec36-4d65-9820-23ff2eace5e9	TCGA-BG-A0MG-01A-21R-A103-13	TCGA-BG-A0MG-01A-21D-A10B-09	TCGA-BG-A0MG-01A-11-A163-20	ae2a43df-8dea-4bdb-b68e-2de4221d0cc0	TCGA-BG-A0MG-01		TCGA-BG-A0MG-01A-21D-A10B-09		TCGA-BG-A0MG-01A-21D-A10B-09	ae2a43df-8dea-4bdb-b68e-2de4221d0cc0	TCGA-BG-A0MG-01A-21D-A102-01		TCGA-BG-A0MG-01A-21R-A103-13	
TCGA-BG-A0MH-01	MSS	0	TCGA-BG-A0MH-01	1930	0	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 1		TCGA-BG-A0MH	1930	0	1930	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	61			TCGA-BG-A0MH-F49548		Stage IC			-22475	1000		0	1930							2013-10-3	FEMALE	154	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	790	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	TCGA-BG-A0MH.F641C526-7A0D-46C3-92EE-CD9CB0D13960.pdf	90	20	2	0	3	20	2	20	8	30	0	50	20	20	78	20	80		TUMOR FREE		0	NO		Complete Remission/Response	No			YES					Primary Tumor	01	open	1988		NO	YES	BG				8	Endometrial	A	LIVING	136	2007	f73e7e5b-239b-4ac9-861e-c8f42e68188e				TCGA-BG-A0MH-01A-11R-A119-13				f73e7e5b-239b-4ac9-861e-c8f42e68188e	TCGA-BG-A0MH-01A-11D-A123-05	61cc9b5c-c646-4d6c-92ff-cec57cd68fb7			TCGA-BG-A0MH-01A-21-A163-20		TCGA-BG-A0MH-01								TCGA-BG-A0MH-01A-11R-A119-13	
TCGA-BG-A0MI-01	MSS	1	TCGA-BG-A0MI-01	714	1	Quiet	C6-UCEC	UCEC CIMP c18	cluster 2		UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 4	TCGA-BG-A0MI	714	0	714	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	83	0	0	TCGA-BG-A0MI-F17205	Never Used	Stage IA	NO		-30334		714	0					NO		Scheduled Follow-up Submission	2011-10-4	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO			13																	negative	TUMOR FREE	0	0		3		No	Never Used		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	BG	0	2	0	13	Endometrial		DECEASED	101	2007	c199bab3-c6e3-4123-811c-2c50e8d44fae	TCGA-BG-A0MI-01	TCGA-BG-A0MI-01			TCGA-BG-A0MI-01A-11D-A042-01	TCGA-BG-A0MI-01	TCGA-BG-A0MI-01A-11D-A039-05	c199bab3-c6e3-4123-811c-2c50e8d44fae			TCGA-BG-A0MI-01A-11R-A041-13	TCGA-BG-A0MI-01A-11W-A062-09		ac480d07-b41b-4e88-99c8-3a09b7a073b3	TCGA-BG-A0MI-01		TCGA-BG-A0MI-01A-11W-A062-09	TCGA-BG-A0MI-01A-11R-A040-07	TCGA-BG-A0MI-01A-11W-A062-09	ac480d07-b41b-4e88-99c8-3a09b7a073b3	TCGA-BG-A0MI-01A-11D-A042-01		TCGA-BG-A0MI-01A-11R-A041-13	
TCGA-BG-A0MK-01	Indeterminate	1	TCGA-BG-A0MK-01	1317	1	Quiet		UCEC CIMP c18		squamous c3		miRNA c1uster 10			TCGA-BG-A0MK	1317	0	1317	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Progressive Disease	52			TCGA-BG-A0MK-F39617		Stage IIB			-19034	1399	1317	0								2013-1-28	FEMALE		Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	1100	NO	NO	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3					NO	true	TCGA-BG-A0MK.9D631FCB-78A9-4CA9-A033-D66CB78D8CA3.pdf			0		0		15		0		0		15		70		60	negative	WITH TUMOR			NO		Progressive Disease	No			YES				R0	Primary Tumor	01	Minimally Invasive	1995		YES	NO	BG					Endometrial	A	DECEASED		2006			TCGA-BG-A0MK-01	1f577d0a-ab0b-4464-b75d-4d3dc2b80cd3	TCGA-BG-A0MK-01A-51R-A19V-13	TCGA-BG-A0MK-01A-51D-A19X-01				TCGA-BG-A0MK-01A-51D-A19Z-05				TCGA-BG-A0MK-01A-41-A23Z-20	59abd764-0b1d-4f9e-982e-714fa99acb43	TCGA-BG-A0MK-01	1f577d0a-ab0b-4464-b75d-4d3dc2b80cd3				59abd764-0b1d-4f9e-982e-714fa99acb43	TCGA-BG-A0MK-01A-51D-A19X-01	1f577d0a-ab0b-4464-b75d-4d3dc2b80cd3	TCGA-BG-A0MK-01A-51R-A19V-13	1f577d0a-ab0b-4464-b75d-4d3dc2b80cd3
TCGA-BG-A0MO-01	MSS	0	TCGA-BG-A0MO-01	1309	0	Iq	C6-UCEC	UCEC non-CIMP c3	cluster 2		UCEC-like c11	miRNA c1uster 10	cluster 1	mutation c1uster 9	TCGA-BG-A0MO	1309	0	1309	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	63			TCGA-BG-A0MO-F19273	Never Used	Stage IA	NO		-23287	854		0	1309				NO		Scheduled Follow-up Submission	2011-12-6	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	100	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	TCGA-BG-A0MO.C120AC98-36D2-49AD-84A1-6EA168D2A2BA.pdf	35.7	2	1	0	0	4	1	0	0	0	0	6	3	90	96	96	97	negative	TUMOR FREE					Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	1988	NO	NO	YES	BG					Endometrial	A	LIVING	83	2008	7fc96ce5-b529-4d89-8b27-5f8ba4e301e9		TCGA-BG-A0MO-01			TCGA-BG-A0MO-01A-11D-A042-01		TCGA-BG-A0MO-01A-11D-A039-05	7fc96ce5-b529-4d89-8b27-5f8ba4e301e9			TCGA-BG-A0MO-01A-11R-A041-13	TCGA-BG-A0MO-01A-11W-A062-09		371ef0ae-e02b-4cd5-955c-3e16b2cd3678	TCGA-BG-A0MO-01		TCGA-BG-A0MO-01A-11W-A062-09		TCGA-BG-A0MO-01A-11W-A062-09	371ef0ae-e02b-4cd5-955c-3e16b2cd3678	TCGA-BG-A0MO-01A-11D-A042-01		TCGA-BG-A0MO-01A-11R-A041-13	
TCGA-BG-A0MQ-01	MSI-H	0	TCGA-BG-A0MQ-01	1196	0	BRCA-LUAD+	C6-UCEC	UCEC CIMP c18	cluster 1		UCEC-like c11	miRNA cluster 12	cluster 5	mutation cluster 6	TCGA-BG-A0MQ	1196	0	1196	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Stable Disease	71			TCGA-BG-A0MQ-F19286	Never Used	Stage IA			-26284	692		0	1196				YES		Scheduled Follow-up Submission	2011-12-7	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	120	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	TCGA-BG-A0MQ.3252AEB3-3B0D-4066-B18E-31096F928D63.pdf	25	5	4	1	1	18	18	3	2	0	0	5	3	77	79	88	90	negative	TUMOR FREE					Stable Disease	No	Never Used		YES				R0	Primary Tumor	01	open	1988	NO	NO	YES	BG					Endometrial	A	LIVING	101	2008	37d2da87-d591-440d-87d3-a34a038bef5b		TCGA-BG-A0MQ-01			TCGA-BG-A0MQ-01A-11D-A102-01		TCGA-BG-A0MQ-01A-11D-A10Q-05	37d2da87-d591-440d-87d3-a34a038bef5b			TCGA-BG-A0MQ-01A-11R-A103-13	TCGA-BG-A0MQ-01A-11D-A10B-09		0750756a-4f85-4749-96be-9b55bb9773b1	TCGA-BG-A0MQ-01		TCGA-BG-A0MQ-01A-11D-A10B-09		TCGA-BG-A0MQ-01A-11D-A10B-09	0750756a-4f85-4749-96be-9b55bb9773b1	TCGA-BG-A0MQ-01A-11D-A102-01		TCGA-BG-A0MQ-01A-11R-A103-13	
TCGA-BG-A0MS-01	MSS	0	TCGA-BG-A0MS-01	937	0	BRCA-LUAD+	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 4	TCGA-BG-A0MS	937	0	937	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	53			TCGA-BG-A0MS-F19317	Never Used	Stage IIIC1			-19547	420		0	937				NO		Scheduled Follow-up Submission	2011-12-8	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	560	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-BG-A0MS.7BE89F2D-74E5-4D9E-8270-A216D79ADCD7.pdf	44	7	15	0	1	1	1	0	3	0	30	10	5	89	64	85	60	negative	TUMOR FREE					Complete Remission/Response	Yes	Never Used		YES				R0	Primary Tumor	01	open	2009	YES	NO	YES	BG					Endometrial	A	LIVING	65	2009	09b4aa83-d8e7-4615-bfad-da877df4fe7d		TCGA-BG-A0MS-01			TCGA-BG-A0MS-01A-11D-A102-01		TCGA-BG-A0MS-01A-11D-A10Q-05	09b4aa83-d8e7-4615-bfad-da877df4fe7d		c7a57035-fac8-466b-b969-37a70c4d246f	TCGA-BG-A0MS-01A-11R-A103-13	TCGA-BG-A0MS-01A-11D-A10B-09	TCGA-BG-A0MS-01A-21-A163-20	1e6dbf12-f9e0-4237-b2b4-bad33bb41fde	TCGA-BG-A0MS-01		TCGA-BG-A0MS-01A-11D-A10B-09		TCGA-BG-A0MS-01A-11D-A10B-09	1e6dbf12-f9e0-4237-b2b4-bad33bb41fde	TCGA-BG-A0MS-01A-11D-A102-01		TCGA-BG-A0MS-01A-11R-A103-13	
TCGA-BG-A0MT-01	MSS	0	TCGA-BG-A0MT-01	644	0	BRCA-LUAD+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation c1uster 10	TCGA-BG-A0MT	565	1	644	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma		YES		Partial Response	64			TCGA-BG-A0MT-F19318	Never Used	Stage IA			-23574	344		0	644			565	NO		Scheduled Follow-up Submission	2011-12-8	FEMALE	168	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	820	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2	Other, specify	Locoregional Disease	locally in the endometrium		YES	true	TCGA-BG-A0MT.89610F48-AC0D-431D-8A9E-FC9E51CF8FC0.pdf	25	7	6	5	3	1	1	1	0	0	0	9	3	90	96	85	85	negative	TUMOR FREE					Partial Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	BG					Endometrial	A	LIVING	73	2009	578f3ec4-17e0-4cf9-bfa8-56624d174374		TCGA-BG-A0MT-01			TCGA-BG-A0MT-01A-11D-A102-01		TCGA-BG-A0MT-01A-11D-A10Q-05	578f3ec4-17e0-4cf9-bfa8-56624d174374		9170fa52-8cc4-465c-8de7-94199ff1e4e4	TCGA-BG-A0MT-01A-11R-A103-13	TCGA-BG-A0MT-01A-11D-A10B-09	TCGA-BG-A0MT-01A-21-A163-20	134dc5d6-78a9-4647-b408-d3538bb4352f	TCGA-BG-A0MT-01		TCGA-BG-A0MT-01A-11D-A10B-09		TCGA-BG-A0MT-01A-11D-A10B-09	134dc5d6-78a9-4647-b408-d3538bb4352f	TCGA-BG-A0MT-01A-11D-A102-01		TCGA-BG-A0MT-01A-11R-A103-13	
TCGA-BG-A0MU-01	MSS	0	TCGA-BG-A0MU-01	617	0	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 1	mutation cluster 4	TCGA-BG-A0MU	617	0	617	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	78	0	0	TCGA-BG-A0MU-F19322	Never Used	Stage IIIA			-28621	121		0	617				NO		Scheduled Follow-up Submission	2011-12-8	FEMALE	152	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Tumor resection	860	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	TCGA-BG-A0MU.7162F7A7-7295-4736-B721-B13DAE006092.pdf	76.9	1	2	1	1	3	2	1	1	0	0	7	6	90	92	94	94	negative	TUMOR FREE	0	0			Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	2009	NO	NO	YES	BG	0	1	0	8	Endometrial	A	LIVING	68	2010	06c39fc6-9167-4913-bf84-4fde036869a2		TCGA-BG-A0MU-01			TCGA-BG-A0MU-01A-11D-A102-01		TCGA-BG-A0MU-01A-11D-A10Q-05	06c39fc6-9167-4913-bf84-4fde036869a2		2220b369-d1d5-48e1-8f1d-2bf17726a5c9	TCGA-BG-A0MU-01A-11R-A103-13	TCGA-BG-A0MU-01A-11D-A10B-09	TCGA-BG-A0MU-01A-21-A163-20	145dcf88-52e3-4df7-bdd3-9fad30fa1ff5	TCGA-BG-A0MU-01		TCGA-BG-A0MU-01A-11D-A10B-09		TCGA-BG-A0MU-01A-11D-A10B-09	145dcf88-52e3-4df7-bdd3-9fad30fa1ff5	TCGA-BG-A0MU-01A-11D-A102-01		TCGA-BG-A0MU-01A-11R-A103-13	
TCGA-BG-A0RY-01	MSS	0	TCGA-BG-A0RY-01	469	0	BRCA-LUAD+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 1	mutation cluster 4	TCGA-BG-A0RY	469	0	469	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	68	0	0	TCGA-BG-A0RY-F19333	Never Used	Stage IB			-24952	49		0	469				NO		Scheduled Follow-up Submission	2011-12-8	FEMALE	170	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	450	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	TCGA-BG-A0RY.170B34D7-94B3-4129-9B4D-E36AF7A09897.pdf	96	0	0	0	0	0	0	0	0	0	0	0	0	100	100	90	85	negative	TUMOR FREE	0	0			Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	2009	NO	NO	YES	BG	0	0	0	9	Endometrial	A	LIVING	118	2010	514a9fc3-0b51-41f3-8c94-f6c8d8c0911e		TCGA-BG-A0RY-01			TCGA-BG-A0RY-01A-11D-A102-01		TCGA-BG-A0RY-01A-11D-A10Q-05	514a9fc3-0b51-41f3-8c94-f6c8d8c0911e		c6b6d0ce-40de-4854-9839-31e44642187f	TCGA-BG-A0RY-01A-11R-A103-13	TCGA-BG-A0RY-01A-11D-A10B-09	TCGA-BG-A0RY-01A-21-A163-20	5c2be319-25da-4db3-9f47-891954970ec4	TCGA-BG-A0RY-01		TCGA-BG-A0RY-01A-11D-A10B-09		TCGA-BG-A0RY-01A-11D-A10B-09	5c2be319-25da-4db3-9f47-891954970ec4	TCGA-BG-A0RY-01A-11D-A102-01		TCGA-BG-A0RY-01A-11R-A103-13	
TCGA-BG-A0VT-01	MSS	0	TCGA-BG-A0VT-01	742	0	Iq	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation c1uster 9	TCGA-BG-A0VT	742	0	742	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	56		0	TCGA-BG-A0VT-F34081	Former User	Stage IIIA	NO		-20602	87		0	742				NO			2012-7-30	FEMALE	170	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	70	NO	NO	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2					NO	true	TCGA-BG-A0VT.0BC38740-A7B9-4086-9F03-A139287B33CC.pdf	20	30	1	20	0	10	10	40	0	0	30	20	0	70	60	70	70		TUMOR FREE		0	YES	0	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009		NO	YES	BG		3		3	Endometrial	A	LIVING	144	2010	666ecfed-75d2-412a-bd7f-24b9775db969		TCGA-BG-A0VT-01			TCGA-BG-A0VT-01A-11D-A10L-01			666ecfed-75d2-412a-bd7f-24b9775db969	TCGA-BG-A0VT-01A-11D-A10N-05	ea1d2d67-9237-433d-a6b5-d3918d8bf59a	TCGA-BG-A0VT-01A-11R-A10I-13	TCGA-BG-A0VT-01A-11D-A10M-09	TCGA-BG-A0VT-01A-31-A163-20	285be971-f390-411c-891c-7a44cc4f61a1	TCGA-BG-A0VT-01		TCGA-BG-A0VT-01A-11D-A10M-09		TCGA-BG-A0VT-01A-11D-A10M-09	285be971-f390-411c-891c-7a44cc4f61a1	TCGA-BG-A0VT-01A-11D-A10L-01		TCGA-BG-A0VT-01A-11R-A10I-13	
TCGA-BG-A0VV-01	MSS	0	TCGA-BG-A0VV-01	811	0	Iq	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 4	TCGA-BG-A0VV	811	0	811	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	53		0	TCGA-BG-A0VV-F34083		Stage IA	NO		-19581	217		0	811				YES			2012-7-30	FEMALE	162	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	130	NO	NO	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1					NO	true	TCGA-BG-A0VV.42E7D5FF-18CD-4DEA-9518-9B9732BCA635.pdf	50	40	60	40	5	0	10	20	30	10	0	30	20	60	70	60	70	negative	TUMOR FREE		0	NO	3	Complete Remission/Response	No			NO				R0	Primary Tumor	01	open	2009		NO	YES	BG		2		6	Endometrial	A	LIVING	147	2010	34a66e0d-169f-4e39-89a2-78376bf741ae		TCGA-BG-A0VV-01		TCGA-BG-A0VV-01A-21R-A119-13	TCGA-BG-A0VV-01A-21D-A120-01			34a66e0d-169f-4e39-89a2-78376bf741ae	TCGA-BG-A0VV-01A-21D-A123-05	b296bc3f-3e22-46fd-ad09-8c08d18cc239		TCGA-BG-A0VV-01A-21D-A122-09	TCGA-BG-A0VV-01A-11-A163-20	459b5330-498b-44f5-a007-83a7ee7dc199	TCGA-BG-A0VV-01				TCGA-BG-A0VV-01A-21D-A122-09	459b5330-498b-44f5-a007-83a7ee7dc199	TCGA-BG-A0VV-01A-21D-A120-01		TCGA-BG-A0VV-01A-21R-A119-13	
TCGA-BG-A0VW-01	MSI-H	0	TCGA-BG-A0VW-01	497	0	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 2		UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 12	TCGA-BG-A0VW	497	0	497	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	77		0	TCGA-BG-A0VW-F34084		Stage IA			-28383	246		0	497				NO			2012-7-30	FEMALE	157	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	90	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	TCGA-BG-A0VW.7663D410-13EC-4A5B-B655-F7DCCC9C8E8D.pdf	50	40	40	20	30	0	5	30	30	0	10	40	25	60	60	60	60	negative	TUMOR FREE		0	NO		Complete Remission/Response	No			NO				R0	Primary Tumor	01	open	2009		NO	YES	BG		2		10	Endometrial	A	LIVING	93	2010	818368c5-a7b6-40d2-a24f-39604ea80303		TCGA-BG-A0VW-01		TCGA-BG-A0VW-01A-11R-A119-13	TCGA-BG-A0VW-01A-11D-A120-01			818368c5-a7b6-40d2-a24f-39604ea80303	TCGA-BG-A0VW-01A-11D-A123-05			TCGA-BG-A0VW-01A-11D-A122-09		adc828a4-74b6-406b-8bfe-f273b8ddfc23	TCGA-BG-A0VW-01				TCGA-BG-A0VW-01A-11D-A122-09	adc828a4-74b6-406b-8bfe-f273b8ddfc23	TCGA-BG-A0VW-01A-11D-A120-01		TCGA-BG-A0VW-01A-11R-A119-13	
TCGA-BG-A0VX-01	MSS	0	TCGA-BG-A0VX-01	1043	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4		UCEC-like c11	miRNA cluster 13	cluster 2	mutation cluster 4	TCGA-BG-A0VX	1043	0	1043	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	58			TCGA-BG-A0VX-F34087		Stage IB	NO		-21425	729		0	1043				NO			2012-7-30	FEMALE	152	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Excisional Biopsy	90	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	TCGA-BG-A0VX.D0131F13-2BA5-4B20-8D3D-25743A258C06.pdf	15	40	60	25	15	10	5	30	20	0	10	20	35	70	50	70	50		TUMOR FREE			NO		Complete Remission/Response	No			YES				RX	Primary Tumor	01	open	1988		NO	YES	BG					Endometrial	A	LIVING	157	2008	e6322f79-edd2-48f2-9712-82f7153b6e1e		TCGA-BG-A0VX-01		TCGA-BG-A0VX-01A-11R-A119-13	TCGA-BG-A0VX-01A-11D-A120-01			e6322f79-edd2-48f2-9712-82f7153b6e1e	TCGA-BG-A0VX-01A-11D-A123-05			TCGA-BG-A0VX-01A-11D-A122-09		07e2b355-c96e-495f-9db6-51c947bc621b	TCGA-BG-A0VX-01		TCGA-BG-A0VX-01A-11D-A122-09		TCGA-BG-A0VX-01A-11D-A122-09	07e2b355-c96e-495f-9db6-51c947bc621b	TCGA-BG-A0VX-01A-11D-A120-01		TCGA-BG-A0VX-01A-11R-A119-13	
TCGA-BG-A0VZ-01	MSI-H	0	TCGA-BG-A0VZ-01	1601	0	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 1		UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 1	TCGA-BG-A0VZ	1601	0	1601	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	58			TCGA-BG-A0VZ-F34091		Stage IIIA	NO		-21414	876		0	1601				NO			2012-7-30	FEMALE	165	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	70	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	TCGA-BG-A0VZ.6CCCA758-AB3D-4260-BD25-16716E34B3BB.pdf	52	40	40	20	20	0	5	30	30	10	0	20	25	70	70	70	70	negative	TUMOR FREE			YES	1	Complete Remission/Response	No			NO				R0	Primary Tumor	01	open	1988		NO	YES	BG					Endometrial	A	LIVING	109	2008	740f4c64-0bc1-4691-8b37-7830ae67a080		TCGA-BG-A0VZ-01			TCGA-BG-A0VZ-01A-11D-A107-01			740f4c64-0bc1-4691-8b37-7830ae67a080	TCGA-BG-A0VZ-01A-11D-A10A-05		TCGA-BG-A0VZ-01A-11R-A108-13	TCGA-BG-A0VZ-01A-11D-A10G-09		5fa97bf1-3133-47f7-bb03-49a7fa4a22fc	TCGA-BG-A0VZ-01		TCGA-BG-A0VZ-01A-11D-A10G-09		TCGA-BG-A0VZ-01A-11D-A10G-09	5fa97bf1-3133-47f7-bb03-49a7fa4a22fc	TCGA-BG-A0VZ-01A-11D-A107-01		TCGA-BG-A0VZ-01A-11R-A108-13	
TCGA-BG-A0W1-01	MSS	0	TCGA-BG-A0W1-01	1607	0	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 4	TCGA-BG-A0W1	1607	0	1607	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	89			TCGA-BG-A0W1-F34127		Stage II	NO		-32750	1014		0	1607				NO			2012-7-30	FEMALE	130	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	100	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	TCGA-BG-A0W1.BE7CC54D-8220-4AC6-9F8D-016DE4167B35.pdf	45	40	30	20	20	5	5	30	40	0	0	25	25	70	70	70	70		TUMOR FREE		0	NO		Complete Remission/Response	No			NO				R0	Primary Tumor	01	open	1988		NO	YES	BG				11	Endometrial	A	LIVING	56	2007	85dd6956-38ee-4f12-9210-ffe2a8964aef		TCGA-BG-A0W1-01			TCGA-BG-A0W1-01A-12D-A107-01			85dd6956-38ee-4f12-9210-ffe2a8964aef	TCGA-BG-A0W1-01A-12D-A10A-05	882f0777-cf03-43ce-acad-42a6e98d7d64	TCGA-BG-A0W1-01A-12R-A108-13	TCGA-BG-A0W1-01A-12D-A10G-09	TCGA-BG-A0W1-01A-21-A163-20	ed5d11e3-b4f2-41be-8719-858ed03b1465	TCGA-BG-A0W1-01		TCGA-BG-A0W1-01A-12D-A10G-09		TCGA-BG-A0W1-01A-12D-A10G-09	ed5d11e3-b4f2-41be-8719-858ed03b1465	TCGA-BG-A0W1-01A-12D-A107-01		TCGA-BG-A0W1-01A-12R-A108-13	
TCGA-BG-A0W2-01	MSS	0	TCGA-BG-A0W2-01	1721	0	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4		UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 4	TCGA-BG-A0W2	1721	0	1721	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	57			TCGA-BG-A0W2-F49543		Stage IA			-20998	1073		0	1721							2013-10-3	FEMALE	165	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	80	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	TCGA-BG-A0W2.D9BDB0FB-9205-4E41-9D7D-B12C206A608E.pdf	0	40	40	20	10	5	5	30	30	5	10	20	15	70	70	70	70		TUMOR FREE			NO		Complete Remission/Response	No			NO				RX	Primary Tumor	01	open	1988		NO	YES	BG		0		0	Endometrial	A	LIVING	121	2007	8f9d6b78-c294-4f11-99ea-dc834a7f1741		TCGA-BG-A0W2-01			TCGA-BG-A0W2-01A-11D-A107-01			8f9d6b78-c294-4f11-99ea-dc834a7f1741	TCGA-BG-A0W2-01A-11D-A10A-05		TCGA-BG-A0W2-01A-11R-A108-13	TCGA-BG-A0W2-01A-11D-A117-09		5785ce79-2554-44d4-a461-25e6a2da246d	TCGA-BG-A0W2-01		TCGA-BG-A0W2-01A-11D-A117-09		TCGA-BG-A0W2-01A-11D-A117-09	5785ce79-2554-44d4-a461-25e6a2da246d	TCGA-BG-A0W2-01A-11D-A107-01		TCGA-BG-A0W2-01A-11R-A108-13	
TCGA-BG-A0YU-01	MSS	0	TCGA-BG-A0YU-01	451	0	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5	mutation cluster 4	TCGA-BG-A0YU	451	0	451	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	37			TCGA-BG-A0YU-F19334		Stage IA			-13644	166		0	451				NO		Scheduled Follow-up Submission	2011-12-8	FEMALE	157	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES	pelvic wash specimen from PAP	Other method, specify:	310	NO		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1					NO	true	TCGA-BG-A0YU.5E3AA4BA-20F6-4241-AD70-8E5DEDA9D129.pdf	50	20	20	0	0	20	10	10	10	0	0	20	10	60	80	80	90		TUMOR FREE					Complete Remission/Response	No	Never Used		NO				RX	Primary Tumor	01	open	2009	NO	NO	YES	BG					Endometrial	A	LIVING	107	2010	6e00c57a-69e5-4b00-9e5e-97aa1d4933c7		TCGA-BG-A0YU-01			TCGA-BG-A0YU-01A-21D-A10L-01			6e00c57a-69e5-4b00-9e5e-97aa1d4933c7	TCGA-BG-A0YU-01A-21D-A10N-05	3f6a7393-8558-4803-bc69-541fbb713cf3	TCGA-BG-A0YU-01A-21R-A10I-13	TCGA-BG-A0YU-01A-21D-A10M-09	TCGA-BG-A0YU-01A-11-A163-20	1e4f0760-0794-40ff-8002-f48f698b4c14	TCGA-BG-A0YU-01		TCGA-BG-A0YU-01A-21D-A10M-09		TCGA-BG-A0YU-01A-21D-A10M-09	1e4f0760-0794-40ff-8002-f48f698b4c14	TCGA-BG-A0YU-01A-21D-A10L-01		TCGA-BG-A0YU-01A-21R-A10I-13	
TCGA-BG-A0YV-01	MSS	0	TCGA-BG-A0YV-01	382	0	Squamous	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 2	mutation cluster 13	TCGA-BG-A0YV	382	0	382	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	67			TCGA-BG-A0YV-F19335	Never Used	Stage IIIA			-24567	62		0	382				NO		Scheduled Follow-up Submission	2011-12-8	FEMALE	155	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Cytology (e.g. Peritoneal or pleural fluid)	330	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-BG-A0YV.D037EFD1-22CB-43FE-BE0A-F2189C5FB202.pdf		10	10	10	10	20	20	20	10	0	0	20	20	60	60	80	80		TUMOR FREE					Complete Remission/Response	Yes	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009	YES	NO	YES	BG					Endometrial	A	LIVING	54	2010	9b120d0b-5e47-4428-8116-557fcb7edf8a		TCGA-BG-A0YV-01		TCGA-BG-A0YV-01A-11R-A10I-13	TCGA-BG-A0YV-01A-11D-A10L-01			9b120d0b-5e47-4428-8116-557fcb7edf8a	TCGA-BG-A0YV-01A-11D-A10N-05	5f0a557d-f6a8-4ffa-93c5-0236054db568		TCGA-BG-A0YV-01A-11D-A10M-09	TCGA-BG-A0YV-01A-21-A163-20	0ab30587-4e88-49f5-ac2d-c619c68419a0	TCGA-BG-A0YV-01		TCGA-BG-A0YV-01A-11D-A10M-09		TCGA-BG-A0YV-01A-11D-A10M-09	0ab30587-4e88-49f5-ac2d-c619c68419a0	TCGA-BG-A0YV-01A-11D-A10L-01		TCGA-BG-A0YV-01A-11R-A10I-13	
TCGA-BG-A186-01	MSS	0	TCGA-BG-A186-01	419	0	Iq	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 4	TCGA-BG-A186	419	0	419	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	61		0	TCGA-BG-A186-F28644		Stage IIIA	NO		-22370	104		0	419				NO		Scheduled Follow-up Submission	2012-2-22	FEMALE	162	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	100	NO			G2					NO	true	TCGA-BG-A186.76C588F1-ED43-485D-8FFF-32F4C5D92202.pdf	28		0		0		0		0		20		0		80		70	positive	TUMOR FREE		0		2	Complete Remission/Response	No	Never Used		YES				RX	Primary Tumor	01	open	2009	YES	NO	NO	BG		6		23	Endometrial	A	LIVING	75	2010	fcf451be-340a-4479-86ed-d6757d680386		TCGA-BG-A186-01		TCGA-BG-A186-01A-11R-A12H-13	TCGA-BG-A186-01A-11D-A12G-01			fcf451be-340a-4479-86ed-d6757d680386	TCGA-BG-A186-01A-11D-A12K-05	f987438a-987d-4fb1-87b9-4faa77e7aa3c		TCGA-BG-A186-01A-11D-A12J-09	TCGA-BG-A186-01A-21-A164-20	57e1a7e7-28bc-448a-9967-341f5965aa80	TCGA-BG-A186-01		TCGA-BG-A186-01A-11D-A12J-09		TCGA-BG-A186-01A-11D-A12J-09	57e1a7e7-28bc-448a-9967-341f5965aa80	TCGA-BG-A186-01A-11D-A12G-01		TCGA-BG-A186-01A-11R-A12H-13	
TCGA-BG-A187-01	MSI-L	0	TCGA-BG-A187-01	448	0	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 1	TCGA-BG-A187	448	0	448	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	65			TCGA-BG-A187-F28645		Stage IB	NO		-24099	97		0	448				NO		Scheduled Follow-up Submission	2012-2-22	FEMALE	160	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	360	NO			G2					NO	true	TCGA-BG-A187.CB8E915A-CE5D-4181-9303-22BD8CBCB80D.pdf	80		0		0		0		0		0		0		100		70	negative	TUMOR FREE		0		0	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	BG		3		4	Endometrial	A	LIVING	61	2010	3486bd36-927d-46c7-8efe-5f2d6c80ac5e		TCGA-BG-A187-01		TCGA-BG-A187-01A-11R-A12H-13	TCGA-BG-A187-01A-11D-A12G-01			3486bd36-927d-46c7-8efe-5f2d6c80ac5e	TCGA-BG-A187-01A-11D-A12K-05	f00fe736-702f-4cfe-9019-012cfd2d2ba0		TCGA-BG-A187-01A-11D-A12J-09	TCGA-BG-A187-01A-21-A164-20	a1493060-f538-4db2-b21b-dd0fa5fdbd22	TCGA-BG-A187-01		TCGA-BG-A187-01A-11D-A12J-09		TCGA-BG-A187-01A-11D-A12J-09	a1493060-f538-4db2-b21b-dd0fa5fdbd22	TCGA-BG-A187-01A-11D-A12G-01		TCGA-BG-A187-01A-11R-A12H-13	
TCGA-BG-A18A-01	MSS	0	TCGA-BG-A18A-01	426	0	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 4	mutation cluster 4	TCGA-BG-A18A	426	0	426	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	74		0	TCGA-BG-A18A-F28647	Former User	Stage IA	NO		-27086	146		0	426				NO		Scheduled Follow-up Submission	2012-2-22	FEMALE	162	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	130	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	TCGA-BG-A18A.099561AC-A5E7-4CA9-8F07-EEA7B3A96EEA.pdf	50		0		0		0		0		0		30		70		60	negative	TUMOR FREE		0		2	Complete Remission/Response	No	Never Used		YES				RX	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	BG		2		11	Endometrial	A	LIVING	84	2010	71679725-d65f-47d4-b851-e4467f9d3f62		TCGA-BG-A18A-01		TCGA-BG-A18A-01A-21R-A12H-13	TCGA-BG-A18A-01A-21D-A12G-01			71679725-d65f-47d4-b851-e4467f9d3f62	TCGA-BG-A18A-01A-21D-A12K-05	a76c4656-73ef-4f33-af5f-0278428fb79a		TCGA-BG-A18A-01A-21D-A12J-09	TCGA-BG-A18A-01A-11-A163-20	c8c71158-487a-48d9-bb5f-2b0aa6e00cc8	TCGA-BG-A18A-01		TCGA-BG-A18A-01A-21D-A12J-09		TCGA-BG-A18A-01A-21D-A12J-09	c8c71158-487a-48d9-bb5f-2b0aa6e00cc8	TCGA-BG-A18A-01A-21D-A12G-01		TCGA-BG-A18A-01A-21R-A12H-13	
TCGA-BG-A18B-01	MSI-H	0	TCGA-BG-A18B-01	470	0	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 6	mutation cluster 7	TCGA-BG-A18B	470	0	470	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	53			TCGA-BG-A18B-F28649	Former User	Stage I	NO		-19550	56		0	470				NO		Scheduled Follow-up Submission	2012-2-22	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	480	NO		Peri (6-12 months since last menstrual period)	G2					NO	true	TCGA-BG-A18B.E7006FF4-33D9-4369-A4E0-42D124EAE1E0.pdf			0		0		0		0		0		0		100		75		TUMOR FREE		0		1	Complete Remission/Response	No	Never Used		NO				RX	Primary Tumor	01	open	2009	NO	NO	YES	BG		0		5	Endometrial	A	LIVING	116	2010	5e981b2d-fef0-44c2-8228-8f5f7e9e3026		TCGA-BG-A18B-01		TCGA-BG-A18B-01A-11R-A12H-13	TCGA-BG-A18B-01A-11D-A12G-01			5e981b2d-fef0-44c2-8228-8f5f7e9e3026	TCGA-BG-A18B-01A-11D-A12K-05	8a7e6c09-e5b7-4c2e-b645-c88db29f8318		TCGA-BG-A18B-01A-11D-A12J-09	TCGA-BG-A18B-01A-21-A164-20	dde9a702-751a-4e89-a10f-ffa6b0b4f7df	TCGA-BG-A18B-01		TCGA-BG-A18B-01A-11D-A12J-09		TCGA-BG-A18B-01A-11D-A12J-09	dde9a702-751a-4e89-a10f-ffa6b0b4f7df	TCGA-BG-A18B-01A-11D-A12G-01		TCGA-BG-A18B-01A-11R-A12H-13	
TCGA-BG-A18C-01	MSS	0	TCGA-BG-A18C-01	470	0	High	C6-UCEC	Cluster 5	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5	mutation cluster 13	TCGA-BG-A18C	470	0	470	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	72		0	TCGA-BG-A18C-F28650	Never Used	Stage IA	NO		-26602	52		0	470				YES		Scheduled Follow-up Submission	2012-2-22	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	340	NO			G2					NO	true	TCGA-BG-A18C.2A6FB6E4-7FBF-45EA-B9B0-C4EDC78C35E2.pdf	13		40		20		10		20		0		30		60		60		TUMOR FREE		0		2	Complete Remission/Response	No	Never Used		NO				RX	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	BG		5		25	Endometrial	A	LIVING	96	2010	484a9564-c6dd-4e54-a319-4d826f308d0c		TCGA-BG-A18C-01		TCGA-BG-A18C-01A-11R-A12H-13	TCGA-BG-A18C-01A-11D-A12G-01			484a9564-c6dd-4e54-a319-4d826f308d0c	TCGA-BG-A18C-01A-11D-A12K-05	42648ef0-3a6a-4cf2-9a7b-e3aa008d4bee		TCGA-BG-A18C-01A-11D-A12J-09	TCGA-BG-A18C-01A-21-A164-20	4a197c6b-20f4-4b94-acd4-738da9837178	TCGA-BG-A18C-01		TCGA-BG-A18C-01A-11D-A12J-09		TCGA-BG-A18C-01A-11D-A12J-09	4a197c6b-20f4-4b94-acd4-738da9837178	TCGA-BG-A18C-01A-11D-A12G-01		TCGA-BG-A18C-01A-11R-A12H-13	
TCGA-BG-A220-01	MSI-H	0	TCGA-BG-A220-01	434	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11				TCGA-BG-A220	434	0	434	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	69			TCGA-BG-A220-F28651		Stage IA	NO		-25346			0	434				YES		Scheduled Follow-up Submission	2012-2-22	FEMALE		Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy					G3					NO																					TUMOR FREE				4+	Complete Remission/Response	Yes	Never Used		YES					Primary Tumor	01	open	2009	NO	NO	YES	BG		0		0	Endometrial		LIVING	127	2010	f26378d3-9f18-4367-a553-1a6c02e72575		TCGA-BG-A220-01			TCGA-BG-A220-01A-11D-A160-01			f26378d3-9f18-4367-a553-1a6c02e72575	TCGA-BG-A220-01A-11D-A161-05				TCGA-BG-A220-01A-21-A18R-20	d96db850-ddfc-4396-907a-5df3f1f7aa1f	TCGA-BG-A220-01					d96db850-ddfc-4396-907a-5df3f1f7aa1f	TCGA-BG-A220-01A-11D-A160-01			
TCGA-BG-A221-01	MSI-H	0	TCGA-BG-A221-01	55	0	BRCA-LUAD+	C6-UCEC	UCEC non-CIMP c3	cluster 4	squamous c3	UCEC-like c11	miRNA cluster 4	cluster 2		TCGA-BG-A221	55	0	55	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	84		0	TCGA-BG-A221-F28653		Stage IB	NO		-30960	99		0	55				NO		Scheduled Follow-up Submission	2012-2-22	FEMALE	157	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	240	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-BG-A221.58D68577-9022-4EF3-82E9-6EE159D41947.pdf			40		20		10		20		0		10		80		80		TUMOR FREE		0		4+	Complete Remission/Response	Yes	Never Used		NO					Primary Tumor	01	open	2009	NO	NO	YES	BG		3		15	Endometrial	A	LIVING	62	2010	58957940-d71f-4ad5-98a8-c8f2913801c5		TCGA-BG-A221-01		TCGA-BG-A221-01A-21R-A156-13	TCGA-BG-A221-01A-21D-A160-01			58957940-d71f-4ad5-98a8-c8f2913801c5	TCGA-BG-A221-01A-21D-A161-05				TCGA-BG-A221-01A-11-A18R-20	4720fb28-170c-451c-8c31-64239ce466e8	TCGA-BG-A221-01					4720fb28-170c-451c-8c31-64239ce466e8	TCGA-BG-A221-01A-21D-A160-01		TCGA-BG-A221-01A-21R-A156-13	
TCGA-BG-A222-01	MSI-H	0	TCGA-BG-A222-01	291	0	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	squamous c3	UCEC-like c11	miRNA cluster 7	cluster 1		TCGA-BG-A222	291	0	291	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	49		0	TCGA-BG-A222-F28654		Stage IA	NO		-18220	50		0	291				NO		Scheduled Follow-up Submission	2012-2-22	FEMALE	167	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	630	NO			G3					NO	true	TCGA-BG-A222.32837D2C-0D2B-4A47-9E42-1A809CB4A25A.pdf			40		20		10		20		0		10		80		80	negative	TUMOR FREE		0		1	Complete Remission/Response	No	Never Used		YES					Primary Tumor	01	open	2009	YES	NO	YES	BG		7		25	Endometrial	A	LIVING	132	2011	0e8881cf-4745-4fb5-9842-dface6532da3		TCGA-BG-A222-01		TCGA-BG-A222-01A-11R-A156-13	TCGA-BG-A222-01A-11D-A160-01			0e8881cf-4745-4fb5-9842-dface6532da3	TCGA-BG-A222-01A-11D-A161-05				TCGA-BG-A222-01A-21-A18R-20	0d5987a4-3a91-4cd8-aa9b-c000e549393c	TCGA-BG-A222-01					0d5987a4-3a91-4cd8-aa9b-c000e549393c	TCGA-BG-A222-01A-11D-A160-01		TCGA-BG-A222-01A-11R-A156-13	
TCGA-BG-A2AD-01	MSI-H	0	TCGA-BG-A2AD-01	609	0	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 6		TCGA-BG-A2AD	609	0	609	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	63		0	TCGA-BG-A2AD-F49552		Stage IIIB			-23064			0	609							2013-10-3	FEMALE	160	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Dilation and curettage procedure			NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO																				positive	TUMOR FREE		0	YES		Complete Remission/Response	No			NO					Primary Tumor	01	Minimally Invasive	2009		NO	YES	BG		8		18	Endometrial		LIVING	80	2011	a6ed9981-f7df-4f36-be2e-da4c96722680		TCGA-BG-A2AD-01		TCGA-BG-A2AD-01A-21R-A16E-13	TCGA-BG-A2AD-01A-21D-A16C-01			a6ed9981-f7df-4f36-be2e-da4c96722680	TCGA-BG-A2AD-01A-21D-A16G-05				TCGA-BG-A2AD-01A-11-A18R-20	dec64915-9d68-4e01-ae3f-0fd3ef29adca	TCGA-BG-A2AD-01					dec64915-9d68-4e01-ae3f-0fd3ef29adca	TCGA-BG-A2AD-01A-21D-A16C-01		TCGA-BG-A2AD-01A-21R-A16E-13	
TCGA-BG-A2AD-11	MSI-H	0	TCGA-BG-A2AD-11	609	0		C6-UCEC								TCGA-BG-A2AD	609	0	609	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	63		0	TCGA-BG-A2AD-F49552		Stage IIIB			-23064	45		0	609							2013-10-3	FEMALE	160	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	120	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true				30		20		0		30		100		0		0		0	positive	TUMOR FREE		0	YES		Complete Remission/Response	No			NO					Solid Tissue Normal	11	Minimally Invasive	2009		NO	YES	BG		8		18	Endometrial	A	LIVING	80	2011				be03335f-81c9-4cdc-8805-c47c3e7756a1	TCGA-BG-A2AD-11A-11R-A16E-13					TCGA-BG-A2AD-11A-11D-A16G-05							be03335f-81c9-4cdc-8805-c47c3e7756a1						be03335f-81c9-4cdc-8805-c47c3e7756a1	TCGA-BG-A2AD-11A-11R-A16E-13	be03335f-81c9-4cdc-8805-c47c3e7756a1
TCGA-BG-A2AE-01	MSS	0	TCGA-BG-A2AE-01	721	0	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5	mutation cluster 1	TCGA-BG-A2AE	721	0	721	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	57			TCGA-BG-A2AE-F49553		Stage IB			-21069	50		0	721							2013-10-3	FEMALE	179	Endometrioid endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	460	NO	NO	Peri (6-12 months since last menstrual period)	G3					NO	true	TCGA-BG-A2AE.BA5BC88E-6A6C-425E-84B4-EC33DB9AC146.pdf			40		20		10		20		0		0		90		90		TUMOR FREE		1	YES		Complete Remission/Response	No			YES					Primary Tumor	01	open	2009		NO	YES	BG				8	Endometrial	A	LIVING	135	2011	7a5dd0ca-549d-452a-beb8-ea8a3f5528ec		TCGA-BG-A2AE-01		TCGA-BG-A2AE-01A-11R-A16E-13	TCGA-BG-A2AE-01A-11D-A16C-01			7a5dd0ca-549d-452a-beb8-ea8a3f5528ec	TCGA-BG-A2AE-01A-11D-A16G-05			TCGA-BG-A2AE-01A-11D-A16D-09	TCGA-BG-A2AE-01A-21-A18R-20	85f9a340-d736-47a4-a957-e6875691bf98	TCGA-BG-A2AE-01		TCGA-BG-A2AE-01A-11D-A16D-09		TCGA-BG-A2AE-01A-11D-A16D-09	85f9a340-d736-47a4-a957-e6875691bf98	TCGA-BG-A2AE-01A-11D-A16C-01		TCGA-BG-A2AE-01A-11R-A16E-13	
TCGA-BG-A2AE-11	MSS	0	TCGA-BG-A2AE-11	721	0		C6-UCEC							mutation cluster 1	TCGA-BG-A2AE	721	0	721	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	57			TCGA-BG-A2AE-F49553		Stage IB			-21069	50		0	721							2013-10-3	FEMALE	179	Endometrioid endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	40	NO	NO	Peri (6-12 months since last menstrual period)	G3					NO	true				40		20		0		20		100		0		0		0		TUMOR FREE		1	YES		Complete Remission/Response	No			YES					Solid Tissue Normal	11	open	2009		NO	YES	BG				8	Endometrial	A	LIVING	135	2011										TCGA-BG-A2AE-11A-11D-A16G-05															
TCGA-BG-A2L7-01	MSI-H	0	TCGA-BG-A2L7-01	612	0	Quiet	C6-UCEC	UCEC CIMP c18		UCEC-like c5	UCEC-like c11	miRNA c1uster 10			TCGA-BG-A2L7	612	0	612	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	68		0	TCGA-BG-A2L7-F49554		Stage IA			-25091	141		0	612							2013-10-3	FEMALE		Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	110	NO	NO		G3					NO	true	TCGA-BG-A2L7.6A14E5E4-ED0F-415A-B54B-DE16D7DC6E78.pdf			40		20		10		20		0		20		70		70		TUMOR FREE		0	YES		Complete Remission/Response	No			YES				RX	Primary Tumor	01	open	2009		NO	YES	BG		1		15	Endometrial	A	LIVING		2011	16ce8070-8c04-4cc7-b00a-c094a524b133		TCGA-BG-A2L7-01		TCGA-BG-A2L7-01A-11R-A18L-13	TCGA-BG-A2L7-01A-11D-A18N-01			16ce8070-8c04-4cc7-b00a-c094a524b133	TCGA-BG-A2L7-01A-11D-A18O-05				TCGA-BG-A2L7-01A-21-A23Z-20	0d8ffdbe-9459-4ce5-b473-f2af37dddcd9	TCGA-BG-A2L7-01					0d8ffdbe-9459-4ce5-b473-f2af37dddcd9	TCGA-BG-A2L7-01A-11D-A18N-01		TCGA-BG-A2L7-01A-11R-A18L-13	
TCGA-BG-A2L7-11	MSI-H	0	TCGA-BG-A2L7-11	612	0		C6-UCEC								TCGA-BG-A2L7	612	0	612	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	68		0	TCGA-BG-A2L7-F49554		Stage IA			-25091	141		0	612							2013-10-3	FEMALE		Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	320	NO	NO		G3					NO	true				40		0		0		10		100		0		0		0		TUMOR FREE		0	YES		Complete Remission/Response	No			YES				RX	Solid Tissue Normal	11	open	2009		NO	YES	BG		1		15	Endometrial	A	LIVING		2011										TCGA-BG-A2L7-11A-11D-A18O-05															
TCGA-BG-A3EW-01	MSI-H	0	TCGA-BG-A3EW-01	344	0	Iq		UCEC CIMP c18		UCEC-like c5		miRNA c1uster 10			TCGA-BG-A3EW	344	0	344	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	62		0	TCGA-BG-A3EW-F39618		Stage III			-22705	24		0	344							2013-1-28	FEMALE	166	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	130	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-BG-A3EW.0463CA05-339C-4AB9-A236-CEAE733AD5F6.pdf	12		2		0		0		0		5		15		80		85		TUMOR FREE		0	NO		Complete Remission/Response	No			YES				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	BG		2		9	Endometrial	A	LIVING	126	2011			TCGA-BG-A3EW-01	8b8048b4-fe60-45f4-97c5-662c45169334	TCGA-BG-A3EW-01A-11R-A22I-13	TCGA-BG-A3EW-01A-11D-A227-01				TCGA-BG-A3EW-01A-11D-A22B-05				TCGA-BG-A3EW-01A-21-A23Z-20	f1d7b569-d44b-42be-b570-910c78207803	TCGA-BG-A3EW-01	8b8048b4-fe60-45f4-97c5-662c45169334				f1d7b569-d44b-42be-b570-910c78207803	TCGA-BG-A3EW-01A-11D-A227-01	8b8048b4-fe60-45f4-97c5-662c45169334	TCGA-BG-A3EW-01A-11R-A22I-13	8b8048b4-fe60-45f4-97c5-662c45169334
TCGA-BG-A3EW-11	MSI-H	0	TCGA-BG-A3EW-11	344	0										TCGA-BG-A3EW	344	0	344	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	62		0	TCGA-BG-A3EW-F39618		Stage III			-22705	24		0	344							2013-1-28	FEMALE	166	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	220	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true		12		1		0		0		0		100		0		0		0		TUMOR FREE		0	NO		Complete Remission/Response	No			YES				R0	Solid Tissue Normal	11	Minimally Invasive	2009		YES	NO	BG		2		9	Endometrial	A	LIVING	126	2011				a75c4597-041a-44ad-88e1-0466278f621c	TCGA-BG-A3EW-11A-22R-A22I-13					TCGA-BG-A3EW-11A-22D-A22B-05							a75c4597-041a-44ad-88e1-0466278f621c						a75c4597-041a-44ad-88e1-0466278f621c	TCGA-BG-A3EW-11A-22R-A22I-13	a75c4597-041a-44ad-88e1-0466278f621c
TCGA-BG-A3PP-01	MSS	0	TCGA-BG-A3PP-01	207	0	Squamous		UCEC Serous c4		UCEC-like c5		miRNA cluster 5			TCGA-BG-A3PP			207	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					82					Stage II			-30227	143		0	207							2012-7-2	FEMALE		Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	320	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	TCGA-BG-A3PP.728D12CF-B846-49B7-8B16-463460CAD5C0.pdf			2		0		5		0		15		0		80		70	positive	TUMOR FREE		0				No							R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	BG				3	Endometrial	A	LIVING		2011			TCGA-BG-A3PP-01	5ece050b-b22d-44b9-b920-257a351b5602	TCGA-BG-A3PP-01A-11R-A22I-13	TCGA-BG-A3PP-01A-11D-A227-01				TCGA-BG-A3PP-01A-11D-A22B-05				TCGA-BG-A3PP-01A-21-A23Z-20	6a35ca87-4e02-4b4b-8969-cf0b39d4f883	TCGA-BG-A3PP-01	5ece050b-b22d-44b9-b920-257a351b5602				6a35ca87-4e02-4b4b-8969-cf0b39d4f883	TCGA-BG-A3PP-01A-11D-A227-01	5ece050b-b22d-44b9-b920-257a351b5602	TCGA-BG-A3PP-01A-11R-A22I-13	5ece050b-b22d-44b9-b920-257a351b5602
TCGA-BG-A3PP-11	MSS	0	TCGA-BG-A3PP-11	207	0										TCGA-BG-A3PP			207	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					82					Stage II			-30227	143		0	207							2012-7-2	FEMALE		Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	190	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true				1		0		0		0		100		0		0		0	positive	TUMOR FREE		0				No							R0	Solid Tissue Normal	11	Minimally Invasive	2009		YES	NO	BG				3	Endometrial	A	LIVING		2011				02446b95-1e3f-474b-8123-f49117f58893	TCGA-BG-A3PP-11A-11R-A22I-13					TCGA-BG-A3PP-11A-11D-A22B-05							02446b95-1e3f-474b-8123-f49117f58893						02446b95-1e3f-474b-8123-f49117f58893	TCGA-BG-A3PP-11A-11R-A22I-13	02446b95-1e3f-474b-8123-f49117f58893
TCGA-BK-A0C9-01	MSI-H	0	TCGA-BK-A0C9-01	1092	0	BRCA-LUAD+	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 7	TCGA-BK-A0C9	1092	0	1092	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	57	0	0	TCGA-BK-A0C9-F41805	Never Used	Stage IB	NO		-20876	192		0	1092				NO			2013-3-28	FEMALE	168	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	490	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	TCGA-BK-A0C9.3E14F5F3-2C40-403F-A499-BE64857E8559.pdf	40	0	0	0	0	0	0	0	0	0	0	15	25	85	75	85	75	negative	TUMOR FREE	0	0	NO	0	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open		NO	YES	NO	BK	0	4	0	18	Endometrial	A	LIVING	127	2009	71ef8bce-4b04-4fba-9ae6-8c8f2b18b2c7	TCGA-BK-A0C9-01	TCGA-BK-A0C9-01			TCGA-BK-A0C9-01A-11D-A00X-01	TCGA-BK-A0C9-01	TCGA-BK-A0C9-01A-11D-A00U-05	71ef8bce-4b04-4fba-9ae6-8c8f2b18b2c7		fc84bd3f-bce6-41af-98d4-a4586b56f810	TCGA-BK-A0C9-01A-11R-A00W-13	TCGA-BK-A0C9-01A-11W-A027-09	TCGA-BK-A0C9-01A-21-A162-20	8990079d-caab-4d85-9905-7cc5db3cf152	TCGA-BK-A0C9-01		TCGA-BK-A0C9-01A-11W-A027-09	TCGA-BK-A0C9-01A-11R-A00V-07	TCGA-BK-A0C9-01A-11W-A027-09	8990079d-caab-4d85-9905-7cc5db3cf152	TCGA-BK-A0C9-01A-11D-A00X-01		TCGA-BK-A0C9-01A-11R-A00W-13	
TCGA-BK-A0CA-01	MSS	0	TCGA-BK-A0CA-01	1064	0	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 4	mutation cluster 4	TCGA-BK-A0CA	1064	0	1064	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	61		29	TCGA-BK-A0CA-F40261		Stage IIIC	NO		-22378	86		0	1064				NO	FPPP		2013-2-14	FEMALE	163	Mixed serous and endometrioid	No		YES	C54.1	8441/3	C54.1	YES		Cytology (e.g. Peritoneal or pleural fluid)	300	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-BK-A0CA.883D4832-75FB-495C-B93F-904FCA1AB18C.pdf		0	0	0	0	0	0	0	0	50	0	50	25	0	75	0	75	negative	TUMOR FREE		9	YES	1	Complete Remission/Response	No	Never Used	TCGA	NO				RX	Primary Tumor	01	Minimally Invasive		YES	YES	NO	BK	29	32	9	14	Endometrial	A	LIVING		2010	20f433c2-0909-4b42-9429-215774b19604		TCGA-BK-A0CA-01		TCGA-BK-A0CA-01A-21R-A27D-13,TCGA-BK-A0CA-01A-21R-A119-13,TCGA-BK-A0CA-01B-02R-A27D-13	TCGA-BK-A0CA-01A-21D-A120-01			20f433c2-0909-4b42-9429-215774b19604	TCGA-BK-A0CA-01A-21D-A27B-05,TCGA-BK-A0CA-01B-02D-A27B-05,TCGA-BK-A0CA-01A-21D-A123-05	30a62556-2260-4232-ba09-e3efca44ef7e		TCGA-BK-A0CA-01A-21D-A122-09	TCGA-BK-A0CA-01A-11-A162-20	b4e3a69e-a888-44bf-8223-e526e05e76cc,b938fd48-bdf6-4924-a85e-aac80a7b3af8,e488e03b-31e3-4e7f-87a4-6e30612add04	TCGA-BK-A0CA-01		TCGA-BK-A0CA-01A-21D-A122-09		TCGA-BK-A0CA-01A-21D-A122-09	b4e3a69e-a888-44bf-8223-e526e05e76cc,b938fd48-bdf6-4924-a85e-aac80a7b3af8,e488e03b-31e3-4e7f-87a4-6e30612add04	TCGA-BK-A0CA-01A-21D-A120-01		TCGA-BK-A0CA-01A-21R-A27D-13,TCGA-BK-A0CA-01A-21R-A119-13,TCGA-BK-A0CA-01B-02R-A27D-13	
TCGA-BK-A0CB-01	MSS	0	TCGA-BK-A0CB-01	189	0	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11			mutation cluster 4	TCGA-BK-A0CB			189	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					60	0	2	TCGA-BK-A0CB-F3361		Stage IIIC	NO		-21930	64		0	189				YES			2010-11-10	FEMALE	154	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Incisional Biopsy	450	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2						false	TCGA-BK-A0CB.37923E3D-3CCB-41DB-8F30-C19FDE7407CB.pdf	76	5	0	1	0	1	0	0	0	15	0	14	25	70	75	70	75	negative	TUMOR FREE	0	0		0	Complete Remission/Response	No			NO				R0	Primary Tumor	01	open		YES	YES	NO	BK	2	8	0	13	Endometrial	A	LIVING	111	2010	6b8a0d03-6a82-49ed-b3ee-66937dc06201		TCGA-BK-A0CB-01			TCGA-BK-A0CB-01A-32D-A102-01		TCGA-BK-A0CB-01A-32D-A10Q-05	6b8a0d03-6a82-49ed-b3ee-66937dc06201		248c77aa-3235-42dd-ae94-a1415f70ab72		TCGA-BK-A0CB-01A-32D-A10B-09	TCGA-BK-A0CB-01A-21-A162-20	998efc9a-dee1-45b0-a551-1a017103ea5c	TCGA-BK-A0CB-01		TCGA-BK-A0CB-01A-32D-A10B-09		TCGA-BK-A0CB-01A-32D-A10B-09	998efc9a-dee1-45b0-a551-1a017103ea5c	TCGA-BK-A0CB-01A-32D-A102-01			
TCGA-BK-A0CB-11	MSS	0	TCGA-BK-A0CB-11	189	0		C6-UCEC							mutation cluster 4	TCGA-BK-A0CB			189	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					60	0	2	TCGA-BK-A0CB-F3361		Stage IIIC	NO		-21930	64		0	189				YES			2010-11-10	FEMALE	154	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Incisional Biopsy	420	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2						false		76		5		0				0		100				0			negative	TUMOR FREE	0	0		0	Complete Remission/Response	No			NO				R0	Solid Tissue Normal	11	open		YES	YES	NO	BK	2	8	0	13	Endometrial	A	LIVING	111	2010	7865a23a-f7a6-43b0-b395-16c8306cea2f							TCGA-BK-A0CB-11A-33D-A10Q-05	7865a23a-f7a6-43b0-b395-16c8306cea2f			TCGA-BK-A0CB-11A-33R-A103-13												TCGA-BK-A0CB-11A-33R-A103-13	
TCGA-BK-A0CC-01	MSS	0	TCGA-BK-A0CC-01	311	0	High	C6-UCEC	UCEC Serous c4	cluster 3	OV-like c4	UCEC-like c11	miRNA cluster 14	cluster 2	mutation cluster 5	TCGA-BK-A0CC			311	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					69	0	0	TCGA-BK-A0CC-F5131		Stage IIIC	NO		-25479	52		0	311				YES	FPPP		2011-1-17	FEMALE	152	Serous endometrial adenocarcinoma	No		YES	C54.1	8441/3	C54.1	YES		Incisional Biopsy	310	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	TCGA-BK-A0CC.6A2AAC78-98B9-44D4-AF8D-9A132579CC2D.pdf	54	0	0	0	0	25	0	0	0	0	0	15	30	60	70	75	70	negative	TUMOR FREE	0	2		3	Complete Remission/Response	No	Never Used	TCGA	YES				RX	Primary Tumor	01	open		YES	YES	NO	BK	0	5	2	12	Endometrial	A	LIVING	72	2010	ac44efb2-7079-49a7-8bc6-285ae009ad89	TCGA-BK-A0CC-01	TCGA-BK-A0CC-01		TCGA-BK-A0CC-01A-21R-A27D-13,TCGA-BK-A0CC-01B-04R-A27D-13	TCGA-BK-A0CC-01A-21D-A00X-01	TCGA-BK-A0CC-01	TCGA-BK-A0CC-01A-21D-A00U-05	ac44efb2-7079-49a7-8bc6-285ae009ad89	TCGA-BK-A0CC-01A-21D-A27B-05,TCGA-BK-A0CC-01B-04D-A27B-05	d106bf3b-a21d-465d-873e-dd7478086913	TCGA-BK-A0CC-01A-21R-A00W-13	TCGA-BK-A0CC-01A-21W-A027-09	TCGA-BK-A0CC-01A-11-A162-20	60db069d-225d-4113-9ee2-9843e71e7fe0,7a52efc5-0d32-4147-a2a0-67576bb190b7,bb8680b9-5753-4ee4-8260-e9373fd4aaa7	TCGA-BK-A0CC-01		TCGA-BK-A0CC-01A-21W-A027-09	TCGA-BK-A0CC-01A-21R-A00V-07	TCGA-BK-A0CC-01A-21W-A027-09	60db069d-225d-4113-9ee2-9843e71e7fe0,7a52efc5-0d32-4147-a2a0-67576bb190b7,bb8680b9-5753-4ee4-8260-e9373fd4aaa7	TCGA-BK-A0CC-01A-21D-A00X-01		TCGA-BK-A0CC-01A-21R-A00W-13,TCGA-BK-A0CC-01A-21R-A27D-13,TCGA-BK-A0CC-01B-04R-A27D-13	
TCGA-BK-A139-01	MSS	0	TCGA-BK-A139-01	309	0	Squamous	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 2	mutation cluster 3	TCGA-BK-A139	309	0	309	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Stable Disease	74	0	0	TCGA-BK-A139-F13253		Stage IB	NO		-27077	175		0	309				NO	FPPP	Scheduled Follow-up Submission	2011-6-22	FEMALE	154	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	770	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-BK-A139.5F8C376B-31F8-4566-8EBF-21E7F4E6499D.pdf		50	20	20	10	60	20	50	20	0	0	10	20	30	60	90	80		TUMOR FREE	0	0		2	Stable Disease	No	Never Used	TCGA	NO				R0	Primary Tumor	01	Minimally Invasive		NO	YES	NO	BK	0	9	0	24	Endometrial	A	LIVING	59	2010	4b398b99-8916-440b-9ed5-9ed67db19b9b		TCGA-BK-A139-01		TCGA-BK-A139-01A-11R-A119-13,TCGA-BK-A139-01A-11R-A27D-13	TCGA-BK-A139-01A-11D-A120-01			4b398b99-8916-440b-9ed5-9ed67db19b9b	TCGA-BK-A139-01C-08D-A27B-05,TCGA-BK-A139-01A-11D-A123-05,TCGA-BK-A139-01A-11D-A27B-05	1260487b-9cf7-43e6-8b3a-ad1b7cc40dec		TCGA-BK-A139-01A-11D-A122-09	TCGA-BK-A139-01A-21-A163-20	256ea8d6-4586-479a-899a-0988acf58f68,2ef29d3d-8c10-41eb-8547-ed3ba852b890,e844a3bb-b90c-4109-89cd-44fb50d6d175	TCGA-BK-A139-01				TCGA-BK-A139-01A-11D-A122-09	256ea8d6-4586-479a-899a-0988acf58f68,2ef29d3d-8c10-41eb-8547-ed3ba852b890,e844a3bb-b90c-4109-89cd-44fb50d6d175	TCGA-BK-A139-01A-11D-A120-01		TCGA-BK-A139-01A-11R-A119-13,TCGA-BK-A139-01A-11R-A27D-13	
TCGA-BK-A139-02	MSS	0	TCGA-BK-A139-02	309	0		C6-UCEC							mutation cluster 3	TCGA-BK-A139	309	0	309	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Stable Disease	74	0	0	TCGA-BK-A139-F13253		Stage IB	NO		-27077	874		0	309				NO	FPPP	Scheduled Follow-up Submission	2011-6-22	FEMALE	154	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	430	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-BK-A139.FE6C557C-6F28-4F5C-B48C-E2A3BB7EF14F.pdf			3		0		20		0		40		0		40		65		TUMOR FREE	0	0		2	Stable Disease	No	Never Used	TCGA	NO				R0	Recurrent Tumor	02	Minimally Invasive		NO	YES	NO	BK	0	9	0	24	Endometrial	A	LIVING	59	2010				923217e0-602c-4cf7-b17a-37269d9371c4	TCGA-BK-A139-02A-11R-A27R-13					TCGA-BK-A139-02A-11D-A27Y-05					566ca050-688b-48d2-813a-fe1a753eabca		923217e0-602c-4cf7-b17a-37269d9371c4				566ca050-688b-48d2-813a-fe1a753eabca		923217e0-602c-4cf7-b17a-37269d9371c4	TCGA-BK-A139-02A-11R-A27R-13	923217e0-602c-4cf7-b17a-37269d9371c4
TCGA-BK-A13B-01	MSI-H	0	TCGA-BK-A13B-01	966	0	Iq		UCEC CIMP c18		UCEC-like c5		miRNA cluster 7			TCGA-BK-A13B	760	1	966	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	NO		Progressive Disease	58			TCGA-BK-A13B-F40746		Stage IB	NO		-21493			0	966			760	YES		Scheduled Follow-up Submission	2013-3-14	FEMALE	170	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy			NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Locoregional Recurrence	Vaginal	NO	YES																				negative	WITH TUMOR			NO	1	Complete Remission/Response	No	Never Used		YES	Other Method, Specify Below	Vaginal Biopsy			Primary Tumor	01		2009	NO	YES	NO	BK	0	10	0	15	Endometrial		LIVING	131	2010			TCGA-BK-A13B-01	ed2e8014-4042-45fe-ae9d-78606344955b	TCGA-BK-A13B-01A-51R-A22I-13	TCGA-BK-A13B-01A-51D-A227-01				TCGA-BK-A13B-01A-51D-A22B-05				TCGA-BK-A13B-01A-41-A23Z-20	d1024d00-c963-4115-ba4d-12d3de17e55d	TCGA-BK-A13B-01	ed2e8014-4042-45fe-ae9d-78606344955b				d1024d00-c963-4115-ba4d-12d3de17e55d	TCGA-BK-A13B-01A-51D-A227-01	ed2e8014-4042-45fe-ae9d-78606344955b	TCGA-BK-A13B-01A-51R-A22I-13	ed2e8014-4042-45fe-ae9d-78606344955b
TCGA-BK-A13C-01	MSS	0	TCGA-BK-A13C-01	760	0	Iq	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation c1uster 10	TCGA-BK-A13C	760	0	760	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	47	0	0	TCGA-BK-A13C-F40813		Stage IB	NO		-17317	146		0	760				NO		Scheduled Follow-up Submission	2013-3-1	FEMALE	166	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	310	NO	NO	Peri (6-12 months since last menstrual period)	G2					NO	false	TCGA-BK-A13C.2043D579-6785-4775-8A28-CDE3F1400BA2.pdf	17	10	20	0	10	10	20	0	20	10	10	0	10	80	60	90	80	negative	TUMOR FREE	0	0	NO	0	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive		NO	YES	NO	BK	0	5	0	25	Endometrial	A	LIVING	93	2010	a7dc4fdb-a62d-4d84-b351-16d84ab202e3		TCGA-BK-A13C-01		TCGA-BK-A13C-01A-11R-A119-13	TCGA-BK-A13C-01A-11D-A120-01			a7dc4fdb-a62d-4d84-b351-16d84ab202e3	TCGA-BK-A13C-01A-11D-A123-05	c833d378-9b97-4808-806e-a9dee1298ae3		TCGA-BK-A13C-01A-11D-A122-09	TCGA-BK-A13C-01A-21-A163-20	13f92a01-8a19-4f2e-82be-409d5ae4131e	TCGA-BK-A13C-01				TCGA-BK-A13C-01A-11D-A122-09	13f92a01-8a19-4f2e-82be-409d5ae4131e	TCGA-BK-A13C-01A-11D-A120-01		TCGA-BK-A13C-01A-11R-A119-13	
TCGA-BK-A13C-11	MSS	0	TCGA-BK-A13C-11	760	0		C6-UCEC							mutation c1uster 10	TCGA-BK-A13C	760	0	760	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	47	0	0	TCGA-BK-A13C-F40813		Stage IB	NO		-17317	146		0	760				NO		Scheduled Follow-up Submission	2013-3-1	FEMALE	166	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	270	NO	NO	Peri (6-12 months since last menstrual period)	G2					NO	false		17		10		0		0		0		100		0		0		0	negative	TUMOR FREE	0	0	NO	0	Complete Remission/Response	No	Never Used		NO				R0	Solid Tissue Normal	11	Minimally Invasive		NO	YES	NO	BK	0	5	0	25	Endometrial	A	LIVING	93	2010	a6ba27cf-7e06-4a44-a948-8575593272cb								a6ba27cf-7e06-4a44-a948-8575593272cb	TCGA-BK-A13C-11A-11D-A123-05															
TCGA-BK-A26L-01	MSS	0	TCGA-BK-A26L-01	734	0	Squamous	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 2		TCGA-BK-A26L	734	0	734	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	71	0	0	TCGA-BK-A26L-F40279	Former User	Stage IIIC1	NO		-26002	347		0	734				NO	FPPP	Scheduled Follow-up Submission	2013-2-15	FEMALE	152	Serous endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy		YES	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false		80	4	4	0	0	2	2	0	0	0	0	0	0	98	98	75	75	negative	TUMOR FREE	0	0	YES	3	Complete Remission/Response	No	Never Used	TCGA	YES				RX	Primary Tumor	01	Minimally Invasive	2009	YES	YES	NO	BK	0	3	1	10	Endometrial	C	LIVING	75	2010	80b16496-74bd-4fe7-967c-31058b2c022b		TCGA-BK-A26L-01		TCGA-BK-A26L-01A-11R-A16E-13,TCGA-BK-A26L-01C-04R-A27D-13,TCGA-BK-A26L-01A-11R-A27D-13	TCGA-BK-A26L-01A-11D-A16C-01			80b16496-74bd-4fe7-967c-31058b2c022b	TCGA-BK-A26L-01A-11D-A16G-05,TCGA-BK-A26L-01C-04D-A27B-05,TCGA-BK-A26L-01A-11D-A27B-05				TCGA-BK-A26L-01A-21-A18R-20	0a3da6e7-e5dd-4016-8637-987111d86c7c,1cf1c682-d68f-459c-ae71-925766e0e9c5,834f93d8-3dc3-4f3f-b0ff-3a39d874ddbe	TCGA-BK-A26L-01					0a3da6e7-e5dd-4016-8637-987111d86c7c,1cf1c682-d68f-459c-ae71-925766e0e9c5,834f93d8-3dc3-4f3f-b0ff-3a39d874ddbe	TCGA-BK-A26L-01A-11D-A16C-01		TCGA-BK-A26L-01A-11R-A16E-13,TCGA-BK-A26L-01C-04R-A27D-13,TCGA-BK-A26L-01A-11R-A27D-13	
TCGA-BK-A4ZD-01	MSS	0	TCGA-BK-A4ZD-01	506	0										TCGA-BK-A4ZD	506	0	506	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	42		0	TCGA-BK-A4ZD-F52698		Stage IA	NO		-15536	92		0	506				YES			2013-12-5	FEMALE	163	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	300	NO	NO	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3					NO	false	TCGA-BK-A4ZD.388C7674-9CA2-446C-A67D-9639A28ADEB4.pdf	25		3		0		0		0		0		0		100		75	negative	TUMOR FREE		0	NO	3	Complete Remission/Response	No			NO				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	BK	0	2	0	14	Endometrial	A	LIVING	142	2012			TCGA-BK-A4ZD-01	31bd06c7-98c1-4d2e-81ff-4e210e7bba75	TCGA-BK-A4ZD-01A-11R-A27R-13	TCGA-BK-A4ZD-01A-11D-A27O-01				TCGA-BK-A4ZD-01A-11D-A27Y-05					631fb5a3-e799-40eb-8484-0b70bbd58006	TCGA-BK-A4ZD-01	31bd06c7-98c1-4d2e-81ff-4e210e7bba75				631fb5a3-e799-40eb-8484-0b70bbd58006	TCGA-BK-A4ZD-01A-11D-A27O-01	31bd06c7-98c1-4d2e-81ff-4e210e7bba75	TCGA-BK-A4ZD-01A-11R-A27R-13	31bd06c7-98c1-4d2e-81ff-4e210e7bba75
TCGA-BK-A4ZD-11	MSS	0	TCGA-BK-A4ZD-11	506	0										TCGA-BK-A4ZD	506	0	506	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	42		0	TCGA-BK-A4ZD-F52698		Stage IA	NO		-15536	92		0	506				YES			2013-12-5	FEMALE	163	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	210	NO	NO	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3					NO	false		25		2		0		0		0		100		0		0		0	negative	TUMOR FREE		0	NO	3	Complete Remission/Response	No			NO				R0	Solid Tissue Normal	11	Minimally Invasive	2009		YES	NO	BK	0	2	0	14	Endometrial	A	LIVING	142	2012				babe74ee-b0dc-41c3-9968-2faac94addf2	TCGA-BK-A4ZD-11A-12R-A27R-13					TCGA-BK-A4ZD-11A-12D-A27Y-05							babe74ee-b0dc-41c3-9968-2faac94addf2						babe74ee-b0dc-41c3-9968-2faac94addf2	TCGA-BK-A4ZD-11A-12R-A27R-13	babe74ee-b0dc-41c3-9968-2faac94addf2
TCGA-BK-A56F-01	MSS	0	TCGA-BK-A56F-01	401	0										TCGA-BK-A56F	401	0	401	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	75			TCGA-BK-A56F-F49745		Stage IB	NO		-27523	93		0	401				YES			2013-10-10	FEMALE	163	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	360	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	TCGA-BK-A56F.2778F3EE-0211-4B51-8FBE-050FC7A4D0FF.pdf	60		3		0		10		0		0		0		90		60	negative	TUMOR FREE			NO	4+	Complete Remission/Response	No			YES				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	BK	0	3	0	10	Endometrial	A	LIVING	84	2012			TCGA-BK-A56F-01	5d83ceb3-a3f0-419e-945a-a5cf49d439e9	TCGA-BK-A56F-01A-32R-A27R-13	TCGA-BK-A56F-01A-32D-A27O-01				TCGA-BK-A56F-01A-32D-A27Y-05					4600d3ec-c67f-4b6e-9d26-eb1fd9efd534	TCGA-BK-A56F-01	5d83ceb3-a3f0-419e-945a-a5cf49d439e9				4600d3ec-c67f-4b6e-9d26-eb1fd9efd534	TCGA-BK-A56F-01A-32D-A27O-01	5d83ceb3-a3f0-419e-945a-a5cf49d439e9	TCGA-BK-A56F-01A-32R-A27R-13	5d83ceb3-a3f0-419e-945a-a5cf49d439e9
TCGA-BK-A6W3-01	MSS	0	TCGA-BK-A6W3-01	305	0										TCGA-BK-A6W3	305	0	305	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	34			TCGA-BK-A6W3-F57503		Stage II	NO		-12590			0	305				NO			2014-3-12	FEMALE	167	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy			NO	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2					NO																				negative	TUMOR FREE			NO	3	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01		2009		YES	NO	BK		0		0	Endometrial		LIVING	89	2013			TCGA-BK-A6W3-01	abec519f-1747-400d-944d-7e53d12d6dea	TCGA-BK-A6W3-01A-12R-A34O-13	TCGA-BK-A6W3-01A-12D-A34P-01				TCGA-BK-A6W3-01A-12D-A34S-05					be5262d0-52cc-41f1-b89a-156aa7d35675	TCGA-BK-A6W3-01	abec519f-1747-400d-944d-7e53d12d6dea				be5262d0-52cc-41f1-b89a-156aa7d35675	TCGA-BK-A6W3-01A-12D-A34P-01	abec519f-1747-400d-944d-7e53d12d6dea	TCGA-BK-A6W3-01A-12R-A34O-13	abec519f-1747-400d-944d-7e53d12d6dea
TCGA-BK-A6W4-01	MSS	0	TCGA-BK-A6W4-01	300	0										TCGA-BK-A6W4	300	0	300	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	62			TCGA-BK-A6W4-F57489		Stage IA	NO		-22766	118		0	300				YES			2014-3-12	FEMALE	157	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	180	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	TCGA-BK-A6W4.5F25185F-4F80-4137-A07C-230FB3ACE3AE.pdf	32		5		2		0		2		15		10		75		75		TUMOR FREE			NO	4+	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01		2009		YES	NO	BK		0		0	Endometrial	A	LIVING	107	2013			TCGA-BK-A6W4-01	1073a603-5546-48b8-b6aa-9a16f909547b	TCGA-BK-A6W4-01A-12R-A34O-13	TCGA-BK-A6W4-01A-12D-A34P-01				TCGA-BK-A6W4-01A-12D-A34S-05					a49de896-e6c9-43b3-8d28-acec57a77bfc	TCGA-BK-A6W4-01	1073a603-5546-48b8-b6aa-9a16f909547b				a49de896-e6c9-43b3-8d28-acec57a77bfc	TCGA-BK-A6W4-01A-12D-A34P-01	1073a603-5546-48b8-b6aa-9a16f909547b	TCGA-BK-A6W4-01A-12R-A34O-13	1073a603-5546-48b8-b6aa-9a16f909547b
TCGA-BS-A0T9-01	MSS	1	TCGA-BS-A0T9-01	1428	1	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 2	mutation cluster 4	TCGA-BS-A0T9			1428	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	YES	YES	Progressive Disease	39	0	0	TCGA-BS-A0T9-F9188	Never Used	Stage IVB	NO	922	-14253	2009	1428	0				634	NO			2010-11-19	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Tumor resection	600	NO		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3						false	TCGA-BS-A0T9.C9151621-D012-48F9-B7E1-F540567E791C.pdf	67	40	40	10	5	5	15	30	20	0	0	15	15	80	70	80	70	positive	WITH TUMOR	0	0		0	Complete Remission/Response	No	Never Used		NO	Surgical Resection		R2	R2	Primary Tumor	01	open	1988	YES	NO	YES	BS	1	2	2	2	Endometrial	A	DECEASED	109	2005	8947d611-8c3f-4096-9479-063660ee8607		TCGA-BS-A0T9-01		TCGA-BS-A0T9-01A-11R-A12H-13	TCGA-BS-A0T9-01A-11D-A12G-01			8947d611-8c3f-4096-9479-063660ee8607	TCGA-BS-A0T9-01A-11D-A12K-05	ba865e56-ef20-4543-ae3b-465967c47508		TCGA-BS-A0T9-01A-11D-A12J-09	TCGA-BS-A0T9-01A-21-A163-20	cc851a47-e25e-4d55-9a63-1aa15cb096d5	TCGA-BS-A0T9-01		TCGA-BS-A0T9-01A-11D-A12J-09		TCGA-BS-A0T9-01A-11D-A12J-09	cc851a47-e25e-4d55-9a63-1aa15cb096d5	TCGA-BS-A0T9-01A-11D-A12G-01		TCGA-BS-A0T9-01A-11R-A12H-13	
TCGA-BS-A0TA-01	MSI-H	0	TCGA-BS-A0TA-01	714	0	Quiet	C6-UCEC	UCEC CIMP c18	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 4	cluster 2	mutation c1uster 10	TCGA-BS-A0TA			714	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	YES	NO	Progressive Disease	58	0	0	TCGA-BS-A0TA-F4422	Never Used	Stage IVB	NO		-21505	1788		0	714			394	YES			2010-11-19	FEMALE	152	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Fine needle aspiration biopsy	300	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	TCGA-BS-A0TA.5F009A9A-549F-4EEB-BB6D-C67353C7A292.pdf	88	40	50	20	30	5	5	30	40	0	0	5	10	90	85	90	85	negative	WITH TUMOR	0	0		0	Stable Disease	No	Never Used		YES				RX	Primary Tumor	01	open	1988	YES	NO	YES	BS	1	1	2	14	Endometrial	A	LIVING	90	2005	c1621135-fa9b-4043-8168-356402d45f01		TCGA-BS-A0TA-01			TCGA-BS-A0TA-01A-11D-A102-01		TCGA-BS-A0TA-01A-11D-A10Q-05	c1621135-fa9b-4043-8168-356402d45f01		9553c69b-1fb7-4d93-9b62-19e9a7ae9c62	TCGA-BS-A0TA-01A-11R-A103-13	TCGA-BS-A0TA-01A-11D-A10B-09	TCGA-BS-A0TA-01A-21-A163-20	a8f954fc-1ddf-4b0c-b30b-4ecc02c3b744	TCGA-BS-A0TA-01		TCGA-BS-A0TA-01A-11D-A10B-09		TCGA-BS-A0TA-01A-11D-A10B-09	a8f954fc-1ddf-4b0c-b30b-4ecc02c3b744	TCGA-BS-A0TA-01A-11D-A102-01		TCGA-BS-A0TA-01A-11R-A103-13	
TCGA-BS-A0TC-01	MSS	0	TCGA-BS-A0TC-01	2602	0	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 11	TCGA-BS-A0TC			2602	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					69	0	0	TCGA-BS-A0TC-F4391	Never Used	Stage IB	NO		-25560	2227		0	2602				YES			2010-11-19	FEMALE	147	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.3	8380/3	C54.1	YES		Office Endometrial Biopsy	120	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1						false	TCGA-BS-A0TC.8AA64402-A062-410D-85B8-24DAD320916D.pdf	9	20	50	0	10	0	0	5	20	0	0	10	10	90	90	90	90	negative	TUMOR FREE	0	0		4+	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	BS	0	03	0	20	Endometrial	A	LIVING	68	2004	0b2aa3d5-f8cd-4047-91cf-295e6b4c8891		TCGA-BS-A0TC-01			TCGA-BS-A0TC-01A-11D-A102-01		TCGA-BS-A0TC-01A-11D-A10Q-05	0b2aa3d5-f8cd-4047-91cf-295e6b4c8891		5f9c0254-8925-4a04-a019-c001594ff615	TCGA-BS-A0TC-01A-11R-A103-13	TCGA-BS-A0TC-01A-11D-A10B-09	TCGA-BS-A0TC-01A-21-A163-20	14be6109-a70f-4096-a0cc-d574028cff65	TCGA-BS-A0TC-01				TCGA-BS-A0TC-01A-11D-A10B-09	14be6109-a70f-4096-a0cc-d574028cff65	TCGA-BS-A0TC-01A-11D-A102-01		TCGA-BS-A0TC-01A-11R-A103-13	
TCGA-BS-A0TD-01	MSS	0	TCGA-BS-A0TD-01	2379	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 2	mutation cluster 4	TCGA-BS-A0TD			2379	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					65			TCGA-BS-A0TD-F4393	Former User	Stage IB	NO		-23950	2004		0	2379				YES			2010-11-19	FEMALE	155	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.9	8380/3	C54.1	YES		Tumor resection	150	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1						false	TCGA-BS-A0TD.51ABEFF0-EEA1-48CA-9E00-CC57D1A2DEB0.pdf	3	40	40	20	10	5	0	20	20	0	0	15	20	80	80	80	80	negative	TUMOR FREE	0	0		2	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	BS		0	0	13	Endometrial	A	LIVING	85	2005	ca81a393-ec7d-4538-a64a-417ed188a320		TCGA-BS-A0TD-01			TCGA-BS-A0TD-01A-11D-A102-01		TCGA-BS-A0TD-01A-11D-A10Q-05	ca81a393-ec7d-4538-a64a-417ed188a320		930aab77-0151-4616-8e43-674b780895e3	TCGA-BS-A0TD-01A-11R-A103-13	TCGA-BS-A0TD-01A-11D-A10B-09	TCGA-BS-A0TD-01A-21-A163-20	86430c4d-95c8-4346-8ed5-8d10b68113aa	TCGA-BS-A0TD-01		TCGA-BS-A0TD-01A-11D-A10B-09		TCGA-BS-A0TD-01A-11D-A10B-09	86430c4d-95c8-4346-8ed5-8d10b68113aa	TCGA-BS-A0TD-01A-11D-A102-01		TCGA-BS-A0TD-01A-11R-A103-13	
TCGA-BS-A0TE-01	MSI-H	1	TCGA-BS-A0TE-01	146	1	High	C1-LUAD-enriched	Cluster 5	cluster 3		COADREAD-like c15	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-BS-A0TE			146	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	YES	NO	Progressive Disease	35			TCGA-BS-A0TE-F4407	Former User	Stage IVB	NO		-12983	1835	146	0				58	NO			2010-11-19	FEMALE	168	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.9	8380/3	C54.1	YES	biopsy of cervical tissue	Other method, specify:	50	NO		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3						false	TCGA-BS-A0TE.8FD57BC9-19A1-4427-B68F-3E58639FEA40.pdf	100	40	40	20	20	10	10	30	30	0	0	5	10	85	80	85	80	positive	WITH TUMOR	4	0		1	Progressive Disease	No	Never Used		NO				R2	Primary Tumor	01	open	1988	YES	NO	YES	BS		0	0	6	Endometrial	A	DECEASED	91	2005	8edc23c4-43f8-4dd3-8c40-257297393492		TCGA-BS-A0TE-01			TCGA-BS-A0TE-01A-11D-A102-01		TCGA-BS-A0TE-01A-11D-A10Q-05	8edc23c4-43f8-4dd3-8c40-257297393492			TCGA-BS-A0TE-01A-11R-A103-13	TCGA-BS-A0TE-01A-11D-A10B-09		a0f910d2-657e-4458-9ebd-047c2ff4646a	TCGA-BS-A0TE-01		TCGA-BS-A0TE-01A-11D-A10B-09		TCGA-BS-A0TE-01A-11D-A10B-09	a0f910d2-657e-4458-9ebd-047c2ff4646a	TCGA-BS-A0TE-01A-11D-A102-01		TCGA-BS-A0TE-01A-11R-A103-13	
TCGA-BS-A0TG-01	MSS	0	TCGA-BS-A0TG-01	2371	0	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4	squamous c3	UCEC-like c11	miRNA cluster 13	cluster 2	mutation cluster 1	TCGA-BS-A0TG			2371	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					60	0	0	TCGA-BS-A0TG-F4395	Former User	Stage IIIA	NO		-22043	1996		0	2371				NO			2010-11-19	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	270	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2						false	TCGA-BS-A0TG.7A7B4B4B-5EE2-4D8D-A90A-DDFB96AE49A8.pdf	40	10	0	0	0	20	0	0	0	10	0	0	20	70	80	100	70	positive	WITH TUMOR	0	0		3	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	1988	NO	NO	YES	BS	0	1	0	07	Endometrial	A	LIVING	64	2005	5fcefe73-6ed0-42f2-beda-3afc67aba867		TCGA-BS-A0TG-01			TCGA-BS-A0TG-01A-32D-A102-01		TCGA-BS-A0TG-01A-32D-A10Q-05	5fcefe73-6ed0-42f2-beda-3afc67aba867		70de1bc1-f8a6-49a4-b2b2-22905d8c2a48	TCGA-BS-A0TG-01A-32R-A103-13	TCGA-BS-A0TG-01A-32D-A10B-09	TCGA-BS-A0TG-01A-21-A163-20	b6d7ce8b-701a-4b75-aea8-db61ef72168d	TCGA-BS-A0TG-01		TCGA-BS-A0TG-01A-32D-A10B-09		TCGA-BS-A0TG-01A-32D-A10B-09	b6d7ce8b-701a-4b75-aea8-db61ef72168d	TCGA-BS-A0TG-01A-32D-A102-01		TCGA-BS-A0TG-01A-32R-A103-13	
TCGA-BS-A0TI-01	MSS	0	TCGA-BS-A0TI-01	1882	0	High	C6-UCEC	UCEC Serous c4	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 1	mutation cluster 5	TCGA-BS-A0TI			1882	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					64	0	0	TCGA-BS-A0TI-F4406	Former User	Stage IC	NO		-23705	1507		0	1882				NO			2010-11-19	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	250	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	TCGA-BS-A0TI.60212550-2757-4AB0-B778-723AE046F6BE.pdf	92	0	0	0	0	0	0	0	0	0	0	0	0	100	100	98	98	negative	TUMOR FREE	0	0		0	Complete Remission/Response	No			NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	BS	0	4	0	14	Endometrial	A	LIVING	59	2006	4fefb750-f793-4c1f-92cc-bd8fd9998cc6		TCGA-BS-A0TI-01			TCGA-BS-A0TI-01A-11D-A102-01		TCGA-BS-A0TI-01A-11D-A10Q-05	4fefb750-f793-4c1f-92cc-bd8fd9998cc6		03d002a0-05de-4b9b-99b9-0dd455e3bad7	TCGA-BS-A0TI-01A-11R-A103-13	TCGA-BS-A0TI-01A-11D-A10B-09	TCGA-BS-A0TI-01A-21-A163-20	d631ccd7-7f32-49ff-8d94-071ea56ae0e8	TCGA-BS-A0TI-01		TCGA-BS-A0TI-01A-11D-A10B-09		TCGA-BS-A0TI-01A-11D-A10B-09	d631ccd7-7f32-49ff-8d94-071ea56ae0e8	TCGA-BS-A0TI-01A-11D-A102-01		TCGA-BS-A0TI-01A-11R-A103-13	
TCGA-BS-A0TJ-01	MSI-H	0	TCGA-BS-A0TJ-01	2068	0	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5	mutation cluster 1	TCGA-BS-A0TJ			2068	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					59	0	0	TCGA-BS-A0TJ-F4441	Former User	Stage IC	NO		-21663	1431		0	2068				NO			2010-11-19	FEMALE	152	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	270	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	TCGA-BS-A0TJ.17D921D9-F2ED-4F8E-8C6F-729C9A0FE5B0.pdf	58	1	1	1	0	0	2	1	0	0	0	10	2	90	96	90	96	negative	TUMOR FREE	0	0		3	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	1988	NO	NO	YES	BS	0	9	0	34	Endometrial	A	LIVING	88	2006	3ecbfdb2-c75a-47ce-9db6-ae7d36eab559		TCGA-BS-A0TJ-01			TCGA-BS-A0TJ-01A-11D-A102-01		TCGA-BS-A0TJ-01A-11D-A10Q-05	3ecbfdb2-c75a-47ce-9db6-ae7d36eab559		6da84eaf-5e8e-48c1-b7d2-bc98eb76e31a	TCGA-BS-A0TJ-01A-11R-A103-13	TCGA-BS-A0TJ-01A-11D-A10B-09	TCGA-BS-A0TJ-01A-21-A163-20	e6d13c68-deb5-4f15-aa75-fdaa957e30de	TCGA-BS-A0TJ-01		TCGA-BS-A0TJ-01A-11D-A10B-09		TCGA-BS-A0TJ-01A-11D-A10B-09	e6d13c68-deb5-4f15-aa75-fdaa957e30de	TCGA-BS-A0TJ-01A-11D-A102-01		TCGA-BS-A0TJ-01A-11R-A103-13	
TCGA-BS-A0U5-01	MSS	0	TCGA-BS-A0U5-01	2935	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4		UCEC-like c11	miRNA cluster 12	cluster 2	mutation cluster 4	TCGA-BS-A0U5	2935	0	2935	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					76	0	0	TCGA-BS-A0U5-F16697		Stage IA	NO		-27945	2525		0	2935				NO		Scheduled Follow-up Submission	2011-3-25	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	Yes, I am currently taking menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	110	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	TCGA-BS-A0U5.8024498D-449C-45C6-B57D-846DDBA3FF30.pdf	0	30	0	40	0	0	0	20	0	0	0	30	10	70	90	70	80		TUMOR FREE	0	0			Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	BS	0	1	0	10	Endometrial	A	LIVING	59	2003	2bb7d230-0982-4ce5-908a-a04064cb7665		TCGA-BS-A0U5-01			TCGA-BS-A0U5-01A-11D-A107-01			2bb7d230-0982-4ce5-908a-a04064cb7665	TCGA-BS-A0U5-01A-11D-A10A-05		TCGA-BS-A0U5-01A-11R-A108-13	TCGA-BS-A0U5-01A-11D-A10G-09		7410789b-e593-4282-9182-4aed03770eb6	TCGA-BS-A0U5-01		TCGA-BS-A0U5-01A-11D-A10G-09		TCGA-BS-A0U5-01A-11D-A10G-09	7410789b-e593-4282-9182-4aed03770eb6	TCGA-BS-A0U5-01A-11D-A107-01		TCGA-BS-A0U5-01A-11R-A108-13	
TCGA-BS-A0U7-01	MSI-L	1	TCGA-BS-A0U7-01	935	1	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 2	mutation cluster 14	TCGA-BS-A0U7	935	0	935	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					63	0	0	TCGA-BS-A0U7-F16698		Stage IC	NO		-23166	2466	935	0					NO		Scheduled Follow-up Submission	2011-3-25	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	190	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	TCGA-BS-A0U7.BE83021F-D4D5-4ECA-8484-8A37B2FE67C0.pdf	51	30	30	10	20	5	5	40	40	0	0	15	15	80	80	80	80		TUMOR FREE	0	0		0	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	BS	0	14	0	13	Endometrial	A	DECEASED	66	2003	cf1bf8d7-3971-4919-93ef-2ef85b3dc61d		TCGA-BS-A0U7-01			TCGA-BS-A0U7-01A-21D-A102-01		TCGA-BS-A0U7-01A-21D-A10Q-05	cf1bf8d7-3971-4919-93ef-2ef85b3dc61d		d35aaf56-a418-4154-bf07-5e0f655276d1	TCGA-BS-A0U7-01A-21R-A103-13	TCGA-BS-A0U7-01A-21D-A10B-09	TCGA-BS-A0U7-01A-11-A163-20	1db89f55-5e5b-4eef-9748-f1c939ccfbf0	TCGA-BS-A0U7-01		TCGA-BS-A0U7-01A-21D-A10B-09		TCGA-BS-A0U7-01A-21D-A10B-09	1db89f55-5e5b-4eef-9748-f1c939ccfbf0	TCGA-BS-A0U7-01A-21D-A102-01		TCGA-BS-A0U7-01A-21R-A103-13	
TCGA-BS-A0U8-01	MSI-H	0	TCGA-BS-A0U8-01	2963	0	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 12	TCGA-BS-A0U8	2963	0	2963	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					55	0	0	TCGA-BS-A0U8-F16703		Stage IIIC	NO		-20402	2432		0	2963				NO		Scheduled Follow-up Submission	2011-3-25	FEMALE	170	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	190	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	TCGA-BS-A0U8.EAE30BBB-B895-42B9-8AAB-937278A3EBB0.pdf	100	40	30	10	20	0	5	30	40	0	0	20	15	80	80	80	80	negative	TUMOR FREE	0	0		0	Complete Remission/Response	No	Never Used		YES					Primary Tumor	01	open	1988	YES	NO	YES	BS	0	1	3	4	Endometrial	A	LIVING	82	2004	6fc8c938-15ec-452d-9cf7-16b97e0a2c8f		TCGA-BS-A0U8-01			TCGA-BS-A0U8-01A-11D-A102-01		TCGA-BS-A0U8-01A-11D-A10Q-05	6fc8c938-15ec-452d-9cf7-16b97e0a2c8f		0a9a4e64-690f-4d6d-aa72-633b924e0adf	TCGA-BS-A0U8-01A-11R-A103-13	TCGA-BS-A0U8-01A-11D-A10B-09	TCGA-BS-A0U8-01A-21-A163-20	c20535da-6a2e-4d50-ab40-07a0ad66ce4d	TCGA-BS-A0U8-01		TCGA-BS-A0U8-01A-11D-A10B-09		TCGA-BS-A0U8-01A-11D-A10B-09	c20535da-6a2e-4d50-ab40-07a0ad66ce4d	TCGA-BS-A0U8-01A-11D-A102-01		TCGA-BS-A0U8-01A-11R-A103-13	
TCGA-BS-A0U9-01	MSS	0	TCGA-BS-A0U9-01	2044	0	High	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5	mutation cluster 3	TCGA-BS-A0U9	2044	0	2044	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					59	0	0	TCGA-BS-A0U9-F17011	Never Used	Stage IIA	NO		-21580			0	2044				YES		Scheduled Follow-up Submission	2011-3-28	FEMALE	170	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Cytology (e.g. Peritoneal or pleural fluid)				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO			5																	negative	TUMOR FREE	0	0		4+	Complete Remission/Response	No	Never Used		NO				RX	Primary Tumor	01	open	1988	NO	NO	YES	BS	0	3	0	34	Endometrial		LIVING	99	2006	b280c179-336d-4638-9309-0f51426f8054		TCGA-BS-A0U9-01			TCGA-BS-A0U9-01B-21D-A10L-01			b280c179-336d-4638-9309-0f51426f8054	TCGA-BS-A0U9-01B-21D-A10N-05	f2d7c005-5ab3-44ec-954f-d0cdfb98c51f	TCGA-BS-A0U9-01B-21R-A10I-13	TCGA-BS-A0U9-01B-21D-A10M-09	TCGA-BS-A0U9-01B-11-A163-20	e17cff3b-72d9-4e46-8c9b-fddc81452f6c	TCGA-BS-A0U9-01		TCGA-BS-A0U9-01B-21D-A10M-09		TCGA-BS-A0U9-01B-21D-A10M-09	e17cff3b-72d9-4e46-8c9b-fddc81452f6c	TCGA-BS-A0U9-01B-21D-A10L-01		TCGA-BS-A0U9-01B-21R-A10I-13	
TCGA-BS-A0UA-01	MSI-H	0	TCGA-BS-A0UA-01	2687	0	Quiet	C6-UCEC	UCEC CIMP c18	cluster 2		UCEC-like c11	miRNA cluster 13	cluster 1	mutation cluster 4	TCGA-BS-A0UA	520	1	2687	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	NO	YES	NO		68			TCGA-BS-A0UA-F16708		Stage IB	NO		-24872	2361		0	2687			520	NO		Scheduled Follow-up Submission	2011-3-25	FEMALE	152	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	50	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1	Other, specify	Locoregional Disease	endometrium		YES	false	TCGA-BS-A0UA.58DC7332-5100-408B-9A1E-F0282B013648.pdf	26	0	0	0	20	0	0	0	0	10	0	40	10	50	90	50	100	negative	TUMOR FREE				1	Complete Remission/Response	No	Never Used		NO	Other Method, Specify Below	right vaginal cuff biopsy		R0	Primary Tumor	01	open	1988	NO	NO	YES	BS		0		0	Endometrial	A	LIVING	64	2004	97ffaeb2-3ff9-41ff-9552-27f622469460		TCGA-BS-A0UA-01		TCGA-BS-A0UA-01A-11R-A119-13	TCGA-BS-A0UA-01A-11D-A120-01			97ffaeb2-3ff9-41ff-9552-27f622469460	TCGA-BS-A0UA-01A-11D-A123-05			TCGA-BS-A0UA-01A-11D-A122-09		1d98d549-8481-42e9-9313-5da4ebf50635	TCGA-BS-A0UA-01				TCGA-BS-A0UA-01A-11D-A122-09	1d98d549-8481-42e9-9313-5da4ebf50635	TCGA-BS-A0UA-01A-11D-A120-01		TCGA-BS-A0UA-01A-11R-A119-13	
TCGA-BS-A0UF-01	MSS	0	TCGA-BS-A0UF-01	2611	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 1	mutation cluster 11	TCGA-BS-A0UF	2611	0	2611	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					65	0	0	TCGA-BS-A0UF-F16712	Never Used	Stage IB	NO		-23771	2285		0	2611				NO		Scheduled Follow-up Submission	2011-3-28	FEMALE	147	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	270	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-BS-A0UF.719E2A48-0E04-4EAD-A5CC-6416450FC68F.pdf	30	3	6	0	0	10	10	0	0	0	0	8	10	82	80	92	90	negative	TUMOR FREE	0	0		3	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	BS	0	4	0	9	Endometrial	A	LIVING	57	2004	2ae9f382-fd01-4707-8dae-3ec3c527a226		TCGA-BS-A0UF-01			TCGA-BS-A0UF-01A-11D-A102-01		TCGA-BS-A0UF-01A-11D-A10Q-05	2ae9f382-fd01-4707-8dae-3ec3c527a226		27e906a3-706b-43a0-b6b4-46a029c7ab11	TCGA-BS-A0UF-01A-11R-A103-13	TCGA-BS-A0UF-01A-11D-A10B-09	TCGA-BS-A0UF-01A-21-A163-20	a4b835d0-da5e-4351-8355-b0268bc25c0a	TCGA-BS-A0UF-01				TCGA-BS-A0UF-01A-11D-A10B-09	a4b835d0-da5e-4351-8355-b0268bc25c0a	TCGA-BS-A0UF-01A-11D-A102-01		TCGA-BS-A0UF-01A-11R-A103-13	
TCGA-BS-A0UJ-01	MSI-H	0	TCGA-BS-A0UJ-01	2506	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 11	TCGA-BS-A0UJ	2506	0	2506	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					68			TCGA-BS-A0UJ-F16700		Stage IA	NO		-25149	2180		0	2506				YES		Scheduled Follow-up Submission	2011-3-25	FEMALE	155	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	160	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	TCGA-BS-A0UJ.DEE9AA2E-DA73-4074-9588-C75DDEC4D29B.pdf	0	0	0	0	0	0	0	0	0	0	0	0	0	100	100	85	85	negative	TUMOR FREE				4+	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	BS		0		0	Endometrial	A	LIVING	52	2004	835f4f9a-3c90-45d5-809c-6b4316a972b9		TCGA-BS-A0UJ-01			TCGA-BS-A0UJ-01A-12D-A102-01		TCGA-BS-A0UJ-01A-12D-A10Q-05	835f4f9a-3c90-45d5-809c-6b4316a972b9		8b861700-dd5c-42de-ad5c-357ce568b427	TCGA-BS-A0UJ-01A-12R-A103-13	TCGA-BS-A0UJ-01A-12D-A10B-09	TCGA-BS-A0UJ-01A-21-A163-20	96a1ee2e-f682-40ca-bc29-7bb899861843	TCGA-BS-A0UJ-01				TCGA-BS-A0UJ-01A-12D-A10B-09	96a1ee2e-f682-40ca-bc29-7bb899861843	TCGA-BS-A0UJ-01A-12D-A102-01		TCGA-BS-A0UJ-01A-12R-A103-13	
TCGA-BS-A0UL-01	MSI-H	0	TCGA-BS-A0UL-01	2481	0	Quiet	C6-UCEC	UCEC CIMP c18	cluster 2		UCEC-like c11	miRNA cluster 13	cluster 4	mutation cluster 1	TCGA-BS-A0UL	2481	0	2481	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					54			TCGA-BS-A0UL-F16702		Stage IA	NO		-19982	2155		0	2481				YES		Scheduled Follow-up Submission	2011-3-25	FEMALE	170	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	70	NO		Peri (6-12 months since last menstrual period)	G1					NO	false	TCGA-BS-A0UL.323FC36E-D8E3-4F6B-A8FE-2040F3E44BB9.pdf	0	0	0	0	0	0	0	0	0	0	0	25	0	75	100	70	75	negative	TUMOR FREE				2	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	BS		0		0	Endometrial	A	LIVING	114	2004	954c9805-885f-481a-9dac-024d4481256b		TCGA-BS-A0UL-01			TCGA-BS-A0UL-01A-11D-A107-01			954c9805-885f-481a-9dac-024d4481256b	TCGA-BS-A0UL-01A-11D-A10A-05		TCGA-BS-A0UL-01A-11R-A108-13	TCGA-BS-A0UL-01A-11D-A10G-09		53c85f93-6635-4e27-9c32-be3d1faea1d4	TCGA-BS-A0UL-01		TCGA-BS-A0UL-01A-11D-A10G-09		TCGA-BS-A0UL-01A-11D-A10G-09	53c85f93-6635-4e27-9c32-be3d1faea1d4	TCGA-BS-A0UL-01A-11D-A107-01		TCGA-BS-A0UL-01A-11R-A108-13	
TCGA-BS-A0UM-01	MSI-H	0	TCGA-BS-A0UM-01	2644	0			UCEC CIMP c18	cluster 1		UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 1	TCGA-BS-A0UM	1454	1	2644	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	YES	NO		64	0	0	TCGA-BS-A0UM-F17016		Stage IB	NO		-23400	2072		0	2644			1454	NO		Scheduled Follow-up Submission	2011-3-25	FEMALE	160	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	90	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1	Brain	Metastatic			YES	false	TCGA-BS-A0UM.97354B28-9E9A-4DBD-B0C7-79C1165AD1CA.pdf	22	0	0	0	0	0	0	0	0	0	0	10	0	90	100	70	75	negative	WITH TUMOR	0	0		2	Complete Remission/Response	No	Never Used		NO	Other Method, Specify Below	lef lung biopsy		R0	Primary Tumor	01	open	1988	NO	NO	YES	BS	0	4	0	5	Endometrial	A	LIVING	90	2005	40c2c93a-81a9-4baa-91b3-3c950042475a							TCGA-BS-A0UM-01A-11D-A10Q-05	40c2c93a-81a9-4baa-91b3-3c950042475a			TCGA-BS-A0UM-01A-11R-A103-13	TCGA-BS-A0UM-01A-11W-A10C-09			TCGA-BS-A0UM-01		TCGA-BS-A0UM-01A-11W-A10C-09		TCGA-BS-A0UM-01A-11W-A10C-09				TCGA-BS-A0UM-01A-11R-A103-13	
TCGA-BS-A0UT-01	MSS	0	TCGA-BS-A0UT-01	2212	0	High	C6-UCEC	UCEC non-CIMP c3	cluster 4		UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 4	TCGA-BS-A0UT	2212	0	2212	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					62	0	0	TCGA-BS-A0UT-F16711	Never Used	Stage IIB	NO		-22775	1886		0	2212				NO		Scheduled Follow-up Submission	2011-3-25	FEMALE	152	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	90	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	TCGA-BS-A0UT.326838B8-D069-4F9C-9353-F806B56DCA48.pdf	33	80	0	0	0	5	0	20	0	0	0	25	5	70	95	70	80	negative	TUMOR FREE	0	0		3	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	BS	0	5	0	22	Endometrial	A	LIVING	65	2005	ece7dac4-4f09-45c9-8a63-e4375ebf4c88		TCGA-BS-A0UT-01			TCGA-BS-A0UT-01A-11D-A102-01		TCGA-BS-A0UT-01A-11D-A10Q-05	ece7dac4-4f09-45c9-8a63-e4375ebf4c88			TCGA-BS-A0UT-01A-11R-A103-13	TCGA-BS-A0UT-01A-11D-A10B-09		0f540e0a-21b9-45ec-b2a4-2b4bb73409f1	TCGA-BS-A0UT-01		TCGA-BS-A0UT-01A-11D-A10B-09		TCGA-BS-A0UT-01A-11D-A10B-09	0f540e0a-21b9-45ec-b2a4-2b4bb73409f1	TCGA-BS-A0UT-01A-11D-A102-01		TCGA-BS-A0UT-01A-11R-A103-13	
TCGA-BS-A0UV-01	MSI-L	0	TCGA-BS-A0UV-01	2228	0	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4		UCEC-like c11	miRNA cluster 12	cluster 2	mutation cluster 11	TCGA-BS-A0UV	2228	0	2228	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					55	0	0	TCGA-BS-A0UV-F16696	Former User	Stage IIIC	NO		-20266	1902		0	2228				YES		Scheduled Follow-up Submission	2011-3-28	FEMALE	168	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	80	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-BS-A0UV.9414D0B9-3126-42E9-8189-7C1EC38B2AAB.pdf	65	40	40	0	0	15	20	57	57	0	0	10	10	75	70	90	90	negative	TUMOR FREE	0	0		4+	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	BS	0	8	1	8	Endometrial	A	LIVING	112	2005	08890bb3-7ad1-41c2-8774-b10bf86ee047		TCGA-BS-A0UV-01			TCGA-BS-A0UV-01A-11D-A102-01		TCGA-BS-A0UV-01A-11D-A10Q-05	08890bb3-7ad1-41c2-8774-b10bf86ee047			TCGA-BS-A0UV-01A-11R-A103-13	TCGA-BS-A0UV-01A-11D-A10B-09		a3631721-6ed0-4e88-b96d-9a6896deb6f5	TCGA-BS-A0UV-01				TCGA-BS-A0UV-01A-11D-A10B-09	a3631721-6ed0-4e88-b96d-9a6896deb6f5	TCGA-BS-A0UV-01A-11D-A102-01		TCGA-BS-A0UV-01A-11R-A103-13	
TCGA-BS-A0V4-01	MSI-H	0	TCGA-BS-A0V4-01	1810	0	Iq		UCEC CIMP c18	cluster 1	UCEC-like c5		miRNA cluster 7	cluster 1		TCGA-BS-A0V4	1810	0	1810	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					56	0	0	TCGA-BS-A0V4-F16710	Never Used	Stage IB	NO		-20777	1576		0	1810				NO		Scheduled Follow-up Submission	2011-3-25	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	310	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	TCGA-BS-A0V4.AA0FFBF8-693C-484E-A29D-02F859E1E4C5.pdf	4	50	40	20	20	0	5	20	20	0	0	20	25	80	70	80	70	negative	TUMOR FREE	0	0		3	Complete Remission/Response	No	Never Used		NO					Primary Tumor	01	open	1988	NO	NO	YES	BS	0	2	0	33	Endometrial	A	LIVING	96	2006			TCGA-BS-A0V4-01	5deaf911-f777-4c38-95bf-19af647e7806	TCGA-BS-A0V4-01A-11R-A14C-13	TCGA-BS-A0V4-01A-11D-A14F-01				TCGA-BS-A0V4-01A-11D-A14H-05				TCGA-BS-A0V4-01A-21-A18Q-20	0e431798-9643-49bf-a5a3-bcb80350ee52	TCGA-BS-A0V4-01	5deaf911-f777-4c38-95bf-19af647e7806				0e431798-9643-49bf-a5a3-bcb80350ee52	TCGA-BS-A0V4-01A-11D-A14F-01	5deaf911-f777-4c38-95bf-19af647e7806	TCGA-BS-A0V4-01A-11R-A14C-13	5deaf911-f777-4c38-95bf-19af647e7806
TCGA-BS-A0V6-01	MSS	0	TCGA-BS-A0V6-01	1910	0	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 2		UCEC-like c11	miRNA c1uster 10	cluster 4	mutation cluster 4	TCGA-BS-A0V6	1910	0	1910	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					55	0	0	TCGA-BS-A0V6-F17013	Never Used	Stage IB	NO		-20369	1462		0	1910				NO		Scheduled Follow-up Submission	2011-3-28	FEMALE	157	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	80	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	TCGA-BS-A0V6.657466BC-3CA2-4568-BF64-2905571C3666.pdf	5.6	40	30	2	0	5	20	2	20	25	0	30	10	40	70	30	90	negative	TUMOR FREE	0	0		1	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	BS	0	8	0	22	Endometrial	A	LIVING	83	2006	a7efbfc2-48f4-44ec-a8a6-7e565cfe2b6a		TCGA-BS-A0V6-01		TCGA-BS-A0V6-01A-11R-A119-13	TCGA-BS-A0V6-01A-11D-A120-01			a7efbfc2-48f4-44ec-a8a6-7e565cfe2b6a	TCGA-BS-A0V6-01A-11D-A123-05			TCGA-BS-A0V6-01A-11D-A122-09		853556aa-caf6-4bcd-9dca-5b234f569113	TCGA-BS-A0V6-01		TCGA-BS-A0V6-01A-11D-A122-09		TCGA-BS-A0V6-01A-11D-A122-09	853556aa-caf6-4bcd-9dca-5b234f569113	TCGA-BS-A0V6-01A-11D-A120-01		TCGA-BS-A0V6-01A-11R-A119-13	
TCGA-BS-A0V7-01	MSS	0	TCGA-BS-A0V7-01	1934	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5		miRNA cluster 5	cluster 4	mutation cluster 1	TCGA-BS-A0V7	1934	0	1934	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					48	0	0	TCGA-BS-A0V7-F17014	Never Used	Stage IB	NO		-17810	1455		0	1934				YES		Scheduled Follow-up Submission	2011-3-28	FEMALE	170	Endometrioid endometrial adenocarcinoma	No	Yes, I am currently taking menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES	suction using pipelle	Other method, specify:	130	NO		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1					NO	false	TCGA-BS-A0V7.A4515806-9888-48E8-8F9E-491527FFC29C.pdf	36.7	20	10	2	0	2	20	1	10	15	20	47	0	30	60	35	80	negative	TUMOR FREE	0	0		2	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	BS	0	1	0	26	Endometrial	A	LIVING	102	2006			TCGA-BS-A0V7-01	0fcc0aec-5ef8-4284-a7b5-eb8b328ef02c	TCGA-BS-A0V7-01A-21R-A119-13	TCGA-BS-A0V7-01A-21D-A120-01				TCGA-BS-A0V7-01A-21D-A123-05	e32601c9-c3cf-4923-93aa-40ddfa630978		TCGA-BS-A0V7-01A-21D-A122-09	TCGA-BS-A0V7-01A-11-A163-20	1472e71a-54c3-43e6-9758-680257ad4de8	TCGA-BS-A0V7-01	0fcc0aec-5ef8-4284-a7b5-eb8b328ef02c			TCGA-BS-A0V7-01A-21D-A122-09	1472e71a-54c3-43e6-9758-680257ad4de8	TCGA-BS-A0V7-01A-21D-A120-01	0fcc0aec-5ef8-4284-a7b5-eb8b328ef02c	TCGA-BS-A0V7-01A-21R-A119-13	0fcc0aec-5ef8-4284-a7b5-eb8b328ef02c
TCGA-BS-A0V8-01	MSS	0	TCGA-BS-A0V8-01	1507	0	Squamous	C6-UCEC	UCEC non-CIMP c3	cluster 3		UCEC-like c11	miRNA cluster 5	cluster 4	mutation cluster 5	TCGA-BS-A0V8	1507	0	1507	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					68	0	0	TCGA-BS-A0V8-F17015	Never Used	Stage IIB	NO		-24981	1410		0	1507				YES		Scheduled Follow-up Submission	2011-3-28	FEMALE	157	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	120	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	TCGA-BS-A0V8.A024F121-F6C9-4CDF-B0ED-B58708DB6DFE.pdf	75	10	5	0	0	20	1	20	0	30	59	0	15	50	25	70	15	negative	TUMOR FREE	0	0		4+	Complete Remission/Response	No	Never Used		YES				R1	Primary Tumor	01	open	1988	NO	NO	YES	BS	0	5	0	13	Endometrial	A	LIVING	85	2006	1c908135-7fdf-4257-8b9e-92e6aa0850a6		TCGA-BS-A0V8-01		TCGA-BS-A0V8-01A-11R-A119-13	TCGA-BS-A0V8-01A-11D-A120-01			1c908135-7fdf-4257-8b9e-92e6aa0850a6	TCGA-BS-A0V8-01A-11D-A123-05			TCGA-BS-A0V8-01A-11D-A122-09		03fb1ece-f53f-45b0-ab35-20d762859ad4	TCGA-BS-A0V8-01				TCGA-BS-A0V8-01A-11D-A122-09	03fb1ece-f53f-45b0-ab35-20d762859ad4	TCGA-BS-A0V8-01A-11D-A120-01		TCGA-BS-A0V8-01A-11R-A119-13	
TCGA-BS-A0VI-01	MSI-H	0	TCGA-BS-A0VI-01	1921	0	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	squamous c3	UCEC-like c11	miRNA cluster 7	cluster 1		TCGA-BS-A0VI	1921	0	1921	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					58	0	0	TCGA-BS-A0VI-F17012	Never Used	Stage IIB	NO		-21198			0	1921				NO		Scheduled Follow-up Submission	2011-3-28	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO			93																		TUMOR FREE	0	0		1	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	BS	0	1	0	23	Endometrial		LIVING	91	2006	eb32a70b-8e73-4c44-8a44-c623158e87b1		TCGA-BS-A0VI-01		TCGA-BS-A0VI-01A-11R-A14C-13	TCGA-BS-A0VI-01A-11D-A14F-01			eb32a70b-8e73-4c44-8a44-c623158e87b1	TCGA-BS-A0VI-01A-11D-A14H-05				TCGA-BS-A0VI-01A-21-A18Q-20	aceca06e-8b29-4590-ae3b-04effd75ce25	TCGA-BS-A0VI-01					aceca06e-8b29-4590-ae3b-04effd75ce25	TCGA-BS-A0VI-01A-11D-A14F-01		TCGA-BS-A0VI-01A-11R-A14C-13	
TCGA-BS-A0WQ-01	MSS	0	TCGA-BS-A0WQ-01	2022	0	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4		UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 4	TCGA-BS-A0WQ	2022	0	2022	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					55	0	0	TCGA-BS-A0WQ-F16701		Stage IA	NO		-20131	1696		0	2022				YES		Scheduled Follow-up Submission	2011-3-25	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	140	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	TCGA-BS-A0WQ.207B2565-ABB2-4F05-8B54-2280DAC57AD3.pdf	0	0	0	0	0	0	0	0	0	0	0	0	0	100	100	85	80	negative	TUMOR FREE	0	0		0	Complete Remission/Response	No	Former User		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	BS	0	11	0	14	Endometrial	A	LIVING	93	2006	432f025e-4ece-432e-b573-01a8e6f9a1e5		TCGA-BS-A0WQ-01			TCGA-BS-A0WQ-01A-21D-A107-01			432f025e-4ece-432e-b573-01a8e6f9a1e5	TCGA-BS-A0WQ-01A-21D-A10A-05		TCGA-BS-A0WQ-01A-21R-A108-13	TCGA-BS-A0WQ-01A-21D-A10G-09		57255c6d-5e07-4850-805e-82ee7f3b2c2b	TCGA-BS-A0WQ-01		TCGA-BS-A0WQ-01A-21D-A10G-09		TCGA-BS-A0WQ-01A-21D-A10G-09	57255c6d-5e07-4850-805e-82ee7f3b2c2b	TCGA-BS-A0WQ-01A-21D-A107-01		TCGA-BS-A0WQ-01A-21R-A108-13	
TCGA-D1-A0ZN-01	MSS	0	TCGA-D1-A0ZN-01	512	0	Iq	C6-UCEC	UCEC CIMP c18	cluster 1		UCEC-like c11	miRNA cluster 13	cluster 1	mutation cluster 4	TCGA-D1-A0ZN	448	1	512	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	NO	YES	NO	Complete Response	60	0	0	TCGA-D1-A0ZN-F17736		Stage IA	NO		-22026	567		0	512			448	NO		Scheduled Follow-up Submission	2011-10-24	FEMALE	168	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	YES	C54.1	8380/3	C54.1	YES		Tumor resection	120	NO		Peri (6-12 months since last menstrual period)	G1	Other, specify	New Primary Tumor	Breast left		YES	false	TCGA-D1-A0ZN.53DB2270-9308-47F5-BD1F-4D4C737F98AC.pdf	0	8	20	0	0	0	10	1	10	2	20	38	10	60	60	60	70	negative	TUMOR FREE	0	0		2	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open		NO	NO	YES	D1	0	0	0	0	Endometrial	A	LIVING	82	2009	2d12622b-f828-43b0-a63f-fc542af894db		TCGA-D1-A0ZN-01		TCGA-D1-A0ZN-01A-11R-A119-13	TCGA-D1-A0ZN-01A-11D-A120-01			2d12622b-f828-43b0-a63f-fc542af894db	TCGA-D1-A0ZN-01A-11D-A123-05			TCGA-D1-A0ZN-01A-11D-A122-09		23b00fa6-d62a-4ff5-afc4-bbc3d28067a3	TCGA-D1-A0ZN-01				TCGA-D1-A0ZN-01A-11D-A122-09	23b00fa6-d62a-4ff5-afc4-bbc3d28067a3	TCGA-D1-A0ZN-01A-11D-A120-01		TCGA-D1-A0ZN-01A-11R-A119-13	
TCGA-D1-A0ZO-01	MSI-H	0	TCGA-D1-A0ZO-01	602	0	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 1		UCEC-like c11	miRNA cluster 13	cluster 4	mutation cluster 1	TCGA-D1-A0ZO	602	0	602	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	75	0	0	TCGA-D1-A0ZO-F17744		Stage IB	NO		-27482	586		0	602				NO		Scheduled Follow-up Submission	2011-10-24	FEMALE	165	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	50	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	TCGA-D1-A0ZO.13826E23-2184-4D03-B67C-B312BF4FA87E.pdf	30	20	20	0	0	10	10	10	10	70	30	0	10	20	50	30	60	negative	TUMOR FREE	0	0		3	Complete Remission/Response	Yes	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive		NO	NO	YES	D1	0	0	0	18	Endometrial	A	LIVING	110	2009	0e70ff34-799d-4e88-9911-85357f2bb0a2		TCGA-D1-A0ZO-01		TCGA-D1-A0ZO-01A-11R-A119-13	TCGA-D1-A0ZO-01A-11D-A120-01			0e70ff34-799d-4e88-9911-85357f2bb0a2	TCGA-D1-A0ZO-01A-11D-A123-05			TCGA-D1-A0ZO-01A-11D-A122-09		44c4a21c-c1f6-41c8-85c8-137f7849f43a	TCGA-D1-A0ZO-01		TCGA-D1-A0ZO-01A-11D-A122-09		TCGA-D1-A0ZO-01A-11D-A122-09	44c4a21c-c1f6-41c8-85c8-137f7849f43a	TCGA-D1-A0ZO-01A-11D-A120-01		TCGA-D1-A0ZO-01A-11R-A119-13	
TCGA-D1-A0ZP-01	MSI-L	0	TCGA-D1-A0ZP-01	911	0	Squamous	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 4	cluster 2	mutation cluster 4	TCGA-D1-A0ZP	629	1	911	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	NO	YES	Complete Response	59	0	0	TCGA-D1-A0ZP-F17745		Stage IVA	NO	783	-21581	552		0	911			629	NO		Scheduled Follow-up Submission	2011-10-24	FEMALE	161	Serous endometrial adenocarcinoma	No		NO	C54.1	8441/3	C54.1	YES		Tumor resection	180	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Locoregional Disease	Recurrent endometrial carcinoma in retriponeal lymphnodes		YES	false	TCGA-D1-A0ZP.FD46BB74-914F-4B4E-819A-5AD5F4548672.pdf	30	10	8	0	0	10	0	10	1	0	2	10	23	80	75	90	75	positive	TUMOR FREE	0	0		1	Complete Remission/Response	No	Never Used		YES	Excisional Biopsy		R0	RX	Primary Tumor	01	open		YES	NO	YES	D1	0	19	0	51	Endometrial	A	LIVING	58	2009	2188d23d-209d-4d3c-b737-f48892e08d31		TCGA-D1-A0ZP-01			TCGA-D1-A0ZP-01A-21D-A10L-01			2188d23d-209d-4d3c-b737-f48892e08d31	TCGA-D1-A0ZP-01A-21D-A10N-05	a0ff554c-edc0-4e64-b073-e447db25593b	TCGA-D1-A0ZP-01A-21R-A10I-13	TCGA-D1-A0ZP-01A-21D-A10M-09	TCGA-D1-A0ZP-01A-11-A163-20	bd245adc-270d-4707-9153-36ff2b262a53	TCGA-D1-A0ZP-01		TCGA-D1-A0ZP-01A-21D-A10M-09		TCGA-D1-A0ZP-01A-21D-A10M-09	bd245adc-270d-4707-9153-36ff2b262a53	TCGA-D1-A0ZP-01A-21D-A10L-01		TCGA-D1-A0ZP-01A-21R-A10I-13	
TCGA-D1-A0ZQ-01	MSS	0	TCGA-D1-A0ZQ-01	260	0	Iq	C6-UCEC	UCEC non-CIMP c3	cluster 2		UCEC-like c11	miRNA cluster 5	cluster 4	mutation cluster 4	TCGA-D1-A0ZQ	260	0	260	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	90	0	0	TCGA-D1-A0ZQ-F17747	Never Used	Stage IB	NO		-32873	540		0	260				NO		Scheduled Follow-up Submission	2011-10-24	FEMALE	155	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	120	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	TCGA-D1-A0ZQ.BAC6E925-0499-41AD-9F58-2CB8E3EE058E.pdf	60	20	8	0	0	20	3	20	2	20	0	10	67	50	30	70	30		TUMOR FREE	0	0		3	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive		NO	NO	YES	D1	0	0	0	0	Endometrial	A	LIVING	69	2009	650687c0-616b-41a5-ae29-322ba9cfc462		TCGA-D1-A0ZQ-01		TCGA-D1-A0ZQ-01A-11R-A119-13	TCGA-D1-A0ZQ-01A-11D-A120-01			650687c0-616b-41a5-ae29-322ba9cfc462	TCGA-D1-A0ZQ-01A-11D-A123-05			TCGA-D1-A0ZQ-01A-11D-A122-09		83f9c1f1-0973-400d-8116-0a63194bda66	TCGA-D1-A0ZQ-01		TCGA-D1-A0ZQ-01A-11D-A122-09		TCGA-D1-A0ZQ-01A-11D-A122-09	83f9c1f1-0973-400d-8116-0a63194bda66	TCGA-D1-A0ZQ-01A-11D-A120-01		TCGA-D1-A0ZQ-01A-11R-A119-13	
TCGA-D1-A0ZR-01	MSS	0	TCGA-D1-A0ZR-01	17	0	Iq	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 3	mutation c1uster 10	TCGA-D1-A0ZR	17	0	17	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	57	0	0	TCGA-D1-A0ZR-F17748		Stage IB	NO		-21157	537		0	17				YES		Scheduled Follow-up Submission	2011-10-24	FEMALE	165	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	240	NO		Indeterminate (neither Pre or Postmenopausal)	G2					NO	false	TCGA-D1-A0ZR.ECC5B77F-7B6C-4C4A-A32C-1346DC3AF24D.pdf	12	20	20	0	0	10	10	10	20	0	0	10	30	80	60	90	70	negative	TUMOR FREE	0	0		4+	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	D1	0	10	0	48	Endometrial	A	LIVING	117	2009	41f4268d-a222-4d6b-b4aa-515bb8765c6c		TCGA-D1-A0ZR-01			TCGA-D1-A0ZR-01A-21D-A10L-01			41f4268d-a222-4d6b-b4aa-515bb8765c6c	TCGA-D1-A0ZR-01A-21D-A10N-05	b7cae504-6f63-49df-8575-2409eead4418	TCGA-D1-A0ZR-01A-21R-A10I-13	TCGA-D1-A0ZR-01A-21D-A10M-09	TCGA-D1-A0ZR-01A-11-A163-20	c4873666-a94b-4325-a371-c8c62baa836a	TCGA-D1-A0ZR-01		TCGA-D1-A0ZR-01A-21D-A10M-09		TCGA-D1-A0ZR-01A-21D-A10M-09	c4873666-a94b-4325-a371-c8c62baa836a	TCGA-D1-A0ZR-01A-21D-A10L-01		TCGA-D1-A0ZR-01A-21R-A10I-13	
TCGA-D1-A0ZS-01	MSI-H	0	TCGA-D1-A0ZS-01	148	0	Quiet	C11-small-various	UCEC CIMP c18	cluster 2		GBM-like c6	miRNA cluster 5	cluster 4	mutation cluster 1	TCGA-D1-A0ZS	148	0	148	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	54	0	0	TCGA-D1-A0ZS-F17755		Stage IB	NO		-19821	308		0	148				NO		Scheduled Follow-up Submission	2011-10-24	FEMALE	164	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	120	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-D1-A0ZS.313BCAEC-965D-4FF4-BAAA-3CAF48C739C6.pdf	40	40	10	20	0	10	10	30	10	0	10	20	0	70	80	70	90		TUMOR FREE	0	0		2	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive		NO	NO	YES	D1	0	19	0	27	Endometrial	A	LIVING	62	2009	f35db751-0250-4045-9faf-2c0f1158b354		TCGA-D1-A0ZS-01		TCGA-D1-A0ZS-01A-11R-A119-13	TCGA-D1-A0ZS-01A-11D-A120-01			f35db751-0250-4045-9faf-2c0f1158b354	TCGA-D1-A0ZS-01A-11D-A123-05			TCGA-D1-A0ZS-01A-11D-A122-09		52898478-8c27-4d1d-a5eb-e233b98e2fd0	TCGA-D1-A0ZS-01		TCGA-D1-A0ZS-01A-11D-A122-09		TCGA-D1-A0ZS-01A-11D-A122-09	52898478-8c27-4d1d-a5eb-e233b98e2fd0	TCGA-D1-A0ZS-01A-11D-A120-01		TCGA-D1-A0ZS-01A-11R-A119-13	
TCGA-D1-A0ZU-01	MSS	0	TCGA-D1-A0ZU-01	872	0	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 4	mutation cluster 4	TCGA-D1-A0ZU	872	0	872	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	34	0	0	TCGA-D1-A0ZU-F17749		Stage IB	NO		-12458	508		0	872				NO		Scheduled Follow-up Submission	2011-10-24	FEMALE	170	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8382/3	C54.1	YES		Office Endometrial Biopsy	180	NO		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2					NO	false	TCGA-D1-A0ZU.D0BC0903-390B-4344-A613-48ABF71CF08D.pdf	5	10	10	0	0	10	10	10	10	20	10	0	10	70	70	80	80	negative	TUMOR FREE	0	0		0	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive		YES	NO	YES	D1	0	0	0	0	Endometrial	A	LIVING	94	2009	8708462d-d090-4fa2-95a6-f6021ce0489b		TCGA-D1-A0ZU-01			TCGA-D1-A0ZU-01A-11D-A10L-01			8708462d-d090-4fa2-95a6-f6021ce0489b	TCGA-D1-A0ZU-01A-11D-A10N-05	8c9b9c6b-d8eb-4609-aaf6-8c92ba431fef	TCGA-D1-A0ZU-01A-11R-A10I-13	TCGA-D1-A0ZU-01A-11D-A10M-09	TCGA-D1-A0ZU-01A-21-A163-20	711e48c8-b4c1-4399-b4b0-ef738816d29d	TCGA-D1-A0ZU-01		TCGA-D1-A0ZU-01A-11D-A10M-09		TCGA-D1-A0ZU-01A-11D-A10M-09	711e48c8-b4c1-4399-b4b0-ef738816d29d	TCGA-D1-A0ZU-01A-11D-A10L-01		TCGA-D1-A0ZU-01A-11R-A10I-13	
TCGA-D1-A0ZV-01	MSS	0	TCGA-D1-A0ZV-01	728	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4		UCEC-like c11	miRNA cluster 12	cluster 2	mutation cluster 4	TCGA-D1-A0ZV	728	0	728	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	58	0	0	TCGA-D1-A0ZV-F19531		Stage IB	NO		-21374	324		0	728				NO		Scheduled Follow-up Submission	2011-12-13	FEMALE	170	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	110	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	TCGA-D1-A0ZV.C9AE2762-705F-4061-B3B6-325426D0C0C8.pdf	30	20	20	0	0	10	10	20	20	0	0	20	20	70	70	80	80		TUMOR FREE	0	0		2	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	D1	0	0	0	23	Endometrial	A	LIVING	77	2009	45676252-677e-45f6-a1e3-3052d3615472		TCGA-D1-A0ZV-01			TCGA-D1-A0ZV-01A-11D-A10L-01			45676252-677e-45f6-a1e3-3052d3615472	TCGA-D1-A0ZV-01A-11D-A10N-05		TCGA-D1-A0ZV-01A-11R-A10I-13	TCGA-D1-A0ZV-01A-11D-A10M-09		db5ce9c7-c3c4-4043-8d09-d76453429dac	TCGA-D1-A0ZV-01		TCGA-D1-A0ZV-01A-11D-A10M-09		TCGA-D1-A0ZV-01A-11D-A10M-09	db5ce9c7-c3c4-4043-8d09-d76453429dac	TCGA-D1-A0ZV-01A-11D-A10L-01		TCGA-D1-A0ZV-01A-11R-A10I-13	
TCGA-D1-A0ZZ-01	MSS	0	TCGA-D1-A0ZZ-01	686	0	Squamous	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 2	cluster 2	mutation cluster 13	TCGA-D1-A0ZZ	686	0	686	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	80	0	0	TCGA-D1-A0ZZ-F17753		Stage IB	NO		-29420	349		0	686				NO		Scheduled Follow-up Submission	2011-10-24	FEMALE	154	Mixed serous and endometrioid	No		NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	220	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-D1-A0ZZ.4339EAC6-F56E-49E6-8EF9-2256165CADB5.pdf	11	0	0	0	0	0	0	0	0	0	0	15	0	85	100	75	90	negative	TUMOR FREE	0	0		4+	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open		YES	NO	YES	D1	0	12	0	26	Endometrial	A	LIVING	51	2009	b50b6ebf-8b11-47db-803b-e2739e7dd005		TCGA-D1-A0ZZ-01			TCGA-D1-A0ZZ-01A-11D-A10L-01			b50b6ebf-8b11-47db-803b-e2739e7dd005	TCGA-D1-A0ZZ-01A-11D-A10N-05	9ad5db69-7dca-4be6-ba19-74509c89a963	TCGA-D1-A0ZZ-01A-11R-A10I-13	TCGA-D1-A0ZZ-01A-11D-A10M-09	TCGA-D1-A0ZZ-01A-21-A163-20	38e02a30-4bca-4031-b90f-9df7697093f6	TCGA-D1-A0ZZ-01		TCGA-D1-A0ZZ-01A-11D-A10M-09		TCGA-D1-A0ZZ-01A-11D-A10M-09	38e02a30-4bca-4031-b90f-9df7697093f6	TCGA-D1-A0ZZ-01A-11D-A10L-01		TCGA-D1-A0ZZ-01A-11R-A10I-13	
TCGA-D1-A101-01	MSI-H	0	TCGA-D1-A101-01	53	0	Quiet	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 4	mutation cluster 1	TCGA-D1-A101	53	0	53	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	60	0	0	TCGA-D1-A101-F17752		Stage IB	NO		-22078	349		0	53				YES		Scheduled Follow-up Submission	2011-10-24	FEMALE	150	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	150	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	TCGA-D1-A101.2D6287C8-9C22-4046-8F14-3886DDE62695.pdf	10	0	0	0	0	0	0	0	0	0	35	0	0	100	65	80	60	negative	TUMOR FREE	0	0		2	Complete Remission/Response	No	Never Used		NO				RX	Primary Tumor	01	Minimally Invasive		NO	NO	YES	D1	0	0	0	0	Endometrial	A	LIVING	82	2009	df97f5e0-e49a-4f34-911c-92502e7df570		TCGA-D1-A101-01			TCGA-D1-A101-01A-12D-A10L-01			df97f5e0-e49a-4f34-911c-92502e7df570	TCGA-D1-A101-01A-12D-A10N-05	af6eec20-46d9-4b44-989e-b36509847182	TCGA-D1-A101-01A-12R-A10I-13	TCGA-D1-A101-01A-12D-A10M-09	TCGA-D1-A101-01A-21-A163-20	44dc168b-61e9-4f16-bd18-a7b73a095f91	TCGA-D1-A101-01		TCGA-D1-A101-01A-12D-A10M-09		TCGA-D1-A101-01A-12D-A10M-09	44dc168b-61e9-4f16-bd18-a7b73a095f91	TCGA-D1-A101-01A-12D-A10L-01		TCGA-D1-A101-01A-12R-A10I-13	
TCGA-D1-A102-01	MSS	0	TCGA-D1-A102-01	135	0	BRCA-LUAD+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 1	mutation cluster 4	TCGA-D1-A102	135	0	135	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	49	0	0	TCGA-D1-A102-F17750		Stage IB	NO		-17991	380		0	135				YES		Scheduled Follow-up Submission	2011-10-24	FEMALE	178	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	200	NO		Peri (6-12 months since last menstrual period)	G2					NO	false	TCGA-D1-A102.9983D576-706A-48D2-93EE-70EABB3BD77C.pdf	13	0	0	0	0	0	0	0	0	0	0	0	5	100	95	75	75	negative	TUMOR FREE	0	0		0	Complete Remission/Response	Yes	Never Used		NO				RX	Primary Tumor	01	open		NO	NO	YES	D1	0	0	0	45	Endometrial	A	LIVING	122	2009	120e984a-ef3b-4240-8990-20aeadce8226		TCGA-D1-A102-01		TCGA-D1-A102-01A-11R-A10I-13	TCGA-D1-A102-01A-11D-A10L-01			120e984a-ef3b-4240-8990-20aeadce8226	TCGA-D1-A102-01A-11D-A10N-05	e113e37b-d85d-48e7-9ae4-dd3fdf12155c		TCGA-D1-A102-01A-11D-A10M-09	TCGA-D1-A102-01A-21-A163-20	81e228ef-8fd1-4939-ba6c-eb6101c727b0	TCGA-D1-A102-01		TCGA-D1-A102-01A-11D-A10M-09		TCGA-D1-A102-01A-11D-A10M-09	81e228ef-8fd1-4939-ba6c-eb6101c727b0	TCGA-D1-A102-01A-11D-A10L-01		TCGA-D1-A102-01A-11R-A10I-13	
TCGA-D1-A103-01	MSI-L	0	TCGA-D1-A103-01	669	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 3	mutation cluster 11	TCGA-D1-A103	669	0	669	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	87	0	0	TCGA-D1-A103-F17751		Stage IB	NO		-31841	376		0	669				NO		Scheduled Follow-up Submission	2011-10-24	FEMALE	150	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	170	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	TCGA-D1-A103.AE2FAD3D-FA6A-4648-90A5-2D2C442796AF.pdf	0	0	40	0	30	0	5	0	20	0	0	15	15	85	80	70	80		TUMOR FREE	0	0		3	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	D1	0	0	0	0	Endometrial	A	LIVING	60	2009	ba50902a-fcf9-4023-bdbc-3e7d61c7011b		TCGA-D1-A103-01		TCGA-D1-A103-01A-11R-A10I-13	TCGA-D1-A103-01A-11D-A10L-01			ba50902a-fcf9-4023-bdbc-3e7d61c7011b	TCGA-D1-A103-01A-11D-A10N-05	93fd8223-7024-4a46-88f8-922b00c25efa		TCGA-D1-A103-01A-11D-A10M-09	TCGA-D1-A103-01A-21-A163-20	12e4dfcd-bca4-4d2f-994c-c25cde523184	TCGA-D1-A103-01				TCGA-D1-A103-01A-11D-A10M-09	12e4dfcd-bca4-4d2f-994c-c25cde523184	TCGA-D1-A103-01A-11D-A10L-01		TCGA-D1-A103-01A-11R-A10I-13	
TCGA-D1-A15V-01	MSS	0	TCGA-D1-A15V-01	1201	0	Squamous	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 6	mutation cluster 3	TCGA-D1-A15V	1201	0	1201	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	68	0	0	TCGA-D1-A15V-F18453		Stage IB	NO		-24886	895		0	1201				NO		Scheduled Follow-up Submission	2011-11-17	FEMALE	160	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	250	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-D1-A15V.597F20F2-AE36-4A9F-A7AF-1647CB56B453.pdf	20		0		0		0		0		0		0		100		75	negative	TUMOR FREE	0	0		0	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	1995	YES	NO	YES	D1	0	16	0	38	Endometrial	A	LIVING	69	2008	30f27799-c311-47c4-ad9e-6c80863a3cd2		TCGA-D1-A15V-01		TCGA-D1-A15V-01A-11R-A119-13	TCGA-D1-A15V-01A-11D-A120-01			30f27799-c311-47c4-ad9e-6c80863a3cd2	TCGA-D1-A15V-01A-11D-A123-05	034bef37-e51a-43dc-8c33-a8d8423ebe75		TCGA-D1-A15V-01A-11D-A122-09	TCGA-D1-A15V-01A-21-A163-20	9f4f99ea-e7f6-461e-8971-19d58cd8c513	TCGA-D1-A15V-01				TCGA-D1-A15V-01A-11D-A122-09	9f4f99ea-e7f6-461e-8971-19d58cd8c513	TCGA-D1-A15V-01A-11D-A120-01		TCGA-D1-A15V-01A-11R-A119-13	
TCGA-D1-A15W-01	MSS	0	TCGA-D1-A15W-01	915	0	Quiet	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 5	cluster 4	mutation cluster 7	TCGA-D1-A15W	915	0	915	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	58	0	0	TCGA-D1-A15W-F18462		Stage IIIC	NO		-21545	906		0	915				YES		Scheduled Follow-up Submission	2011-11-17	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	190	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	TCGA-D1-A15W.1C938760-9492-4F4E-87CE-85CE3C15BBCA.pdf	38		0		0		0		0		5		0		95		80	negative	TUMOR FREE	0	1		0	Complete Remission/Response	No	Never Used		YES				RX	Primary Tumor	01	open	1995	YES	NO	YES	D1	0	8	1	34	Endometrial	A	LIVING	126	2008	9def1496-a891-431c-b5c2-75d258e7ec29		TCGA-D1-A15W-01		TCGA-D1-A15W-01A-11R-A119-13	TCGA-D1-A15W-01A-11D-A120-01			9def1496-a891-431c-b5c2-75d258e7ec29	TCGA-D1-A15W-01A-11D-A123-05	cafd3fc6-b826-40d0-bda1-e66ab5bfa073		TCGA-D1-A15W-01A-11D-A122-09	TCGA-D1-A15W-01A-21-A164-20	b351310a-4ec2-4f35-91ff-e50fe1ae679c	TCGA-D1-A15W-01		TCGA-D1-A15W-01A-11D-A122-09		TCGA-D1-A15W-01A-11D-A122-09	b351310a-4ec2-4f35-91ff-e50fe1ae679c	TCGA-D1-A15W-01A-11D-A120-01		TCGA-D1-A15W-01A-11R-A119-13	
TCGA-D1-A15X-01	MSI-L	0	TCGA-D1-A15X-01	909	0	Quiet	C6-UCEC	UCEC CIMP c18	cluster 2	squamous c3	UCEC-like c11	miRNA cluster 14	cluster 2	mutation cluster 11	TCGA-D1-A15X	909	0	909	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	45	0	0	TCGA-D1-A15X-F18473	Current User	Stage IA	NO		-16532	897		0	909				NO		Scheduled Follow-up Submission	2011-11-17	FEMALE	169	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	130	NO		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	High Grade					NO	false	TCGA-D1-A15X.F32EB1C9-4802-4873-8F0E-E10724DA9C15.pdf	0		0		0		0		0		0		0		100		70	negative	TUMOR FREE	0	0		2	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	1995	NO	NO	YES	D1	0	16	0	29	Endometrial	A	LIVING	72	2008	51f60923-90f4-4bf7-9cc4-0bcdd9ed50e1		TCGA-D1-A15X-01		TCGA-D1-A15X-01A-11R-A119-13	TCGA-D1-A15X-01A-11D-A120-01			51f60923-90f4-4bf7-9cc4-0bcdd9ed50e1	TCGA-D1-A15X-01A-11D-A123-05	d5df60b0-aec5-44e0-bb4c-99df11b9ae51		TCGA-D1-A15X-01A-11D-A122-09	TCGA-D1-A15X-01A-21-A164-20	9f6c96ff-24b0-46ff-b652-082109a8304d	TCGA-D1-A15X-01				TCGA-D1-A15X-01A-11D-A122-09	9f6c96ff-24b0-46ff-b652-082109a8304d	TCGA-D1-A15X-01A-11D-A120-01		TCGA-D1-A15X-01A-11R-A119-13	
TCGA-D1-A15Z-01	MSI-L	1	TCGA-D1-A15Z-01	58	1	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation c1uster 9	TCGA-D1-A15Z	58	0	58	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	72	0	0	TCGA-D1-A15Z-F18475		Stage IB	NO		-26638	884	58	0					YES		Scheduled Follow-up Submission	2011-11-17	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	160	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	TCGA-D1-A15Z.280F86BF-4834-4FA9-B153-DE7BE312E619.pdf	30		0		0		0		0		5		0		95		85		TUMOR FREE	0	0		4+	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	1995	NO	NO	YES	D1	0	5	0	28	Endometrial	A	DECEASED	125	2008	0ca45a1d-6cdc-48f5-8bde-633cfd15d687		TCGA-D1-A15Z-01		TCGA-D1-A15Z-01A-11R-A119-13	TCGA-D1-A15Z-01A-11D-A120-01			0ca45a1d-6cdc-48f5-8bde-633cfd15d687	TCGA-D1-A15Z-01A-11D-A123-05	9589df72-d456-456f-8b39-94e788adcc03		TCGA-D1-A15Z-01A-11D-A122-09	TCGA-D1-A15Z-01A-21-A163-20	19447dec-ec8c-4e5f-abd7-3f70f03341c8	TCGA-D1-A15Z-01		TCGA-D1-A15Z-01A-11D-A122-09		TCGA-D1-A15Z-01A-11D-A122-09	19447dec-ec8c-4e5f-abd7-3f70f03341c8	TCGA-D1-A15Z-01A-11D-A120-01		TCGA-D1-A15Z-01A-11R-A119-13	
TCGA-D1-A160-01	MSI-H	0	TCGA-D1-A160-01	112	0	Iq	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 1	TCGA-D1-A160	112	0	112	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	70	0	0	TCGA-D1-A160-F18477		Stage IB	NO		-25673			0	112				YES		Scheduled Follow-up Submission	2011-11-17	FEMALE	172	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO			20																	negative	TUMOR FREE	0	0		4+	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	1995	NO	NO	YES	D1	0	13	0	29	Endometrial		LIVING	122	2008	ac9c8753-ae35-4367-9aef-d42522bc8db7		TCGA-D1-A160-01		TCGA-D1-A160-01A-11R-A119-13	TCGA-D1-A160-01A-11D-A120-01			ac9c8753-ae35-4367-9aef-d42522bc8db7	TCGA-D1-A160-01A-11D-A123-05	a35bf473-635a-43cf-8507-e4328b2155fc		TCGA-D1-A160-01A-11D-A122-09	TCGA-D1-A160-01A-21-A163-20	e1745c3d-7d51-427c-941d-86c8f22aa2ed	TCGA-D1-A160-01				TCGA-D1-A160-01A-11D-A122-09	e1745c3d-7d51-427c-941d-86c8f22aa2ed	TCGA-D1-A160-01A-11D-A120-01		TCGA-D1-A160-01A-11R-A119-13	
TCGA-D1-A161-01	MSS	0	TCGA-D1-A161-01	892	0	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 4	mutation cluster 4	TCGA-D1-A161	892	0	892	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	78	0	0	TCGA-D1-A161-F18478		Stage IC	NO		-28695	864		0	892				NO		Scheduled Follow-up Submission	2011-11-17	FEMALE	159	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	170	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	TCGA-D1-A161.E68A0ED2-CBE3-40A9-8DBF-A3BBC49204DD.pdf	70		0		0		0		0		25		0		75		60	negative	TUMOR FREE	0	0		3	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	1995	NO	NO	YES	D1	0	9	0	21	Endometrial	A	LIVING	71	2008	9336e8ea-7afe-45b3-b9e7-add7141ecca0		TCGA-D1-A161-01		TCGA-D1-A161-01A-11R-A119-13	TCGA-D1-A161-01A-11D-A120-01			9336e8ea-7afe-45b3-b9e7-add7141ecca0	TCGA-D1-A161-01A-11D-A123-05	e9312de7-7981-4e1c-864b-5c4273a4c04b		TCGA-D1-A161-01A-11D-A122-09	TCGA-D1-A161-01A-21-A163-20	318b1bd7-176b-457c-ae14-f5433f15c95c	TCGA-D1-A161-01				TCGA-D1-A161-01A-11D-A122-09	318b1bd7-176b-457c-ae14-f5433f15c95c	TCGA-D1-A161-01A-11D-A120-01		TCGA-D1-A161-01A-11R-A119-13	
TCGA-D1-A162-01	MSS	0	TCGA-D1-A162-01	1145	0	Iq	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-D1-A162	1145	0	1145	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	69	0	0	TCGA-D1-A162-F18479		Stage IB	NO		-25543	874		0	1145				NO		Scheduled Follow-up Submission	2011-11-17	FEMALE	170	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	180	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	TCGA-D1-A162.CB5E7FA1-33EE-492F-B2B0-F4C9332640A9.pdf	50		0		0		0		0		25		0		75		70	negative	TUMOR FREE	0	0		3	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	1995	NO	NO	YES	D1	0	16	0	45	Endometrial	A	LIVING	100	2008	4f440484-1605-442b-b1e5-b3534277b9c2				TCGA-D1-A162-01A-11R-A119-13				4f440484-1605-442b-b1e5-b3534277b9c2	TCGA-D1-A162-01A-11D-A123-05	192b1720-c24a-43fe-9f8b-d9164e4c37c0			TCGA-D1-A162-01A-21-A163-20		TCGA-D1-A162-01								TCGA-D1-A162-01A-11R-A119-13	
TCGA-D1-A163-01	MSI-H	0	TCGA-D1-A163-01	991	0	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 1	TCGA-D1-A163	223	1	991	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	NO	YES	Complete Response	50	0	0	TCGA-D1-A163-F18485		Stage IIIC	NO	327	-18604	854		0	991			223	NO		Scheduled Follow-up Submission	2011-11-17	FEMALE	169	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	170	NO		Peri (6-12 months since last menstrual period)	G2	Other, specify	Metastatic	Paraaortic retroperitoneal lymphnode		YES	false	TCGA-D1-A163.993B9CE9-7D25-4B2B-B246-F642550C70CD.pdf	12		0		0		0		0		10		0		90		60	negative	TUMOR FREE	0	2		1	Complete Remission/Response	No	Never Used		YES	Surgical Resection		R0	R0	Primary Tumor	01	open	1995	NO	NO	YES	D1	0	38	2	53	Endometrial	A	LIVING	109	2008	b9d45e58-d758-4aa0-a282-1366dc00f833		TCGA-D1-A163-01		TCGA-D1-A163-01A-11R-A12H-13	TCGA-D1-A163-01A-11D-A12G-01			b9d45e58-d758-4aa0-a282-1366dc00f833	TCGA-D1-A163-01A-11D-A12K-05	78cb9680-d489-4ed4-bfdf-56cf4e9b2c9c		TCGA-D1-A163-01A-11D-A12J-09	TCGA-D1-A163-01A-21-A163-20	0926ebba-18f1-497f-8115-fdf7b3e54adf	TCGA-D1-A163-01		TCGA-D1-A163-01A-11D-A12J-09		TCGA-D1-A163-01A-11D-A12J-09	0926ebba-18f1-497f-8115-fdf7b3e54adf	TCGA-D1-A163-01A-11D-A12G-01		TCGA-D1-A163-01A-11R-A12H-13	
TCGA-D1-A165-01	MSS	0	TCGA-D1-A165-01	20	0	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 4	mutation cluster 4	TCGA-D1-A165	20	0	20	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	64	0	0	TCGA-D1-A165-F18493		Stage IIIA	NO		-23526	848		0	20				NO		Scheduled Follow-up Submission	2011-11-17	FEMALE	181	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	90	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	TCGA-D1-A165.476F8219-DAAE-4DB3-BA31-C64AC24ACF65.pdf	25		4		1		0		0		0		40		60		60	positive	TUMOR FREE	0	0		2	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	1995	NO	NO	YES	D1	0	13	0	30	Endometrial	A	LIVING	87	2008	6d1d9284-004e-4ed7-91dd-71f4fa919632		TCGA-D1-A165-01		TCGA-D1-A165-01A-11R-A12H-13	TCGA-D1-A165-01A-11D-A12G-01			6d1d9284-004e-4ed7-91dd-71f4fa919632	TCGA-D1-A165-01A-11D-A12K-05	2dc14a00-8265-4379-a0fd-eb8e9e199b59		TCGA-D1-A165-01A-11D-A12J-09	TCGA-D1-A165-01A-21-A163-20	588d23ac-6352-443b-88f0-cc2c5ced007d	TCGA-D1-A165-01		TCGA-D1-A165-01A-11D-A12J-09		TCGA-D1-A165-01A-11D-A12J-09	588d23ac-6352-443b-88f0-cc2c5ced007d	TCGA-D1-A165-01A-11D-A12G-01		TCGA-D1-A165-01A-11R-A12H-13	
TCGA-D1-A167-01	MSI-H	0	TCGA-D1-A167-01	478	0	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 11	TCGA-D1-A167	478	0	478	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	70	0	0	TCGA-D1-A167-F18494		Stage IC	NO		-25575	841		0	478				NO		Scheduled Follow-up Submission	2011-11-17	FEMALE	152	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	140	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	TCGA-D1-A167.4E67EAA4-3069-4B62-A403-9300A9FA494C.pdf	60		4		1		3		3		0		15		82		85	negative	TUMOR FREE	0	0		2	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	1995	NO	NO	YES	D1	0	20	0	52	Endometrial	A	LIVING	72	2008	09807f16-30aa-47b0-ace0-0dfb6a5342c2		TCGA-D1-A167-01		TCGA-D1-A167-01A-11R-A12H-13	TCGA-D1-A167-01A-11D-A12G-01			09807f16-30aa-47b0-ace0-0dfb6a5342c2	TCGA-D1-A167-01A-11D-A12K-05	8abc7390-66a1-4e32-b8b5-747673551370		TCGA-D1-A167-01A-11D-A12J-09	TCGA-D1-A167-01A-21-A163-20	4925481a-9d16-4ca9-bbf3-b41a792ffea0	TCGA-D1-A167-01				TCGA-D1-A167-01A-11D-A12J-09	4925481a-9d16-4ca9-bbf3-b41a792ffea0	TCGA-D1-A167-01A-11D-A12G-01		TCGA-D1-A167-01A-11R-A12H-13	
TCGA-D1-A168-01	MSS	0	TCGA-D1-A168-01	1098	0	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	BLCA nonsquamous-like c1	miRNA cluster 12	cluster 4	mutation cluster 1	TCGA-D1-A168	1098	0	1098	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	67	0	0	TCGA-D1-A168-F18501		Stage IB	NO		-24586	821		0	1098				NO		Scheduled Follow-up Submission	2011-11-18	FEMALE	162	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	120	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-D1-A168.B9D9D808-17B1-415F-9E58-4FDBC1BF30C0.pdf	35		0		0		5		0		0		5		90		95	negative	TUMOR FREE	0	0		3	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	1995	NO	NO	YES	D1	0	19	0	49	Endometrial	A	LIVING	76	2008	9ca7ed26-2a2c-47cd-8423-f9b100beccc3		TCGA-D1-A168-01		TCGA-D1-A168-01A-31R-A12H-13	TCGA-D1-A168-01A-31D-A12G-01			9ca7ed26-2a2c-47cd-8423-f9b100beccc3	TCGA-D1-A168-01A-31D-A12K-05	770c564f-5591-4122-9855-ba6c3ce96517		TCGA-D1-A168-01A-31D-A12J-09	TCGA-D1-A168-01A-21-A163-20	4f0555c2-45e5-4459-af6b-db805ab171bd	TCGA-D1-A168-01		TCGA-D1-A168-01A-31D-A12J-09		TCGA-D1-A168-01A-31D-A12J-09	4f0555c2-45e5-4459-af6b-db805ab171bd	TCGA-D1-A168-01A-31D-A12G-01		TCGA-D1-A168-01A-31R-A12H-13	
TCGA-D1-A169-01	MSS	0	TCGA-D1-A169-01	1135	0	Squamous	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 1	mutation cluster 3	TCGA-D1-A169	519	1	1135	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	NO	YES	Stable Disease	63	0	0	TCGA-D1-A169-F18503		Stage IV	NO	519	-23238	800		0	1135			519	NO		Scheduled Follow-up Submission	2011-11-18	FEMALE	170	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	180	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2	Other, specify	Metastatic	Bladder nodule		YES	false	TCGA-D1-A169.F7B4C0DC-2259-4A0A-81D3-E145EFA91279.pdf	45		4		6		20		2		0		30		50		70	positive	WITH TUMOR	0	0		0	Complete Remission/Response	No	Never Used		NO	Excisional Biopsy		R2	R0	Primary Tumor	01	Minimally Invasive	1995	YES	NO	YES	D1	0	23	0	29	Endometrial	A	LIVING	102	2008	7a487d4e-9e11-4adc-86a1-cf6a7bde4f67		TCGA-D1-A169-01		TCGA-D1-A169-01A-11R-A12H-13	TCGA-D1-A169-01A-11D-A12G-01			7a487d4e-9e11-4adc-86a1-cf6a7bde4f67	TCGA-D1-A169-01A-11D-A12K-05	eed70d33-031c-4464-a665-1e4b090ecae8		TCGA-D1-A169-01A-11D-A12J-09	TCGA-D1-A169-01A-21-A163-20	a3426ec0-6081-434b-beb4-f3e5436fa5ec	TCGA-D1-A169-01		TCGA-D1-A169-01A-11D-A12J-09		TCGA-D1-A169-01A-11D-A12J-09	a3426ec0-6081-434b-beb4-f3e5436fa5ec	TCGA-D1-A169-01A-11D-A12G-01		TCGA-D1-A169-01A-11R-A12H-13	
TCGA-D1-A16B-01	MSS	0	TCGA-D1-A16B-01	1106	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 2	mutation cluster 4	TCGA-D1-A16B	1106	0	1106	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	64	0	0	TCGA-D1-A16B-F18508		Stage IC	NO		-23450	793		0	1106				NO		Scheduled Follow-up Submission	2011-11-18	FEMALE	159	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	150	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	TCGA-D1-A16B.1B9ED459-4046-4DD9-ABA5-E815A90601A3.pdf	56		2		2		5		6		0		30		65		70	negative	TUMOR FREE	0	0		2	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	1995	NO	NO	YES	D1	0	12	0	18	Endometrial	A	LIVING	86	2008	90250b43-5a36-42c0-886f-32a0ed39bea6		TCGA-D1-A16B-01		TCGA-D1-A16B-01A-11R-A12H-13	TCGA-D1-A16B-01A-11D-A12G-01			90250b43-5a36-42c0-886f-32a0ed39bea6	TCGA-D1-A16B-01A-11D-A12K-05	faac5466-a988-4df3-8098-c4208c4d0453		TCGA-D1-A16B-01A-11D-A12J-09	TCGA-D1-A16B-01A-21-A163-20	feedfb94-0fa5-4088-a3a1-8b7f20f2320c	TCGA-D1-A16B-01		TCGA-D1-A16B-01A-11D-A12J-09		TCGA-D1-A16B-01A-11D-A12J-09	feedfb94-0fa5-4088-a3a1-8b7f20f2320c	TCGA-D1-A16B-01A-11D-A12G-01		TCGA-D1-A16B-01A-11R-A12H-13	
TCGA-D1-A16D-01	MSS	0	TCGA-D1-A16D-01	1141	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 6	mutation cluster 1	TCGA-D1-A16D	1141	0	1141	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	49	0	0	TCGA-D1-A16D-F18509		Stage IC	NO		-17933	799		0	1141				YES		Scheduled Follow-up Submission	2011-11-18	FEMALE	164	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	130	NO		Peri (6-12 months since last menstrual period)	G2					NO	false	TCGA-D1-A16D.795A5264-493A-498D-A731-87ECB0A7F612.pdf	86		5		8		10		12		0		40		50		60	negative	TUMOR FREE	0	0		0	Complete Remission/Response	No	Never Used		YES				RX	Primary Tumor	01	open	1995	YES	NO	YES	D1	0	0	0	34	Endometrial	A	LIVING	151	2008	619e7a96-8900-484b-b1e2-54ef91b9109d		TCGA-D1-A16D-01		TCGA-D1-A16D-01A-11R-A12H-13	TCGA-D1-A16D-01A-11D-A12G-01			619e7a96-8900-484b-b1e2-54ef91b9109d	TCGA-D1-A16D-01A-11D-A12K-05	5f2c5422-2513-4c05-9668-74e46bca6563		TCGA-D1-A16D-01A-11D-A12J-09	TCGA-D1-A16D-01A-21-A164-20	57e6b93f-cd52-42e5-958a-c8218ff4a930	TCGA-D1-A16D-01		TCGA-D1-A16D-01A-11D-A12J-09		TCGA-D1-A16D-01A-11D-A12J-09	57e6b93f-cd52-42e5-958a-c8218ff4a930	TCGA-D1-A16D-01A-11D-A12G-01		TCGA-D1-A16D-01A-11R-A12H-13	
TCGA-D1-A16E-01	MSS	0	TCGA-D1-A16E-01	1119	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 2	squamous c3	UCEC-like c11	miRNA cluster 13	cluster 4	mutation cluster 4	TCGA-D1-A16E	1119	0	1119	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	73	0	0	TCGA-D1-A16E-F18558		Stage IB	NO		-26859	790		0	1119				NO		Scheduled Follow-up Submission	2011-11-21	FEMALE	154	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	170	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	TCGA-D1-A16E.DF926973-D344-48AE-A6F6-5901A4A8C846.pdf	25		5		4		0		12		0		20		80		80		TUMOR FREE	0	0		2	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	1995	NO	NO	YES	D1	0	0	0	0	Endometrial	A	LIVING	60	2008	abe099ed-caea-4903-aa4a-2729d2b28da2		TCGA-D1-A16E-01		TCGA-D1-A16E-01A-22R-A12H-13	TCGA-D1-A16E-01A-22D-A12G-01			abe099ed-caea-4903-aa4a-2729d2b28da2	TCGA-D1-A16E-01A-22D-A12K-05	564e1d1e-8143-473d-b49a-a701458f6516		TCGA-D1-A16E-01A-22D-A12J-09	TCGA-D1-A16E-01A-11-A164-20	80213970-7001-4cb8-938c-92a8716b6994	TCGA-D1-A16E-01		TCGA-D1-A16E-01A-22D-A12J-09		TCGA-D1-A16E-01A-22D-A12J-09	80213970-7001-4cb8-938c-92a8716b6994	TCGA-D1-A16E-01A-22D-A12G-01		TCGA-D1-A16E-01A-22R-A12H-13	
TCGA-D1-A16F-01	MSI-H	0	TCGA-D1-A16F-01	80	0		C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 6	mutation cluster 7	TCGA-D1-A16F	80	0	80	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	60	0	0	TCGA-D1-A16F-F18559		Stage IB	NO		-22242	783		0	80				YES		Scheduled Follow-up Submission	2011-11-21	FEMALE	157	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	280	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	TCGA-D1-A16F.E89C4CBF-45D5-405D-A673-F67186C206B3.pdf	25		0		0		0		0		0		34		66		66	negative	TUMOR FREE	0	0		3	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	1995	NO	NO	YES	D1	0	6	0	15	Endometrial	A	LIVING	90	2008	7eab3a7a-c66e-4289-8fb4-ae751b2103e6				TCGA-D1-A16F-01A-11R-A12H-13				7eab3a7a-c66e-4289-8fb4-ae751b2103e6	TCGA-D1-A16F-01A-11D-A12K-05	2d4eb2c7-4e8d-4d10-b6d7-c6ee8965053e		TCGA-D1-A16F-01A-11D-A12J-09	TCGA-D1-A16F-01A-21-A164-20		TCGA-D1-A16F-01				TCGA-D1-A16F-01A-11D-A12J-09				TCGA-D1-A16F-01A-11R-A12H-13	
TCGA-D1-A16G-01	MSS	1	TCGA-D1-A16G-01	834	1	Squamous	C7-COAD/READ	UCEC non-CIMP c3	cluster 4	squamous c3	COADREAD-like c15	miRNA cluster 8	cluster 2	mutation cluster 3	TCGA-D1-A16G	642	1	834	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	NO	NO	Progressive Disease	74	0	0	TCGA-D1-A16G-F18560		Stage IV	NO		-27065	769	834	0				642	NO		Scheduled Follow-up Submission	2011-11-21	FEMALE	173	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	250	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	High Grade	Other, specify	Locoregional Disease	Lymph nodes		YES	false	TCGA-D1-A16G.778F9F58-841E-48F3-B6EA-7CF58463808B.pdf	100		10		0		0		30		0		40		60		60	positive	WITH TUMOR	0	0		3	Complete Remission/Response	No	Never Used		YES				RX	Primary Tumor	01	open	1995	YES	NO	YES	D1	0	15	0	30	Endometrial	A	DECEASED	75	2008	deeb2238-8ed6-4651-8b63-428c76914c94		TCGA-D1-A16G-01		TCGA-D1-A16G-01A-31R-A12H-13	TCGA-D1-A16G-01A-31D-A12G-01			deeb2238-8ed6-4651-8b63-428c76914c94	TCGA-D1-A16G-01A-31D-A12K-05	d63db6bf-75da-431d-947c-1609c481a48a		TCGA-D1-A16G-01A-31D-A12J-09	TCGA-D1-A16G-01A-21-A164-20	3840de23-bdc6-44c8-8a40-70809b957822	TCGA-D1-A16G-01		TCGA-D1-A16G-01A-31D-A12J-09		TCGA-D1-A16G-01A-31D-A12J-09	3840de23-bdc6-44c8-8a40-70809b957822	TCGA-D1-A16G-01A-31D-A12G-01		TCGA-D1-A16G-01A-31R-A12H-13	
TCGA-D1-A16I-01	MSS	1	TCGA-D1-A16I-01	350	1	High	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 4	mutation cluster 5	TCGA-D1-A16I	350	0	350	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	62	0	0	TCGA-D1-A16I-F18573		Stage IC	NO		-22836	763	350	0					NO		Scheduled Follow-up Submission	2011-11-21	FEMALE	163	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	190	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	High Grade					NO	false	TCGA-D1-A16I.3D30B053-444A-4F4D-B451-EB8746A157A2.pdf	66		0		0		5		0		0		15		80		90		TUMOR FREE	0	0		2	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	1995	YES	NO	YES	D1	0	22	0	29	Endometrial	A	DECEASED	84	2008	21e840d7-f768-45b3-8a3a-bf228f7227e7		TCGA-D1-A16I-01		TCGA-D1-A16I-01A-11R-A12H-13	TCGA-D1-A16I-01A-11D-A12G-01			21e840d7-f768-45b3-8a3a-bf228f7227e7	TCGA-D1-A16I-01A-11D-A12K-05	86d661f5-6386-4735-b9f1-04b2b4b96418		TCGA-D1-A16I-01A-11D-A12J-09	TCGA-D1-A16I-01A-21-A164-20	1079ecf6-e788-4778-be30-d26b0193f4d9	TCGA-D1-A16I-01		TCGA-D1-A16I-01A-11D-A12J-09		TCGA-D1-A16I-01A-11D-A12J-09	1079ecf6-e788-4778-be30-d26b0193f4d9	TCGA-D1-A16I-01A-11D-A12G-01		TCGA-D1-A16I-01A-11R-A12H-13	
TCGA-D1-A16J-01	MSS	0	TCGA-D1-A16J-01	910	0	COAD-READ	C1-LUAD-enriched	Cluster 6	cluster 1	squamous c3	UCEC-like c11	miRNA cluster 7	cluster 2	mutation cluster 1	TCGA-D1-A16J	910	0	910	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	61	0	0	TCGA-D1-A16J-F18579		Stage IIB	NO		-22319	735		0	910				NO		Scheduled Follow-up Submission	2011-11-21	FEMALE	174	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	150	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	TCGA-D1-A16J.7A1F7567-5D17-4074-B099-1E60C8069FA1.pdf	100		0		0		0		0		0		20		80		65	negative	TUMOR FREE	0	0		2	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	1995	YES	NO	YES	D1	0	13	0	50	Endometrial	A	LIVING	130	2008	43ae3721-059e-467e-a8a3-7875e738ccef		TCGA-D1-A16J-01		TCGA-D1-A16J-01A-11R-A12H-13	TCGA-D1-A16J-01A-11D-A12G-01			43ae3721-059e-467e-a8a3-7875e738ccef	TCGA-D1-A16J-01A-11D-A12K-05	6c745697-65bc-44b8-8f15-b8482f902e85		TCGA-D1-A16J-01A-11D-A12J-09	TCGA-D1-A16J-01A-21-A164-20	ff0c1fbf-95fb-4201-b346-4c1739172560	TCGA-D1-A16J-01		TCGA-D1-A16J-01A-11D-A12J-09		TCGA-D1-A16J-01A-11D-A12J-09	ff0c1fbf-95fb-4201-b346-4c1739172560	TCGA-D1-A16J-01A-11D-A12G-01		TCGA-D1-A16J-01A-11R-A12H-13	
TCGA-D1-A16N-01	MSI-H	0	TCGA-D1-A16N-01	945	0	Squamous	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 3	mutation cluster 3	TCGA-D1-A16N	945	0	945	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	51	0	0	TCGA-D1-A16N-F18584		Stage IIIA	NO		-18787	629		0	945				YES		Scheduled Follow-up Submission	2011-11-21	FEMALE	155	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	240	NO		Peri (6-12 months since last menstrual period)	G3					NO	false	TCGA-D1-A16N.81CFA07C-5FCE-41F3-88D1-FFD17840B293.pdf	42		0		0		3		0		0		2		95		95	positive	TUMOR FREE	0	0		2	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	1995	YES	NO	YES	D1	0	10	0	49	Endometrial	A	LIVING	89	2009	55b006ca-aacf-4ed5-a0bc-7238eacfb23e		TCGA-D1-A16N-01		TCGA-D1-A16N-01A-11R-A12H-13	TCGA-D1-A16N-01A-11D-A12G-01			55b006ca-aacf-4ed5-a0bc-7238eacfb23e	TCGA-D1-A16N-01A-11D-A12K-05	4c1fd9bc-7ae2-4325-b08f-56075e677662		TCGA-D1-A16N-01A-11D-A12J-09	TCGA-D1-A16N-01A-21-A164-20	f0aa12b1-6f2f-4204-b623-6424f0845543	TCGA-D1-A16N-01		TCGA-D1-A16N-01A-11D-A12J-09		TCGA-D1-A16N-01A-11D-A12J-09	f0aa12b1-6f2f-4204-b623-6424f0845543	TCGA-D1-A16N-01A-11D-A12G-01		TCGA-D1-A16N-01A-11R-A12H-13	
TCGA-D1-A16O-01	MSS	0	TCGA-D1-A16O-01	1023	0	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 1	mutation cluster 1	TCGA-D1-A16O	1023	0	1023	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	44	0	0	TCGA-D1-A16O-F18652		Stage IB	NO		-16114	756		0	1023				NO		Scheduled Follow-up Submission	2011-11-21	FEMALE	169	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	120	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	TCGA-D1-A16O.B4EFFDB8-CB4C-46D7-96AD-9D33DF7163C0.pdf	12		10		0		20		0		10		10		60		80	negative	TUMOR FREE	0	0		2	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	D1	0	0	0	0	Endometrial	A	LIVING	102	2008	3581b34d-0e76-4feb-a872-b510effff12a		TCGA-D1-A16O-01		TCGA-D1-A16O-01A-11R-A12H-13	TCGA-D1-A16O-01A-11D-A12G-01			3581b34d-0e76-4feb-a872-b510effff12a	TCGA-D1-A16O-01A-11D-A12K-05	641d2d76-4bc1-4a7f-8f59-87bf90319d4f		TCGA-D1-A16O-01A-11D-A12J-09	TCGA-D1-A16O-01A-21-A164-20	6d417fc1-1b0e-40cd-96ba-e681f4a5f0f6	TCGA-D1-A16O-01		TCGA-D1-A16O-01A-11D-A12J-09		TCGA-D1-A16O-01A-11D-A12J-09	6d417fc1-1b0e-40cd-96ba-e681f4a5f0f6	TCGA-D1-A16O-01A-11D-A12G-01		TCGA-D1-A16O-01A-11R-A12H-13	
TCGA-D1-A16Q-01	MSS	0	TCGA-D1-A16Q-01	324	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 6	mutation cluster 4	TCGA-D1-A16Q	324	0	324	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	54	0	0	TCGA-D1-A16Q-F18653		Stage II	NO		-19873	136		0	324				YES		Scheduled Follow-up Submission	2011-11-21	FEMALE	172	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	240	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	TCGA-D1-A16Q.60635568-D27E-4C72-BFF2-238CF2992925.pdf	77		30		0		20		10		0		10		70		90	negative	TUMOR FREE	0	0		0	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	2009	YES	NO	YES	D1	0	19	0	74	Endometrial	A	LIVING	117	2010	6f456a65-f075-469d-a0f9-365cae129564		TCGA-D1-A16Q-01		TCGA-D1-A16Q-01A-12R-A12H-13	TCGA-D1-A16Q-01A-12D-A12G-01			6f456a65-f075-469d-a0f9-365cae129564	TCGA-D1-A16Q-01A-12D-A12K-05	088c67d6-5a80-407a-ba4a-2f02c25c7a65		TCGA-D1-A16Q-01A-12D-A12J-09	TCGA-D1-A16Q-01A-21-A164-20	1a293216-4c5a-4df4-b2f6-e158ed2a46f2	TCGA-D1-A16Q-01		TCGA-D1-A16Q-01A-12D-A12J-09		TCGA-D1-A16Q-01A-12D-A12J-09	1a293216-4c5a-4df4-b2f6-e158ed2a46f2	TCGA-D1-A16Q-01A-12D-A12G-01		TCGA-D1-A16Q-01A-12R-A12H-13	
TCGA-D1-A16R-01	MSS	0	TCGA-D1-A16R-01	21	0	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 4	TCGA-D1-A16R	21	0	21	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	39	0	0	TCGA-D1-A16R-F20316		Stage IA	NO		-14465	161		0	21				NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	159	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	290	NO		Indeterminate (neither Pre or Postmenopausal)	G1					NO	false	TCGA-D1-A16R.D9641375-D204-4469-989A-ED08DDE66408.pdf	19		10		0		20		0		10		20		50		70	negative	TUMOR FREE	0	0		1	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	D1	0	0	0	49	Endometrial	A	LIVING	105	2010	16c07e59-0ad4-4a8d-82a0-a77c78119175		TCGA-D1-A16R-01		TCGA-D1-A16R-01A-11R-A12H-13	TCGA-D1-A16R-01A-11D-A12G-01			16c07e59-0ad4-4a8d-82a0-a77c78119175	TCGA-D1-A16R-01A-11D-A12K-05	b11290fb-906e-40fd-bb7c-b6f5660388eb		TCGA-D1-A16R-01A-11D-A12J-09	TCGA-D1-A16R-01A-21-A164-20	7e8e52bd-778b-4f44-8757-20aa29335f8e	TCGA-D1-A16R-01		TCGA-D1-A16R-01A-11D-A12J-09		TCGA-D1-A16R-01A-11D-A12J-09	7e8e52bd-778b-4f44-8757-20aa29335f8e	TCGA-D1-A16R-01A-11D-A12G-01		TCGA-D1-A16R-01A-11R-A12H-13	
TCGA-D1-A16S-01	MSS	0	TCGA-D1-A16S-01	568	0	High	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 2	mutation cluster 3	TCGA-D1-A16S	568	0	568	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	70	0	0	TCGA-D1-A16S-F20314		Stage IIIC	NO		-25690	177		0	568				NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	162	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	290	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	High Grade					NO	false	TCGA-D1-A16S.D69D2E09-B195-4F3F-B5A1-821A87852266.pdf	100		3		4		3		1		0		40		57		60	negative	TUMOR FREE	0	1		2	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	D1	0	20	1	35	Endometrial	A	LIVING	59	2010	7c0fca0e-60ff-4c7e-a337-fb7489f69151		TCGA-D1-A16S-01		TCGA-D1-A16S-01A-11R-A12H-13	TCGA-D1-A16S-01A-11D-A12G-01			7c0fca0e-60ff-4c7e-a337-fb7489f69151	TCGA-D1-A16S-01A-11D-A12K-05	70a0402e-460f-443a-8851-58c7a2d0bd97		TCGA-D1-A16S-01A-11D-A12J-09	TCGA-D1-A16S-01A-21-A164-20	08fc4f13-5ebb-4549-9d9b-895a15fd1395	TCGA-D1-A16S-01		TCGA-D1-A16S-01A-11D-A12J-09		TCGA-D1-A16S-01A-11D-A12J-09	08fc4f13-5ebb-4549-9d9b-895a15fd1395	TCGA-D1-A16S-01A-11D-A12G-01		TCGA-D1-A16S-01A-11R-A12H-13	
TCGA-D1-A16V-01	MSS	1	TCGA-D1-A16V-01	120	1	Squamous	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 3		TCGA-D1-A16V	120	0	120	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Stable Disease	78	0	7	TCGA-D1-A16V-F20230		Stage IIIC	NO		-28635	609	120	0	43				YES		Scheduled Follow-up Submission	2012-1-8	FEMALE	173	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Tumor resection	410	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-D1-A16V.92EA83B6-8041-4449-BAE6-5060C32966D0.pdf	73		15		2		6		3		2		10		82		90		TUMOR FREE	0	15		2	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	D1	7	30	15	35	Endometrial	A	DECEASED	105	2009	860613bc-72b2-47bb-90ac-2b272e549860		TCGA-D1-A16V-01		TCGA-D1-A16V-01A-11R-A12H-13	TCGA-D1-A16V-01A-11D-A12G-01			860613bc-72b2-47bb-90ac-2b272e549860	TCGA-D1-A16V-01A-11D-A12K-05	c3d27b98-8016-4388-9f04-b07d6389f0ef			TCGA-D1-A16V-01A-21-A164-20	55c081fc-f912-43c4-8fbd-9bb51d20b5d9	TCGA-D1-A16V-01					55c081fc-f912-43c4-8fbd-9bb51d20b5d9	TCGA-D1-A16V-01A-11D-A12G-01		TCGA-D1-A16V-01A-11R-A12H-13	
TCGA-D1-A16X-01	MSS	0	TCGA-D1-A16X-01	111	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 11	TCGA-D1-A16X	111	0	111	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	54	0	0	TCGA-D1-A16X-F20231		Stage IB	NO		-19799	618		0	111				NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	230	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	TCGA-D1-A16X.0C395D2C-1864-448E-8FB7-09BFE5FF4C50.pdf	18		3		10		1		15		0		5		94		95	negative	TUMOR FREE	0	0		3	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	D1	0	26	0	46	Endometrial	A	LIVING	101	2009	4468bb31-bb94-4353-9d13-556d4b8a892a		TCGA-D1-A16X-01		TCGA-D1-A16X-01A-11R-A12H-13	TCGA-D1-A16X-01A-11D-A12G-01			4468bb31-bb94-4353-9d13-556d4b8a892a	TCGA-D1-A16X-01A-11D-A12K-05	3845198c-ce52-4bac-936e-cb1fc79d2176		TCGA-D1-A16X-01A-11D-A12J-09	TCGA-D1-A16X-01A-21-A164-20	88937360-1ff3-42c4-b0e7-34b3ba0319f5	TCGA-D1-A16X-01				TCGA-D1-A16X-01A-11D-A12J-09	88937360-1ff3-42c4-b0e7-34b3ba0319f5	TCGA-D1-A16X-01A-11D-A12G-01		TCGA-D1-A16X-01A-11R-A12H-13	
TCGA-D1-A16Y-01	MSI-L	0	TCGA-D1-A16Y-01	532	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 2	mutation cluster 2	TCGA-D1-A16Y	532	0	532	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	56	0	0	TCGA-D1-A16Y-F20232		Stage IB	NO		-20455	610		0	532				NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	156	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	220	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	TCGA-D1-A16Y.0A0451C4-2A58-4404-934E-3517443E4CEE.pdf	8		4		2		0		1		0		25		75		75	negative	TUMOR FREE	0	0		3	Complete Remission/Response	No	Never Used		NO				RX	Primary Tumor	01	open	2009	NO	NO	YES	D1	0	6	0	20	Endometrial	A	LIVING	87	2009	486755e1-9b18-4310-a1bb-ddd325f212b0		TCGA-D1-A16Y-01		TCGA-D1-A16Y-01A-31R-A12H-13	TCGA-D1-A16Y-01A-31D-A12G-01			486755e1-9b18-4310-a1bb-ddd325f212b0	TCGA-D1-A16Y-01A-31D-A12K-05	b3d6caec-cbfc-4417-8810-8cb3bf4ae37b		TCGA-D1-A16Y-01A-31D-A12J-09	TCGA-D1-A16Y-01A-21-A164-20	d729cb1a-cf24-4c17-bc05-df11fa560bec	TCGA-D1-A16Y-01				TCGA-D1-A16Y-01A-31D-A12J-09	d729cb1a-cf24-4c17-bc05-df11fa560bec	TCGA-D1-A16Y-01A-31D-A12G-01		TCGA-D1-A16Y-01A-31R-A12H-13	
TCGA-D1-A174-01	MSI-H	0	TCGA-D1-A174-01	594	0	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 1		UCEC-like c11	miRNA cluster 6	cluster 1	mutation cluster 11	TCGA-D1-A174	594	0	594	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	51	0	0	TCGA-D1-A174-F20312		Stage IA	NO		-18702	219		0	594				NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	157	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	80	NO		Indeterminate (neither Pre or Postmenopausal)	G3					NO	false	TCGA-D1-A174.E45B2436-C0B2-44C3-B400-49C668114B01.pdf	8		40		10		0		20		30		30		40		60	negative	TUMOR FREE	0	0		3	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	D1	0	9	0	19	Endometrial	A	LIVING	65	2010	67f6f0d9-6581-4946-a9c7-a6629da86888		TCGA-D1-A174-01		TCGA-D1-A174-01A-11R-A12H-13	TCGA-D1-A174-01A-11D-A12G-01			67f6f0d9-6581-4946-a9c7-a6629da86888	TCGA-D1-A174-01A-11D-A12K-05			TCGA-D1-A174-01A-11D-A12J-09		83bd3bdb-9bd3-46fa-888c-f6f5efec530f	TCGA-D1-A174-01		TCGA-D1-A174-01A-11D-A12J-09		TCGA-D1-A174-01A-11D-A12J-09	83bd3bdb-9bd3-46fa-888c-f6f5efec530f	TCGA-D1-A174-01A-11D-A12G-01		TCGA-D1-A174-01A-11R-A12H-13	
TCGA-D1-A175-01	MSI-H	0	TCGA-D1-A175-01	202	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1		TCGA-D1-A175	202	0	202	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	48	0	0	TCGA-D1-A175-F20245		Stage IC	NO		-17802	566		0	202				NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	161	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	200	NO		Indeterminate (neither Pre or Postmenopausal)	G3					NO	false	TCGA-D1-A175.4A0D74F3-74A0-4CAE-960B-71D37DF4F4DE.pdf	90		40		20		10		20		0		30		60		60	negative	TUMOR FREE	0	0		3	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	2009	YES	NO	YES	D1	0	17	0	23	Endometrial	A	LIVING	64	2009	5ff09a0f-1deb-41fe-9cad-4ed6556f2bf8		TCGA-D1-A175-01		TCGA-D1-A175-01A-11R-A12H-13	TCGA-D1-A175-01A-11D-A12G-01			5ff09a0f-1deb-41fe-9cad-4ed6556f2bf8	TCGA-D1-A175-01A-11D-A12K-05	e0b67c97-4029-436e-9e17-2a5595c3cf03			TCGA-D1-A175-01A-21-A164-20	ff563951-1c29-4b68-90d1-d120eacd10c5	TCGA-D1-A175-01					ff563951-1c29-4b68-90d1-d120eacd10c5	TCGA-D1-A175-01A-11D-A12G-01		TCGA-D1-A175-01A-11R-A12H-13	
TCGA-D1-A176-01	MSI-H	0	TCGA-D1-A176-01	917	0	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 1	mutation cluster 4	TCGA-D1-A176	917	0	917	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	67		0	TCGA-D1-A176-F20248		Stage IB	NO		-24521	555		0	917				NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	167	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	100	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	TCGA-D1-A176.6F361A45-F13E-44F7-8F3C-00C8B30ACB7A.pdf	13		40		20		10		20		0		20		70		70	negative	TUMOR FREE		0		2	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	D1	0	33	0	57	Endometrial	A	LIVING	94	2009	8e075c0e-43b4-48b0-9bdc-b27b6d6568b3		TCGA-D1-A176-01		TCGA-D1-A176-01A-11R-A12H-13	TCGA-D1-A176-01A-11D-A12G-01			8e075c0e-43b4-48b0-9bdc-b27b6d6568b3	TCGA-D1-A176-01A-11D-A12K-05	cf18931d-e2f9-4e89-a78d-93e5de195854		TCGA-D1-A176-01A-11D-A12J-09	TCGA-D1-A176-01A-21-A164-20	74db6f4a-4298-48d6-93ce-c04b2364a74e	TCGA-D1-A176-01		TCGA-D1-A176-01A-11D-A12J-09		TCGA-D1-A176-01A-11D-A12J-09	74db6f4a-4298-48d6-93ce-c04b2364a74e	TCGA-D1-A176-01A-11D-A12G-01		TCGA-D1-A176-01A-11R-A12H-13	
TCGA-D1-A177-01	MSI-H	0	TCGA-D1-A177-01	548	0	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 12	TCGA-D1-A177	347	1	548	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	NO	YES	YES	Complete Response	70		0	TCGA-D1-A177-F20307		Stage IB	NO	347	-25602	227		0	548			347	NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	152	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	190	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2	Other, specify	Locoregional Disease	paraaortic lymph nodes		YES	false	TCGA-D1-A177.28FF1BEE-6F93-4BCA-A6DC-56A1EA8EA337.pdf	93		40		20		10		20		0		30		60		60	negative	TUMOR FREE		0		2	Complete Remission/Response	No	Never Used		YES	Surgical Resection		RX	R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	D1	0	15	0	45	Endometrial	A	LIVING	53	2010	75b0fdbd-9670-468e-b426-410c95d84426		TCGA-D1-A177-01		TCGA-D1-A177-01A-21R-A12H-13	TCGA-D1-A177-01A-21D-A12G-01			75b0fdbd-9670-468e-b426-410c95d84426	TCGA-D1-A177-01A-21D-A12K-05	10e516c6-19dc-483a-aba2-471e8fb9cb7e		TCGA-D1-A177-01A-21D-A12J-09	TCGA-D1-A177-01A-11-A164-20	fee19b05-44df-4dfe-9d85-c3400673c926	TCGA-D1-A177-01		TCGA-D1-A177-01A-21D-A12J-09		TCGA-D1-A177-01A-21D-A12J-09	fee19b05-44df-4dfe-9d85-c3400673c926	TCGA-D1-A177-01A-21D-A12G-01		TCGA-D1-A177-01A-21R-A12H-13	
TCGA-D1-A179-01	MSS	1	TCGA-D1-A179-01	448	1	Squamous	C6-UCEC	UCEC Serous c4	cluster 3	OV-like c4	UCEC-like c11	miRNA cluster 13	cluster 6		TCGA-D1-A179	427	1	448	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma			NO	Progressive Disease	76		6	TCGA-D1-A179-F20304		Stage IIIC	NO		-28037	230	448	0	206			427	YES		Scheduled Follow-up Submission	2012-1-9	FEMALE	162	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	250	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	High Grade	Lung	Metastatic			YES	false	TCGA-D1-A179.F8F4C024-B723-424C-B98D-AA885C38CDFB.pdf	25		40		10		20		40		0		10		70		70	negative	WITH TUMOR		2		4+	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	YES	NO	YES	D1	6	9	2	21	Endometrial	A	DECEASED	95	2010	c64d52eb-c0aa-4ebe-a21d-0e7f11be7d09		TCGA-D1-A179-01		TCGA-D1-A179-01A-11R-A12H-13	TCGA-D1-A179-01A-11D-A12G-01			c64d52eb-c0aa-4ebe-a21d-0e7f11be7d09	TCGA-D1-A179-01A-11D-A12K-05	1dbc4edf-4733-486e-9f7e-fe0bff8a4428			TCGA-D1-A179-01A-21-A164-20	808b6fb6-14d6-4f7d-b0b9-4550d76ff2f1	TCGA-D1-A179-01					808b6fb6-14d6-4f7d-b0b9-4550d76ff2f1	TCGA-D1-A179-01A-11D-A12G-01		TCGA-D1-A179-01A-11R-A12H-13	
TCGA-D1-A17A-01	MSI-H	0	TCGA-D1-A17A-01	48	0	Iq	C6-UCEC	UCEC CIMP c18	cluster 1		UCEC-like c11	miRNA cluster 13	cluster 6	mutation cluster 1	TCGA-D1-A17A	48	0	48	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	59		0	TCGA-D1-A17A-F20250		Stage IIA	NO		-21560	553		0	48				NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	176	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	60	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-D1-A17A.9E0E5CDA-AE46-4ABC-8AF7-C89FE86B7472.pdf	41		30		10		10		50		0		10		80		80	negative	TUMOR FREE		0		2	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	D1	0	23	0	40	Endometrial	A	LIVING	102	2009	88aec124-1462-4fd5-b209-b0dadf1138bc		TCGA-D1-A17A-01		TCGA-D1-A17A-01A-11R-A12H-13	TCGA-D1-A17A-01A-11D-A12G-01			88aec124-1462-4fd5-b209-b0dadf1138bc	TCGA-D1-A17A-01A-11D-A12K-05			TCGA-D1-A17A-01A-11D-A12J-09		086642bd-2a88-4e8d-a401-7b9f801c78f8	TCGA-D1-A17A-01		TCGA-D1-A17A-01A-11D-A12J-09		TCGA-D1-A17A-01A-11D-A12J-09	086642bd-2a88-4e8d-a401-7b9f801c78f8	TCGA-D1-A17A-01A-11D-A12G-01		TCGA-D1-A17A-01A-11R-A12H-13	
TCGA-D1-A17B-01	MSI-H	0	TCGA-D1-A17B-01	213	0	Iq	C6-UCEC	UCEC CIMP c18	cluster 2	squamous c3	UCEC-like c11	miRNA cluster 12	cluster 2	mutation cluster 4	TCGA-D1-A17B	213	0	213	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	69			TCGA-D1-A17B-F20251		Stage IB	NO		-25504	685		0	213				NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	162	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	140	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	TCGA-D1-A17B.FBE330EA-52BC-4B16-A046-3858318348F5.pdf	8		30		10		10		50		0		20		70		70	negative	TUMOR FREE		0		3	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	D1			0	42	Endometrial	A	LIVING	110	2009	7dc8574f-d39c-4a7d-be83-e326a577b5bb		TCGA-D1-A17B-01		TCGA-D1-A17B-01A-22R-A12H-13	TCGA-D1-A17B-01A-22D-A12G-01			7dc8574f-d39c-4a7d-be83-e326a577b5bb	TCGA-D1-A17B-01A-22D-A12K-05	b0a6109a-aa31-450b-ad32-4b07eb833ec4		TCGA-D1-A17B-01A-22D-A12J-09	TCGA-D1-A17B-01A-31-A164-20	13e38a08-5e5e-4d3e-bd1f-79630bd6b60f	TCGA-D1-A17B-01		TCGA-D1-A17B-01A-22D-A12J-09		TCGA-D1-A17B-01A-22D-A12J-09	13e38a08-5e5e-4d3e-bd1f-79630bd6b60f	TCGA-D1-A17B-01A-22D-A12G-01		TCGA-D1-A17B-01A-22R-A12H-13	
TCGA-D1-A17C-01	MSS	0	TCGA-D1-A17C-01	30	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 4	mutation cluster 4	TCGA-D1-A17C	30	0	30	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	78			TCGA-D1-A17C-F20302		Stage IA	NO		-28571	249		0	30				NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	161	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	130	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	TCGA-D1-A17C.213A073E-C5E1-4BA8-B4D5-23C92E539FA5.pdf	14		5		3		0		5		5		40		55		60	negative	TUMOR FREE				3	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	D1		0		0	Endometrial	A	LIVING	81	2010	1f3910ae-d1c0-4815-836b-25f2926f9258		TCGA-D1-A17C-01		TCGA-D1-A17C-01A-11R-A12H-13	TCGA-D1-A17C-01A-11D-A12G-01			1f3910ae-d1c0-4815-836b-25f2926f9258	TCGA-D1-A17C-01A-11D-A12K-05	1ea520e6-0092-4deb-992a-8ca0bb2b9b6c		TCGA-D1-A17C-01A-11D-A12J-09	TCGA-D1-A17C-01A-21-A164-20	075b0a96-49a0-46af-83ba-5ac2efa09bf2	TCGA-D1-A17C-01		TCGA-D1-A17C-01A-11D-A12J-09		TCGA-D1-A17C-01A-11D-A12J-09	075b0a96-49a0-46af-83ba-5ac2efa09bf2	TCGA-D1-A17C-01A-11D-A12G-01		TCGA-D1-A17C-01A-11R-A12H-13	
TCGA-D1-A17D-01	MSI-H	0	TCGA-D1-A17D-01	926	0	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5	mutation cluster 6	TCGA-D1-A17D	926	0	926	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	58		0	TCGA-D1-A17D-F20254		Stage IB	NO		-21441	541		0	926				YES		Scheduled Follow-up Submission	2012-1-9	FEMALE	155	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	160	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-D1-A17D.1042404C-E963-4620-BC02-E33751FDB96C.pdf	67		5		5		10		5		0		20		70		80	negative	TUMOR FREE		0		1	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009	YES	NO	YES	D1	0	36	0	23	Endometrial	A	LIVING	68	2009	ceaaf6e4-8f99-4fe0-8d2e-8d5aee22ebb9		TCGA-D1-A17D-01		TCGA-D1-A17D-01A-12R-A12H-13	TCGA-D1-A17D-01A-12D-A12G-01			ceaaf6e4-8f99-4fe0-8d2e-8d5aee22ebb9	TCGA-D1-A17D-01A-12D-A12K-05	ad75151c-839f-4245-9f2c-94bf67fc993d		TCGA-D1-A17D-01A-12D-A12J-09	TCGA-D1-A17D-01A-21-A164-20	79f92468-9f12-468e-9a4b-d6962dda3689	TCGA-D1-A17D-01		TCGA-D1-A17D-01A-12D-A12J-09		TCGA-D1-A17D-01A-12D-A12J-09	79f92468-9f12-468e-9a4b-d6962dda3689	TCGA-D1-A17D-01A-12D-A12G-01		TCGA-D1-A17D-01A-12R-A12H-13	
TCGA-D1-A17F-01	MSI-H	0	TCGA-D1-A17F-01	39	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 4	TCGA-D1-A17F	39	0	39	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	68			TCGA-D1-A17F-F20300		Stage IA	NO		-25116	269		0	39				NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	158	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	200	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	TCGA-D1-A17F.62F464EA-9410-4511-8DE8-F0E62AB1E482.pdf	21		3		5		0		2		2		35		63		65	negative	TUMOR FREE		0		2	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	D1		0	0	42	Endometrial	A	LIVING	79	2010	67a8a629-6001-48cb-99b1-588a69f49ecc		TCGA-D1-A17F-01		TCGA-D1-A17F-01A-11R-A12H-13	TCGA-D1-A17F-01A-11D-A12G-01			67a8a629-6001-48cb-99b1-588a69f49ecc	TCGA-D1-A17F-01A-11D-A12K-05	4f996645-41f2-42ca-9d4e-f34184b6f95f		TCGA-D1-A17F-01A-11D-A12J-09	TCGA-D1-A17F-01A-21-A164-20	67291cc4-5864-4c51-a7e7-e96ab1910565	TCGA-D1-A17F-01		TCGA-D1-A17F-01A-11D-A12J-09		TCGA-D1-A17F-01A-11D-A12J-09	67291cc4-5864-4c51-a7e7-e96ab1910565	TCGA-D1-A17F-01A-11D-A12G-01		TCGA-D1-A17F-01A-11R-A12H-13	
TCGA-D1-A17H-01	MSI-H	0	TCGA-D1-A17H-01	852	0	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 4	mutation cluster 7	TCGA-D1-A17H	852	0	852	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	61			TCGA-D1-A17H-F20263	Never Used	Stage IB	NO		-22389			0	852				NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	167	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO			57																	negative	TUMOR FREE		0		0	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	D1		0	0	28	Endometrial		LIVING	96	2009	e9e9ace8-7686-48a6-9e1b-91899268bd11		TCGA-D1-A17H-01		TCGA-D1-A17H-01A-11R-A12H-13	TCGA-D1-A17H-01A-11D-A12G-01			e9e9ace8-7686-48a6-9e1b-91899268bd11	TCGA-D1-A17H-01A-11D-A12K-05	e8a0f2a3-5323-48fe-be8b-d1782ec2cb1e		TCGA-D1-A17H-01A-11D-A12J-09	TCGA-D1-A17H-01A-21-A164-20	cc740327-d6d9-4cf9-a839-81d27eb76cee	TCGA-D1-A17H-01		TCGA-D1-A17H-01A-11D-A12J-09		TCGA-D1-A17H-01A-11D-A12J-09	cc740327-d6d9-4cf9-a839-81d27eb76cee	TCGA-D1-A17H-01A-11D-A12G-01		TCGA-D1-A17H-01A-11R-A12H-13	
TCGA-D1-A17K-01	MSS	0	TCGA-D1-A17K-01	854	0	Squamous	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5	mutation cluster 3	TCGA-D1-A17K	815	1	854	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	NO	NO	YES	Progressive Disease	74			TCGA-D1-A17K-F20268		Stage IA	NO	832	-27283	513		0	854			815	NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	161	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	140	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2	Other, specify	Locoregional Disease	Vagina, apex		YES	false	TCGA-D1-A17K.C9E1B85A-8637-4421-A8CD-2E4BB28B3A73.pdf	0		3		10		5		2		0		5		90		95		TUMOR FREE				2	Complete Remission/Response	No	Never Used		NO	Surgical Resection		R2	R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	D1		0		0	Endometrial	A	LIVING	97	2009	de485b7d-cd88-4889-aff4-e290027f26bb		TCGA-D1-A17K-01		TCGA-D1-A17K-01A-11R-A12H-13	TCGA-D1-A17K-01A-11D-A12G-01			de485b7d-cd88-4889-aff4-e290027f26bb	TCGA-D1-A17K-01A-11D-A12K-05	0c2f85cc-eefa-46ba-adf8-a437b7cfdc8e		TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-01A-21-A164-20	3201128d-0764-462c-a2cf-dde84359dc0c	TCGA-D1-A17K-01		TCGA-D1-A17K-01A-11D-A12J-09		TCGA-D1-A17K-01A-11D-A12J-09	3201128d-0764-462c-a2cf-dde84359dc0c	TCGA-D1-A17K-01A-11D-A12G-01		TCGA-D1-A17K-01A-11R-A12H-13	
TCGA-D1-A17L-01	MSS	0	TCGA-D1-A17L-01	802	0	Iq	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 1	TCGA-D1-A17L	802	0	802	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	81			TCGA-D1-A17L-F20271		Stage IA	NO		-29899	493		0	802				NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	172	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	210	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	TCGA-D1-A17L.BCF17C02-8F6E-419F-AEDF-3AC03AA883E7.pdf	22		12		0		0		2		2		15		83		85	negative	TUMOR FREE		0		0	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	D1		0	0	34	Endometrial	A	LIVING	123	2009	1622de43-ddd8-4a57-a89c-70c427d0a9f6		TCGA-D1-A17L-01		TCGA-D1-A17L-01A-11R-A12H-13	TCGA-D1-A17L-01A-11D-A12G-01			1622de43-ddd8-4a57-a89c-70c427d0a9f6	TCGA-D1-A17L-01A-11D-A12K-05	3d47ab97-2f85-4789-82b6-82268abb08ac		TCGA-D1-A17L-01A-11D-A12J-09	TCGA-D1-A17L-01A-21-A164-20	0edbfb4b-8a04-48c2-a22f-c52068fe3746	TCGA-D1-A17L-01		TCGA-D1-A17L-01A-11D-A12J-09		TCGA-D1-A17L-01A-11D-A12J-09	0edbfb4b-8a04-48c2-a22f-c52068fe3746	TCGA-D1-A17L-01A-11D-A12G-01		TCGA-D1-A17L-01A-11R-A12H-13	
TCGA-D1-A17M-01	MSI-H	0	TCGA-D1-A17M-01	311	0	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 4	TCGA-D1-A17M	311	0	311	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	56			TCGA-D1-A17M-F20272		Stage II	NO		-20685	454		0	311				NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	140	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	TCGA-D1-A17M.E69EF984-AF58-4EB0-93D2-CADE53DF0A6D.pdf	24	10		2		0		3		0		35		65		65		negative	TUMOR FREE		0		3	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	D1		0	0	14	Endometrial	A	LIVING	142	2009	7e8a4ecc-07b0-4765-a8da-5868523736f5		TCGA-D1-A17M-01		TCGA-D1-A17M-01A-21R-A12H-13	TCGA-D1-A17M-01A-21D-A12G-01			7e8a4ecc-07b0-4765-a8da-5868523736f5	TCGA-D1-A17M-01A-21D-A12K-05	c86897da-da1f-47f9-9c4c-3922e75ebe55		TCGA-D1-A17M-01A-21D-A12J-09	TCGA-D1-A17M-01A-11-A164-20	39c3fca6-5049-41cd-b724-9d6bf335ac38	TCGA-D1-A17M-01		TCGA-D1-A17M-01A-21D-A12J-09		TCGA-D1-A17M-01A-21D-A12J-09	39c3fca6-5049-41cd-b724-9d6bf335ac38	TCGA-D1-A17M-01A-21D-A12G-01		TCGA-D1-A17M-01A-21R-A12H-13	
TCGA-D1-A17N-01	MSS	0	TCGA-D1-A17N-01	46	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	squamous c3	UCEC-like c11	miRNA cluster 13	cluster 4	mutation c1uster 9	TCGA-D1-A17N	46	0	46	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	46			TCGA-D1-A17N-F20274		Stage IA	NO		-17045	451		0	46				NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	166	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	110	NO		Peri (6-12 months since last menstrual period)	G2					NO	false	TCGA-D1-A17N.AD892375-1A50-4D9E-8235-A9A495C35B97.pdf	0		0		0		0		0		15		0		85		80	negative	TUMOR FREE				1	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	D1		0		0	Endometrial	A	LIVING	134	2009	ab241aac-4962-4ccd-919c-140031a13dba		TCGA-D1-A17N-01		TCGA-D1-A17N-01A-11R-A12H-13	TCGA-D1-A17N-01A-11D-A12G-01			ab241aac-4962-4ccd-919c-140031a13dba	TCGA-D1-A17N-01A-11D-A12K-05	2cc2a0b7-b673-4572-94ca-c7fedd1db0ac		TCGA-D1-A17N-01A-11D-A12J-09	TCGA-D1-A17N-01A-21-A164-20	7bcfc8b7-4bcd-4d38-8ca5-70b524d25059	TCGA-D1-A17N-01		TCGA-D1-A17N-01A-11D-A12J-09		TCGA-D1-A17N-01A-11D-A12J-09	7bcfc8b7-4bcd-4d38-8ca5-70b524d25059	TCGA-D1-A17N-01A-11D-A12G-01		TCGA-D1-A17N-01A-11R-A12H-13	
TCGA-D1-A17Q-01	MSI-L	0	TCGA-D1-A17Q-01	54	0	Quiet	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5	mutation cluster 11	TCGA-D1-A17Q	54	0	54	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	54			TCGA-D1-A17Q-F20277		Stage IA	NO		-20015	434		0	54				NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	169	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	130	NO		Peri (6-12 months since last menstrual period)	G2					NO	false	TCGA-D1-A17Q.698079B6-EB07-4491-9672-4BDE4E5DAC49.pdf	12		0		0		0		0		0		0		100		65	negative	TUMOR FREE		0		2	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	D1		0	0	29	Endometrial	A	LIVING	68	2009	85b22bad-9b11-474f-9c87-5ddb98c76ccb		TCGA-D1-A17Q-01		TCGA-D1-A17Q-01A-11R-A12H-13	TCGA-D1-A17Q-01A-11D-A12G-01			85b22bad-9b11-474f-9c87-5ddb98c76ccb	TCGA-D1-A17Q-01A-11D-A12K-05	5518e1c8-0cb5-4944-b0cd-c80de1e1b87f		TCGA-D1-A17Q-01A-11D-A12J-09	TCGA-D1-A17Q-01A-21-A164-20	d3437954-4aaf-49c4-9a72-df4f52940ca8	TCGA-D1-A17Q-01				TCGA-D1-A17Q-01A-11D-A12J-09	d3437954-4aaf-49c4-9a72-df4f52940ca8	TCGA-D1-A17Q-01A-11D-A12G-01		TCGA-D1-A17Q-01A-11R-A12H-13	
TCGA-D1-A17R-01	MSI-H	1	TCGA-D1-A17R-01	339	1	BRCA-LUAD+	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 4	TCGA-D1-A17R	339	0	339	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	58			TCGA-D1-A17R-F20285		Stage IA	NO		-21382		339	0					NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy				Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2					NO			5																	negative	TUMOR FREE		0		2	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	D1		0	0	11	Endometrial		DECEASED	126	2009	e500f620-089f-4e15-ba8c-25c91e88e7e2		TCGA-D1-A17R-01		TCGA-D1-A17R-01A-11R-A12H-13	TCGA-D1-A17R-01A-11D-A12G-01			e500f620-089f-4e15-ba8c-25c91e88e7e2	TCGA-D1-A17R-01A-11D-A12K-05	b75b6784-2f5f-4900-8541-d7ad05da5233		TCGA-D1-A17R-01A-11D-A12J-09	TCGA-D1-A17R-01A-21-A164-20	e8cff4ea-f692-4834-86b3-b6c93c157277	TCGA-D1-A17R-01		TCGA-D1-A17R-01A-11D-A12J-09		TCGA-D1-A17R-01A-11D-A12J-09	e8cff4ea-f692-4834-86b3-b6c93c157277	TCGA-D1-A17R-01A-11D-A12G-01		TCGA-D1-A17R-01A-11R-A12H-13	
TCGA-D1-A17S-01	MSS	0	TCGA-D1-A17S-01	739	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 4	TCGA-D1-A17S	739	0	739	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	59			TCGA-D1-A17S-F20288		Stage IA	NO		-21794	419		0	739				NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	280	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	TCGA-D1-A17S.54337BED-9366-4CB6-BA95-BB5999CBF342.pdf	18		0		0		0		0		0		0		100		90	negative	TUMOR FREE		0		2	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	D1		0	0	52	Endometrial	A	LIVING	109	2009	dcd43fa2-2529-47e6-9d9f-931cbf8d4da5		TCGA-D1-A17S-01		TCGA-D1-A17S-01A-11R-A12H-13	TCGA-D1-A17S-01A-11D-A12G-01			dcd43fa2-2529-47e6-9d9f-931cbf8d4da5	TCGA-D1-A17S-01A-11D-A12K-05	3a7c1301-5b80-4043-97f5-99e5b02456a1		TCGA-D1-A17S-01A-11D-A12J-09	TCGA-D1-A17S-01A-21-A164-20	70a8a75a-4f2b-43b8-9183-ca48bc1d238e	TCGA-D1-A17S-01		TCGA-D1-A17S-01A-11D-A12J-09		TCGA-D1-A17S-01A-11D-A12J-09	70a8a75a-4f2b-43b8-9183-ca48bc1d238e	TCGA-D1-A17S-01A-11D-A12G-01		TCGA-D1-A17S-01A-11R-A12H-13	
TCGA-D1-A17T-01	MSS	0	TCGA-D1-A17T-01	71	0	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 3	mutation cluster 4	TCGA-D1-A17T	71	0	71	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	67			TCGA-D1-A17T-F20289		Stage IA	NO		-24652	318		0	71				NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	159	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	130	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	TCGA-D1-A17T.D5927418-5A2B-477D-9917-7CE912628CA4.pdf	25		0		0		0		0		0		0		100		85		TUMOR FREE		0		0	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	D1		0	0	24	Endometrial	A	LIVING	83	2010	2ede539e-5856-4781-bb6f-b1c6efbdf23d		TCGA-D1-A17T-01		TCGA-D1-A17T-01A-11R-A12H-13	TCGA-D1-A17T-01A-11D-A12G-01			2ede539e-5856-4781-bb6f-b1c6efbdf23d	TCGA-D1-A17T-01A-11D-A12K-05	a27dced7-d683-4251-a4a8-a087059d6f19		TCGA-D1-A17T-01A-11D-A12J-09	TCGA-D1-A17T-01A-21-A164-20	c39bb6eb-0427-4ce2-aef9-4a91b67f62fa	TCGA-D1-A17T-01		TCGA-D1-A17T-01A-11D-A12J-09		TCGA-D1-A17T-01A-11D-A12J-09	c39bb6eb-0427-4ce2-aef9-4a91b67f62fa	TCGA-D1-A17T-01A-11D-A12G-01		TCGA-D1-A17T-01A-11R-A12H-13	
TCGA-D1-A17U-01	MSI-H	0	TCGA-D1-A17U-01	697	0	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 4	mutation cluster 1	TCGA-D1-A17U	697	0	697	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	53		4	TCGA-D1-A17U-F20293		Stage IIIC2	NO		-19544	314		0	697				NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	168	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	210	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	TCGA-D1-A17U.A0A4164D-FD8D-4472-BAFA-A036469E22CC.pdf	100	0		0		0		0		0		0		100		65		negative	TUMOR FREE		0		0	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	2009	YES	NO	YES	D1	4	9	0	3	Endometrial	A	LIVING	87	2010	07508c27-8f79-414e-af9d-e78240df5c48		TCGA-D1-A17U-01		TCGA-D1-A17U-01A-21R-A12H-13	TCGA-D1-A17U-01A-21D-A12G-01			07508c27-8f79-414e-af9d-e78240df5c48	TCGA-D1-A17U-01A-21D-A12K-05	0d4eb4b1-2250-4bfe-a2b0-cdc6aa7e7247		TCGA-D1-A17U-01A-21D-A12J-09	TCGA-D1-A17U-01A-11-A164-20	9687df3a-b5c5-4b4e-a11f-a77af2656449	TCGA-D1-A17U-01		TCGA-D1-A17U-01A-21D-A12J-09		TCGA-D1-A17U-01A-21D-A12J-09	9687df3a-b5c5-4b4e-a11f-a77af2656449	TCGA-D1-A17U-01A-21D-A12G-01		TCGA-D1-A17U-01A-21R-A12H-13	
TCGA-D1-A1NS-01	MSI-H	0	TCGA-D1-A1NS-01	43	0	Quiet	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 2		TCGA-D1-A1NS	43	0	43	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	53			TCGA-D1-A1NS-F21633		Stage IA	NO		-19638	92		0	43				NO		Scheduled Follow-up Submission	2012-2-16	FEMALE	178	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	220	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	TCGA-D1-A1NS.FE397385-B600-4450-AE73-3CB62D5FEA3B.pdf	17		40		20		10		20		0		20		70		70	negative	TUMOR FREE	0	0		3	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	D1		0	0	41	Endometrial	A	LIVING	126	2010	48ade293-84c9-41cf-97aa-c28bb4ac4ca6		TCGA-D1-A1NS-01		TCGA-D1-A1NS-01A-11R-A14C-13	TCGA-D1-A1NS-01A-11D-A14F-01			48ade293-84c9-41cf-97aa-c28bb4ac4ca6	TCGA-D1-A1NS-01A-11D-A14H-05				TCGA-D1-A1NS-01A-21-A18Q-20	890c4121-e342-4a2c-b46c-607b0a10e9dc	TCGA-D1-A1NS-01					890c4121-e342-4a2c-b46c-607b0a10e9dc	TCGA-D1-A1NS-01A-11D-A14F-01		TCGA-D1-A1NS-01A-11R-A14C-13	
TCGA-D1-A1NU-01	MSS	0	TCGA-D1-A1NU-01	402	0	Squamous	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 3	TCGA-D1-A1NU	402	0	402	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	74	0	0	TCGA-D1-A1NU-F21638		Stage IA	NO		-27272	87		0	402				NO		Scheduled Follow-up Submission	2012-2-16	FEMALE	151	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	120	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-D1-A1NU.08AE92E6-EDAB-4059-AF51-4A8522EDD463.pdf	16		40		20		10		20		0		25		65		65	negative	TUMOR FREE	0	0		2	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	2009	YES	NO	YES	D1	0	8	0	37	Endometrial	A	LIVING	93	2010	543b9907-bf2a-4f64-b83f-13cc4289310b		TCGA-D1-A1NU-01		TCGA-D1-A1NU-01A-11R-A14C-13	TCGA-D1-A1NU-01A-11D-A14F-01			543b9907-bf2a-4f64-b83f-13cc4289310b	TCGA-D1-A1NU-01A-11D-A14H-05			TCGA-D1-A1NU-01A-11D-A14G-09	TCGA-D1-A1NU-01A-21-A18Q-20	05232d31-7107-4a58-bc70-3a7ef04c1ed1	TCGA-D1-A1NU-01		TCGA-D1-A1NU-01A-11D-A14G-09		TCGA-D1-A1NU-01A-11D-A14G-09	05232d31-7107-4a58-bc70-3a7ef04c1ed1	TCGA-D1-A1NU-01A-11D-A14F-01		TCGA-D1-A1NU-01A-11R-A14C-13	
TCGA-D1-A1NW-01	MSI-L	0	TCGA-D1-A1NW-01	22	0	Squamous		UCEC Serous c4	cluster 3		UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-D1-A1NW	22	0	22	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	72	0	2	TCGA-D1-A1NW-F21642		Stage IVB	NO		-26556	199		0	22				NO		Scheduled Follow-up Submission	2012-2-12	FEMALE	160	Mixed serous and endometrioid	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	80	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-D1-A1NW.10E1E872-408C-458D-9438-00F5ECA3083A.pdf	0		40		20		5		20		0		5		90		90	positive	TUMOR FREE	0	0		4+	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	D1	2	26	0	36	Endometrial	A	LIVING	98	2010	35759844-0020-4b37-bd5a-ede870b7f0ab		TCGA-D1-A1NW-01		TCGA-D1-A1NW-01A-11R-A14L-13	TCGA-D1-A1NW-01A-11D-A14J-01			35759844-0020-4b37-bd5a-ede870b7f0ab	TCGA-D1-A1NW-01A-11D-A14N-05					fb8c4afc-c930-474c-a28a-8f9a408059be	TCGA-D1-A1NW-01					fb8c4afc-c930-474c-a28a-8f9a408059be	TCGA-D1-A1NW-01A-11D-A14J-01		TCGA-D1-A1NW-01A-11R-A14L-13	
TCGA-D1-A1NX-01	MSS	0	TCGA-D1-A1NX-01	555	0	High	C6-UCEC	UCEC Serous c4	cluster 3		UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 3	TCGA-D1-A1NX	476	1	555	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma		YES	NO	Partial Response	66	0	13	TCGA-D1-A1NX-F21565		Stage IIIC	NO		-24441	204		0	555			476	NO		Scheduled Follow-up Submission	2012-2-15	FEMALE	159	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	50	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Metastatic	Supraclavicular lymphnodes		YES	false	TCGA-D1-A1NX.C2A3FA63-63A1-4424-BD92-FAEC1C377C62.pdf	95		2		0		5		4		20		5		70		65	positive	WITH TUMOR	0	8		2	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	2009	YES	NO	YES	D1	13	23	8	39	Endometrial	A	LIVING	87	2010	d04855a8-fdd2-464c-967d-1a58e530539f		TCGA-D1-A1NX-01		TCGA-D1-A1NX-01A-11R-A16E-13	TCGA-D1-A1NX-01A-11D-A16C-01			d04855a8-fdd2-464c-967d-1a58e530539f	TCGA-D1-A1NX-01A-11D-A16G-05			TCGA-D1-A1NX-01A-11D-A16D-09		36253961-4505-4fa9-ae57-96162540c7e5	TCGA-D1-A1NX-01				TCGA-D1-A1NX-01A-11D-A16D-09	36253961-4505-4fa9-ae57-96162540c7e5	TCGA-D1-A1NX-01A-11D-A16C-01		TCGA-D1-A1NX-01A-11R-A16E-13	
TCGA-D1-A1NY-01	MSI-H	0	TCGA-D1-A1NY-01	513	0	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 4		TCGA-D1-A1NY	513	0	513	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	67	0	0	TCGA-D1-A1NY-F21629		Stage IB	NO		-24683	199		0	513				NO		Scheduled Follow-up Submission	2012-2-16	FEMALE	168	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	110	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-D1-A1NY.8F963009-F6C3-4F45-B714-0E96F5D5E526.pdf	85		8		1		3		2		5		20		72		80	negative	TUMOR FREE	0	0		2	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	2009	YES	NO	YES	D1	0	10	0	17	Endometrial	A	LIVING	97	2010	e0397750-69a4-41ef-bcb0-70bc4b2d7c87		TCGA-D1-A1NY-01		TCGA-D1-A1NY-01A-11R-A16E-13	TCGA-D1-A1NY-01A-11D-A16C-01			e0397750-69a4-41ef-bcb0-70bc4b2d7c87	TCGA-D1-A1NY-01A-11D-A16G-05				TCGA-D1-A1NY-01A-21-A18Q-20	8336b6ee-2ac2-4f22-9ca5-f2571d24162d	TCGA-D1-A1NY-01					8336b6ee-2ac2-4f22-9ca5-f2571d24162d	TCGA-D1-A1NY-01A-11D-A16C-01		TCGA-D1-A1NY-01A-11R-A16E-13	
TCGA-D1-A1NZ-01	MSI-H	0	TCGA-D1-A1NZ-01	548	0	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	squamous c3	UCEC-like c11	miRNA cluster 13	cluster 6		TCGA-D1-A1NZ	548	0	548	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	60			TCGA-D1-A1NZ-F17383		Stage IA	NO		-22027	191		0	548				NO		Scheduled Follow-up Submission	2012-2-16	FEMALE	159	Endometrioid endometrial adenocarcinoma	No	Yes, I am currently taking menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	140	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	TCGA-D1-A1NZ.0AFDCBC0-FA0A-4138-A0BE-E374AEB3CB25.pdf	33		50		20		5		20		10		15		70		70	negative	TUMOR FREE	0	0		2	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	D1		0	0	34	Endometrial	A	LIVING	90	2010	e947ba64-793a-4462-9447-5c02a4a9ff39		TCGA-D1-A1NZ-01		TCGA-D1-A1NZ-01A-21R-A14C-13	TCGA-D1-A1NZ-01A-21D-A14F-01			e947ba64-793a-4462-9447-5c02a4a9ff39	TCGA-D1-A1NZ-01A-21D-A14H-05				TCGA-D1-A1NZ-01A-11-A18Q-20	3d88a14a-8f83-4d7a-a5fc-817a49742bf4	TCGA-D1-A1NZ-01					3d88a14a-8f83-4d7a-a5fc-817a49742bf4	TCGA-D1-A1NZ-01A-21D-A14F-01		TCGA-D1-A1NZ-01A-21R-A14C-13	
TCGA-D1-A1O0-01	MSS	0	TCGA-D1-A1O0-01	63	0	BRCA-LUAD+		UCEC non-CIMP c3	cluster 3		UCEC-like c11	miRNA cluster 12	cluster 5		TCGA-D1-A1O0	63	0	63	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	77	0	0	TCGA-D1-A1O0-F21636		Stage IA	NO		-28162	195		0	63				YES		Scheduled Follow-up Submission	2012-2-16	FEMALE	157	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	50	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-D1-A1O0.2F5CADA5-176C-4B9D-9660-53BE86B1CD39.pdf	5		5		8		5		1		0		5		90		95	negative	TUMOR FREE	0	0		0	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	D1	0	5	0	38	Endometrial	A	LIVING	117	2010	6eefe77a-d312-44fc-9b9e-7c3b439a7e23		TCGA-D1-A1O0-01		TCGA-D1-A1O0-01A-11R-A17A-13	TCGA-D1-A1O0-01A-11D-A17C-01			6eefe77a-d312-44fc-9b9e-7c3b439a7e23	TCGA-D1-A1O0-01A-11D-A17F-05					e24d8eeb-9377-48e2-ba3e-b408d1ce7725	TCGA-D1-A1O0-01					e24d8eeb-9377-48e2-ba3e-b408d1ce7725	TCGA-D1-A1O0-01A-11D-A17C-01		TCGA-D1-A1O0-01A-11R-A17A-13	
TCGA-D1-A1O5-01	MSS	0	TCGA-D1-A1O5-01	458	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5		TCGA-D1-A1O5	458	0	458	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	61			TCGA-D1-A1O5-F21574		Stage IA	NO		-22580	174		0	458				NO		Scheduled Follow-up Submission	2012-2-15	FEMALE	161	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	100	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	TCGA-D1-A1O5.F8BEE46E-D0C9-4977-B1C3-DA87AF089B6D.pdf	8		40		20		5		20		10		15		70		70	negative	TUMOR FREE	0	0		3	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	D1		0	0	20	Endometrial	A	LIVING	80	2010	7bc83c49-3fd8-4048-adf4-b461fcffcc00		TCGA-D1-A1O5-01		TCGA-D1-A1O5-01A-11R-A14C-13	TCGA-D1-A1O5-01A-11D-A14F-01			7bc83c49-3fd8-4048-adf4-b461fcffcc00	TCGA-D1-A1O5-01A-11D-A14H-05				TCGA-D1-A1O5-01A-21-A18Q-20	98f3496f-a457-47fa-bb1f-4514f6b33aab	TCGA-D1-A1O5-01					98f3496f-a457-47fa-bb1f-4514f6b33aab	TCGA-D1-A1O5-01A-11D-A14F-01		TCGA-D1-A1O5-01A-11R-A14C-13	
TCGA-D1-A1O7-01	MSI-H	0	TCGA-D1-A1O7-01	32	0	Quiet		UCEC CIMP c18	cluster 2		UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-D1-A1O7	32	0	32	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	60			TCGA-D1-A1O7-F21637		Stage IA	NO		-22037	154		0	32				YES		Scheduled Follow-up Submission	2012-2-16	FEMALE	148	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	50	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	TCGA-D1-A1O7.37C25226-AD56-487E-969B-1538E6E00A5D.pdf	5		40		10		5		40		10		15		70		70		TUMOR FREE				2	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	D1		0		0	Endometrial	A	LIVING	96	2010	00ea54c2-1043-4a7f-ae62-e2851eb94ba1		TCGA-D1-A1O7-01		TCGA-D1-A1O7-01A-11R-A14C-13	TCGA-D1-A1O7-01A-11D-A14F-01			00ea54c2-1043-4a7f-ae62-e2851eb94ba1	TCGA-D1-A1O7-01A-11D-A14H-05					b93d56e4-ebb6-4a1e-855a-c0e1b220968f	TCGA-D1-A1O7-01					b93d56e4-ebb6-4a1e-855a-c0e1b220968f	TCGA-D1-A1O7-01A-11D-A14F-01		TCGA-D1-A1O7-01A-11R-A14C-13	
TCGA-D1-A1O8-01	MSS	1	TCGA-D1-A1O8-01	120	1	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	RNA cluster 3	miRNA cluster 6	cluster 1		TCGA-D1-A1O8	120	0	120	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	70			TCGA-D1-A1O8-F21635		Stage IIIC	NO		-25789	147	120	0					NO		Scheduled Follow-up Submission	2012-2-16	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	200	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-D1-A1O8.8E7FDFD5-892F-4671-8172-FC2BFB800AE9.pdf	85		30		30		10		30		0		10		80		80	negative	TUMOR FREE	0	3		0	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	D1		0	3	3	Endometrial	A	DECEASED	85	2010	980faf04-5313-4f74-99b7-ca004f698a93		TCGA-D1-A1O8-01		TCGA-D1-A1O8-01A-11R-A14C-13	TCGA-D1-A1O8-01A-11D-A14F-01			980faf04-5313-4f74-99b7-ca004f698a93	TCGA-D1-A1O8-01A-11D-A14H-05				TCGA-D1-A1O8-01A-21-A18Q-20	8b15d405-32eb-4f8f-918d-8ae0f3adecc1	TCGA-D1-A1O8-01					8b15d405-32eb-4f8f-918d-8ae0f3adecc1	TCGA-D1-A1O8-01A-11D-A14F-01		TCGA-D1-A1O8-01A-11R-A14C-13	
TCGA-D1-A2G0-01	MSI-H	0	TCGA-D1-A2G0-01	107	0	Kirc+		UCEC CIMP c18	cluster 1	UCEC-like c5		miRNA c1uster 10	cluster 3		TCGA-D1-A2G0			107	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					70	0	0			Stage IB			-25573	1416		0	107							2011-6-2	FEMALE	171	Mixed serous and endometrioid	No			C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	90	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	TCGA-D1-A2G0.02872006-6F7E-4FB7-B1C2-1C5DD3199FE3.pdf	17		20		0		20		10		10		0		70		90	negative	TUMOR FREE	0	0				No							R0	Primary Tumor	01	open	1995		NO	YES	D1	0	13	0	37	Endometrial	A	LIVING	73	2007			TCGA-D1-A2G0-01	ca1b7ca7-5c8b-442d-ab3d-29bd16de1229	TCGA-D1-A2G0-01A-11R-A17A-13	TCGA-D1-A2G0-01A-11D-A17C-01				TCGA-D1-A2G0-01A-11D-A17F-05				TCGA-D1-A2G0-01A-21-A18Q-20	816a5e27-94a6-4934-84e3-0fc510310496	TCGA-D1-A2G0-01	ca1b7ca7-5c8b-442d-ab3d-29bd16de1229				816a5e27-94a6-4934-84e3-0fc510310496	TCGA-D1-A2G0-01A-11D-A17C-01	ca1b7ca7-5c8b-442d-ab3d-29bd16de1229	TCGA-D1-A2G0-01A-11R-A17A-13	ca1b7ca7-5c8b-442d-ab3d-29bd16de1229
TCGA-D1-A2G5-01	MSI-H	0	TCGA-D1-A2G5-01	1260	0	Iq		UCEC CIMP c18	cluster 2		UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-D1-A2G5			1260	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					50	0	0			Stage IB			-18322	1354		0	1260							2011-10-11	FEMALE	173	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	70	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	TCGA-D1-A2G5.741AB1D9-493E-4659-BC2E-BF77A7E1CC14.pdf	20		10		0		10		10		10		0		80		90	negative	WITH TUMOR	0	1				Yes							R0	Primary Tumor	01	open	1995		NO	YES	D1	0	15	1	37	Endometrial	A	LIVING	143	2007	c890843b-4712-4d9f-998d-8ddcb2c39c3c		TCGA-D1-A2G5-01		TCGA-D1-A2G5-01A-11R-A17A-13	TCGA-D1-A2G5-01A-11D-A17C-01			c890843b-4712-4d9f-998d-8ddcb2c39c3c	TCGA-D1-A2G5-01A-11D-A17F-05					8ab4f745-fe1f-4c60-8358-c98023e42e04	TCGA-D1-A2G5-01					8ab4f745-fe1f-4c60-8358-c98023e42e04	TCGA-D1-A2G5-01A-11D-A17C-01		TCGA-D1-A2G5-01A-11R-A17A-13	
TCGA-D1-A2G6-01	MSI-H	1	TCGA-D1-A2G6-01	258	1	BRCA-LUAD+	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 4		TCGA-D1-A2G6			258	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					53	0	0			Stage IIIC			-19547		258	0								2011-6-2	FEMALE	168	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3								94																	positive	WITH TUMOR	0	2				No							R0	Primary Tumor	01	open	1995		NO	YES	D1	0	20	2	30	Endometrial		DECEASED	80	2007	ccc7b7d6-f3a1-48b7-a266-73080858257d		TCGA-D1-A2G6-01		TCGA-D1-A2G6-01A-11R-A17A-13	TCGA-D1-A2G6-01A-11D-A17C-01			ccc7b7d6-f3a1-48b7-a266-73080858257d	TCGA-D1-A2G6-01A-11D-A17F-05				TCGA-D1-A2G6-01A-21-A18Q-20	f03739c0-ba46-429b-a01a-6e68cadf3e57	TCGA-D1-A2G6-01					f03739c0-ba46-429b-a01a-6e68cadf3e57	TCGA-D1-A2G6-01A-11D-A17C-01		TCGA-D1-A2G6-01A-11R-A17A-13	
TCGA-D1-A2G7-01	MSS	0	TCGA-D1-A2G7-01	1365	0	Squamous	C6-UCEC	UCEC Serous c4		UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-D1-A2G7			1365	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					65	0	0			Stage IB			-23913			0	1365							2011-10-11	FEMALE	164	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy				Peri (6-12 months since last menstrual period)	G3								8																	negative	TUMOR FREE	0	0				No							R0	Primary Tumor	01	open	1995		NO	YES	D1	0	23	0	48	Endometrial		LIVING	133	2007	bddd28d0-8d22-4949-b890-9cd54a4a0f29		TCGA-D1-A2G7-01		TCGA-D1-A2G7-01A-21R-A17X-13	TCGA-D1-A2G7-01A-21D-A17U-01			bddd28d0-8d22-4949-b890-9cd54a4a0f29	TCGA-D1-A2G7-01A-21D-A17Z-05				TCGA-D1-A2G7-01A-12-A18R-20	ca99ea64-d659-46e3-acf0-aaad68d89aaf	TCGA-D1-A2G7-01					ca99ea64-d659-46e3-acf0-aaad68d89aaf	TCGA-D1-A2G7-01A-21D-A17U-01		TCGA-D1-A2G7-01A-21R-A17X-13	
TCGA-D1-A3DA-01	MSI-L	0	TCGA-D1-A3DA-01	8	0	Iq		UCEC non-CIMP c3		UCEC-like c5		miRNA cluster 13			TCGA-D1-A3DA			8	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					77					Stage IIIC1			-28142	128		0	8							2012-2-15	FEMALE	152	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Excisional Biopsy	110	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	TCGA-D1-A3DA.8F3D4AFC-2E70-4633-A58F-C98ED00A8964.pdf	17		2		0		5		0		0		5		90		85	positive	TUMOR FREE						No							R0	Primary Tumor	01	open	2009		NO	YES	D1	0	19	1	34	Endometrial	A	LIVING	57	2011			TCGA-D1-A3DA-01	21fd1035-30e0-4851-88c6-35d2693e6dcd	TCGA-D1-A3DA-01A-12R-A214-13	TCGA-D1-A3DA-01A-12D-A20R-01				TCGA-D1-A3DA-01A-12D-A212-05				TCGA-D1-A3DA-01A-21-A23Z-20	702f6e84-0194-44b9-ba70-6ea6f5abdaf6	TCGA-D1-A3DA-01	21fd1035-30e0-4851-88c6-35d2693e6dcd				702f6e84-0194-44b9-ba70-6ea6f5abdaf6	TCGA-D1-A3DA-01A-12D-A20R-01	21fd1035-30e0-4851-88c6-35d2693e6dcd	TCGA-D1-A3DA-01A-12R-A214-13	21fd1035-30e0-4851-88c6-35d2693e6dcd
TCGA-D1-A3DG-01	MSS	0	TCGA-D1-A3DG-01	130	0	Squamous		UCEC non-CIMP c3		UCEC-like c5		miRNA c1uster 10			TCGA-D1-A3DG			130	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					81					Stage IVB			-29771	49		0	130							2012-2-15	FEMALE	168	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Excisional Biopsy	140	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	TCGA-D1-A3DG.97C44FFC-8D88-43DC-BCC9-F634151C7098.pdf	41		0		0		0		0		0		0		100		75	positive	TUMOR FREE						No							R0	Primary Tumor	01	open	2009		NO	YES	D1		0		0	Endometrial	A	LIVING	86	2011			TCGA-D1-A3DG-01	11a0e295-f45e-4979-8317-10429d515d34	TCGA-D1-A3DG-01A-11R-A19V-13	TCGA-D1-A3DG-01A-11D-A19X-01				TCGA-D1-A3DG-01A-11D-A19Z-05				TCGA-D1-A3DG-01A-21-A23Z-20	0b411fe7-3550-44e6-96c4-75771ed40448	TCGA-D1-A3DG-01	11a0e295-f45e-4979-8317-10429d515d34				0b411fe7-3550-44e6-96c4-75771ed40448	TCGA-D1-A3DG-01A-11D-A19X-01	11a0e295-f45e-4979-8317-10429d515d34	TCGA-D1-A3DG-01A-11R-A19V-13	11a0e295-f45e-4979-8317-10429d515d34
TCGA-D1-A3DH-01	MSS	0	TCGA-D1-A3DH-01	125	0	High		UCEC Serous c4		UCEC-like c5		miRNA c1uster 9			TCGA-D1-A3DH			125	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					71					Stage IA			-25935	43		0	125							2012-2-15	FEMALE	168	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Excisional Biopsy	150	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	TCGA-D1-A3DH.C63CF985-CF78-42EE-A7A2-22083FED571D.pdf	11		0		0		0		0		0		0		100		85	negative	TUMOR FREE						No							R0	Primary Tumor	01	open	2009		NO	YES	D1	0	14	0	48	Endometrial	A	LIVING	76	2011			TCGA-D1-A3DH-01	8576f260-e8fb-4fbf-81ad-34fb4af302fd	TCGA-D1-A3DH-01A-11R-A19V-13	TCGA-D1-A3DH-01A-11D-A19X-01				TCGA-D1-A3DH-01A-11D-A19Z-05				TCGA-D1-A3DH-01A-21-A23Z-20	b698ed44-9263-4ea7-9c55-0f3449c60bf7	TCGA-D1-A3DH-01	8576f260-e8fb-4fbf-81ad-34fb4af302fd				b698ed44-9263-4ea7-9c55-0f3449c60bf7	TCGA-D1-A3DH-01A-11D-A19X-01	8576f260-e8fb-4fbf-81ad-34fb4af302fd	TCGA-D1-A3DH-01A-11R-A19V-13	8576f260-e8fb-4fbf-81ad-34fb4af302fd
TCGA-D1-A3JP-01	MSS	0	TCGA-D1-A3JP-01	515	0	Squamous		UCEC Serous c4		UCEC-like c5		miRNA cluster 4			TCGA-D1-A3JP	515	0	515	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					61					Stage IA	NO		-22538	101		0	515				NO			2013-3-20	FEMALE	159	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	170	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-D1-A3JP.62290E86-409F-4590-AA2C-D3D2F77148FF.pdf	0		0		0		0		0		0		0		100		60	negative	TUMOR FREE			NO	2	Partial Remission/Response	Yes	Never Used		YES				R0	Primary Tumor	01	open	2009		NO	YES	D1	0	18	0	56	Endometrial	A	LIVING	59	2011			TCGA-D1-A3JP-01	f579f0dc-d6e3-4960-9769-5038e69aa712	TCGA-D1-A3JP-01A-31R-A22I-13	TCGA-D1-A3JP-01A-31D-A227-01				TCGA-D1-A3JP-01A-31D-A22B-05				TCGA-D1-A3JP-01A-21-A240-20	82de897e-d9cd-4e1a-84ba-6b036a71933f	TCGA-D1-A3JP-01	f579f0dc-d6e3-4960-9769-5038e69aa712				82de897e-d9cd-4e1a-84ba-6b036a71933f	TCGA-D1-A3JP-01A-31D-A227-01	f579f0dc-d6e3-4960-9769-5038e69aa712	TCGA-D1-A3JP-01A-31R-A22I-13	f579f0dc-d6e3-4960-9769-5038e69aa712
TCGA-D1-A3JQ-01	MSS		TCGA-D1-A3JQ-01			Squamous		UCEC Serous c4		UCEC-like c5		miRNA cluster 14			TCGA-D1-A3JQ				Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma														77																							150	NO									true	TCGA-D1-A3JQ.2001A1EC-1385-4EB3-BC9E-7E48143FD663.pdf			15		8		5		5		0		25		70		75																Primary Tumor	01												A						TCGA-D1-A3JQ-01	10c76952-15aa-44e9-8197-26529889bb6a	TCGA-D1-A3JQ-01A-11R-A22I-13	TCGA-D1-A3JQ-01A-11D-A227-01				TCGA-D1-A3JQ-01A-11D-A22B-05				TCGA-D1-A3JQ-01A-21-A23Z-20	4e3bbb25-a4de-4bbb-b500-c98089fdce7b	TCGA-D1-A3JQ-01	10c76952-15aa-44e9-8197-26529889bb6a				4e3bbb25-a4de-4bbb-b500-c98089fdce7b	TCGA-D1-A3JQ-01A-11D-A227-01	10c76952-15aa-44e9-8197-26529889bb6a	TCGA-D1-A3JQ-01A-11R-A22I-13	10c76952-15aa-44e9-8197-26529889bb6a
TCGA-DF-A2KN-01	MSI-H		TCGA-DF-A2KN-01			Quiet		UCEC CIMP c18		UCEC-like c5		miRNA cluster 5			TCGA-DF-A2KN				Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma																																					200	NO									false	TCGA-DF-A2KN.A61CE064-B18B-429E-93F1-BA0FC06AB310.pdf			20		6		0		3		0		10		90		90																Primary Tumor	01												A						TCGA-DF-A2KN-01	291167cc-8f00-47e1-abe2-72388c98170d	TCGA-DF-A2KN-01A-11R-A17X-13	TCGA-DF-A2KN-01A-11D-A17U-01				TCGA-DF-A2KN-01A-11D-A17Z-05				TCGA-DF-A2KN-01A-21-A18R-20	23f03fb6-b053-43c3-879e-ea71f99dab44	TCGA-DF-A2KN-01	291167cc-8f00-47e1-abe2-72388c98170d				23f03fb6-b053-43c3-879e-ea71f99dab44	TCGA-DF-A2KN-01A-11D-A17U-01	291167cc-8f00-47e1-abe2-72388c98170d	TCGA-DF-A2KN-01A-11R-A17X-13	291167cc-8f00-47e1-abe2-72388c98170d
TCGA-DF-A2KR-01	MSS		TCGA-DF-A2KR-01			High		UCEC non-CIMP c3				miRNA c1uster 10	cluster 2		TCGA-DF-A2KR				Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma																																					80	NO									false	TCGA-DF-A2KR.7252DF0D-0D16-48DD-9484-9C4B83012927.pdf			25		15		2		5		0		5		93		95																Primary Tumor	01												A						TCGA-DF-A2KR-01	b8e18fd7-ff5d-44b9-b977-945622d2a59e	TCGA-DF-A2KR-01A-11R-A17X-13	TCGA-DF-A2KR-01A-11D-A17U-01				TCGA-DF-A2KR-01A-11D-A17Z-05					273b9927-b093-4071-9163-64b44ea7d4c2	TCGA-DF-A2KR-01	b8e18fd7-ff5d-44b9-b977-945622d2a59e				273b9927-b093-4071-9163-64b44ea7d4c2	TCGA-DF-A2KR-01A-11D-A17U-01	b8e18fd7-ff5d-44b9-b977-945622d2a59e	TCGA-DF-A2KR-01A-11R-A17X-13	b8e18fd7-ff5d-44b9-b977-945622d2a59e
TCGA-DF-A2KS-01	MSS		TCGA-DF-A2KS-01			High	C6-UCEC	UCEC non-CIMP c3		UCEC-like c5	UCEC-like c11	miRNA cluster 12			TCGA-DF-A2KS				Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma																																					120	NO									false	TCGA-DF-A2KS.C6638C17-4F05-491F-86ED-6D7DDB1B8FDE.pdf			5		3		20		8		0		5		75		95																Primary Tumor	01												A				05a3cad5-b1a2-481d-a2b7-f0e80ec78ed2		TCGA-DF-A2KS-01		TCGA-DF-A2KS-01A-11R-A18L-13	TCGA-DF-A2KS-01A-11D-A18N-01			05a3cad5-b1a2-481d-a2b7-f0e80ec78ed2	TCGA-DF-A2KS-01A-11D-A18O-05				TCGA-DF-A2KS-01A-21-A23Z-20	bb4cff70-b866-4f37-aa9e-745d32627ff0	TCGA-DF-A2KS-01					bb4cff70-b866-4f37-aa9e-745d32627ff0	TCGA-DF-A2KS-01A-11D-A18N-01		TCGA-DF-A2KS-01A-11R-A18L-13	
TCGA-DF-A2KU-01	MSI-L		TCGA-DF-A2KU-01			Kirc+		UCEC CIMP c18		UCEC-like c5		miRNA cluster 13			TCGA-DF-A2KU				Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma																																																																																	Primary Tumor	01																		TCGA-DF-A2KU-01	ee0873f1-b89d-44ef-9aad-d40c5a8999f1	TCGA-DF-A2KU-01A-11R-A17X-13	TCGA-DF-A2KU-01A-11D-A17U-01				TCGA-DF-A2KU-01A-11D-A17Z-05				TCGA-DF-A2KU-01A-21-A18R-20	a726d588-1f2a-4d15-bed4-fdb6831e0a18	TCGA-DF-A2KU-01	ee0873f1-b89d-44ef-9aad-d40c5a8999f1				a726d588-1f2a-4d15-bed4-fdb6831e0a18	TCGA-DF-A2KU-01A-11D-A17U-01	ee0873f1-b89d-44ef-9aad-d40c5a8999f1	TCGA-DF-A2KU-01A-11R-A17X-13	ee0873f1-b89d-44ef-9aad-d40c5a8999f1
TCGA-DF-A2KV-01	MSS	0	TCGA-DF-A2KV-01	936	0	Quiet		UCEC non-CIMP c3		UCEC-like c5		miRNA c1uster 10			TCGA-DF-A2KV	936	0	936	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	55			TCGA-DF-A2KV-F49904		Stage IB	NO		-20160			0	936				NO			2013-10-14	FEMALE		Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Cytology (e.g. Peritoneal or pleural fluid)	580	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-DF-A2KV.5717937B-AC81-452E-9B4D-3301FDA7CD0B.pdf	21		5		5		0		25		0		15		85		85	negative	TUMOR FREE	0	0		0		No							RX	Primary Tumor	01	open			NO	YES	DF		0	0	21	Endometrial	A	LIVING					TCGA-DF-A2KV-01	5378bbbf-3ddf-43bf-824d-fcb46028f571	TCGA-DF-A2KV-01A-11R-A17X-13	TCGA-DF-A2KV-01A-11D-A17U-01				TCGA-DF-A2KV-01A-11D-A17Z-05				TCGA-DF-A2KV-01A-21-A18R-20	9cc217c6-880d-416b-afdb-300c56a3c8e6	TCGA-DF-A2KV-01	5378bbbf-3ddf-43bf-824d-fcb46028f571				9cc217c6-880d-416b-afdb-300c56a3c8e6	TCGA-DF-A2KV-01A-11D-A17U-01	5378bbbf-3ddf-43bf-824d-fcb46028f571	TCGA-DF-A2KV-01A-11R-A17X-13	5378bbbf-3ddf-43bf-824d-fcb46028f571
TCGA-DF-A2KY-01	MSI-H	0	TCGA-DF-A2KY-01	332	0	Kirc+		BRCA CIMP c7		BRCA basal-like c6		miRNA c1uster 9			TCGA-DF-A2KY			332	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					49	0	0			Stage IVA			-18086			0	332							2014-6-20	FEMALE		Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES	Hysteroscopy and endometrial ablation	Other method, specify:	960	NO		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3						false	TCGA-DF-A2KY.8A35F74A-AFA4-4B2D-931B-FA2DE895F010.pdf	73.3		0		0		0		0		0		0		100		90		WITH TUMOR	0	1	YES			No			NO				R1	Primary Tumor	01	open	2009		NO	YES	DF	0	0	1	12	Endometrial	A	LIVING					TCGA-DF-A2KY-01	872ef409-1ec0-4856-859c-37be70ebce35	TCGA-DF-A2KY-01A-21R-A214-13	TCGA-DF-A2KY-01A-21D-A20R-01				TCGA-DF-A2KY-01A-21D-A212-05				TCGA-DF-A2KY-01A-41-A23Z-20	cbf4a517-14f1-41b9-a97f-322fba5c37bf	TCGA-DF-A2KY-01	872ef409-1ec0-4856-859c-37be70ebce35				cbf4a517-14f1-41b9-a97f-322fba5c37bf	TCGA-DF-A2KY-01A-21D-A20R-01	872ef409-1ec0-4856-859c-37be70ebce35	TCGA-DF-A2KY-01A-21R-A214-13	872ef409-1ec0-4856-859c-37be70ebce35
TCGA-DF-A2KZ-01	MSI-H	0	TCGA-DF-A2KZ-01	826	0	Iq		UCEC CIMP c18		UCEC-like c5		miRNA cluster 13			TCGA-DF-A2KZ	826	0	826	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					87	0	0			Stage IB			-31973			0	826							2014-6-11	FEMALE		Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Tumor resection	450	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-DF-A2KZ.D69C73D1-1CEB-4AF5-AAF2-8E707EF4CA38.pdf	25		0		0		0		0		0		25		75		75	negative	TUMOR FREE	0	0	NO			No			YES				RX	Primary Tumor	01	open	2009		NO	YES	DF	0	0	0	0	Endometrial	A	LIVING					TCGA-DF-A2KZ-01	dff76521-f81c-4de8-9a80-d75d18fe7982	TCGA-DF-A2KZ-01A-11R-A214-13	TCGA-DF-A2KZ-01A-11D-A20R-01				TCGA-DF-A2KZ-01A-11D-A212-05				TCGA-DF-A2KZ-01A-21-A23Z-20	3f881f6d-0ef2-4ef6-9e3c-8723150c71f0	TCGA-DF-A2KZ-01	dff76521-f81c-4de8-9a80-d75d18fe7982				3f881f6d-0ef2-4ef6-9e3c-8723150c71f0	TCGA-DF-A2KZ-01A-11D-A20R-01	dff76521-f81c-4de8-9a80-d75d18fe7982	TCGA-DF-A2KZ-01A-11R-A214-13	dff76521-f81c-4de8-9a80-d75d18fe7982
TCGA-DF-A2L0-01	MSS		TCGA-DF-A2L0-01			High		UCEC non-CIMP c3		UCEC-like c5		miRNA cluster 5			TCGA-DF-A2L0				Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma																																					520	NO									false	TCGA-DF-A2L0.1679CA2C-86BF-41D1-96E1-62FC89D9AAA7.pdf			5		5		5		10		0		20		75		80																Primary Tumor	01												A						TCGA-DF-A2L0-01	60fc2e50-f36c-4074-879b-b5773d75a466	TCGA-DF-A2L0-01A-11R-A17X-13	TCGA-DF-A2L0-01A-11D-A17U-01				TCGA-DF-A2L0-01A-11D-A17Z-05				TCGA-DF-A2L0-01A-21-A18R-20	11d73d7e-bb9d-4e7c-96df-7342e0de106f	TCGA-DF-A2L0-01	60fc2e50-f36c-4074-879b-b5773d75a466				11d73d7e-bb9d-4e7c-96df-7342e0de106f	TCGA-DF-A2L0-01A-11D-A17U-01	60fc2e50-f36c-4074-879b-b5773d75a466	TCGA-DF-A2L0-01A-11R-A17X-13	60fc2e50-f36c-4074-879b-b5773d75a466
TCGA-DI-A0WH-01	MSI-H	0	TCGA-DI-A0WH-01	496	0	Iq	C6-UCEC	UCEC non-CIMP c3	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 1	TCGA-DI-A0WH	496	0	496	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	64	0	0	TCGA-DI-A0WH-F16112	Former User	Stage IB	NO		-23692	244		0	496				YES		Scheduled Follow-up Submission	2011-9-13	FEMALE	173	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	180	NO			G3					NO	false	TCGA-DI-A0WH.3D6B2D82-2F6D-40E6-8138-4DBF33DE8BEF.pdf	15.6	0	0	0	0	0	0	0	0	0	0	10	5	90	95	90	95		TUMOR FREE	0	0		2	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01		2009	NO	NO	YES	DI	0	2	0	18	Endometrial	A	LIVING	107	2010	46b06f7a-18ed-42a6-9cb9-75e6dc98b30e		TCGA-DI-A0WH-01		TCGA-DI-A0WH-01A-12R-A12H-13	TCGA-DI-A0WH-01A-12D-A12G-01			46b06f7a-18ed-42a6-9cb9-75e6dc98b30e	TCGA-DI-A0WH-01A-12D-A12K-05	3f62fddf-883b-41e2-8ba6-226563893ce0		TCGA-DI-A0WH-01A-12D-A12J-09	TCGA-DI-A0WH-01A-21-A163-20	c59351e2-41f9-4c88-8a72-571cdb4bb797	TCGA-DI-A0WH-01		TCGA-DI-A0WH-01A-12D-A12J-09		TCGA-DI-A0WH-01A-12D-A12J-09	c59351e2-41f9-4c88-8a72-571cdb4bb797	TCGA-DI-A0WH-01A-12D-A12G-01		TCGA-DI-A0WH-01A-12R-A12H-13	
TCGA-DI-A1BU-01	MSI-H	0	TCGA-DI-A1BU-01	1195	0	Quiet		UCEC non-CIMP c3	cluster 2	UCEC-like c5		miRNA cluster 6	cluster 1		TCGA-DI-A1BU	1195	0	1195	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	55	0	0	TCGA-DI-A1BU-F20903	Former User	Stage IIB	NO		-20114	903		0	1195				NO		Scheduled Follow-up Submission	2012-1-24	FEMALE	171	Mixed serous and endometrioid	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES	endometrial biopsy	Other method, specify:	140	NO			G3					NO	false	TCGA-DI-A1BU.18A286FD-E85B-48FC-B193-456AB10D24B9.pdf	15.8		40		20		10		20		0		10		80		80		TUMOR FREE	0	0		3	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01		2009	YES	NO	YES	DI	0	6	0	25	Endometrial	A	LIVING	93	2008				60728ff8-1098-4ed9-9cc0-b3d5523736d3	TCGA-DI-A1BU-01A-11R-A136-13	TCGA-DI-A1BU-01A-11D-A134-01				TCGA-DI-A1BU-01A-11D-A138-05				TCGA-DI-A1BU-01A-21-A18Q-20	6b81a2af-e9da-4ab6-a5a3-b80fd6fc442f		60728ff8-1098-4ed9-9cc0-b3d5523736d3				6b81a2af-e9da-4ab6-a5a3-b80fd6fc442f	TCGA-DI-A1BU-01A-11D-A134-01	60728ff8-1098-4ed9-9cc0-b3d5523736d3	TCGA-DI-A1BU-01A-11R-A136-13	60728ff8-1098-4ed9-9cc0-b3d5523736d3
TCGA-DI-A1BY-01	MSS	0	TCGA-DI-A1BY-01	1114	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 4		TCGA-DI-A1BY	1114	0	1114	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	63			TCGA-DI-A1BY-F20963	Never Used	Stage IIB	NO		-23113	989		0	1114				YES		Scheduled Follow-up Submission	2012-1-25	FEMALE	155	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES	Uterine scrapings	Other method, specify:	140	NO			G2					NO	false	TCGA-DI-A1BY.8B96371D-5E42-461B-B7A2-AB9641D842CD.pdf	17		40		20		10		20		0		30		60		60	negative	TUMOR FREE	0	0		4+	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01		2009	NO	NO	YES	DI		0	0	6	Endometrial	A	LIVING	125	2008	4d54cfbb-2bb7-4a45-b870-7ac7c87cae5e		TCGA-DI-A1BY-01		TCGA-DI-A1BY-01A-21R-A136-13	TCGA-DI-A1BY-01A-21D-A134-01			4d54cfbb-2bb7-4a45-b870-7ac7c87cae5e	TCGA-DI-A1BY-01A-21D-A138-05				TCGA-DI-A1BY-01A-31-A18Q-20	21c0c9eb-31d7-4c52-9c55-b8b6cc00160e	TCGA-DI-A1BY-01					21c0c9eb-31d7-4c52-9c55-b8b6cc00160e	TCGA-DI-A1BY-01A-21D-A134-01		TCGA-DI-A1BY-01A-21R-A136-13	
TCGA-DI-A1C3-01	MSS	0	TCGA-DI-A1C3-01	739	0	Quiet		UCEC non-CIMP c3	cluster 4			miRNA cluster 13	cluster 4		TCGA-DI-A1C3	739	0	739	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	38			TCGA-DI-A1C3-F20968	Never Used	Stage IB	NO		-13885	755		0	739				YES		Scheduled Follow-up Submission	2012-1-25	FEMALE	171	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES	polyp removal	Other method, specify:	170	NO			G2					NO	false	TCGA-DI-A1C3.63A6706E-823B-456E-A3BC-65755C07CF62.pdf	8.6		40		20		10		20		0		10		80		80		TUMOR FREE				0	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01		2009	NO	NO	YES	DI		0		0	Endometrial	A	LIVING	144	2008			TCGA-DI-A1C3-01	016f584a-453b-4e91-a311-0c0120e127d0	TCGA-DI-A1C3-01A-41R-A136-13	TCGA-DI-A1C3-01A-41D-A134-01				TCGA-DI-A1C3-01A-41D-A138-05					5b26fbee-95aa-44bd-9c32-7ff0046e8105	TCGA-DI-A1C3-01	016f584a-453b-4e91-a311-0c0120e127d0				5b26fbee-95aa-44bd-9c32-7ff0046e8105	TCGA-DI-A1C3-01A-41D-A134-01	016f584a-453b-4e91-a311-0c0120e127d0	TCGA-DI-A1C3-01A-41R-A136-13	016f584a-453b-4e91-a311-0c0120e127d0
TCGA-DI-A1NN-01	MSS	0	TCGA-DI-A1NN-01	1076	0	High	C6-UCEC	OV-like c1	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 4	cluster 2	mutation cluster 5	TCGA-DI-A1NN	1023	1	1076	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	NO	YES	Complete Response	63	0	2	TCGA-DI-A1NN-F19104		Stage IIIC	NO	1023	-23026	813		0	1076			1023	NO		Scheduled Follow-up Submission	2011-12-2	FEMALE	173	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.		C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	300	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Metastatic	vagina		YES	false	TCGA-DI-A1NN.EBBDE504-29C9-4662-8D06-44E8CBAD0741.pdf	3		40		10		10		30		0		10		80		80		WITH TUMOR	0	0		2	Complete Remission/Response	No	Never Used		NO	Excisional Biopsy		R2	R0	Primary Tumor	01	Minimally Invasive	1988	YES	NO	YES	DI	2	9	0	10	Endometrial	A	LIVING	71	2008	1857cddd-76d1-403b-a14e-f14d0781f68b		TCGA-DI-A1NN-01		TCGA-DI-A1NN-01A-11R-A16E-13	TCGA-DI-A1NN-01A-11D-A16C-01			1857cddd-76d1-403b-a14e-f14d0781f68b	TCGA-DI-A1NN-01A-11D-A16G-05			TCGA-DI-A1NN-01A-11D-A16D-09	TCGA-DI-A1NN-01A-21-A18Q-20	9beb761d-638d-4b8b-be2b-975404a92ab2	TCGA-DI-A1NN-01		TCGA-DI-A1NN-01A-11D-A16D-09		TCGA-DI-A1NN-01A-11D-A16D-09	9beb761d-638d-4b8b-be2b-975404a92ab2	TCGA-DI-A1NN-01A-11D-A16C-01		TCGA-DI-A1NN-01A-11R-A16E-13	
TCGA-DI-A1NN-11	MSS	0	TCGA-DI-A1NN-11	1076	0		C6-UCEC							mutation cluster 5	TCGA-DI-A1NN	1023	1	1076	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	NO	YES	Complete Response	63	0	2	TCGA-DI-A1NN-F19104		Stage IIIC	NO	1023	-23026	813		0	1076			1023	NO		Scheduled Follow-up Submission	2011-12-2	FEMALE	173	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.		C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	100	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Metastatic	vagina		YES	false		3		40		20		0		20		100		0		0		0		WITH TUMOR	0	0		2	Complete Remission/Response	No	Never Used		NO	Excisional Biopsy		R2	R0	Solid Tissue Normal	11	Minimally Invasive	1988	YES	NO	YES	DI	2	9	0	10	Endometrial	A	LIVING	71	2008										TCGA-DI-A1NN-11A-21D-A16G-05															
TCGA-DI-A1NO-01	MSS	1	TCGA-DI-A1NO-01	285	1	Squamous	C6-UCEC	OV-like c1	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5		TCGA-DI-A1NO	285	0	285	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Progressive Disease	68	0	0	TCGA-DI-A1NO-F20801	Never Used	Stage IIIA	NO		-24996	688	285	0					YES		Scheduled Follow-up Submission	2012-1-23	FEMALE	166	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	270	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-DI-A1NO.11CEAAB6-3853-48EB-94CE-1B11FEF45B4C.pdf	1.03		40		20		10		20		0		10		80		80		WITH TUMOR	0	0		1	Complete Remission/Response	No	Never Used		NO				RX	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	DI	0	0	0	2	Endometrial	A	DECEASED	122	2009	272f94bc-ce8b-46ff-b13f-827bba6071d5		TCGA-DI-A1NO-01		TCGA-DI-A1NO-01A-31R-A156-13	TCGA-DI-A1NO-01A-31D-A160-01			272f94bc-ce8b-46ff-b13f-827bba6071d5	TCGA-DI-A1NO-01A-31D-A161-05				TCGA-DI-A1NO-01A-21-A18Q-20	3fdbb9cf-afb9-41f3-8963-eef43dafc703	TCGA-DI-A1NO-01					3fdbb9cf-afb9-41f3-8963-eef43dafc703	TCGA-DI-A1NO-01A-31D-A160-01		TCGA-DI-A1NO-01A-31R-A156-13	
TCGA-DI-A1NO-11	MSS	1	TCGA-DI-A1NO-11	285	1		C6-UCEC								TCGA-DI-A1NO	285	0	285	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Progressive Disease	68	0	0	TCGA-DI-A1NO-F20801	Never Used	Stage IIIA	NO		-24996	688	285	0					YES		Scheduled Follow-up Submission	2012-1-23	FEMALE	166	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	240	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false		1.03		40		10		0		40		100		0		0		0		WITH TUMOR	0	0		1	Complete Remission/Response	No	Never Used		NO				RX	Solid Tissue Normal	11	Minimally Invasive	2009	NO	NO	YES	DI	0	0	0	2	Endometrial	A	DECEASED	122	2009										TCGA-DI-A1NO-11A-11D-A161-05															
TCGA-DI-A2QT-01	MSS	1	TCGA-DI-A2QT-01	377	1	BRCA-LUAD+		UCEC Serous c4		squamous c3		miRNA cluster 14			TCGA-DI-A2QT			377	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					51	0	10			Stage IIIC			-18835	1186	377	0								2011-8-26	FEMALE	156	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	280	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	TCGA-DI-A2QT.416DF035-67B0-4461-9523-EB4A4A1FBA5B.pdf	96		20		5		0		5		0		40		60		60		WITH TUMOR	0	7				No							R2	Primary Tumor	01	Minimally Invasive	1988		NO	YES	DI	10	10	7	15	Endometrial	A	DECEASED	62	2008			TCGA-DI-A2QT-01	859fec54-ae79-44fa-8021-b6dd66d529da	TCGA-DI-A2QT-01A-12R-A19V-13	TCGA-DI-A2QT-01A-12D-A19X-01				TCGA-DI-A2QT-01A-12D-A19Z-05				TCGA-DI-A2QT-01A-21-A23Z-20	22b4f846-1d1e-421c-bbae-0ab9e6a67275	TCGA-DI-A2QT-01	859fec54-ae79-44fa-8021-b6dd66d529da				22b4f846-1d1e-421c-bbae-0ab9e6a67275	TCGA-DI-A2QT-01A-12D-A19X-01	859fec54-ae79-44fa-8021-b6dd66d529da	TCGA-DI-A2QT-01A-12R-A19V-13	859fec54-ae79-44fa-8021-b6dd66d529da
TCGA-DI-A2QU-01	MSS	1	TCGA-DI-A2QU-01	946	1	Squamous	C6-UCEC	UCEC Serous c4		UCEC-like c5	UCEC-like c11	miRNA c1uster 10			TCGA-DI-A2QU			946	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					67					Stage IVB			-24488	2296	946	0								2011-8-26	FEMALE	160	Endometrioid endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	240	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	TCGA-DI-A2QU.43F1EE09-6F10-4BCE-A55C-147084A26999.pdf	0		8		15		3		3		0		10		87		90		WITH TUMOR	0	0				No							RX	Primary Tumor	01	Minimally Invasive	1988		NO	YES	DI		0	0	6	Endometrial	A	DECEASED	93	2005	94746e57-a703-4b53-bcdc-11107424eb23		TCGA-DI-A2QU-01		TCGA-DI-A2QU-01A-11R-A18L-13	TCGA-DI-A2QU-01A-11D-A18N-01			94746e57-a703-4b53-bcdc-11107424eb23	TCGA-DI-A2QU-01A-11D-A18O-05				TCGA-DI-A2QU-01A-21-A23Z-20	bf3a4f6b-cf84-4d78-9aee-902fa24e6f9c	TCGA-DI-A2QU-01					bf3a4f6b-cf84-4d78-9aee-902fa24e6f9c	TCGA-DI-A2QU-01A-11D-A18N-01		TCGA-DI-A2QU-01A-11R-A18L-13	
TCGA-DI-A2QU-11	MSS	1	TCGA-DI-A2QU-11	946	1		C6-UCEC								TCGA-DI-A2QU			946	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					67					Stage IVB			-24488	2296	946	0								2011-8-26	FEMALE	160	Endometrioid endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	230	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false		0		5		0		0		0		0		100		0		0		WITH TUMOR	0	0				No							RX	Solid Tissue Normal	11	Minimally Invasive	1988		NO	YES	DI		0	0	6	Endometrial	A	DECEASED	93	2005	8fefb116-ef42-4566-a5e3-8793ca8b7cda				TCGA-DI-A2QU-11A-11R-A18L-13				8fefb116-ef42-4566-a5e3-8793ca8b7cda	TCGA-DI-A2QU-11A-11D-A18O-05														TCGA-DI-A2QU-11A-11R-A18L-13	
TCGA-DI-A2QY-01	MSS	1	TCGA-DI-A2QY-01	3349	1	High		UCEC Serous c4		UCEC-like c5		miRNA c1uster 10			TCGA-DI-A2QY	3349	0	3349	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	64	0	0	TCGA-DI-A2QY-F60669	Never Used	Stage IIB	NO		-23398	2957	3349	0	2797				NO			2014-6-13	FEMALE	160	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES	endocervical smear	Other method, specify:	120	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-DI-A2QY.C78D0C27-34C3-44C4-9814-94EEE8A8AB95.pdf	50		40		20		5		20		0		5		90		90	positive	TUMOR FREE	0	0	YES	2	Complete Remission/Response	No	Never Used		YES				RX	Primary Tumor	01	Minimally Invasive	1988		NO	YES	DI	0	3	0	6	Endometrial	A	DECEASED	85	2003			TCGA-DI-A2QY-01	ea5e5dcc-54e2-43a4-bcc6-ab7b81c87927	TCGA-DI-A2QY-01A-12R-A19V-13	TCGA-DI-A2QY-01A-12D-A19X-01				TCGA-DI-A2QY-01A-12D-A19Z-05				TCGA-DI-A2QY-01A-21-A23Z-20	9c6a2560-1a39-492b-b2c8-ad24e41b62dc	TCGA-DI-A2QY-01	ea5e5dcc-54e2-43a4-bcc6-ab7b81c87927				9c6a2560-1a39-492b-b2c8-ad24e41b62dc	TCGA-DI-A2QY-01A-12D-A19X-01	ea5e5dcc-54e2-43a4-bcc6-ab7b81c87927	TCGA-DI-A2QY-01A-12R-A19V-13	ea5e5dcc-54e2-43a4-bcc6-ab7b81c87927
TCGA-DI-A2QY-11	MSS	1	TCGA-DI-A2QY-11	3349	1										TCGA-DI-A2QY	3349	0	3349	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	64	0	0	TCGA-DI-A2QY-F60669	Never Used	Stage IIB	NO		-23398	2957	3349	0	2797				NO			2014-6-13	FEMALE	160	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES	endocervical smear	Other method, specify:	110	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false		50		30		30		0		10		90		10		0		0	positive	TUMOR FREE	0	0	YES	2	Complete Remission/Response	No	Never Used		YES				RX	Solid Tissue Normal	11	Minimally Invasive	1988		NO	YES	DI	0	3	0	6	Endometrial	A	DECEASED	85	2003				9ba4d4d3-4640-40b7-8a67-72f384858b93	TCGA-DI-A2QY-11A-11R-A19V-13					TCGA-DI-A2QY-11A-11D-A19Z-05							9ba4d4d3-4640-40b7-8a67-72f384858b93						9ba4d4d3-4640-40b7-8a67-72f384858b93	TCGA-DI-A2QY-11A-11R-A19V-13	9ba4d4d3-4640-40b7-8a67-72f384858b93
TCGA-E6-A1LX-01	MSI-L	0	TCGA-E6-A1LX-01	711	0	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 2		TCGA-E6-A1LX	711	0	711	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	40		0	TCGA-E6-A1LX-F20265	Never Used	Stage IB	NO		-14731	1539		0	711				NO		Scheduled Follow-up Submission	2011-12-28	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Tumor resection	190	NO		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3					NO	false	TCGA-E6-A1LX.73CEBF93-0E7C-4EF9-A695-AF489AF3F0F0.pdf	14		0		0		0		0		0		0		100		75	negative	TUMOR FREE				1	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	1988	NO	NO	YES	E6	0	3		0	Endometrial	A	LIVING		2006	ca056af5-cdea-498c-adaf-9550e8fb4336		TCGA-E6-A1LX-01		TCGA-E6-A1LX-01A-11R-A14C-13	TCGA-E6-A1LX-01A-11D-A14F-01			ca056af5-cdea-498c-adaf-9550e8fb4336	TCGA-E6-A1LX-01A-11D-A14H-05				TCGA-E6-A1LX-01A-21-A18Q-20	510bba6a-9044-421e-9906-0a395d7798d1	TCGA-E6-A1LX-01					510bba6a-9044-421e-9906-0a395d7798d1	TCGA-E6-A1LX-01A-11D-A14F-01		TCGA-E6-A1LX-01A-11R-A14C-13	
TCGA-E6-A1LZ-01	MSS	0	TCGA-E6-A1LZ-01	1471	0	High	C6-UCEC	UCEC non-CIMP c3	cluster 4	BRCA basal-like c6	UCEC-like c11	miRNA cluster 14	cluster 2	mutation cluster 8	TCGA-E6-A1LZ	1471	0	1471	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	76		0	TCGA-E6-A1LZ-F20242		Stage IA	NO		-28054	1233		0	1471				NO		Scheduled Follow-up Submission	2011-12-28	FEMALE		Serous endometrial adenocarcinoma	No		YES	C54.1	8441/3	C54.1	YES		Tumor resection	350	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-E6-A1LZ.55F7B7D0-D30A-4E78-B91A-CE794784CA3C.pdf			0		0		20		0		0		0		80		80	negative	TUMOR FREE		0		4+	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	1988	YES	NO	YES	E6	0	5	0	26	Endometrial	A	LIVING	65	2007	4f4a8bd9-c07f-4930-8600-349ab60a37a7		TCGA-E6-A1LZ-01		TCGA-E6-A1LZ-01A-11R-A143-13	TCGA-E6-A1LZ-01A-11D-A141-01			4f4a8bd9-c07f-4930-8600-349ab60a37a7	TCGA-E6-A1LZ-01A-11D-A145-05			TCGA-E6-A1LZ-01A-11D-A142-09	TCGA-E6-A1LZ-01A-21-A18Q-20	32496629-22b4-4ba7-9f7b-454475783f77	TCGA-E6-A1LZ-01		TCGA-E6-A1LZ-01A-11D-A142-09		TCGA-E6-A1LZ-01A-11D-A142-09	32496629-22b4-4ba7-9f7b-454475783f77	TCGA-E6-A1LZ-01A-11D-A141-01		TCGA-E6-A1LZ-01A-11R-A143-13	
TCGA-E6-A1M0-01	MSS	0	TCGA-E6-A1M0-01	519	0	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5		TCGA-E6-A1M0	519	0	519	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	56		0	TCGA-E6-A1M0-F19865		Stage IIIC	NO		-20629	360		0	519				NO		Scheduled Follow-up Submission	2011-12-28	FEMALE	174	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Tumor resection	160	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-E6-A1M0.F1AF61FE-BF05-49E2-85DA-F4CE37596DEA.pdf	90		0		0		5		0		0		0		95		85	negative	TUMOR FREE		2		3	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	2009	YES	NO	YES	E6	0	5	2	13	Endometrial	A	LIVING	114	2010	e527020e-6b3f-4837-87d1-8f7ba68c19d6		TCGA-E6-A1M0-01		TCGA-E6-A1M0-01A-11R-A143-13	TCGA-E6-A1M0-01A-11D-A141-01			e527020e-6b3f-4837-87d1-8f7ba68c19d6	TCGA-E6-A1M0-01A-11D-A145-05				TCGA-E6-A1M0-01A-21-A18Q-20	416b7410-aa61-4adc-9b05-387e58780c79	TCGA-E6-A1M0-01					416b7410-aa61-4adc-9b05-387e58780c79	TCGA-E6-A1M0-01A-11D-A141-01		TCGA-E6-A1M0-01A-11R-A143-13	
TCGA-E6-A1M0-11	MSS	0	TCGA-E6-A1M0-11	519	0		C6-UCEC								TCGA-E6-A1M0	519	0	519	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	56		0	TCGA-E6-A1M0-F19865		Stage IIIC	NO		-20629	360		0	519				NO		Scheduled Follow-up Submission	2011-12-28	FEMALE	174	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Tumor resection	130	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false		90		0		0		0		0		100		0		0		0	negative	TUMOR FREE		2		3	Complete Remission/Response	No	Never Used		NO				R0	Solid Tissue Normal	11	open	2009	YES	NO	YES	E6	0	5	2	13	Endometrial	A	LIVING	114	2010	a0c84298-852b-454f-aab8-fb64656834dc				TCGA-E6-A1M0-11A-11R-A143-13				a0c84298-852b-454f-aab8-fb64656834dc	TCGA-E6-A1M0-11A-11D-A145-05														TCGA-E6-A1M0-11A-11R-A143-13	
TCGA-E6-A2P8-01	MSI-H	1	TCGA-E6-A2P8-01	72	1	Quiet		UCEC CIMP c18		UCEC-like c5		miRNA cluster 5			TCGA-E6-A2P8	60	1	72	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	NO	NO	NO	Progressive Disease	53		0	TCGA-E6-A2P8-F33518		Stage IV	NO		-19448	254	72	0				60	NO		Scheduled Follow-up Submission	2012-6-29	FEMALE	156	Mixed serous and endometrioid	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	100	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Lung	Metastatic			YES	true	TCGA-E6-A2P8.B67CD692-73B4-4A61-A65B-65964AA3ACF4.pdf	89.1		1		0		0		0		0		10		90		85	negative	WITH TUMOR		1		2	Progressive Disease	No			NO					Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	E6	0	0	1	1	Endometrial	A	DECEASED	76	2010			TCGA-E6-A2P8-01	db3429ba-32b0-40ef-bc81-ad0a8b097610	TCGA-E6-A2P8-01A-11R-A19V-13	TCGA-E6-A2P8-01A-11D-A19X-01				TCGA-E6-A2P8-01A-11D-A19Z-05				TCGA-E6-A2P8-01A-21-A23Z-20	2ed1681a-3284-4139-9d1e-d8cb82101767	TCGA-E6-A2P8-01	db3429ba-32b0-40ef-bc81-ad0a8b097610				2ed1681a-3284-4139-9d1e-d8cb82101767	TCGA-E6-A2P8-01A-11D-A19X-01	db3429ba-32b0-40ef-bc81-ad0a8b097610	TCGA-E6-A2P8-01A-11R-A19V-13	db3429ba-32b0-40ef-bc81-ad0a8b097610
TCGA-E6-A2P9-01	MSI-H	0	TCGA-E6-A2P9-01	203	0	Iq		UCEC CIMP c18		UCEC-like c5		miRNA cluster 7			TCGA-E6-A2P9	203	0	203	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	65		0	TCGA-E6-A2P9-F33520		Stage IA	NO		-24088	189		0	203				NO		Scheduled Follow-up Submission	2012-6-29	FEMALE	173	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	230	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-E6-A2P9.EF7B01C4-0952-4FE8-B128-2A43FA31E6F5.pdf	20		3		0		0		0		0		5		95		96	negative	TUMOR FREE		0		4+	Complete Remission/Response	No			YES				RX	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	E6	0	1	0	7	Endometrial	A	LIVING	125	2011			TCGA-E6-A2P9-01	08576085-2f37-41fc-82f6-39d396d75862	TCGA-E6-A2P9-01A-11R-A19V-13	TCGA-E6-A2P9-01A-11D-A19X-01				TCGA-E6-A2P9-01A-11D-A19Z-05				TCGA-E6-A2P9-01A-21-A23Z-20	24b4ea2b-4d46-4078-a426-f97cafe7a0fb	TCGA-E6-A2P9-01	08576085-2f37-41fc-82f6-39d396d75862				24b4ea2b-4d46-4078-a426-f97cafe7a0fb	TCGA-E6-A2P9-01A-11D-A19X-01	08576085-2f37-41fc-82f6-39d396d75862	TCGA-E6-A2P9-01A-11R-A19V-13	08576085-2f37-41fc-82f6-39d396d75862
TCGA-E6-A8L9-01	MSS	0	TCGA-E6-A8L9-01	831	0										TCGA-E6-A8L9	831	0	831	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	61		0	TCGA-E6-A8L9-F67179	Never Used	Stage IB	NO		-22333	657		0	831				YES			2014-10-31	FEMALE	162	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	200	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-E6-A8L9.40CB57C1-7E8C-45B0-BEDD-DFE531C9201E.pdf	1.92		5		1		0		1		10		20		70		70	negative	TUMOR FREE		0	YES	4+	Complete Remission/Response	Yes	Never Used		YES				R0	Primary Tumor	01	open	2009		NO	YES	E6	0	5	0	15	Endometrial	A	LIVING	78	2012			TCGA-E6-A8L9-01	916cf47a-0100-4e01-a912-2e884777186f	TCGA-E6-A8L9-01A-21R-A37P-13	TCGA-E6-A8L9-01A-21D-A37M-01				TCGA-E6-A8L9-01A-21D-A37Q-05					b42799cc-b938-4660-bf60-f6963f156736	TCGA-E6-A8L9-01	916cf47a-0100-4e01-a912-2e884777186f				b42799cc-b938-4660-bf60-f6963f156736	TCGA-E6-A8L9-01A-21D-A37M-01	916cf47a-0100-4e01-a912-2e884777186f	TCGA-E6-A8L9-01A-21R-A37P-13	916cf47a-0100-4e01-a912-2e884777186f
TCGA-EC-A1NJ-01	MSI-H	0	TCGA-EC-A1NJ-01	487	0	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-EC-A1NJ	487	0	487	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	73			TCGA-EC-A1NJ-F40579	Never Used	Stage IA	NO		-27002	60		0	487				YES		Scheduled Follow-up Submission	2013-2-25	FEMALE	153	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Tumor resection	620	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	TCGA-EC-A1NJ.8E02F7D6-EBE4-46CB-B05C-B41FDCDC1141.pdf	33		20		0		10		10		20		20		50		60	negative	TUMOR FREE			NO	1	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	YES	NO	EC		0		0	Endometrial	A	LIVING	62	2010	838b151f-4608-4981-89f3-0cba9ec540fb		TCGA-EC-A1NJ-01		TCGA-EC-A1NJ-01A-31R-A14C-13	TCGA-EC-A1NJ-01A-31D-A14F-01			838b151f-4608-4981-89f3-0cba9ec540fb	TCGA-EC-A1NJ-01A-31D-A14H-05				TCGA-EC-A1NJ-01A-21-A18Q-20	4cfd4667-0cf2-4d98-8776-5bedaba265eb	TCGA-EC-A1NJ-01					4cfd4667-0cf2-4d98-8776-5bedaba265eb	TCGA-EC-A1NJ-01A-31D-A14F-01		TCGA-EC-A1NJ-01A-31R-A14C-13	
TCGA-EC-A1QX-01	MSI-H	0	TCGA-EC-A1QX-01	224	0	Iq	C6-UCEC	UCEC CIMP c18	cluster 2	squamous c3	UCEC-like c11	miRNA cluster 4	cluster 2		TCGA-EC-A1QX	219	1	224	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	NO	NO	YES	Complete Response	71			TCGA-EC-A1QX-F48708	Never Used	Stage IB	NO	219	-26259	81		0	224			219	YES		Scheduled Follow-up Submission	2013-9-19	FEMALE	161	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	560	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					YES	true	TCGA-EC-A1QX.0C3EABFA-0F72-47C9-9A8B-6B14F2CD2D12.pdf			40		20		5		20		0		15		80		80	negative	TUMOR FREE				2	Progressive Disease	No	Never Used		YES	Surgical Resection		RX	R0	Primary Tumor	01		2009	YES	YES	NO	EC		0		0	Endometrial	A	LIVING	90	2010	bfa1d102-0917-407f-a158-3125d4219c6c		TCGA-EC-A1QX-01		TCGA-EC-A1QX-01A-31R-A16E-13	TCGA-EC-A1QX-01A-31D-A16C-01			bfa1d102-0917-407f-a158-3125d4219c6c	TCGA-EC-A1QX-01A-31D-A16G-05				TCGA-EC-A1QX-01A-21-A18Q-20	0de53204-dbcc-4778-9d57-0ae7269b70e9	TCGA-EC-A1QX-01					0de53204-dbcc-4778-9d57-0ae7269b70e9	TCGA-EC-A1QX-01A-31D-A16C-01		TCGA-EC-A1QX-01A-31R-A16E-13	
TCGA-EC-A24G-01	MSI-H	0	TCGA-EC-A24G-01	511	0	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 4		TCGA-EC-A24G	511	0	511	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	57	0	0	TCGA-EC-A24G-F40428	Never Used	Stage II	NO		-20857	78		0	511				NO		Scheduled Follow-up Submission	2013-2-20	FEMALE	148	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	410	NO	YES	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3					NO	true	TCGA-EC-A24G.5DE142C5-7A0D-4C5E-8EF6-2809B10378C4.pdf	50		10		3		0		3		0		15		85		85		TUMOR FREE	0	0	YES	3	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01		2009	YES	YES	NO	EC	0	0	0	15	Endometrial	A	LIVING	93	2011	92f1d13e-3dbb-4a41-aac4-5887b50bc19f		TCGA-EC-A24G-01		TCGA-EC-A24G-01A-11R-A16E-13	TCGA-EC-A24G-01A-11D-A16C-01			92f1d13e-3dbb-4a41-aac4-5887b50bc19f	TCGA-EC-A24G-01A-11D-A16G-05				TCGA-EC-A24G-01A-21-A18R-20	a569702d-9894-4fd0-9163-e16a183252a6	TCGA-EC-A24G-01					a569702d-9894-4fd0-9163-e16a183252a6	TCGA-EC-A24G-01A-11D-A16C-01		TCGA-EC-A24G-01A-11R-A16E-13	
TCGA-EO-A1Y5-01	MSS	0	TCGA-EO-A1Y5-01	327	0	Squamous	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 2	cluster 2	mutation cluster 13	TCGA-EO-A1Y5	327	0	327	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	63		1	TCGA-EO-A1Y5-F56547	Never Used	Stage IIIC2	NO		-23251	223		0	327				NO			2014-2-12	FEMALE	161	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	110	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-EO-A1Y5.B3A96371-1CD6-4B08-BDA5-C8CD7C7DE81F.pdf	100		0		0		0		0		0		20		80		80		TUMOR FREE		8	YES	4+	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009	YES	NO	YES	EO	1	1	8	17	Endometrial	A	LIVING	79	2010	fd13e02a-4bfb-4aaa-bbf7-488660106a31		TCGA-EO-A1Y5-01		TCGA-EO-A1Y5-01A-11R-A156-13	TCGA-EO-A1Y5-01A-11D-A160-01			fd13e02a-4bfb-4aaa-bbf7-488660106a31	TCGA-EO-A1Y5-01A-11D-A161-05			TCGA-EO-A1Y5-01A-11D-A159-09	TCGA-EO-A1Y5-01A-21-A18Q-20	38f48281-d72d-4524-b6f2-4cdfb21c53f3	TCGA-EO-A1Y5-01		TCGA-EO-A1Y5-01A-11D-A159-09		TCGA-EO-A1Y5-01A-11D-A159-09	38f48281-d72d-4524-b6f2-4cdfb21c53f3	TCGA-EO-A1Y5-01A-11D-A160-01		TCGA-EO-A1Y5-01A-11R-A156-13	
TCGA-EO-A1Y7-01	MSS	0	TCGA-EO-A1Y7-01	1495	0	High		UCEC non-CIMP c3	cluster 4	UCEC-like c5		miRNA cluster 12	cluster 5		TCGA-EO-A1Y7	880	1	1495	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES			Stable Disease	65		0	TCGA-EO-A1Y7-F68567	Never Used	Stage IB	NO		-24085	196		0	1495			880	NO			2014-11-26	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	140	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Lung	Distant Metastasis		NO	YES	false	TCGA-EO-A1Y7.88AABD4B-ECB4-4748-B59F-BD4AE0621BFB.pdf	60		4		8		0		0		0		10		90		90		WITH TUMOR		0	YES	4+	Stable Disease	No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	EO	0	8	0	3	Endometrial	A	LIVING	95	2010			TCGA-EO-A1Y7-01	4da7543e-f58a-46f1-bf94-834d4ce4cbff	TCGA-EO-A1Y7-01A-11R-A156-13	TCGA-EO-A1Y7-01A-11D-A160-01				TCGA-EO-A1Y7-01A-11D-A161-05				TCGA-EO-A1Y7-01A-21-A18Q-20	7f49942f-804b-48af-a0bc-7d7efdd90110	TCGA-EO-A1Y7-01	4da7543e-f58a-46f1-bf94-834d4ce4cbff				7f49942f-804b-48af-a0bc-7d7efdd90110	TCGA-EO-A1Y7-01A-11D-A160-01	4da7543e-f58a-46f1-bf94-834d4ce4cbff	TCGA-EO-A1Y7-01A-11R-A156-13	4da7543e-f58a-46f1-bf94-834d4ce4cbff
TCGA-EO-A1Y8-01	MSS	0	TCGA-EO-A1Y8-01	1147	0	High	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 6	mutation cluster 3	TCGA-EO-A1Y8	1147	0	1147	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	87			TCGA-EO-A1Y8-F56552	Never Used	Stage IA	NO		-31971			0	1147				NO			2014-2-12	FEMALE	146	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy			NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO			40																		TUMOR FREE		0	NO	1	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	EO		0	0	16	Endometrial		LIVING	58	2010	a1d4b9ef-6fe5-49b5-9bb5-686d253baa4c		TCGA-EO-A1Y8-01		TCGA-EO-A1Y8-01A-11R-A156-13	TCGA-EO-A1Y8-01A-11D-A160-01			a1d4b9ef-6fe5-49b5-9bb5-686d253baa4c	TCGA-EO-A1Y8-01A-11D-A161-05			TCGA-EO-A1Y8-01A-11D-A159-09	TCGA-EO-A1Y8-01A-21-A18Q-20	c565d919-87e8-4450-8103-c2a375f30acc	TCGA-EO-A1Y8-01		TCGA-EO-A1Y8-01A-11D-A159-09		TCGA-EO-A1Y8-01A-11D-A159-09	c565d919-87e8-4450-8103-c2a375f30acc	TCGA-EO-A1Y8-01A-11D-A160-01		TCGA-EO-A1Y8-01A-11R-A156-13	
TCGA-EO-A22R-01	MSI-L	0	TCGA-EO-A22R-01	1878	0	Kirc+	C6-UCEC	UCEC CIMP c18		UCEC-like c5	UCEC-like c11	miRNA c1uster 10			TCGA-EO-A22R	1878	0	1878	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	56			TCGA-EO-A22R-F62603		Stage IB	NO		-20604	925		0	1878				YES			2014-9-25	FEMALE	168	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	130	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-EO-A22R.5B97D87A-5D28-417F-A942-21775156B46C.pdf	51		40		20		5		20		0		15		80		80	negative	TUMOR FREE		0	NO	4+	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	2009		NO	YES	EO			0	18	Endometrial	A	LIVING	88	2008	21aa44a9-e23e-4ab9-aa35-6942b118b066		TCGA-EO-A22R-01		TCGA-EO-A22R-01A-11R-A18L-13	TCGA-EO-A22R-01A-11D-A18N-01			21aa44a9-e23e-4ab9-aa35-6942b118b066	TCGA-EO-A22R-01A-11D-A18O-05				TCGA-EO-A22R-01A-21-A23Z-20	d762ca66-78bb-49a9-a1c7-07db0d7de1be	TCGA-EO-A22R-01					d762ca66-78bb-49a9-a1c7-07db0d7de1be	TCGA-EO-A22R-01A-11D-A18N-01		TCGA-EO-A22R-01A-11R-A18L-13	
TCGA-EO-A22R-11	MSI-L	0	TCGA-EO-A22R-11	1878	0		C6-UCEC								TCGA-EO-A22R	1878	0	1878	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	56			TCGA-EO-A22R-F62603		Stage IB	NO		-20604	1058		0	1878				YES			2014-9-25	FEMALE	168	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	70	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false		51		50		10		0		10		100		0		0		0	negative	TUMOR FREE		0	NO	4+	Complete Remission/Response	No	Never Used		YES				R0	Solid Tissue Normal	11	open	2009		NO	YES	EO			0	18	Endometrial	A	LIVING	88	2008										TCGA-EO-A22R-11A-11D-A18O-05															
TCGA-EO-A22S-01	MSI-H	0	TCGA-EO-A22S-01	1872	0	Quiet	C6-UCEC	UCEC CIMP c18		squamous c3	UCEC-like c11	miRNA cluster 12			TCGA-EO-A22S	1872	0	1872	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	58		0	TCGA-EO-A22S-F62595		Stage IB	NO		-21328	919		0	1872				NO			2014-8-13	FEMALE	156	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	100	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-EO-A22S.DB26485C-BE5C-4874-B79D-7FCFFFF70C4E.pdf	51		40		20		5		20		0		15		80		80		TUMOR FREE		0	NO	2	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	2009		NO	YES	EO		5		25	Endometrial	A	LIVING	84	2008	b8177a01-9ec3-47dc-a776-1794f693d9e7		TCGA-EO-A22S-01		TCGA-EO-A22S-01A-11R-A18L-13	TCGA-EO-A22S-01A-11D-A18N-01			b8177a01-9ec3-47dc-a776-1794f693d9e7	TCGA-EO-A22S-01A-11D-A18O-05				TCGA-EO-A22S-01A-21-A23Z-20	4ed824a0-0fb8-4fab-8323-b4bb5ac2bb52	TCGA-EO-A22S-01					4ed824a0-0fb8-4fab-8323-b4bb5ac2bb52	TCGA-EO-A22S-01A-11D-A18N-01		TCGA-EO-A22S-01A-11R-A18L-13	
TCGA-EO-A22S-11	MSI-H	0	TCGA-EO-A22S-11	1872	0		C6-UCEC								TCGA-EO-A22S	1872	0	1872	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	58		0	TCGA-EO-A22S-F62595		Stage IB	NO		-21328	1052		0	1872				NO			2014-8-13	FEMALE	156	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	80	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false		51		40		20		0		20		80		20		0		0		TUMOR FREE		0	NO	2	Complete Remission/Response	No	Never Used		YES				R0	Solid Tissue Normal	11	open	2009		NO	YES	EO		5		25	Endometrial	A	LIVING	84	2008										TCGA-EO-A22S-11A-11D-A18O-05															
TCGA-EO-A22T-01	MSI-H	0	TCGA-EO-A22T-01	2035	0	Kirc+	C6-UCEC	UCEC CIMP c18		UCEC-like c5	UCEC-like c11	miRNA cluster 5			TCGA-EO-A22T	2035	0	2035	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	56		0	TCGA-EO-A22T-F62605		Stage II	NO		-20608			0	2035				NO			2014-9-25	FEMALE	152	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy			NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO			49																		TUMOR FREE		0	NO	2	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	2009		NO	YES	EO		11	0	19	Endometrial		LIVING	53	2008	fe8a344f-fc0b-415c-b388-c71e82b64703		TCGA-EO-A22T-01		TCGA-EO-A22T-01A-21R-A18L-13	TCGA-EO-A22T-01A-21D-A18N-01			fe8a344f-fc0b-415c-b388-c71e82b64703	TCGA-EO-A22T-01A-21D-A18O-05				TCGA-EO-A22T-01A-11-A23Z-20	afc0af2b-e4c9-4cfa-87cc-776501f7d92c	TCGA-EO-A22T-01					afc0af2b-e4c9-4cfa-87cc-776501f7d92c	TCGA-EO-A22T-01A-21D-A18N-01		TCGA-EO-A22T-01A-21R-A18L-13	
TCGA-EO-A22T-11	MSI-H	0	TCGA-EO-A22T-11	2035	0		C6-UCEC								TCGA-EO-A22T	2035	0	2035	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	56		0	TCGA-EO-A22T-F62605		Stage II	NO		-20608	1049		0	2035				NO			2014-9-25	FEMALE	152	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	180	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false		49		40		20		0		20		90		10		0		0		TUMOR FREE		0	NO	2	Complete Remission/Response	No	Never Used		YES				R0	Solid Tissue Normal	11	open	2009		NO	YES	EO		11	0	19	Endometrial	A	LIVING	53	2008										TCGA-EO-A22T-11A-11D-A18O-05															
TCGA-EO-A22U-01	MSI-H	0	TCGA-EO-A22U-01	1407	0	Quiet		UCEC CIMP c18		UCEC-like c5		miRNA cluster 12	cluster 4		TCGA-EO-A22U	1407	0	1407	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	83			TCGA-EO-A22U-F62597	Former User	Stage IB	NO		-30557	758		0	1407				NO			2014-9-25	FEMALE	150	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	110	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-EO-A22U.DB7D72BC-F9C7-4726-98F4-A4F642B125C6.pdf	51		40		20		5		20		0		15		80		80	negative	TUMOR FREE			NO	0	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009		NO	YES	EO		0		0	Endometrial	A	LIVING	59	2009			TCGA-EO-A22U-01	3513c95d-9ea0-4c3b-9e8e-0f148231bc83	TCGA-EO-A22U-01A-11R-A17X-13	TCGA-EO-A22U-01A-11D-A17U-01				TCGA-EO-A22U-01A-11D-A17Z-05				TCGA-EO-A22U-01A-21-A18R-20	06a49298-2737-4513-82ed-b29e0aa8aff4	TCGA-EO-A22U-01	3513c95d-9ea0-4c3b-9e8e-0f148231bc83				06a49298-2737-4513-82ed-b29e0aa8aff4	TCGA-EO-A22U-01A-11D-A17U-01	3513c95d-9ea0-4c3b-9e8e-0f148231bc83	TCGA-EO-A22U-01A-11R-A17X-13	3513c95d-9ea0-4c3b-9e8e-0f148231bc83
TCGA-EO-A22X-01	MSS	0	TCGA-EO-A22X-01	1346	0	Kirc+		UCEC non-CIMP c3		UCEC-like c5		miRNA cluster 5	cluster 4		TCGA-EO-A22X	1346	0	1346	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	36		0	TCGA-EO-A22X-F39978		Stage IIIA			-13245	842		0	1346				NO			2013-2-7	FEMALE	152	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	110	NO	NO	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3					NO	false	TCGA-EO-A22X.4D919902-FBCE-4AAC-ACD2-38A2F1D8E901.pdf	100		40		20		0		20		0		30		70		70	negative	TUMOR FREE		0	YES		Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	YES	NO	YES	EO	0	10	0	26	Endometrial	A	LIVING	56	2008			TCGA-EO-A22X-01	ca6bff3c-e95e-42e6-8eff-76d66e8031b0	TCGA-EO-A22X-01A-11R-A17X-13	TCGA-EO-A22X-01A-11D-A17U-01				TCGA-EO-A22X-01A-11D-A17Z-05				TCGA-EO-A22X-01A-21-A18R-20	9cca3077-f98f-4e40-89fe-41f5674ab0be	TCGA-EO-A22X-01	ca6bff3c-e95e-42e6-8eff-76d66e8031b0				9cca3077-f98f-4e40-89fe-41f5674ab0be	TCGA-EO-A22X-01A-11D-A17U-01	ca6bff3c-e95e-42e6-8eff-76d66e8031b0	TCGA-EO-A22X-01A-11R-A17X-13	ca6bff3c-e95e-42e6-8eff-76d66e8031b0
TCGA-EO-A22Y-01	MSS	0	TCGA-EO-A22Y-01	1567	0	BRCA-LUAD+		UCEC CIMP c18		UCEC-like c5		miRNA cluster 5	cluster 4		TCGA-EO-A22Y	1567	0	1567	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	68			TCGA-EO-A22Y-F56824	Never Used	Stage IA	NO		-25127	692		0	1567				NO			2014-2-24	FEMALE		Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	110	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-EO-A22Y.44F2A17C-265B-4C2A-9AA0-42C55A23B592.pdf	51		40		20		5		20		0		15		80		80	negative	TUMOR FREE		0	NO	2	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	2009	NO	NO	YES	EO			0	33	Endometrial	A	LIVING		2009			TCGA-EO-A22Y-01	24ee58d3-60c9-4808-b35a-2767594b83f8	TCGA-EO-A22Y-01A-11R-A17X-13	TCGA-EO-A22Y-01A-11D-A17U-01				TCGA-EO-A22Y-01A-11D-A17Z-05				TCGA-EO-A22Y-01A-21-A18R-20	ba20325d-3d34-4037-a1aa-9ec61d569a38	TCGA-EO-A22Y-01	24ee58d3-60c9-4808-b35a-2767594b83f8				ba20325d-3d34-4037-a1aa-9ec61d569a38	TCGA-EO-A22Y-01A-11D-A17U-01	24ee58d3-60c9-4808-b35a-2767594b83f8	TCGA-EO-A22Y-01A-11R-A17X-13	24ee58d3-60c9-4808-b35a-2767594b83f8
TCGA-EO-A2CG-01	MSS	0	TCGA-EO-A2CG-01	1564	0	High		OV-like c1			UCEC-like c11	miRNA cluster 5			TCGA-EO-A2CG	1564	0	1564	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	69		0	TCGA-EO-A2CG-F56877	Never Used	Stage IA	NO		-25279	643		0	1564				NO			2014-2-25	FEMALE	152	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	60	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-EO-A2CG.CAF671DB-2DD1-43D5-99C8-185253775B37.pdf	49		0		0		0		0		20		0		80		75	negative	TUMOR FREE		0	YES	4+	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009	YES		YES	EO	0	11	0	8	Endometrial	A	LIVING	68	2009	5f65a8b5-2460-4544-be71-5e7b7347b0fa		TCGA-EO-A2CG-01		TCGA-EO-A2CG-01A-12R-A17X-13	TCGA-EO-A2CG-01A-12D-A17U-01			5f65a8b5-2460-4544-be71-5e7b7347b0fa	TCGA-EO-A2CG-01A-12D-A17Z-05					06834dfb-7b97-4e1e-9716-cfaf47d15141	TCGA-EO-A2CG-01					06834dfb-7b97-4e1e-9716-cfaf47d15141	TCGA-EO-A2CG-01A-12D-A17U-01		TCGA-EO-A2CG-01A-12R-A17X-13	
TCGA-EO-A2CH-01	MSS	1	TCGA-EO-A2CH-01	590	1	Squamous	C6-UCEC	UCEC non-CIMP c3		UCEC-like c5	UCEC-like c11	miRNA cluster 1			TCGA-EO-A2CH	413	1	590	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	YES	NO	Progressive Disease	73			TCGA-EO-A2CH-F70417	Never Used	Stage IVB	NO		-26966	802	590	0				413	YES			2015-2-12	FEMALE	152	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	80	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Lung	Distant Metastasis		NO	YES	false	TCGA-EO-A2CH.B4A5577E-C043-4D25-8D53-77A43C5EC0CC.pdf	51		0		0		0		0		0		0		100		85		WITH TUMOR			YES	1	Progressive Disease	No	Never Used		NO				R2	Primary Tumor	01	open	2009	YES	NO	YES	EO		0		0	Endometrial	A	DECEASED	66	2009	f9814b3c-60f3-4d83-885e-1e1a88e520a9		TCGA-EO-A2CH-01		TCGA-EO-A2CH-01A-11R-A17X-13	TCGA-EO-A2CH-01A-11D-A17U-01			f9814b3c-60f3-4d83-885e-1e1a88e520a9	TCGA-EO-A2CH-01A-11D-A17Z-05				TCGA-EO-A2CH-01A-21-A18R-20	453a93db-c5f0-49df-92ae-03906adb4f37	TCGA-EO-A2CH-01					453a93db-c5f0-49df-92ae-03906adb4f37	TCGA-EO-A2CH-01A-11D-A17U-01		TCGA-EO-A2CH-01A-11R-A17X-13	
TCGA-EO-A3AS-01	MSS	0	TCGA-EO-A3AS-01	1046	0	Squamous		UCEC non-CIMP c3				miRNA cluster 4			TCGA-EO-A3AS	1046	0	1046	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	86			TCGA-EO-A3AS-F38250	Never Used	Stage IA	NO		-31450	850		0	1046				NO			2013-1-31	FEMALE	147	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	70	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-EO-A3AS.844799B1-4C96-473A-8ECB-71ACB080F95E.pdf	49		0		0		2		0		0		18		80		80		TUMOR FREE			NO	3	Complete Remission/Response	No	Never Used		NO					Primary Tumor	01	open	2009			YES	EO		0		0	Endometrial	A	LIVING	58	2009			TCGA-EO-A3AS-01	0ce294d7-8111-474c-be3a-19195f5d49ab	TCGA-EO-A3AS-01A-11R-A19V-13	TCGA-EO-A3AS-01A-11D-A19X-01				TCGA-EO-A3AS-01A-11D-A19Z-05					5616b45b-3b67-4ce3-a990-a4ca972bf7a1	TCGA-EO-A3AS-01	0ce294d7-8111-474c-be3a-19195f5d49ab				5616b45b-3b67-4ce3-a990-a4ca972bf7a1	TCGA-EO-A3AS-01A-11D-A19X-01	0ce294d7-8111-474c-be3a-19195f5d49ab	TCGA-EO-A3AS-01A-11R-A19V-13	0ce294d7-8111-474c-be3a-19195f5d49ab
TCGA-EO-A3AU-01	MSI-H	0	TCGA-EO-A3AU-01	804	0	Quiet		UCEC CIMP c18		UCEC-like c5		miRNA cluster 11			TCGA-EO-A3AU	804	0	804	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	72		0	TCGA-EO-A3AU-F38256		Stage II	NO		-26406	393		0	804				YES			2013-2-5	FEMALE	150	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES	Endocervical curettage	Other method, specify:	130	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-EO-A3AU.B1D13355-6346-4FA4-950A-84114901515C.pdf	51		40		20		10		20		0		10		80		80	negative	TUMOR FREE		1	YES	4+	Complete Remission/Response	No	Never Used		YES					Primary Tumor	01	Minimally Invasive	2009			YES	EO		1		14	Endometrial	A	LIVING	78	2010			TCGA-EO-A3AU-01	f6c13e4d-5a10-48cc-8ce1-a535565b6006	TCGA-EO-A3AU-01A-21R-A19V-13	TCGA-EO-A3AU-01A-21D-A19X-01				TCGA-EO-A3AU-01A-21D-A19Z-05				TCGA-EO-A3AU-01A-11-A23Z-20	2a5de006-d336-41d0-a288-32d0a5450484	TCGA-EO-A3AU-01	f6c13e4d-5a10-48cc-8ce1-a535565b6006				2a5de006-d336-41d0-a288-32d0a5450484	TCGA-EO-A3AU-01A-21D-A19X-01	f6c13e4d-5a10-48cc-8ce1-a535565b6006	TCGA-EO-A3AU-01A-21R-A19V-13	f6c13e4d-5a10-48cc-8ce1-a535565b6006
TCGA-EO-A3AV-01	MSS	0	TCGA-EO-A3AV-01	762	0	Kirc+		UCEC non-CIMP c3		BRCA basal-like c6		miRNA cluster 4			TCGA-EO-A3AV	762	0	762	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	51		0	TCGA-EO-A3AV-F38255		Stage IIIC1	NO		-18713	407		0	762				NO			2013-2-5	FEMALE	158	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	130	NO	NO	Peri (6-12 months since last menstrual period)	G3					NO	false	TCGA-EO-A3AV.9FF6FADC-4F38-41A2-8B96-24CB1EB2010E.pdf	51		70		10		5		10		0		5		90		90	negative	TUMOR FREE		6	YES	1	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009		NO	YES	EO		3	6	33	Endometrial	A	LIVING	45	2010			TCGA-EO-A3AV-01	ec7693cf-c6ec-4fff-9d18-d1fd165a1a6f	TCGA-EO-A3AV-01A-12R-A19V-13	TCGA-EO-A3AV-01A-12D-A19X-01				TCGA-EO-A3AV-01A-12D-A19Z-05				TCGA-EO-A3AV-01A-21-A23Z-20	0ca9ef86-aaee-48b0-85f7-5ad3e4549416	TCGA-EO-A3AV-01	ec7693cf-c6ec-4fff-9d18-d1fd165a1a6f				0ca9ef86-aaee-48b0-85f7-5ad3e4549416	TCGA-EO-A3AV-01A-12D-A19X-01	ec7693cf-c6ec-4fff-9d18-d1fd165a1a6f	TCGA-EO-A3AV-01A-12R-A19V-13	ec7693cf-c6ec-4fff-9d18-d1fd165a1a6f
TCGA-EO-A3AY-01	MSS	0	TCGA-EO-A3AY-01	523	0	Quiet		UCEC CIMP c18		UCEC-like c5		miRNA cluster 4			TCGA-EO-A3AY	523	0	523	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	58			TCGA-EO-A3AY-F38252		Stage IB	NO		-21291	227		0	523				NO			2013-2-5	FEMALE	164	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	150	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-EO-A3AY.330AEFE0-D564-4799-8928-B05280BACA91.pdf	50		0		0		2		0		0		8		90		90	negative	TUMOR FREE		0	NO	2	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009			YES	EO		0		25	Endometrial	A	LIVING	76	2011			TCGA-EO-A3AY-01	8025c2b5-a137-4c88-9ac4-cc4be43e4f25	TCGA-EO-A3AY-01A-12R-A19V-13	TCGA-EO-A3AY-01A-12D-A19X-01				TCGA-EO-A3AY-01A-12D-A19Z-05				TCGA-EO-A3AY-01A-21-A23Z-20	71e19d7f-813d-42cc-a68c-120842f84a63	TCGA-EO-A3AY-01	8025c2b5-a137-4c88-9ac4-cc4be43e4f25				71e19d7f-813d-42cc-a68c-120842f84a63	TCGA-EO-A3AY-01A-12D-A19X-01	8025c2b5-a137-4c88-9ac4-cc4be43e4f25	TCGA-EO-A3AY-01A-12R-A19V-13	8025c2b5-a137-4c88-9ac4-cc4be43e4f25
TCGA-EO-A3AZ-01	MSI-H	0	TCGA-EO-A3AZ-01	630	0	Squamous		UCEC non-CIMP c3		UCEC-like c5		miRNA cluster 5			TCGA-EO-A3AZ	630	0	630	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	80			TCGA-EO-A3AZ-F38251	Never Used	Stage IB	NO		-29234	241		0	630				NO			2013-2-5	FEMALE	140	Mixed serous and endometrioid	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	120	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-EO-A3AZ.EA5D2C1C-703B-46BE-8B16-C40CE4BA0B46.pdf	51		70		10		5		10		0		15		80		80	negative	TUMOR FREE			NO	2	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009		NO	YES	EO		0		0	Endometrial	A	LIVING	78	2011			TCGA-EO-A3AZ-01	78ab0c5d-29cf-4660-bd1f-1a0eb5edaf2f	TCGA-EO-A3AZ-01A-12R-A19V-13	TCGA-EO-A3AZ-01A-12D-A19X-01				TCGA-EO-A3AZ-01A-12D-A19Z-05				TCGA-EO-A3AZ-01A-21-A23Z-20	0e9c5e91-6af9-48a6-8f8d-691287a23343	TCGA-EO-A3AZ-01	78ab0c5d-29cf-4660-bd1f-1a0eb5edaf2f				0e9c5e91-6af9-48a6-8f8d-691287a23343	TCGA-EO-A3AZ-01A-12D-A19X-01	78ab0c5d-29cf-4660-bd1f-1a0eb5edaf2f	TCGA-EO-A3AZ-01A-12R-A19V-13	78ab0c5d-29cf-4660-bd1f-1a0eb5edaf2f
TCGA-EO-A3B0-01	MSS	0	TCGA-EO-A3B0-01	544	0	Kirc+		UCEC CIMP c18		UCEC-like c5		miRNA cluster 5			TCGA-EO-A3B0	544	0	544	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	43		2	TCGA-EO-A3B0-F38253	Former User	Stage IIIC2	NO		-15954	196		0	544							2013-2-5	FEMALE	152	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	160	NO	NO	Indeterminate (neither Pre or Postmenopausal)	G3					NO	false	TCGA-EO-A3B0.5B8CD9C0-148B-4421-AA68-C1F2DF7F9B28.pdf			0		0		10		0		0		20		70		70		TUMOR FREE		5	NO	2	Stable Disease	No	Never Used		NO				RX	Primary Tumor	01	open	2009			YES	EO		3		7	Endometrial	A	LIVING	53	2011			TCGA-EO-A3B0-01	cad7a685-cb28-44bf-ad8e-e4528a73f0b6	TCGA-EO-A3B0-01A-12R-A19V-13	TCGA-EO-A3B0-01A-12D-A19X-01				TCGA-EO-A3B0-01A-12D-A19Z-05				TCGA-EO-A3B0-01A-21-A23Z-20	4df884c2-27fa-429c-ba68-581402f28717	TCGA-EO-A3B0-01	cad7a685-cb28-44bf-ad8e-e4528a73f0b6				4df884c2-27fa-429c-ba68-581402f28717	TCGA-EO-A3B0-01A-12D-A19X-01	cad7a685-cb28-44bf-ad8e-e4528a73f0b6	TCGA-EO-A3B0-01A-12R-A19V-13	cad7a685-cb28-44bf-ad8e-e4528a73f0b6
TCGA-EO-A3B1-01	MSS	0	TCGA-EO-A3B1-01	540	0	High		UCEC Serous c4		squamous c3		miRNA cluster 4			TCGA-EO-A3B1	540	0	540	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	63			TCGA-EO-A3B1-F38254		Stage IB	NO		-23162	163		0	540				NO			2013-2-5	FEMALE	170	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	90	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-EO-A3B1.D3309430-5427-4FAD-BDD6-A6E9BABE29D2.pdf	51		60		20		0		20		0		10		90		90		TUMOR FREE		0	YES		Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009		NO	YES	EO		0		13	Endometrial	A	LIVING	93	2011			TCGA-EO-A3B1-01	2b0670d8-a2b4-4e1b-a3b3-4ec277e0078f	TCGA-EO-A3B1-01A-12R-A19V-13	TCGA-EO-A3B1-01A-12D-A19X-01				TCGA-EO-A3B1-01A-12D-A19Z-05				TCGA-EO-A3B1-01A-21-A23Z-20	fb17e0c7-b2e5-4db8-870b-3937e2432699	TCGA-EO-A3B1-01	2b0670d8-a2b4-4e1b-a3b3-4ec277e0078f				fb17e0c7-b2e5-4db8-870b-3937e2432699	TCGA-EO-A3B1-01A-12D-A19X-01	2b0670d8-a2b4-4e1b-a3b3-4ec277e0078f	TCGA-EO-A3B1-01A-12R-A19V-13	2b0670d8-a2b4-4e1b-a3b3-4ec277e0078f
TCGA-EO-A3KU-01	MSS	0	TCGA-EO-A3KU-01	427	0	High		UCEC Serous c4		UCEC-like c5		miRNA c1uster 10			TCGA-EO-A3KU	427	0	427	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	68		0	TCGA-EO-A3KU-F39921		Stage II	NO		-25116	93		0	427				NO			2013-2-6	FEMALE	163	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	110	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-EO-A3KU.B6945BE4-FA4A-4ED4-9233-B32123F41C95.pdf	0		5		5		10		15		0		10		80		90		TUMOR FREE		0	YES	3	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009		NO	YES	EO		9		6	Endometrial	A	LIVING	65	2011			TCGA-EO-A3KU-01	91238210-9f8d-4c09-8016-fd0a7d135023	TCGA-EO-A3KU-01A-11R-A22I-13	TCGA-EO-A3KU-01A-11D-A227-01				TCGA-EO-A3KU-01A-11D-A22B-05				TCGA-EO-A3KU-01A-21-A23Z-20	b2c845f0-18ac-4b85-b0f9-43a12d2eebce	TCGA-EO-A3KU-01	91238210-9f8d-4c09-8016-fd0a7d135023				b2c845f0-18ac-4b85-b0f9-43a12d2eebce	TCGA-EO-A3KU-01A-11D-A227-01	91238210-9f8d-4c09-8016-fd0a7d135023	TCGA-EO-A3KU-01A-11R-A22I-13	91238210-9f8d-4c09-8016-fd0a7d135023
TCGA-EO-A3KW-01	MSS	0	TCGA-EO-A3KW-01	497	0	High		UCEC Serous c4		UCEC-like c5		miRNA cluster 4			TCGA-EO-A3KW	497	0	497	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	72			TCGA-EO-A3KW-F39967		Stage IA	NO		-26492	205		0	497				NO			2013-2-7	FEMALE	153	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	150	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-EO-A3KW.C1CFE3DE-628B-4C0F-881B-588C613498DA.pdf			1		0		0		0		20		0		80		90		TUMOR FREE		0	YES	2	Complete Remission/Response	No			YES				R0	Primary Tumor	01	Minimally Invasive	2009		NO	YES	EO		0		21	Endometrial	A	LIVING	62	2011			TCGA-EO-A3KW-01	eb279337-8251-4442-905c-8a4be743f057	TCGA-EO-A3KW-01A-11R-A22I-13	TCGA-EO-A3KW-01A-11D-A227-01				TCGA-EO-A3KW-01A-11D-A22B-05				TCGA-EO-A3KW-01A-21-A23Z-20	9f2fa014-c04b-45c8-ac72-8720574ca7fd	TCGA-EO-A3KW-01	eb279337-8251-4442-905c-8a4be743f057				9f2fa014-c04b-45c8-ac72-8720574ca7fd	TCGA-EO-A3KW-01A-11D-A227-01	eb279337-8251-4442-905c-8a4be743f057	TCGA-EO-A3KW-01A-11R-A22I-13	eb279337-8251-4442-905c-8a4be743f057
TCGA-EO-A3KX-01	MSI-H	0	TCGA-EO-A3KX-01	442	0	Quiet		UCEC CIMP c18		UCEC-like c5		miRNA cluster 12			TCGA-EO-A3KX	442	0	442	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	80			TCGA-EO-A3KX-F39933		Stage IA	NO		-29260			0	442				YES			2013-2-7	FEMALE	145	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy			NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO																					TUMOR FREE		0	NO		Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009		NO	YES	EO		0		3	Endometrial		LIVING	44	2011			TCGA-EO-A3KX-01	babc3b9e-a99f-490b-a277-ab4e6f6b5449	TCGA-EO-A3KX-01A-11R-A22I-13	TCGA-EO-A3KX-01A-11D-A227-01				TCGA-EO-A3KX-01A-11D-A22B-05				TCGA-EO-A3KX-01A-21-A23Z-20	c5e61b67-aaf5-4182-b148-acbb4c11a1d0	TCGA-EO-A3KX-01	babc3b9e-a99f-490b-a277-ab4e6f6b5449				c5e61b67-aaf5-4182-b148-acbb4c11a1d0	TCGA-EO-A3KX-01A-11D-A227-01	babc3b9e-a99f-490b-a277-ab4e6f6b5449	TCGA-EO-A3KX-01A-11R-A22I-13	babc3b9e-a99f-490b-a277-ab4e6f6b5449
TCGA-EO-A3L0-01	MSS	0	TCGA-EO-A3L0-01	757	0	Kirc+		UCEC CIMP c18		squamous c3		miRNA c1uster 10			TCGA-EO-A3L0	757	0	757	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	76		0	TCGA-EO-A3L0-F39975		Stage IA	NO		-28003	422		0	757				NO			2013-2-7	FEMALE	159	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	110	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-EO-A3L0.AD1F0EEC-20B6-416B-9728-BC103D2B3B87.pdf	49		1		0		0		0		0		0		100		95		TUMOR FREE		0	NO	2	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	2009		NO	YES	EO		2		11	Endometrial	A	LIVING	110	2010			TCGA-EO-A3L0-01	4383201e-ca97-4192-8e89-c63b10caaa0c	TCGA-EO-A3L0-01A-11R-A22I-13	TCGA-EO-A3L0-01A-11D-A227-01				TCGA-EO-A3L0-01A-11D-A22B-05				TCGA-EO-A3L0-01A-21-A23Z-20	57994dee-6985-4c11-a12b-eb35f6a44c16	TCGA-EO-A3L0-01	4383201e-ca97-4192-8e89-c63b10caaa0c				57994dee-6985-4c11-a12b-eb35f6a44c16	TCGA-EO-A3L0-01A-11D-A227-01	4383201e-ca97-4192-8e89-c63b10caaa0c	TCGA-EO-A3L0-01A-11R-A22I-13	4383201e-ca97-4192-8e89-c63b10caaa0c
TCGA-EY-A1G7-01	MSS	1	TCGA-EY-A1G7-01	189	1	BRCA-LUAD+	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 6		TCGA-EY-A1G7			189	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	NO	YES	NO	Partial Response	86			TCGA-EY-A1G7-F10982	Never Used	Stage II	NO		-31603	1002	189	0				95	NO			2011-5-2	FEMALE	151	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Tumor resection	140	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2						false	TCGA-EY-A1G7.2803014E-7E68-463F-BF3C-C5E4DF9FA421.pdf	96		20		0		20		20		20		10		50		70	negative	WITH TUMOR				4+	Complete Remission/Response	Yes	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	1988	NO	NO	YES	EY		0		0	Endometrial	A	DECEASED	85	2008	c3c8ccb3-db16-4cc6-b790-204473be0f25		TCGA-EY-A1G7-01		TCGA-EY-A1G7-01A-11R-A13R-13	TCGA-EY-A1G7-01A-11D-A13J-01			c3c8ccb3-db16-4cc6-b790-204473be0f25	TCGA-EY-A1G7-01A-11D-A13K-05				TCGA-EY-A1G7-01A-21-A18Q-20	378b2d7b-b5ea-4809-996d-eff3ac596650	TCGA-EY-A1G7-01					378b2d7b-b5ea-4809-996d-eff3ac596650	TCGA-EY-A1G7-01A-11D-A13J-01		TCGA-EY-A1G7-01A-11R-A13R-13	
TCGA-EY-A1G8-01	MSS	1	TCGA-EY-A1G8-01	456	1	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 6		TCGA-EY-A1G8			456	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					83			TCGA-EY-A1G8-F10562		Stage IB	NO		-30517		456	0					NO			2011-4-21	FEMALE	160	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Tumor resection				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3								38																	negative	TUMOR FREE		0		2	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	EY		0		40	Endometrial		DECEASED	49	2008	d653b50c-d568-48a1-bbed-5e36fbf525ac		TCGA-EY-A1G8-01		TCGA-EY-A1G8-01A-11R-A13R-13	TCGA-EY-A1G8-01A-11D-A13J-01			d653b50c-d568-48a1-bbed-5e36fbf525ac	TCGA-EY-A1G8-01A-11D-A13K-05				TCGA-EY-A1G8-01A-21-A18Q-20	b828f9c8-06b7-4115-8266-3c5ed53db749	TCGA-EY-A1G8-01					b828f9c8-06b7-4115-8266-3c5ed53db749	TCGA-EY-A1G8-01A-11D-A13J-01		TCGA-EY-A1G8-01A-11R-A13R-13	
TCGA-EY-A1GC-01	MSS	0	TCGA-EY-A1GC-01	138	0	High	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 14	cluster 3		TCGA-EY-A1GC	138	0	138	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	62			TCGA-EY-A1GC-F19721		Stage IB	NO		-22656	519		0	138				NO		Scheduled Follow-up Submission	2011-12-21	FEMALE	167	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Tumor resection	290	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-EY-A1GC.62D18250-0D82-43AB-AADE-E152D6FF74BB.pdf	5		0		0		0		0		0		0		100		85	negative	TUMOR FREE		0		3	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	EY		0	0	24	Endometrial	A	LIVING	96	2009	b408b777-f98b-4660-b01b-89fa0c607c3b		TCGA-EY-A1GC-01		TCGA-EY-A1GC-01A-11R-A13R-13	TCGA-EY-A1GC-01A-11D-A13J-01			b408b777-f98b-4660-b01b-89fa0c607c3b	TCGA-EY-A1GC-01A-11D-A13K-05				TCGA-EY-A1GC-01A-21-A18Q-20	22338f69-1830-4640-a0ec-f155a46605c7	TCGA-EY-A1GC-01					22338f69-1830-4640-a0ec-f155a46605c7	TCGA-EY-A1GC-01A-11D-A13J-01		TCGA-EY-A1GC-01A-11R-A13R-13	
TCGA-EY-A1GD-01	MSS	0	TCGA-EY-A1GD-01	1639	0	Iq	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 3		TCGA-EY-A1GD	1639	0	1639	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	51		0	TCGA-EY-A1GD-F70252	Former User	Stage IA	NO		-18638	511		0	1639				NO		Scheduled Follow-up Submission	2015-2-2	FEMALE	157	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Tumor resection	230	NO	NO	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1					NO	false	TCGA-EY-A1GD.65C636F7-B24D-479C-A607-FEFEE7D7E30D.pdf	0		0		0		0		0		0		0		100		80	negative	TUMOR FREE		0	NO	3	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	EY	0	3	0	20	Endometrial	A	LIVING	79	2009	5d109d0e-7bc8-4d3e-898b-a48ab288a5ee		TCGA-EY-A1GD-01		TCGA-EY-A1GD-01A-11R-A13R-13	TCGA-EY-A1GD-01A-11D-A13J-01			5d109d0e-7bc8-4d3e-898b-a48ab288a5ee	TCGA-EY-A1GD-01A-11D-A13K-05				TCGA-EY-A1GD-01A-21-A18Q-20	3cf4b678-ec71-4a35-83d3-8500a8400880	TCGA-EY-A1GD-01					3cf4b678-ec71-4a35-83d3-8500a8400880	TCGA-EY-A1GD-01A-11D-A13J-01		TCGA-EY-A1GD-01A-11R-A13R-13	
TCGA-EY-A1GE-01	MSS	0	TCGA-EY-A1GE-01	741	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 1		TCGA-EY-A1GE	741	0	741	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	67		0	TCGA-EY-A1GE-F19724	Never Used	Stage IA	NO		-24667	506		0	741				NO		Scheduled Follow-up Submission	2011-12-21	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	410	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	TCGA-EY-A1GE.432813D0-4B52-4941-940C-5725BCE4211A.pdf	0		0		0		0		0		0		0		100		65	negative	TUMOR FREE		0		4+	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	EY	0	10	0	27	Endometrial	A	LIVING	103	2009	d2a5585a-76fe-4e69-bf8a-36553bf282fb		TCGA-EY-A1GE-01		TCGA-EY-A1GE-01A-11R-A13R-13	TCGA-EY-A1GE-01A-11D-A13J-01			d2a5585a-76fe-4e69-bf8a-36553bf282fb	TCGA-EY-A1GE-01A-11D-A13K-05				TCGA-EY-A1GE-01A-21-A18Q-20	5e86027c-1e42-489f-9ed3-fa8801261e8a	TCGA-EY-A1GE-01					5e86027c-1e42-489f-9ed3-fa8801261e8a	TCGA-EY-A1GE-01A-11D-A13J-01		TCGA-EY-A1GE-01A-11R-A13R-13	
TCGA-EY-A1GF-01	MSI-H	0	TCGA-EY-A1GF-01	826	0	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-EY-A1GF	826	0	826	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	75		0	TCGA-EY-A1GF-F19725	Never Used	Stage IA	NO		-27450	504		0	826				NO		Scheduled Follow-up Submission	2011-12-21	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	160	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	TCGA-EY-A1GF.0C63BAC2-FD3E-49CB-A352-0B1653B78BDD.pdf	11		0		0		0		0		0		0		100		80	negative	TUMOR FREE		0		2	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	EY	0	9	0	16	Endometrial	A	LIVING	71	2009	e8d79b43-6ed3-40f4-854e-5fd23204381f		TCGA-EY-A1GF-01		TCGA-EY-A1GF-01A-11R-A13R-13	TCGA-EY-A1GF-01A-11D-A13J-01			e8d79b43-6ed3-40f4-854e-5fd23204381f	TCGA-EY-A1GF-01A-11D-A13K-05				TCGA-EY-A1GF-01A-21-A18Q-20	349a9a64-1ed0-4e8f-9170-4863f9a9797f	TCGA-EY-A1GF-01					349a9a64-1ed0-4e8f-9170-4863f9a9797f	TCGA-EY-A1GF-01A-11D-A13J-01		TCGA-EY-A1GF-01A-11R-A13R-13	
TCGA-EY-A1GH-01	MSS	0	TCGA-EY-A1GH-01	710	0	BRCA-LUAD+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 3		TCGA-EY-A1GH	710	0	710	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	70			TCGA-EY-A1GH-F19726	Never Used	Stage IA	NO		-25802	452		0	710				NO		Scheduled Follow-up Submission	2011-12-21	FEMALE	170	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	280	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	TCGA-EY-A1GH.29D738E9-2F8D-4909-A427-7C056859B89A.pdf	33		0		0		0		0		0		0		100		75	negative	TUMOR FREE				2	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	EY		0			Endometrial	A	LIVING	117	2009	55f89e0e-bb6b-40e0-bc85-602a011c764b		TCGA-EY-A1GH-01		TCGA-EY-A1GH-01A-11R-A13R-13	TCGA-EY-A1GH-01A-11D-A13J-01			55f89e0e-bb6b-40e0-bc85-602a011c764b	TCGA-EY-A1GH-01A-11D-A13K-05				TCGA-EY-A1GH-01A-21-A18Q-20	6e09f700-6829-4cf4-8e9b-dad32e4f9972	TCGA-EY-A1GH-01					6e09f700-6829-4cf4-8e9b-dad32e4f9972	TCGA-EY-A1GH-01A-11D-A13J-01		TCGA-EY-A1GH-01A-11R-A13R-13	
TCGA-EY-A1GI-01	MSS	0	TCGA-EY-A1GI-01	710	0	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 4		TCGA-EY-A1GI	710	0	710	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	52			TCGA-EY-A1GI-F19727	Never Used	Stage IB	NO		-19117	444		0	710				NO		Scheduled Follow-up Submission	2011-12-21	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Excisional Biopsy	150	NO		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2					NO	false	TCGA-EY-A1GI.1D56F7CA-A3F0-4078-B8E3-A10CD97873D4.pdf	76		0		0		0		0		0		0		100		85	negative	TUMOR FREE		0		2	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	2009	NO	NO	YES	EY		0	0	23	Endometrial	A	LIVING	69	2009	e505cac9-a568-42db-bc67-d90af57e5265		TCGA-EY-A1GI-01		TCGA-EY-A1GI-01A-11R-A13R-13	TCGA-EY-A1GI-01A-11D-A13J-01			e505cac9-a568-42db-bc67-d90af57e5265	TCGA-EY-A1GI-01A-11D-A13K-05				TCGA-EY-A1GI-01A-21-A18Q-20	153eae8f-9ec2-4afe-bf8a-90d6c59754b4	TCGA-EY-A1GI-01					153eae8f-9ec2-4afe-bf8a-90d6c59754b4	TCGA-EY-A1GI-01A-11D-A13J-01		TCGA-EY-A1GI-01A-11R-A13R-13	
TCGA-EY-A1GJ-01	MSS	0	TCGA-EY-A1GJ-01	727	0	High		UCEC Serous c4	cluster 3	UCEC-like c5		miRNA cluster 13	cluster 6		TCGA-EY-A1GJ	727	0	727	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	73		0	TCGA-EY-A1GJ-F19728	Never Used	Stage IA	NO		-26715	434		0	727				YES		Scheduled Follow-up Submission	2011-12-21	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	300	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-EY-A1GJ.505FE0B0-068C-4B2A-AA40-4657FB2E0425.pdf	0		0		0		0		0		0		0		100		95	negative	TUMOR FREE		0		4+	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009	NO	YES	NO	EY	0	10	0	15	Endometrial	A	LIVING	85	2009					TCGA-EY-A1GJ-01A-12R-A143-13	TCGA-EY-A1GJ-01A-12D-A141-01				TCGA-EY-A1GJ-01A-12D-A145-05				TCGA-EY-A1GJ-01A-21-A18Q-20	9c296211-e36d-47dd-a48f-7a496ca47c97						9c296211-e36d-47dd-a48f-7a496ca47c97	TCGA-EY-A1GJ-01A-12D-A141-01		TCGA-EY-A1GJ-01A-12R-A143-13	
TCGA-EY-A1GK-01	MSI-H	0	TCGA-EY-A1GK-01	693	0	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 4		TCGA-EY-A1GK	693	0	693	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	74		0	TCGA-EY-A1GK-F19756	Never Used	Stage IB	NO		-27127	409		0	693				NO		Scheduled Follow-up Submission	2011-12-22	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	120	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-EY-A1GK.B5024D10-E23D-4B3B-8C54-13EBAA423A04.pdf	58		30		30		5		30		0		15		80		80	negative	TUMOR FREE		0		3	Complete Remission/Response	Yes	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009	NO	YES	NO	EY	0	12	0	14	Endometrial	A	LIVING	105	2009	bfbb3c82-87b0-44b2-bf2c-5c9bdc318460		TCGA-EY-A1GK-01		TCGA-EY-A1GK-01A-11R-A13R-13	TCGA-EY-A1GK-01A-11D-A13J-01			bfbb3c82-87b0-44b2-bf2c-5c9bdc318460	TCGA-EY-A1GK-01A-11D-A13K-05				TCGA-EY-A1GK-01A-21-A18Q-20	85a79731-1cae-4f2d-8d98-60802c59fb3e	TCGA-EY-A1GK-01					85a79731-1cae-4f2d-8d98-60802c59fb3e	TCGA-EY-A1GK-01A-11D-A13J-01		TCGA-EY-A1GK-01A-11R-A13R-13	
TCGA-EY-A1GL-01	MSS	0	TCGA-EY-A1GL-01	425	0	Kirc+		UCEC CIMP c18	cluster 1	UCEC-like c5		miRNA cluster 11	cluster 2		TCGA-EY-A1GL	425	0	425	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	51		0	TCGA-EY-A1GL-F19757	Never Used	Stage II	NO		-18761	366		0	425				NO		Scheduled Follow-up Submission	2011-12-22	FEMALE	173	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	300	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	TCGA-EY-A1GL.449C1D9F-6A1F-4523-8C86-AFED911D95D4.pdf	83		40		20		5		20		0		25		70		70	negative	TUMOR FREE		0		0	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	2009	NO	YES	NO	EY	0	6	0	13	Endometrial	A	LIVING	73	2010			TCGA-EY-A1GL-01	94120972-002e-4dbd-8bb1-7f41f05f2b0f	TCGA-EY-A1GL-01A-11R-A13R-13	TCGA-EY-A1GL-01A-11D-A13J-01				TCGA-EY-A1GL-01A-11D-A13K-05				TCGA-EY-A1GL-01A-21-A18Q-20	b8dbdef6-924f-476b-b151-d75f606e3fd4	TCGA-EY-A1GL-01	94120972-002e-4dbd-8bb1-7f41f05f2b0f				b8dbdef6-924f-476b-b151-d75f606e3fd4	TCGA-EY-A1GL-01A-11D-A13J-01	94120972-002e-4dbd-8bb1-7f41f05f2b0f	TCGA-EY-A1GL-01A-11R-A13R-13	94120972-002e-4dbd-8bb1-7f41f05f2b0f
TCGA-EY-A1GM-01	MSS	0	TCGA-EY-A1GM-01	210	0	COAD-READ	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5		TCGA-EY-A1GM	210	0	210	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	60		0	TCGA-EY-A1GM-F19758	Never Used	Stage IIIA	NO		-22010	323		0	210				NO		Scheduled Follow-up Submission	2011-12-22	FEMALE	157	Mixed serous and endometrioid	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	140	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-EY-A1GM.C3599CB9-3B69-4083-AA2E-5BB52CF1ED93.pdf	33		20		20		5		40		0		5		90		90	positive	TUMOR FREE		0		1	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	YES	YES	NO	EY	0	13	0	11	Endometrial	A	LIVING	71	2010	9713963c-c7c7-47a0-ba01-6710bd4e9fea		TCGA-EY-A1GM-01		TCGA-EY-A1GM-01A-12R-A14C-13	TCGA-EY-A1GM-01A-12D-A14F-01			9713963c-c7c7-47a0-ba01-6710bd4e9fea	TCGA-EY-A1GM-01A-12D-A14H-05				TCGA-EY-A1GM-01A-21-A18Q-20	4a6e9d76-8069-4978-a4ca-916e1a70478c	TCGA-EY-A1GM-01					4a6e9d76-8069-4978-a4ca-916e1a70478c	TCGA-EY-A1GM-01A-12D-A14F-01		TCGA-EY-A1GM-01A-12R-A14C-13	
TCGA-EY-A1GO-01	MSI-H	0	TCGA-EY-A1GO-01	586	0	Squamous		UCEC Serous c4	cluster 4	UCEC-like c5		miRNA c1uster 10	cluster 3		TCGA-EY-A1GO	517	1	586	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	NO	YES	Progressive Disease	65		0	TCGA-EY-A1GO-F19759	Former User	Stage IIIC1	NO	517	-23853	259		0	586			517	NO		Scheduled Follow-up Submission	2011-12-22	FEMALE	156	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8380/3	C54.1	YES		Tumor resection	100	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2	Lung	Metastatic			YES	false	TCGA-EY-A1GO.82216372-E1EF-47F2-B57A-25C1DCB24E5E.pdf	98		40		20		10		20		0		10		80		80	negative	WITH TUMOR		1		2	Complete Remission/Response	No	Never Used		YES	Other Method, Specify Below	VATS Wedge resection	RX	R0	Primary Tumor	01	Minimally Invasive	2009	YES	YES	NO	EY	0	6	1	17	Endometrial	A	LIVING	76	2010			TCGA-EY-A1GO-01	8bf59d5d-e4e0-48c3-9ae7-16feeb2675e7	TCGA-EY-A1GO-01A-11R-A14C-13	TCGA-EY-A1GO-01A-11D-A14F-01				TCGA-EY-A1GO-01A-11D-A14H-05				TCGA-EY-A1GO-01A-21-A18Q-20	0c40376c-214f-4e02-ab6c-d03bd3a39450	TCGA-EY-A1GO-01	8bf59d5d-e4e0-48c3-9ae7-16feeb2675e7				0c40376c-214f-4e02-ab6c-d03bd3a39450	TCGA-EY-A1GO-01A-11D-A14F-01	8bf59d5d-e4e0-48c3-9ae7-16feeb2675e7	TCGA-EY-A1GO-01A-11R-A14C-13	8bf59d5d-e4e0-48c3-9ae7-16feeb2675e7
TCGA-EY-A1GP-01	MSS	0	TCGA-EY-A1GP-01	573	0	BRCA-LUAD+		UCEC Serous c4	cluster 3	UCEC-like c5		miRNA cluster 13	cluster 6		TCGA-EY-A1GP	573	0	573	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	54			TCGA-EY-A1GP-F19766	Never Used	Stage IA	NO		-20011	262		0	573				YES		Scheduled Follow-up Submission	2011-12-22	FEMALE	158	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	90	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	TCGA-EY-A1GP.D9933BA3-3D3B-4B93-AD6C-22ED47C4DBB1.pdf	32		40		20		10		20		0		10		80		80	negative	TUMOR FREE				0	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	NO	YES	NO	EY		0		0	Endometrial	A	LIVING	72	2010			TCGA-EY-A1GP-01	c3740105-aee5-42ef-94e9-50f6b242b7c8	TCGA-EY-A1GP-01A-11R-A13R-13	TCGA-EY-A1GP-01A-11D-A13J-01				TCGA-EY-A1GP-01A-11D-A13K-05				TCGA-EY-A1GP-01A-21-A18Q-20	9d7008dd-fa7d-447a-b38c-06b4e1f332df	TCGA-EY-A1GP-01	c3740105-aee5-42ef-94e9-50f6b242b7c8				9d7008dd-fa7d-447a-b38c-06b4e1f332df	TCGA-EY-A1GP-01A-11D-A13J-01	c3740105-aee5-42ef-94e9-50f6b242b7c8	TCGA-EY-A1GP-01A-11R-A13R-13	c3740105-aee5-42ef-94e9-50f6b242b7c8
TCGA-EY-A1GQ-01	MSI-H	0	TCGA-EY-A1GQ-01	544	0	BRCA-LUAD+	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 5	cluster 4		TCGA-EY-A1GQ	334	1	544	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES		NO	Partial Response	76			TCGA-EY-A1GQ-F13192		Stage IB	NO		-27905	274		0	544			334	NO		Additional New Tumor Event	2011-12-22	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	160	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Metastatic	R external iliac node, presacral peritoneal implant, ascitic fluid		YES	false	TCGA-EY-A1GQ.9A8D1D19-18D8-483B-BD87-B686D25C617F.pdf	98		40		20		10		20		0		30		60		60	negative	WITH TUMOR		0		4+	Complete Remission/Response	Yes	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009	NO	YES	NO	EY		0	0	29	Endometrial	A	LIVING	81	2010	afceaea6-337b-4ac4-a7fb-773c98d95547		TCGA-EY-A1GQ-01		TCGA-EY-A1GQ-01A-21R-A13R-13	TCGA-EY-A1GQ-01A-21D-A13J-01			afceaea6-337b-4ac4-a7fb-773c98d95547	TCGA-EY-A1GQ-01A-21D-A13K-05				TCGA-EY-A1GQ-01A-11-A18Q-20	7f575268-a427-4a9d-971d-d46bdea8947c	TCGA-EY-A1GQ-01					7f575268-a427-4a9d-971d-d46bdea8947c	TCGA-EY-A1GQ-01A-21D-A13J-01		TCGA-EY-A1GQ-01A-21R-A13R-13	
TCGA-EY-A1GR-01	MSS	0	TCGA-EY-A1GR-01	536	0	Squamous	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-EY-A1GR	536	0	536	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	67		0	TCGA-EY-A1GR-F19769	Never Used	Stage IA	NO		-24784	263		0	536				YES		Scheduled Follow-up Submission	2011-12-22	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	410	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-EY-A1GR.1C53C957-1A0A-46AF-A53B-0287683D52F6.pdf	33		20		20		15		40		0		5		80		80	negative	TUMOR FREE		0		3	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	YES	NO	EY	0	9	0	16	Endometrial	A	LIVING	93	2010	64b366d1-dfb2-4488-9fd1-e6b26998bb9d		TCGA-EY-A1GR-01		TCGA-EY-A1GR-01A-11R-A13R-13	TCGA-EY-A1GR-01A-11D-A13J-01			64b366d1-dfb2-4488-9fd1-e6b26998bb9d	TCGA-EY-A1GR-01A-11D-A13K-05				TCGA-EY-A1GR-01A-21-A18Q-20	09f0ac08-ffd3-4ab6-907f-f392d7c7b368	TCGA-EY-A1GR-01					09f0ac08-ffd3-4ab6-907f-f392d7c7b368	TCGA-EY-A1GR-01A-11D-A13J-01		TCGA-EY-A1GR-01A-11R-A13R-13	
TCGA-EY-A1GS-01	MSS	0	TCGA-EY-A1GS-01	459	0	High	C6-UCEC	BRCA CIMP c7	cluster 2	BRCA basal-like c6	UCEC-like c11	miRNA c1uster 10	cluster 2	mutation cluster 2	TCGA-EY-A1GS	459	0	459	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Stable Disease	71			TCGA-EY-A1GS-F19874		Stage IVB			-26012	211		0	459				NO		Scheduled Follow-up Submission	2012-1-3	FEMALE	161	Serous endometrial adenocarcinoma	No		YES	C54.1	8441/3	C54.1	YES		Tumor resection	270	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-EY-A1GS.3F953015-45DC-4678-A8B3-DC55339DE717.pdf	50		40		20		10		20		0		10		80		80		WITH TUMOR		7		0	Stable Disease	No			NO				R2	Primary Tumor	01	open	2009	YES	YES	NO	EY		0	7	9	Endometrial	A	LIVING	62	2010	7348f1f9-8bcf-41e2-bcb0-743823cac926		TCGA-EY-A1GS-01		TCGA-EY-A1GS-01A-11R-A13R-13	TCGA-EY-A1GS-01A-11D-A13J-01			7348f1f9-8bcf-41e2-bcb0-743823cac926	TCGA-EY-A1GS-01A-11D-A13K-05			TCGA-EY-A1GS-01A-11D-A13L-09	TCGA-EY-A1GS-01A-21-A18Q-20	0902cfd2-1f9f-4114-a4d0-6ed304cd569f	TCGA-EY-A1GS-01				TCGA-EY-A1GS-01A-11D-A13L-09	0902cfd2-1f9f-4114-a4d0-6ed304cd569f	TCGA-EY-A1GS-01A-11D-A13J-01		TCGA-EY-A1GS-01A-11R-A13R-13	
TCGA-EY-A1GT-01	MSS	0	TCGA-EY-A1GT-01	490	0	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 2		TCGA-EY-A1GT	490	0	490	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	68			TCGA-EY-A1GT-F19877	Former User	Stage IIIA	NO		-25151	225		0	490				NO		Scheduled Follow-up Submission	2012-1-3	FEMALE	168	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	380	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	TCGA-EY-A1GT.2F5AE4E7-9411-461D-ACD9-EB7D51CEF872.pdf	10		40		20		10		20		0		30		60		60	positive	TUMOR FREE		0		1	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	YES	YES	NO	EY		0	0	25	Endometrial	A	LIVING	70	2010	654f3e2f-00c7-4db6-b092-e2d0d50845da		TCGA-EY-A1GT-01		TCGA-EY-A1GT-01A-11R-A13R-13	TCGA-EY-A1GT-01A-11D-A13J-01			654f3e2f-00c7-4db6-b092-e2d0d50845da	TCGA-EY-A1GT-01A-11D-A13K-05				TCGA-EY-A1GT-01A-21-A18Q-20	cebaeede-1f83-408a-a594-568af129c762	TCGA-EY-A1GT-01					cebaeede-1f83-408a-a594-568af129c762	TCGA-EY-A1GT-01A-11D-A13J-01		TCGA-EY-A1GT-01A-11R-A13R-13	
TCGA-EY-A1GU-01	MSI-H	0	TCGA-EY-A1GU-01	378	0	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1		TCGA-EY-A1GU	378	0	378	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	66		0	TCGA-EY-A1GU-F19879	Never Used	Stage IB	NO		-24304	189		0	378				YES		Scheduled Follow-up Submission	2012-1-3	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	380	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	TCGA-EY-A1GU.7A06A8F8-416F-41CD-B546-95DEA06996D0.pdf	94		40		10		5		40		0		15		80		80	negative	TUMOR FREE		0		4+	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009	NO	YES	NO	EY	0	5	0	11	Endometrial	A	LIVING	90	2010	02302c44-fe54-4b39-9bef-c56db229c2ac		TCGA-EY-A1GU-01		TCGA-EY-A1GU-01A-11R-A13R-13	TCGA-EY-A1GU-01A-11D-A13J-01			02302c44-fe54-4b39-9bef-c56db229c2ac	TCGA-EY-A1GU-01A-11D-A13K-05				TCGA-EY-A1GU-01A-21-A18Q-20	b86dd881-6cee-4666-a252-d95ffdf1d5b1	TCGA-EY-A1GU-01					b86dd881-6cee-4666-a252-d95ffdf1d5b1	TCGA-EY-A1GU-01A-11D-A13J-01		TCGA-EY-A1GU-01A-11R-A13R-13	
TCGA-EY-A1GV-01	MSS	0	TCGA-EY-A1GV-01	481	0	High	C6-UCEC	OV-like c1	cluster 3	BRCA basal-like c6	UCEC-like c11	miRNA cluster 13	cluster 2		TCGA-EY-A1GV	481	0	481	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	75		0	TCGA-EY-A1GV-F19882		Stage IIIC1	NO		-27581	156		0	481				YES		Scheduled Follow-up Submission	2012-1-3	FEMALE	165	Mixed serous and endometrioid	No		YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	300	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-EY-A1GV.87A6A698-71B7-41D8-AE28-C2FCC92F9A94.pdf	59		40		20		10		20		0		10		80		80	negative	TUMOR FREE		1		4+	Complete Remission/Response	No			YES				R0	Primary Tumor	01	Minimally Invasive	2009	YES	YES	NO	EY	0	11	1	17	Endometrial	A	LIVING	79	2010	2b56219d-b0d0-4107-acdf-b2ad9c18f090		TCGA-EY-A1GV-01		TCGA-EY-A1GV-01A-11R-A13R-13	TCGA-EY-A1GV-01A-11D-A13J-01			2b56219d-b0d0-4107-acdf-b2ad9c18f090	TCGA-EY-A1GV-01A-11D-A13K-05				TCGA-EY-A1GV-01A-21-A18Q-20	56b14a4b-e32b-4aae-b4fa-6c4b89e59d50	TCGA-EY-A1GV-01					56b14a4b-e32b-4aae-b4fa-6c4b89e59d50	TCGA-EY-A1GV-01A-11D-A13J-01		TCGA-EY-A1GV-01A-11R-A13R-13	
TCGA-EY-A1GW-01	MSS	1	TCGA-EY-A1GW-01	337	1	Squamous	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-EY-A1GW	190	1	337	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	NO	NO	Progressive Disease	73			TCGA-EY-A1GW-F12151	Never Used	Stage IVB	NO		-26979	155	337	0	260			190	NO		Additional New Tumor Event	2012-1-3	FEMALE	149	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	410	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Liver	Metastatic			YES	false	TCGA-EY-A1GW.52C26330-540E-4409-ACDF-4D56EA1E7D7F.pdf	62		30		20		10		30		0		10		80		80	positive	WITH TUMOR				2	Progressive Disease	No	Never Used		NO				R1	Primary Tumor	01	open	2009	YES	YES	NO	EY		0		0	Endometrial	A	DECEASED	81	2010	4e6ddf28-1fb2-4527-b415-30c714ecde09		TCGA-EY-A1GW-01		TCGA-EY-A1GW-01A-22R-A13R-13	TCGA-EY-A1GW-01A-22D-A13J-01			4e6ddf28-1fb2-4527-b415-30c714ecde09	TCGA-EY-A1GW-01A-22D-A13K-05				TCGA-EY-A1GW-01A-11-A18Q-20	fbf09e20-a8ae-43ba-90c2-04465fa9c060	TCGA-EY-A1GW-01					fbf09e20-a8ae-43ba-90c2-04465fa9c060	TCGA-EY-A1GW-01A-22D-A13J-01		TCGA-EY-A1GW-01A-22R-A13R-13	
TCGA-EY-A1GX-01	MSS	0	TCGA-EY-A1GX-01	197	0	BRCA-LUAD+		UCEC CIMP c18	cluster 1	UCEC-like c5		miRNA c1uster 10	cluster 1		TCGA-EY-A1GX	197	0	197	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	76		0	TCGA-EY-A1GX-F19893		Stage IIIA	NO		-27962	172		0	197				NO		Scheduled Follow-up Submission	2012-1-3	FEMALE	160	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	370	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	TCGA-EY-A1GX.4AD600AE-7CE0-4BBA-B4FC-0EB8C460502B.pdf	25		40		20		10		20		0		30		60		60	negative	TUMOR FREE		0		2	Complete Remission/Response	No			NO				R0	Primary Tumor	01	Minimally Invasive	2009	NO	YES	NO	EY	0	6	0	8	Endometrial	A	LIVING	69	2010			TCGA-EY-A1GX-01	253d79e4-6505-4704-8cd4-aafa5d36b4a4	TCGA-EY-A1GX-01A-12R-A13R-13	TCGA-EY-A1GX-01A-12D-A13J-01				TCGA-EY-A1GX-01A-12D-A13K-05				TCGA-EY-A1GX-01A-21-A18Q-20	3100b35c-dae3-40a8-83f6-301ea116e439	TCGA-EY-A1GX-01	253d79e4-6505-4704-8cd4-aafa5d36b4a4				3100b35c-dae3-40a8-83f6-301ea116e439	TCGA-EY-A1GX-01A-12D-A13J-01	253d79e4-6505-4704-8cd4-aafa5d36b4a4	TCGA-EY-A1GX-01A-12R-A13R-13	253d79e4-6505-4704-8cd4-aafa5d36b4a4
TCGA-EY-A1H0-01	MSI-H	0	TCGA-EY-A1H0-01	588	0	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5		TCGA-EY-A1H0	588	0	588	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Stable Disease	57		1	TCGA-EY-A1H0-F19894		Stage IIIC2	NO		-20937	262		0	588				YES		Scheduled Follow-up Submission	2012-1-3	FEMALE	163	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	330	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	TCGA-EY-A1H0.CE7F1184-9FFC-4A30-926B-0008915893F2.pdf	23		30		20		5		30		0		25		70		70	negative	WITH TUMOR		3		1	Partial Remission/Response	No			YES				R0	Primary Tumor	01	open	2009	YES	YES	NO	EY	1	4	3	8	Endometrial	A	LIVING	90	2010	8b72e6e7-cac5-4b7f-8f6a-7abef8b24e01		TCGA-EY-A1H0-01		TCGA-EY-A1H0-01A-11R-A13R-13	TCGA-EY-A1H0-01A-11D-A13J-01			8b72e6e7-cac5-4b7f-8f6a-7abef8b24e01	TCGA-EY-A1H0-01A-11D-A13K-05				TCGA-EY-A1H0-01A-21-A18Q-20	c68e9d43-b306-40c5-907c-fa548a70da1b	TCGA-EY-A1H0-01					c68e9d43-b306-40c5-907c-fa548a70da1b	TCGA-EY-A1H0-01A-11D-A13J-01		TCGA-EY-A1H0-01A-11R-A13R-13	
TCGA-EY-A210-01	MSI-L	0	TCGA-EY-A210-01	383	0	High		UCEC non-CIMP c3	cluster 3	UCEC-like c5		miRNA cluster 12	cluster 5		TCGA-EY-A210	383	0	383	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	82		7	TCGA-EY-A210-F21703	Never Used	Stage IIIC2	NO		-30095	70		0	383				NO		Scheduled Follow-up Submission	2012-2-17	FEMALE	155	Mixed serous and endometrioid	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	840	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-EY-A210.51A98C43-6A6A-4027-8E92-B3B9AA1A63D4.pdf	38		35		5		0		15		0		5		95		95	positive	TUMOR FREE		6		4+	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	NO	YES	NO	EY	7	8	6	20	Endometrial	A	LIVING	63	2011			TCGA-EY-A210-01	4547d0d6-21ed-4128-9be9-34555bff3b83	TCGA-EY-A210-01A-11R-A156-13	TCGA-EY-A210-01A-11D-A160-01				TCGA-EY-A210-01A-11D-A161-05				TCGA-EY-A210-01A-21-A18Q-20	a24cc805-6f92-4528-9113-e6d4dec34138	TCGA-EY-A210-01	4547d0d6-21ed-4128-9be9-34555bff3b83				a24cc805-6f92-4528-9113-e6d4dec34138	TCGA-EY-A210-01A-11D-A160-01	4547d0d6-21ed-4128-9be9-34555bff3b83	TCGA-EY-A210-01A-11R-A156-13	4547d0d6-21ed-4128-9be9-34555bff3b83
TCGA-EY-A212-01	MSS	1	TCGA-EY-A212-01	310	1	High	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 2	mutation cluster 5	TCGA-EY-A212	310	0	310	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Partial Response	83		0	TCGA-EY-A212-F21719		Stage IIIC1	YES		-30680	112	310	0	110				YES		Scheduled Follow-up Submission	2012-2-17	FEMALE	159	Serous endometrial adenocarcinoma	No		YES	C54.1	8460/3	C54.1	YES		Office Endometrial Biopsy	290	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-EY-A212.3E8012E3-97F1-48A2-B1C0-5C814DF8EE01.pdf	45		40		20		5		20		0		5		90		90	positive	WITH TUMOR		1		4+	Partial Remission/Response	Yes			NO				R0	Primary Tumor	01	Minimally Invasive	2009	NO	YES	NO	EY	0	19	1	33	Endometrial	A	DECEASED	81	2010	6c1a95ef-3b5a-49ac-aaeb-dcd8071bed23		TCGA-EY-A212-01		TCGA-EY-A212-01A-11R-A14L-13	TCGA-EY-A212-01A-11D-A14J-01			6c1a95ef-3b5a-49ac-aaeb-dcd8071bed23	TCGA-EY-A212-01A-11D-A14N-05			TCGA-EY-A212-01A-11D-A14K-09	TCGA-EY-A212-01A-21-A18R-20	ab417d3f-22ed-4c4f-a239-e14422b6ad5c	TCGA-EY-A212-01				TCGA-EY-A212-01A-11D-A14K-09	ab417d3f-22ed-4c4f-a239-e14422b6ad5c	TCGA-EY-A212-01A-11D-A14J-01		TCGA-EY-A212-01A-11R-A14L-13	
TCGA-EY-A214-01	MSS	0	TCGA-EY-A214-01	438	0	High	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-EY-A214	438	0	438	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	66		0	TCGA-EY-A214-F22091	Former User	Stage IIIC1	NO		-24136	160		0	438				NO		Scheduled Follow-up Submission	2012-2-23	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	330	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-EY-A214.90B0CBB0-3AC0-44F8-9C49-310CFFE0370C.pdf	72		40		20		10		20		0		20		70		70	negative	TUMOR FREE		1		2	Complete Remission/Response	Yes	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009	YES	YES	NO	EY	0	19	1	31	Endometrial	A	LIVING	94	2010	32d0d293-ce07-487a-b914-062548072260		TCGA-EY-A214-01		TCGA-EY-A214-01A-12R-A156-13	TCGA-EY-A214-01A-12D-A160-01			32d0d293-ce07-487a-b914-062548072260	TCGA-EY-A214-01A-12D-A161-05				TCGA-EY-A214-01A-21-A18R-20	30bf82ef-59e9-426d-8ad1-be329b70b63c	TCGA-EY-A214-01					30bf82ef-59e9-426d-8ad1-be329b70b63c	TCGA-EY-A214-01A-12D-A160-01		TCGA-EY-A214-01A-12R-A156-13	
TCGA-EY-A215-01	MSI-H	0	TCGA-EY-A215-01	574	0	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	COADREAD-like c15	miRNA c1uster 10	cluster 3		TCGA-EY-A215	574	0	574	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	60		0	TCGA-EY-A215-F21735		Stage IB	NO		-22076	293		0	574				NO		Scheduled Follow-up Submission	2012-2-17	FEMALE	168	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	210	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-EY-A215.C0F970E3-E534-4A34-B87A-4383FD261B53.pdf	50		40		40		10		10		0		10		80		80	negative	TUMOR FREE		0		2	Complete Remission/Response	Yes			YES				R0	Primary Tumor	01	Minimally Invasive	2009	NO	YES	NO	EY	0	14	0	7	Endometrial	A	LIVING	49	2010	9ea0e44d-a6c8-4e54-9e1f-ebdb82d0c5ab		TCGA-EY-A215-01		TCGA-EY-A215-01A-11R-A14L-13	TCGA-EY-A215-01A-11D-A14J-01			9ea0e44d-a6c8-4e54-9e1f-ebdb82d0c5ab	TCGA-EY-A215-01A-11D-A14N-05				TCGA-EY-A215-01A-21-A18R-20	ac513be6-1288-4ea6-bed1-8bd37eacf47a	TCGA-EY-A215-01					ac513be6-1288-4ea6-bed1-8bd37eacf47a	TCGA-EY-A215-01A-11D-A14J-01		TCGA-EY-A215-01A-11R-A14L-13	
TCGA-EY-A2OM-01	MSI-H	0	TCGA-EY-A2OM-01	393	0	Kirc+	C6-UCEC	UCEC CIMP c18		UCEC-like c5	UCEC-like c11	miRNA cluster 12			TCGA-EY-A2OM	393	0	393	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	55			TCGA-EY-A2OM-F34170	Never Used	Stage IA	NO		-20398	176		0	393				NO			2012-8-1	FEMALE	152	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	640	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-EY-A2OM.7C46CE28-FC96-47FD-A133-B95EA93E1D8B.pdf	20		40		20		10		20		0		20		70		70	negative	TUMOR FREE		0	YES	2	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	EY		0	0	13	Endometrial	A	LIVING	110	2011	0c622763-f905-4eaa-a05b-ea27dbd49888		TCGA-EY-A2OM-01		TCGA-EY-A2OM-01A-11R-A18L-13	TCGA-EY-A2OM-01A-11D-A18N-01			0c622763-f905-4eaa-a05b-ea27dbd49888	TCGA-EY-A2OM-01A-11D-A18O-05				TCGA-EY-A2OM-01A-21-A23Z-20	661df309-688d-4557-97d6-edfe7d7441ae	TCGA-EY-A2OM-01					661df309-688d-4557-97d6-edfe7d7441ae	TCGA-EY-A2OM-01A-11D-A18N-01		TCGA-EY-A2OM-01A-11R-A18L-13	
TCGA-EY-A2ON-01	MSS	0	TCGA-EY-A2ON-01	409	0	High		UCEC non-CIMP c3		BRCA basal-like c6		miRNA cluster 14			TCGA-EY-A2ON	226	1	409	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	NO			61			TCGA-EY-A2ON-F34164		Stage IVB	NO		-22624	80		0	409			226	NO			2012-7-31	FEMALE	165	Serous endometrial adenocarcinoma	No		YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	650	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3				NO	YES	false	TCGA-EY-A2ON.AB1B272C-E1ED-4E7B-AAD2-F6B7E741E134.pdf			40		10		15		30		0		5		80		80	positive	WITH TUMOR			YES	3	Progressive Disease	No	Never Used		NO				R2	Primary Tumor	01	Minimally Invasive	2009		YES	NO	EY		0		0	Endometrial	A	LIVING	100	2011			TCGA-EY-A2ON-01	10a6bc01-f811-400f-a205-caf7879008fe	TCGA-EY-A2ON-01A-21R-A18L-13	TCGA-EY-A2ON-01A-21D-A18N-01				TCGA-EY-A2ON-01A-21D-A18O-05				TCGA-EY-A2ON-01A-11-A23Z-20	274c3cc1-d020-4268-9fdb-bfdbaf8e4db1	TCGA-EY-A2ON-01	10a6bc01-f811-400f-a205-caf7879008fe				274c3cc1-d020-4268-9fdb-bfdbaf8e4db1	TCGA-EY-A2ON-01A-21D-A18N-01	10a6bc01-f811-400f-a205-caf7879008fe	TCGA-EY-A2ON-01A-21R-A18L-13	10a6bc01-f811-400f-a205-caf7879008fe
TCGA-EY-A2OO-01	MSS	0	TCGA-EY-A2OO-01	1065	0	BRCA-LUAD+		UCEC CIMP c18		UCEC-like c5		miRNA cluster 13			TCGA-EY-A2OO	1065	0	1065	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	56		0	TCGA-EY-A2OO-F34159		Stage IB	NO		-20797	715		0	1065				NO			2012-7-31	FEMALE	175	Mixed serous and endometrioid	No		NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	1	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-EY-A2OO.CC94C4BA-FBF6-4F0D-93DD-C2D98D965DF8.pdf	14		0		0		0		0		0		10		90		75	negative	TUMOR FREE		0	YES	0	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009		NO	YES	EY	0	3	0	21	Endometrial	A	LIVING	79	2009			TCGA-EY-A2OO-01	060787cf-a4a0-402f-8534-742157bb4a2c	TCGA-EY-A2OO-01A-11R-A19V-13	TCGA-EY-A2OO-01A-11D-A19X-01				TCGA-EY-A2OO-01A-11D-A19Z-05				TCGA-EY-A2OO-01A-21-A23Z-20	73f094ed-d3fd-4c3a-bb26-03dd07a068da	TCGA-EY-A2OO-01	060787cf-a4a0-402f-8534-742157bb4a2c				73f094ed-d3fd-4c3a-bb26-03dd07a068da	TCGA-EY-A2OO-01A-11D-A19X-01	060787cf-a4a0-402f-8534-742157bb4a2c	TCGA-EY-A2OO-01A-11R-A19V-13	060787cf-a4a0-402f-8534-742157bb4a2c
TCGA-EY-A2OP-01	MSI-H	0	TCGA-EY-A2OP-01	504	0	Iq		UCEC CIMP c18		UCEC-like c5		miRNA cluster 12			TCGA-EY-A2OP	504	0	504	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	63		0	TCGA-EY-A2OP-F34160		Stage IA	NO		-23090	521		0	504				NO			2012-7-31	FEMALE	150	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	1	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-EY-A2OP.E16B08BE-7F2E-4F0E-9FC8-40FCC29F7BC7.pdf	10		0		0		8		0		0		5		92		85	negative	TUMOR FREE		0	NO	2	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	EY	0	7	0	12	Endometrial	A	LIVING	57	2010			TCGA-EY-A2OP-01	48c88e05-4d0e-444a-8c57-8c9c0c3e7a1f	TCGA-EY-A2OP-01A-11R-A19V-13	TCGA-EY-A2OP-01A-11D-A19X-01				TCGA-EY-A2OP-01A-11D-A19Z-05				TCGA-EY-A2OP-01A-21-A23Z-20	8b7913ad-7ae3-4a72-9f39-ec96ddee748f	TCGA-EY-A2OP-01	48c88e05-4d0e-444a-8c57-8c9c0c3e7a1f				8b7913ad-7ae3-4a72-9f39-ec96ddee748f	TCGA-EY-A2OP-01A-11D-A19X-01	48c88e05-4d0e-444a-8c57-8c9c0c3e7a1f	TCGA-EY-A2OP-01A-11R-A19V-13	48c88e05-4d0e-444a-8c57-8c9c0c3e7a1f
TCGA-EY-A2OQ-01	MSS	0	TCGA-EY-A2OQ-01	495	0	Squamous		UCEC Serous c4		UCEC-like c5		miRNA cluster 4			TCGA-EY-A2OQ	495	0	495	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	61		0	TCGA-EY-A2OQ-F34161		Stage IA	NO		-22309	217		0	495				NO			2012-7-31	FEMALE	155	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	1	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-EY-A2OQ.BD1FB0FF-176C-42D9-843E-2F2BF2EBCCC2.pdf	29		0		0		0		0		0		10		90		60	negative	TUMOR FREE		0	NO	3	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	EY	0	15	0	22	Endometrial	A	LIVING	79	2011			TCGA-EY-A2OQ-01	fe9055e4-f25c-4b7b-9479-a8468c36310f	TCGA-EY-A2OQ-01A-11R-A19V-13	TCGA-EY-A2OQ-01A-11D-A19X-01				TCGA-EY-A2OQ-01A-11D-A19Z-05				TCGA-EY-A2OQ-01A-21-A23Z-20	1677d55c-45e5-4749-a578-7db262323bb9	TCGA-EY-A2OQ-01	fe9055e4-f25c-4b7b-9479-a8468c36310f				1677d55c-45e5-4749-a578-7db262323bb9	TCGA-EY-A2OQ-01A-11D-A19X-01	fe9055e4-f25c-4b7b-9479-a8468c36310f	TCGA-EY-A2OQ-01A-11R-A19V-13	fe9055e4-f25c-4b7b-9479-a8468c36310f
TCGA-EY-A3L3-01	MSS	0	TCGA-EY-A3L3-01	545	0	High		UCEC Serous c4		BRCA basal-like c6		miRNA c1uster 10			TCGA-EY-A3L3	545	0	545	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	82		0	TCGA-EY-A3L3-F38200	Never Used	Stage IA	NO		-30138			0	545				NO			2012-12-11	FEMALE	161	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy			NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO			28																	negative	TUMOR FREE		0	YES	4+	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	EY	0	3	0	14	Endometrial		LIVING	92	2011			TCGA-EY-A3L3-01	eacfdc9c-b044-4dd5-a153-1ed9b62b0fb8	TCGA-EY-A3L3-01A-11R-A22I-13	TCGA-EY-A3L3-01A-11D-A227-01				TCGA-EY-A3L3-01A-11D-A22B-05				TCGA-EY-A3L3-01A-21-A23Z-20	b4ea4572-1e5e-48fd-85e0-2895acd6cd99	TCGA-EY-A3L3-01	eacfdc9c-b044-4dd5-a153-1ed9b62b0fb8				b4ea4572-1e5e-48fd-85e0-2895acd6cd99	TCGA-EY-A3L3-01A-11D-A227-01	eacfdc9c-b044-4dd5-a153-1ed9b62b0fb8	TCGA-EY-A3L3-01A-11R-A22I-13	eacfdc9c-b044-4dd5-a153-1ed9b62b0fb8
TCGA-EY-A3QX-01	MSS	0	TCGA-EY-A3QX-01	421	0	Squamous		UCEC non-CIMP c3		UCEC-like c5		miRNA cluster 4			TCGA-EY-A3QX	421	0	421	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	64			TCGA-EY-A3QX-F40907		Stage IVB	NO		-23663	112		0	421				NO			2013-3-6	FEMALE	168	Serous endometrial adenocarcinoma	No		YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	659	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-EY-A3QX.8AED036E-FB86-42D1-B840-FB4AD6E8D0EF.pdf	95		5		1		10		0		0		0		90		75	positive	TUMOR FREE			YES	4+	Complete Remission/Response	No			NO				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	EY		0		0	Endometrial	A	LIVING	63	2011			TCGA-EY-A3QX-01	cdb9c4a5-81e3-4718-bb7e-ace2bc04b7c3	TCGA-EY-A3QX-01A-11R-A22I-13	TCGA-EY-A3QX-01A-11D-A227-01				TCGA-EY-A3QX-01A-11D-A22B-05				TCGA-EY-A3QX-01A-21-A23Z-20	93970094-a2ed-42f0-a74d-d42a728abfb0	TCGA-EY-A3QX-01	cdb9c4a5-81e3-4718-bb7e-ace2bc04b7c3				93970094-a2ed-42f0-a74d-d42a728abfb0	TCGA-EY-A3QX-01A-11D-A227-01	cdb9c4a5-81e3-4718-bb7e-ace2bc04b7c3	TCGA-EY-A3QX-01A-11R-A22I-13	cdb9c4a5-81e3-4718-bb7e-ace2bc04b7c3
TCGA-EY-A4KR-01	MSS	1	TCGA-EY-A4KR-01	346	1										TCGA-EY-A4KR	346	0	346	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Progressive Disease	56			TCGA-EY-A4KR-F44431		Stage IIIC1	NO		-20669	147	346	0	196				NO			2013-6-19	FEMALE	164	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	610	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-EY-A4KR.D8669681-B1D2-4D39-B7BB-5207F901A937.pdf	99		5		0		3		0		0		0		97		80	positive	WITH TUMOR		7	YES	2	Progressive Disease	No	Never Used		YES				RX	Primary Tumor	01	Minimally Invasive			YES	NO	EY		0	7	9	Endometrial	A	DECEASED	114	2012			TCGA-EY-A4KR-01	8bc81bd5-9814-4a83-b78d-6d5722a1a53d	TCGA-EY-A4KR-01A-11R-A27R-13	TCGA-EY-A4KR-01A-11D-A27O-01				TCGA-EY-A4KR-01A-11D-A27Y-05					78c85b81-6dfd-4151-a9cd-b81e569c9ec1	TCGA-EY-A4KR-01	8bc81bd5-9814-4a83-b78d-6d5722a1a53d				78c85b81-6dfd-4151-a9cd-b81e569c9ec1	TCGA-EY-A4KR-01A-11D-A27O-01	8bc81bd5-9814-4a83-b78d-6d5722a1a53d	TCGA-EY-A4KR-01A-11R-A27R-13	8bc81bd5-9814-4a83-b78d-6d5722a1a53d
TCGA-EY-A547-01	Indeterminate	0	TCGA-EY-A547-01	545	0										TCGA-EY-A547	545	0	545	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					75		0			Stage IA	NO		-27686			0	545				YES			2013-2-27	FEMALE	166	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO			14																	negative	TUMOR FREE		0	NO	1	Complete Remission/Response	Yes	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive			YES	NO	EY	0	8	0	10	Endometrial		LIVING	108	2011			TCGA-EY-A547-01	cc3bf52b-7b69-40c9-9358-f66cb7b1dd87	TCGA-EY-A547-01A-11R-A27R-13	TCGA-EY-A547-01A-11D-A27O-01				TCGA-EY-A547-01A-11D-A27Y-05					e4de0a98-89c9-4439-af6d-acb4e5cb08a3	TCGA-EY-A547-01	cc3bf52b-7b69-40c9-9358-f66cb7b1dd87				e4de0a98-89c9-4439-af6d-acb4e5cb08a3	TCGA-EY-A547-01A-11D-A27O-01	cc3bf52b-7b69-40c9-9358-f66cb7b1dd87	TCGA-EY-A547-01A-11R-A27R-13	cc3bf52b-7b69-40c9-9358-f66cb7b1dd87
TCGA-EY-A548-01	MSI-H	0	TCGA-EY-A548-01	65	0										TCGA-EY-A548	65	0	65	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					83				Never Used	Stage IA	NO		-30544	169		0	65				NO			2013-2-27	FEMALE	157	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	850	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	TCGA-EY-A548.A9ACF7BF-BB91-4B56-A398-C7A0FD473FC5.pdf	0		3		2		0		0		0		0		100		80	negative	TUMOR FREE		0	NO	4+	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive			YES	NO	EY		0	0	12	Endometrial	A	LIVING	67	2012			TCGA-EY-A548-01	32b29d34-5d28-4b68-9d64-61290448fca5	TCGA-EY-A548-01A-11R-A27R-13	TCGA-EY-A548-01A-11D-A27O-01				TCGA-EY-A548-01A-11D-A27Y-05					964753ab-2673-4b84-ad0e-a83297e864f7	TCGA-EY-A548-01	32b29d34-5d28-4b68-9d64-61290448fca5				964753ab-2673-4b84-ad0e-a83297e864f7	TCGA-EY-A548-01A-11D-A27O-01	32b29d34-5d28-4b68-9d64-61290448fca5	TCGA-EY-A548-01A-11R-A27R-13	32b29d34-5d28-4b68-9d64-61290448fca5
TCGA-EY-A549-01	MSI-H	0	TCGA-EY-A549-01	605	0										TCGA-EY-A549	605	0	605	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	78		0	TCGA-EY-A549-F55760	Never Used	Stage IA	YES		-28570	191		0	605				NO			2014-1-14	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.9	8380/3	C54.9	YES		Office Endometrial Biopsy	370	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-EY-A549.F6D1F090-C601-4212-951E-BEE086DDD24F.pdf	33		3		2		5		0		0		0		95		80		TUMOR FREE		0	NO	4+	Complete Remission/Response	Yes	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive			YES	NO	EY	0	18	0	22	Endometrial	A	LIVING	74	2012			TCGA-EY-A549-01	4cbce4ad-3208-4463-a06d-75edce32ed3f	TCGA-EY-A549-01A-11R-A27R-13	TCGA-EY-A549-01A-11D-A27O-01				TCGA-EY-A549-01A-11D-A27Y-05					50898253-5037-4733-84a8-334a1d602ad2	TCGA-EY-A549-01	4cbce4ad-3208-4463-a06d-75edce32ed3f				50898253-5037-4733-84a8-334a1d602ad2	TCGA-EY-A549-01A-11D-A27O-01	4cbce4ad-3208-4463-a06d-75edce32ed3f	TCGA-EY-A549-01A-11R-A27R-13	4cbce4ad-3208-4463-a06d-75edce32ed3f
TCGA-EY-A54A-01	Indeterminate	0	TCGA-EY-A54A-01	447	0										TCGA-EY-A54A	447	0	447	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	67		1	TCGA-EY-A54A-F57555	Former User	Stage IIIC2	NO		-24822	105		0	447				YES			2014-3-17	FEMALE	161	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.9	8380/3	C54.9	YES		Office Endometrial Biopsy	500	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-EY-A54A.E3C3D3B8-550A-4652-9B17-122BC64A437A.pdf	41		5		3		0		0		0		0		100		65		TUMOR FREE		4	YES	4+	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	EY	1	8	4	16	Endometrial	A	LIVING	70	2012			TCGA-EY-A54A-01	a7c691a2-a91d-44d0-8e91-0234cddb1e92	TCGA-EY-A54A-01A-11R-A27R-13	TCGA-EY-A54A-01A-11D-A27O-01				TCGA-EY-A54A-01A-11D-A27Y-05					2387f2b0-3e8d-4512-bdb5-30c9fc0c5c3b	TCGA-EY-A54A-01	a7c691a2-a91d-44d0-8e91-0234cddb1e92				2387f2b0-3e8d-4512-bdb5-30c9fc0c5c3b	TCGA-EY-A54A-01A-11D-A27O-01	a7c691a2-a91d-44d0-8e91-0234cddb1e92	TCGA-EY-A54A-01A-11R-A27R-13	a7c691a2-a91d-44d0-8e91-0234cddb1e92
TCGA-EY-A5W2-01	MSI-H	0	TCGA-EY-A5W2-01	516	0										TCGA-EY-A5W2	516	0	516	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	72		0	TCGA-EY-A5W2-F58696		Stage IB	NO		-26498	105		0	516				NO			2014-4-22	FEMALE	161	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	870	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-EY-A5W2.C09EED3C-50CC-47CB-BA81-96D05E53D9F0.pdf	52		0		0		0		0		0		20		80		80	negative	TUMOR FREE		0	NO	4+	Complete Remission/Response	No			YES				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	EY	0	7	0	16	Endometrial	A	LIVING	83	2012			TCGA-EY-A5W2-01	894b867a-591d-4d05-b008-db1a90b18a60	TCGA-EY-A5W2-01A-11R-A31S-13	TCGA-EY-A5W2-01A-11D-A31T-01				TCGA-EY-A5W2-01A-11D-A31V-05					c35227f5-d306-4575-b5d9-94576f7c9c56	TCGA-EY-A5W2-01	894b867a-591d-4d05-b008-db1a90b18a60				c35227f5-d306-4575-b5d9-94576f7c9c56	TCGA-EY-A5W2-01A-11D-A31T-01	894b867a-591d-4d05-b008-db1a90b18a60	TCGA-EY-A5W2-01A-11R-A31S-13	894b867a-591d-4d05-b008-db1a90b18a60
TCGA-EY-A72D-01	MSS	0	TCGA-EY-A72D-01	179	0										TCGA-EY-A72D	179	0	179	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	87			TCGA-EY-A72D-F63789	Never Used	Stage II	NO		-31818	120		0	179				NO			2014-8-18	FEMALE	162	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	340	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	TCGA-EY-A72D.6F2C081B-8D36-4DB4-9846-67DC1D3964E0.pdf	22.5		40		20		10		20		0		10		80		80		TUMOR FREE			NO	2	Complete Remission/Response	Yes	Never Used		NO				R0	Primary Tumor	01	open	2009		YES	NO	EY		0		0	Endometrial	A	LIVING	106	2013			TCGA-EY-A72D-01	051469db-cfa9-4907-ae54-13c060ad2958	TCGA-EY-A72D-01A-12R-A34O-13	TCGA-EY-A72D-01A-12D-A34P-01				TCGA-EY-A72D-01A-12D-A34S-05					93de183e-0225-4aea-8a8d-c745b27ece86	TCGA-EY-A72D-01	051469db-cfa9-4907-ae54-13c060ad2958				93de183e-0225-4aea-8a8d-c745b27ece86	TCGA-EY-A72D-01A-12D-A34P-01	051469db-cfa9-4907-ae54-13c060ad2958	TCGA-EY-A72D-01A-12R-A34O-13	051469db-cfa9-4907-ae54-13c060ad2958
TCGA-FI-A2CX-01	MSS	0	TCGA-FI-A2CX-01	1207	0	Kirc+		OV-like c1	cluster 3		LAML-like c13	miRNA c1uster 9	cluster 2		TCGA-FI-A2CX	1207	0	1207	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	82	0	0	TCGA-FI-A2CX-F31725	Never Used	Stage IB	NO		-30224	1067		0	1207				NO		Scheduled Follow-up Submission	2012-5-8	FEMALE	155	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	80	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-FI-A2CX.0F6F56E4-C4F9-4915-BE4E-1FBF4C6D93AD.pdf	33		40		35		10		2		0		2		88		98		TUMOR FREE	0	0		2	Complete Remission/Response	Yes	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	1988	NO	NO	YES	FI	0	3	0	7	Endometrial	A	LIVING	52	2008	ab3e5a04-9d4c-4289-93ed-38dba3e619b2		TCGA-FI-A2CX-01		TCGA-FI-A2CX-01A-11R-A17A-13	TCGA-FI-A2CX-01A-11D-A17C-01			ab3e5a04-9d4c-4289-93ed-38dba3e619b2	TCGA-FI-A2CX-01A-11D-A17F-05					8638db1c-490a-49fe-8620-68072054d3e8	TCGA-FI-A2CX-01					8638db1c-490a-49fe-8620-68072054d3e8	TCGA-FI-A2CX-01A-11D-A17C-01		TCGA-FI-A2CX-01A-11R-A17A-13	
TCGA-FI-A2CY-01	MSS	0	TCGA-FI-A2CY-01	1249	0	Squamous	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 4	cluster 2		TCGA-FI-A2CY	1249	0	1249	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	60	0	0	TCGA-FI-A2CY-F31727	Never Used	Stage IA	NO		-22098	1067		0	1249				NO		Scheduled Follow-up Submission	2012-5-8	FEMALE	145	Mixed serous and endometrioid	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	110	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-FI-A2CY.2C4CE5F5-AD46-427E-A787-529DF9FA891A.pdf	0		5		8		2		2		0		2		96		98	negative	TUMOR FREE	0	0		2	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	1988	YES	NO	YES	FI	0	2	0	15	Endometrial	A	LIVING	100	2008	4bcff10b-20ad-4635-bbcd-855826277b8a		TCGA-FI-A2CY-01		TCGA-FI-A2CY-01A-11R-A17A-13	TCGA-FI-A2CY-01A-11D-A17C-01			4bcff10b-20ad-4635-bbcd-855826277b8a	TCGA-FI-A2CY-01A-11D-A17F-05				TCGA-FI-A2CY-01A-21-A18R-20	29d427bd-1787-4eb6-9ffd-3dc6f752ef9e	TCGA-FI-A2CY-01					29d427bd-1787-4eb6-9ffd-3dc6f752ef9e	TCGA-FI-A2CY-01A-11D-A17C-01		TCGA-FI-A2CY-01A-11R-A17A-13	
TCGA-FI-A2D0-01	MSI-H	0	TCGA-FI-A2D0-01	1213	0	Quiet		UCEC non-CIMP c3	cluster 4		UCEC-like c11	miRNA cluster 12	cluster 2		TCGA-FI-A2D0	1213	0	1213	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	55	0	0	TCGA-FI-A2D0-F31611	Never Used	Stage IA	NO		-20393			0	1213				NO		Scheduled Follow-up Submission	2012-5-8	FEMALE	158	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy				Peri (6-12 months since last menstrual period)	G3					NO			0																	negative	TUMOR FREE	0	0		2	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	FI	0	7	0	21	Endometrial		LIVING	135	2008	e8736e4d-6e9b-49b0-a321-0e42740a11c1		TCGA-FI-A2D0-01		TCGA-FI-A2D0-01A-11R-A17A-13	TCGA-FI-A2D0-01A-11D-A17C-01			e8736e4d-6e9b-49b0-a321-0e42740a11c1	TCGA-FI-A2D0-01A-11D-A17F-05					c2788bc5-c24a-4f7b-8b3e-f34b6c08eae6	TCGA-FI-A2D0-01					c2788bc5-c24a-4f7b-8b3e-f34b6c08eae6	TCGA-FI-A2D0-01A-11D-A17C-01		TCGA-FI-A2D0-01A-11R-A17A-13	
TCGA-FI-A2D2-01	MSS	0	TCGA-FI-A2D2-01	1215	0	Squamous	C6-UCEC	UCEC Serous c4	cluster 3		UCEC-like c11	miRNA c1uster 10	cluster 2	mutation cluster 3	TCGA-FI-A2D2	1215	0	1215	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	66			TCGA-FI-A2D2-F31732		Stage IB	NO		-24260	975		0	1215				NO		Scheduled Follow-up Submission	2012-4-18	FEMALE	168	Mixed serous and endometrioid	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	70	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-FI-A2D2.75FB8F31-5C30-48C2-B4A5-2DA184DC039C.pdf	33		5		5		2		5		0		2		96		98	negative	TUMOR FREE				2	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	1988	YES	NO	YES	FI		0		0	Endometrial	A	LIVING	166	2008	941d70e7-2ac8-4809-baa4-7752df3c2ee3		TCGA-FI-A2D2-01		TCGA-FI-A2D2-01A-11R-A17A-13	TCGA-FI-A2D2-01A-11D-A17C-01			941d70e7-2ac8-4809-baa4-7752df3c2ee3	TCGA-FI-A2D2-01A-11D-A17F-05			TCGA-FI-A2D2-01A-11D-A17D-09		955a9988-ae3e-4ed4-a05b-b49d94ab35eb	TCGA-FI-A2D2-01		TCGA-FI-A2D2-01A-11D-A17D-09		TCGA-FI-A2D2-01A-11D-A17D-09	955a9988-ae3e-4ed4-a05b-b49d94ab35eb	TCGA-FI-A2D2-01A-11D-A17C-01		TCGA-FI-A2D2-01A-11R-A17A-13	
TCGA-FI-A2D4-01	MSI-H	1	TCGA-FI-A2D4-01	243	1	Kirc+		UCEC CIMP c18	cluster 1		UCEC-like c11	miRNA cluster 12	cluster 5		TCGA-FI-A2D4			243	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					44					Stage IIIC			-16163		243	0								2011-10-28	FEMALE	163	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy				Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3								100																		WITH TUMOR	0	1				No							R2	Primary Tumor	01	open	1988		NO	YES	FI		0	1	1	Endometrial		DECEASED	112	2009	c3c9142f-d5c8-44ef-90c2-9ae69846dc60		TCGA-FI-A2D4-01		TCGA-FI-A2D4-01A-12R-A17A-13	TCGA-FI-A2D4-01A-12D-A17C-01			c3c9142f-d5c8-44ef-90c2-9ae69846dc60	TCGA-FI-A2D4-01A-12D-A17F-05					cb3a88ca-b88d-4f8a-989b-41141aae27f7	TCGA-FI-A2D4-01					cb3a88ca-b88d-4f8a-989b-41141aae27f7	TCGA-FI-A2D4-01A-12D-A17C-01		TCGA-FI-A2D4-01A-12R-A17A-13	
TCGA-FI-A2D5-01	MSS	1	TCGA-FI-A2D5-01	421	1	Quiet		UCEC non-CIMP c3	cluster 4		UCEC-like c11	miRNA c1uster 9	cluster 4		TCGA-FI-A2D5	280	1	421	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	YES	YES	NO	Progressive Disease	56	0	0	TCGA-FI-A2D5-F31743	Never Used	Stage IVB	NO		-20666	702	421	0				280	NO		Scheduled Follow-up Submission	2012-5-8	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	60	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Metastatic	vaginal cuff, periaortic lymphnodes		YES	true	TCGA-FI-A2D5.A8F4B3DC-7B7D-4F1F-A909-E23DAE23E52C.pdf	100		15		5		15		3		0		2		83		98	positive	WITH TUMOR	0	1		1	Partial Remission/Response	Yes	Never Used		NO				R0	Primary Tumor	01	open	2009	YES	NO	YES	FI	0	0	1	2	Endometrial	A	DECEASED	92	2009	33655926-ef2e-4e77-8be7-3f9c921db77c		TCGA-FI-A2D5-01		TCGA-FI-A2D5-01A-11R-A17A-13	TCGA-FI-A2D5-01A-11D-A17C-01			33655926-ef2e-4e77-8be7-3f9c921db77c	TCGA-FI-A2D5-01A-11D-A17F-05					4a11d7fe-ece3-41f2-b25b-ceeaaea6babc	TCGA-FI-A2D5-01					4a11d7fe-ece3-41f2-b25b-ceeaaea6babc	TCGA-FI-A2D5-01A-11D-A17C-01		TCGA-FI-A2D5-01A-11R-A17A-13	
TCGA-FI-A2D6-01	MSI-H	0	TCGA-FI-A2D6-01	263	0	Kirc+		BRCA CIMP c7	cluster 1		GBM-like c6	miRNA cluster 13	cluster 6		TCGA-FI-A2D6	263	0	263	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	74			TCGA-FI-A2D6-F31746		Stage IB	NO		-27060			0	263				NO		Scheduled Follow-up Submission	2012-5-8	FEMALE	165	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO			74																	negative	TUMOR FREE				2	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	FI		0		0	Endometrial		LIVING	95	2009	fffc5da3-ed33-4f8d-982e-e75b2d707c4b		TCGA-FI-A2D6-01		TCGA-FI-A2D6-01A-11R-A17A-13	TCGA-FI-A2D6-01A-11D-A17C-01			fffc5da3-ed33-4f8d-982e-e75b2d707c4b	TCGA-FI-A2D6-01A-11D-A17F-05					f6715a0f-7ef1-4b97-bfc5-67c4fb0a2d7e	TCGA-FI-A2D6-01					f6715a0f-7ef1-4b97-bfc5-67c4fb0a2d7e	TCGA-FI-A2D6-01A-11D-A17C-01		TCGA-FI-A2D6-01A-11R-A17A-13	
TCGA-FI-A2EU-01	MSS	0	TCGA-FI-A2EU-01	2941	0	High	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 2		TCGA-FI-A2EU	2941	0	2941	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	68	0	0	TCGA-FI-A2EU-F31382		Stage IA	NO		-24837	2779		0	2941				YES		Scheduled Follow-up Submission	2012-5-1	FEMALE	168	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	110	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-FI-A2EU.95F8FB60-A533-4A37-8B4B-FC6811A77636.pdf	0		40		20		5		20		0		5		90		90	negative	TUMOR FREE	0	0		2	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	1988	YES	NO	YES	FI	0	2	0	11	Endometrial	A	LIVING	93	2003	1d3ec463-a3c0-4aa5-8fc0-d221be3a0700		TCGA-FI-A2EU-01		TCGA-FI-A2EU-01A-11R-A17A-13	TCGA-FI-A2EU-01A-11D-A17C-01			1d3ec463-a3c0-4aa5-8fc0-d221be3a0700	TCGA-FI-A2EU-01A-11D-A17F-05				TCGA-FI-A2EU-01A-21-A18Q-20	833e261d-d303-4bbc-93ad-e47ca166d2c8	TCGA-FI-A2EU-01					833e261d-d303-4bbc-93ad-e47ca166d2c8	TCGA-FI-A2EU-01A-11D-A17C-01		TCGA-FI-A2EU-01A-11R-A17A-13	
TCGA-FI-A2EW-01	Indeterminate	0	TCGA-FI-A2EW-01	1795	0	High	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 14	cluster 2	mutation cluster 13	TCGA-FI-A2EW			1795	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					71	0	0			Stage IIB			-26267			0	1795							2011-10-27	FEMALE	160	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3								75																	negative	WITH TUMOR	0	0				No							R0	Primary Tumor	01	open	1988		NO	YES	FI	0	8	0	29	Endometrial		LIVING	83	2005	e3abb7cf-945d-496f-8bf0-828ddfef6538		TCGA-FI-A2EW-01		TCGA-FI-A2EW-01A-11R-A17A-13	TCGA-FI-A2EW-01A-11D-A17C-01			e3abb7cf-945d-496f-8bf0-828ddfef6538	TCGA-FI-A2EW-01A-11D-A17F-05			TCGA-FI-A2EW-01A-11D-A17D-09	TCGA-FI-A2EW-01A-21-A18Q-20	d1a0f50a-6966-4f62-9d20-65bd4121ed82	TCGA-FI-A2EW-01		TCGA-FI-A2EW-01A-11D-A17D-09		TCGA-FI-A2EW-01A-11D-A17D-09	d1a0f50a-6966-4f62-9d20-65bd4121ed82	TCGA-FI-A2EW-01A-11D-A17C-01		TCGA-FI-A2EW-01A-11R-A17A-13	
TCGA-FI-A2EX-01	MSS	0	TCGA-FI-A2EX-01	276	0	High	C6-UCEC	UCEC non-CIMP c3	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 14	cluster 2	mutation cluster 5	TCGA-FI-A2EX			276	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					58	0	0			Stage IIIA			-21489	2201		0	276							2011-10-27	FEMALE	154	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	110	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	TCGA-FI-A2EX.68355069-2D77-4C5C-9AA9-E93A0C3CFD94.pdf	13		40		20		5		20		0		5		90		90	positive	WITH TUMOR	0	0				No							R0	Primary Tumor	01	open	1988		NO	YES	FI	0	6	0	28	Endometrial	A	LIVING	89	2005	06745c8c-5e2b-4131-93a5-9023c32665ac		TCGA-FI-A2EX-01		TCGA-FI-A2EX-01A-11R-A17A-13	TCGA-FI-A2EX-01A-11D-A17C-01			06745c8c-5e2b-4131-93a5-9023c32665ac	TCGA-FI-A2EX-01A-11D-A17F-05			TCGA-FI-A2EX-01A-11D-A17D-09	TCGA-FI-A2EX-01A-21-A18Q-20	295ec2f3-d4ee-4929-86d4-92c848cc0a6d	TCGA-FI-A2EX-01		TCGA-FI-A2EX-01A-11D-A17D-09		TCGA-FI-A2EX-01A-11D-A17D-09	295ec2f3-d4ee-4929-86d4-92c848cc0a6d	TCGA-FI-A2EX-01A-11D-A17C-01		TCGA-FI-A2EX-01A-11R-A17A-13	
TCGA-FI-A2EY-01	MSI-L	1	TCGA-FI-A2EY-01	880	1	Squamous		OV-like c1		squamous c3		miRNA cluster 14			TCGA-FI-A2EY	577	1	880	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma	NO	NO	YES	Complete Response	63	0	0	TCGA-FI-A2EY-F31521		Stage IIIA	NO	670	-23042		880	0				577	NO		Scheduled Follow-up Submission	2012-5-4	FEMALE	183	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Tumor resection				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Lung	New Primary Tumor			YES			93																	negative	TUMOR FREE	0	0		3	Complete Remission/Response	No	Never Used		NO	Surgical Resection		R0	R0	Primary Tumor	01	open	1988	YES	NO	YES	FI	0	0	0	0	Endometrial		DECEASED	96	2006			TCGA-FI-A2EY-01	c23bc644-ff87-4c84-a156-686903524aaa	TCGA-FI-A2EY-01A-12R-A18L-13	TCGA-FI-A2EY-01A-12D-A18N-01				TCGA-FI-A2EY-01A-12D-A18O-05				TCGA-FI-A2EY-01A-21-A23Z-20	addcd76a-d0a9-4c04-828c-fbb391be6f0d	TCGA-FI-A2EY-01	c23bc644-ff87-4c84-a156-686903524aaa				addcd76a-d0a9-4c04-828c-fbb391be6f0d	TCGA-FI-A2EY-01A-12D-A18N-01	c23bc644-ff87-4c84-a156-686903524aaa	TCGA-FI-A2EY-01A-12R-A18L-13	c23bc644-ff87-4c84-a156-686903524aaa
TCGA-FI-A2F4-01	MSI-H	0	TCGA-FI-A2F4-01	519	0	Iq		UCEC CIMP c18	cluster 1		UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-FI-A2F4	519	0	519	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	64	0	0	TCGA-FI-A2F4-F31736		Stage IC	NO		-23621	860		0	519				YES		Scheduled Follow-up Submission	2012-5-8	FEMALE	165	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	60	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-FI-A2F4.B57570A5-2AE1-4D8B-9284-AB5769DDFDA6.pdf	59		40		30		5		20		0		5		90		90		TUMOR FREE	0	0		4+	Complete Remission/Response	Yes	Never Used		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	FI	0	4	0	28	Endometrial	A	LIVING	74	2009	14198ecd-3508-4ece-8fea-8141d3e4b1e7		TCGA-FI-A2F4-01		TCGA-FI-A2F4-01A-11R-A17A-13	TCGA-FI-A2F4-01A-11D-A17C-01			14198ecd-3508-4ece-8fea-8141d3e4b1e7	TCGA-FI-A2F4-01A-11D-A17F-05					acb9dc3a-2f3c-444b-89bc-b368425b3d59	TCGA-FI-A2F4-01					acb9dc3a-2f3c-444b-89bc-b368425b3d59	TCGA-FI-A2F4-01A-11D-A17C-01		TCGA-FI-A2F4-01A-11R-A17A-13	
TCGA-FI-A2F8-01	MSS	0	TCGA-FI-A2F8-01	761	0	Squamous	C6-UCEC	UCEC Serous c4	cluster 3		UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 5	TCGA-FI-A2F8			761	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					64	0	0			Stage II			-23649	679		0	761							2011-10-28	FEMALE	173	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	70	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	TCGA-FI-A2F8.9445945A-A7AC-4C36-889B-68A50644D556.pdf	26		40		20		10		20		0		20		70		70	positive	TUMOR FREE	0	0				No							R0	Primary Tumor	01	open	2009		NO	YES	FI	0	6	0	24	Endometrial	A	LIVING	99	2009	1b38dbc6-5830-4514-9317-9dcb23e36b98		TCGA-FI-A2F8-01		TCGA-FI-A2F8-01A-12R-A17A-13	TCGA-FI-A2F8-01A-12D-A17C-01			1b38dbc6-5830-4514-9317-9dcb23e36b98	TCGA-FI-A2F8-01A-12D-A17F-05			TCGA-FI-A2F8-01A-12D-A17D-09		a32fe338-a25a-4702-9e9a-8f95f6b13c74	TCGA-FI-A2F8-01		TCGA-FI-A2F8-01A-12D-A17D-09		TCGA-FI-A2F8-01A-12D-A17D-09	a32fe338-a25a-4702-9e9a-8f95f6b13c74	TCGA-FI-A2F8-01A-12D-A17C-01		TCGA-FI-A2F8-01A-12R-A17A-13	
TCGA-FI-A2F9-01	MSS	0	TCGA-FI-A2F9-01	889	0	Kirc+		UCEC Serous c4	cluster 3		UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-FI-A2F9	889	0	889	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	79	0	0	TCGA-FI-A2F9-F31741	Never Used	Stage IA	NO		-28886	709		0	889				NO		Scheduled Follow-up Submission	2012-5-8	FEMALE	175	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	60	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-FI-A2F9.5D03E085-0588-47A8-8B1C-E243D8127325.pdf	44		40		20		5		20		0		5		90		90	negative	TUMOR FREE	0	0		4+	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	2009	NO	NO	YES	FI	0	3	0	35	Endometrial	A	LIVING	99	2009	2aef2acc-a065-4196-a278-1c1ce689e689		TCGA-FI-A2F9-01		TCGA-FI-A2F9-01A-11R-A17A-13	TCGA-FI-A2F9-01A-11D-A17C-01			2aef2acc-a065-4196-a278-1c1ce689e689	TCGA-FI-A2F9-01A-11D-A17F-05					20f6fe00-da13-4af4-a8e7-9c0cc1635fca	TCGA-FI-A2F9-01					20f6fe00-da13-4af4-a8e7-9c0cc1635fca	TCGA-FI-A2F9-01A-11D-A17C-01		TCGA-FI-A2F9-01A-11R-A17A-13	
TCGA-FI-A3PV-01	MSS	1	TCGA-FI-A3PV-01	1249	1	Squamous		UCEC Serous c4				miRNA c1uster 10			TCGA-FI-A3PV			1249	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					68	0	0			Stage IA			-24898	3199	1249	0								2012-6-15	FEMALE	174	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	60	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	High Grade						true	TCGA-FI-A3PV.0EBA5D54-65AC-4F79-ACE9-29FB1F924E3A.pdf	0		0		0		0		0		0		35		65		65	negative	WITH TUMOR	0	0				No							R0	Primary Tumor	01	open	2009		NO	YES	FI	0	6	0	10	Endometrial	A	DECEASED	105	2003			TCGA-FI-A3PV-01	af1f390e-abd4-4ed2-bc65-0b1080b786a9	TCGA-FI-A3PV-01A-11R-A22I-13	TCGA-FI-A3PV-01A-11D-A227-01				TCGA-FI-A3PV-01A-11D-A22B-05					33181af3-11a1-463d-b8b4-a8d38ff0bcc6	TCGA-FI-A3PV-01	af1f390e-abd4-4ed2-bc65-0b1080b786a9				33181af3-11a1-463d-b8b4-a8d38ff0bcc6	TCGA-FI-A3PV-01A-11D-A227-01	af1f390e-abd4-4ed2-bc65-0b1080b786a9	TCGA-FI-A3PV-01A-11R-A22I-13	af1f390e-abd4-4ed2-bc65-0b1080b786a9
TCGA-FI-A3PX-01	MSS	0	TCGA-FI-A3PX-01	1369	0	High		UCEC Serous c4		UCEC-like c5		miRNA cluster 14			TCGA-FI-A3PX			1369	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					57		2			Stage IIIC2			-21063	1280		0	1369							2012-6-15	FEMALE	170	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	130	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	High Grade						true	TCGA-FI-A3PX.5E3FD49D-DE9B-4A5B-B4FC-2825CCB48B46.pdf	92		0		0		15		0		0		0		85		90	negative	TUMOR FREE		4				No							R0	Primary Tumor	01	open	2009		NO	YES	FI	2	5	4	10	Endometrial	A	LIVING	90	2008			TCGA-FI-A3PX-01	773a978c-a52f-470b-b659-4c06de8a7e5b	TCGA-FI-A3PX-01A-11R-A22I-13	TCGA-FI-A3PX-01A-11D-A227-01				TCGA-FI-A3PX-01A-11D-A22B-05				TCGA-FI-A3PX-01A-21-A23Z-20	513a1d74-b4a7-4ccb-a865-86ecb48407ce	TCGA-FI-A3PX-01	773a978c-a52f-470b-b659-4c06de8a7e5b				513a1d74-b4a7-4ccb-a865-86ecb48407ce	TCGA-FI-A3PX-01A-11D-A227-01	773a978c-a52f-470b-b659-4c06de8a7e5b	TCGA-FI-A3PX-01A-11R-A22I-13	773a978c-a52f-470b-b659-4c06de8a7e5b
TCGA-FL-A1YF-11			TCGA-FL-A1YF-11												TCGA-FL-A1YF				Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma																																					130	NO									false												100				0																		Solid Tissue Normal	11												A							b80bd803-b042-474e-864e-b2c6ee4708e5	TCGA-FL-A1YF-11A-12R-A16E-13					TCGA-FL-A1YF-11A-12D-A16G-05							b80bd803-b042-474e-864e-b2c6ee4708e5						b80bd803-b042-474e-864e-b2c6ee4708e5	TCGA-FL-A1YF-11A-12R-A16E-13	b80bd803-b042-474e-864e-b2c6ee4708e5
TCGA-FL-A1YG-11			TCGA-FL-A1YG-11												TCGA-FL-A1YG				Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma																																					170	NO									false												100				0																		Solid Tissue Normal	11												A							88802e34-7269-4b5e-b552-a969281ab241	TCGA-FL-A1YG-11A-12R-A16E-13					TCGA-FL-A1YG-11A-12D-A16G-05							88802e34-7269-4b5e-b552-a969281ab241						88802e34-7269-4b5e-b552-a969281ab241	TCGA-FL-A1YG-11A-12R-A16E-13	88802e34-7269-4b5e-b552-a969281ab241
TCGA-FL-A1YH-11			TCGA-FL-A1YH-11												TCGA-FL-A1YH				Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma																																					310	NO									false												100				0																		Solid Tissue Normal	11												A							ba70deb1-e8c2-4f74-9883-46e7095f677d	TCGA-FL-A1YH-11A-11R-A16E-13					TCGA-FL-A1YH-11A-11D-A16G-05							ba70deb1-e8c2-4f74-9883-46e7095f677d						ba70deb1-e8c2-4f74-9883-46e7095f677d	TCGA-FL-A1YH-11A-11R-A16E-13	ba70deb1-e8c2-4f74-9883-46e7095f677d
TCGA-FL-A1YI-11			TCGA-FL-A1YI-11												TCGA-FL-A1YI				Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma																																					120	NO									false												100				0																		Solid Tissue Normal	11												A							0c5df2a7-417c-478d-9a7e-675a8777747c	TCGA-FL-A1YI-11A-11R-A16E-13					TCGA-FL-A1YI-11A-11D-A16G-05							0c5df2a7-417c-478d-9a7e-675a8777747c						0c5df2a7-417c-478d-9a7e-675a8777747c	TCGA-FL-A1YI-11A-11R-A16E-13	0c5df2a7-417c-478d-9a7e-675a8777747c
TCGA-FL-A1YL-11			TCGA-FL-A1YL-11												TCGA-FL-A1YL				Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma																																					80	NO									false												100				0																		Solid Tissue Normal	11												A							4ad4e642-d5fc-459e-8553-bb1c9795c09d	TCGA-FL-A1YL-11A-11R-A16E-13					TCGA-FL-A1YL-11A-11D-A16G-05							4ad4e642-d5fc-459e-8553-bb1c9795c09d						4ad4e642-d5fc-459e-8553-bb1c9795c09d	TCGA-FL-A1YL-11A-11R-A16E-13	4ad4e642-d5fc-459e-8553-bb1c9795c09d
TCGA-FL-A1YM-11			TCGA-FL-A1YM-11												TCGA-FL-A1YM				Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma																																					80	NO									false												100				0																		Solid Tissue Normal	11												A				3499b1ce-1d6d-423d-8509-77e3f6818b0c				TCGA-FL-A1YM-11A-12R-A17A-13				3499b1ce-1d6d-423d-8509-77e3f6818b0c	TCGA-FL-A1YM-11A-12D-A17F-05														TCGA-FL-A1YM-11A-12R-A17A-13	
TCGA-FL-A1YN-11			TCGA-FL-A1YN-11												TCGA-FL-A1YN				Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma																																					60	NO									false												100				0																		Solid Tissue Normal	11												A							331785a5-59ba-441f-81dc-384d7f80905b	TCGA-FL-A1YN-11A-11R-A17A-13					TCGA-FL-A1YN-11A-11D-A17F-05							331785a5-59ba-441f-81dc-384d7f80905b						331785a5-59ba-441f-81dc-384d7f80905b	TCGA-FL-A1YN-11A-11R-A17A-13	331785a5-59ba-441f-81dc-384d7f80905b
TCGA-FL-A1YQ-11			TCGA-FL-A1YQ-11												TCGA-FL-A1YQ				Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma																																					130	NO									false												100				0																		Solid Tissue Normal	11												A							21a04fd6-500e-4d42-846b-b6b7783098fb	TCGA-FL-A1YQ-11A-11R-A17A-13					TCGA-FL-A1YQ-11A-11D-A17F-05							21a04fd6-500e-4d42-846b-b6b7783098fb						21a04fd6-500e-4d42-846b-b6b7783098fb	TCGA-FL-A1YQ-11A-11R-A17A-13	21a04fd6-500e-4d42-846b-b6b7783098fb
TCGA-FL-A1YT-11			TCGA-FL-A1YT-11												TCGA-FL-A1YT				Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma																																					70	NO									false												100				0																		Solid Tissue Normal	11												A							2532b16b-1217-43df-aa69-cdbb5f9c3778	TCGA-FL-A1YT-11A-12R-A17A-13					TCGA-FL-A1YT-11A-12D-A17F-05							2532b16b-1217-43df-aa69-cdbb5f9c3778						2532b16b-1217-43df-aa69-cdbb5f9c3778	TCGA-FL-A1YT-11A-12R-A17A-13	2532b16b-1217-43df-aa69-cdbb5f9c3778
TCGA-FL-A1YU-11			TCGA-FL-A1YU-11												TCGA-FL-A1YU				Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma																																					50	NO									false												100				0																		Solid Tissue Normal	11												A							f0d6b561-bfd2-41b7-a43c-1006370eec8f	TCGA-FL-A1YU-11A-11R-A17A-13					TCGA-FL-A1YU-11A-11D-A17F-05							f0d6b561-bfd2-41b7-a43c-1006370eec8f						f0d6b561-bfd2-41b7-a43c-1006370eec8f	TCGA-FL-A1YU-11A-11R-A17A-13	f0d6b561-bfd2-41b7-a43c-1006370eec8f
TCGA-FL-A1YV-11			TCGA-FL-A1YV-11												TCGA-FL-A1YV				Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma																																					110	NO									false												100				0																		Solid Tissue Normal	11												A							da44c9b1-d38b-4b75-887c-ec1646969758						TCGA-FL-A1YV-11A-12D-A17F-05							da44c9b1-d38b-4b75-887c-ec1646969758						da44c9b1-d38b-4b75-887c-ec1646969758		da44c9b1-d38b-4b75-887c-ec1646969758
TCGA-FL-A3WE-11			TCGA-FL-A3WE-11												TCGA-FL-A3WE				Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma																																					80	NO									true				0		0		0		0		30		70		0		0																Solid Tissue Normal	11												A							6b961695-40e4-4c88-976a-8fb6c99b4f0f	TCGA-FL-A3WE-11A-11R-A22I-13					TCGA-FL-A3WE-11A-11D-A22B-05							6b961695-40e4-4c88-976a-8fb6c99b4f0f						6b961695-40e4-4c88-976a-8fb6c99b4f0f	TCGA-FL-A3WE-11A-11R-A22I-13	6b961695-40e4-4c88-976a-8fb6c99b4f0f
TCGA-H5-A2HR-01	MSI-L	0	TCGA-H5-A2HR-01	53	0	High		UCEC Serous c4		UCEC-like c5		miRNA cluster 12			TCGA-H5-A2HR			53	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					71					Stage IB			-25986	1627		0	53							2011-10-1	FEMALE		Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	110	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	TCGA-H5-A2HR.3747A4AC-811E-49A1-8459-93807BB363C6.pdf	18		20		0		20		10		0		10		70		90	negative	TUMOR FREE		0				No							R0	Primary Tumor	01	open	1988		NO	YES	H5		0	0	19	Endometrial	A	LIVING	95	2006			TCGA-H5-A2HR-01	9ed0c69e-a7e6-4c99-8c93-541d7bde4be6	TCGA-H5-A2HR-01A-11R-A17X-13	TCGA-H5-A2HR-01A-11D-A17U-01				TCGA-H5-A2HR-01A-11D-A17Z-05				TCGA-H5-A2HR-01A-21-A18R-20	a6114b8c-e31d-451b-bb32-8fa69e06402d	TCGA-H5-A2HR-01	9ed0c69e-a7e6-4c99-8c93-541d7bde4be6				a6114b8c-e31d-451b-bb32-8fa69e06402d	TCGA-H5-A2HR-01A-11D-A17U-01	9ed0c69e-a7e6-4c99-8c93-541d7bde4be6	TCGA-H5-A2HR-01A-11R-A17X-13	9ed0c69e-a7e6-4c99-8c93-541d7bde4be6
TCGA-JU-AAVI-01	MSS	0	TCGA-JU-AAVI-01	236	0										TCGA-JU-AAVI	236	0	236	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					61					Stage IIIC1	NO		-22289	139		0	236				NO			2014-4-3	FEMALE	150	Serous endometrial adenocarcinoma	No		YES	C54.1	8441/3	C54.1	YES		Incisional Biopsy	20	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-JU-AAVI.8639CE54-3D67-4E2E-BECB-26755EE726C5.pdf	93		40		20		5		20		0		25		70		70	negative	TUMOR FREE			YES	1		No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	1988		YES	NO	JU	0	2	2	16	Endometrial	A	LIVING	121	2013				e860c29e-5d8d-4aee-b631-f55664403bdc	TCGA-JU-AAVI-01A-11R-A404-13	TCGA-JU-AAVI-01A-11D-A402-01				TCGA-JU-AAVI-01A-11D-A409-05					f3c19064-fbab-4608-9f18-1478e3c50056		e860c29e-5d8d-4aee-b631-f55664403bdc				f3c19064-fbab-4608-9f18-1478e3c50056	TCGA-JU-AAVI-01A-11D-A402-01	e860c29e-5d8d-4aee-b631-f55664403bdc	TCGA-JU-AAVI-01A-11R-A404-13	e860c29e-5d8d-4aee-b631-f55664403bdc
TCGA-K6-A3WQ-01	MSS	0	TCGA-K6-A3WQ-01	400	0	Squamous		UCEC Serous c4		UCEC-like c5		miRNA cluster 12			TCGA-K6-A3WQ	382	1	400	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Progressive Disease	60			TCGA-K6-A3WQ-F55413		Stage IVB	NO		-22092	63		0	400			382	YES			2014-1-7	FEMALE	171	Serous endometrial adenocarcinoma	No		NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	440	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Locoregional Recurrence	peritoneall carcinomatosis		YES	true	TCGA-K6-A3WQ.16F848AA-C14C-45F7-A756-414615853761.pdf	95		50		10		2		20		0		3		95		95	positive	WITH TUMOR	1	1	YES	1		No			YES					Primary Tumor	01	Minimally Invasive	2009		YES	NO	K6		0	1	2	Endometrial	A	LIVING	99	2012			TCGA-K6-A3WQ-01	8fac215c-7172-42ed-af07-00b27c05d3a6	TCGA-K6-A3WQ-01A-11R-A22I-13	TCGA-K6-A3WQ-01A-11D-A227-01				TCGA-K6-A3WQ-01A-11D-A22B-05				TCGA-K6-A3WQ-01A-21-A240-20	ef7a4bd8-9ecd-4c64-a1bf-4c0afb5799e6	TCGA-K6-A3WQ-01	8fac215c-7172-42ed-af07-00b27c05d3a6				ef7a4bd8-9ecd-4c64-a1bf-4c0afb5799e6	TCGA-K6-A3WQ-01A-11D-A227-01	8fac215c-7172-42ed-af07-00b27c05d3a6	TCGA-K6-A3WQ-01A-11R-A22I-13	8fac215c-7172-42ed-af07-00b27c05d3a6
TCGA-KJ-A3U4-01	MSS	0	TCGA-KJ-A3U4-01	74	0	Squamous		UCEC Serous c4		UCEC-like c5		miRNA cluster 4			TCGA-KJ-A3U4			74	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					55		0			Stage IA			-20392			0	74							2012-5-24	FEMALE	165	Serous endometrial adenocarcinoma	Yes			C54.1	8441/3	C54.1	YES		Tumor resection				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1								21																		TUMOR FREE		0				Yes							R0	Primary Tumor	01	open	2009		YES	NO	KJ	0	1	0	11	Endometrial		LIVING	96	2012			TCGA-KJ-A3U4-01	ad229cea-5cac-422d-a773-370ed37152e9	TCGA-KJ-A3U4-01A-11R-A22I-13	TCGA-KJ-A3U4-01A-11D-A227-01				TCGA-KJ-A3U4-01A-11D-A22B-05				TCGA-KJ-A3U4-01A-21-A23Z-20	e6ca3933-6ec1-4f3c-8243-3a86ba62186d	TCGA-KJ-A3U4-01	ad229cea-5cac-422d-a773-370ed37152e9				e6ca3933-6ec1-4f3c-8243-3a86ba62186d	TCGA-KJ-A3U4-01A-11D-A227-01	ad229cea-5cac-422d-a773-370ed37152e9	TCGA-KJ-A3U4-01A-11R-A22I-13	ad229cea-5cac-422d-a773-370ed37152e9
TCGA-KP-A3VZ-01	MSS	0	TCGA-KP-A3VZ-01	722	0	High		OV-like c1		UCEC-like c5		miRNA cluster 13			TCGA-KP-A3VZ			722	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					69					Stage IV			-25366	633		0	722							2012-7-16	FEMALE	163	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	200	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	High Grade						true	TCGA-KP-A3VZ.FF834E31-78F7-4A56-8EC0-E026BE940FD4.pdf	75		60		20		5		10		0		5		90		90	positive	WITH TUMOR	0	0				Yes							RX	Primary Tumor	01	open	2009		NO	YES	KP		0	0	7	Endometrial	A	LIVING	55	2010			TCGA-KP-A3VZ-01	0f347f95-e4bc-480e-ab1a-84c9df4018c9	TCGA-KP-A3VZ-01A-11R-A22I-13	TCGA-KP-A3VZ-01A-11D-A227-01				TCGA-KP-A3VZ-01A-11D-A22B-05				TCGA-KP-A3VZ-01A-21-A240-20	0238f14f-917b-4c02-a59f-518665e5afce	TCGA-KP-A3VZ-01	0f347f95-e4bc-480e-ab1a-84c9df4018c9				0238f14f-917b-4c02-a59f-518665e5afce	TCGA-KP-A3VZ-01A-11D-A227-01	0f347f95-e4bc-480e-ab1a-84c9df4018c9	TCGA-KP-A3VZ-01A-11R-A22I-13	0f347f95-e4bc-480e-ab1a-84c9df4018c9
TCGA-KP-A3W0-01	MSS	0	TCGA-KP-A3W0-01	404	0	BRCA-LUAD+		OV-like c1		UCEC-like c5		miRNA cluster 5			TCGA-KP-A3W0	404	0	404	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					72				Never Used	Stage IB	NO		-26378	351		0	404				NO			2012-7-19	FEMALE	162	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	90	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-KP-A3W0.8623B627-C3E3-469B-A640-2F8BCFC0B711.pdf	75		60		20		10		10		0		30		60		60	positive	TUMOR FREE			YES	2	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009		NO	YES	KP		0		0	Endometrial	A	LIVING	94	2011			TCGA-KP-A3W0-01	0ed2207e-47d3-47aa-804f-abffb6f42e64	TCGA-KP-A3W0-01A-21R-A22I-13	TCGA-KP-A3W0-01A-21D-A227-01				TCGA-KP-A3W0-01A-21D-A22B-05				TCGA-KP-A3W0-01A-11-A240-20	72b4b9c4-5386-4fa6-b267-22418140cff9	TCGA-KP-A3W0-01	0ed2207e-47d3-47aa-804f-abffb6f42e64				72b4b9c4-5386-4fa6-b267-22418140cff9	TCGA-KP-A3W0-01A-21D-A227-01	0ed2207e-47d3-47aa-804f-abffb6f42e64	TCGA-KP-A3W0-01A-21R-A22I-13	0ed2207e-47d3-47aa-804f-abffb6f42e64
TCGA-KP-A3W1-01	MSS	0	TCGA-KP-A3W1-01	288	0	High		UCEC non-CIMP c3		BRCA basal-like c6		miRNA cluster 14			TCGA-KP-A3W1	288	0	288	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					76				Never Used	Stage IA	NO		-27902	198		0	288				NO			2012-7-19	FEMALE	170	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	710	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-KP-A3W1.58145248-B111-463A-A1CC-32DA993F0B26.pdf	25		60		20		5		10		0		5		90		90	negative	TUMOR FREE	0	0	YES	1	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009		NO	YES	KP		0	0	5	Endometrial	A	LIVING	66	2011			TCGA-KP-A3W1-01	b1ee7148-ddae-404a-b796-004539c02aa7	TCGA-KP-A3W1-01A-11R-A22I-13	TCGA-KP-A3W1-01A-11D-A227-01				TCGA-KP-A3W1-01A-11D-A22B-05				TCGA-KP-A3W1-01A-21-A240-20	4600ba03-2e46-4737-b23d-e47aa72997cc	TCGA-KP-A3W1-01	b1ee7148-ddae-404a-b796-004539c02aa7				4600ba03-2e46-4737-b23d-e47aa72997cc	TCGA-KP-A3W1-01A-11D-A227-01	b1ee7148-ddae-404a-b796-004539c02aa7	TCGA-KP-A3W1-01A-11R-A22I-13	b1ee7148-ddae-404a-b796-004539c02aa7
TCGA-KP-A3W3-01	MSS	0	TCGA-KP-A3W3-01	794	0	High		UCEC Serous c4		UCEC-like c5		miRNA cluster 7			TCGA-KP-A3W3			794	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					72					Stage IB	NO		-26310	739		0	794				NO			2012-7-19	FEMALE	164	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	680	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					YES	true	TCGA-KP-A3W3.9D8F170A-A4B1-463A-B92C-357870762EAD.pdf	75		60		20		5		10		0		5		90		90	positive	WITH TUMOR			YES	2	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009		NO	YES	KP		0		0	Endometrial	A	LIVING	126	2010			TCGA-KP-A3W3-01	b2d5d73b-6669-438a-b6fd-0e29b7bce645	TCGA-KP-A3W3-01A-11R-A22I-13	TCGA-KP-A3W3-01A-11D-A227-01				TCGA-KP-A3W3-01A-11D-A22B-05				TCGA-KP-A3W3-01A-22-A240-20	7f244e48-3db6-447d-b74a-d667f0c0ad4e	TCGA-KP-A3W3-01	b2d5d73b-6669-438a-b6fd-0e29b7bce645				7f244e48-3db6-447d-b74a-d667f0c0ad4e	TCGA-KP-A3W3-01A-11D-A227-01	b2d5d73b-6669-438a-b6fd-0e29b7bce645	TCGA-KP-A3W3-01A-11R-A22I-13	b2d5d73b-6669-438a-b6fd-0e29b7bce645
TCGA-KP-A3W4-01	MSS	1	TCGA-KP-A3W4-01	554	1	Kirc+		UCEC Serous c4		UCEC-like c5		miRNA cluster 4			TCGA-KP-A3W4			554	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					63				Former User	Stage IIIA	NO		-23200	688	554	0					NO			2012-7-19	FEMALE	151	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	540	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					YES	true	TCGA-KP-A3W4.5B8C1B60-7046-4A3A-9D65-ECCB91BF9847.pdf	75		60		20		10		10		0		20		70		70	positive	WITH TUMOR	0	0	YES	3	Partial Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	2009		NO	YES	KP		0	0	19	Endometrial	A	DECEASED	61	2010			TCGA-KP-A3W4-01	8488db37-440c-407d-a184-72ee19632c9f	TCGA-KP-A3W4-01A-11R-A22I-13	TCGA-KP-A3W4-01A-11D-A227-01				TCGA-KP-A3W4-01A-11D-A22B-05				TCGA-KP-A3W4-01A-21-A240-20	6cdf4839-6b21-496d-8734-0bd34fcf9d9b	TCGA-KP-A3W4-01	8488db37-440c-407d-a184-72ee19632c9f				6cdf4839-6b21-496d-8734-0bd34fcf9d9b	TCGA-KP-A3W4-01A-11D-A227-01	8488db37-440c-407d-a184-72ee19632c9f	TCGA-KP-A3W4-01A-11R-A22I-13	8488db37-440c-407d-a184-72ee19632c9f
TCGA-PG-A5BC-01	MSS	0	TCGA-PG-A5BC-01	707	0										TCGA-PG-A5BC	707	0	707	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	72			TCGA-PG-A5BC-F59222		Stage II	NO		-26436	205		0	707				YES			2014-5-6	FEMALE	163	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	120	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-PG-A5BC.040F4583-2683-42A8-B185-56A08874F3A0.pdf			2		0		0		0		0		0		100		80		TUMOR FREE			NO	4+	Complete Remission/Response	No	Never Used		NO					Primary Tumor	01		2009		NO	YES	PG					Endometrial	A	LIVING	87	2012			TCGA-PG-A5BC-01	47e8bbd2-fd10-4dc8-882e-cb88ca27338d	TCGA-PG-A5BC-01A-12R-A27R-13	TCGA-PG-A5BC-01A-12D-A27O-01				TCGA-PG-A5BC-01A-12D-A27Y-05					40390b34-4b2c-4afa-919b-fbffe1dbce9b	TCGA-PG-A5BC-01	47e8bbd2-fd10-4dc8-882e-cb88ca27338d				40390b34-4b2c-4afa-919b-fbffe1dbce9b	TCGA-PG-A5BC-01A-12D-A27O-01	47e8bbd2-fd10-4dc8-882e-cb88ca27338d	TCGA-PG-A5BC-01A-12R-A27R-13	47e8bbd2-fd10-4dc8-882e-cb88ca27338d
TCGA-PG-A6IB-01	MSI-H	0	TCGA-PG-A6IB-01	470	0										TCGA-PG-A6IB	470	0	470	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	68			TCGA-PG-A6IB-F59226	Former User	Stage IA	NO		-24969	160		0	470				NO			2014-5-6	FEMALE		Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	100	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-PG-A6IB.C975AE5D-7370-4D1D-81AE-D3ABE5364055.pdf	38		1		1		10		2		10		20		60		60	negative	TUMOR FREE				2	Complete Remission/Response	No	Never Used						R0	Primary Tumor	01	open	2009		NO	YES	PG		0		0	Endometrial	A	LIVING		2012			TCGA-PG-A6IB-01	55b5dd8f-9e80-4084-9cb2-c04ccf558802	TCGA-PG-A6IB-01A-21R-A31S-13	TCGA-PG-A6IB-01A-21D-A31T-01				TCGA-PG-A6IB-01A-21D-A31V-05					54c8761f-4df0-4a18-9f4b-2e3fa6e6a56e	TCGA-PG-A6IB-01	55b5dd8f-9e80-4084-9cb2-c04ccf558802				54c8761f-4df0-4a18-9f4b-2e3fa6e6a56e	TCGA-PG-A6IB-01A-21D-A31T-01	55b5dd8f-9e80-4084-9cb2-c04ccf558802	TCGA-PG-A6IB-01A-21R-A31S-13	55b5dd8f-9e80-4084-9cb2-c04ccf558802
TCGA-PG-A7D5-01	MSS	0	TCGA-PG-A7D5-01	729	0										TCGA-PG-A7D5	729	0	729	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					62				Never Used	Stage IA			-23006	618		0	729				YES			2014-2-5	FEMALE	158	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.8	YES		Office Endometrial Biopsy	100	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-PG-A7D5.2E996CFE-9F6E-432F-9B09-6FBC2A920B24.pdf	47		40		20		10		20		0		30		60		60	negative	TUMOR FREE			NO	4+	Stable Disease	No	Never Used		NO				R0	Primary Tumor	01	open	2009		NO	YES	PG		0		0	Endometrial	A	LIVING	79	2011			TCGA-PG-A7D5-01	460f0df0-00fb-43bf-9143-782a45ca490c	TCGA-PG-A7D5-01A-11R-A34O-13	TCGA-PG-A7D5-01A-11D-A34P-01				TCGA-PG-A7D5-01A-11D-A34S-05					d65c4213-0170-4422-a860-4d977f1545ae	TCGA-PG-A7D5-01	460f0df0-00fb-43bf-9143-782a45ca490c				d65c4213-0170-4422-a860-4d977f1545ae	TCGA-PG-A7D5-01A-11D-A34P-01	460f0df0-00fb-43bf-9143-782a45ca490c	TCGA-PG-A7D5-01A-11R-A34O-13	460f0df0-00fb-43bf-9143-782a45ca490c
TCGA-PG-A914-01	MSS	0	TCGA-PG-A914-01	393	0										TCGA-PG-A914	393	0	393	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					73				Never Used	Stage IA	NO		-26992	263		0	393				NO			2014-4-23	FEMALE		Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES		8461/3	C54.1	YES		Cytology (e.g. Peritoneal or pleural fluid)	260	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	TCGA-PG-A914.B073614D-A6E3-4A83-96C4-1F189F8D16B4.pdf	13		0		0		0		0		0		20		80		90	negative	TUMOR FREE			NO	4+	Progressive Disease	No	Never Used		YES				R0	Primary Tumor	01	open	2009		NO	YES	PG		0		0	Endometrial	A	LIVING		2013			TCGA-PG-A914-01	6e5ab8c9-03de-4a9d-ac92-37f28170c0a0	TCGA-PG-A914-01A-11R-A37P-13	TCGA-PG-A914-01A-11D-A37M-01				TCGA-PG-A914-01A-11D-A37Q-05					3232b3ee-fea0-4aec-93f7-afa71e0b32ed	TCGA-PG-A914-01	6e5ab8c9-03de-4a9d-ac92-37f28170c0a0				3232b3ee-fea0-4aec-93f7-afa71e0b32ed	TCGA-PG-A914-01A-11D-A37M-01	6e5ab8c9-03de-4a9d-ac92-37f28170c0a0	TCGA-PG-A914-01A-11R-A37P-13	6e5ab8c9-03de-4a9d-ac92-37f28170c0a0
TCGA-PG-A915-01	MSS	0	TCGA-PG-A915-01	213	0										TCGA-PG-A915	213	0	213	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					60				Former User	Stage IA	NO		-22119			0	213				NO			2014-4-25	FEMALE		Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO		8461/3	C54.1	YES		Cytology (e.g. Peritoneal or pleural fluid)				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO																				negative	TUMOR FREE			NO	2	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	2009		NO	YES	PG		0		0	Endometrial		LIVING		2013			TCGA-PG-A915-01	c590ff56-1d2d-40ea-9fba-0768d66ec12c	TCGA-PG-A915-01A-11R-A37P-13	TCGA-PG-A915-01A-11D-A37M-01				TCGA-PG-A915-01A-11D-A37Q-05					fa9a5214-e8f8-4803-9f7e-440e7cd32820	TCGA-PG-A915-01	c590ff56-1d2d-40ea-9fba-0768d66ec12c				fa9a5214-e8f8-4803-9f7e-440e7cd32820	TCGA-PG-A915-01A-11D-A37M-01	c590ff56-1d2d-40ea-9fba-0768d66ec12c	TCGA-PG-A915-01A-11R-A37P-13	c590ff56-1d2d-40ea-9fba-0768d66ec12c
TCGA-PG-A916-01	MSS	0	TCGA-PG-A916-01	342	0										TCGA-PG-A916	342	0	342	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					70				Never Used	Stage I	NO		-25617	224		0	342				NO			2014-4-28	FEMALE		Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.3	YES		Office Endometrial Biopsy	220	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	TCGA-PG-A916.3E66FA38-0D87-47CA-A72D-63C0619A2182.pdf			0		0		10		0		0		30		60		70	negative	TUMOR FREE			NO	1	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	2009		NO	YES	PG		0		0	Endometrial	A	LIVING		2013			TCGA-PG-A916-01	a9430dc8-38cf-4ef1-8442-e20582f6d893	TCGA-PG-A916-01A-11R-A37P-13	TCGA-PG-A916-01A-11D-A37M-01				TCGA-PG-A916-01A-11D-A37Q-05					9643cd67-b303-4472-8fd2-41eeb9cb9b79	TCGA-PG-A916-01	a9430dc8-38cf-4ef1-8442-e20582f6d893				9643cd67-b303-4472-8fd2-41eeb9cb9b79	TCGA-PG-A916-01A-11D-A37M-01	a9430dc8-38cf-4ef1-8442-e20582f6d893	TCGA-PG-A916-01A-11R-A37P-13	a9430dc8-38cf-4ef1-8442-e20582f6d893
TCGA-PG-A917-01	MSI-H	0	TCGA-PG-A917-01	212	0										TCGA-PG-A917	212	0	212	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	74			TCGA-PG-A917-F67180	Former User	Stage IA	NO		-27104	583		0	212				NO			2014-10-31	FEMALE		Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Cytology (e.g. Peritoneal or pleural fluid)	390	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	TCGA-PG-A917.9836008F-81F7-4029-9A28-10AB6021DFEA.pdf			0		0		0		0		20		10		70		80	positive	TUMOR FREE			NO	2	Complete Remission/Response	No	Never Used		NO				R0	Primary Tumor	01	open	2009		NO	YES	PG		0		0	Endometrial	A	LIVING		2012			TCGA-PG-A917-01	2dc0d41b-72fa-4514-889f-3c46507fd5e8	TCGA-PG-A917-01A-31R-A37P-13	TCGA-PG-A917-01A-31D-A37M-01				TCGA-PG-A917-01A-31D-A37Q-05					181344cc-cfbc-4dbd-b90e-ebcd26e0f20b	TCGA-PG-A917-01	2dc0d41b-72fa-4514-889f-3c46507fd5e8				181344cc-cfbc-4dbd-b90e-ebcd26e0f20b	TCGA-PG-A917-01A-31D-A37M-01	2dc0d41b-72fa-4514-889f-3c46507fd5e8	TCGA-PG-A917-01A-31R-A37P-13	2dc0d41b-72fa-4514-889f-3c46507fd5e8
TCGA-QF-A5YS-01	MSS	0	TCGA-QF-A5YS-01	573	0										TCGA-QF-A5YS	573	0	573	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	57		0	TCGA-QF-A5YS-F58613	Never Used	Stage II	NO		-20841	158		0	573				NO			2014-4-16	FEMALE	162	Mixed serous and endometrioid	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.0	YES		Office Endometrial Biopsy	120	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	TCGA-QF-A5YS.2608B03E-0D29-49EF-BC3D-A26D5017C265.pdf	22		1		1		0		1		0		10		90		90		TUMOR FREE		0	YES	2	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009		NO	YES	QF	0	5	0	2	Endometrial	A	LIVING	79	2012			TCGA-QF-A5YS-01	646422f2-97e3-43e4-bb4f-260277cff6f4	TCGA-QF-A5YS-01A-11R-A31S-13	TCGA-QF-A5YS-01A-11D-A31T-01				TCGA-QF-A5YS-01A-11D-A31V-05					b8346173-15d5-42d9-8d00-dae5615ba4df	TCGA-QF-A5YS-01	646422f2-97e3-43e4-bb4f-260277cff6f4				b8346173-15d5-42d9-8d00-dae5615ba4df	TCGA-QF-A5YS-01A-11D-A31T-01	646422f2-97e3-43e4-bb4f-260277cff6f4	TCGA-QF-A5YS-01A-11R-A31S-13	646422f2-97e3-43e4-bb4f-260277cff6f4
TCGA-QF-A5YT-01	MSS	0	TCGA-QF-A5YT-01	1215	0										TCGA-QF-A5YT	1215	0	1215	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	57			TCGA-QF-A5YT-F58612	Never Used	Stage II	NO		-20981	804		0	1215				NO			2014-4-16	FEMALE	170	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.0	8380/3	C54.0	YES		Office Endometrial Biopsy	40	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	TCGA-QF-A5YT.1CCA2D47-BA5D-46A9-89F9-681C58EFC10D.pdf	50		0		0		0		0		10		10		80		90		TUMOR FREE			NO	0	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009		NO	YES	QF		0		0	Endometrial	A	LIVING	146	2010			TCGA-QF-A5YT-01	86ae75e5-6460-45a3-89f0-aaeba2462268	TCGA-QF-A5YT-01A-11R-A31S-13	TCGA-QF-A5YT-01A-11D-A31T-01				TCGA-QF-A5YT-01A-11D-A31V-05					05e5d95f-b31f-44b1-a31c-640f6061a9e6	TCGA-QF-A5YT-01	86ae75e5-6460-45a3-89f0-aaeba2462268				05e5d95f-b31f-44b1-a31c-640f6061a9e6	TCGA-QF-A5YT-01A-11D-A31T-01	86ae75e5-6460-45a3-89f0-aaeba2462268	TCGA-QF-A5YT-01A-11R-A31S-13	86ae75e5-6460-45a3-89f0-aaeba2462268
TCGA-QS-A5YQ-01	MSS	0	TCGA-QS-A5YQ-01	393	0										TCGA-QS-A5YQ	393	0	393	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	55			TCGA-QS-A5YQ-F59570		Stage IIIA	NO		-20425	43		0	393				NO			2014-5-15	FEMALE	160	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	370	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	TCGA-QS-A5YQ.D1631D6F-F055-4D35-A6DD-FE7A251BD4C2.pdf	10		20		0		0		0		0		30		70		70		TUMOR FREE	0	0	YES	1		No	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	QS		0	0	7	Endometrial	A	LIVING	83	2013			TCGA-QS-A5YQ-01	618b52e3-9797-4c61-a0dd-1ffa8ea6d321	TCGA-QS-A5YQ-01A-11R-A31S-13	TCGA-QS-A5YQ-01A-11D-A31T-01				TCGA-QS-A5YQ-01A-11D-A31V-05					24823f6d-b745-4552-9db4-2bddc5aff9e5	TCGA-QS-A5YQ-01	618b52e3-9797-4c61-a0dd-1ffa8ea6d321				24823f6d-b745-4552-9db4-2bddc5aff9e5	TCGA-QS-A5YQ-01A-11D-A31T-01	618b52e3-9797-4c61-a0dd-1ffa8ea6d321	TCGA-QS-A5YQ-01A-11R-A31S-13	618b52e3-9797-4c61-a0dd-1ffa8ea6d321
TCGA-QS-A5YR-01	MSI-H	0	TCGA-QS-A5YR-01	719	0										TCGA-QS-A5YR	719	0	719	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Stable Disease	61			TCGA-QS-A5YR-F58590	Never Used	Stage IIIB	NO		-22372	118		0	719				YES			2014-4-15	FEMALE	168	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	280	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	TCGA-QS-A5YR.D9417AEE-FD30-42FA-986E-26C98E29C428.pdf	13		40		20		10		20		0		20		70		70		WITH TUMOR	0	0	NO	4+	Stable Disease	No	Never Used		NO				RX	Primary Tumor	01	Minimally Invasive	2009		YES	NO	QS		0	0	5	Endometrial	A	LIVING	100	2012			TCGA-QS-A5YR-01	0c0e6adb-5f3b-429c-bbc4-5d3d74e9ef63	TCGA-QS-A5YR-01A-31R-A31S-13	TCGA-QS-A5YR-01A-31D-A31T-01				TCGA-QS-A5YR-01A-31D-A31V-05					3217f633-42cb-4460-aba9-830da179b857	TCGA-QS-A5YR-01	0c0e6adb-5f3b-429c-bbc4-5d3d74e9ef63				3217f633-42cb-4460-aba9-830da179b857	TCGA-QS-A5YR-01A-31D-A31T-01	0c0e6adb-5f3b-429c-bbc4-5d3d74e9ef63	TCGA-QS-A5YR-01A-31R-A31S-13	0c0e6adb-5f3b-429c-bbc4-5d3d74e9ef63
TCGA-QS-A744-01	MSS	0	TCGA-QS-A744-01	451	0										TCGA-QS-A744	451	0	451	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					86			TCGA-QS-A744-F64971		Stage IIIB	NO		-31520	44		0	451				NO			2014-9-16	FEMALE	163	Endometrioid endometrial adenocarcinoma	No		YES	C54.0	8380/3	C54.1	YES		Office Endometrial Biopsy	310	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	TCGA-QS-A744.F37C9C5C-8AAA-47FB-8BAD-AE2EB0F70B4F.pdf	86		40		20		5		20		0		15		80		80		TUMOR FREE			YES	4+		No	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	QS		0		0	Endometrial	A	LIVING	76	2013			TCGA-QS-A744-01	2eede096-06aa-4026-9c23-2a2d1d9015c1	TCGA-QS-A744-01A-11R-A34O-13	TCGA-QS-A744-01A-11D-A34P-01				TCGA-QS-A744-01A-11D-A34S-05					2ab43d44-a20c-40b5-a790-53931e6730c3	TCGA-QS-A744-01	2eede096-06aa-4026-9c23-2a2d1d9015c1				2ab43d44-a20c-40b5-a790-53931e6730c3	TCGA-QS-A744-01A-11D-A34P-01	2eede096-06aa-4026-9c23-2a2d1d9015c1	TCGA-QS-A744-01A-11R-A34O-13	2eede096-06aa-4026-9c23-2a2d1d9015c1
TCGA-QS-A8F1-01	MSS	1	TCGA-QS-A8F1-01	135	1										TCGA-QS-A8F1	135	0	135	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Progressive Disease	85			TCGA-QS-A8F1-F66552	Never Used	Stage IIIA	NO		-31386		135	0	125				NO			2014-10-20	FEMALE	168	Serous endometrial adenocarcinoma	No		NO		8441/3	C55.9	YES		Tumor resection			NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO			50																	negative	WITH TUMOR			YES	0	Progressive Disease	No	Never Used		NO					Primary Tumor	01	Minimally Invasive	2009		YES	NO	QS		0		0	Other  Specify		DECEASED	75	2013			TCGA-QS-A8F1-01	d05ea5d7-8d21-4fd6-9199-fdc606a9843c	TCGA-QS-A8F1-01A-21R-A37P-13	TCGA-QS-A8F1-01A-21D-A37M-01				TCGA-QS-A8F1-01A-21D-A37Q-05					bcb7e25c-77aa-4599-be3e-2efbee5ef4e4	TCGA-QS-A8F1-01	d05ea5d7-8d21-4fd6-9199-fdc606a9843c				bcb7e25c-77aa-4599-be3e-2efbee5ef4e4	TCGA-QS-A8F1-01A-21D-A37M-01	d05ea5d7-8d21-4fd6-9199-fdc606a9843c	TCGA-QS-A8F1-01A-21R-A37P-13	d05ea5d7-8d21-4fd6-9199-fdc606a9843c
TCGA-SJ-A6ZI-01	MSI-H	0	TCGA-SJ-A6ZI-01	428	0										TCGA-SJ-A6ZI	428	0	428	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	64	0	0	TCGA-SJ-A6ZI-F59212	Never Used	Stage IB	NO		-23653	88		0	428				NO			2014-7-11	FEMALE	66	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES	Radical hysterectomy, bilateral salpingo-oophorectomy	Other method, specify:	880	NO	NO		G1					NO	false	TCGA-SJ-A6ZI.2CA0FD3F-7635-4395-A13B-C3BB9D3FF0D8.pdf	75		5		0		0		0		0		20		80		80	negative	TUMOR FREE	0	0	NO	2	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	2009		YES	NO	SJ	0	9	0	18	Endometrial	A	LIVING	93	2013			TCGA-SJ-A6ZI-01	0d5a9a1e-e473-4b9a-bc27-60147dca9fe6	TCGA-SJ-A6ZI-01A-12R-A34O-13	TCGA-SJ-A6ZI-01A-12D-A34P-01				TCGA-SJ-A6ZI-01A-12D-A34S-05					e013d935-aa3c-43cf-b973-bd3356e2b4d0	TCGA-SJ-A6ZI-01	0d5a9a1e-e473-4b9a-bc27-60147dca9fe6				e013d935-aa3c-43cf-b973-bd3356e2b4d0	TCGA-SJ-A6ZI-01A-12D-A34P-01	0d5a9a1e-e473-4b9a-bc27-60147dca9fe6	TCGA-SJ-A6ZI-01A-12R-A34O-13	0d5a9a1e-e473-4b9a-bc27-60147dca9fe6
TCGA-SJ-A6ZJ-01	MSS	0	TCGA-SJ-A6ZJ-01	556	0										TCGA-SJ-A6ZJ	556	0	556	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma				Complete Response	61			TCGA-SJ-A6ZJ-F59211	Former User	Stage IB	NO		-22597	216		0	556				NO			2014-7-11	FEMALE	168	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	580	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	TCGA-SJ-A6ZJ.B7C3C4EC-E494-4290-AFDA-FEFEBA8A3BA5.pdf	62.5		1		1		0		1		20		10		70		70	negative	TUMOR FREE	0	0	NO	1	Complete Remission/Response	No	Never Used		YES				R0	Primary Tumor	01	open	2009		YES	NO	SJ			0	28	Endometrial	A	LIVING	132	2012			TCGA-SJ-A6ZJ-01	d3473471-b625-4f56-8300-590324d48002	TCGA-SJ-A6ZJ-01A-12R-A34O-13	TCGA-SJ-A6ZJ-01A-12D-A34P-01				TCGA-SJ-A6ZJ-01A-12D-A34S-05					9d0827c7-84f9-4147-92f7-1ac653028f34	TCGA-SJ-A6ZJ-01	d3473471-b625-4f56-8300-590324d48002				9d0827c7-84f9-4147-92f7-1ac653028f34	TCGA-SJ-A6ZJ-01A-12D-A34P-01	d3473471-b625-4f56-8300-590324d48002	TCGA-SJ-A6ZJ-01A-12R-A34O-13	d3473471-b625-4f56-8300-590324d48002
TCGA-SL-A6J9-01	MSS		TCGA-SL-A6J9-01												TCGA-SL-A6J9				Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma														86																							280	NO									true	TCGA-SL-A6J9.DFD43EFD-E91F-487F-A737-93C57C065A49.pdf			0		5		0		0		0		10		90		90																Primary Tumor	01												A						TCGA-SL-A6J9-01	55477806-1928-4281-8ee4-69da5b60c6a8	TCGA-SL-A6J9-01A-11R-A31S-13	TCGA-SL-A6J9-01A-11D-A31T-01				TCGA-SL-A6J9-01A-11D-A31V-05					3ae98c63-77e6-416e-ad96-c65ac0cc490c	TCGA-SL-A6J9-01	55477806-1928-4281-8ee4-69da5b60c6a8				3ae98c63-77e6-416e-ad96-c65ac0cc490c	TCGA-SL-A6J9-01A-11D-A31T-01	55477806-1928-4281-8ee4-69da5b60c6a8	TCGA-SL-A6J9-01A-11R-A31S-13	55477806-1928-4281-8ee4-69da5b60c6a8
TCGA-SL-A6JA-01	MSI-H	0	TCGA-SL-A6JA-01	7	0										TCGA-SL-A6JA			7	Endometrium	TCGA Endometrioid Cancer	uterine corpus endometrioid carcinoma					77	0	0	TCGA-SL-A6JA-F68333		Stage IB	NO		-28401	45		0	7				NO			2014-11-14	FEMALE	167	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Tumor resection	200	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	TCGA-SL-A6JA.60CDA761-5DF1-4580-AD84-1CE9A15F31F8.pdf	50		1		1		5		1		5		5		85		85		TUMOR FREE	0	0	NO	4+	Complete Remission/Response	No			NO					Primary Tumor	01	open	2009		NO	YES	SL	0	1	0	11	Endometrial	A	LIVING	129	2013			TCGA-SL-A6JA-01	1be5c0c6-8645-4894-8573-05ece1839689	TCGA-SL-A6JA-01A-11R-A31S-13	TCGA-SL-A6JA-01A-11D-A31T-01				TCGA-SL-A6JA-01A-11D-A31V-05					52b7e50d-43fb-4b75-bbc3-800fbe26204a	TCGA-SL-A6JA-01	1be5c0c6-8645-4894-8573-05ece1839689				52b7e50d-43fb-4b75-bbc3-800fbe26204a	TCGA-SL-A6JA-01A-11D-A31T-01	1be5c0c6-8645-4894-8573-05ece1839689	TCGA-SL-A6JA-01A-11R-A31S-13	1be5c0c6-8645-4894-8573-05ece1839689
